Citrus Sinensis ID: 024460
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 267 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.872 | 0.510 | 0.716 | 1e-100 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.880 | 0.567 | 0.689 | 8e-95 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.872 | 0.550 | 0.673 | 2e-93 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.853 | 0.535 | 0.571 | 4e-73 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.861 | 0.539 | 0.553 | 3e-72 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.868 | 0.470 | 0.557 | 4e-71 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.872 | 0.568 | 0.555 | 1e-70 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.891 | 0.611 | 0.534 | 5e-70 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.853 | 0.465 | 0.549 | 5e-70 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.872 | 0.571 | 0.550 | 2e-69 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 365 bits (938), Expect = e-100, Method: Compositional matrix adjust.
Identities = 167/233 (71%), Positives = 193/233 (82%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLEDHL+DL PD+E L WN RMKIA G
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GLE+LH KANPPVIYRD KS+NILLD F+PKLSDFGLAKLGP GD +HVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA+D GEQNLV+W+RP D++
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233
KF+ L DP L GR+P R L A+AV +MC+ E+A RPLI D+V AL YL +Q
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 346 bits (888), Expect = 8e-95, Method: Compositional matrix adjust.
Identities = 162/235 (68%), Positives = 190/235 (80%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH +LV LIGYC GDQRLLVYEYM GSLEDHL DL PDQ PL W+TR++IA+G
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALG 186
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA GLEYLH KANPPVIYRDLK+ANILLD +FN KLSDFGLAKLGPVGD HVS+RVMGT
Sbjct: 187 AAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGT 246
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +D ++ + EQNLV+W++P K+
Sbjct: 247 YGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPS 306
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235
+F L DP L G +P + LN AVAV AMCL EEA RPL++D+V AL +L + D
Sbjct: 307 RFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAPD 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (876), Expect = 2e-93, Method: Compositional matrix adjust.
Identities = 157/233 (67%), Positives = 190/233 (81%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
LSL H NLV LIG+C GDQRLLVYEYMP GSLEDHL+ L ++PL WNTRMKIA GA
Sbjct: 152 LSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGA 211
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
ARGLEYLH + PPVIYRDLK +NILL D+ PKLSDFGLAK+GP GD THVSTRVMGTY
Sbjct: 212 ARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTY 271
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
GYCAP+YAM+G+LT KSDIYSFGVVLLELITGRKA+D +K + +QNLV W+RP KD++
Sbjct: 272 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFKDRRN 331
Query: 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234
F +VDPLL G+YP R L A+A++AMC+ E+ RP+++D+V+AL++L S +
Sbjct: 332 FPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSK 384
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (701), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 132/231 (57%), Positives = 170/231 (73%), Gaps = 3/231 (1%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H NLV L+GYC G+ RLLVYE+MP GSLE+HL+ +PL+W RMK+AVGA
Sbjct: 144 LGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLF--RRGAQPLTWAIRMKVAVGA 201
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
A+GL +LH +A VIYRD K+ANILLD DFN KLSDFGLAK GP GDNTHVST+V+GT+
Sbjct: 202 AKGLTFLH-EAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKVIGTH 260
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
GY APEY +G+LT KSD+YSFGVVLLELI+GR+AMD S G E +LV W+ P+L D++K
Sbjct: 261 GYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDWATPYLGDKRK 320
Query: 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232
++D L G+YP++ A + CLN +A RP +++++V L+ L S
Sbjct: 321 LFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLES 371
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 271 bits (693), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 129/233 (55%), Positives = 170/233 (72%), Gaps = 3/233 (1%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H NLV L+GYC G+ RLLVYE+MP GSLE+HL+ +PL+W RMK+A+GA
Sbjct: 141 LGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLF--RRGAQPLTWAIRMKVAIGA 198
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
A+GL +LH A VIYRD K+ANILLD +FN KLSDFGLAK GP GD THVST+VMGT+
Sbjct: 199 AKGLTFLH-DAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTH 257
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
GY APEY +G+LT KSD+YSFGVVLLEL++GR+A+D SK EQ+LV W+ P+L D++K
Sbjct: 258 GYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRK 317
Query: 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234
++D L G+YP++ A ++ CLN +A RP +++++ LD L S +
Sbjct: 318 LFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 268 bits (684), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 131/235 (55%), Positives = 165/235 (70%), Gaps = 3/235 (1%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L L H NLV L+GYC DQRLLVYE+MP GSLE+HL+ PL W+ RMKIA+G
Sbjct: 199 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALG 255
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GL +LH +A PVIYRD K++NILLD D+N KLSDFGLAK P THVSTRVMGT
Sbjct: 256 AAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGT 315
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGY APEY M+G LT KSD+YSFGVVLLE++TGR++MD ++ GE NLV W+RP L D++
Sbjct: 316 YGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKR 375
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235
+F L+DP L G + + + A CL+ + RP ++D+V AL L +D
Sbjct: 376 RFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKD 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 266 bits (680), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 131/236 (55%), Positives = 167/236 (70%), Gaps = 3/236 (1%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L L H NLV LIGYC D RLLVYE+M GSLE+HL+ PLSW+ RM IA+G
Sbjct: 123 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLF--RKTTAPLSWSRRMMIALG 180
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GL +LH A PVIYRD K++NILLD+D+ KLSDFGLAK GP GD THVSTRVMGT
Sbjct: 181 AAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGY APEY M+G LT +SD+YSFGVVLLE++TGRK++D ++ EQNLV W+RP L D++
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236
K + ++DP L +Y R A ++ CL++ RPL++D+V L+ L D+
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGDA 355
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 5e-70, Method: Compositional matrix adjust.
Identities = 130/243 (53%), Positives = 181/243 (74%), Gaps = 5/243 (2%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H NLV LIGYC + RLLVYE+M GSLE+HL+ +PLSWNTR+++A+GA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
ARGL +LH A P VIYRD K++NILLD+++N KLSDFGLA+ GP+GDN+HVSTRVMGT
Sbjct: 186 ARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
GY APEY +G L++KSD+YSFGVVLLEL++GR+A+D ++ GE NLV W+RP+L ++++
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRR 304
Query: 182 FVHLVDPLLHGRYP-RRCLNYAVAVTAM-CLNEEANFRPLINDIVVALDYLVSQRDSHPV 239
+ ++DP L G+Y R L +AV A+ C++ +A RP +N+IV ++ L Q+++
Sbjct: 305 LLRVMDPRLQGQYSLTRALK--IAVLALDCISIDAKSRPTMNEIVKTMEELHIQKEASKE 362
Query: 240 SRN 242
+N
Sbjct: 363 QQN 365
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (675), Expect = 5e-70, Method: Compositional matrix adjust.
Identities = 127/231 (54%), Positives = 164/231 (70%), Gaps = 3/231 (1%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H NLV L+GYC DQRLLVYE+MP GSLE+HL+ PL W+ RMKIA+GAA+G
Sbjct: 197 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFR---RSLPLPWSIRMKIALGAAKG 253
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
L +LH +A PVIYRD K++NILLD ++N KLSDFGLAK P THVSTRVMGTYGY
Sbjct: 254 LSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYA 313
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 184
APEY M+G LT KSD+YSFGVVLLE++TGR++MD ++ GE NLV W+RP L D+++F
Sbjct: 314 APEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYR 373
Query: 185 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235
L+DP L G + + + A CL+ ++ RP ++++V L L +D
Sbjct: 374 LLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKD 424
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 2e-69, Method: Compositional matrix adjust.
Identities = 130/236 (55%), Positives = 168/236 (71%), Gaps = 3/236 (1%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L L H NLV LIGYC + R+L+YEYM GS+E++L+ PLSW RMKIA G
Sbjct: 133 FLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRV--LLPLSWAIRMKIAFG 190
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GL +LH +A PVIYRD K++NILLD D+N KLSDFGLAK GPVGD +HVSTR+MGT
Sbjct: 191 AAKGLAFLH-EAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRIMGT 249
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGY APEY M+G LT SD+YSFGVVLLEL+TGRK++D S+ EQNL+ W+ P LK++K
Sbjct: 250 YGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLKEKK 309
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236
K +++VDP ++ YP + + A + CLN RPL+ DIV +L+ L + +
Sbjct: 310 KVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEE 365
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 267 | ||||||
| 255539234 | 381 | receptor serine-threonine protein kinase | 0.996 | 0.698 | 0.789 | 1e-122 | |
| 224061871 | 313 | predicted protein [Populus trichocarpa] | 0.872 | 0.744 | 0.888 | 1e-122 | |
| 145335950 | 381 | protein kinase-like protein [Arabidopsis | 0.940 | 0.658 | 0.805 | 1e-120 | |
| 51971074 | 381 | unknown protein [Arabidopsis thaliana] | 0.940 | 0.658 | 0.805 | 1e-120 | |
| 297850486 | 381 | protein kinase [Arabidopsis lyrata subsp | 0.940 | 0.658 | 0.805 | 1e-120 | |
| 359491840 | 401 | PREDICTED: serine/threonine-protein kina | 0.973 | 0.648 | 0.800 | 1e-118 | |
| 297745557 | 433 | unnamed protein product [Vitis vinifera] | 0.973 | 0.600 | 0.800 | 1e-118 | |
| 224086050 | 338 | predicted protein [Populus trichocarpa] | 0.988 | 0.781 | 0.779 | 1e-118 | |
| 449455605 | 389 | PREDICTED: serine/threonine-protein kina | 0.940 | 0.645 | 0.778 | 1e-113 | |
| 449485117 | 385 | PREDICTED: serine/threonine-protein kina | 0.940 | 0.651 | 0.778 | 1e-113 |
| >gi|255539234|ref|XP_002510682.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223551383|gb|EEF52869.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 444 bits (1141), Expect = e-122, Method: Compositional matrix adjust.
Identities = 210/266 (78%), Positives = 235/266 (88%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCT+GDQRLLVYEYM MGS+EDH++DL+PD+EPL+W+TRMKIA+G
Sbjct: 111 MLSLLHHSNLVTLIGYCTAGDQRLLVYEYMQMGSVEDHIFDLDPDKEPLNWSTRMKIAIG 170
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARGLEYLHCKANPPVIYRDLKSANILLD DFNPKLSDFGLAKLGPVG+NTHVSTRVMGT
Sbjct: 171 AARGLEYLHCKANPPVIYRDLKSANILLDTDFNPKLSDFGLAKLGPVGENTHVSTRVMGT 230
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK GEQNLV+W+RPFLKDQK
Sbjct: 231 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDRSKRPGEQNLVAWARPFLKDQK 290
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF LVDPLL G YPRRCLNYA+A+TAMCL+EEANFRPLI DIVVAL+YL SQ +
Sbjct: 291 KFYQLVDPLLQGCYPRRCLNYAIAITAMCLHEEANFRPLIGDIVVALEYLASQCHGSESN 350
Query: 241 RNAGARGVPTSASDVSQGSNSRRSSS 266
+ G+P S+ ++G+ S+ S
Sbjct: 351 SSQVRSGIPQSSMATNRGAVSQEPMS 376
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224061871|ref|XP_002300640.1| predicted protein [Populus trichocarpa] gi|222842366|gb|EEE79913.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-122, Method: Compositional matrix adjust.
Identities = 207/233 (88%), Positives = 222/233 (95%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLEPD+EPLSW+TRMKIAVG
Sbjct: 71 MLSLLHHSNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLEPDKEPLSWSTRMKIAVG 130
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARGLEYLHCKA+PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG+NTHVSTRVMGT
Sbjct: 131 AARGLEYLHCKADPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGENTHVSTRVMGT 190
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLT+KSDIYSFGVVLLELITGRKA+D SK GEQNLV+WSR FLK+QK
Sbjct: 191 YGYCAPEYAMSGKLTVKSDIYSFGVVLLELITGRKAIDRSKKPGEQNLVAWSRAFLKEQK 250
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233
K+ L DPLL G YPRRCLNYA+A+TAMCLNEEANFRPLI+DI+VAL+YL SQ
Sbjct: 251 KYCQLADPLLEGCYPRRCLNYAIAITAMCLNEEANFRPLISDILVALEYLASQ 303
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145335950|ref|NP_173489.2| protein kinase-like protein [Arabidopsis thaliana] gi|8778594|gb|AAF79602.1|AC027665_3 F5M15.3 [Arabidopsis thaliana] gi|8886951|gb|AAF80637.1|AC069251_30 F2D10.13 [Arabidopsis thaliana] gi|51971194|dbj|BAD44289.1| unknown protein [Arabidopsis thaliana] gi|332191880|gb|AEE30001.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1123), Expect = e-120, Method: Compositional matrix adjust.
Identities = 207/257 (80%), Positives = 229/257 (89%), Gaps = 6/257 (2%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIAVG
Sbjct: 125 MLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVG 184
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 185 AARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGT 244
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKDQK
Sbjct: 245 YGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQK 304
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 305 KFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE-- 362
Query: 241 RNAGARGVPTSASDVSQ 257
AR V + + ++S+
Sbjct: 363 ----ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|51971074|dbj|BAD44229.1| unknown protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1123), Expect = e-120, Method: Compositional matrix adjust.
Identities = 207/257 (80%), Positives = 229/257 (89%), Gaps = 6/257 (2%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIAVG
Sbjct: 125 MLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVG 184
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 185 AARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGT 244
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKDQK
Sbjct: 245 YGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQK 304
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 305 KFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE-- 362
Query: 241 RNAGARGVPTSASDVSQ 257
AR V + + ++S+
Sbjct: 363 ----ARNVSSPSPEISR 375
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297850486|ref|XP_002893124.1| protein kinase [Arabidopsis lyrata subsp. lyrata] gi|297338966|gb|EFH69383.1| protein kinase [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 435 bits (1119), Expect = e-120, Method: Compositional matrix adjust.
Identities = 207/257 (80%), Positives = 229/257 (89%), Gaps = 6/257 (2%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIAVG
Sbjct: 125 MLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVG 184
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 185 AARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGT 244
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DLS+ QGEQNLV+WSR +LKDQK
Sbjct: 245 YGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLSQKQGEQNLVTWSRSYLKDQK 304
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH
Sbjct: 305 KFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE-- 362
Query: 241 RNAGARGVPTSASDVSQ 257
AR V + + +V++
Sbjct: 363 ----ARNVSSPSPEVTR 375
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359491840|ref|XP_002271454.2| PREDICTED: serine/threonine-protein kinase PBS1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1106), Expect = e-118, Method: Compositional matrix adjust.
Identities = 209/261 (80%), Positives = 227/261 (86%), Gaps = 1/261 (0%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE HL+DL PDQEPL WNTR++IAVG
Sbjct: 131 MLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLEHHLFDLGPDQEPLGWNTRIQIAVG 190
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKLSDFGLAKLGPVGDNTHVSTRVMGT
Sbjct: 191 AARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 250
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK QGEQNLV+WSRPFLKD+K
Sbjct: 251 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDTSKRQGEQNLVAWSRPFLKDRK 310
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF+ LVDP L G +P R L++A+A+TAMCL E+ NFRPLI DIVVAL+YL S+ S
Sbjct: 311 KFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNFRPLIGDIVVALEYLASESHSSEPH 370
Query: 241 RNAGARGVPTSASDVSQGSNS 261
RN R +S S S+ SNS
Sbjct: 371 RNQ-VRLPSSSPSQGSRNSNS 390
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297745557|emb|CBI40722.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 430 bits (1105), Expect = e-118, Method: Compositional matrix adjust.
Identities = 209/261 (80%), Positives = 227/261 (86%), Gaps = 1/261 (0%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE HL+DL PDQEPL WNTR++IAVG
Sbjct: 163 MLSLLHHSNLVTLIGYCTDGDQRLLVYEYMAMGSLEHHLFDLGPDQEPLGWNTRIQIAVG 222
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARGLEYLHCKANPPVIYRDLKSANILLDN+FNPKLSDFGLAKLGPVGDNTHVSTRVMGT
Sbjct: 223 AARGLEYLHCKANPPVIYRDLKSANILLDNEFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 282
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK QGEQNLV+WSRPFLKD+K
Sbjct: 283 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDTSKRQGEQNLVAWSRPFLKDRK 342
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF+ LVDP L G +P R L++A+A+TAMCL E+ NFRPLI DIVVAL+YL S+ S
Sbjct: 343 KFIQLVDPQLQGNFPVRALHHAIAITAMCLQEQPNFRPLIGDIVVALEYLASESHSSEPH 402
Query: 241 RNAGARGVPTSASDVSQGSNS 261
RN R +S S S+ SNS
Sbjct: 403 RNQ-VRLPSSSPSQGSRNSNS 422
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224086050|ref|XP_002307795.1| predicted protein [Populus trichocarpa] gi|222857244|gb|EEE94791.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 429 bits (1103), Expect = e-118, Method: Compositional matrix adjust.
Identities = 212/272 (77%), Positives = 233/272 (85%), Gaps = 8/272 (2%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTL GYCTSGDQRLLVYEYMPMGSLEDHL+DLEP +EPLSW+TR+KIAVG
Sbjct: 68 MLSLLHHSNLVTLTGYCTSGDQRLLVYEYMPMGSLEDHLFDLEPGKEPLSWSTRIKIAVG 127
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARGLEYLHCKA+PPVIYRDLKSANILLDNDF PKLSDFG+AKLGPVG+NTHVSTRVMGT
Sbjct: 128 AARGLEYLHCKADPPVIYRDLKSANILLDNDFQPKLSDFGIAKLGPVGENTHVSTRVMGT 187
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA+D SK GEQNL +WS+PFLKDQK
Sbjct: 188 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAIDRSKKPGEQNLAAWSQPFLKDQK 247
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
K+ L DPLL G YPRRC NYA+A+TAMCLNE+A+FRPLI DI+ AL+YL +Q H
Sbjct: 248 KYCQLADPLLEGCYPRRCFNYAIAITAMCLNEQASFRPLIGDILGALEYLAAQ--CHVSE 305
Query: 241 RNAG-ARGVPTSA--SD---VSQGSNSRRSSS 266
N G RG S+ SD VSQ +SR +S
Sbjct: 306 PNTGRVRGTNPSSPYSDRKVVSQERDSRSRAS 337
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449455605|ref|XP_004145543.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1064), Expect = e-113, Method: Compositional matrix adjust.
Identities = 197/253 (77%), Positives = 220/253 (86%), Gaps = 2/253 (0%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE+HL+ L P + PLSWNTR+KIA+G
Sbjct: 118 MLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLENHLFGLFPKRSPLSWNTRIKIALG 177
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GLEYLHC ANPPVIYRDLKSANILLD+DFNPKLSDFGLAKLGPVGDNTHVSTRVMGT
Sbjct: 178 AAQGLEYLHCTANPPVIYRDLKSANILLDDDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 237
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGRKA+D +K GEQNLV+WSRPFLKD++
Sbjct: 238 YGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGRKAIDTTKKPGEQNLVAWSRPFLKDRR 297
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KFV LVDPLL GRYP RCL++A+A+ AMCL E+ FRP+I+DIVVAL+YL SQ SH
Sbjct: 298 KFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMFRPIISDIVVALEYLASQ--SHASE 355
Query: 241 RNAGARGVPTSAS 253
+ G P+ S
Sbjct: 356 QPREGVGSPSKLS 368
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449485117|ref|XP_004157074.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1063), Expect = e-113, Method: Compositional matrix adjust.
Identities = 197/253 (77%), Positives = 220/253 (86%), Gaps = 2/253 (0%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCT GDQRLLVYEYM MGSLE+HL+ L P + PLSWNTR+KIA+G
Sbjct: 114 MLSLLHHSNLVTLIGYCTDGDQRLLVYEYMSMGSLENHLFGLFPKRSPLSWNTRIKIALG 173
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GLEYLHC ANPPVIYRDLKSANILLD+DFNPKLSDFGLAKLGPVGDNTHVSTRVMGT
Sbjct: 174 AAQGLEYLHCTANPPVIYRDLKSANILLDDDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 233
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLTLKSDIY FGVVLLE+ITGRKA+D +K GEQNLV+WSRPFLKD++
Sbjct: 234 YGYCAPEYAMSGKLTLKSDIYCFGVVLLEIITGRKAIDTTKKPGEQNLVAWSRPFLKDRR 293
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KFV LVDPLL GRYP RCL++A+A+ AMCL E+ FRP+I+DIVVAL+YL SQ SH
Sbjct: 294 KFVQLVDPLLEGRYPLRCLHHAIAIAAMCLQEQPMFRPIISDIVVALEYLASQ--SHASE 351
Query: 241 RNAGARGVPTSAS 253
+ G P+ S
Sbjct: 352 QPREGVGSPSKLS 364
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 267 | ||||||
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.913 | 0.640 | 0.836 | 8.7e-111 | |
| TAIR|locus:2014604 | 381 | AT1G76370 [Arabidopsis thalian | 0.910 | 0.637 | 0.769 | 7.9e-101 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.932 | 0.658 | 0.702 | 2.3e-94 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.932 | 0.485 | 0.709 | 2.7e-93 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.872 | 0.510 | 0.716 | 1.5e-90 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.880 | 0.567 | 0.689 | 4.3e-86 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.906 | 0.666 | 0.657 | 2.4e-85 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.861 | 0.595 | 0.670 | 4.4e-84 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.880 | 0.604 | 0.634 | 1.8e-80 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.872 | 0.549 | 0.643 | 3.7e-80 |
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1094 (390.2 bits), Expect = 8.7e-111, P = 8.7e-111
Identities = 205/245 (83%), Positives = 224/245 (91%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL+DLE +QEPLSWNTRMKIAVG
Sbjct: 125 MLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVG 184
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARG+EYLHC ANPPVIYRDLKSANILLD +F+PKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 185 AARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGT 244
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSGKLT+KSDIY FGVVLLELITGRKA+DL + QGEQNLV+WSRP+LKDQK
Sbjct: 245 YGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQK 304
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF HLVDP L G+YPRRCLNYA+A+ AMCLNEEA++RP I DIVVAL+YL +Q SH +
Sbjct: 305 KFGHLVDPSLRGKYPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQSRSHE-A 363
Query: 241 RNAGA 245
RN +
Sbjct: 364 RNVSS 368
|
|
| TAIR|locus:2014604 AT1G76370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1000 (357.1 bits), Expect = 7.9e-101, P = 7.9e-101
Identities = 187/243 (76%), Positives = 213/243 (87%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLS+ HH NLVTLIGYCTSG QRLLVYEYMPMGSLEDHL+DLEPDQ PLSW TRMKIAVG
Sbjct: 122 MLSVFHHPNLVTLIGYCTSGAQRLLVYEYMPMGSLEDHLFDLEPDQTPLSWYTRMKIAVG 181
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARG+EYLHCK +P VIYRDLKSANILLD +F+ KLSDFGLAK+GPVG+ THVSTRVMGT
Sbjct: 182 AARGIEYLHCKISPSVIYRDLKSANILLDKEFSVKLSDFGLAKVGPVGNRTHVSTRVMGT 241
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAMSG+LT+KSDIYSFGVVLLELI+GRKA+DLSK GEQ LV+W+RP+LKD K
Sbjct: 242 YGYCAPEYAMSGRLTIKSDIYSFGVVLLELISGRKAIDLSKPNGEQYLVAWARPYLKDPK 301
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
KF LVDPLL G++ +RCLNYA+++T MCLN+EAN RP I D+VVA +Y+ SQ S+
Sbjct: 302 KFGLLVDPLLRGKFSKRCLNYAISITEMCLNDEANHRPKIGDVVVAFEYIASQSKSYEDR 361
Query: 241 RNA 243
R A
Sbjct: 362 RTA 364
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 939 (335.6 bits), Expect = 2.3e-94, P = 2.3e-94
Identities = 177/252 (70%), Positives = 207/252 (82%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL+D+ P ++PL WNTRMKIA G
Sbjct: 121 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAG 180
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GLEYLH K PPVIYRDLK +NILLD+D+ PKLSDFGLAKLGPVGD +HVSTRVMGT
Sbjct: 181 AAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGT 240
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAM+G+LTLKSD+YSFGVVLLE+ITGRKA+D S+ GEQNLV+W+RP KD++
Sbjct: 241 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKDRR 300
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-D--SH 237
KF + DP+L G+YP R L A+AV AMC+ E+ N RPLI D+V AL YL SQ+ D +
Sbjct: 301 KFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDPLAQ 360
Query: 238 PVSRNAGARGVP 249
PV + A G P
Sbjct: 361 PVQGSLFAPGTP 372
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.7e-93, P = 2.7e-93
Identities = 178/251 (70%), Positives = 205/251 (81%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL+DL PD+EPL W+TRM IA G
Sbjct: 131 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAG 190
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GLEYLH KANPPVIYRDLKS+NILL + ++PKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 191 AAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 250
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAM+G+LTLKSD+YSFGVV LELITGRKA+D ++ GE NLV+W+RP KD++
Sbjct: 251 YGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLFKDRR 310
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR-DSH-P 238
KF + DP L GRYP R L A+AV AMCL E+A RPLI D+V AL YL SQ D + P
Sbjct: 311 KFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTFDPNAP 370
Query: 239 VSRNAGARGVP 249
+N+ + P
Sbjct: 371 SGQNSRSGSGP 381
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 903 (322.9 bits), Expect = 1.5e-90, P = 1.5e-90
Identities = 167/233 (71%), Positives = 193/233 (82%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLV LIGYC GDQRLLVYE+MP+GSLEDHL+DL PD+E L WN RMKIA G
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+GLE+LH KANPPVIYRD KS+NILLD F+PKLSDFGLAKLGP GD +HVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEYAM+G+LT+KSD+YSFGVV LELITGRKA+D GEQNLV+W+RP D++
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233
KF+ L DP L GR+P R L A+AV +MC+ E+A RPLI D+V AL YL +Q
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 861 (308.1 bits), Expect = 4.3e-86, P = 4.3e-86
Identities = 162/235 (68%), Positives = 190/235 (80%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH +LV LIGYC GDQRLLVYEYM GSLEDHL DL PDQ PL W+TR++IA+G
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALG 186
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA GLEYLH KANPPVIYRDLK+ANILLD +FN KLSDFGLAKLGPVGD HVS+RVMGT
Sbjct: 187 AAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGT 246
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEY +G+LT KSD+YSFGVVLLELITGR+ +D ++ + EQNLV+W++P K+
Sbjct: 247 YGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPS 306
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235
+F L DP L G +P + LN AVAV AMCL EEA RPL++D+V AL +L + D
Sbjct: 307 RFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTAPD 361
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 854 (305.7 bits), Expect = 2.4e-85, P = 2.4e-85
Identities = 159/242 (65%), Positives = 192/242 (79%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLSLLHH NLV LIGYC GDQRLLVYEYMP+GSLEDHL DLEP Q+PL WNTR+KIA+G
Sbjct: 95 MLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIALG 154
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA+G+EYLH +A+PPVIYRDLKS+NILLD ++ KLSDFGLAKLGPVGD HVS+RVMGT
Sbjct: 155 AAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVMGT 214
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
YGYCAPEY +G LT KSD+YSFGVVLLELI+GR+ +D + EQNLV+W+ P +D
Sbjct: 215 YGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRDPT 274
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPVS 240
++ L DPLL G YP + LN A+AV AMCL+EE RPL++D++ AL +L + +S
Sbjct: 275 RYWQLADPLLRGDYPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGASSNSSNTG 334
Query: 241 RN 242
N
Sbjct: 335 SN 336
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 842 (301.5 bits), Expect = 4.4e-84, P = 4.4e-84
Identities = 155/231 (67%), Positives = 190/231 (82%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-PLSWNTRMKIAV 59
MLSLLHH NLV L+GYC GDQR+LVYEYM GSLEDHL +L +++ PL W+TRMK+A
Sbjct: 130 MLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAA 189
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
GAARGLEYLH A+PPVIYRD K++NILLD +FNPKLSDFGLAK+GP G THVSTRVMG
Sbjct: 190 GAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMG 249
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 179
TYGYCAPEYA++G+LT+KSD+YSFGVV LE+ITGR+ +D +K EQNLV+W+ P KD+
Sbjct: 250 TYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDR 309
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230
+KF + DPLL G+YP + L A+AV AMCL EEA RP+++D+V AL+YL
Sbjct: 310 RKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYL 360
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 808 (289.5 bits), Expect = 1.8e-80, P = 1.8e-80
Identities = 149/235 (63%), Positives = 189/235 (80%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
LSLLHH NL LIGYC GDQRLLV+E+MP+GSLEDHL D+ Q+PL WN+R++IA+GA
Sbjct: 120 LSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIALGA 179
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
A+GLEYLH KANPPVIYRD KS+NILL+ DF+ KLSDFGLAKLG VGD +VS+RV+GTY
Sbjct: 180 AKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVVGTY 239
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
GYCAPEY +G+LT+KSD+YSFGVVLLELITG++ +D ++ EQNLV+W++P ++ +
Sbjct: 240 GYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFREPNR 299
Query: 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236
F L DPLL G +P + LN AVA+ AMCL EE RPLI+D+V AL ++ ++ S
Sbjct: 300 FPELADPLLQGEFPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGS 354
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 3.7e-80, P = 3.7e-80
Identities = 150/233 (64%), Positives = 184/233 (78%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
LSL H NLV LIG+C G QRLLVYEYMP+GSL++HL+DL + PL+WNTRMKIA GA
Sbjct: 147 LSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIAAGA 206
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
ARGLEYLH PPVIYRDLK +NIL+D ++ KLSDFGLAK+GP G THVSTRVMGTY
Sbjct: 207 ARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVMGTY 266
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
GYCAP+YA++G+LT KSD+YSFGVVLLELITGRKA D ++ + Q+LV W+ P KD+K
Sbjct: 267 GYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFKDRKN 326
Query: 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234
F +VDPLL G YP R L A+A+ AMC+ E+ + RP+I D+V+ALD+L S +
Sbjct: 327 FKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSK 379
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.II.2013.1 | hypothetical protein (313 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | eugene3.00031887 | hypothetical protein (230 aa) | • | 0.434 | |||||||
 | CPK18 | calcium dependent protein kinase 18 (556 aa) | • | 0.410 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 267 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-44 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 6e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-24 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-24 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 9e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 8e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-17 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-17 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-15 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-15 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-15 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-14 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-14 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-14 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-12 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-11 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-10 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-10 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-09 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-09 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-09 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 8e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 6e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 9e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-44
Identities = 62/152 (40%), Positives = 86/152 (56%), Gaps = 10/152 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L+H N+V L G + LV EY GSL+D L + E LS + ++I +
Sbjct: 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQ 100
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
GLEYLH +I+RDLK NILLD+D KL+DFGL+KL + + + ++G
Sbjct: 101 ILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVG 155
Query: 120 TYGYCAPEYAMS-GKLTLKSDIYSFGVVLLEL 150
T Y APE + G + KSDI+S GV+L EL
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-41
Identities = 64/155 (41%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V LI D LV EY G L D+L PLS + KIA+
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQ 106
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
RGLEYLH +I+RDLK NILLD + K++DFGLAK + ++ ++T V GT
Sbjct: 107 ILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GT 161
Query: 121 YGYCAPE-YAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE K D++S GV+L EL+TG+
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 5e-41
Identities = 58/152 (38%), Positives = 83/152 (54%), Gaps = 6/152 (3%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H N+V L+G CT + ++V EYMP G L D+L P + LS + + A+
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQ 111
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
ARG+EYL K I+RDL + N L+ + K+SDFGL++ D V
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLP 167
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE GK T KSD++SFGV+L E+ T
Sbjct: 168 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-40
Identities = 55/152 (36%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H N+V L+G CT + +V EYM G L +L P LS + + A+
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
ARG+EYL K I+RDL + N L+ + K+SDFGL++ D
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLP 166
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE GK T KSD++SFGV+L E+ T
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 6e-40
Identities = 57/154 (37%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L D+ LV EY G L D L E +
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR----FYLRQ 105
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
LEYLH K +++RDLK NILLD D + KL+DFGLA+ + ++T V GT
Sbjct: 106 ILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GT 159
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE + DI+S GV+L EL+TG+
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 7e-40
Identities = 56/157 (35%), Positives = 80/157 (50%), Gaps = 8/157 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----YDLEPDQEPLSWNTRM 55
++ L H N+V L+G CT + LV EYM G L D+L P++ LS +
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
A+ A+G+EYL K ++RDL + N L+ D K+SDFGL++ D T
Sbjct: 109 SFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE G T KSD++SFGV+L E+ T
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-39
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H N+V L+G CT G+ +V EYMP G L D L E L+ +++A+
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A+G+EYL K ++RDL + N L+ + K+SDFGL++ D
Sbjct: 111 IAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+ APE GK T KSD++SFGV+L E+ T
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-32
Identities = 51/158 (32%), Positives = 76/158 (48%), Gaps = 13/158 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPL--SWNTRMK 56
+LS L H N+V G + + EY+ GSL L EP+ + TR
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQI 110
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+ GL YLH +++RD+K ANIL+D+D KL+DFG AK + +
Sbjct: 111 L-----EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V GT + APE + +DI+S G ++E+ TG+
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 29/239 (12%)
Query: 5 LHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 62
L H+N+V G C R L+ EY+P GSL D+L ++ ++ + +
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQIC 119
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--RVMGT 120
+G++YL + I+RDL + NIL++++ K+SDFGLAK+ P + +
Sbjct: 120 KGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL---- 176
+ Y APE + K + SD++SFGV L EL T G+ + +
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT----------YGDPSQSPPAEFLRMIGI 225
Query: 177 -KDQKKFVHLVDPLLHG-RYPR--RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231
+ Q L++ L G R PR C + + +C E RP D+++ +D L
Sbjct: 226 AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-25
Identities = 61/199 (30%), Positives = 88/199 (44%), Gaps = 33/199 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAV 59
+L H N+V G D+ +V E+ GSL+D L + E +IA
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-------QIAY 102
Query: 60 ---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+GLEYLH +I+RD+K+ANILL +D KL DFGL+ +T
Sbjct: 103 VCKELLKGLEYLH-SNG--IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNT 156
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE-- 165
++GT + APE K+DI+S G+ +EL G+ KA+ G
Sbjct: 157 MVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPG 216
Query: 166 -QNLVSWSRPFLKDQKKFV 183
+N WS F K F+
Sbjct: 217 LRNPEKWSDEF----KDFL 231
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 55/162 (33%), Positives = 81/162 (50%), Gaps = 13/162 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD----------QEPLS 50
+L+ H+N+V G CT GD ++V+EYM G L L PD L+
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 51 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 110
+ ++IAV A G+ YL A+ ++RDL + N L+ D K+ DFG+++ D
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 111 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
V M + PE M K T +SD++SFGVVL E+ T
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 6e-25
Identities = 55/154 (35%), Positives = 84/154 (54%), Gaps = 13/154 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L HD LV L C+ + +V EYM GSL D L + + L + +A A G
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEG 115
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL + I+RDL + NIL+ + K++DFGLA+L + D+ + + G
Sbjct: 116 MAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTAR--EGAKFPI 168
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
+ APE A G+ T+KSD++SFG++L E++T GR
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 8e-25
Identities = 52/158 (32%), Positives = 80/158 (50%), Gaps = 15/158 (9%)
Query: 2 LSLLH---HDNLVTLIG-YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 57
L L +V G + G+ + V EYM GSL D L + EP+ I
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVL----AYI 104
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTR 116
A +GL+YLH K + +I+RD+K +N+L+++ K++DFG++K L D + T
Sbjct: 105 ARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TF 160
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V GT Y +PE + +DI+S G+ LLE G+
Sbjct: 161 V-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 64/168 (38%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 62
SL H N+V L + LV EY+ GSLED L + PLS + + I
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQIL 111
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKL----GPVGDNTHVSTRV 117
LEYLH K +I+RD+K NILLD + KL DFGLAKL G + +
Sbjct: 112 SALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 118 MGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKAMDLSKG 162
+GT GY APE + L + SDI+S G+ L EL+TG + K
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
|
Length = 384 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 74/241 (30%), Positives = 112/241 (46%), Gaps = 32/241 (13%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H N+V LIG C S L++EY+ +L + L +L SW R KIA+G A+
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKIAIGIAKA 792
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
L +LHC+ +P V+ +L I++D P L +L G T+ + Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPG-LLCTDTKCFISSAYV 845
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 184
APE + +T KSDIY FG++L+EL+TG+ D G ++V W+R D H
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD----CH 900
Query: 185 L---VDPLL------HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235
L +DP + + +N A+ TA + RP ND++ L+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTAT----DPTARPCANDVLKTLESASRSSS 956
Query: 236 S 236
S
Sbjct: 957 S 957
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 6e-24
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L+H N++ + +V EY G L + + + +P + V
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
L+YLH + +++RD+K NI L ++ KL DFG++K+ + ++ V+GT
Sbjct: 113 CLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTP 167
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
Y +PE + KSDI+S G VL EL T + + G+ L K
Sbjct: 168 YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFE---GENLLELA----------LK 214
Query: 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
+ P + +Y L V + L ++ RP I I
Sbjct: 215 ILKGQYPPIPSQYSSE-LRNLV---SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 7e-24
Identities = 57/157 (36%), Positives = 76/157 (48%), Gaps = 15/157 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK-I 57
+LS ++H +V L + + LV EY P G L HL E R +
Sbjct: 46 ILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFY 98
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
A LEYLH +IYRDLK NILLD D + KL+DFGLAK + + +T
Sbjct: 99 AAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS-EGSRTNTFC 154
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE + D +S GV+L E++TG+
Sbjct: 155 -GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-23
Identities = 56/154 (36%), Positives = 78/154 (50%), Gaps = 11/154 (7%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H N+V IG + D ++ EY GSL + P E L ++
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVL--- 109
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
+GL YLH VI+RD+K+ANIL D KL+DFG+A + D + V+GT
Sbjct: 110 -QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTP 163
Query: 122 GYCAPE-YAMSGKLTLKSDIYSFGVVLLELITGR 154
+ APE MSG + SDI+S G ++EL+TG
Sbjct: 164 YWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 2e-22
Identities = 53/151 (35%), Positives = 80/151 (52%), Gaps = 11/151 (7%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H NLV L+G G+ +V EYM GSL D+L + ++ ++ A+ G
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEG 114
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+EYL K ++RDL + N+L+ D K+SDFGLAK G S ++ +
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWT 166
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
APE K + KSD++SFG++L E+ + GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-22
Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 15/162 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEP 48
++S L H N+V L+G CT +++EY+ G L + L E +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
L + + IA+ A G+EYL ++ ++RDL + N L+ K+SDFGL++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150
D V ++ + + PE + GK T +SDI+SFGVVL E+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-22
Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PL 49
+L++L H ++V G CT G L+V+EYM G L L PD + L
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 50 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 109
+ + IA A G+ YL A+ ++RDL + N L+ K+ DFG+++ D
Sbjct: 120 TLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 110 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 169
V R M + PE + K T +SDI+SFGVVL E+ T G+Q
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT----------YGKQ--- 223
Query: 170 SWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
W Q ++ + GR PR C A+ C E R +I DI
Sbjct: 224 PWY------QLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 4e-22
Identities = 60/157 (38%), Positives = 85/157 (54%), Gaps = 13/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L HDN+V G C S +R LV EY+P GSL D+L + +E L + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYA 114
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+G+EYL K ++RDL + NIL++++ K+ DFGL K+ P D + R
Sbjct: 115 SQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170
Query: 119 G---TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
G + Y APE K ++ SD++SFGVVL EL T
Sbjct: 171 GESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-22
Identities = 54/161 (33%), Positives = 76/161 (47%), Gaps = 23/161 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAV 59
+LS L H N+V +G D + E +P GSL L EP+ TR +
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL- 113
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM- 118
GLEYLH + ++RD+K ANIL+D + KL+DFG+AK V
Sbjct: 114 ----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFA 158
Query: 119 ----GTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154
G+ + APE G L +DI+S G +LE+ TG+
Sbjct: 159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 9e-22
Identities = 69/230 (30%), Positives = 105/230 (45%), Gaps = 19/230 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L+H+N+V G C+ + L+ EY+P+GSL D+L + L+ + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFA 113
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-VSTRV 117
G+ YLH + I+RDL + N+LLDND K+ DFGLAK P G + V
Sbjct: 114 QQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 177
+ A E K + SD++SFGV L EL+T + + E+ + +
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-----GPKQ 225
Query: 178 DQKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIV 224
Q V L++ L G P+ C + C EA FRP ++
Sbjct: 226 GQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-21
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED--HLYDLEPDQEPLSWNTRMKIA 58
+L+ L ++ + +V EY G L + P E W +
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFF 107
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ GL +LH K +++RD+KS N+ LD N K+ D G+AKL + DNT+ + ++
Sbjct: 108 IQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIV 162
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 178
GT Y +PE KSD+++ GVVL E TG+ PF D
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK------------------HPF--D 202
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAM---CLNEEANFRP 218
L+ ++ G +P Y+ + + CL ++ RP
Sbjct: 203 ANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-20
Identities = 50/148 (33%), Positives = 83/148 (56%), Gaps = 7/148 (4%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H +L++L C+ G+ ++ E M GSL L P+ + L + + +A A G
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEG 116
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+ YL + I+RDL + NIL+ D K++DFGLA+L + ++ ++S+ Y +
Sbjct: 117 MAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWT 171
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT 152
APE A G + KSD++SFG++L E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 52/157 (33%), Positives = 74/157 (47%), Gaps = 25/157 (15%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
+ +V G + + EYM GSL D + + P KIAV +GL
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPER--ILGKIAVAVLKGL 113
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM------- 118
YLH K +I+RD+K +NIL+++ KL DFG VS +++
Sbjct: 114 TYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTF 159
Query: 119 -GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE ++KSDI+S G+ L+EL TGR
Sbjct: 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-20
Identities = 56/160 (35%), Positives = 76/160 (47%), Gaps = 13/160 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
+S +H N+V GD+ LV Y+ GSL D+ P IA
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLDEAIIATV 107
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTH-VST 115
+GLEYLH I+RD+K+ NILL D + K++DFG+ A L GD T V
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164
Query: 116 RVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
+GT + APE K+DI+SFG+ +EL TG
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-20
Identities = 51/173 (29%), Positives = 78/173 (45%), Gaps = 22/173 (12%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQR--LLVYEYMP---MGSLEDHLYDLEPDQEPLSWNTRMK 56
L L H N+V L TS + +V+EYM G L+ Q +K
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQ--------IK 103
Query: 57 -IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
GL+YLH +++RD+K +NIL++ND KL+DFGLA+ N+ T
Sbjct: 104 CYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYT 159
Query: 116 RVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 167
+ T Y PE + + + + D++S G +L EL G+ +G E
Sbjct: 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIF---QGSTELE 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-20
Identities = 59/156 (37%), Positives = 89/156 (57%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L HD LV L S + +V EYM GSL D L D + L + +A
Sbjct: 54 IMKKLRHDKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMG 119
A G+ Y+ + N I+RDL+SANIL+ + K++DFGLA+L + DN + + +
Sbjct: 111 VAAGMAYIE-RMN--YIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKF 165
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
+ APE A+ G+ T+KSD++SFG++L EL+T GR
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-20
Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H L+ L CT + +V E M GSL ++L L + +A A G
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASG 115
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL + I+RDL + N+L+ + K++DFGLA++ + ++ + + G
Sbjct: 116 MAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARV--IKEDIYEARE--GAKFPI 168
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
+ APE A+ + ++KSD++SFG++L E++T GR
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 35/203 (17%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA-- 62
H N+V GD+ +V EYM GSL D + Q + N V
Sbjct: 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT-----QNFVRMNEPQIAYVCREVL 126
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR--VMGT 120
+GLEYLH + VI+RD+KS NILL D + KL+DFG A S R V+GT
Sbjct: 127 QGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVGT 179
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDL--SKGQGE-QNL 168
+ APE K DI+S G++ +E+ G +A+ L +KG +N
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP 239
Query: 169 VSWSRPFLKDQKKFVHL---VDP 188
WS F K F++ DP
Sbjct: 240 EKWSPEF----KDFLNKCLVKDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 6e-19
Identities = 58/164 (35%), Positives = 86/164 (52%), Gaps = 25/164 (15%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKI 57
LS +V L Y G + L LV EY+P G SL +++ L+ D R+ I
Sbjct: 47 LSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDED------VARIYI 99
Query: 58 A--VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS- 114
A V A LEYLH + +I+RDLK NIL+D++ + KL+DFGL+K+G V +++
Sbjct: 100 AEIVLA---LEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153
Query: 115 -----TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
R++GT Y APE + + D +S G +L E + G
Sbjct: 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 7e-19
Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 16/160 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMK 56
+++ + H ++V L+G C S Q L+ + MP+G L D++ + + Q L+W
Sbjct: 62 VMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNW----- 114
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
V A+G+ YL K +++RDL + N+L+ + K++DFGLAKL V + + +
Sbjct: 115 -CVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ A E + T KSD++S+GV + EL+T G K
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 8e-19
Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H+N+V +G D + EY+P GS+ L + +E L N +I
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-- 116
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----LGPVGDNTHVST 115
+GL YLH N +I+RD+K ANIL+DN K+SDFG++K N +
Sbjct: 117 --KGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ G+ + APE T K+DI+S G +++E++TG+
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 1e-18
Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIA 58
M SL H+NL+ L G + ++V E P+GSL D L +S + ++IA
Sbjct: 50 MHSL-DHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--- 115
G+ YL K I+RDL + NILL +D K+ DFGL + P ++ +V
Sbjct: 108 ----NGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+V + +CAPE + + SD++ FGV L E+ T
Sbjct: 161 KV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-18
Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--------PLSWN 52
++S L + N++ L+G C S D ++ EYM G L L E + +S
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 53 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 112
+ +AV A G++YL A+ ++RDL + N L+ N + K++DFG+++ GD
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 172
+ R + + A E + GK T SD+++FGV L E+ T K S EQ ++ +
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENT 245
Query: 173 RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
F ++Q + ++L L C + + C + + RP N I
Sbjct: 246 GEFFRNQGRQIYLSQTPL-------CPSPVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 50/155 (32%), Positives = 69/155 (44%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AV 59
+L + +V+L + D LV M G L+ H+Y++ EP R A
Sbjct: 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG---EPGFPEARAIFYAA 102
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
GLE+LH ++YRDLK N+LLD+ N ++SD GLA G G
Sbjct: 103 QIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---G 156
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T GY APE D ++ G L E+I GR
Sbjct: 157 TPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-18
Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N+V LIG C +V E +P GSL L + L+ +++++ AA G+E
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGME 107
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 126
YL K I+RDL + N L+ + K+SDFG+++ G T + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 127 EYAMSGKLTLKSDIYSFGVVLLELITG 153
E G+ T +SD++S+G++L E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-18
Identities = 61/230 (26%), Positives = 110/230 (47%), Gaps = 18/230 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP-------LSWNT 53
++S L N++ L+ C + D ++ EYM G L L EP + +S++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 54 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
+ +A A G++YL ++ ++RDL + N L+ ++ K++DFG+++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 173
R + + + E + GK T SD+++FGV L E++T K S+ EQ ++ +
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTG 247
Query: 174 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
F +DQ + V+L P C + + C A RP +I
Sbjct: 248 EFFRDQGRQVYLPK-------PALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-18
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ------EPLSWNTR 54
+L+ L H+++V G C GD ++V+EYM G L L PD +P
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 55 M------KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
+ IA A G+ YL A+ ++RDL + N L+ + K+ DFG+++
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D V M + PE M K T +SD++SFGV+L E+ T
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-18
Identities = 47/158 (29%), Positives = 68/158 (43%), Gaps = 23/158 (14%)
Query: 6 HHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRM------KI 57
+V G + EY GSL D +Y ++ R+ KI
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIY-----KKVKKRGGRIGEKVLGKI 110
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTR 116
A +GL YLH + +I+RD+K +NILL KL DFG++ +L T
Sbjct: 111 AESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--- 164
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE ++ SD++S G+ LLE+ R
Sbjct: 165 --GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-18
Identities = 58/156 (37%), Positives = 91/156 (58%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L HD LV L S + +V E+M GSL D L E D + L + +A
Sbjct: 54 IMKKLRHDKLVPLYA-VVSEEPIYIVTEFMGKGSLLDFLK--EGDGKYLKLPQLVDMAAQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMG 119
A G+ Y+ + N I+RDL++ANIL+ ++ K++DFGLA+L + DN + + +
Sbjct: 111 IADGMAYIE-RMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKF 165
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
+ APE A+ G+ T+KSD++SFG++L EL+T GR
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-18
Identities = 54/152 (35%), Positives = 82/152 (53%), Gaps = 10/152 (6%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H LV L T + ++ EYM GSL D L P+ L+ N + +A A G
Sbjct: 58 LQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEG 114
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGY 123
+ ++ K I+RDL++ANIL+ K++DFGLA+L + DN + + +
Sbjct: 115 MAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKFPIKW 169
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
APE G T+KSD++SFG++L E++T GR
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 62/238 (26%), Positives = 112/238 (47%), Gaps = 26/238 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEP---------- 48
+LS L N++ L+G C D ++ EYM G L L + L+ +E
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 49 ---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 105
+S+++ + +A+ A G++YL ++ ++RDL + N L+ + K++DFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 106 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165
GD + R + + A E + GK T SD+++FGV L E++ K + E
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDE 248
Query: 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
Q ++ + F +DQ + V+L R P C + C + + RP +DI
Sbjct: 249 Q-VIENAGEFFRDQGRQVYL------FR-PPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-17
Identities = 47/148 (31%), Positives = 79/148 (53%), Gaps = 6/148 (4%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
+ H NLV L+G CT ++ E+M G+L D+L E +++ ++ + +A +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSA 116
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+EYL K I+RDL + N L+ + K++DFGL++L GD +
Sbjct: 117 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWT 172
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT 152
APE K ++KSD+++FGV+L E+ T
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-17
Identities = 54/154 (35%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H N+V L+ + + LV+EY M L+ +L PLS N I
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPG---PLSPNLIKSIMYQL 107
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
RGL Y H +++RDLK NIL++ D KL+DFGLA+ + T+ + V+ T
Sbjct: 108 LRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TL 162
Query: 122 GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
Y APE + K + DI+S G + E+ITG+
Sbjct: 163 WYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-17
Identities = 52/154 (33%), Positives = 75/154 (48%), Gaps = 13/154 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H NLV L G CT +V EYM G L ++L + + W M V
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDV--CEA 112
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+EYL I+RDL + N L+ D K+SDFGLA+ V D+ + S+ GT
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPV 165
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155
+ PE + + KSD++SFGV++ E+ + K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 27/229 (11%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAV 59
HH +V L+G ++G L+V E M G L+ +L P+ E P + +++A
Sbjct: 69 HH--VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
A G+ YL K ++RDL + N ++ D K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 179
+ APE G T KSD++SFGVVL E+ T A +G + ++ F+ D
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLSNEEVLK----FVIDG 237
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
H P C + + + MC RP +IV +L
Sbjct: 238 G----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 53/161 (32%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L LL H NLV G ++ + EY G+LE+ L E + +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQL 108
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM--- 118
GL YLH +++RD+K ANI LD++ KL DFG A + +NT +
Sbjct: 109 LEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVK--LKNNTTTMGEEVQSL 163
Query: 119 -GTYGYCAPEYAMSGKLTLK---SDIYSFGVVLLELITGRK 155
GT Y APE GK +DI+S G V+LE+ TG++
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 52/152 (34%), Positives = 83/152 (54%), Gaps = 14/152 (9%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
LHH NLV L+G + +V E M G+L + L + ++ ++ A G
Sbjct: 56 LHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEG 112
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG-DNTHVSTRVMGTYGY 123
+EYL K +++RDL + NIL+ D K+SDFGLA++G +G DN+ + + +
Sbjct: 113 MEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------W 163
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
APE K + KSD++S+GV+L E+ + GR
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-17
Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMK 56
+L LL H N++ ++V EY P G+L +++ L + L + ++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVST 115
+A L ++H K +++RDLK+ NILLD K+ DFG++K+ + + T
Sbjct: 112 LA------LHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT 160
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158
V+GT Y +PE KSDI++ G VL EL + ++A +
Sbjct: 161 -VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 21/160 (13%)
Query: 1 MLSL--LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY----DLEPDQEPLSWNTR 54
ML++ L H +V L+G C G LV + P+GSL DH+ L+P Q L+W
Sbjct: 60 MLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNW--- 114
Query: 55 MKIAVGAARGLEYL--HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 112
V A+G+ YL H +++R+L + NILL +D +++DFG+A L D +
Sbjct: 115 ---CVQIAKGMYYLEEHR-----MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + A E + G+ T +SD++S+GV + E+++
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 6e-17
Identities = 56/159 (35%), Positives = 72/159 (45%), Gaps = 22/159 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVY---EYMPMGSLEDHLYD---LEPDQEPLSWNTRM 55
L +H +V L Y T D++ +Y EY G L L D + R
Sbjct: 47 LEECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFDEYT------ARF 97
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
IA EYLH N +IYRDLK N+LLD++ KL DFG AK G T
Sbjct: 98 YIA-CVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-- 151
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE ++ D +S G++L EL+TGR
Sbjct: 152 -FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 8e-17
Identities = 49/182 (26%), Positives = 71/182 (39%), Gaps = 45/182 (24%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+ L H ++ L Y T D+ L V EY P G L ++ +
Sbjct: 55 LTRLNGHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYI------------RKYGSLD 100
Query: 59 VGAAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGD 109
R LEYLH K +I+RDLK NILLD D + K++DFG AK L P
Sbjct: 101 EKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
Query: 110 NTHVSTRVM-----------------GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
GT Y +PE SD+++ G ++ +++T
Sbjct: 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217
Query: 153 GR 154
G+
Sbjct: 218 GK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L+H+N+V G CT L+ E++P GSL+++L ++ ++ ++K A
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYA 115
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST--- 115
V +G++YL + ++RDL + N+L++++ K+ DFGL K + + T
Sbjct: 116 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK--AIETDKEYYTVKD 170
Query: 116 -RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ Y APE + K + SD++SFGV L EL+T
Sbjct: 171 DLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-16
Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ---------EPLSW 51
+L+ L H+++V G C GD ++V+EYM G L L PD L+
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 52 NTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
+ + IA A G+ YL A+ ++RDL + N L+ + K+ DFG+++ D
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
V M + PE M K T +SD++S GVVL E+ T
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 50/163 (30%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED---HLYDLEPDQEPLSWNTRMKI 57
+LSLL H N++ + + L+ EY G+L D ++E + W
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLF 108
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
+ +A + Y+H KA +++RD+K+ NI L KL DFG++K+ +G ++ V
Sbjct: 109 QIVSA--VSYIH-KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETV 161
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160
+GT Y +PE K KSDI++ G VL EL+T ++ D +
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-16
Identities = 51/154 (33%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L HD LV L T + ++ EYM GSL D L E + L + +
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQ 111
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ Y+ K I+RDL++AN+L+ K++DFGLA++ + DN + + R
Sbjct: 112 IAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEY-TAREGAK 165
Query: 121 Y--GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + APE G T+KSD++SFG++L E++T
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 50/157 (31%), Positives = 74/157 (47%), Gaps = 18/157 (11%)
Query: 16 YCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA--RGLEYLHCK 71
+CT + + V EY+ G L H+ Q ++ A GL++LH K
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHI------QSSGRFDEARARFYAAEIICGLQFLHKK 115
Query: 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 131
+IYRDLK N+LLD D + K++DFG+ K G+ ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 132 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
K D +SFGV+L E++ G+ G+ E L
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-16
Identities = 52/156 (33%), Positives = 86/156 (55%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L HD LV L T + ++ E+M GSL D L E ++PL + +
Sbjct: 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMG 119
A G+ ++ + N I+RDL++ANIL+ K++DFGLA++ + DN + +
Sbjct: 111 IAEGMAFIE-QRN--YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKF 165
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
+ APE G T+KSD++SFG++L+E++T GR
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-16
Identities = 55/163 (33%), Positives = 81/163 (49%), Gaps = 25/163 (15%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL---------YDLEPDQEP---LSWNTR 54
H N++ L+G CT ++ EY G+L ++L Y P Q P LS+
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ A ARG+EYL A+ I+RDL + N+L+ D K++DFGLA+ D H+
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 194
Query: 115 TRVMGTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
T G + APE T +SD++SFGV+L E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-16
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 5 LHHDNLVTLIGYCTSGDQRLL-VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR 63
L+H N+V L+ + L V+EY+P +L + L L ++ +
Sbjct: 35 LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL----AADGALPAGETGRLM---LQ 87
Query: 64 GLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGP-VGDNTHV----ST 115
L+ L C N +++RDLK NI++ + K+ DFG+ L P V D +T
Sbjct: 88 VLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157
V+GT YCAPE +T SD+Y++G++ LE +TG++ +
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-16
Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+L L H+ +V G C D+ L ++ EYMP GS++D L L+ K
Sbjct: 57 LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTR 111
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM 118
G+EYLH +++RD+K ANIL D+ N KL DFG +K L + + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
GT + +PE K+D++S G ++E++T
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-16
Identities = 50/170 (29%), Positives = 70/170 (41%), Gaps = 32/170 (18%)
Query: 2 LSLLHHDNLVTLIG---------------YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 46
L L H N+V YC GD L+ + ++ Y +E
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK-----KERKY-IE--- 103
Query: 47 EPLSWNTRMKIAVGAARGLEYLH--CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104
E W +I L H V++RDLK ANI LD + N KL DFGLAK+
Sbjct: 104 EEFIW----RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159
Query: 105 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+G ++ + +GT Y +PE KSDI+S G ++ EL
Sbjct: 160 --LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 51/158 (32%), Positives = 82/158 (51%), Gaps = 17/158 (10%)
Query: 2 LSLLHH---DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L ++H +V+ G + + + E+M GSL D +Y P+ KIA
Sbjct: 54 LQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYK---KGGPIPVEILGKIA 109
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD--NTHVSTR 116
V GL YL+ +++RD+K +NIL+++ KL DFG++ G+ N+ T
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTF 162
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V GT Y +PE GK T+KSD++S G+ ++EL G+
Sbjct: 163 V-GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-16
Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H+ LV L G CT +V EYM G L ++L + +P +++ G
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEG 112
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL K I+RDL + N L+D+ K+SDFGL++ V D+ + S+ +G+
Sbjct: 113 MAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPV 165
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ PE + K + KSD+++FGV++ E+ +
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 9e-16
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQEPLSWNTR 54
LS L N+ L+G CT ++ EYM G L L + + LS++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ +A A G+ YL + ++RDL + N L+ ++ K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
R + A E + GK T KSD+++FGV L E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 9e-16
Identities = 53/162 (32%), Positives = 74/162 (45%), Gaps = 30/162 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+L + H LV L G D L LV EY+P G L HL +
Sbjct: 54 ILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHL------------RKSGRFPE 100
Query: 60 GAAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
AR LEYLH + ++YRDLK N+LLD+D K++DFG AK V T
Sbjct: 101 PVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRT 155
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+ + GT Y APE +S D ++ G+++ E++ G
Sbjct: 156 YT---LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 9e-16
Identities = 49/153 (32%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAA 62
L H +V LIG C G+ +LV E P+G L +L P + ++ A
Sbjct: 53 LDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------A 105
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY 121
G+ YL K ++RDL + N+LL N K+SDFG+++ LG + + G +
Sbjct: 106 MGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA--GSDYYRATTAGRW 160
Query: 122 --GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE GK + KSD++S+GV L E +
Sbjct: 161 PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-16
Identities = 51/160 (31%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEPLSWNTR 54
H N++ L+G CT +V EY G+L D L D P +E L+
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ A ARG+E+L A+ I+RDL + N+L+ D K++DFGLA+ + +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYR 189
Query: 115 TRVMG--TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
G + APE T +SD++SFGV+L E+ T
Sbjct: 190 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 16/152 (10%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
H N++ L G T +++ EYM GSL+ L E D + + + + G A G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGK-FTVGQLVGMLRGIASGM 119
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--- 122
+YL + ++RDL + NIL++++ K+SDFG L +++ + G G
Sbjct: 120 KYL---SEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKG--GKIP 171
Query: 123 --YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE K T SD++SFG+V+ E+++
Sbjct: 172 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-15
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 16/165 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------- 47
+++ LHH N+V L+G T +++EY+ G L + L P +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 48 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 107
L + IA+ A G+EYL ++ +++DL + NIL+ + K+SD GL++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 108 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D V + + + PE M GK + SDI+SFGVVL E+ +
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L L H N+V +G+ T+ + + EY+P GS+ L +E L ++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-- 118
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-- 118
GL YLH K +++RDLK+ N+L+D D K+SDFG++K D+ + + + M
Sbjct: 119 --EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYDNDQNMSM 170
Query: 119 -GTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRK 155
G+ + APE S + K DI+S G V+LE+ GR+
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-15
Identities = 57/184 (30%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEY 67
LVTL Y D +L L+ +Y+ G L HLY E E + +++ + L++
Sbjct: 67 LVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE-----SEVRVYIAEIVLALDH 120
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 127
LH +IYRD+K NILLD++ + L+DFGL+K + + + GT Y APE
Sbjct: 121 LHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSFCGTIEYMAPE 176
Query: 128 YAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHL 185
G D +S GV+ EL+TG + Q Q+ + SR LK + F
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SRRILKSKPPFPKT 234
Query: 186 VDPL 189
+
Sbjct: 235 MSAE 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-15
Identities = 43/153 (28%), Positives = 66/153 (43%), Gaps = 13/153 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+ + L S D LV EY+ G + L P W +
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAK--QYIAE 105
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
G+E LH + +I+RD+K N+L+D + KL+DFGL++ G + + +GT
Sbjct: 106 VVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGT 156
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
Y APE + SD +S G V+ E + G
Sbjct: 157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 52/155 (33%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 16 YCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73
YCT + + V EY+ G L H+ P + +I G L++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQFLHSKG- 116
Query: 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK 133
++YRDLK NILLD D + K++DFG+ K +GD + GT Y APE + K
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 134 LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
D +SFGV+L E++ G+ G E+ L
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPF---HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-15
Identities = 55/152 (36%), Positives = 85/152 (55%), Gaps = 10/152 (6%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H+ LV L S + +V EYM GSL D L + L + +A A G
Sbjct: 58 LRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASG 114
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGY 123
+ Y+ + N ++RDL++ANIL+ + K++DFGLA+L + DN + + + +
Sbjct: 115 MAYVE-RMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKW 169
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
APE A+ G+ T+KSD++SFG++L EL T GR
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---GAAR 63
+V G +V EY GS+ D + + + L T +IA +
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM---KITNKTL---TEEEIAAILYQTLK 110
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 123
GLEYLH I+RD+K+ NILL+ + KL+DFG++ G + D V+GT +
Sbjct: 111 GLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFW 165
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE K+DI+S G+ +E+ G+
Sbjct: 166 MAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 47/172 (27%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------------Y 40
+L ++H +++ L G C+ LL+ EY GSL L Y
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 41 DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100
PD+ L+ + A +RG++YL A +++RDL + N+L+ K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 101 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
L++ D+ ++ + A E T +SD++SFGV+L E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-15
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 25/227 (11%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N++ L G T +++ EYM G+L+ +L D + + ++ G A G++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 125
YL ++ ++RDL + NIL++++ K+SDFGL++ L + T+ ++ + A
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKFVH 184
PE K T SD++SFG+V+ E+++ GE RP+ + +
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMS----------FGE-------RPYWDMSNHEVMK 221
Query: 185 LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231
++ P C + + C ++ RP DIV LD L+
Sbjct: 222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-15
Identities = 49/143 (34%), Positives = 73/143 (51%), Gaps = 15/143 (10%)
Query: 16 YCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR--GLEYLHCK 71
YCT + + V E++ G L H+ Q+ ++ A GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHI------QDKGRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS 131
+IYRDLK N++LD D + K++DFG+ K GDN ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQG 170
Query: 132 GKLTLKSDIYSFGVVLLELITGR 154
K T D +SFGV+L E++ G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-15
Identities = 68/246 (27%), Positives = 109/246 (44%), Gaps = 47/246 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
++ H N+++L+G C + L+V YM G L + + + N +K +
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-------THNPTVKDLI 101
Query: 60 G----AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK------LGPVGD 109
G A+G+EYL A+ ++RDL + N +LD F K++DFGLA+ V +
Sbjct: 102 GFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158
Query: 110 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 169
+T V + A E + K T KSD++SFGV+L EL+T R A
Sbjct: 159 HTGAKLPVK----WMALESLQTQKFTTKSDVWSFGVLLWELMT-RGA------------- 200
Query: 170 SWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226
P D F + LL GR P C + V C + + RP +++V
Sbjct: 201 ----PPYPDVDSF-DITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255
Query: 227 LDYLVS 232
++ + S
Sbjct: 256 IEQIFS 261
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-15
Identities = 52/195 (26%), Positives = 89/195 (45%), Gaps = 16/195 (8%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
H N+V + GD+ +V E++ G+L D + ++E ++ + + + L
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKAL 128
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 125
+LH + VI+RD+KS +ILL +D KLSDFG V ++GT + A
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMA 183
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRPFLKDQKKFVH 184
PE + DI+S G++++E++ G + Q + + P LK+ K
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHK--- 240
Query: 185 LVDPLLHGRYPRRCL 199
V P L + R L
Sbjct: 241 -VSPRLRS-FLDRML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-15
Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAV 59
HH +V L+G + G L++ E M G L+ +L L P+ E P S +++A
Sbjct: 69 HH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
A G+ YL+ AN ++RDL + N ++ DF K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ +PE G T SD++SFGVVL E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 14/149 (9%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEYLHCKANPPVIYR 79
D+ V EY+ G L H+ EP R + A GL++LH + +IYR
Sbjct: 69 DRLFFVMEYVNGGDLMFHIQRSGRFDEP-----RARFYAAEIVLGLQFLHERG---IIYR 120
Query: 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 139
DLK N+LLD++ + K++DFG+ K G +G T ++ GT Y APE D
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQPYGPAVD 178
Query: 140 IYSFGVVLLELITGRKAMDLSKGQGEQNL 168
++ GV+L E++ G+ + G E L
Sbjct: 179 WWALGVLLYEMLAGQSPFE---GDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-15
Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 12/156 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AV 59
+L L+H LV L + LV + + G L HL E ++K
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSE-----EQVKFWIC 107
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
LEYLH K +I+RD+K NILLD + ++DF +A T T G
Sbjct: 108 EIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSG 161
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155
T GY APE ++ D +S GV E + G++
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 70/242 (28%), Positives = 101/242 (41%), Gaps = 38/242 (15%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTRMKIAV 59
HH +V L+G + G L+V E M G L+ +L L P+ E P + +++A
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
A G+ YL+ K ++RDL + N ++ +DF K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 179
+ APE G T SD++SFGVVL E IT EQ L
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLAEQPYQGLSNEQVL----------- 231
Query: 180 KKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236
KFV + G Y P C + MC RP +IV L + D
Sbjct: 232 -KFV------MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL-----KDDL 279
Query: 237 HP 238
HP
Sbjct: 280 HP 281
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 48/158 (30%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-------DLEPD-----QEPLSWNTR 54
H N++ L+G CT ++ EY G+L + L D D +E LS+
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ A ARG+EYL + I+RDL + N+L+ D K++DFGLA+ D +
Sbjct: 137 VSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + APE T +SD++SFG+++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTR 54
H N++ L+G CT ++ EY G+L ++L P +E L++
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ A ARG+EYL A+ I+RDL + N+L+ D K++DFGLA+ D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
T + APE T +SD++SFGV+L E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 54/152 (35%), Positives = 78/152 (51%), Gaps = 20/152 (13%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80
D+ V EY+ G L H+ + +EP + +IA+G L +LH K +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG----LFFLHSKG---IIYRD 126
Query: 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE---YAMSGKLTL 136
LK N++LD + + K++DFG+ K G T TR GT Y APE Y GK
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGK--- 180
Query: 137 KSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
D ++FGV+L E++ G+ D G+ E L
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-14
Identities = 54/168 (32%), Positives = 82/168 (48%), Gaps = 26/168 (15%)
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
KIAV + LEYLH K + VI+RD+K +N+L++ + KL DFG++ G + D+ T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKT 161
Query: 116 RVMGTYGYCAPEY---AMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 171
G Y APE ++ K +KSD++S G+ ++EL TGR D SW
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SW 210
Query: 172 SRPFLKDQKKFVHLVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRP 218
PF + K+ V P L ++ ++ CL + RP
Sbjct: 211 KTPF-QQLKQVVEEPSPQLPAEKFSPEFQDF----VNKCLKKNYKERP 253
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 51/166 (30%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEP 48
+ L HH N++ L+G C + + EY P G+L D L LE D
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
L+ ++ A A G++YL K I+RDL + N+L+ + K++DFGL++ G
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----G 168
Query: 109 DNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ +V + MG + A E T KSD++SFGV+L E+++
Sbjct: 169 EEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 2e-14
Identities = 47/156 (30%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
LS + G G + ++ EY GS D L E IA
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDE-------TYIAFI 103
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
GLEYLH + I+RD+K+ANILL + + KL+DFG++ G +
Sbjct: 104 LREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTF 158
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+GT + APE K+DI+S G+ +EL G
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 49/159 (30%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----------YDLE--PDQEPLSWNT 53
H N++ L+G CT ++ EY G+L ++L YD+ PD E +++
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD-EQMTFKD 138
Query: 54 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
+ ARG+EYL A+ I+RDL + N+L+ + K++DFGLA+ D
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+T + APE T +SD++SFGV++ E+ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-14
Identities = 43/158 (27%), Positives = 66/158 (41%), Gaps = 15/158 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H+N+V L + LV+EY+ LE LE L +
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLEL----LEASPGGLPPDAVRSYIWQ 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+ + Y H +I+RD+K NIL+ KL DFG A+ + ++ V T
Sbjct: 109 LLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 121 YGYCAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE GK D+++ G ++ EL+ G
Sbjct: 165 RWYRAPELLVGDTNYGK---PVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+++ L H NLV L+G L +V EYM GSL D+L + L + +K ++
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSL 109
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVM 118
+EYL +AN ++RDL + N+L+ D K+SDFGL K D + +
Sbjct: 110 DVCEAMEYL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154
+ APE K + KSD++SFG++L E+ + GR
Sbjct: 165 ----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-----YDLEPDQEPLSWNTRM 55
M L H N+V L+G C + ++ EY +G L+ L D + PLS ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ A G+++L +N ++RDL + N L+ + K+S L+K +
Sbjct: 121 ALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLR 176
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + APE + KSD++SFGV++ E+ T
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-14
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEP 48
+ L HH N++ L+G C L EY P G+L D L LE D
Sbjct: 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
LS + A ARG++YL K I+RDL + NIL+ ++ K++DFGL++ G
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----G 161
Query: 109 DNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+V + MG + A E T SD++S+GV+L E+++
Sbjct: 162 QEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 44/130 (33%), Positives = 62/130 (47%), Gaps = 5/130 (3%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
LV M G L H+Y+++ + GLE+LH + +IYRDLK
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPE 126
Query: 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 144
N+LLDND N ++SD GLA + D + GT G+ APE + D ++ G
Sbjct: 127 NVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALG 184
Query: 145 VVLLELITGR 154
V L E+I R
Sbjct: 185 VTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 47/155 (30%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M L +H+N+V L+G CT G L++ EY G L + L + L+ + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQ 149
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRV 117
A+G+ +L K I+RDL + N+LL + K+ DFGLA+ + D+ +V + R+
Sbjct: 150 VAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL 205
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE + T +SD++S+G++L E+ +
Sbjct: 206 --PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-14
Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 39/240 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIA 58
ML L H+NLV LI + LV+E++ DH L DLE L + K
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYL 106
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRV 117
RG+E+ H + +I+RD+K NIL+ KL DFG A+ L G+ V T
Sbjct: 107 FQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDY 160
Query: 118 MGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITG-----------------RKAMDL 159
+ T Y APE + K DI++ G ++ E++TG + +L
Sbjct: 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220
Query: 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN-YAVAVTAMCLNEEANFRP 218
Q + + F + V ++P L R+P+ L+ + + CL + + RP
Sbjct: 221 IPRH--QEIFQKNPLFAGMRLPEVKEIEP-LEKRFPK--LSGLVLDLAKQCLRIDPDDRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-14
Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
HH+N+V + GD+ +V E++ G+L D + ++E ++ + + R L
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRAL 131
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 125
YLH N VI+RD+KS +ILL +D KLSDFG V ++GT + A
Sbjct: 132 SYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMA 186
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITG 153
PE + DI+S G++++E+I G
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-14
Identities = 55/156 (35%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
ML H N+V G D+ +V EY GSL+D +Y + + PLS +
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQV--TRGPLSELQIAYVCRE 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR--V 117
+GL YLH I+RD+K ANILL D + KL+DFG+ A+L T ++ R
Sbjct: 110 TLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL----TAT-IAKRKSF 161
Query: 118 MGTYGYCAPEYA---MSGKLTLKSDIYSFGVVLLEL 150
+GT + APE A G K DI++ G+ +EL
Sbjct: 162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-14
Identities = 43/130 (33%), Positives = 65/130 (50%), Gaps = 7/130 (5%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
+V EY P G L + + ++ + +I + RGL+ LH + +++RDLKSA
Sbjct: 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSA 132
Query: 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 144
NILL + K+ D G++K V T +GT Y APE + KSDI+S G
Sbjct: 133 NILLVANDLVKIGDLGISK---VLKKNMAKT-QIGTPHYMAPEVWKGRPYSYKSDIWSLG 188
Query: 145 VVLLELITGR 154
+L E+ T
Sbjct: 189 CLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAV 59
+L L+H N++ L+ LV+E+M + LY L D Q L +
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLY 105
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTR 116
+GL + H +++RDLK N+L++ + KL+DFGLA+ PV TH V TR
Sbjct: 106 QLLQGLAFCH-SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR 162
Query: 117 VMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
Y APE + + DI+S G + EL++ R
Sbjct: 163 -----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 1e-13
Identities = 61/205 (29%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 21 DQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79
D +L ++ EY+ GS D L EP PL I +GL+YLH + I+R
Sbjct: 74 DTKLWIIMEYLGGGSALDLL---EPG--PLDETQIATILREILKGLDYLHSEKK---IHR 125
Query: 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 139
D+K+AN+LL KL+DFG+A G + D +GT + APE K+D
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKAD 183
Query: 140 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCL 199
I+S G+ +EL G L+ + P P L G Y +
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKPLK 230
Query: 200 NYAVAVTAMCLNEEANFRPLINDIV 224
+ A CLN+E +FRP +++
Sbjct: 231 EFVEA----CLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 51/148 (34%), Positives = 79/148 (53%), Gaps = 12/148 (8%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N+V + GD+ +V EY+ GSL D + + D+ ++ R + + LE
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALE 129
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCA 125
+LH VI+RD+KS NILL D + KL+DFG A++ P + + ST V GT + A
Sbjct: 130 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMA 183
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITG 153
PE K DI+S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 50/138 (36%), Positives = 71/138 (51%), Gaps = 16/138 (11%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAAR---GLEYLHCKANPPV 76
D LV M G L+ H+Y++ P E + AA GLE LH +
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNMGNPGFE------EERALFYAAEILCGLEDLHREN---T 123
Query: 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 136
+YRDLK NILLD+ + ++SD GLA P G++ + RV GT GY APE + + TL
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNNQRYTL 180
Query: 137 KSDIYSFGVVLLELITGR 154
D + G ++ E+I G+
Sbjct: 181 SPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V +G C + + E++P GS+ L P EP+ +I G
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----LGPVGDNTHVSTR 116
A YLH N V++RD+K N++L + KL DFG A+ +G G ++++
Sbjct: 115 VA----YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ GT + APE KSDI+S G + E+ TG+
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 1 MLSLLHHDNLVTLI-GYCTSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIA 58
+LS H N+V L Y +L+ E+ G+L+ + +LE EP +I
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLELERGLTEP-------QIR 106
Query: 59 V---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
L +LH VI+RDLK+ NILL D + KL+DFG++ +
Sbjct: 107 YVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT- 162
Query: 116 RVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGR 154
+GT + APE K+DI+S G+ L+EL
Sbjct: 163 -FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-13
Identities = 49/151 (32%), Positives = 76/151 (50%), Gaps = 13/151 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H LV L G CT LV+E+M G L D+ L + S T + + + G
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEG 112
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL VI+RDL + N L+ + K+SDFG+ + V D+ + S+ GT
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF--VLDDQYTSST--GTKFPV 165
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ +PE K + KSD++SFGV++ E+ +
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 39/94 (41%), Positives = 61/94 (64%), Gaps = 5/94 (5%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMGTY 121
RGL+Y+H AN V++RDLK +N+LL+ + + K+ DFGLA++ P D+T T + T
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 122 GYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGR 154
Y APE ++ K K+ DI+S G +L E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-13
Identities = 51/203 (25%), Positives = 89/203 (43%), Gaps = 25/203 (12%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
L+ EY G L + L D E D LS+ T++ +A+ +GL L+ N P Y++L S
Sbjct: 99 LILEYCTRGYLREVL-DKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152
Query: 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 144
+ L+ ++ K+ GL K+ +V+ V +Y ++ + T+K DIYS G
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKDDIYSLG 209
Query: 145 VVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVA 204
VVL E+ TG+ + + +L+ + + P C
Sbjct: 210 VVLWEIFTGKIPFENLTTKEIYDLI------INKNNSL----------KLPLDCPLEIKC 253
Query: 205 VTAMCLNEEANFRPLINDIVVAL 227
+ C + ++ RP I +I+ L
Sbjct: 254 IVEACTSHDSIKRPNIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 60/238 (25%), Positives = 98/238 (41%), Gaps = 37/238 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ-------------- 46
M S L H N+V L+G T +++ Y L + L P
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 47 -EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 105
EP + + I A G+E+L ++ V+++DL + N+L+ + N K+SD GL +
Sbjct: 121 LEPADF---VHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 106 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165
D + + + +PE M GK ++ SDI+S+GVVL E+ + + G
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS--YGLQPYCGYSN 232
Query: 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
Q+++ R V P P C + + C NE + RP DI
Sbjct: 233 QDVIEMIRN---------RQVLPC-----PDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-13
Identities = 46/143 (32%), Positives = 74/143 (51%), Gaps = 7/143 (4%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N+V LIG CT QR +Y M + D L L ++ L +K A+ AA G+
Sbjct: 51 HPNIVKLIGVCT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 126
YL K I+RDL + N L+ + K+SDFG+++ G + + + + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAP 163
Query: 127 EYAMSGKLTLKSDIYSFGVVLLE 149
E G+ + +SD++S+G++L E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-13
Identities = 42/157 (26%), Positives = 78/157 (49%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+++ L+H +++ ++G L E+M GS+ L +E + N ++
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLL-- 113
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLA-KLGPVGDNT-HVSTRV 117
RGL YLH +I+RD+K AN+L+D+ +++DFG A +L G ++
Sbjct: 114 --RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQL 168
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+GT + APE + D++S G V++E+ T +
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-13
Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 33/176 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---------------- 44
+++ H N+V L+G C G L++EYM G L + L P
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 45 --DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102
+ PLS ++ IA A G+ YL + ++RDL + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 103 KLGPVGD------NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ D N + R M PE + T +SD++++GVVL E+ +
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-13
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 31/228 (13%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H LV L G CT +V E+M G L L L Q LS + + + G
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEG 112
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR-VMGTYGY 123
+EYL + I+RDL + N L+ + K+SDFG+ + V D+ + S+ +
Sbjct: 113 MEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKW 167
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV 183
PE K + KSD++SFGV++ E+ T K PF ++K
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM-----------------PF--EKKSNY 208
Query: 184 HLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
+V+ + G P+ V C +E+ RP +++ A+
Sbjct: 209 EVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-13
Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 18/156 (11%)
Query: 17 CTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73
C RL LV EY+ G L H+ P++ + + IA L +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHERG- 116
Query: 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMS 131
+IYRDLK N+LLD D + KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPEILRG 170
Query: 132 GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 167
+ D ++ GV++ E++ GR D+ + N
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 58/246 (23%), Positives = 92/246 (37%), Gaps = 47/246 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKI 57
++S +H N+V LIG R ++ E M G L+ L + P E L+ +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHV 113
A A+G +YL I+RD+ + N LL P K++DFG+A+
Sbjct: 122 ARDVAKGCKYLEENH---FIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRK 177
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI----------TGRKAMDLSKGQ 163
R M + PE + G T K+D++SFGV+L E+ T ++ M+ G
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG 237
Query: 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
G + P+ C + C RP I
Sbjct: 238 GRLD--------------------------PPKGCPGPVYRIMTDCWQHTPEDRPNFATI 271
Query: 224 VVALDY 229
+ + Y
Sbjct: 272 LERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-13
Identities = 49/169 (28%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 1 MLSLLHHDNLVTL--IGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKI 57
+L L H N+VT+ + ++ D+ +V EY+ E L L E ++P + +
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCL 111
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
+ G+ +LH +++RDLK++N+LL+N K+ DFGLA+ G T++
Sbjct: 112 MLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQL 166
Query: 118 MGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165
+ T Y APE + K + D++S G + EL+T + L G+ E
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP---LFPGKSE 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-13
Identities = 47/134 (35%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80
D LV M G L+ H+Y + + + A GLE LH ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRD 127
Query: 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 140
LK NILLD+ + ++SD GLA P G + RV GT GY APE + + T D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 141 YSFGVVLLELITGR 154
++ G +L E+I G+
Sbjct: 185 WALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L + H ++ L + T DQR L + EY+P G L +L + ++ +
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLF 105
Query: 59 VGA--ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+ LEYLH K ++YRDLK NILLD + + KL+DFG AK + D T
Sbjct: 106 YASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT--- 157
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+ GT Y APE S D ++ G+++ E++ G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 53/166 (31%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD---LEPD---------QEP 48
+ L HH N++ L+G C L EY P G+L D L LE D
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
LS + A ARG++YL K I+RDL + NIL+ ++ K++DFGL++ G
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----G 173
Query: 109 DNTHVSTRVMGTYG--YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+V + MG + A E T SD++S+GV+L E+++
Sbjct: 174 QEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP---LSWNTRMKI 57
++S +H N+V L+G C + + ++ E M G L +L D ++ L+ + I
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILL-----DNDFNPKLSDFGLAKLGPVGDNTH 112
+ A+G YL I+RDL + N L+ D D K+ DFGLA+ D
Sbjct: 112 CLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + APE + GK T +SD++SFGV++ E++T
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-12
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 10/160 (6%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
LV M G L+ H+Y++ + L + + G+ +LH + ++YRD+K
Sbjct: 70 LVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPE 124
Query: 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFG 144
N+LLD+ N +LSD GLA G T+ GT GY APE + D ++ G
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYSYPVDWFAMG 181
Query: 145 VVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVH 184
+ E++ GR K + + + R L+D+ KF H
Sbjct: 182 CSIYEMVAGRTPFKDHKEKVAKEEL--KRRTLEDEVKFEH 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 37/102 (36%), Positives = 59/102 (57%), Gaps = 12/102 (11%)
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTH 112
KI++ RGL YL + +++RD+K +NIL+++ KL DFG++ G + D N+
Sbjct: 103 KISIAVLRGLTYL--REKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSF 158
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V TR Y +PE T++SDI+S G+ L+E+ GR
Sbjct: 159 VGTR-----SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 31/200 (15%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
H+N+V + GD+ +V E++ G+L D + ++E ++ + + + L
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKAL 129
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 125
LH + VI+RD+KS +ILL +D KLSDFG V ++GT + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMA 184
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGEQNLVSWSRPFL 176
PE + DI+S G++++E++ G KAM + + NL P L
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----DNL----PPKL 236
Query: 177 KDQKKFVHLVDPLLHGRYPR 196
K+ +H V P L G R
Sbjct: 237 KN----LHKVSPSLKGFLDR 252
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 15/170 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+L+L +T + C RL V EY+ G L H+ + +EP + +I+V
Sbjct: 53 VLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV 112
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM- 118
G L +LH + +IYRDLK N++LD++ + K++DFG+ K V V+TR
Sbjct: 113 G----LFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFC 162
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
GT Y APE D +++GV+L E++ G+ D G+ E L
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 40/103 (38%), Positives = 58/103 (56%), Gaps = 9/103 (8%)
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
K+ V + L YL K VI+RD+K +NILLD N KL DFG++ G + D + T
Sbjct: 118 KMTVAIVKALHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKT 172
Query: 116 RVMGTYGYCAPEY----AMSGKLTLKSDIYSFGVVLLELITGR 154
R G Y APE + K +++D++S G+ L+EL TG+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 49/140 (35%), Positives = 71/140 (50%), Gaps = 20/140 (14%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAAR---GLEYLHCKANP 74
D LV M G L+ H+Y++ D+E + AA GLE LH +
Sbjct: 73 DALCLVLTLMNGGDLKFHIYNMGNPGFDEE--------RAVFYAAEITCGLEDLHRER-- 122
Query: 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL 134
++YRDLK NILLD+ + ++SD GLA P G+ + RV GT GY APE + +
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERY 178
Query: 135 TLKSDIYSFGVVLLELITGR 154
T D + G ++ E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L H N+V LIG CT Q+ +Y M + D L L + L +++
Sbjct: 46 ILKQYSHPNIVRLIGVCT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVEN 102
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA G+EYL K I+RDL + N L+ K+SDFG+++ D + ST M
Sbjct: 103 AAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQ 157
Query: 121 --YGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149
+ APE G+ + +SD++SFG++L E
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-12
Identities = 49/158 (31%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 17 CTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73
C + RL V E++ G L H+ P++ ++ + +A L +LH +
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNFLHERG- 116
Query: 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCAPEYAMS 131
+IYRDLK N+LLD + + KL+D+G+ K + P GD T ST GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT--ST-FCGTPNYIAPEILRG 170
Query: 132 GKLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 167
D ++ GV++ E++ GR D+ +QN
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-12
Identities = 37/90 (41%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
L+Y+H VI+RD+K+ANIL+ N N KL DFG+A L + N+ + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 125 APEYAMSGKL-TLKSDIYSFGVVLLELITG 153
APE GK K+DI+S G+ + E+ TG
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 38/92 (41%), Positives = 53/92 (57%), Gaps = 5/92 (5%)
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
A L++LH + +IYRDLK NILLD + + KL+DFGL+K + S GT
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTV 162
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
Y APE T +D +SFGV++ E++TG
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 36/164 (21%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWN 52
L H N++ L+ LV+E+M DLE D +
Sbjct: 59 LKHPNIIGLLDVFGHKSNINLVFEFME--------TDLEKVIKDKSIVLTPADIKSYMLM 110
Query: 53 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD-NT 111
T RGLEYLH + +++RDLK N+L+ +D KL+DFGLA+ G N
Sbjct: 111 T--------LRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS--FGSPNR 157
Query: 112 HVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
++ +V+ T Y APE + + D++S G + EL+
Sbjct: 158 KMTHQVV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 13/101 (12%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---------GPVGDNTHVS 114
G+ YLH +++RD+K+ANIL+DN K++DFGLA+ G G T
Sbjct: 127 GINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 115 TRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
T ++ T Y PE + + T DI+ G V E+ T R
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 50/150 (33%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L + N+V + GD+ +V EY+ GSL D + + D+ ++ R + +
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QA 127
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGY 123
LE+LH VI+RD+KS N+LL D + KL+DFG A++ P + + ST V GT +
Sbjct: 128 LEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 181
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
APE K DI+S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 20 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79
G + ++ EY+ GS D L +P PL I +GL+YLH + I+R
Sbjct: 74 GTKLWIIMEYLGGGSALDLL---KPG--PLEETYIATILREILKGLDYLHSERK---IHR 125
Query: 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 139
D+K+AN+LL + KL+DFG+A G + D +GT + APE K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKAD 183
Query: 140 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCL 199
I+S G+ A++L+KG+ + + R K P L G+Y +
Sbjct: 184 IWSLGIT---------AIELAKGEPPNSDLHPMRVLFLIPKN----SPPTLEGQYSKPFK 230
Query: 200 NYAVAVTAMCLNEEANFRPLINDIV 224
+ A CLN++ FRP +++
Sbjct: 231 EFVEA----CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-12
Identities = 47/163 (28%), Positives = 87/163 (53%), Gaps = 20/163 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD--LEPDQEPLSWNTR--M 55
+L L H N++ ++ C G+ ++Y YM G+L+ L L P + +T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGP-----VGD 109
+A+ A G+ YLH + VI++D+ + N ++D + K++D L++ L P +GD
Sbjct: 121 HMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 110 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
N + + M A E ++ + + SD++SFGV+L EL+T
Sbjct: 178 NENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-12
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 17 CTSGDQRLL-VYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73
C + RL V EY+ G L H+ P++ ++ + +A L YLH +
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA------LNYLHERG- 116
Query: 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLG-PVGDNTHVSTRVMGTYGYCAPEYAMSG 132
+IYRDLK N+LLD++ + KL+D+G+ K G GD T + GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRGE 171
Query: 133 KLTLKSDIYSFGVVLLELITGRKAMDL--SKGQGEQN 167
D ++ GV++ E++ GR D+ S +QN
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 5 LHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYD--LEPDQEPLSWNTRMK 56
H N++ LIG C +++ +M G L L L E L T +K
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD---NTHV 113
V A G+EYL +N I+RDL + N +L D ++DFGL+K GD +
Sbjct: 118 FMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + + A E T KSD+++FGV + E+ T
Sbjct: 175 AKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 48/151 (31%), Positives = 78/151 (51%), Gaps = 8/151 (5%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H+N+V L + ++ +LV+EYM L+ ++ D + L NT +G
Sbjct: 55 LKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKG 112
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+ + H V++RDLK N+L++ KL+DFGLA+ + NT + V T Y
Sbjct: 113 IAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYR 167
Query: 125 APEYAMSGKLTLKS-DIYSFGVVLLELITGR 154
AP+ + + S DI+S G ++ E+ITGR
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL----------LVYEYMP---MGSLEDHLYDLEPDQE 47
+L L+H N+V L T L LV+EYM MG LE L D
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 48 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 107
+ MK + GL Y H K ++RD+K +NILL+N KL+DFGLA+L
Sbjct: 119 ----KSFMKQLL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 108 GDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154
++ + +V+ T Y PE + + D++S G +L EL T +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-12
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 55
+L L H+N++ L+ +V E M D L+ + +PL+ + +
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMET----D-LHKVIKSPQPLT-DDHI 105
Query: 56 K-IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ RGL+YLH AN VI+RDLK +NIL++++ + K+ DFGLA+ D
Sbjct: 106 QYFLYQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDE 159
Query: 115 TRVMGTY----GYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
+ Y Y APE +S T DI+S G + EL+T +
Sbjct: 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.4 bits (156), Expect = 5e-12
Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 12/146 (8%)
Query: 9 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 68
N+V + GD+ +V EY+ GSL D + + D+ ++ R + + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFL 132
Query: 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE 127
H VI+RD+KS NILL D + KL+DFG A++ P + ++GT + APE
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPE 186
Query: 128 YAMSGKLTLKSDIYSFGVVLLELITG 153
K DI+S G++ +E+I G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-12
Identities = 39/103 (37%), Positives = 57/103 (55%), Gaps = 10/103 (9%)
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVS 114
KIAV + L YL K +I+RD+K +NILLD + N KL DFG++ +L ++
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL----VDSIAK 164
Query: 115 TRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGR 154
TR G Y APE ++SD++S G+ L E+ TG+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-12
Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H N+V D+ +V + + L +H L+ ++ + I V
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
L YLH + +++RDL NI+L D ++DFGLAK + + T V+GT Y
Sbjct: 126 LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKL-TSVVGTILYS 180
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT 152
PE + K+D+++FG +L ++ T
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-12
Identities = 39/88 (44%), Positives = 48/88 (54%), Gaps = 8/88 (9%)
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 125
EYLH K +IYRDLK N+LLDN + K++DFG AK V D T + GT Y A
Sbjct: 132 EYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLA 183
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITG 153
PE S D ++ GV+L E I G
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 61/189 (32%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA-RGLEY 67
LVTL Y + +L L+ +Y+ G + HLY + E ++ G LE+
Sbjct: 67 LVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGEIILALEH 120
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGYCA 125
LH ++YRD+K NILLD++ + L+DFGL+K L + T+ GT Y A
Sbjct: 121 LH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFCGTIEYMA 174
Query: 126 PEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSRPFLKDQK 180
PE GK D +S G+++ EL+TG L +GE+N S SR LK
Sbjct: 175 PEIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTL---EGERNTQSEVSRRILKCDP 228
Query: 181 KFVHLVDPL 189
F + P
Sbjct: 229 PFPSFIGPE 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 7 HDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIA 58
H N++ LIG C + +++ +M G L L P T+M K
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
A G+EYL K+ I+RDL + N +L+ + N ++DFGL+K GD
Sbjct: 119 TDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ A E T KSD++SFGV + E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-11
Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 20 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79
G + ++ EY+ GS D L D+ ++ T +K + +GL+YLH + I+R
Sbjct: 74 GTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLHSEKK---IHR 125
Query: 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 139
D+K+AN+LL + KL+DFG+A G + D +GT + APE K+D
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKAD 183
Query: 140 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCL 199
I+S G+ A++L+KG+ + + R K P L G + +
Sbjct: 184 IWSLGIT---------AIELAKGEPPNSDMHPMRVLFLIPK----NNPPTLTGEFSKPFK 230
Query: 200 NYAVAVTAMCLNEEANFRPLINDIV 224
+ CLN++ +FRP +++
Sbjct: 231 EF----IDACLNKDPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-11
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL-VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-A 58
+LSL + +T + C RL V E++ G L H+ E R + A
Sbjct: 48 ILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYA 102
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
L +LH K +IYRDLK N+LLD++ + KL+DFG+ K G + + ST
Sbjct: 103 AEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FC 157
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT Y APE D ++ GV+L E++ G
Sbjct: 158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD----LEPDQEPLSWNTRMK 56
+L+ + H N+V + +V EY G L + L P+ L W +M
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVS 114
+ V +++H K V++RD+KS NI L + KL DFG A+L P +
Sbjct: 111 LGV------QHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYAC 158
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
T V GT Y PE + KSDI+S G +L EL T
Sbjct: 159 TYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 18/158 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL-----EDHLYDLEPDQEPLSWNTRM 55
+L+ + H N+VT + +V EY G L DQ LSW ++
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ-ILSWFVQI 110
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVS 114
+ GL+++H + +++RD+KS NI L N KL DFG+A+ + D+ ++
Sbjct: 111 SL------GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA 159
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+GT Y +PE + K+DI+S G VL EL T
Sbjct: 160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 49/146 (33%), Positives = 78/146 (53%), Gaps = 12/146 (8%)
Query: 9 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 68
N+V + GD+ +V EY+ GSL D + + D+ ++ R + + L++L
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFL 131
Query: 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMGTYGYCAPE 127
H VI+RD+KS NILL D + KL+DFG A++ P + + ST V GT + APE
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPE 185
Query: 128 YAMSGKLTLKSDIYSFGVVLLELITG 153
K DI+S G++ +E++ G
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 2e-11
Identities = 51/166 (30%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE--PLSWNTRMKIAV 59
L H N+V L D+ V+EYM E +LY L D++ P S + I
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIY 106
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN----THVST 115
+GL ++H K +RDLK N+L+ K++DFGLA+ + +VST
Sbjct: 107 QILQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVST 161
Query: 116 RVMGTYGYCAPEYAMSGKLTLKS-------DIYSFGVVLLELITGR 154
R Y APE + L+S DI++ G ++ EL T R
Sbjct: 162 R-----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 51/150 (34%), Positives = 70/150 (46%), Gaps = 13/150 (8%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA--ARG 64
H L L + D+ V EY G L HL +E + R + GA
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARF-YGAEIVSA 107
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
LEYLH + V+YRD+K N++LD D + K++DFGL K G + D + T GT Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE D + GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-11
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L H+ +V G +R L E+MP GS++D L L+ N K
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYT 112
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRV 117
G+ YLH +++RD+K ANIL D+ N KL DFG +K L + + V
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT + +PE K+DI+S G ++E++T +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 47/134 (35%), Positives = 65/134 (48%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80
D LV M G L+ H+Y++ + A GLE L ++YRD
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRD 127
Query: 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 140
LK NILLD+ + ++SD GLA P G+ V RV GT GY APE + K T D
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDW 184
Query: 141 YSFGVVLLELITGR 154
+ G ++ E+I G+
Sbjct: 185 WGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLV--YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L H+ +V G ++ L EYMP GS++D L E ++ +I
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL 116
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRV 117
G+ YLH +++RD+K ANIL D+ N KL DFG +K L + + V
Sbjct: 117 ----EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT + +PE K+D++S G ++E++T +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-11
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L HD +V G +++ L EYMP GS++D L L+ N +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYT 112
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRV 117
+G+ YLH +++RD+K ANIL D+ N KL DFG +K + + + V
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV 169
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
GT + +PE K+D++S ++E++T
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
L +LH VIYRDLK NILLD + + KL+DFG+ K G + T +T GT Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYI 163
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE + D ++ GV++ E++ G+
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-11
Identities = 60/185 (32%), Positives = 87/185 (47%), Gaps = 18/185 (9%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA-ARGLEY 67
LVTL Y D +L L+ +Y+ G L HL E +E ++I G LE+
Sbjct: 67 LVTL-HYAFQTDTKLHLILDYINGGELFTHLSQRERFKE-----QEVQIYSGEIVLALEH 120
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 127
LH +IYRD+K NILLD++ + L+DFGL+K D + GT Y AP+
Sbjct: 121 LH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEYMAPD 176
Query: 128 YAMSGKLTLKS--DIYSFGVVLLELITGRKAMDLSKGQGEQNLVS-WSRPFLKDQKKFVH 184
G D +S GV++ EL+TG + GE+N + SR LK + +
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD---GEKNSQAEISRRILKSEPPYPQ 233
Query: 185 LVDPL 189
+ L
Sbjct: 234 EMSAL 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-11
Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 16/151 (10%)
Query: 13 LIGYC-TSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVGAARGLEYL 68
L+G C TS Q LV + MP G L D++ D Q+ L+W V A+G+ YL
Sbjct: 74 LLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEY 128
+++RDL + N+L+ + + K++DFGLA+L + + + + + A E
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 129 AMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158
+ + T +SD++S+GV + EL+T G K D
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 9/93 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RGL+Y+H V++RDLK +NIL++ + + K+ DFGLA++ +VSTR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 123 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154
Y APE ++ K ++ DI+S G + E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 49/156 (31%), Positives = 83/156 (53%), Gaps = 13/156 (8%)
Query: 2 LSLLHHDN---LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L +LH N +V G S + + E+M GSL+ L + + E + K++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEI----LGKVS 109
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ RGL YL K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +
Sbjct: 110 IAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y +PE +++SDI+S G+ L+EL GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 50/150 (33%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 7 HDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
H LV L C + + V EY G L H++ + S + A GL
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGL 114
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK--LGPVGDNTHVSTRVMGTYGY 123
+YLH ++YRDLK N+LLD + K++DFGL K +G GD T ST GT +
Sbjct: 115 QYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTPEF 167
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
APE T D + GV++ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 55/160 (34%), Positives = 76/160 (47%), Gaps = 22/160 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH--LYDLEPDQEPLSWNTRMKIA 58
ML L H NLV LI + LV+EY DH L +LE + + + KI
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKII 106
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNT-HVST 115
+ + + H K N I+RD+K NIL+ KL DFG A++ GP D T +V+T
Sbjct: 107 WQTLQAVNFCH-KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163
Query: 116 RVMGTYGYCAPEYAMSGKLTLKS--DIYSFGVVLLELITG 153
R Y APE + G D+++ G V EL+TG
Sbjct: 164 R-----WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 58/229 (25%), Positives = 104/229 (45%), Gaps = 29/229 (12%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N++ L G T ++V EYM GSL+ L + + ++ G A G++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMK 120
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG---TYGY 123
YL ++ ++RDL + NIL++++ K+SDFGL+++ + D+ + G +
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIRW 175
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQKKF 182
APE K T SD++S+G+V+ E+++ GE RP+ + +
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS----------YGE-------RPYWEMSNQDV 218
Query: 183 VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231
+ ++ P C + C ++ N RP IV LD L+
Sbjct: 219 IKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-11
Identities = 51/130 (39%), Positives = 67/130 (51%), Gaps = 18/130 (13%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
LV EY +GS D L E ++PL I GA +GL YLH + I+RD+K+
Sbjct: 92 LVMEYC-LGSASDIL---EVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAG 144
Query: 85 NILLDNDFNPKLSDFGLAKL-GPVGDNTHVSTRVMGTYGYCAPE--YAM-SGKLTLKSDI 140
NILL KL+DFG A L P N+ V GT + APE AM G+ K D+
Sbjct: 145 NILLTEPGTVKLADFGSASLVSPA--NSFV-----GTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 141 YSFGVVLLEL 150
+S G+ +EL
Sbjct: 198 WSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-11
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-- 58
+L L+H N+V L+ S ++ LV+E++ + L+ ++ D PL+ I
Sbjct: 51 LLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM-----DSSPLTGLDPPLIKSY 104
Query: 59 -VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVST 115
+G+ Y H V++RDLK N+L+D + KL+DFGLA+ G PV TH
Sbjct: 105 LYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--- 158
Query: 116 RVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
V+ T Y APE + + + DI+S G + E++ R
Sbjct: 159 EVV-TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 48/151 (31%), Positives = 77/151 (50%), Gaps = 18/151 (11%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80
D+ V EY+ G L + + +EP + +IA+G L +LH K +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFFLHSKG---IIYRD 126
Query: 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVM-GTYGYCAPEYAMSGKLTLK 137
LK N++LD++ + K++DFG+ K +N V+T+ GT Y APE
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 181
Query: 138 SDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
D ++FGV+L E++ G+ + G+ E L
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFE---GEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 5e-11
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 23/162 (14%)
Query: 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAA 62
S L H N+V +G + + E +P GSL L PL N + I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL---LRSKWGPLKDNEQTIIFYTKQ 116
Query: 63 --RGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFG----LAKLGPVGDNTHVS 114
GL+YLH + +++RD+K N+L+ N ++ K+SDFG LA + P +
Sbjct: 117 ILEGLKYLH---DNQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPCTET---- 168
Query: 115 TRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGR 154
GT Y APE G +DI+S G ++E+ TG+
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIA 58
L H +V L+ G +LV EYMP L + L D E P+ + S+ RM +
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY-MRMLL- 109
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+G+ Y+H +++RDLK AN+L+ D K++DFGLA+L + S +V
Sbjct: 110 ----KGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV- 161
Query: 119 GTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
T Y APE + K D+++ G + EL+ G
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-11
Identities = 37/91 (40%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 123
L+YLH + N V+YRDLK N++LD D + K++DFGL K G + D + T GT Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEY 162
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE D + GVV+ E++ GR
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 35/93 (37%), Positives = 56/93 (60%), Gaps = 5/93 (5%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RGL+YLH A +++RD+K N+L++++ K+ DFGLA++ ++ H++ V+ Y
Sbjct: 114 RGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 123 YCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
Y APE M S T DI+S G + EL+ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-11
Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N++ L G T +++ E+M G+L+ L + + ++ G A G++
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMK 120
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG---- 122
YL + ++RDL + NIL++++ K+SDFGL++ + D+T T G
Sbjct: 121 YL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF--LEDDTSDPTYTSSLGGKIPI 175
Query: 123 -YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-DQK 180
+ APE K T SD++S+G+V+ E+ +S G+ RP+ +
Sbjct: 176 RWTAPEAIAYRKFTSASDVWSYGIVMWEV--------MSYGE---------RPYWDMSNQ 218
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231
++ ++ P C + C ++ N RP IV LD ++
Sbjct: 219 DVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-11
Identities = 41/95 (43%), Positives = 53/95 (55%), Gaps = 16/95 (16%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMG 119
GLE++H N V+YRDLK ANILLD + ++SD GLA K P H S +G
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157
Query: 120 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITG 153
T+GY APE G S D +S G +L +L+ G
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 40/89 (44%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
LE LH K N VIYRDLK NILLD + L DFGL KL D+ + GT Y
Sbjct: 106 LENLH-KFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYL 160
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITG 153
APE + T D ++ GV+L E++TG
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 39/101 (38%), Positives = 60/101 (59%), Gaps = 17/101 (16%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNT-------HVS 114
+ L+Y+H N VI+RDLK +NILL++D KL+DFGLA+ L + +N +V+
Sbjct: 118 KALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 115 TRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
TR Y APE + S + T D++S G +L E++ G+
Sbjct: 175 TR-----WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-10
Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 10 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH 69
+V +IG C + + +LV E G L L + D+ +S + V + G++YL
Sbjct: 57 IVRMIGVCEA-EALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQV--SMGMKYLE 112
Query: 70 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTY--GYCAP 126
K ++RDL + N+LL N K+SDFGL+K LG D+++ R G + + AP
Sbjct: 113 GKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAP 167
Query: 127 EYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 162
E K + +SD++S+G+ + E + G+K KG
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 49/169 (28%), Positives = 72/169 (42%), Gaps = 40/169 (23%)
Query: 16 YCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 71
Y + D+ L V EYMP G L + L D+ P++ + + +A+ + L ++H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH-- 124
Query: 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------------LGPVGDNTHVST 115
RD+K NIL+D D + KL+DFGL K DN V
Sbjct: 125 -------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 116 R-----------VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
R +GT Y APE L+ D +S GV+L E++ G
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 49/162 (30%), Positives = 88/162 (54%), Gaps = 14/162 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMKI 57
+++ + H +LV L+G C S +L V + MP G L D++++ + + Q L+W
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------ 114
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
V A+G+ YL + +++RDL + N+L+ + + K++DFGLA+L + + +
Sbjct: 115 CVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGG 171
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158
+ A E K T +SD++S+GV + EL+T G K D
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 36/90 (40%), Positives = 48/90 (53%), Gaps = 5/90 (5%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
L YLH V+YRDLK N++LD D + K++DFGL K G + D + T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE D + GVV+ E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
H N+V + G++ ++ E++ G+L D + ++E ++ + + L
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA-----TVCESVLQAL 130
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 125
YLH + VI+RD+KS +ILL D KLSDFG + + ++GT + A
Sbjct: 131 CYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMA 185
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITG 153
PE + DI+S G++++E++ G
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 49/170 (28%), Positives = 79/170 (46%), Gaps = 26/170 (15%)
Query: 28 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 87
E+M GSL+ +Y P+ +IAV +GL YL + +++RD+K +N+L
Sbjct: 79 EFMDGGSLD--VYRKIPEH------VLGRIAVAVVKGLTYLW---SLKILHRDVKPSNML 127
Query: 88 LDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
++ KL DFG++ ++ +GT Y APE + + SD++S G+
Sbjct: 128 VNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 148 LELITGR-KAMDLSKGQGE-------QNLVSWSRPFLKD---QKKFVHLV 186
+EL GR + K QG Q +V P L +KFVH +
Sbjct: 184 MELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 5 LHHDNLVTLIGYC--TSGDQRL----LVYEYMPMGSLEDHLYDLEPDQEP--LSWNTRMK 56
H N++ LIG + RL ++ +M G L L +EP L T ++
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+ A G+EYL ++ I+RDL + N +L+ + ++DFGL+K GD
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ A E T SD+++FGV + E++T
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 50/152 (32%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H N + G LV EY +GS D L E ++PL I GA
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGA 130
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
+GL YLH +I+RD+K+ NILL KL+DFG A ++ +GT
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTP 181
Query: 122 GYCAPEYAMS---GKLTLKSDIYSFGVVLLEL 150
+ APE ++ G+ K D++S G+ +EL
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-10
Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 18/160 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM--KIA 58
+L + H N+V L S + LV+EY+ + L+ H+ D PD + N R+
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIKTYL 108
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LG-PVGDNTHVST 115
RG+ Y H V++RDLK N+L+D N KL+DFGLA+ G PV TH
Sbjct: 109 YQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV 165
Query: 116 RVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
T Y APE + + + DI+S G + E++ +
Sbjct: 166 ----TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 4e-10
Identities = 33/83 (39%), Positives = 49/83 (59%)
Query: 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT 135
+I+RD+KSANILL ++ KL DFG +K+ + V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 136 LKSDIYSFGVVLLELITGRKAMD 158
K+D++S GV+L EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 35/93 (37%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RGL+Y+H A +I+RDLK +NI ++ D K+ DFGLA+ +V+TR
Sbjct: 129 RGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 123 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154
Y APE ++ DI+S G ++ EL+TG+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 8/155 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L + L++E++ M L+ +L L Q +
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQ 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+G+ + H + V++RDLK N+L+DN KL+DFGLA+ G V T + T
Sbjct: 110 ILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVT 164
Query: 121 YGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
Y APE + S + + DI+S G + E+ T +
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-10
Identities = 41/95 (43%), Positives = 53/95 (55%), Gaps = 16/95 (16%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA----KLGPVGDNTHVSTRVMG 119
GLE++H N V+YRDLK ANILLD + ++SD GLA K P H S +G
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157
Query: 120 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITG 153
T+GY APE G S D +S G +L +L+ G
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-10
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSW----NTRMKIAVG 60
L+H N++ +G C LLV E+ P+G L+++ L ++ ++ + ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNY---LRSNRGMVAQMAQKDVLQRMACE 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A GL +LH +A+ I+ DL N L D + K+ D+GLA D
Sbjct: 109 VASGLLWLH-QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP 165
Query: 121 YGYCAPEYA-------MSGKLTLKSDIYSFGVVLLELIT 152
+ APE + T KS+I+S GV + EL T
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-10
Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 18/149 (12%)
Query: 9 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLE 66
N+V L Y S D LV ++ G L H+ + P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCA 125
LH + ++ RDL NILLD+ + +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITGR 154
PE + T D +S G +L EL+TG+
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-10
Identities = 52/154 (33%), Positives = 68/154 (44%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AV 59
+L + H LV L + D+ V +Y+ G L HL EP R + A
Sbjct: 49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-----RARFYAA 103
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
A L YLH +IYRDLK NILLD+ + L+DFGL K G T ++ G
Sbjct: 104 EIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCG 158
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
T Y APE D + G VL E++ G
Sbjct: 159 TPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 8e-10
Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGL 65
H L +L + D+ V EY+ G L HL +E + R + L
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSAL 108
Query: 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCA 125
+YLH + ++YRDLK N++LD D + K++DFGL K G + D + T GT Y A
Sbjct: 109 DYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLA 163
Query: 126 PEYAMSGKLTLKSDIYSFGVVLLELITGR 154
PE D + GVV+ E++ GR
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-10
Identities = 50/155 (32%), Positives = 73/155 (47%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H +V LI +G + L+ EY+ G L HL ++E + +
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLS 107
Query: 61 A-ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVM 118
+ LE+LH + +IYRDLK NILLD + KL+DFGL K TH
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FC 161
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT Y APE M D +S G ++ +++TG
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-10
Identities = 44/135 (32%), Positives = 67/135 (49%), Gaps = 17/135 (12%)
Query: 28 EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANIL 87
EYM GSL D LY E + + +I +GL++L K +I+RD+K N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL--KEEHNIIHRDVKPTNVL 135
Query: 88 LDNDFNPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKL------TLKSD 139
++ + KL DFG V N ++ +G Y APE SG T++SD
Sbjct: 136 VNGNGQVKLCDFG------VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 140 IYSFGVVLLELITGR 154
++S G+ +LE+ GR
Sbjct: 190 VWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+LS L H +V D ++ EY L+ L +L+ + LS N + +
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
G+ Y+H + +++RDLK+ NI L N+ K+ DFG+++L + + ++T GT
Sbjct: 115 LLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGT 168
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y +PE KSDI+S G +L E+ A + FL
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------------FLSVVL 215
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224
+ V P L Y R+ LN ++ LN++ + RP +I+
Sbjct: 216 RIVEGPTPSLPETYSRQ-LN---SIMQSMLNKDPSLRPSAAEIL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 47/163 (28%), Positives = 86/163 (52%), Gaps = 16/163 (9%)
Query: 1 MLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPD---QEPLSWNTRMK 56
+++ + + ++ L+G C TS Q L+ + MP G L D++ + + + Q L+W
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYLLNW----- 114
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
V A+G+ YL + +++RDL + N+L+ + K++DFGLAKL + + +
Sbjct: 115 -CVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158
+ A E + T +SD++S+GV + EL+T G K D
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 48/155 (30%), Positives = 72/155 (46%), Gaps = 16/155 (10%)
Query: 5 LHHDNLVTLIGYCT--SGDQRLLVYEY--MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L H N+V L D LV EY + SL D++ P S + + +
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQ 116
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
RGL+YLH +I+RDLK +N+LL + K++DFGLA+ G T + T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVT 171
Query: 121 YGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
Y APE + T D+++ G +L EL+ +
Sbjct: 172 LWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+ H N+V G S ++ + EY GSL+D +Y + PLS +
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHV---TGPLSELQIAYVCRE 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GL YLH K ++RD+K ANILL ++ + KL+DFG+A + +GT
Sbjct: 115 TLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGT 169
Query: 121 YGYCAPEYAM---SGKLTLKSDIYSFGVVLLEL 150
+ APE A +G DI++ G+ +EL
Sbjct: 170 PYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 50/227 (22%), Positives = 88/227 (38%), Gaps = 27/227 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N++ + ++ +V E G L + + + + T K V
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
LE++H K +++RD+K AN+ + KL D GL + T + ++GT
Sbjct: 115 LCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y +PE KSDI+S G +L E + + PF D+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKM 211
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLINDI 223
L + YP ++ + + C+N + RP I+ +
Sbjct: 212 NLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 36/90 (40%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
LE+LH K + ++YRDLK NILLD + L DFGL+K + T + GT Y
Sbjct: 109 LEHLH-KYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 125 APEYAMSGK-LTLKSDIYSFGVVLLELITG 153
APE + K T D +S GV++ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 40/99 (40%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK---LGPVGDNTHVSTRVMG 119
GL+Y+H AN V++RDLK N+L++ D K+ DFGLA+ P G+N T +
Sbjct: 116 CGLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVA 171
Query: 120 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 157
T Y APE +S + K+ D++S G +L EL+ GRK +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 35/99 (35%), Positives = 59/99 (59%), Gaps = 9/99 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---GPVGDNTHVSTRVMG 119
RGL+Y+H AN VI+RDLK +N+L++ D ++ DFG+A+ P ++ + T +
Sbjct: 118 RGLKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT-EHKYFMTEYVA 173
Query: 120 TYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAM 157
T Y APE +S + T D++S G + E++ GR+ +
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 38/95 (40%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTY 121
R L+Y+H AN V +RDLK NIL + D K+ DFGLA++ T + T + T
Sbjct: 114 RALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 122 GYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGR 154
Y APE S K T DI+S G + E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 13/156 (8%)
Query: 2 LSLLHHDN---LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L +LH N +V G S + + E+M GSL+ L E + K++
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVS 109
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ +GL YL K +++RD+K +NIL+++ KL DFG++ G + D+ ++ +
Sbjct: 110 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 163
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y +PE +++SDI+S G+ L+E+ GR
Sbjct: 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 49/152 (32%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H N + G LV EY +GS D L E ++PL + GA
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAVTHGA 124
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
+GL YLH + +I+RD+K+ NILL KL DFG A + + +GT
Sbjct: 125 LQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTP 175
Query: 122 GYCAPEYAMS---GKLTLKSDIYSFGVVLLEL 150
+ APE ++ G+ K D++S G+ +EL
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 14/160 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L+H N+V L+ + ++ LV+E++ L+ + PL +
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQL- 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVM 118
+GL + H V++RDLK N+L++ + KL+DFGLA+ G PV TH V+
Sbjct: 110 -LQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH---EVV 162
Query: 119 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 157
T Y APE + K + DI+S G + E++T R+A+
Sbjct: 163 -TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 21/159 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAV 59
+L+ +H +V L+G + ++ E+ P G+++ + +L+ EP +I V
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQV 114
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR--- 116
+ LE L + +I+RDLK+ N+LL D + KL+DFG++ N R
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS-----AKNVKTLQRRDS 169
Query: 117 VMGTYGYCAPEYAMSGKLT-----LKSDIYSFGVVLLEL 150
+GT + APE M + K+DI+S G+ L+E+
Sbjct: 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 52/162 (32%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 6 HHDNLVTLIG------YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+H N+ T G + DQ LV E GS+ D + L + L I
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR-- 116
RGL YLH VI+RD+K NILL + KL DFG+ A+L D+T + R
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DST-LGRRNT 172
Query: 117 VMGTYGYCAPEYAMSGK-----LTLKSDIYSFGVVLLELITG 153
+GT + APE + +SD++S G+ +EL G
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-09
Identities = 49/152 (32%), Positives = 72/152 (47%), Gaps = 16/152 (10%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L + H N + G LV EY +GS D L E ++PL I GA
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLL---EVHKKPLQEVEIAAITHGA 134
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
+GL YLH +I+RD+K+ NILL KL+DFG A + ++ +GT
Sbjct: 135 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTP 185
Query: 122 GYCAPEYAMS---GKLTLKSDIYSFGVVLLEL 150
+ APE ++ G+ K D++S G+ +EL
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 51/188 (27%), Positives = 67/188 (35%), Gaps = 48/188 (25%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L+ L H L TL + LV +Y P G L L +P + + V
Sbjct: 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK-------CLSEEV-- 104
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
AR LEYLH ++YRDLK NILL + LSDF L+K V
Sbjct: 105 ARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVS 161
Query: 114 ------------------------STRVM---GTYGYCAPEYAMSGKLTLKSDIYSFGVV 146
S R GT Y APE D ++ G++
Sbjct: 162 KALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGIL 221
Query: 147 LLELITGR 154
L E++ G
Sbjct: 222 LYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-09
Identities = 36/94 (38%), Positives = 56/94 (59%), Gaps = 7/94 (7%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RGL+Y+H AN V++RDLK +N+LL+ + + K+ DFGLA+ + T + T
Sbjct: 119 RGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 123 YCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK 155
Y APE ++ + T D++S G + EL+ GRK
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-09
Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR---LLVYEYMPMGSLEDHLYD----LEPDQEPLSWNT 53
+LS + H N+V Y S ++ +V +Y G L + L P+ + L W
Sbjct: 52 VLSNMKHPNIVQ---YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108
Query: 54 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
++ +A L+++H + +++RD+KS NI L D KL DFG+A++ + +
Sbjct: 109 QICLA------LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVEL 157
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 173
+ +GT Y +PE + KSDI++ G VL E+ T + A + +NLV
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MKNLV---- 210
Query: 174 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAV---AVTAMCLNEEANFRPLINDIV 224
LK ++ G YP +Y+ + + RP +N I+
Sbjct: 211 --LK-----------IIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 12/153 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+ H N+V G D+ + E+ GSL+D +Y + PLS + ++
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHV---TGPLSESQIAYVSRE 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GL YLH K ++RD+K ANILL ++ + KL+DFG++ + +GT
Sbjct: 115 TLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGT 169
Query: 121 YGYCAPEYAM---SGKLTLKSDIYSFGVVLLEL 150
+ APE A G DI++ G+ +EL
Sbjct: 170 PYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 18/94 (19%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RG+++LH +++RDLK NIL+ +D K++DFGLA+ + T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVTLW 171
Query: 123 YCAPE------YAMSGKLTLKSDIYSFGVVLLEL 150
Y APE YA D++S G + EL
Sbjct: 172 YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-09
Identities = 44/125 (35%), Positives = 65/125 (52%), Gaps = 12/125 (9%)
Query: 34 SLEDHLYDLEPD---QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 90
SL D D E D +EPL+ + + ARG+E+L A+ I+RDL + NILL
Sbjct: 152 SLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSE 208
Query: 91 DFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
+ K+ DFGLA+ D +V R+ + APE T +SD++SFGV+L
Sbjct: 209 NNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLL 265
Query: 148 LELIT 152
E+ +
Sbjct: 266 WEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-09
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 25/163 (15%)
Query: 1 MLSLLHHDNLVTLIGYCT---SGDQRLLVYEYMP-----MGSLEDHLYDLEPDQEPLSWN 52
+L + H+N++ L+ T S D+ Y MP +G L H E LS +
Sbjct: 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLSED 118
Query: 53 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 112
+ +GL+Y+H +I+RDLK N+ ++ D K+ DFGLA+ +
Sbjct: 119 RIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGY 175
Query: 113 VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154
V TR Y APE ++ T DI+S G ++ E++TG+
Sbjct: 176 VVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 43/172 (25%), Positives = 83/172 (48%), Gaps = 34/172 (19%)
Query: 1 MLSLLHHDNLVT--------------LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQ 46
+LS L H N+V ++G+C GD +Y L++ L P+
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPEN 102
Query: 47 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 106
+ + W ++ +A L+YLH K +++RDLK+ N+ L K+ D G+A++
Sbjct: 103 QVVEWFVQIAMA------LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV-- 151
Query: 107 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158
+ + +++ ++GT Y +PE + KSD+++ G + E+ T + A +
Sbjct: 152 LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 8e-09
Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 42/200 (21%)
Query: 1 MLSLLHHDNLVTLIGYC-TSGDQRL-LVYEYMPMGSLEDHLYDL--------EPDQEPLS 50
+L L H+N+V+L+ D+ + L+++Y +DL + + +
Sbjct: 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDLWQIIKFHRQAKRVSIP 106
Query: 51 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKL-- 104
+ + G+ YLH +N V++RDLK ANIL+ + K+ D GLA+L
Sbjct: 107 PSMVKSLLWQILNGVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
Query: 105 ----GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDL 159
+ V+ T Y APE + + K+ DI++ G + EL+T
Sbjct: 164 APLKPLADLD-----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF-- 216
Query: 160 SKGQGEQNLVSWSRPFLKDQ 179
+G + + S PF +DQ
Sbjct: 217 ---KGREAKIKKSNPFQRDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-09
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 27/224 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L+H N++ + ++ +V E G L + + + + T K V
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+E++H + V++RD+K AN+ + KL D GL + T + ++GT
Sbjct: 115 LCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y +PE KSDI+S G +L E + + PF D+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE------------------MAALQSPFYGDKM 211
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVA----VTAMCLNEEANFRPLI 220
L + YP + + +MC+ + + RP I
Sbjct: 212 NLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 9e-09
Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 19/158 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L+ H N+V L+ + ++ E+ G+++ + +LE PL T +I V
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPL---TEPQIRVV 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---V 117
+ LE L+ +I+RDLK+ NIL D + KL+DFG++ NT R
Sbjct: 109 CKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSF 163
Query: 118 MGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLEL 150
+GT + APE M K+D++S G+ L+E+
Sbjct: 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 9e-09
Identities = 51/154 (33%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AV 59
+L L H LV L + ++ V +Y+ G L HL EP R + A
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-----RARFYAA 103
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
A + YLH +IYRDLK NILLD+ + L+DFGL K G + T ++ G
Sbjct: 104 EVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCG 158
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
T Y APE D + G VL E++ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 42/134 (31%), Positives = 64/134 (47%), Gaps = 3/134 (2%)
Query: 19 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78
S D+ LL+ EY G L + + P + L+ +H + +++
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMH 192
Query: 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKS 138
RDLKSANI L KL DFG +K + V++ GT Y APE + + K+
Sbjct: 193 RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKA 252
Query: 139 DIYSFGVVLLELIT 152
D++S GV+L EL+T
Sbjct: 253 DMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 36/105 (34%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 47 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLG 105
PL + I L YLH + +I+RD+K+ NI LD N L DFG A KL
Sbjct: 180 GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLD 236
Query: 106 PVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150
+T GT +PE K+DI+S G+VL E+
Sbjct: 237 -AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 50/153 (32%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H LV L + ++ V +++ G L HL EP R A
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP---RARFYAA-E 104
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A L YLH + ++YRDLK NILLD+ + L+DFGL K G +T +T GT
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGT 159
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
Y APE D + G VL E++ G
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L ++H +++ + SG +V +P S + + Y L PL + + I
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-LTKRSRPLPIDQALIIEKQ 165
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
GL YLH + +I+RD+K+ NI +++ + D G A+ PV + + GT
Sbjct: 166 ILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGT 219
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151
APE K K+DI+S G+VL E++
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 40/148 (27%), Positives = 71/148 (47%), Gaps = 11/148 (7%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N+V L G T G+ ++V EYM G+L+ L E L M + G A G++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ---LVAGQLMGMLPGLASGMK 121
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG--YC 124
YL + +++ L + +L+++D K+S F + + T + G +
Sbjct: 122 YL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWA 175
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT 152
APE + SD++SFG+V+ E+++
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 61/210 (29%), Positives = 90/210 (42%), Gaps = 28/210 (13%)
Query: 6 HHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
HH N+ T G DQ LV E+ GS+ D + + + + W I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICR 128
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR-- 116
RGL +LH VI+RD+K N+LL + KL DFG+ A+L D T V R
Sbjct: 129 EILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNT 180
Query: 117 VMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKAM-DLSKGQGEQNLVS 170
+GT + APE +SDI+S G+ +E+ G + D+ + +
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 171 WSRPFLKDQ---KKFVHLVDPLLHGRYPRR 197
P LK + KKF+ ++ L Y R
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSR 270
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RGL+Y+H + +I+RDLK +N+ ++ D K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 123 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154
Y APE ++ DI+S G ++ EL+TGR
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 42/193 (21%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWN 52
+L LL H+N+V LI C + LV+E+ +H D L N
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFC------EH------DLAGLLSN 111
Query: 53 TRMKIAVGAAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK- 103
+K + + GL Y+H +++RD+K+ANIL+ D KL+DFGLA+
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168
Query: 104 --LGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAM 157
L + RV+ T Y PE + G D++ G ++ E+ T M
Sbjct: 169 FSLSKNSKPNRYTNRVV-TLWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWTRSPIM 224
Query: 158 DLSKGQGEQNLVS 170
+ Q + L+S
Sbjct: 225 QGNTEQHQLTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 51/189 (26%), Positives = 75/189 (39%), Gaps = 41/189 (21%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPM--GSLEDHLYDLEPDQEPLSWNTRMKIAVGA- 61
L H +V + C+ GD VY MP G L +E LS K +VGA
Sbjct: 59 LIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 62 -------ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---------- 104
+EY+H K V++RDLK NILL + D+G A
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 105 ------GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT------ 152
+ + +++GT Y APE + + +DIY+ GV+L +++T
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232
Query: 153 ---GRKAMD 158
GRK
Sbjct: 233 RKKGRKISY 241
|
Length = 932 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 39/150 (26%), Positives = 66/150 (44%), Gaps = 5/150 (3%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L+H N++ ++ +V E G L + + + + T K V
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
LE++H + V++RD+K AN+ + KL D GL + T + ++GT
Sbjct: 115 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150
Y +PE KSDI+S G +L E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 10/170 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+VTL + LV+EY+ L+ ++ D +S +
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQ 112
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
RGL Y H + V++RDLK N+L++ KL+DFGLA+ V T+ + V T
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--T 167
Query: 121 YGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 169
Y P+ + S + + + D++ G + E+ +GR S + E +L+
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 5e-08
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 22/178 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWNTRM 55
+L ++H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 73 LLKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ 131
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ N ++
Sbjct: 132 MLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTP 181
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 173
V+ Y Y APE + DI+S G ++ EL+ G QG ++ W++
Sbjct: 182 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIF-----QGTDHIDQWNK 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 32/164 (19%)
Query: 1 MLSLLHHDNLVTLIGYC---TSGDQRL-LVYEYMPMGSLEDHLYDLEPDQ-EPLSWNTRM 55
+ L H N++ LI +G RL LV+E M M +LY+L + PL
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTG--RLALVFELMDM-----NLYELIKGRKRPLPEKRVK 103
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--- 112
+ L+++H + +RD+K NIL+ +D KL+DFG + G +
Sbjct: 104 SYMYQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPY 155
Query: 113 ---VSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELIT 152
+STR Y APE + G K DI++ G V E+++
Sbjct: 156 TEYISTR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-08
Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 2 LSLLHHDNLVTLIGYCTSG--DQRL---LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
L H N+V L+ C + D+ LV+E++ L +L + P P T
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA--ETIKD 112
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-T 115
+ RGL++LH +++RDLK NIL+ + KL+DFGLA++ + ++ T
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALT 165
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 166
V+ T Y APE + D++S G + E+ RK + + +Q
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-08
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 27/166 (16%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGA 61
+ H+N++ L+ GD LV + M DL+ + L+ + I +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDLKKVVDRKIRLTESQVKCILLQI 128
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-------LGPVGDNTHVS 114
GL LH ++RDL ANI +++ K++DFGLA+ + + +
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 115 TRVMGTYG-----YCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
R T Y APE M + K D++S G + EL+TG+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 7e-08
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 16/161 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKI 57
+L L H N+V L + + LV+EY+ ++ H L P+ L
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------F 108
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
RGL Y+H + +++RDLK N+L+ + KL+DFGLA+ V +T+ + V
Sbjct: 109 LFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV 165
Query: 118 MGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAM 157
T Y P+ + S + + D++ G + +E+I G A
Sbjct: 166 --TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 51/153 (33%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H LV L + D+ V +Y+ G L Y L+ ++ L R A
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL---FYHLQRERCFLEPRARF-YAAE 104
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A L YLH + ++YRDLK NILLD+ + L+DFGL K + N ST GT
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNGTTST-FCGT 159
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
Y APE D + G VL E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-08
Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 2 LSLLHHDNLVTLIGYCT-SGDQR----LLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRM 55
L H N+V L CT S R LV+E++ +D L+ EP + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIK 113
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ RGL++LH V++RDLK NIL+ + KL+DFGLA++ T
Sbjct: 114 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALT 167
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V+ T Y APE + D++S G + E+ +
Sbjct: 168 SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 49/172 (28%), Positives = 81/172 (47%), Gaps = 14/172 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L H N+VTL + LV+EY+ + D+ +L +S +
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNL------MSMHNVKIFM 109
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
RGL Y H + +++RDLK N+L++ KL+DFGLA+ V T+ + V
Sbjct: 110 FQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV- 165
Query: 119 GTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLV 169
T Y P+ + S + + D++ G +L E+ TGR S + E +L+
Sbjct: 166 -TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 35/102 (34%), Positives = 54/102 (52%), Gaps = 16/102 (15%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-------STR- 116
LEYLH N +++RDLK N+L+ + + KL+DFGL+K+G + T++ TR
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 117 -----VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
V GT Y APE + D ++ G++L E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 41/120 (34%), Positives = 61/120 (50%), Gaps = 16/120 (13%)
Query: 43 EPDQE-------PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 95
P QE PL+ + + ARG+E+L A+ I+RDL + NILL + K
Sbjct: 158 NPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVK 214
Query: 96 LSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ DFGLA+ D +V S R+ + APE T +SD++SFGV+L E+ +
Sbjct: 215 ICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 1e-07
Identities = 45/159 (28%), Positives = 67/159 (42%), Gaps = 18/159 (11%)
Query: 6 HHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
HH N+ T G DQ LV E+ GS+ D + + + + W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
RGL +LH VI+RD+K N+LL + KL DFG++ + +G
Sbjct: 119 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIG 173
Query: 120 TYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITG 153
T + APE KSD++S G+ +E+ G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 6/91 (6%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 123
G+++LH + +I+RDLK +NI++ +D K+ DFGLA+ G + ++ V+ Y Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE + DI+S G ++ E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 50/159 (31%), Positives = 73/159 (45%), Gaps = 21/159 (13%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY------DLEPDQEPLSWNTRMKIA 58
L H NL+ +G CT LLV E+ P+G L+ +L + PD L ++A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-----RMA 106
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
A GL +LH K N I+ DL N LL D K+ D+GL+ D ++
Sbjct: 107 CEIALGLLHLH-KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLW 163
Query: 119 GTYGYCAPEYA--MSGKL-----TLKSDIYSFGVVLLEL 150
+ APE + G L T +S+++S GV + EL
Sbjct: 164 VPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 30/216 (13%)
Query: 5 LHHDNLVTLIGYCTSGDQRL--------------LVYEYMPMGSLEDHLYDLEPDQEPLS 50
L HDN+V + L +V EYM E L ++ +Q PLS
Sbjct: 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVL-EQGPLS 112
Query: 51 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK-LGPVG 108
RGL+Y+H AN V++RDLK AN+ ++ D K+ DFGLA+ + P
Sbjct: 113 EEHARLFMYQLLRGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 109 DNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 167
+ + + T Y +P +S T D+++ G + E++TG+ + +
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ 229
Query: 168 LVSWSRPFLKDQKKFVHL-VDPLL---HGRYPRRCL 199
L+ S P ++++ + L V P G PRR L
Sbjct: 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPL 265
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 37/173 (21%)
Query: 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66
H N+V + ++ E+M GSLE E L+ +A G+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF---LA-----DVARQILSGIA 182
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCA 125
YLH + +++RD+K +N+L+++ N K++DFG+++ L D + S +GT Y +
Sbjct: 183 YLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMS 236
Query: 126 PE-------------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165
PE YA DI+S GV +LE GR + + QG+
Sbjct: 237 PERINTDLNHGAYDGYA--------GDIWSLGVSILEFYLGRFPFGVGR-QGD 280
|
Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 20/160 (12%)
Query: 4 LLHHDN-LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIA 58
L++ DN +T + Y + L LV +Y G L L E P+ + M IA
Sbjct: 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIA 114
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ + L Y+H RD+K NIL+D + + +L+DFG + L + D T S+ +
Sbjct: 115 IDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAV 164
Query: 119 GTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITG 153
GT Y +PE + GK + D +S GV + E++ G
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+VTL + LV+EY+ L+ +L D ++ +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDC---GNSINMHNVKLFLFQ 112
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
RGL Y H + V++RDLK N+L++ KL+DFGLA+ + T+ + V T
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--T 167
Query: 121 YGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGR 154
Y P+ + S + + D++ G + E+ TGR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
GL+Y+H +I+RDLK N+ ++ D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 123 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154
Y APE ++ DI+S G ++ E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 29/81 (35%), Positives = 45/81 (55%), Gaps = 11/81 (13%)
Query: 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---VMGTYGYCAPEYAMSG 132
++YRDLK N+LLD D K++DFG AK+ V TR + GT Y APE ++
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYIAPEILLNV 203
Query: 133 KLTLKSDIYSFGVVLLELITG 153
+D ++ G+ + E++ G
Sbjct: 204 GHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 49/170 (28%), Positives = 75/170 (44%), Gaps = 16/170 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKI 57
+L L H N+VTL + LV+EY+ ++D L N R+
Sbjct: 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH------NVRL-F 108
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
RGL Y H + V++RDLK N+L+ KL+DFGLA+ V T+ + V
Sbjct: 109 LFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV 165
Query: 118 MGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 166
T Y P+ + S + + D++ G + E+ TGR S +Q
Sbjct: 166 --TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 43/136 (31%), Positives = 66/136 (48%), Gaps = 19/136 (13%)
Query: 25 LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
+V EYMP G L + + YD+ P++ + + +A+ A + ++H RD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDI-PEKWARFYTAEVVLALDAIHSMGFIH---------RDVK 169
Query: 83 SANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLK 137
N+LLD + KL+DFG K+ G T V GT Y +PE S G +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRE 227
Query: 138 SDIYSFGVVLLELITG 153
D +S GV L E++ G
Sbjct: 228 CDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 47/150 (31%), Positives = 65/150 (43%), Gaps = 18/150 (12%)
Query: 7 HDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAAR 63
+ LV L+ Y D+ L L EY+P G L +L + + M AV A
Sbjct: 60 SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 123
L Y+H RDLK N L+D + KL+DFGL+K N+ V+G+ Y
Sbjct: 119 ELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDY 164
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
APE D +S G +L E + G
Sbjct: 165 MAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 46/147 (31%), Positives = 69/147 (46%), Gaps = 21/147 (14%)
Query: 16 YCTSGDQRLL--VYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 71
+C D + L V EYMP G L + + YD+ P++ + + +A+ A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFYTAEVVLALDAIHSMGLIH-- 165
Query: 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVMGTYGYCAPEYAM 130
RD+K N+LLD + KL+DFG K+ G T V GT Y +PE
Sbjct: 166 -------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLK 216
Query: 131 S----GKLTLKSDIYSFGVVLLELITG 153
S G + D +S GV L E++ G
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 14/166 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L + +V +IG C + +LV E +G L L + ++ ++
Sbjct: 49 VMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFL----QKNKHVTEKNITELVHQ 103
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMG 119
+ G++YL + N ++RDL + N+LL K+SDFGL+K LG D + + G
Sbjct: 104 VSMGMKYLE-ETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHG 158
Query: 120 TY--GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKG 162
+ + APE K + KSD++SFGV++ E + G+K KG
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-07
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+S L H +LV G C GD+ ++V EY+ GSL+ +L + +SW ++++A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQ 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A L +L K + + ++ + N+LL + + K + KL G + V + +
Sbjct: 109 LAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILL 165
Query: 121 --YGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITG 153
+ PE + + L+L +D +SFG L E+ +G
Sbjct: 166 ERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-07
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 7/127 (5%)
Query: 27 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86
Y+ +++ L D E L+ + ARG+E+L A+ ++RDL + N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 87 LLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 145
LL K+ DFGLA+ + D+ +VS + APE T SD++S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 146 VLLELIT 152
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-07
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 22/159 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++S L H +LV L G C D+ ++V EY+ G L+ L+ E + L W ++ +A
Sbjct: 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQ 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILL----DNDFNP---KLSDFGLAKLGPVGDNTHV 113
A L YL K +++ ++ NIL+ N+ KLSD G+ V
Sbjct: 110 LASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREER 164
Query: 114 STRVMGTYGYCAPEY--AMSGKLTLKSDIYSFGVVLLEL 150
R+ + APE LT+ +D +SFG LLE+
Sbjct: 165 VERI----PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-07
Identities = 48/176 (27%), Positives = 78/176 (44%), Gaps = 16/176 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG---SLEDHLYDLEPDQEPLSWNTRMKI 57
+L L H N+V L + + V+EYM + H L P +N R+
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHP------YNVRL-F 108
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
RGL Y+H + +++RDLK N+L+ KL+DFGLA+ + T+ S V
Sbjct: 109 MFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 118 MGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 172
T Y P+ + + + DI+ G + +E++ G+ A EQ W+
Sbjct: 166 --TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-07
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 16/157 (10%)
Query: 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY---DLEPDQEPLSWNTRMKIAVG 60
+L H N++ +G C LLV+EY +G L+ +L + + L ++A
Sbjct: 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ ++H K N ++ DL N L +D K+ D+G+ D
Sbjct: 108 IAAGVTHMH-KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 121 YGYCAPEYAMS--GKL-----TLKSDIYSFGVVLLEL 150
+ APE G L T S++++ GV L EL
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 9/157 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L ++H +++ L G T L+ + + LY + ++ + I
Sbjct: 136 ILRAINHPSIIQLKGTFTYNKFTCLI-----LPRYKTDLYCYLAAKRNIAICDILAIERS 190
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
R ++YLH +I+RD+K+ NI +++ + L DFG A PV N + GT
Sbjct: 191 VLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGT 246
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157
APE DI+S G+VL E+ T ++
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 8e-07
Identities = 38/148 (25%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H ++V LIG T + +V E P+G L +L + ++ L + + + +
Sbjct: 64 FDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTA 119
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGY 123
L YL K ++RD+ + N+L+ + KL DFGL++ + D ++ +++ +
Sbjct: 120 LAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKW 174
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELI 151
APE + T SD++ FGV + E++
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 8e-07
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
ML L +N+V L + LV+EY+ LE L + P+ P K+
Sbjct: 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSY 105
Query: 61 AARGLEYLH-CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
+ ++ +H C N +++RD+K N+L+ ++ KL DFG A+ G N + T +
Sbjct: 106 IYQLIKAIHWCHKND-IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVA 163
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSR---PF 175
T Y +PE + D++S G +L EL G+ L G+ E L + + P
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP---LFPGESEIDQLFTIQKVLGPL 220
Query: 176 LKDQKKFVHLVDPLLHG-RYP 195
+Q K + +P HG R+P
Sbjct: 221 PAEQMKLFY-SNPRFHGLRFP 240
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 34/94 (36%), Positives = 53/94 (56%), Gaps = 9/94 (9%)
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVM 118
A+G+E+L A+ I+RDL + NILL + K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE T++SD++SFGV+L E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 43/159 (27%), Positives = 81/159 (50%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWNTRM 55
++ ++H N++ L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 76 LMKCVNHKNIIGLLNVFTP-QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQ 134
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ G + ++
Sbjct: 135 MLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V+ Y Y APE + DI+S G ++ E+I G
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 23/141 (16%)
Query: 25 LVYEYMPMGSLEDHL--YDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIYRD 80
LV EY P G L L Y+ + E ++ + + +A+ + + Y+H RD
Sbjct: 78 LVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVH---------RD 127
Query: 81 LKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHVSTRVMGTYGYCAPEY--AMSGKLT-- 135
+K N+L+D + KL+DFG A+L + S +GT Y APE M+G
Sbjct: 128 IKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 136 --LKSDIYSFGVVLLELITGR 154
++ D +S GV+ E+I GR
Sbjct: 186 YGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
RGL+Y+H +I+RDLK +N+ ++ D ++ DFGLA+ +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 123 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154
Y APE ++ DI+S G ++ EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 11 VTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLE 66
+T + Y + L LV +Y G L L E P+ + M +A+ + L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP 126
Y+H RD+K N+LLD + + +L+DFG + L D T S+ +GT Y +P
Sbjct: 123 YVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISP 172
Query: 127 EY--AMS---GKLTLKSDIYSFGVVLLELITG 153
E AM GK + D +S GV + E++ G
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 2e-06
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 46/172 (26%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYE---YMPMGSLEDHLY------DLEPDQEPLSWN 52
L L+H+N++ + + +L E YM + LY + PL
Sbjct: 217 LGRLNHENILKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 53 TR--MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-------- 102
TR MK + A +EY+H K +I+RD+K NI L+ D L DFG A
Sbjct: 269 TRAIMKQLLCA---VEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 103 --KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
G VG S ++ GYC +DI+S G++LL++++
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCE-----------ITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 2e-06
Identities = 41/156 (26%), Positives = 81/156 (51%), Gaps = 17/156 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYE--YMPMGSLEDHL---YDLEPDQEPLSWNTRM 55
++ ++H N+++L+ T + L ++ Y+ M ++ +L +E D E +S+
Sbjct: 69 LMKCVNHKNIISLLNVFTP-QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ G + ++
Sbjct: 128 MLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 177
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151
V+ Y Y APE + DI+S G ++ E++
Sbjct: 178 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 44/139 (31%), Positives = 68/139 (48%), Gaps = 25/139 (17%)
Query: 25 LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
+V EYMP G L + + YD+ P++ + + +A+ A + ++H RD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH---------RDVK 169
Query: 83 SANILLDNDFNPKLSDFG----LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKL 134
N+LLD + KL+DFG + K G V +T V GT Y +PE S G
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYY 224
Query: 135 TLKSDIYSFGVVLLELITG 153
+ D +S GV L E++ G
Sbjct: 225 GRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 50/159 (31%), Positives = 70/159 (44%), Gaps = 11/159 (6%)
Query: 3 SLLHHDNLVTLIGYC-----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 57
SL +H N+V G G Q LV E GS+ + + L + L I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGP--VGDNTHVS 114
GA GL++LH N +I+RD+K NILL + KL DFG+ A+L + NT V
Sbjct: 134 LYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG 190
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
T A E + D++S G+ +EL G
Sbjct: 191 TPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 34/111 (30%), Positives = 56/111 (50%), Gaps = 3/111 (2%)
Query: 42 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101
LE D+ L + + A+G+ +L A+ I+RDL + NILL + K+ DFGL
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 260
Query: 102 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
A+ N V + APE + T +SD++S+G++L E+ +
Sbjct: 261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 45/161 (27%), Positives = 67/161 (41%), Gaps = 15/161 (9%)
Query: 3 SLLHHDNLVTLIGY-----CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 57
+L H N+V G +GDQ LV E GS+ D + E + I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
A GL++LH I+RD+K NILL + KL DFG++ +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTS 184
Query: 118 MGTYGYCAPEY-----AMSGKLTLKSDIYSFGVVLLELITG 153
+GT + APE + + D++S G+ +EL G
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L S + LV+EY L+ + D +P
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDP---EIVKSFMFQ 107
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LG-PVGDNTHVSTRVM 118
+GL + H V++RDLK N+L++ + KL+DFGLA+ G PV S V+
Sbjct: 108 LLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV---RCYSAEVV 161
Query: 119 GTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLEL 150
T Y P+ KL S D++S G + EL
Sbjct: 162 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 7e-06
Identities = 31/109 (28%), Positives = 56/109 (51%), Gaps = 3/109 (2%)
Query: 44 PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 103
D PL + ++ + A+G+++L K I+RD+ + N+LL + K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 104 LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
N V + APE T++SD++S+G++L E+ +
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 7e-06
Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ H N++T T+G ++ +M GS L P E +S I G
Sbjct: 52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFG 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD----FGLAKLGP----VGDNTH 112
A RGL YLH I+R++K+++IL+ D LS + L + G V D
Sbjct: 110 ALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166
Query: 113 VSTRVMGTYGYCAPEYA---MSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQ 163
ST V+ + +PE + G +KSDIYS G+ EL TGR D+ + Q
Sbjct: 167 FSTSVLP---WLSPELLRQDLYG-YNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 25/151 (16%)
Query: 8 DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 67
+NL ++ Y GD L+ ++ ED L P+ + M +A+ + L Y
Sbjct: 74 NNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVLAIDSVHQLGY 123
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 127
+H RD+K N+LLD + + +L+DFG + L + D T S +GT Y +PE
Sbjct: 124 VH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPE 173
Query: 128 Y--AM---SGKLTLKSDIYSFGVVLLELITG 153
AM G+ + D +S GV + E++ G
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 46/188 (24%), Positives = 74/188 (39%), Gaps = 49/188 (26%)
Query: 26 VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85
V +Y+P G + L L +E L+ R IA +E +H I+RD+K N
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDLA---RFYIA-ELTCAIESVH---KMGFIHRDIKPDN 131
Query: 86 ILLDNDFNPKLSDFGL-----------------------------------AKLGPVGD- 109
IL+D D + KL+DFGL +L P+
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERR 191
Query: 110 NTHVSTRVM-----GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQ 163
R + GT Y APE + T D +S GV+L E++ G+ + + +
Sbjct: 192 RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251
Query: 164 GEQNLVSW 171
+ +++W
Sbjct: 252 TQLKVINW 259
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK--LGPVGDNTHVSTRVMG 119
R L Y+H K + +RDLK N+L+D N KL DFG AK L +++ +R
Sbjct: 181 RALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-- 235
Query: 120 TYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITG 153
Y APE + + T D++S G ++ E+I G
Sbjct: 236 ---YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 26/85 (30%), Positives = 43/85 (50%), Gaps = 3/85 (3%)
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
++Y+H + +I+RD+K+ N+L++ + L DFG A +T + GT
Sbjct: 273 IDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLE 149
APE T DI+S G+V+ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 26/164 (15%)
Query: 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV---G 60
L H N++ + + +V M GS ED L P+ P + IA
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKD 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA--------KLGPVGDNTH 112
L+Y+H K I+R +K+++ILL D LS + + V D
Sbjct: 110 VLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166
Query: 113 VSTRVMGTYGYCAPEY---AMSGKLTLKSDIYSFGVVLLELITG 153
S + + + +PE + G KSDIYS G+ EL G
Sbjct: 167 SSVKNLP---WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 4e-05
Identities = 28/80 (35%), Positives = 45/80 (56%), Gaps = 7/80 (8%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
LV EY+ G ++ L+ E ++ +K A L+YLH +I+RDLK
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRHG---IIHRDLKPD 133
Query: 85 NILLDNDFNPKLSDFGLAKL 104
N+L+ N+ + KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 40/127 (31%), Positives = 59/127 (46%), Gaps = 24/127 (18%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHV 113
G+ YLH V++RDLK ANIL+ + P K++D G A+ L P+ D
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD---- 171
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 172
V+ T+ Y APE + + K+ DI++ G + EL+T Q + S
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTS 226
Query: 173 RPFLKDQ 179
PF DQ
Sbjct: 227 NPFHHDQ 233
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-05
Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 51/188 (27%)
Query: 6 HHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKIAVGA 61
+ +V L Y + D+ L+ EY+P G + L D ++E TR IA
Sbjct: 59 DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE-----TRFYIA-ET 110
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-----------------L 104
++ +H K I+RD+K N+LLD + KLSDFGL L
Sbjct: 111 ILAIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
Query: 105 GPVGDNTHVSTR-------------------VMGTYGYCAPEYAMSGKLTLKSDIYSFGV 145
+ +GT Y APE + + D +S GV
Sbjct: 168 PSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227
Query: 146 VLLELITG 153
++ E++ G
Sbjct: 228 IMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-05
Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 5/109 (4%)
Query: 45 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104
+ LS+ + + A G+E+L A+ ++RDL + N+L+ K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR- 287
Query: 105 GPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ D+ ++S + APE + T SD++SFG++L E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 36/135 (26%), Positives = 55/135 (40%), Gaps = 15/135 (11%)
Query: 25 LVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
LV+EY+ + D PL T +G+ + H V++RDLK
Sbjct: 83 LVFEYLDSDLKKFMDSNGRGPG--RPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLK 137
Query: 83 SANILLDNDFNP-KLSDFGLAKLG--PVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKS 138
N+L+D K++D GL + PV TH + T Y APE + +
Sbjct: 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWYRAPEVLLGSTHYSTPV 193
Query: 139 DIYSFGVVLLELITG 153
DI+S G + E+
Sbjct: 194 DIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-05
Identities = 57/236 (24%), Positives = 100/236 (42%), Gaps = 42/236 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+ + H ++V L G C + ++V E++ G L+ L+ + + L+ + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LF-MHRKSDVLTTPWKFKVAKQ 113
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILL-----DNDFNP--KLSDFGLAKLGPVGDNTHV 113
A L YL K +++ ++ + NILL D + P KLSD G+ P+ V
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----V 162
Query: 114 STR--VMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLEL-ITGRKAM-DLSKGQGEQNL 168
+R + + APE K L++ +D +SFG L E+ G + D + + E+
Sbjct: 163 LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY 222
Query: 169 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224
K+ L+ C+NY N+ FR ++ DI
Sbjct: 223 EGQCMLVTPSCKELADLM---------THCMNYDP-------NQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 24/127 (18%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAK-----LGPVGDNTHV 113
G+ YLH V++RDLK ANIL+ + P K++D G A+ L P+ D
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLAD---- 171
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS 172
V+ T+ Y APE + + K+ DI++ G + EL+T Q + S
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTS 226
Query: 173 RPFLKDQ 179
P+ DQ
Sbjct: 227 NPYHHDQ 233
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 42/181 (23%), Positives = 69/181 (38%), Gaps = 56/181 (30%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIY 78
D V +Y+P G + L + E L+ + + AV + + ++H
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIH--------- 124
Query: 79 RDLKSANILLDNDFNPKLSDFGL---------AKLGPVGDNTH----------------- 112
RD+K NIL+D D + KL+DFGL +K GD+
Sbjct: 125 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCR 184
Query: 113 -------------------VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
++ ++GT Y APE + T D +S GV+L E++ G
Sbjct: 185 CGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 244
Query: 154 R 154
+
Sbjct: 245 Q 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 39/164 (23%), Positives = 61/164 (37%), Gaps = 44/164 (26%)
Query: 25 LVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
L+ E++P G + L D ++ + +A+ A L ++H RD+K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDIK 128
Query: 83 SANILLDNDFNPKLSDFGLA---------------KLGPVGD------------------ 109
N+LLD + KLSDFGL P D
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 110 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 9e-04
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 20/158 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++S + H +L + G C G + ++V E++ G L D E + P++W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQ 125
Query: 61 AARGLEYLHCKANPPVIYRDLKSANIL-----LDNDFNP--KLSDFGLAKLGPVGDNTHV 113
A L YL K +++ ++ + NIL L +P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 114 STRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 150
R+ + APE G L+ +D +SFG LLE+
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 43/181 (23%), Positives = 68/181 (37%), Gaps = 56/181 (30%)
Query: 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLS--WNTRMKIAVGAARGLEYLHCKANPPVIY 78
D V +Y+P G + L +E E L+ + + +A+ + + ++H
Sbjct: 74 DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH--------- 124
Query: 79 RDLKSANILLDNDFNPKLSDFGL---------AKLGPVGD-----------------NTH 112
RD+K NIL+D D + KL+DFGL +K G N
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCR 184
Query: 113 VSTRVM-------------------GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
R+ GT Y APE + T D +S GV+L E++ G
Sbjct: 185 CGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVG 244
Query: 154 R 154
+
Sbjct: 245 Q 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 27/83 (32%), Positives = 40/83 (48%), Gaps = 17/83 (20%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-----VGAARGLEYLHCKANPPVIYR 79
L+ E++P G L L + E + TR +A + A L ++H R
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAECVLAIEAVHKLGFIH---------R 125
Query: 80 DLKSANILLDNDFNPKLSDFGLA 102
D+K NIL+D + KLSDFGL+
Sbjct: 126 DIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 30/122 (24%), Positives = 50/122 (40%), Gaps = 13/122 (10%)
Query: 48 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-----------FNPKL 96
P S +I L+Y H + + +++ DLK NIL++ P
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 97 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156
+ LG D H T ++ T Y +PE + +D++S G ++ EL TG+
Sbjct: 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLL 344
Query: 157 MD 158
D
Sbjct: 345 YD 346
|
Length = 467 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 38/164 (23%), Positives = 62/164 (37%), Gaps = 44/164 (26%)
Query: 25 LVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
L+ E++P G + L D ++E + +A+ + L ++H RD+K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIH---------RDIK 128
Query: 83 SANILLDNDFNPKLSDFGLAKLGPVGDNT------------------------------- 111
N+LLD+ + KLSDFGL T
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 112 --HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
++ +GT Y APE M D +S GV++ E++ G
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.2 bits (88), Expect = 0.004
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 43/170 (25%)
Query: 10 LVTLIGYCTSGD-QRLLVYEYMPMGSLEDH-LYDLEPDQEPLSWNTRMKIAVGAARGLEY 67
L L+ +C +GD R + Y G +E+H + D+ TR + L Y
Sbjct: 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI----------TRQLL-----HALAY 133
Query: 68 LHCKANPP----VIYRDLKSANILLD-------------NDFN----PKLSDFGLAKLGP 106
H + P V++RDLK NI L N+ N K+ DFGL+K
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG 193
Query: 107 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTL--KSDIYSFGVVLLELITGR 154
+ H +GT Y +PE + + KSD+++ G ++ EL +G+
Sbjct: 194 IESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 267 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.93 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.92 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.9 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.88 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.67 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.63 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.59 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.57 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.52 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.52 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.44 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.38 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.36 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.34 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.33 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.25 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.17 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.11 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.03 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.88 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.83 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.8 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.71 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.69 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.38 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.32 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.13 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.08 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.85 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.83 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.36 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.32 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 96.99 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.8 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.57 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.51 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.43 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.41 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.33 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.85 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.99 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.92 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.79 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.46 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.09 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.79 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 93.62 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.41 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 93.27 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.27 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 93.24 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.95 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.95 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 92.9 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.75 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 92.63 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.24 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 91.69 | |
| PLN02236 | 344 | choline kinase | 91.23 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 90.94 | |
| PRK14559 | 645 | putative protein serine/threonine phosphatase; Pro | 90.79 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 90.72 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.56 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 88.15 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 87.47 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 87.29 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 87.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 85.21 | |
| KOG2269 | 531 | consensus Serine/threonine protein kinase [Signal | 84.17 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 84.17 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=292.99 Aligned_cols=196 Identities=29% Similarity=0.419 Sum_probs=166.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++|+|||||+++++|+..+..|+||||++||.|.+++- .++.+.+..-..+++|++.|+.|||++| |+|||
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRD 301 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRD 301 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---ccccc
Confidence 5899999999999999999999999999999999999995 4788888888999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC---cccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLDND---FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~i~~~~l~g~ 154 (267)
|||+|||++.+ ..+||+|||++... .......+..||+.|.|||++....+ ..+.|+|||||++|-+++|.
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~---g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVS---GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhcc---ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 99999999765 67899999999854 34556777899999999999987653 35789999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCC------cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY------PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+||...-+.... .+.+.++++ -...+++..++|.+||..||++|||++|+++
T Consensus 379 pPFS~~~~~~sl-------------------~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 379 PPFSEEYTDPSL-------------------KEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred CCcccccCCccH-------------------HHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 999754433311 111111111 1466888999999999999999999999996
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=290.14 Aligned_cols=214 Identities=37% Similarity=0.520 Sum_probs=177.3
Q ss_pred CCCCCCCCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++|||||+++|++.... .+++||||+++|+|.+++... ....++...++.|+.+|+.|+.|||+++. |+|+
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHr 167 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHR 167 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeec
Confidence 467899999999999999887 799999999999999999763 46789999999999999999999998874 8999
Q ss_pred CCCCCcEEEcCCC-ceEEeccCCcccCCCCCCcceeeecccccceeCCcccc--cCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 80 DLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 80 di~~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||++|+|++.++ .+||+|||+++...... .......||+.|||||++. ...|+.++||||+|+++|||++|..|
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 9999999999997 99999999998543221 2233367899999999999 56999999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
|........ ....+....+-.++..++..+..++..||..+|+.||++.+++..|+.+......
T Consensus 246 f~~~~~~~~----------------~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 246 FEDLAPVQV----------------ASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCHHHH----------------HHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 975543111 1111122222334566889999999999999999999999999999988775443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=293.79 Aligned_cols=212 Identities=33% Similarity=0.489 Sum_probs=183.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++|+|+|||+++++|+.++.+||||||++.|+|.++++. ..+..+.....+.++.|||+|++||++++ +||||
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRD 328 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRD 328 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 57899999999999999999999999999999999999986 45678889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|.++||||+++..+||+|||+++.. ..+.........-+..|.|||.+....|+.++||||||+++|||+| |+.|+..
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARLI-GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hhhhheeeccCceEEEccccccccc-CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 9999999999999999999999943 2333333333444778999999999999999999999999999988 7778764
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
+. +..+.+.++...+-..|..||.++.++|..||..+|++|||++.+...|+.+.....
T Consensus 408 ms-----------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~ 466 (468)
T KOG0197|consen 408 MS-----------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE 466 (468)
T ss_pred CC-----------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence 44 344455566666666788999999999999999999999999999999988765443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=280.39 Aligned_cols=206 Identities=26% Similarity=0.304 Sum_probs=167.8
Q ss_pred CCCCCCCCCccceee-EEeeCC-eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-CCCee
Q 024460 1 MLSLLHHDNLVTLIG-YCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-NPPVI 77 (267)
Q Consensus 1 il~~l~Hpniv~~~~-~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~~i~ 77 (267)
+|++|+|||||++++ .|..+. .+++|||+|+.|+|...++..+.+...+++..+|+++.|++.||..+|.+- ++.+.
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 589999999999998 444444 489999999999999999998889999999999999999999999999832 23489
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||||||.||+++.+|.+||+|||+++++... ........||+.||+||.+...+|+.++||||+||++|||+.-++||
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 9999999999999999999999999975332 33345567999999999999999999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCc-HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...+ ...-...+.+- -..+.| .-++.++.++|..|+..||..||+.-.+++
T Consensus 229 ~g~n-------------~~~L~~KI~qg----d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 229 YGDN-------------LLSLCKKIEQG----DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred cccc-------------HHHHHHHHHcC----CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 7442 11111111111 111224 567899999999999999999998544443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=298.74 Aligned_cols=198 Identities=26% Similarity=0.388 Sum_probs=171.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|.++|+|||||+++++|++.+++|+|.|+|..++|..++++ .+.+++.++..++.||+.|+.|||+++ |+|||
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRD 143 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRD 143 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 46789999999999999999999999999999999999964 689999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||..|+|++++-.+||+|||+|..+. ...+.+.+..||+.|.|||++.....+..+||||+||++|-||.|.|||+..
T Consensus 144 LKLGNlfL~~~~~VKIgDFGLAt~le--~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 144 LKLGNLFLNENMNVKIGDFGLATQLE--YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred cchhheeecCcCcEEecccceeeeec--CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 99999999999999999999998743 2334566789999999999999999999999999999999999999999844
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+.... -.+|...+.+..+||.++|+.+|.+|||+++|+.
T Consensus 222 ~vkety~~Ik~~~------------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 222 TVKETYNKIKLNE------------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hHHHHHHHHHhcC------------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3222221111110 0134566778999999999999999999999997
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=281.28 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=166.8
Q ss_pred CCCCCCCCCccceeeEEeeCCe-eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQ-RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h 78 (267)
||+..+|||||.+|+.|..++. ++++||||++|+|.+.+.. .+++++....+++.+|++||.|||+ ++ |+|
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIH 202 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIH 202 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eee
Confidence 4677899999999999999994 9999999999999999964 4789999999999999999999995 77 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||||+|+|++..|.+||+|||.+...... ......||..|||||.+.+..|+.++||||||+.++|+..|..||.
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 999999999999999999999999864333 4455679999999999999999999999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCC---CcH-HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YPR-RCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .....+++..+..+. +|. .+++++..+|..||+++|.+|||++|+++
T Consensus 279 ~~~~~---------------~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 279 PPNPP---------------YLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CcCCC---------------CCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 44110 011111111111111 234 48899999999999999999999999997
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=280.34 Aligned_cols=229 Identities=59% Similarity=0.993 Sum_probs=194.2
Q ss_pred CCCCCCCCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|.+++|||+|+++|||.+.+ ..++|+||+..|+|.+.+...... .++|..+.+|+.++|.||+|||+...++|+|+
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr 201 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHR 201 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence 467899999999999999988 599999999999999999863221 88999999999999999999999887789999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+.|||+|.+...||+|||++...... .........|+..|++||.+..+..+.++||||+|+++.|+++|..+.+.
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 99999999999999999999999753321 11111111789999999999888999999999999999999999998886
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCC-CCCcH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLH-GRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
...........|..+.+.+. .+.+++|+.+. +.++. .....+..+..+|++.+|++||++.||+++|+.+...
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred CCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 66555555788887777755 88899999987 55554 5677799999999999999999999999999665544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=275.12 Aligned_cols=198 Identities=28% Similarity=0.364 Sum_probs=157.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.++|||||.+++++..++.+|+|||||+||+|.+|++. .+++++..+..++.||+.|+++||+++ |+|||
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRD 134 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRD 134 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 57899999999999999999999999999999999999975 568999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC------CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLDND------FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|||+|||++.. ..+||+|||+++.+. .........|++.|||||++....|+.|+|+||+|+++|+|++|.
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~---~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQ---PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCC---chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCC
Confidence 99999999754 568999999999654 333455678999999999999999999999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev 223 (267)
+||+......-...+.. ...... ..+......+.+++...+..++.+|-+..+-
T Consensus 212 ~Pf~a~t~~eL~~~~~k-------~~~~~~--------~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~ 265 (429)
T KOG0595|consen 212 PPFDAETPKELLLYIKK-------GNEIVP--------VLPAELSNPLRELLISLLQRNPKDRISFEDF 265 (429)
T ss_pred CCccccCHHHHHHHHhc-------cccccC--------chhhhccCchhhhhhHHHhcCccccCchHHh
Confidence 99975443322211111 111111 1123334445566667777777666555543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=267.42 Aligned_cols=196 Identities=30% Similarity=0.397 Sum_probs=165.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++++||+||+++-.|.+.+.+|+|+||+.||.|...+++ .+.+++..+.-++..|+.||.|||+++ |+|||
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRD 150 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRD 150 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 57789999999999999999999999999999999999964 678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+||+|||++.+|.++|+|||++.... ..........||+.|+|||++...+|+.++|.||||+++|+|++|.+||...
T Consensus 151 lKPENILLd~~GHi~LtDFgL~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 151 LKPENILLDEQGHIKLTDFGLCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred CCHHHeeecCCCcEEEeccccchhcc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 99999999999999999999998532 2223445578999999999999999999999999999999999999999744
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCC----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRP----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp----t~~ev~~ 225 (267)
+. .+..+.+.+++ .+.-.+.+.+++++++|..+|.+|. ++++|.+
T Consensus 229 ~~--------------------~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 229 DV--------------------KKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred cH--------------------HHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 32 11222222222 2233578899999999999999995 5555443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=282.38 Aligned_cols=202 Identities=28% Similarity=0.395 Sum_probs=176.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.|+||||+++|++++.+..+|+|.||+++|.|.+++.. .+.+++..+.+++.||+.|+.|+|..+ |+|+|
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRD 137 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRD 137 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceecc
Confidence 57889999999999999999999999999999999999954 788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCc-ccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
+||+|+|++..+++||+|||.|.. ......-.+-.|.++|.+||++.+.+|. .++||||+|+|+|.+|+|..||+
T Consensus 138 LKpENlLLd~~~nIKIADFGMAsL---e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd- 213 (786)
T KOG0588|consen 138 LKPENLLLDVKNNIKIADFGMASL---EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD- 213 (786)
T ss_pred CCchhhhhhcccCEeeeccceeec---ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC-
Confidence 999999999999999999999974 2333345567899999999999999986 68999999999999999999998
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCC--CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhhh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVS 232 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~~ 232 (267)
..++..++.+..++. +|.+++.+..+|+.+||..||+.|.|++||++ .|.....
T Consensus 214 -------------------DdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 214 -------------------DDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -------------------CccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 344444555555554 57888999999999999999999999999997 4544433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=269.39 Aligned_cols=205 Identities=30% Similarity=0.394 Sum_probs=161.6
Q ss_pred CCCCCCCCCccceeeEEeeCC--eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
||++|+|||||++++...... .++++|||+.+|+|.+++.. .++.+++..+..++.|++++|.|||+++ ++|
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~---~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH 140 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR---YGGKLPEPLVRRYTRQILEGLAYLHSKG---IVH 140 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 478899999999999855444 69999999999999999976 3337999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC-CCceEEeccCCcccCCC-CCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDN-DFNPKLSDFGLAKLGPV-GDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~-~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|||||+|||++. ++.+||+|||++..... ...........|++.|+|||++.+. ....++|||||||++.||++|.+
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 999999999999 79999999999875432 1112223346789999999999863 33459999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
||.... . ...+...... .-..| .+|..++.+..+++.+||..+|++|||++++++-
T Consensus 221 PW~~~~-~----~~~~~~~ig~------~~~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 221 PWSEFF-E----EAEALLLIGR------EDSLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred cchhhc-c----hHHHHHHHhc------cCCCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 997530 0 0000000000 00111 3355678889999999999999999999999973
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=265.29 Aligned_cols=210 Identities=26% Similarity=0.340 Sum_probs=168.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||++++..|..+..+|+||+||.+|++.+.+... ....+.+..+..+++++++||.|||.+| .+||||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdv 152 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQNG---HIHRDV 152 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhcC---ceeccc
Confidence 67889999999999999999999999999999999999873 4566999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcce-e-eecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-S-TRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~-~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|+.||||+.+|.|+|+|||........+.... . ....|+++|+|||++.. ..|+.|+||||||++..|+.+|..||
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 99999999999999999998765444332221 1 44678999999999654 47999999999999999999999999
Q ss_pred cccCccCcc-chhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......-. ..++ ..........+.......++..+.+++..||..||..|||++++++
T Consensus 233 ~k~pPmkvLl~tLq---------n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 233 SKYPPMKVLLLTLQ---------NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ccCChHHHHHHHhc---------CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 866543321 1111 1111111111222223455668999999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.64 Aligned_cols=200 Identities=27% Similarity=0.376 Sum_probs=168.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+..+|+|||.+++.|-.++.+|+||||++||+|.|.+. ...+++..+..+..+++.||+|||.++ |+|+|
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrD 394 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHARG---IIHRD 394 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeec
Confidence 4788999999999999999999999999999999999994 466999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||.+|||++.+|.+||+|||++..+..... ......||+.|||||++....|+.+.||||||+++.||+-|++||-..
T Consensus 395 IKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 395 IKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred cccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 999999999999999999999876543322 345577999999999999999999999999999999999999999532
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... -+.....+.+ +.+...+..+.+++.+||+.|+.+|++++|||+
T Consensus 473 ~PlrAly-------------LIa~ng~P~l--k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 473 NPLRALY-------------LIATNGTPKL--KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ChHHHHH-------------HHhhcCCCCc--CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 2211110 0111111222 224567889999999999999999999999997
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=273.19 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=168.9
Q ss_pred CCCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++ ||||+++++++.....+|+||||+.+|.|.+++.. .+++.+..+..++.|++.|++|+|+++ |+||
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HR 144 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHR 144 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeC
Confidence 367788 99999999999999999999999999999999964 678899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-Cc-ccCCeeehHHHHHHHHhCCCC
Q 024460 80 DLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LT-LKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 80 di~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~Dv~slG~i~~~~l~g~~p 156 (267)
||||+|++++.+ +++||+|||++.... ..........|++.|+|||++.+.. |+ .++||||+|+++|.|++|..|
T Consensus 145 DLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 145 DLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred CCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999999999 999999999998643 2334556678999999999999877 86 789999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHH-HHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC-LNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
|+..+....... +.... -.+|..+ +.++..++.+||..+|.+|+|+.+++ +-.-++.
T Consensus 223 F~d~~~~~l~~k----------------i~~~~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 223 FDDSNVPNLYRK----------------IRKGE--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCCccHHHHHHH----------------HhcCC--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 985321111111 00000 0123444 78899999999999999999999999 5555554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=257.86 Aligned_cols=227 Identities=22% Similarity=0.269 Sum_probs=173.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++|+|||+|.++++|.....+++|||||+. ++.+-+.. ....++...+.+++.|++.|+.|+|+++ ++|||
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRD 126 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRD 126 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eeccc
Confidence 57899999999999999999999999999977 55555654 5678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+||+|||+++...... ..-+....|.||+|||.+.+ ..|....|||++||++.||++|.+.|..
T Consensus 127 IKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 127 IKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred CChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 99999999999999999999999765322 22334557999999999987 7899999999999999999999999976
Q ss_pred cCccCccchhhhch--------hhhhcccccccccCCcCCCC--Cc---HHHHHHHHHHHHhhcccCCCCCCCHHHHHH-
Q 024460 160 SKGQGEQNLVSWSR--------PFLKDQKKFVHLVDPLLHGR--YP---RRCLNYAVAVTAMCLNEEANFRPLINDIVV- 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~- 225 (267)
..+..-...+...- .....+.-...+.-|..... +. .+.+.-+.++++.||..||.+|++-++++.
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 66544332222110 11111111122222211111 11 133457899999999999999999999987
Q ss_pred -HHHHhhhccCC
Q 024460 226 -ALDYLVSQRDS 236 (267)
Q Consensus 226 -~l~~l~~~~~~ 236 (267)
-++.++.++..
T Consensus 285 ~yFd~~~er~~~ 296 (396)
T KOG0593|consen 285 PYFDGFIERELK 296 (396)
T ss_pred hHHHHHHHHHHH
Confidence 45555554433
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=271.90 Aligned_cols=199 Identities=29% Similarity=0.350 Sum_probs=172.6
Q ss_pred CCCCCCCCCccceeeEEeeCCe-eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQ-RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++|||||.+.+.|..++. ++|||+||+||++.+.+... .+..+++..+++|+.|++.|+.|||++. |+||
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHR 130 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHR 130 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcc
Confidence 3678999999999999998887 99999999999999999873 3678999999999999999999999988 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+.|||++.++.++|+|||+++...... .......||+.|++||.+.+.+|..++|+|+|||++|||++-+++|..
T Consensus 131 DlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 131 DLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred cchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 999999999999999999999998643332 245557799999999999999999999999999999999999999973
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcC---CCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
.+ ...++.++. ....|..++.++..+|..||..+|..||++.+++..
T Consensus 209 ~~--------------------m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 209 SN--------------------MSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cc--------------------hHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 32 222222222 234577889999999999999999999999999985
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=268.44 Aligned_cols=213 Identities=27% Similarity=0.375 Sum_probs=164.0
Q ss_pred CCCC-CCCCccceeeEEeeC-CeeEEEEecCCCCCHHHHhcccCCC----------------------------------
Q 024460 2 LSLL-HHDNLVTLIGYCTSG-DQRLLVYEYMPMGSLEDHLYDLEPD---------------------------------- 45 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~---------------------------------- 45 (267)
|+++ +||||+++++++... +.++++|||+++|+|.+++......
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 4556 899999999988764 4689999999999999998752210
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCC
Q 024460 46 ------------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101 (267)
Q Consensus 46 ------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~ 101 (267)
...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~ 220 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 220 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccc
Confidence 234778888999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhccc
Q 024460 102 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQK 180 (267)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 180 (267)
++...............++..|+|||++.+..++.++||||||+++|+|++ |..||........ ... ...
T Consensus 221 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~--- 291 (338)
T cd05102 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLK--- 291 (338)
T ss_pred ccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHh---
Confidence 875432222222223345678999999988899999999999999999997 9999864332110 000 000
Q ss_pred ccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
....-..+..++..+.+++.+||..+|++|||+.||++.|+.+...
T Consensus 292 -------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 292 -------DGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred -------cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0000112345567899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.40 Aligned_cols=206 Identities=31% Similarity=0.430 Sum_probs=176.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++|+||||+.+.|+|+....+|||||||..|-|...++. +..+.......|..+|+.+++|||.+. |+||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDL 238 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDL 238 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---Hhhhcc
Confidence 6899999999999999999999999999999999999965 667888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
|.-||||+.+..|||+|||-++..... ..+-...||..|||||++.+.+.++|.||||||+++||||||..||..-.
T Consensus 239 KSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 239 KSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred CCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 999999999999999999998864333 22334678999999999999999999999999999999999999995221
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
. ...+-..-...+.-..|..|+..|.=||++||+-.|..||++.+++.-|+-+.+.
T Consensus 316 s----------------sAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 316 S----------------SAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred h----------------heeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 1 1111122333444556889999999999999999999999999999988765543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=270.55 Aligned_cols=199 Identities=25% Similarity=0.327 Sum_probs=166.0
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|.+| .||+|++++-.|.++..+|+|+||+++|+|.++|.. -+.+.+.....++.+|+.||.|||++| |||||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRD 199 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRD 199 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 4556 899999999999999999999999999999999975 578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-----------ceeeecccccceeCCcccccCCCcccCCeeehHHHHHH
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-----------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 149 (267)
|||+|||++.++.++|+|||.+..+...... .......||-.|++||++.....+..+|+|+||||+|+
T Consensus 200 lKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQ 279 (604)
T KOG0592|consen 200 LKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQ 279 (604)
T ss_pred CChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHH
Confidence 9999999999999999999999875432221 11134678999999999999999999999999999999
Q ss_pred HHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 150 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|+.|.+||...+.-.....+... .=.++...++...+||++.|..+|++|+|+++|.+
T Consensus 280 mlaG~PPFra~NeyliFqkI~~l------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 280 MLAGQPPFRAANEYLIFQKIQAL------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HhcCCCCCccccHHHHHHHHHHh------------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 99999999754421111111000 01234455688999999999999999999999987
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=260.42 Aligned_cols=204 Identities=23% Similarity=0.355 Sum_probs=164.4
Q ss_pred CCCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~ 75 (267)
+|++++||||+++++++.+ ...+++||||+++|+|.+++.. ...+++.....++.+++.++.+||+. +
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~--- 143 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN--- 143 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---
Confidence 3678999999999999876 3478999999999999999964 45688899999999999999999974 6
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++|+||+|+||+++.++.+|++|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++|
T Consensus 144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g 218 (283)
T PHA02988 144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218 (283)
T ss_pred CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence 8899999999999999999999999987532211 12346788999999876 6899999999999999999999
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
..||........ .. ........-..+..++..+.+++.+||+.+|++|||++++++.|+++++
T Consensus 219 ~~Pf~~~~~~~~---~~-------------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 219 KIPFENLTTKEI---YD-------------LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCCCHHHH---HH-------------HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 999974321110 00 0000111112334567889999999999999999999999999998875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=279.54 Aligned_cols=216 Identities=31% Similarity=0.465 Sum_probs=184.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC----------CCCCCHHHHHHHHHHHHHHHHHhhhc
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD----------QEPLSWNTRMKIAVGAARGLEYLHCK 71 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lH~~ 71 (267)
|..|+|||||+++|+|..++.+|+|+|||..|+|.+|++...+. ...++..+.+.++.|||.++.||-++
T Consensus 543 la~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~ 622 (774)
T KOG1026|consen 543 LAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH 622 (774)
T ss_pred HHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56899999999999999999999999999999999999874321 22378889999999999999999999
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHH
Q 024460 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 72 ~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l 151 (267)
. +|||||..+|+||.++-.|||+|||+++..+..+.+.......-..+|||||.+..++|+.++||||+|+++||++
T Consensus 623 ~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIF 699 (774)
T KOG1026|consen 623 H---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIF 699 (774)
T ss_pred c---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhh
Confidence 8 9999999999999999999999999999887777777666667788999999999999999999999999999998
Q ss_pred h-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 152 T-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
+ |..||.....+.-.. .+....--..|.+||.++.+||..||+.+|++||+++||..+|+.+
T Consensus 700 syG~QPy~glSn~EVIe-----------------~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 700 SYGKQPYYGLSNQEVIE-----------------CIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred ccccCcccccchHHHHH-----------------HHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 8 777876443222211 1111111345789999999999999999999999999999999988
Q ss_pred hhccCCC
Q 024460 231 VSQRDSH 237 (267)
Q Consensus 231 ~~~~~~~ 237 (267)
-+..+..
T Consensus 763 ~~~s~~~ 769 (774)
T KOG1026|consen 763 AQASPKY 769 (774)
T ss_pred HhcCccc
Confidence 7766543
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=264.88 Aligned_cols=214 Identities=22% Similarity=0.265 Sum_probs=169.7
Q ss_pred CCCCC-CCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLH-HDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++|+ ||||+++.+++.+++ .+|+|||||+ .+|++++.. .+..+++..+..|+.||+.+|+|+|++| +-||
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHR 134 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHR 134 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 67888 999999999998887 9999999995 599999987 4789999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|+||+|||+..+..+||+|||+++....... -+....|.||+|||++.. ..|+.+.|+|++|||++|+.+-++.|.
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred cCChhheEecccceeEecccccccccccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 9999999999989999999999997543322 233446899999998875 578999999999999999999999997
Q ss_pred ccCccCccchhhh-----chhhhhcccccccccCCc--------CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSW-----SRPFLKDQKKFVHLVDPL--------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+.........+.- .+..+....++...++=. +...++ +++.+..++|.+|+..||.+|||+++.++
T Consensus 212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 7665443322221 111111122222222221 111223 37889999999999999999999999998
Q ss_pred H
Q 024460 226 A 226 (267)
Q Consensus 226 ~ 226 (267)
.
T Consensus 291 ~ 291 (538)
T KOG0661|consen 291 H 291 (538)
T ss_pred C
Confidence 3
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=274.62 Aligned_cols=205 Identities=24% Similarity=0.298 Sum_probs=165.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++..++..|+||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrD 194 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRD 194 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECC
Confidence 367899999999999999999999999999999999988653334567889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++................|++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 195 lkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543322222233456899999999999889999999999999999999999998633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ... ..+.. .....+..++.++.++|.+||..+|++||++++++.
T Consensus 275 ~~~~---~~~-------------~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 275 SQRE---IMQ-------------QVLYG-KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CHHH---HHH-------------HHHhC-CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2110 000 00000 001123345678999999999999999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=255.67 Aligned_cols=209 Identities=31% Similarity=0.474 Sum_probs=166.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHhh
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLH 69 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lH 69 (267)
|++++||||+++++++...+..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999965321 1156788899999999999999999
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHH
Q 024460 70 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 70 ~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 149 (267)
+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+....++.++|+||||+++|+
T Consensus 142 ~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999 99999999999999999999999999875432222222333455778999999988889999999999999999
Q ss_pred HHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 150 LIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 150 ~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
|++ |..||........ .. .+........+..++.++.+++.+||+.+|.+||++++|++.|+
T Consensus 219 l~~~g~~p~~~~~~~~~---~~--------------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 219 IFSYGLQPYYGFSNQEV---IE--------------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHHHH---HH--------------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 998 8888864322110 00 01011111234567889999999999999999999999999997
Q ss_pred Hh
Q 024460 229 YL 230 (267)
Q Consensus 229 ~l 230 (267)
.+
T Consensus 282 ~~ 283 (283)
T cd05048 282 SW 283 (283)
T ss_pred cC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=261.23 Aligned_cols=198 Identities=29% Similarity=0.335 Sum_probs=161.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+|
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrD 120 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 36788999999999999999999999999999999998854 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 99999999999999999999987422111 1223345899999999999999999999999999999999999999633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........ .. .. .-.++..++.++.+++.+||..||++|| +++++++
T Consensus 199 ~~~~~~~~------~~----------~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 199 DHEKLFEL------IL----------ME--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CHHHHHHH------HH----------cC--CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 21110000 00 00 0122445677899999999999999999 7999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=264.65 Aligned_cols=211 Identities=27% Similarity=0.406 Sum_probs=164.2
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------------------------------
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------------------------ 44 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------ 44 (267)
|+.+ +||||++++++|...+..++|||||++|+|.++++....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 5567 899999999999999999999999999999998854210
Q ss_pred ------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCce
Q 024460 45 ------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP 94 (267)
Q Consensus 45 ------------------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~ 94 (267)
....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeE
Confidence 1234778889999999999999999999 9999999999999999999
Q ss_pred EEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccchhhhch
Q 024460 95 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSR 173 (267)
Q Consensus 95 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~ 173 (267)
+|+|||++................++..|+|||++....++.++||||||+++|+|++ |..||......... .
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~---- 325 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--Y---- 325 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--H----
Confidence 9999999875433222222222334567999999988899999999999999999997 99998643221110 0
Q ss_pred hhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 174 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
..+........+...+.++.+++.+||+.+|++|||+++|+++|+++.
T Consensus 326 ----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 326 ----------KMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----------HHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 000001111122334678999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=266.03 Aligned_cols=195 Identities=29% Similarity=0.369 Sum_probs=170.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++.|+||||+.++++|+...++|+|.||+.| +|..++. .++.+++..+..++.+++.||.|||+++ |+|+|
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd 125 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRD 125 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 57899999999999999999999999999976 9999995 4788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+||+|||+..++.+|++|||+++-.. ....+.....|++.|||||++.+.+|+..+|+|||||++|||+.|+|||-
T Consensus 126 ~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~-- 201 (808)
T KOG0597|consen 126 MKPQNILLEKGGTLKLCDFGLARAMS--TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY-- 201 (808)
T ss_pred CCcceeeecCCCceeechhhhhhhcc--cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch--
Confidence 99999999999999999999998632 34456677889999999999999999999999999999999999999995
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCC--CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...+.+++..+..+. +|...+..+..+++..|.+||.+|.|..+++.
T Consensus 202 ------------------a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 202 ------------------ARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ------------------HHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 222222222222222 45677889999999999999999999999987
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=253.05 Aligned_cols=212 Identities=28% Similarity=0.436 Sum_probs=168.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHhh
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLH 69 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lH 69 (267)
+++++||||+++++++..++..++||||+++++|.+++..... ..+.+++..++.++.|++.|++|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999965321 2245788999999999999999999
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHH
Q 024460 70 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 70 ~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 149 (267)
+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+
T Consensus 141 ~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999 99999999999999999999999999875433222222233445778999999988899999999999999999
Q ss_pred HHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 150 LIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 150 ~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
|++ |..||....... .... +........+..++..+.+++.+||..+|++|||+++|+++|+
T Consensus 218 l~t~g~~p~~~~~~~~---~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 218 IFTYGKQPWFQLSNTE---VIEC--------------ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHhCCCCCCCCCCHHH---HHHH--------------HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 998 999985432211 0000 0000001112345677999999999999999999999999999
Q ss_pred Hhhhc
Q 024460 229 YLVSQ 233 (267)
Q Consensus 229 ~l~~~ 233 (267)
++...
T Consensus 281 ~~~~~ 285 (291)
T cd05094 281 ALGKA 285 (291)
T ss_pred HHHhh
Confidence 98653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=244.67 Aligned_cols=187 Identities=28% Similarity=0.371 Sum_probs=160.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.+.||+++++++.|.+.+.+|+||||.+||.|..+++. .+++++..+.-++.||+.|+.|||+.+ |++||
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRD 169 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRD 169 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 57889999999999999999999999999999999999975 678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+||+|||++.+|-+||+|||++.... ...-+..||+.|+|||++...++..++|-|+||+++|||+.|.+||...
T Consensus 170 LKPENiLlD~~G~iKitDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 170 LKPENLLLDQNGHIKITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred CChHHeeeccCCcEEEEeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 99999999999999999999997431 2255678999999999999999999999999999999999999999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 217 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 217 (267)
....- ..+++...+ ++|.-.+.++.+++...|+.|-.+|
T Consensus 245 ~~~~i----------------Y~KI~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 245 NPIQI----------------YEKILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ChHHH----------------HHHHHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 33111 111111111 3466677889999999999999888
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=258.92 Aligned_cols=198 Identities=28% Similarity=0.307 Sum_probs=159.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrD 118 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRD 118 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 35778999999999999999999999999999999999854 456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 99999999999999999999987432211 1223346889999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL---INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt---~~ev~~ 225 (267)
..... ... .... .-.++..++..+.+++.+||..+|++||+ ++++++
T Consensus 197 ~~~~~------~~~----------~~~~--~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 197 NVNEM------YRK----------ILQE--PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHH------HHH----------HHcC--CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 21100 000 0000 01234456778999999999999999985 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=250.49 Aligned_cols=205 Identities=25% Similarity=0.373 Sum_probs=163.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.|++|||+++ ++|+||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~di 133 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGL 133 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 5678999999999999999999999999999999999865 3457889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++++|||.......... .......++..|+|||.+.+..++.++||||+|+++|++++ |..||...
T Consensus 134 kp~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 134 AAHKVLVNSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cHhhEEEcCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 99999999999999999998764211111 11112234568999999998999999999999999999775 99998644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
..... ... +........+..++..+.+++.+||..+|.+||++++|.+.|..+
T Consensus 213 ~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 213 SGQDV---IKA--------------VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CHHHH---HHH--------------HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 32110 000 000011122456678899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=248.57 Aligned_cols=206 Identities=25% Similarity=0.371 Sum_probs=161.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..+...++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 119 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 36788999999999999999999999999999999999864 3456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred cchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999864321111111111123456999999988889999999999999999997 8888853
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
...... ...+........+..++..+.+++.+||+.+|++|||+++|+++|++
T Consensus 200 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 200 LSNQQT-----------------REAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCHHHH-----------------HHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 321110 00000111112234556789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=252.74 Aligned_cols=212 Identities=29% Similarity=0.468 Sum_probs=167.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---------CCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---------DQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
|++++||||+++++++..++..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+++
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5788999999999999999999999999999999999864221 2235899999999999999999999999
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 141 ---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 141 ---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999875432222122223334678999999988889999999999999999998
Q ss_pred -CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 153 -GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
|.+||........ ... .. ... . ...+..++.++.+++.+||+.+|.+|||++++.+.|+.+.
T Consensus 218 ~g~~p~~~~~~~~~---~~~----i~-~~~----~-----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 218 YGKQPWYQLSNNEV---IEC----IT-QGR----V-----LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCCCCCCCCHHHH---HHH----HH-cCC----c-----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 8888853321110 000 00 000 0 0112234567999999999999999999999999999887
Q ss_pred hc
Q 024460 232 SQ 233 (267)
Q Consensus 232 ~~ 233 (267)
..
T Consensus 281 ~~ 282 (288)
T cd05093 281 KA 282 (288)
T ss_pred Hh
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.74 Aligned_cols=210 Identities=27% Similarity=0.382 Sum_probs=162.7
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------------------------------
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------------------------ 44 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------ 44 (267)
|+.+ +||||++++++|..++..++|||||++|+|.+++.....
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 4556 899999999999999999999999999999999864221
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 024460 45 -----------------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 89 (267)
Q Consensus 45 -----------------------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~ 89 (267)
....+++..+..++.|++.||+|||+++ ++|+||||+||+++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~ 248 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLT 248 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEE
Confidence 1124678889999999999999999999 99999999999999
Q ss_pred CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccch
Q 024460 90 NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNL 168 (267)
Q Consensus 90 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~ 168 (267)
.++.++|+|||++................++..|+|||++.+..++.++|+||||+++|+|++ |..||........ .
T Consensus 249 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~ 326 (375)
T cd05104 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--F 326 (375)
T ss_pred CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--H
Confidence 999999999999875433222222222334567999999999999999999999999999998 8888864322111 0
Q ss_pred hhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 169 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
... . ........+...+.++.+++.+||+.+|++|||+++|++.|++.
T Consensus 327 ~~~----~----------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 327 YKM----I----------KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHH----H----------HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 000 0 00001111233467899999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=257.88 Aligned_cols=216 Identities=25% Similarity=0.303 Sum_probs=164.7
Q ss_pred CCCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
||++|.||||+++.+...+. +.+|+|||||+. +|.-++.. ..-.|++..+..++.||+.+|.|+|.++ ++|
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlH 241 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLH 241 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eee
Confidence 68999999999999998776 789999999976 88888854 4568999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||||..||||+.+|.+||+|||++++........ -+...-|.||+|||++.+. .|+.+.|+||+|||+.||+.|++.+
T Consensus 242 RDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 242 RDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred ccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 9999999999999999999999999754443322 3334469999999999875 7999999999999999999999999
Q ss_pred cccCccCccchhh----------hchhhhhccc--ccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVS----------WSRPFLKDQK--KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~----------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+......-...+- |....+.... .....-...+.+. -...+....+|+..+|..||.+|.|+.++++
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 7665433221111 1111111000 0000000111111 1234667889999999999999999999886
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=255.00 Aligned_cols=196 Identities=28% Similarity=0.354 Sum_probs=158.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..|+||||+++++|...+. .+.+++..+..++.|++.||.|||+++ ++|+||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdl 127 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDL 127 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 467889999999999999999999999999999998884 357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++...... ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 128 kp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 128 KLDNLLLDTEGFVKIADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CHHHeEECCCCcEEeCcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999988642211 112233567899999999998899999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
..... . .+.... ..++..++.++.+++.+||+.+|++|| +++++++
T Consensus 206 ~~~~~---~-------------~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 206 EEEVF---D-------------SIVNDE--VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHHH---H-------------HHHhCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 21100 0 000000 012345577889999999999999999 5777766
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.04 Aligned_cols=215 Identities=26% Similarity=0.416 Sum_probs=161.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---------------CCCCCCHHHHHHHHHHHHHHH
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---------------DQEPLSWNTRMKIAVGAARGL 65 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---------------~~~~~~~~~~~~~~~~l~~~l 65 (267)
+|++++||||+++++++..++..++||||+.+++|.+++..... ....+++..++.++.|++.||
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 36788999999999999999999999999999999998864221 113467788999999999999
Q ss_pred HHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHH
Q 024460 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 145 (267)
Q Consensus 66 ~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 145 (267)
.|||+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||++....++.++|+||||+
T Consensus 152 ~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 152 KYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999 9999999999999999999999999987543322222223334567899999998888999999999999
Q ss_pred HHHHHHh--CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHH
Q 024460 146 VLLELIT--GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223 (267)
Q Consensus 146 i~~~~l~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev 223 (267)
++|+|++ +..||........ ........... . .......+..++..+.+++.+||..+|++|||+++|
T Consensus 229 ~l~el~~~~~~~p~~~~~~~~~---~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDEQV---IENAGEFFRDQ------G-RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred HHHHHHHccCCCCCCcCCHHHH---HHHHHHHhhhc------c-ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 9999987 4556653321111 11000000000 0 000011133557789999999999999999999999
Q ss_pred HHHHH
Q 024460 224 VVALD 228 (267)
Q Consensus 224 ~~~l~ 228 (267)
.+.|+
T Consensus 299 ~~~l~ 303 (304)
T cd05096 299 HAFLT 303 (304)
T ss_pred HHHHh
Confidence 98875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=250.90 Aligned_cols=208 Identities=30% Similarity=0.453 Sum_probs=165.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC----------CCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE----------PDQEPLSWNTRMKIAVGAARGLEYLHC 70 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----------~~~~~~~~~~~~~~~~~l~~~l~~lH~ 70 (267)
+|++++||||+++++++..++..++||||+++++|.+++.... .....+++..+..++.|++.++.+||+
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 3678899999999999999999999999999999999997532 123457888999999999999999999
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 71 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 71 ~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 141 ~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 141 QH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred CC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998753222222222333456789999999999999999999999999999
Q ss_pred Hh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 151 IT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
++ |..||........ .... ........+..++..+.+++++||..+|++|||++||++.|+
T Consensus 218 ~~~g~~p~~~~~~~~~---~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSNEEV---IECI--------------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCHHHH---HHHH--------------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 9999864332111 0000 000011123345678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=248.09 Aligned_cols=206 Identities=27% Similarity=0.412 Sum_probs=165.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..+++|||+++++|.+++.. ..+.+++..+..++.|++.|+.|||+++ ++|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di 132 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDL 132 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5788999999999999999999999999999999999965 3457899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++++|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999886532222212222334568999999988899999999999999999997 88888533
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
.... ... .+........+..++..+.+++.+|++.+|++||++++|++.|+++
T Consensus 213 ~~~~---~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 213 SNQD---VIK--------------AVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHHH---HHH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2110 000 0000001112335567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=247.89 Aligned_cols=206 Identities=26% Similarity=0.383 Sum_probs=164.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++.++++|||+++++|.+++... ....+++..+..++.|++.+++|||+++ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 130 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 130 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeeccc
Confidence 57789999999999999999999999999999999998652 2456888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred CcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999875422211 11111223567999999988899999999999999999998 88888643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... . .+........+..++..+.+++.+||..+|++|||+.+++++|+.+
T Consensus 210 ~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 210 DLSQVY---E--------------LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHHHHH---H--------------HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 211100 0 0001111122345578899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=254.70 Aligned_cols=198 Identities=27% Similarity=0.326 Sum_probs=160.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++.+..++.+|+||||+.+++|.+++.. .+.+.+..+..++.|++.||.|||+++ ++|+|
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRD 125 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 36789999999999999999999999999999999999854 456788889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 126 LKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999986432211 1223346889999999999888999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
...... ..+.... ...+..++..+.+++.+||+.+|++|| +++++++
T Consensus 204 ~~~~~~----------------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 204 NRKKTI----------------DKILKGK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CHHHHH----------------HHHHcCC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 321100 0000000 112344567789999999999999999 8888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=251.24 Aligned_cols=210 Identities=30% Similarity=0.434 Sum_probs=165.0
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++++ +||||+++++++..++.++++|||+.+++|.+++.... .....+++..++.++.|++.|+.||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4566 79999999999999999999999999999999986422 2345688999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+.+ ++|+||+|+||+++.++.++|+|||++................++..|+|||++.+..++.++|+||||+++|
T Consensus 149 H~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 ASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred HHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9999 9999999999999999999999999987543222111122233456799999998889999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
++++ |..||.......... .+........+..++..+.+++.+||..+|++|||++++++.|
T Consensus 226 el~~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 226 EIFTLGGSPYPGIPVEELFK-----------------LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHhcCCCCCCCCCCHHHHHH-----------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 9997 888875332111100 0000001112334567899999999999999999999999999
Q ss_pred HHhh
Q 024460 228 DYLV 231 (267)
Q Consensus 228 ~~l~ 231 (267)
+.+.
T Consensus 289 ~~~~ 292 (293)
T cd05053 289 DRML 292 (293)
T ss_pred HHhh
Confidence 8775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=253.51 Aligned_cols=212 Identities=22% Similarity=0.368 Sum_probs=166.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..+ ..++++||+.+|+|.+++.. ....++...++.++.|++.||+|||+++ ++|+||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dl 135 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDL 135 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eecccc
Confidence 5788999999999998765 57799999999999999975 3456888899999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++.................+..|++||.+....++.++|+||||+++|+|++ |..||...
T Consensus 136 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 136 AARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred chhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986433222211222334567999999998899999999999999999987 89998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
..... ...+.....-..+..++.++.+++.+||..+|.+||++.+++..|..+.......
T Consensus 216 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~ 275 (316)
T cd05108 216 PASEI-----------------SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY 275 (316)
T ss_pred CHHHH-----------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence 21110 0011111111123345677899999999999999999999999999887666543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=255.08 Aligned_cols=195 Identities=26% Similarity=0.321 Sum_probs=159.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..|+||||+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+|
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 143 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRD 143 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 36788999999999999999999999999999999999964 457888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 144 LKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999998754221 12345789999999999999999999999999999999999999633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
..... .. .+.... -.++..++..+.+++.+||+.||.+||+ ++++++
T Consensus 219 ~~~~~------~~----------~i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 219 TPFRI------YE----------KILAGR--LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHH------HH----------HHhcCC--cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 21100 00 000000 0123334567899999999999999997 688775
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=255.81 Aligned_cols=198 Identities=27% Similarity=0.344 Sum_probs=160.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.||+.||+|||+++ ++|+|
T Consensus 48 ~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 120 (328)
T cd05593 48 VLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRD 120 (328)
T ss_pred HHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 36788999999999999999999999999999999988854 457889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... ........|+..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 121 ikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~ 198 (328)
T cd05593 121 LKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (328)
T ss_pred cCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC
Confidence 9999999999999999999998742211 11122345789999999999889999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........ .... .-.++..++.++.+++.+||..+|++|+ +++++++
T Consensus 199 ~~~~~~~~----------------~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 199 DHEKLFEL----------------ILME--DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CHHHHHHH----------------hccC--CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 21110000 0000 0122345567899999999999999997 8999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=257.43 Aligned_cols=211 Identities=23% Similarity=0.315 Sum_probs=160.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+. + ++|+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~d 129 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRD 129 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCC
Confidence 6788999999999999999999999999999999999954 45688999999999999999999975 5 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 130 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998754221 122345788999999999889999999999999999999999999543
Q ss_pred CccCccchhhhchhhhhc----------------------------cccccc----ccCCcCCCCCcHHHHHHHHHHHHh
Q 024460 161 KGQGEQNLVSWSRPFLKD----------------------------QKKFVH----LVDPLLHGRYPRRCLNYAVAVTAM 208 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~ 208 (267)
.......... ...... ...... +............++.++.++|.+
T Consensus 206 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 283 (331)
T cd06649 206 DAKELEAIFG--RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNK 283 (331)
T ss_pred CHHHHHHHhc--ccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHH
Confidence 2211000000 000000 000000 000000011112456789999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 024460 209 CLNEEANFRPLINDIVV 225 (267)
Q Consensus 209 cl~~~p~~Rpt~~ev~~ 225 (267)
||..||++|||++++++
T Consensus 284 ~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 284 CLIKNPAERADLKMLMN 300 (331)
T ss_pred HccCCcccCCCHHHHhc
Confidence 99999999999999985
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=278.28 Aligned_cols=221 Identities=28% Similarity=0.368 Sum_probs=184.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
+|+.++|||||+++|++-+....++++|||++|+|..+++..+. ....++....+.++.+||+++.||+++. ++
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fv 824 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FV 824 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---Cc
Confidence 47899999999999999999999999999999999999987432 2457889999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCC
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKA 156 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p 156 (267)
||||..+|+|++....+||+|||+++.+.................|||||.+....|+.++||||||+++||+++ |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999996555554444444445679999999999999999999999999999998 7888
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
|.... +.++...+...-+-..|..|+..+.++|..||+.+|++||++..|++.+.++.+.-..
T Consensus 905 Y~~~~-----------------n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 905 YPSRS-----------------NFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred CCCcc-----------------hHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 86333 1122221111124456789999999999999999999999999999999888877666
Q ss_pred CCCcC
Q 024460 237 HPVSR 241 (267)
Q Consensus 237 ~~~~~ 241 (267)
..-.+
T Consensus 968 ~~~~~ 972 (1025)
T KOG1095|consen 968 TIYGP 972 (1025)
T ss_pred Ccccc
Confidence 55333
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=246.53 Aligned_cols=206 Identities=29% Similarity=0.440 Sum_probs=166.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++..+...++||||+++++|.+++... .+..+++..+..++.|++.|+.|||+++ ++|+|
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~d 129 (261)
T cd05148 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRD 129 (261)
T ss_pred HHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 367899999999999999999999999999999999999762 3456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||.+....... .......++..|++||.+....++.++|+|+||+++|+|++ |..||..
T Consensus 130 l~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 130 LAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred cCcceEEEcCCceEEEccccchhhcCCcc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999987542211 11122335668999999988889999999999999999998 8899864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
....... . .+........+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 208 ~~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 208 MNNHEVY---D--------------QITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCHHHHH---H--------------HHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 3311110 0 0001111122345677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=250.71 Aligned_cols=211 Identities=27% Similarity=0.405 Sum_probs=167.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGA 61 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~~~~~~l 61 (267)
|+.++||||+++++.+..++..++++||+.+++|.+++..... ....+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 6788999999999999999999999999999999999864221 12357788999999999
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCee
Q 024460 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 141 (267)
Q Consensus 62 ~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 141 (267)
+.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++...............++..|+|||.+.+..++.++|+|
T Consensus 137 ~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 137 SRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999 999999999999999999999999998754332222122223446689999998888899999999
Q ss_pred ehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 142 SFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 142 slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
|||+++|+|++ |..||....... ... .+........+..++.++.+++.+||+.+|++||++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPER---LFN--------------LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 99999999998 999986432111 000 111111112234556789999999999999999999
Q ss_pred HHHHHHHHHhhh
Q 024460 221 NDIVVALDYLVS 232 (267)
Q Consensus 221 ~ev~~~l~~l~~ 232 (267)
+++++.|+++..
T Consensus 277 ~~i~~~l~~~~~ 288 (290)
T cd05045 277 ADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHh
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=247.18 Aligned_cols=209 Identities=25% Similarity=0.408 Sum_probs=164.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++++.||||+++++++. +...++++||+.+|+|.+++.. ....+++..+..++.|++.|+.|||+++ ++|+||
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 135 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNL 135 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---Eecccc
Confidence 46789999999999875 4567889999999999999965 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||+++...............++..|++||.+....++.++|+||||+++|++++ |..||...
T Consensus 136 kp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999875432222122223445678999999988889999999999999999998 99998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
......... .....-..+..++..+.+++.+|+..+|++|||+.|+++.|..+....
T Consensus 216 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 216 RPHEVPDLL-----------------EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CHHHHHHHH-----------------HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 321110000 000000112234567889999999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=249.47 Aligned_cols=208 Identities=26% Similarity=0.388 Sum_probs=164.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHhh
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYLH 69 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~~~~~~~l~~~l~~lH 69 (267)
+++++||||+++++++......++++||+.+++|.+++.... .....+++..+..++.|++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999985311 12345788889999999999999999
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHH
Q 024460 70 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 70 ~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 149 (267)
+++ ++|+||||+||++++++.++|+|||+++...............++..|+|||.+....++.++|+||||+++|+
T Consensus 142 ~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 142 SHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred HcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 999 99999999999999999999999999875433222222223345678999999988889999999999999999
Q ss_pred HHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 150 LIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 150 ~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
|++ |..||........ ...+........+..++.++.+++..||+.+|.+||++++|++.|+
T Consensus 219 l~~~g~~p~~~~~~~~~-----------------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 219 VFSYGLQPYCGYSNQDV-----------------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHHHH-----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 998 7788764321110 0001111111234567888999999999999999999999999987
Q ss_pred H
Q 024460 229 Y 229 (267)
Q Consensus 229 ~ 229 (267)
.
T Consensus 282 ~ 282 (283)
T cd05091 282 T 282 (283)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=252.66 Aligned_cols=193 Identities=27% Similarity=0.305 Sum_probs=156.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++..|+||||+++++|..++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~di 122 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDL 122 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCC
Confidence 4678999999999999999999999999999999998854 457889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 123 KPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999998642211 112233468899999999999899999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
.... ... ...... ..+...+..+.+++.+||+.+|++||++.
T Consensus 201 ~~~~------~~~----------i~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 201 TAEM------YDN----------ILNKPL--RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHH------HHH----------HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1100 000 000000 11233467799999999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=256.15 Aligned_cols=198 Identities=27% Similarity=0.337 Sum_probs=160.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++..++.+|+||||+++++|..++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 120 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 36788999999999999999999999999999999988854 457889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999988642111 11122345789999999999889999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........ ..... -.++..++.++.+++.+||+.+|++|| ++.++++
T Consensus 199 ~~~~~~~~----------------~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 199 DHERLFEL----------------ILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CHHHHHHH----------------HhcCC--CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 22111000 00000 012345577899999999999999998 8888876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=260.42 Aligned_cols=211 Identities=28% Similarity=0.426 Sum_probs=175.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++||+...+..+++|||+|.||+|.++++. ..+.++......++.+.+.||+|||+++ ++|||
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRD 287 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRD 287 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---Ccchh
Confidence 47889999999999999999999999999999999999986 4457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceee-ecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|-.+|+|++.++.+|++|||+++... ...... ...-+..|+|||.+...-|+.++||||+|+++||+++ |..||.
T Consensus 288 IAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~ 364 (474)
T KOG0194|consen 288 IAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP 364 (474)
T ss_pred HhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC
Confidence 99999999999999999999987532 122222 2235678999999999999999999999999999988 778887
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
........ ..++....+-..+...+.++..++.+|+..+|++|||+.++.+.|+.+......
T Consensus 365 g~~~~~v~----------------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 365 GMKNYEVK----------------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred CCCHHHHH----------------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 55432111 111122223334556688899999999999999999999999999998888775
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=267.81 Aligned_cols=214 Identities=26% Similarity=0.285 Sum_probs=171.6
Q ss_pred CCCCCC-CCCccceeeEE-e---eC---CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 1 MLSLLH-HDNLVTLIGYC-T---SG---DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 1 il~~l~-Hpniv~~~~~~-~---~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
+|++|+ |||||.+++.. . .+ ..++++||||.+|.|-|++..+. ..++++.++++|+.++++|+++||..
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~- 163 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL- 163 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-
Confidence 467787 99999999932 1 11 25789999999999999998643 34599999999999999999999988
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ce------eeecccccceeCCcccc---cCCCcccCCeee
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HV------STRVMGTYGYCAPEYAM---SGKLTLKSDIYS 142 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~------~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~s 142 (267)
.++|+|||||-+|||++.++.+||||||.+......... .. .-...=|+.|++||++. +.+.++|+|||+
T Consensus 164 ~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 164 KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 467999999999999999999999999998754332211 00 01123488999999774 567899999999
Q ss_pred hHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 143 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 143 lG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
|||++|-+|-...||+.. ....+++....-+...+++..+.+||+.||+.||.+||++-+
T Consensus 244 LGclLYkLCy~t~PFe~s--------------------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEES--------------------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHHHHHHHhCCCcCcC--------------------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 999999999999999722 233444444444444688999999999999999999999999
Q ss_pred HHHHHHHhhhccCCC
Q 024460 223 IVVALDYLVSQRDSH 237 (267)
Q Consensus 223 v~~~l~~l~~~~~~~ 237 (267)
|+..+-++...+...
T Consensus 304 v~~~~~~l~~~~~~~ 318 (738)
T KOG1989|consen 304 VLEEIFELANKPCPI 318 (738)
T ss_pred HHHHHHHHhcCCCCc
Confidence 999998887776653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.46 Aligned_cols=195 Identities=25% Similarity=0.299 Sum_probs=158.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 123 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 123 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 36789999999999999999999999999999999999854 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 124 LKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 99999999999999999999987532221 1223356789999999998888999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
...... . .+.... ..++..++.++.+++++||+.+|++||++.+
T Consensus 202 ~~~~~~---~-------------~i~~~~--~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 202 DRKETM---T-------------MILKAK--LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHH---H-------------HHHcCC--CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 211100 0 000000 0123445677999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=250.12 Aligned_cols=213 Identities=27% Similarity=0.416 Sum_probs=167.0
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++.+ +||||+++++++..++..+++|||+.+++|.+++..... ....+++..+..++.|++.||.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999976322 124577888999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||||+||+++.++.++|+|||.+................++..|+|||++.+..++.++|+||||+++|
T Consensus 154 H~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred HHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999987543322222222334567899999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........... .. .......+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 231 el~~~g~~p~~~~~~~~~~~~-------~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 231 EIFTLGGSPYPGIPVEELFKL-------LK----------EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHcCCCCCcccCCHHHHHHH-------HH----------cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9998 7777753321110000 00 0000112345677899999999999999999999999999
Q ss_pred HHhhhcc
Q 024460 228 DYLVSQR 234 (267)
Q Consensus 228 ~~l~~~~ 234 (267)
+++..-.
T Consensus 294 ~~~~~~~ 300 (304)
T cd05101 294 DRILTLT 300 (304)
T ss_pred HHHHHhh
Confidence 9887654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=248.56 Aligned_cols=207 Identities=25% Similarity=0.437 Sum_probs=161.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
++.++||||+++++++..+...++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--- 139 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999999999999999999999999998653221 234567888999999999999999998
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999875432222211222334678999999988889999999999999999998 68
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
.||........ ... . .... ....+..++..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 220 ~p~~~~~~~~~---~~~----~---------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 220 QPYQGMSNEQV---LRF----V---------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHHHH---HHH----H---------HcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 88854322110 000 0 0000 00112345677999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=244.12 Aligned_cols=207 Identities=31% Similarity=0.442 Sum_probs=167.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
++.++|+||+++++++..+..++++|||+++++|.+++...... ...+++..++.++.|++.|+++||+++ +
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 126 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---F 126 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 56789999999999999999999999999999999999763211 477999999999999999999999998 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~ 155 (267)
+|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.++|+||||+++|+|++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986543332223334556788999999988889999999999999999998 589
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
||....... ... .+........+..++.++.+++.+||+.+|++|||++++++.|+
T Consensus 207 p~~~~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 207 PYPGLSNEE---VLE--------------YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCHHH---HHH--------------HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 986442111 000 00001111224455788999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=252.42 Aligned_cols=204 Identities=33% Similarity=0.524 Sum_probs=156.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++...+..++|+||+++|+|.+++... ....+++..+..++.|++.|+.|||+++ ++|++|
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l 129 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNL 129 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccc---cccccc
Confidence 56789999999999999888899999999999999999762 2567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+++||+++.++.+||+|||++....................|+|||.+....++.++||||||+++|||++ |..||...
T Consensus 130 ~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 130 SPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999876532222223333456778999999998889999999999999999999 67887533
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
..... ...+....+...+..++..+.+++..||..+|++|||++++++.|
T Consensus 210 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 DNEEI-----------------IEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp CHHHH-----------------HHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccc-----------------cccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 21110 000011111122445677899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=253.14 Aligned_cols=193 Identities=26% Similarity=0.280 Sum_probs=155.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+...+..|+||||+++++|...+.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dl 122 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDL 122 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999988853 456888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++...... ........+++.|+|||++....++.++|+||||+++|+|++|..||....
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 123 KPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999998642111 112233457899999999998899999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
... ..... .... ...+...+..+.+++.+||+.+|.+||++.
T Consensus 201 ~~~------~~~~i----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 201 VSQ------MYDNI----------LHKP--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHH------HHHHH----------hcCC--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 110 00000 0000 112334466789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=248.21 Aligned_cols=203 Identities=27% Similarity=0.366 Sum_probs=162.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|+||+++++++.+++..++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRD 127 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 367889999999999999999999999999999999887541 2346889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 128 ikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 128 LKPENILLDDRGHIRISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCcEEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753221 1223345789999999999999999999999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
.......... ..+ ......++...+.++.+++++||+.+|++||+ ++++++
T Consensus 205 ~~~~~~~~~~-------------~~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 205 KERVKREEVD-------------RRV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CcchhHHHHH-------------HHh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 3211110000 000 00011233455778999999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.30 Aligned_cols=202 Identities=23% Similarity=0.251 Sum_probs=162.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 127 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDL 127 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999954 456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 128 kp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 128 KPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred CHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 99999999999999999999874322 2233457899999999998899999999999999999999999997443
Q ss_pred ccCccch-hhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 162 GQGEQNL-VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 162 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
....... ..+. ..+...........++.++.+++.+||..+|.+||+++++++.
T Consensus 203 ~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 203 PNETWENLKYWK-----------ETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHhcc-----------ccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 2211100 0000 0000000000012456789999999999999999999999973
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=250.81 Aligned_cols=215 Identities=28% Similarity=0.416 Sum_probs=167.4
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++++ +||||+++++++..++..++++||+++++|.+++..... ....+++..+..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999875321 123577888999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||++....++.++|+||||+++|
T Consensus 151 H~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 ASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred HHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9999 9999999999999999999999999987543222111122233356799999999889999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........... . ........+..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 228 el~~~g~~p~~~~~~~~~~~~-------~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 228 EIFTLGGSPYPGIPVEELFKL-------L----------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHhcCCCCCCCCCHHHHHHH-------H----------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 7888864321111000 0 00011112334567899999999999999999999999999
Q ss_pred HHhhhccCC
Q 024460 228 DYLVSQRDS 236 (267)
Q Consensus 228 ~~l~~~~~~ 236 (267)
+++......
T Consensus 291 ~~~~~~~~~ 299 (334)
T cd05100 291 DRVLTVTST 299 (334)
T ss_pred HHHhhhcCC
Confidence 999865554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=243.39 Aligned_cols=203 Identities=27% Similarity=0.383 Sum_probs=160.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++++|.+++.. ....+++..+..++.|++.|+.|||+++ ++|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 125 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36789999999999999999999999999999999999865 2346888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||..
T Consensus 126 l~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred cCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999998875422211 11112234567999999988889999999999999999999 8889864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
...... ..... . .. .. ..+...+..+.+++.+||..+|++||+++++++.|
T Consensus 205 ~~~~~~---~~~i~---~-~~---~~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 205 KSNYEV---VEMIS---R-GF---RL-------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHH---HHHHH---C-CC---CC-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 322111 00000 0 00 00 01222356789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=250.48 Aligned_cols=214 Identities=29% Similarity=0.419 Sum_probs=166.4
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++++ +||||+++++++..++..|+||||+.+++|.+++..... ....+++..++.++.|++.||+||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4456 799999999999999999999999999999999975322 123578899999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|
T Consensus 157 H~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 157 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred HHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9998 9999999999999999999999999987543221111122223346799999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........... +.....-..+..++.++.+++.+||..+|++|||+++|++.|
T Consensus 234 el~~~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 234 EIFTLGGSPYPGVPVEELFKL-----------------LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHcCCCCCCCcCCHHHHHHH-----------------HHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 8888853321110000 000011112334567899999999999999999999999999
Q ss_pred HHhhhccC
Q 024460 228 DYLVSQRD 235 (267)
Q Consensus 228 ~~l~~~~~ 235 (267)
+++.+...
T Consensus 297 ~~~~~~~~ 304 (307)
T cd05098 297 DRILALTS 304 (307)
T ss_pred HHHHHHhh
Confidence 98877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=249.06 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=163.9
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+++ +||||+++++++..++..+++|||+.+++|.++++.. ....+++..+..++.|++.+|.|||+++ ++|+|
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 166 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRD 166 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhh
Confidence 5677 7999999999999999999999999999999999652 2344899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||++................++..|+|||.+....++.++|+||+|+++|+|++ |..||..
T Consensus 167 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 167 LAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred hccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 999999999999999999999875433322222222345678999999988889999999999999999998 8999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
....... .. .+........+...+..+.+++.+||..+|++|||++++++.|+++
T Consensus 247 ~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 247 MPVDSKF--YK--------------LIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCchHHH--HH--------------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 3321110 00 0000000011223356799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.88 Aligned_cols=215 Identities=27% Similarity=0.420 Sum_probs=166.7
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++++ +||||+++++++..++.++++|||+++++|.+++..... ....+++..+..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 4456 699999999999999999999999999999999975321 224588899999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++|
T Consensus 151 H~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred HHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9999 9999999999999999999999999987543222111111223345799999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||............ . ....-..+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 228 el~~~g~~p~~~~~~~~~~~~~-------~----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 228 EIFTLGGSPYPGIPVEELFKLL-------R----------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHhCCCCCCCCCCHHHHHHHH-------H----------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9998 78888533221110000 0 0000112345567899999999999999999999999999
Q ss_pred HHhhhccCC
Q 024460 228 DYLVSQRDS 236 (267)
Q Consensus 228 ~~l~~~~~~ 236 (267)
+++......
T Consensus 291 ~~~~~~~~~ 299 (314)
T cd05099 291 DKVLAAVSE 299 (314)
T ss_pred HHHHHHhcC
Confidence 988765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=246.76 Aligned_cols=210 Identities=29% Similarity=0.442 Sum_probs=163.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-------------CCCCCCHHHHHHHHHHHHHHHHH
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------------DQEPLSWNTRMKIAVGAARGLEY 67 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------~~~~~~~~~~~~~~~~l~~~l~~ 67 (267)
+|+.++||||+++++++..++..|++|||+++++|.+++..... ....+++..+..++.|++.|+.|
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999853211 12357888899999999999999
Q ss_pred hhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHH
Q 024460 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 68 lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 147 (267)
||+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++
T Consensus 140 lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 140 LSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred HHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999 999999999999999999999999998754322222222333446679999999888899999999999999
Q ss_pred HHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 148 LELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 148 ~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
|+|++ |..||........ .. .+.....-..+..++..+.+++.+||+.+|.+||++.+|++.
T Consensus 217 ~el~~~g~~p~~~~~~~~~---~~--------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQEV---IE--------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCCCCCCCCCHHHH---HH--------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99998 8888853221100 00 000000011234556789999999999999999999999999
Q ss_pred HHHh
Q 024460 227 LDYL 230 (267)
Q Consensus 227 l~~l 230 (267)
|+.+
T Consensus 280 l~~~ 283 (283)
T cd05090 280 LRSW 283 (283)
T ss_pred hhcC
Confidence 8753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=247.74 Aligned_cols=207 Identities=27% Similarity=0.429 Sum_probs=163.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|+.++||||+++++++..+...++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 139 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--- 139 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999999999999999999999999999753321 234678889999999999999999998
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+....++.++|+||||+++|++++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999999999999999999999999875433222222223345678999999988889999999999999999998 88
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
.||........ .. .+........+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 220 ~p~~~~~~~~~---~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 220 QPYQGLSNEEV---LK--------------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCccCCHHHH---HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 88853321111 00 00001111223445778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=253.49 Aligned_cols=195 Identities=28% Similarity=0.337 Sum_probs=159.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+++||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+|
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 126 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRD 126 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 36789999999999999999999999999999999999964 456888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 127 lkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 127 LKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753221 12245788999999999888999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
...... . .... . .-.++..++..+.+++++||+.||.+||+ ++++++
T Consensus 202 ~~~~~~---~---~i~~----------~--~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 202 NPFGIY---E---KILA----------G--KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CHHHHH---H---HHHh----------C--CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 211100 0 0000 0 00123344667899999999999999995 888885
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=245.07 Aligned_cols=207 Identities=29% Similarity=0.400 Sum_probs=161.0
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++++ +||||+++++++...+..+++|||+++++|.+++..... ....+++..+..++.|++.|++||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567 799999999999999999999999999999999865321 123578899999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+.+ ++|+||+|+||+++.++.++++|||++..... .........+..|+|||.+....++.++|+||||+++|
T Consensus 129 H~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 129 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HHCC---EeecccccceEEEcCCCeEEECCCCCccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 9998 99999999999999999999999999753211 11111122345699999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........ .. .+.....-..+..++.++.+++.+|+..+|.+|||++++++.|
T Consensus 203 el~~~g~~pf~~~~~~~~---~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 203 EIVSLGGTPYCGMTCAEL---YE--------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred HHHcCCCCCccccCHHHH---HH--------------HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9997 9999854321110 00 0000001112234566789999999999999999999999999
Q ss_pred HHhh
Q 024460 228 DYLV 231 (267)
Q Consensus 228 ~~l~ 231 (267)
+++.
T Consensus 266 ~~~~ 269 (270)
T cd05047 266 NRML 269 (270)
T ss_pred HHhh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=244.35 Aligned_cols=207 Identities=27% Similarity=0.401 Sum_probs=163.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++.++||||+++++.+..++..+++|||+.+++|.+++... ....+++..+..++.|++.|++|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~d 128 (261)
T cd05072 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRD 128 (261)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 357889999999999999999999999999999999998652 3456888899999999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||++........ .......++..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 129 l~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 129 LRAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred cchhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 999999999999999999999875432211 11122334567999999988889999999999999999998 8999863
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .... . .. ........++.++.+++.+|+..+|++||+++++.+.|+.+
T Consensus 208 ~~~~~~---~~~~----~------~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 208 MSNSDV---MSAL----Q------RG----YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCHHHH---HHHH----H------cC----CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 321110 0000 0 00 00111224567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=255.30 Aligned_cols=195 Identities=23% Similarity=0.295 Sum_probs=160.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++..++.+|+||||+.+|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 156 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRD 156 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccC
Confidence 35778999999999999999999999999999999999964 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.++|+|||++...... .....|++.|+|||++.+..++.++|+||||+++|+|++|.+||...
T Consensus 157 Lkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 157 LKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 9999999999999999999998753211 22346889999999999888999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
...... . . +.... ..++...+..+.+++++||+.+|.+|+ +++++++
T Consensus 232 ~~~~~~---~---~----------i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 232 EPLLIY---Q---K----------ILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CHHHHH---H---H----------HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 221100 0 0 00000 012334456789999999999999995 8998876
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=243.14 Aligned_cols=206 Identities=27% Similarity=0.389 Sum_probs=163.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..+++|||+.+++|.+++... ....+++..+..++.|++.|+.+||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 129 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 57889999999999999999999999999999999999652 2456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ...........|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999875432111 11111223457999999988889999999999999999999 99998633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... . .+........+..++..+.+++.+|++.+|.+||+++++++.|+.+
T Consensus 209 ~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 209 TNAEVL---Q--------------QVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CHHHHH---H--------------HHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 211100 0 0000001112334567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=244.47 Aligned_cols=208 Identities=27% Similarity=0.395 Sum_probs=163.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|+.++||||+++++++..++..++||||+++++|.+++..... ....+++..+..++.|++.+++|||+.+ ++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H 129 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIH 129 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 6788999999999999999999999999999999999975322 2245788999999999999999999998 999
Q ss_pred CCCCCCcEEEcCCC-----ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 79 RDLKSANILLDNDF-----NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 79 ~di~~~nili~~~~-----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
+||+|+||+++.++ .++++|||++................++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 130 ~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~ 209 (269)
T cd05044 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209 (269)
T ss_pred CCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHc
Confidence 99999999998877 899999999875432222122222344678999999998899999999999999999998
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
|..||........ ... +.....-..+..++..+.+++.+||..+|++||++++|+++|++
T Consensus 210 g~~p~~~~~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 210 GQQPYPALNNQEV---LQH--------------VTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred CCCCCcccCHHHH---HHH--------------HhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 9999863321110 000 00000111234567789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=255.24 Aligned_cols=197 Identities=28% Similarity=0.346 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~d 80 (267)
++.++||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+|
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrD 121 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRD 121 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 5678999999999999999999999999999999988854 4578999999999999999999997 68 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 122 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 122 LKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 99999999999999999999986422111 1122345889999999999889999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........+ ... .-.++..++.++.+++.+||+.+|++|+ +++++++
T Consensus 200 ~~~~~~~~i----------------~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 200 DHEKLFELI----------------LME--EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CHHHHHHHH----------------hcC--CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 321110000 000 0112344567899999999999999996 8999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=248.75 Aligned_cols=216 Identities=21% Similarity=0.245 Sum_probs=159.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++||||++++++..+.. ....+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 126 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDI 126 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 578899999999999999999999999998876665442 3457889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 127 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 127 KPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred CHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998754322111 1223457889999999988889999999999999999999999997543
Q ss_pred ccCccchh-hhchh-------hhhcccccccccCCcCC------CCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLV-SWSRP-------FLKDQKKFVHLVDPLLH------GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......+ ..... .............+... ......++.++.+++++||+.+|++|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 206 EIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22111000 00000 00000000000001000 0112235678999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=247.23 Aligned_cols=206 Identities=26% Similarity=0.361 Sum_probs=163.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++.+++..++..++||||+++++|..++.........+++..++.++.|++.||.|||+++ ++|+|
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 122 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRD 122 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 367889999999999999999999999999999999887553334567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 123 lkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 123 LKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986532221 1122345788999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
......... ........ ..++..++..+.+++.+||+.+|++|| |++++++
T Consensus 201 ~~~~~~~~~------------~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 201 GEKVENKEL------------KQRILNDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CcchhHHHH------------HHhhcccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 221110000 00011110 122345677899999999999999999 6677775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=254.52 Aligned_cols=199 Identities=27% Similarity=0.343 Sum_probs=168.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|.+++++||.++|+.+..+..++++||||.||++.+.+.. +..+.+..+..++.+++.|+.|||.++ .+|+|
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrD 136 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRD 136 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eeccc
Confidence 36788999999999999999999999999999999999954 455588889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+.||++...|.++|+|||.+-...... .......||+.|||||++....|+.++||||||++.+||++|.+|+...
T Consensus 137 IKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 137 IKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred ccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 99999999999999999999987644333 2336678999999999999999999999999999999999999999866
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.+......+. +...|.+ ...++..+.++|..||+.||+.||++.++++
T Consensus 215 hPmrvlflIp-------------k~~PP~L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 215 HPMRVLFLIP-------------KSAPPRL----DGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CcceEEEecc-------------CCCCCcc----ccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 6533322222 1222222 2356777999999999999999999999987
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=243.79 Aligned_cols=212 Identities=21% Similarity=0.267 Sum_probs=167.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++...+..++++||+++++|.+++.........+++..+..++.|++.|+.|||+++ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08228 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRD 131 (267)
T ss_pred HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 367889999999999999999999999999999999988654434566888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 132 IKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 99999999999999999999887532221 1112345778899999998888999999999999999999999998532
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
.... ....... . ........+..++..+.+++.+||..+|++||+++++++.+++++
T Consensus 210 ~~~~----~~~~~~~-------~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 210 KMNL----FSLCQKI-------E---QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred cccH----HHHHHHH-------h---cCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 2110 0000000 0 000011112355678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=246.31 Aligned_cols=207 Identities=31% Similarity=0.461 Sum_probs=162.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLHC 70 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lH~ 70 (267)
|+.++||||+++++++..++..+++|||+++++|.+++..... ....+++..+..++.|++.|++|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999875321 11357889999999999999999999
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 71 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 71 ~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
.+ ++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 141 ~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 141 LH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred CC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998754322211122223346789999999888999999999999999999
Q ss_pred Hh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 151 IT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
++ |.+||........... .. .......+..++..+.+++.+||+.+|.+||++++|++.|+
T Consensus 218 ~~~g~~p~~~~~~~~~~~~----------------~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIEC----------------IT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCHHHHHHH----------------HH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 8888853221111000 00 00001112345677999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=257.25 Aligned_cols=212 Identities=25% Similarity=0.330 Sum_probs=165.0
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------------------------------
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------------------------ 44 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------ 44 (267)
|+++. ||||+++++++...+..|+|||||++|+|.+++.....
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 56675 99999999999999999999999999999998864210
Q ss_pred --------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 45 --------------------------------------------------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 45 --------------------------------------------------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
....+++..++.++.|++.||.||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 013477788899999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+.+ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|
T Consensus 254 H~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 254 ASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330 (400)
T ss_pred HhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999987543322222222334567899999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||......... .. ... ....-..+..++.++.+++.+||+.+|++|||+.+|.++|
T Consensus 331 ellt~g~~P~~~~~~~~~~--~~----~~~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 331 EIFSLGGTPYPGMIVDSTF--YN----KIK----------SGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHCCCCCCcccchhHHH--HH----HHh----------cCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 9997 88888643211100 00 000 0001112345677899999999999999999999999999
Q ss_pred HHhhh
Q 024460 228 DYLVS 232 (267)
Q Consensus 228 ~~l~~ 232 (267)
+++.+
T Consensus 395 ~~l~~ 399 (400)
T cd05105 395 ESLLP 399 (400)
T ss_pred HHHcC
Confidence 98754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=242.21 Aligned_cols=206 Identities=24% Similarity=0.370 Sum_probs=161.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++. ....++||||+++++|.+++.. ....+++..++.++.|++.++.|||+++ ++|+|
T Consensus 48 ~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 120 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRD 120 (257)
T ss_pred HHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 367899999999999886 4578999999999999999864 3457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcce-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|+|+||+++.++.++|+|||++........... .....++..|+|||.+....++.++|+||||+++|++++ |..||.
T Consensus 121 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred cchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 999999999999999999999875322221111 111223567999999888889999999999999999996 999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
......... .+........+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 201 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 201 KMKGPEVMS-----------------FIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCHHHHHH-----------------HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 443211100 0000011112345578899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=248.49 Aligned_cols=212 Identities=28% Similarity=0.406 Sum_probs=164.9
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|+++ +||||+++++++..++.+++||||+++++|.+++..... ....+++..++.++.|++.|++||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4566 899999999999999999999999999999999975321 123678999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||+|+||+++.++.++|+|||++..... .........+..|+|||.+....++.++||||||+++|
T Consensus 141 H~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 141 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HhCC---ccccccchheEEecCCCcEEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 9999 99999999999999999999999999863211 11111122356799999988888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........ .. . +........+..++..+.+++.+||+.+|++||+++++++.|
T Consensus 215 ellt~g~~p~~~~~~~~~---~~---~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 215 EIVSLGGTPYCGMTCAEL---YE---K-----------LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHhcCCCCcccCChHHH---HH---H-----------HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998 9999853322110 00 0 000001111223466789999999999999999999999999
Q ss_pred HHhhhccCC
Q 024460 228 DYLVSQRDS 236 (267)
Q Consensus 228 ~~l~~~~~~ 236 (267)
..+...+..
T Consensus 278 ~~~~~~~~~ 286 (303)
T cd05088 278 NRMLEERKT 286 (303)
T ss_pred HHHHHhhhh
Confidence 887666654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=244.41 Aligned_cols=221 Identities=30% Similarity=0.458 Sum_probs=165.1
Q ss_pred CCCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|++++||||+++++++... ..++++|||+++++|.+++.. ..+++..+..++.|++.|+.|||+++ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H 130 (283)
T cd05080 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIH 130 (283)
T ss_pred HHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 36789999999999988653 468999999999999999953 45899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||+|+||+++.++.++|+|||++......... .......++..|++||.+....++.++|+||||+++|+|++|..|+
T Consensus 131 ~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~ 210 (283)
T cd05080 131 RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210 (283)
T ss_pred cccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999998754322211 1112223456799999998888999999999999999999999987
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
......... ........ .........+........+..++..+.+++.+||+.+|++|||+++++++|+++.
T Consensus 211 ~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 211 QSPPKKFEE-MIGPKQGQ-MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCcchhhh-hhcccccc-cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 543211100 00000000 0000111111111222234456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=247.07 Aligned_cols=212 Identities=27% Similarity=0.391 Sum_probs=164.7
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
++++ +||||+++++++...+..++++||+++++|.+++..... ....+++..+..++.|++.|++||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4456 799999999999999999999999999999999964221 123588899999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||||+||+++.++.++|+|||++...... ........+..|+|||......++.++||||||+++|
T Consensus 136 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 136 SEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred HHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 9998 999999999999999999999999998632111 1111112245699999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||......... . .+.....-..+..++..+.+++.+||..+|.+|||++++++.|
T Consensus 210 el~t~g~~pf~~~~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 210 EIVSLGGTPYCGMTCAELY---E--------------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HHHcCCCCCCCCCCHHHHH---H--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9997 99998643221100 0 0000011112344567899999999999999999999999999
Q ss_pred HHhhhccCC
Q 024460 228 DYLVSQRDS 236 (267)
Q Consensus 228 ~~l~~~~~~ 236 (267)
..+......
T Consensus 273 ~~~~~~~~~ 281 (297)
T cd05089 273 SRMLEARKA 281 (297)
T ss_pred HHHHHhhcc
Confidence 888876644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=243.03 Aligned_cols=203 Identities=27% Similarity=0.382 Sum_probs=161.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.+++|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 125 (256)
T cd05059 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125 (256)
T ss_pred HHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999865 2347889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||+++...... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 126 l~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred ccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 99999999999999999999987542211 111112223457999999988899999999999999999998 7888864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
...... .. . +........+..++..+.+++.+||..+|++|||++++++.|
T Consensus 205 ~~~~~~---~~----------~----~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 205 FSNSEV---VE----------S----VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHH---HH----------H----HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 322110 00 0 000011122344677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=242.53 Aligned_cols=202 Identities=26% Similarity=0.396 Sum_probs=159.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..+++|||+.+++|.+++.. ....+++..++.++.|++.|+.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 126 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDL 126 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 6788999999999999999999999999999999999865 2346889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++++|||.+....... ........++..|++||...+..++.++|+||||+++|+|++ |..||...
T Consensus 127 ~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred CcceEEEcCCCCEEECCCccceecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 9999999999999999999987542221 111112334567999999988889999999999999999998 88888633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
...... . . ... ......+...+..+.+++.+||+.+|.+|||+.+|++.|
T Consensus 206 ~~~~~~---~---~----------~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 206 NNSETV---E---K----------VSQ-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CHHHHH---H---H----------Hhc-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 311100 0 0 000 000011223467799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=245.41 Aligned_cols=207 Identities=26% Similarity=0.359 Sum_probs=161.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+++++|+||+++++++.+.+..++||||+++++|.+++..... ....+++..+..++.|++.++.|||+++ ++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH 139 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIH 139 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eee
Confidence 5788999999999999988899999999999999999975321 1235888999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC---ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 79 RDLKSANILLDNDF---NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 79 ~di~~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
+||+|+||+++.++ .++|+|||++.................+..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~ 219 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999997654 589999999875422211111112233567999999988899999999999999999996 88
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
.||.......... .+........+..++..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 220 ~pf~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 220 MPYPGRTNQEVME-----------------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHH-----------------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 9986433211100 00000111223445678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=241.87 Aligned_cols=204 Identities=25% Similarity=0.395 Sum_probs=160.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+++.||||+++++++. ++..++||||+++++|.+++.. ...+++..+..++.|++.|+.+||+++ ++|+||
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl 121 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDL 121 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 56789999999999875 4567899999999999999854 356889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcce-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++|+|||++........... .....++..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 122 kp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred chhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999875433222111 111223568999999888888999999999999999998 9999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .. .+.....-..+..++.++.++|.+||+.+|++||++++|.+.|+.+
T Consensus 202 ~~~~~~---~~--------------~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 202 MKGNEV---TQ--------------MIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCHHHH---HH--------------HHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 322110 00 0111111122345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=245.81 Aligned_cols=204 Identities=24% Similarity=0.312 Sum_probs=160.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..+..+++||||+++++|.+++... ....+++..+..++.|++.|++|||+.+ ++|+|
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 120 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRD 120 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEcc
Confidence 367899999999999999999999999999999999888542 3345888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++...... .......++..|+|||.+....++.++|+||+|+++|+|++|..||...
T Consensus 121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 121 MKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753221 1223356788999999998888999999999999999999999998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ...... ........ ....++.++.+++.+||+.+|++||+++|+++
T Consensus 198 ~~~~~~--~~~~~~----------~~~~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 198 KEKVAK--EELKRR----------TLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cchhhH--HHHHHH----------hhcccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 221110 000000 00000000 01235677999999999999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=247.67 Aligned_cols=196 Identities=26% Similarity=0.356 Sum_probs=166.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.|+||||+.+|.+|+..+.+.+||||..+|.|++|+. ..+.+++..+..++.||+.|+.|+|+++ ++|+|
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRD 178 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRD 178 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecc
Confidence 5789999999999999999999999999999999999994 5789999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCc-ccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
+|.+|||++.++++||+|||++... ......++..|.+.|.+||++.+.+|. +..|-||||+++|-+..|..||+.
T Consensus 179 LKLENILLD~N~NiKIADFGLSNly---~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 179 LKLENILLDQNNNIKIADFGLSNLY---ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred cchhheeecCCCCeeeeccchhhhh---ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 9999999999999999999999743 334456778899999999999998885 789999999999999999999985
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCc-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
....... ..+-++.+. ..-+.+..-+|++||..||.+|.|+++|..-
T Consensus 256 ~Dhk~lv--------------------rQIs~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 256 RDHKRLV--------------------RQISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred chHHHHH--------------------HHhhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 5421111 111111110 1224557789999999999999999999874
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=246.61 Aligned_cols=195 Identities=27% Similarity=0.381 Sum_probs=157.0
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
..+||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp 124 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 45899999999999999999999999999999998854 456899999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCcc
Q 024460 84 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 163 (267)
Q Consensus 84 ~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~ 163 (267)
+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999987432221 2223356899999999999889999999999999999999999999643311
Q ss_pred CccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 024460 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 225 (267)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-ev~~ 225 (267)
.. .. . +.. ....++..++.++.+++.+||..+|++||++. ++++
T Consensus 203 ~~---~~---~----------i~~--~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 203 EL---FD---S----------ILN--DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HH---HH---H----------HHc--CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 10 00 0 000 00112344567789999999999999999876 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=230.18 Aligned_cols=213 Identities=27% Similarity=0.350 Sum_probs=167.5
Q ss_pred CCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 3 SLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
++++||||++++++... ....|++++|+..|+|.+.++.....+..+++..++.|+.++++||.+||+.. ++++
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yA 151 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYA 151 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-Cccc
Confidence 68899999999987643 34589999999999999999988778889999999999999999999999885 4699
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-------ceeeecccccceeCCcccccC---CCcccCCeeehHHHH
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-------HVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVL 147 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~ 147 (267)
|+||||.||++++.+.+++.|||.++.....-.. +.......+..|+|||.+... ..++++|||||||++
T Consensus 152 H~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtL 231 (302)
T KOG2345|consen 152 HRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTL 231 (302)
T ss_pred ccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHH
Confidence 9999999999999999999999998754321111 001123458899999988754 467899999999999
Q ss_pred HHHHhCCCCccccCccCccchhhhchhhhhcccccc-cccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 148 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFV-HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
|.|+.|..||+..-..+. .+. ...++...-+-...+++.+.++|++||+.+|.+||++.+++..
T Consensus 232 Ya~mf~~sPfe~~~~~Gg---------------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 232 YAMMFGESPFERIYQQGG---------------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHcCCcchHHhhcCC---------------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 999999999973322221 111 1111111111123478889999999999999999999999999
Q ss_pred HHHhh
Q 024460 227 LDYLV 231 (267)
Q Consensus 227 l~~l~ 231 (267)
++.++
T Consensus 297 ~d~Li 301 (302)
T KOG2345|consen 297 LDDLI 301 (302)
T ss_pred HHhhc
Confidence 98775
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=253.10 Aligned_cols=196 Identities=26% Similarity=0.271 Sum_probs=157.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++.+|+||||+++++|.+++.. ...+.+..+..++.|++.||.|||+++ ++|+||
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDl 122 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 122 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 4678999999999999999999999999999999999854 456788889999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|.+||....
T Consensus 123 kp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 123 KPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999986432111 12233458899999999999999999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
.... .. .. .... ...+..++..+.+++.+||+.+|.+||++.+.+
T Consensus 201 ~~~~---~~---~i----------~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 201 TAEM---YD---NI----------LNKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHHH---HH---HH----------HhCC--cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 1110 00 00 0000 011234567799999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=242.24 Aligned_cols=209 Identities=25% Similarity=0.376 Sum_probs=163.2
Q ss_pred CCCCCCCCccceeeEEeeCCe------eEEEEecCCCCCHHHHhcccCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQ------RLLVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|+.++||||+++++++..... .++++||+++++|..++..... ....+++..+..++.|++.||.|||+.+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~- 133 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN- 133 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 567899999999998866544 7999999999999998865321 2346889999999999999999999998
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
++|+||+|+||++++++.++|+|||+++...............++..|++||.+....++.++|+||||+++|+|++
T Consensus 134 --i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 134 --FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred --eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999999999999999999876433322222222334567999999988889999999999999999998
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
|..||....... ..... ........+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 212 g~~p~~~~~~~~---~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 212 GQTPYPGVENHE---IYDYL--------------RHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCHHH---HHHHH--------------HcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 888885332110 10000 00001112345677899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=241.39 Aligned_cols=206 Identities=25% Similarity=0.395 Sum_probs=162.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..+...++||||+++++|.+++.. ..+.+++..+..++.|++.|+.|||+++ ++|+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl 132 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDL 132 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 5788999999999999999999999999999999999865 3456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecc---cccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM---GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~ 157 (267)
+|+||+++.++.++++|||++................ .+..|++||.+....++.++|+||+|+++|+|++ |..||
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 9999999999999999999987543222111111111 1357999999988899999999999999999886 89888
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
....... ...+. .....-..+..++..+.+++.+||..+|.+||++++|++.|+++
T Consensus 213 ~~~~~~~---~~~~i--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 213 WDMSNQD---VINAI--------------EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCHHH---HHHHH--------------HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 5332111 00100 00011112335567799999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=244.10 Aligned_cols=215 Identities=26% Similarity=0.423 Sum_probs=162.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-------QEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
|+.++||||+++++++..++..+++|||+++++|.+++...... ...+++..+..++.|++.|++|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 150 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-- 150 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 57889999999999999999999999999999999998753211 234777889999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh--
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-- 152 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-- 152 (267)
++|+||||+||+++.++.++|+|||++.................+..|++||......++.++|+||||+++|+|++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred -eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999875432222112222334567999998888889999999999999999998
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
|..||........ ............ .......+..++..+.+++.+||+.+|++||++++|++.|++
T Consensus 230 ~~~p~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 230 KEQPYSQLSDEQV---IENTGEFFRDQG-------RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred CCCCccccChHHH---HHHHHHHHhhcc-------ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 6677753322111 100000000000 000011123456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=237.02 Aligned_cols=212 Identities=25% Similarity=0.340 Sum_probs=168.9
Q ss_pred CCCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
||+++ -||+|+++.++++++..+++|+|.|+.|.|.|++. ..-++++.....++.|+.+++.|||.++ |+|+
T Consensus 75 ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHR 147 (411)
T KOG0599|consen 75 ILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHR 147 (411)
T ss_pred HHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhc
Confidence 35554 59999999999999999999999999999999995 4678999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC------CCcccCCeeehHHHHHHHHhC
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG~i~~~~l~g 153 (267)
|+||+|||++++-++++.|||+++.+.... .-....||+.|+|||.+... .|+...|+|++|+|+|-++.|
T Consensus 148 DLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 148 DLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred ccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 999999999999999999999998654332 23346799999999998763 578889999999999999999
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhh
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLV 231 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~ 231 (267)
.+||...+...-...+.-. . .++-.+.+ .+++....++|.+||+.||..|.|++|.+. .+.++.
T Consensus 225 cpPFwHRkQmlMLR~ImeG------k---yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 225 CPPFWHRKQMLMLRMIMEG------K---YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred CCchhHHHHHHHHHHHHhc------c---cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 9999643322111111100 0 01111111 466778999999999999999999999998 455555
Q ss_pred hccCC
Q 024460 232 SQRDS 236 (267)
Q Consensus 232 ~~~~~ 236 (267)
++...
T Consensus 291 ~~~~r 295 (411)
T KOG0599|consen 291 QQQAR 295 (411)
T ss_pred Hhccc
Confidence 54443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=241.11 Aligned_cols=206 Identities=26% Similarity=0.370 Sum_probs=163.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ..+.+++..+..++.|++.|+.+||+++ ++|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dl 132 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDL 132 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeehhh
Confidence 5678999999999999999999999999999999999965 3456888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCccee-eecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++++|||++............ ....++..|++||.+.+..++.++|+|+||+++|++++ |..||..
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred chhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 999999999999999999998754332211111 11223467999999988889999999999999999886 9999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .... . .......+..++..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 213 ~~~~~~---~~~~---~-----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 213 MSNQDV---IKAI---E-----------EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHHH---HHHH---h-----------CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 332110 0000 0 0000111234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=250.13 Aligned_cols=194 Identities=25% Similarity=0.349 Sum_probs=156.6
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.+||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~ 125 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLD 125 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH
Confidence 4799999999999999999999999999999998864 456889999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 9999999999999999986432111 12233468999999999998899999999999999999999999996433111
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~------~ev~~ 225 (267)
.. . . +.... -..+..++.++.+++.+||+.+|++||++ +++++
T Consensus 204 ~~---~---~----------i~~~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 204 LF---E---A----------ILNDE--VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HH---H---H----------HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 00 0 0 00000 01233456778999999999999999998 56654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=240.43 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=161.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.+.||||+++++++. ....++||||+++++|.+++.. ...+++..+..++.|++.++.|||..+ ++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di 121 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDL 121 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCc
Confidence 56789999999999876 4468999999999999999965 347889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcce-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++|+|||++........... .....++..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 122 ~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999875432222111 111223457999999988889999999999999999997 9999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
..... .... +........+..++..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 202 ~~~~~---~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 202 MKGAE---VIAM--------------LESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCHHH---HHHH--------------HHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 33211 1110 0000011123445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=250.56 Aligned_cols=194 Identities=26% Similarity=0.333 Sum_probs=157.2
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.+||||+++++++..++.+|+||||+++++|..++.. ...+++..+..++.|++.||.|||+++ ++|+||||+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~ 125 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLD 125 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 4799999999999999999999999999999988854 456888999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 126 Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 203 (321)
T cd05591 126 NILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203 (321)
T ss_pred HeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986432211 12233457899999999998899999999999999999999999997443211
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-------CHHHHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-------LINDIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-------t~~ev~~ 225 (267)
... . +.... ...+..++.++.+++.+||+.+|++|| +++++++
T Consensus 204 ~~~------~----------i~~~~--~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 204 LFE------S----------ILHDD--VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHH------H----------HHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 100 0 00000 012333467799999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=240.84 Aligned_cols=211 Identities=23% Similarity=0.292 Sum_probs=167.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..+++|||+++++|.+++.........+++..++.++.|++.++.|||+++ ++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 132 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDI 132 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 56789999999999999999999999999999999988754334567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||.+....... .......++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999999999999999887532221 11223457888999999988889999999999999999999999985322
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
.. ...... ...... .....+..++..+.+++.+||..+|++|||+++|++.++++.
T Consensus 211 ~~----~~~~~~-------~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 211 MN----LYSLCK-------KIEQCD---YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ch----HHHHhh-------hhhcCC---CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11 000000 000000 000112346778999999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=239.85 Aligned_cols=210 Identities=22% Similarity=0.309 Sum_probs=167.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++|+||+++++.+..++..++||||+++++|.+++.........+++..+..++.+++.++.|||+.+ ++|+||
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl 132 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDI 132 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCc
Confidence 57889999999999999999999999999999999998754444567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... .......++..|.|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 133 ~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 9999999999999999999987532221 11223456788999999988889999999999999999999999985332
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcH-HHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR-RCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
.. ...... .+........+. .++..+.+++.+||..+|++|||+.+|+++|+.+.
T Consensus 211 ~~----~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 211 MN----LYSLCK-----------KIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred cc----HHHHHh-----------hhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 10 000000 000000111222 55678999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=239.10 Aligned_cols=203 Identities=28% Similarity=0.413 Sum_probs=161.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++...+..++||||+++++|.+++.. ....+.+..+..++.+++.++.|||+++ ++|+||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl 119 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDL 119 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence 5678999999999999999999999999999999999865 3446788999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... ........++..|+|||.+....++.++|+||||+++|++++ |..||...
T Consensus 120 ~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 120 AARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred ChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999986432211 111112233567999999988889999999999999999998 88898643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
........ +........+..++..+.+++.+|+..+|++||++.++++.|.
T Consensus 199 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 199 TNQQAREQ-----------------VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHH-----------------HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 22111000 0000111123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=248.67 Aligned_cols=212 Identities=28% Similarity=0.407 Sum_probs=163.3
Q ss_pred CCCC-CCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCC----------------------------------
Q 024460 2 LSLL-HHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPD---------------------------------- 45 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~---------------------------------- 45 (267)
++++ +||||++++++|.. +..+++++||+++++|.+++......
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 4556 79999999998764 45788999999999999998642110
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCc
Q 024460 46 -----------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102 (267)
Q Consensus 46 -----------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~ 102 (267)
...+++..+..++.|++.||.|||+++ ++|+||||.||+++.++.++|+|||++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccc
Confidence 136788899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccc
Q 024460 103 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181 (267)
Q Consensus 103 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (267)
................++..|+|||++.+..++.++|+||||+++|+|++ |..||........ .. ...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~----- 289 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRL----- 289 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHH-----
Confidence 76433222222223345667999999999999999999999999999998 9999864321110 00 000
Q ss_pred cccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 182 FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
........+..++.++.+++.+||+.+|++||+++||++.|+.+.+
T Consensus 290 -----~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 290 -----KEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -----hccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0001111233456779999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=238.68 Aligned_cols=205 Identities=27% Similarity=0.409 Sum_probs=161.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++.||||+++++++......++||||+.+++|.+++.. ....+++..+..++.+++.++.|||+++ ++|+|
T Consensus 45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~d 118 (251)
T cd05041 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118 (251)
T ss_pred HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eehhh
Confidence 36788999999999999999999999999999999999865 3446788999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 999999999999999999999875322111111111223556999999988889999999999999999998 7888854
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
......... +........+..++.++.+++.+||+.+|++|||++||++.|+
T Consensus 199 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 199 MSNQQTRER-----------------IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHH-----------------HhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 332111000 0001111223455778999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=242.30 Aligned_cols=212 Identities=25% Similarity=0.380 Sum_probs=165.5
Q ss_pred CCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPD----QEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++++++.. +...++++||+.+++|.+++...... +..+++..++.++.|++.||.|||+++ +
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i 138 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---V 138 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 577899999999998766 56789999999999999998653322 256889999999999999999999998 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~ 155 (267)
+|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 9999999999999999999999999875432221111222345667999999988889999999999999999998 999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
||....... ...+. . .......+..++.++.+++.+||..+|++|||+.++++.|..+..+
T Consensus 219 p~~~~~~~~---~~~~~----~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 219 PYVEIDPFE---MAAYL----K----------DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CcCcCCHHH---HHHHH----H----------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 986432211 11100 0 0001111234567899999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=246.96 Aligned_cols=216 Identities=25% Similarity=0.327 Sum_probs=158.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+++ ++|+|
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 128 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRD 128 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 36789999999999999999999999999975 89988864 3456788999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++|+||+|+++|+|++|.+||..
T Consensus 129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 129 LKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999875322211 1223456889999998865 5689999999999999999999999965
Q ss_pred cCccCccchhh-h-------chhhhhcccccccccCCcCCCC----CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVS-W-------SRPFLKDQKKFVHLVDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........... . ..+.............+..... .....+.+..+++.+||+.+|.+|||++|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 43221111000 0 0000000111111111111100 01123567899999999999999999999984
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=243.52 Aligned_cols=215 Identities=27% Similarity=0.415 Sum_probs=163.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+|++++||||+++++++..++..+++||++++++|.+++..... ....+++..++.++.|++.||.|||+++
T Consensus 72 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~- 150 (296)
T cd05051 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN- 150 (296)
T ss_pred HHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 36788999999999999999999999999999999999865321 1236889999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
++|+||+|+||+++.++.++|+|||++................++..|+|||.+....++.++||||||+++|+|++
T Consensus 151 --i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 228 (296)
T cd05051 151 --FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228 (296)
T ss_pred --ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence 99999999999999999999999999875433322222333445678999999988889999999999999999988
Q ss_pred -CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 153 -GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
+..||....... .......... ..........+..++.++.+++.+||+.+|++|||+.+|++.|+
T Consensus 229 ~~~~p~~~~~~~~---~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 229 CREQPYEHLTDQQ---VIENAGHFFR-------DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCCcChHH---HHHHHHhccc-------cccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 566765322111 1110000000 00000001112345678999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=240.48 Aligned_cols=201 Identities=24% Similarity=0.260 Sum_probs=161.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++.+|++|||+++++|.+++... ....+++..+..++.|++.|+.+||+++ ++|+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 126 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDI 126 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 57789999999999999999999999999999999988642 3456788999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||.+....... .......++..|+|||++.+..++.++|+||+|+++|+|++|..||....
T Consensus 127 ~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 127 KSKNIFLTQNGKVKLGDFGSARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred CcceEEECCCCcEEEcccCcceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 9999999999999999999987543221 12223457888999999988889999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
...... .+........+..++..+.+++.+||+.+|++|||+++++..
T Consensus 205 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 205 WKNLIL-----------------KVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHH-----------------HHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111000 000000111234456779999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=247.69 Aligned_cols=203 Identities=27% Similarity=0.370 Sum_probs=158.9
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++ +||||+++++++..++.+|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+||
T Consensus 50 ~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 122 (329)
T cd05588 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDL 122 (329)
T ss_pred HhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 344 799999999999999999999999999999988854 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||+...
T Consensus 123 kp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 123 KLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred CHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence 9999999999999999999986421111 12233567899999999999999999999999999999999999996432
Q ss_pred ccCcc--chhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC------HHHHHH
Q 024460 162 GQGEQ--NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL------INDIVV 225 (267)
Q Consensus 162 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt------~~ev~~ 225 (267)
..... ....+.... ..... -..|..++.++.+++.+||+.+|.+|++ ++++++
T Consensus 201 ~~~~~~~~~~~~~~~~---------~~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 201 MSDNPDQNTEDYLFQV---------ILEKQ--IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ccccccccchHHHHHH---------HHcCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 21110 000100000 01111 1123445677999999999999999997 677764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=240.29 Aligned_cols=206 Identities=26% Similarity=0.393 Sum_probs=163.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++.+++...+..++||||+++++|.+++.. ....+++..+..++.|++.|++|||+.+ ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl 133 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDL 133 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 5788999999999999999999999999999999999865 3457888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCccee-eecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++++|||++............ .....+..|++||.+....++.++|+||||+++|+|++ |..||..
T Consensus 134 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 134 AARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred chhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999998754322211111 11223457999999988889999999999999999987 9999853
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .. .+........+..++..+.+++.+|+..+|++||++++|++.|+++
T Consensus 214 ~~~~~~---~~--------------~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 214 MSNHEV---MK--------------AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHHH---HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 321100 00 0000011112234567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=239.25 Aligned_cols=200 Identities=25% Similarity=0.340 Sum_probs=161.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++... ....++...++.++.+++.|+.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl 127 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDI 127 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 67899999999999999999999999999999999999752 2457888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||+.....++.++|+||||+++++|++|..||....
T Consensus 128 ~~~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred CcceEEEeCCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999887543221 11223456788999999998889999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... .. .... ......+..++..+.+++.+||+.+|++||++.++++
T Consensus 206 ~~~~---~~-------------~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 206 QGAL---IL-------------KIIR-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred HHHH---HH-------------HHHc-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1100 00 0000 0011123355678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=242.11 Aligned_cols=209 Identities=23% Similarity=0.367 Sum_probs=163.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++.. ...++++||+++|+|.+++.. ..+.+++..++.++.|++.||+|||+++ ++|+||
T Consensus 63 l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dl 135 (279)
T cd05109 63 MAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDL 135 (279)
T ss_pred HHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 467899999999999865 457899999999999999865 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||++++++.++|+|||++................++..|++||...+..++.++|+||||+++|||++ |..||+..
T Consensus 136 kp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 136 AARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999876433222111222334567999999988889999999999999999998 88888633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
..... ...+........+..++.++.+++.+||..+|++||++.++++.|..+....
T Consensus 216 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 216 PAREI-----------------PDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CHHHH-----------------HHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 21110 0000010111112345677899999999999999999999999998886654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=252.05 Aligned_cols=194 Identities=26% Similarity=0.286 Sum_probs=156.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++..|+||||+.+++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dl 122 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDL 122 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCC
Confidence 5678999999999999999999999999999999988854 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++...... ........|+..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 123 kp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 123 KPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 999999999999999999998642211 112234568899999999999999999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
.... .... +.... ..+...+..+.+++++||..+|.+||++++
T Consensus 201 ~~~~------~~~~----------~~~~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 201 VAEM------YDNI----------LHKPL--VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred HHHH------HHHH----------HcCCc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 1110 0000 00000 112234567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=239.75 Aligned_cols=201 Identities=26% Similarity=0.342 Sum_probs=160.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++|+||+++++|.+++.. .+.+++..+..++.|++.|+.+||+.+ ++|+||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl 130 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDI 130 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 6789999999999999999999999999999999998864 356888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcce-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 131 ~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 131 KGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred CHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999999864322111111 02234677899999999888999999999999999999999998633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ............+..++..+.+++.+||..+|.+|||++++++
T Consensus 211 ~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 211 EAMAAI----------------FKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred chHHHH----------------HHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 211100 0000111111234456778999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=247.60 Aligned_cols=197 Identities=24% Similarity=0.330 Sum_probs=167.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++|||||++|++...+..+|+|.|.-++|+|++|+-. ....+.+..+.+++.||+.||.|+|+.. +||+|+
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDL 144 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDL 144 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccC
Confidence 4568999999999999999999999999999999999976 6788999999999999999999999988 999999
Q ss_pred CCCcEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCc-ccCCeeehHHHHHHHHhCCCCccc
Q 024460 82 KSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 82 ~~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
||+|+.+. .-|.+||.|||++..+... ..-....|...|.|||++.+..|+ ++.||||||+|+|.+.+|++||+.
T Consensus 145 KPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 145 KPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred CcceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 99999886 4588999999998754322 234556789999999999998886 789999999999999999999986
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.+.- +.+.-+++... ..|.-.+.+++++|+.||..+|++|.+.+||..
T Consensus 222 ANDS----------------ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 222 ANDS----------------ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccch----------------hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 6643 33333333322 235677889999999999999999999999874
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=229.84 Aligned_cols=222 Identities=24% Similarity=0.309 Sum_probs=170.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+.++++|.+.+.+.+|+||++. +|+..+++ ....++...+..|+.+++.+++|||.+. |+||||
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDl 127 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDL 127 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccC
Confidence 6789999999999999999999999999965 99999987 6678999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||.|+|++.+|.+|++|||+++.+.......... .-|.||+|||.+.+ ..|+...|+||.||++.||+-+.+.|.+.
T Consensus 128 KPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 128 KPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred CccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 9999999999999999999999765444332222 56899999998876 47999999999999999999999988765
Q ss_pred CccCccchhhh--------chh---hhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 161 KGQGEQNLVSW--------SRP---FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 161 ~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
.+..-..++-. .++ .+.+...+...-.+.....+ ..++.+..+++.+||..||.+|+|+.|.+++ +.
T Consensus 206 sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf-~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~y 283 (318)
T KOG0659|consen 206 SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLF-PAASSDALDLLSKMLTYNPKKRITASQALKH-PY 283 (318)
T ss_pred chHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccccc-ccccHHHHHHHHhhhccCchhcccHHHHhcc-hh
Confidence 54332211110 000 01111111111122222222 2446677999999999999999999999864 34
Q ss_pred hhhcc
Q 024460 230 LVSQR 234 (267)
Q Consensus 230 l~~~~ 234 (267)
+.+..
T Consensus 284 f~~~P 288 (318)
T KOG0659|consen 284 FKSLP 288 (318)
T ss_pred hhcCC
Confidence 44433
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=239.30 Aligned_cols=202 Identities=29% Similarity=0.405 Sum_probs=159.5
Q ss_pred CCCCCCCCccceeeEEe-eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCT-SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++|+|++++++++. .++..+++|||+++++|.+++... ....+++..++.++.|++.+|++||+++ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 127 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRD 127 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeccc
Confidence 67889999999999764 456789999999999999998652 2345888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||++....... .....+..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 128 lkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 128 LAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred cchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987432211 12233567999999988889999999999999999997 8888863
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .. . +........+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 203 ~~~~~~---~~----~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 203 IPLKDV---VP----R----------VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCHHHH---HH----H----------HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 321110 00 0 000011112345577899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=241.18 Aligned_cols=209 Identities=25% Similarity=0.382 Sum_probs=160.2
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|+.++||||+++++++... ...+++|||+.+++|.+++.... .....+++..+..++.|++.||+|||+++
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~- 132 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS- 132 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5678999999999987432 25689999999999998874322 12345889999999999999999999998
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
++|+||||+||+++.++.++|+|||++................++..|++||......++.++|+||||+++|+|++
T Consensus 133 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 133 --FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred --eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876433222111223345678999999998899999999999999999998
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
|..||....... ... ...... .-..+..++..+.+++.+||+.+|.+|||++++++.|+.+
T Consensus 211 g~~p~~~~~~~~---~~~----~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 211 GQTPYPGVENSE---IYD----YLRQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCHHH---HHH----HHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 788886422111 000 000000 0011234566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=249.67 Aligned_cols=193 Identities=27% Similarity=0.389 Sum_probs=156.8
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++++++...+.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||+|+|
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~N 126 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDN 126 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHH
Confidence 799999999999999999999999999999998854 457899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
|+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 127 ill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~ 204 (318)
T cd05570 127 VLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL 204 (318)
T ss_pred eEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH
Confidence 999999999999999986421111 112234578899999999999999999999999999999999999964331110
Q ss_pred cchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 225 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~ev~~ 225 (267)
.. . +.... ...+..++..+.++|++||..+|++||++ .++++
T Consensus 205 ---~~---~----------i~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 205 ---FQ---S----------ILEDE--VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---HH---H----------HHcCC--CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 00 0 00000 11233456789999999999999999999 77775
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=242.70 Aligned_cols=215 Identities=27% Similarity=0.399 Sum_probs=161.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------DQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|++++||||+++++++..++..++||||+.+++|.+++..... ....+++..++.++.|++.|++|||+++
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 6789999999999999999999999999999999999854211 1124678889999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
++|+||+|+||+++.++.++|+|||++................++..|+|||.+....++.++|+||||+++|+|++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999875432222222222344678999999988889999999999999999988
Q ss_pred -CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 153 -GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
+..||........ ......... ..........+..++..+.+++.+||..+|++|||+++|++.|++
T Consensus 228 ~~~~p~~~~~~~~~---~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 228 CKEQPYSLLSDEQV---IENTGEFFR-------NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCCcccChHHH---HHHHHHhhh-------hccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 5566653221111 000000000 000000001122346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=248.89 Aligned_cols=213 Identities=23% Similarity=0.308 Sum_probs=158.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
|++++||||++++++|..++.+++||||+++++|.+++.. .+.+++..+..++.|++.++.|||+. + ++|+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~d 129 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRD 129 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 5788999999999999999999999999999999999854 45688899999999999999999974 6 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||||+++|+|++|..||...
T Consensus 130 lkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999998643221 122345788999999999888999999999999999999999998643
Q ss_pred CccCccchhh------hchh------------h---hhc---ccccccccCCcCCCC---C-cHHHHHHHHHHHHhhccc
Q 024460 161 KGQGEQNLVS------WSRP------------F---LKD---QKKFVHLVDPLLHGR---Y-PRRCLNYAVAVTAMCLNE 212 (267)
Q Consensus 161 ~~~~~~~~~~------~~~~------------~---~~~---~~~~~~~~~~~~~~~---~-~~~~~~~l~~li~~cl~~ 212 (267)
.......... .... . ... ............... . ....+.++.+++.+||+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 285 (333)
T cd06650 206 DAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIK 285 (333)
T ss_pred chhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccC
Confidence 2211100000 0000 0 000 000000000000000 0 112456789999999999
Q ss_pred CCCCCCCHHHHHH
Q 024460 213 EANFRPLINDIVV 225 (267)
Q Consensus 213 ~p~~Rpt~~ev~~ 225 (267)
||++|||++|+++
T Consensus 286 ~P~~Rpt~~ell~ 298 (333)
T cd06650 286 NPAERADLKQLMV 298 (333)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=239.02 Aligned_cols=204 Identities=28% Similarity=0.326 Sum_probs=167.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.+.||+++.+|..|+.+++.|++||||.||+|..+++. ..++.+++..+.-++..++.||+|||..| ||+||
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRD 204 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRD 204 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeecc
Confidence 68899999999999999999999999999999999999987 45788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCC---------------------------------Cc----------------
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGD---------------------------------NT---------------- 111 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~---------------------------------~~---------------- 111 (267)
|||+||||.++|.+-|.||+++....... ..
T Consensus 205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 99999999999999999999875421100 00
Q ss_pred -----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhccccccccc
Q 024460 112 -----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLV 186 (267)
Q Consensus 112 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (267)
.......||-.|+|||++.+..-+.+.|.|+||+++|||+-|..||..... ...+..++
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~----------------~~Tl~NIv 348 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN----------------KETLRNIV 348 (459)
T ss_pred cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc----------------hhhHHHHh
Confidence 000123478899999999999999999999999999999999999975543 22233333
Q ss_pred CCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC----HHHHHH
Q 024460 187 DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL----INDIVV 225 (267)
Q Consensus 187 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~ev~~ 225 (267)
...+.-......+..+.+||++.|.+||++|.- +.||-+
T Consensus 349 ~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 349 GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 333322222355678999999999999999988 777766
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=238.25 Aligned_cols=208 Identities=27% Similarity=0.426 Sum_probs=158.6
Q ss_pred CCCCCCCCccceeeEEe-eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCT-SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++.++||||+++++++. .++..++++||+.+++|.+++.. ......+..+..++.|++.||.|||+.+ ++|+|
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 123 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRS---ETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRD 123 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 67899999999999765 46678999999999999999965 2345677788899999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC-CCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g-~~p~ 157 (267)
|+|+||+++.++.++|+|||+++........ .......++..|+|||.+....++.++||||||+++|+|++| .+||
T Consensus 124 lk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 124 LAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred cCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999998743221111 111123346689999999888899999999999999999995 5666
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
....... .... .. ....-..+..++..+.+++.+||..+|++||++.+|++.|+++..
T Consensus 204 ~~~~~~~---~~~~---~~-----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 204 PDVDSFD---ITVY---LL-----------QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCHHH---HHHH---Hh-----------cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 5322111 0000 00 000001122345679999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=246.83 Aligned_cols=194 Identities=27% Similarity=0.409 Sum_probs=156.4
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
.++||||+++++++..++.+|+||||+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp 124 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCH
Confidence 45899999999999999999999999999999998854 456889999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCcc
Q 024460 84 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 163 (267)
Q Consensus 84 ~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~ 163 (267)
+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999986422111 1233456899999999999999999999999999999999999999643221
Q ss_pred CccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH-HHH
Q 024460 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIV 224 (267)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-ev~ 224 (267)
.....+. ...+ .++..++.++.+++.+||..+|++||++. +++
T Consensus 203 ~~~~~~~--------------~~~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 ELFESIR--------------VDTP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHH--------------hCCC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1000000 0001 12334567789999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=251.36 Aligned_cols=199 Identities=22% Similarity=0.253 Sum_probs=157.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++.+++.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999854 45788899999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC----CCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+|||++.++.++|+|||++........ .......|++.|+|||++... .++.++|+||||+++|+|++|..||
T Consensus 169 kp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 169 KPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 99999999999999999999875322211 112334689999999988653 4788999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCc--HHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~ 225 (267)
......... ..+......-.++ ..++.++.++|.+||+.+|++ |++++++++
T Consensus 248 ~~~~~~~~~----------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 248 YADSLVGTY----------------SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCCCHHHHH----------------HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 643321110 0011000000111 235678999999999999988 999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=239.75 Aligned_cols=208 Identities=26% Similarity=0.393 Sum_probs=164.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.. ...++||||+++++|.+++.. ....+++..++.++.|++.|++|||+.+ ++|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di 135 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDL 135 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeccc
Confidence 567899999999999887 788999999999999999965 3456899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||.+.................+..|++||.+....++.++|+||||+++|++++ |..||...
T Consensus 136 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 136 AARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred CcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999876543222111112223567999999888889999999999999999998 99998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
....- ...+........+..++..+.+++.+||..+|++||++.++++.|+.+...
T Consensus 216 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 216 PAVEI-----------------PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CHHHH-----------------HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 22110 000001111112334556789999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=238.09 Aligned_cols=203 Identities=30% Similarity=0.452 Sum_probs=162.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++|+||+++++++..++..++||||+++++|.+++... ....+++..+..++.|++.++.|||+++ ++|+|
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~d 127 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 357889999999999999899999999999999999999652 2336899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||.+....... .....+..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 128 i~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred cccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999987542111 12234567999999988889999999999999999997 8888853
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... ...+........+..++..+.+++.+||..+|++|||+++++++|+.+
T Consensus 203 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 203 IPLKDV-----------------VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCHHHH-----------------HHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 321110 000000111122344567899999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=243.23 Aligned_cols=215 Identities=23% Similarity=0.296 Sum_probs=156.8
Q ss_pred CCCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|+.++||||+++++++.. +..+++||||++ ++|.+++... ....+++..+..++.|++.||.|||+++ +
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i 131 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---V 131 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 345689999999998852 456899999996 5899988652 3456889999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+|+||||+||+++.++.++|+|||++...... .......++..|+|||++....++.++|+||||+++|+|++|.+|
T Consensus 132 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred eeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998753222 222334578899999999888999999999999999999999999
Q ss_pred ccccCccCccc-hhhhch-h---hhhccccc-ccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQN-LVSWSR-P---FLKDQKKF-VHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~-~~~~~~-~---~~~~~~~~-~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|.......... +..... + ........ .....+..... ....++..+.+++.+||+.+|++|||+.++++
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 209 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 97544322111 110000 0 00000000 00000000000 11234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=250.29 Aligned_cols=216 Identities=21% Similarity=0.211 Sum_probs=158.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+||||++++++|..+...++|+|++. ++|..++.. ...+++..++.++.|++.||.|||+++ ++|+|
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrD 207 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRD 207 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 4678999999999999999999999999995 688888854 456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... ........|++.|+|||++.+..++.++|+||||+++|+|++|..|+...
T Consensus 208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 208 IKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred CChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 99999999999999999999986422111 11222346899999999999889999999999999999999999876432
Q ss_pred CccCcc----chhhhchhhh---------hcccccc----cc-----cCCcCCCCC--cHHHHHHHHHHHHhhcccCCCC
Q 024460 161 KGQGEQ----NLVSWSRPFL---------KDQKKFV----HL-----VDPLLHGRY--PRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 161 ~~~~~~----~~~~~~~~~~---------~~~~~~~----~~-----~~~~~~~~~--~~~~~~~l~~li~~cl~~~p~~ 216 (267)
...... .......... ....... .. ..+..+... ....+.++.++|.+||+.||.+
T Consensus 287 ~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~ 366 (391)
T PHA03212 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHH 366 (391)
T ss_pred ccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhh
Confidence 211100 0000000000 0000000 00 000000000 1234678999999999999999
Q ss_pred CCCHHHHHH
Q 024460 217 RPLINDIVV 225 (267)
Q Consensus 217 Rpt~~ev~~ 225 (267)
|||++|+++
T Consensus 367 Rpta~elL~ 375 (391)
T PHA03212 367 RPSAEALLD 375 (391)
T ss_pred CCCHHHHhc
Confidence 999999996
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=256.43 Aligned_cols=190 Identities=29% Similarity=0.443 Sum_probs=161.6
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||+++.++..|.+..++|+||||+.||++.... ....+++..+.-+++.|+.||+|||+++ |+|||||.+|
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdN 498 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDN 498 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhh
Confidence 6999999999999999999999999999944333 4578999999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
||++.+|-+||+|||+++... .......+..||+.|+|||++.+..|+.+.|.|+||+++||||.|+.||...+.+.
T Consensus 499 iLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee- 575 (694)
T KOG0694|consen 499 LLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE- 575 (694)
T ss_pred eEEcccCcEEecccccccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-
Confidence 999999999999999998633 23345677899999999999999999999999999999999999999997444222
Q ss_pred cchhhhchhhhhcccccccccCCcCCC--CCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
+.+.++.+ .+|..++.+..++++++|.++|.+|.- +++|.+
T Consensus 576 -------------------~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 576 -------------------VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred -------------------HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 12222222 257788899999999999999999974 455554
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=247.06 Aligned_cols=202 Identities=22% Similarity=0.234 Sum_probs=159.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..|+||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dl 128 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNR---YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDI 128 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccC
Confidence 5678999999999999999999999999999999999975 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc------cCCCcccCCeeehHHHHHHHHhCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
||+||+++.++.++|+|||++........ .......++..|+|||++. ...++.++||||||+++|+|++|..
T Consensus 129 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 129 KPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred chHheEECCCCCEEeccCCCCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 99999999999999999999875432221 1223346789999999986 4567789999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||.......... .... . .....-.....++..+.+++..||+ +|++|||++++++
T Consensus 208 Pf~~~~~~~~~~------~i~~-~-------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 208 PFHEGTSAKTYN------NIMN-F-------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCCCCHHHHHH------HHHc-C-------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 996433211100 0000 0 0000001112356778999999998 9999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=242.35 Aligned_cols=209 Identities=27% Similarity=0.434 Sum_probs=161.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------QEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
++.++||||+++++++..++..++||||+++|+|.+++...... ........+..++.|++.||.|||+++
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--- 139 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999999999999999999999999999753211 233466788999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
++|+||+|+||+++.++.++++|||+++...............++..|+|||.+....++.++|+||||+++|+|++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875432222112222334667999999988889999999999999999998 67
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
.||....... ... . ..+.. ....+..++..+.+++.+||+.+|++|||+.++++.|+..
T Consensus 220 ~p~~~~~~~~---~~~----~---------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 220 QPYQGLSNEQ---VLK----F---------VMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCCCHHH---HHH----H---------HHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 7875322111 000 0 00000 0011234467899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=247.05 Aligned_cols=202 Identities=28% Similarity=0.347 Sum_probs=158.3
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+.+ +||||+++++++..++.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrD 130 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRD 130 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecC
Confidence 4556 589999999999999999999999999999999854 456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.++|+|||++........ .......|+..|+|||++.+. .++.++||||||+++|+|++|..||..
T Consensus 131 lkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 999999999999999999999875322211 112234689999999998765 478899999999999999999999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
.......... ..... ..++ .++..++..+.+++.+||..+|++|| +++++++
T Consensus 210 ~~~~~~~~~~--~~~~~--------~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 210 EGERNTQSEV--SRRIL--------KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCHHHH--HHHHh--------cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 3221111000 00000 0111 12334567789999999999999999 7778875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=242.86 Aligned_cols=208 Identities=26% Similarity=0.439 Sum_probs=160.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------------CCCCCCHHHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------DQEPLSWNTRMKIAVGAAR 63 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------~~~~~~~~~~~~~~~~l~~ 63 (267)
+++++||||+++++++..+...+++|||+++++|.+++..... ....+++..++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999974221 1234678889999999999
Q ss_pred HHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeeh
Q 024460 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSF 143 (267)
Q Consensus 64 ~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~sl 143 (267)
||.|||.++ ++|+||+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+|||
T Consensus 142 aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 999999998 99999999999999999999999999875332221111222334567999999988899999999999
Q ss_pred HHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 144 GVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 144 G~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
|+++|+|++ |..||....... .... .. +.. ....+..++.++.+++.+||+.+|++|||++|
T Consensus 219 G~il~el~~~~~~p~~~~~~~~---~~~~----~~---------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAHEE---VIYY----VR---------DGN-VLSCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHH---HHHH----Hh---------cCC-CCCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999997 777775322111 0000 00 000 00113345678999999999999999999999
Q ss_pred HHHHHHH
Q 024460 223 IVVALDY 229 (267)
Q Consensus 223 v~~~l~~ 229 (267)
+++.|++
T Consensus 282 l~~~l~~ 288 (288)
T cd05050 282 INRILQR 288 (288)
T ss_pred HHHHhhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=245.52 Aligned_cols=195 Identities=29% Similarity=0.414 Sum_probs=156.8
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
.++||||+++++++.+++.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp 124 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKL 124 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCH
Confidence 35899999999999999999999999999999999854 356888999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCcc
Q 024460 84 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 163 (267)
Q Consensus 84 ~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~ 163 (267)
+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 125 DNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred HHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999986422111 1223346789999999999889999999999999999999999999643311
Q ss_pred CccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 024460 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 225 (267)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-ev~~ 225 (267)
.....+. ...+ .++..++.++.+++.+||+.+|++||++. ++.+
T Consensus 203 ~~~~~i~--------------~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 203 ELFQSIR--------------MDNP----CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHH--------------hCCC----CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1000000 0011 12233466789999999999999999997 5654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=250.93 Aligned_cols=201 Identities=26% Similarity=0.296 Sum_probs=160.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++.+++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dl 127 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDI 127 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999965 367899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCC---------------------------CcceeeecccccceeCCcccccCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGD---------------------------NTHVSTRVMGTYGYCAPEYAMSGKL 134 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~ 134 (267)
||+||+++.++.++|+|||++....... .........|+..|+|||++.+..+
T Consensus 128 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (350)
T cd05573 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207 (350)
T ss_pred CHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 9999999999999999999987543222 0011223468899999999999999
Q ss_pred cccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccC
Q 024460 135 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 213 (267)
Q Consensus 135 ~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 213 (267)
+.++||||||+++|+|++|..||.......... +..+. ....-.....++.++.++|.+|+. +
T Consensus 208 ~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~~~~~~~li~~ll~-d 271 (350)
T cd05573 208 GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK---------------ESLRFPPDPPVSPEAIDLICRLLC-D 271 (350)
T ss_pred CCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccC---------------CcccCCCCCCCCHHHHHHHHHHcc-C
Confidence 999999999999999999999997443211100 00000 000001111247789999999997 9
Q ss_pred CCCCCC-HHHHHH
Q 024460 214 ANFRPL-INDIVV 225 (267)
Q Consensus 214 p~~Rpt-~~ev~~ 225 (267)
|.+||+ ++++++
T Consensus 272 p~~R~~s~~~ll~ 284 (350)
T cd05573 272 PEDRLGSFEEIKS 284 (350)
T ss_pred hhhcCCCHHHHhc
Confidence 999999 999997
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.43 Aligned_cols=208 Identities=22% Similarity=0.333 Sum_probs=163.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+++.||||+++++++.. ...++||||+++++|.+++.. ....+++..++.++.+++.+|.|||+.+ ++|+||
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl 133 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDI 133 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 578899999999999875 457899999999999999965 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++++|||++......... ......++..|+|||.+....++.++|+||||+++|++++ |..||...
T Consensus 134 ~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 134 AARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999998754322111 1122234567999999888889999999999999999986 99998644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.......... ....-..+..++..+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 213 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 213 KNNDVIGRIE-----------------NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred CHHHHHHHHH-----------------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 3211110000 00000123455778999999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=244.40 Aligned_cols=201 Identities=28% Similarity=0.392 Sum_probs=157.5
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.+||||+++++++..++.+|+||||+++++|..++.. ...+++..+..++.|++.||.|||+++ ++|+||||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~ 125 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 125 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH
Confidence 4899999999999999999999999999999988854 457899999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......
T Consensus 126 Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (329)
T cd05618 126 NVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203 (329)
T ss_pred HEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcC
Confidence 9999999999999999986422111 12233567899999999999999999999999999999999999996322111
Q ss_pred cc--chhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 024460 165 EQ--NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 225 (267)
Q Consensus 165 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~------~ev~~ 225 (267)
.. ....+.... .... ...+|..++..+.+++++||+.+|++||++ +++++
T Consensus 204 ~~~~~~~~~~~~~---------i~~~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 204 NPDQNTEDYLFQV---------ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred CcccccHHHHHHH---------HhcC--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 10 000000000 0000 012344556778999999999999999984 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=238.37 Aligned_cols=211 Identities=21% Similarity=0.305 Sum_probs=156.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+......|+||||+++++|.+++..........+...+..++.|++.||+|||+.+ ++|+||
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~di 125 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDL 125 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999999999999999999999999999764333445677788899999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-------CCCcccCCeeehHHHHHHHHh-C
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT-G 153 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~~l~-g 153 (267)
||+||+++.++.++|+|||++................++..|+|||++.. ..++.++|+||||+++|+|++ +
T Consensus 126 kp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred ccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 99999999999999999998753222111112233456788999998753 245788999999999999987 4
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
..||........ ... .. .........+.. +..+...+.++++.|+ .+|++||++++|++.|.
T Consensus 206 ~~p~~~~~~~~~---~~~---~~--~~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 206 AQPYSHLSDREV---LNH---VI--KDQQVKLFKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCCHHHH---HHH---HH--hhcccccCCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 667753221110 000 00 011111222222 2234566888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=236.87 Aligned_cols=205 Identities=29% Similarity=0.408 Sum_probs=162.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.. ...++++||+++++|.+++..... ..+++..++.++.|++.||+|||+++ ++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di 123 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDL 123 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 678999999999999888 889999999999999999976221 56889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++++|||++......... .......++..|+|||.+....++.++|+||||+++|+|++ |..||..
T Consensus 124 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 124 AARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred CcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998765332211 11122345678999999888889999999999999999998 9999853
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
......... ... .......+..++..+.+++.+||+.+|++|||++++++.|.
T Consensus 204 ~~~~~~~~~------~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 204 LSGSQILKK------IDK----------EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHH------HHh----------cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 322111000 000 00001112345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=259.48 Aligned_cols=204 Identities=23% Similarity=0.258 Sum_probs=162.1
Q ss_pred CCCCCCCCccceeeEEeeCC--------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD--------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|..++|+||+++++.+...+ .+++||||+++|+|.+++.........+++..+..++.|++.+|.|||+.+
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~- 163 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH- 163 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 56789999999988775432 368999999999999999764445567899999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++|+||||+||+++.++.++|+|||+++...............|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 164 --IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 164 --MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred --EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999998754332222223345689999999999999999999999999999999999
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..||....... . ... .+. ......+..++.++.+++.+||+.+|++||++.++++
T Consensus 242 ~~Pf~~~~~~~---~---~~~----------~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 242 KRPFDGENMEE---V---MHK----------TLA-GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCCCCHHH---H---HHH----------Hhc-CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 99996332110 0 000 000 0111234556788999999999999999999999986
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=243.47 Aligned_cols=216 Identities=23% Similarity=0.293 Sum_probs=155.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++..+...++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 128 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 3678899999999999999999999999995 588887764 3466888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+||||+++|+|++|..||..
T Consensus 129 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 129 LKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999986432211 11223456889999998865 4578899999999999999999999974
Q ss_pred cCccCcc-chhh--hchhh---hhcccccccccCCcCCCCCc---------HHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 160 SKGQGEQ-NLVS--WSRPF---LKDQKKFVHLVDPLLHGRYP---------RRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 160 ~~~~~~~-~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
....... .... ...+. ...................+ ..++.++.+++.+||+.+|++|||++|++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 207 MKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred CccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 3321110 0000 00000 00000000000000000000 01235688999999999999999999998
Q ss_pred H
Q 024460 225 V 225 (267)
Q Consensus 225 ~ 225 (267)
+
T Consensus 287 ~ 287 (303)
T cd07869 287 S 287 (303)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=252.42 Aligned_cols=213 Identities=28% Similarity=0.474 Sum_probs=173.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++-||-||+-+.|+|...+. .+|+.+|+|.+|+.+++. ....+.....++|+.|++.|+.|||.++ |+|+|
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrD 513 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRD 513 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhh
Confidence 3678899999999999987766 999999999999999987 5578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||..||++.+++.|+|+|||++................+...|+|||++.. .+|++.+|||++|+++|||++|..||
T Consensus 514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 999999999999999999999986444444444455678899999999874 57999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
.....+.. +....+.++. .+. .....+|+.++.+|+..||..++++||.+.+|+..|..+...
T Consensus 594 si~~~dqI--ifmVGrG~l~-----pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 594 SIQNRDQI--IFMVGRGYLM-----PDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred CCCChhhe--EEEecccccC-----ccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 73322111 1111111100 000 112357888999999999999999999999999988888764
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=239.02 Aligned_cols=211 Identities=25% Similarity=0.349 Sum_probs=156.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++||||+++++++.+....++||||+++++|.++++.... .....+...+..++.|++.|+.|||+.+ ++|+|
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 125 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSD 125 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---Eeccc
Confidence 5788999999999999999999999999999999999975332 2234566778889999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-------CCcccCCeeehHHHHHHHHh-
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-------KLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~Dv~slG~i~~~~l~- 152 (267)
|||+||+++.++.++|+|||++................++..|+|||++... .++.++|+||||+++|+|++
T Consensus 126 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 126 LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred cCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 9999999999999999999998643222211122234457789999987642 35789999999999999996
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
|..||......... ... . .........+.. ....+..+.+++..|+ .+|++|||+++|+..|+
T Consensus 206 g~~p~~~~~~~~~~---~~~---~--~~~~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 206 GSQPYRHLSDEQVL---TYT---V--REQQLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCChHHHH---HHH---h--hcccCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 99999643221110 000 0 000111111111 1233556889999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.36 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=161.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++.+..++.+++||||+++++|.+++.. .....+++..+..++.|++.|+.|||+.+ ++|+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 127 (285)
T cd05605 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRD 127 (285)
T ss_pred HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecC
Confidence 36788999999999999999999999999999999988864 23456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||++++++.++|+|||++....... ......++..|+|||++....++.++|+||+|+++|+|++|..||...
T Consensus 128 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 128 LKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999987532221 122345788999999998888999999999999999999999999743
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........ +...+.. ....++..++..+.+++.+||..||++|| +++++++
T Consensus 205 ~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 205 KEKVKREE-------------VERRVKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred chhhHHHH-------------HHHHhhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 32111000 0000000 01122345677899999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=238.08 Aligned_cols=205 Identities=29% Similarity=0.440 Sum_probs=162.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..+...+++|||+++++|.+++... ....+++..+..++.+++.|+.|||+++ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di 129 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 67899999999999999989999999999999999999652 2356889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++++|||++...... ..........+..|+|||.+.+..++.++|+||+|+++|++++ |..||...
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 130 AARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred chheEEEcCCCCEEECccccceeccch-hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998754321 1111122234567999999988889999999999999999998 89998533
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
..... ... +........+..++.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 209 ~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 209 TNREV---LEQ--------------VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHHHH---HHH--------------HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 21110 000 00001111223346789999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=236.20 Aligned_cols=205 Identities=28% Similarity=0.408 Sum_probs=160.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++. +...++||||+++++|.+++... ....+++..+..++.|++.||++||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl 128 (262)
T cd05071 55 MKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128 (262)
T ss_pred HHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 56789999999999875 45689999999999999999652 2346788999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||.+........ .......++..|++||......++.++|+||||+++|+|++ |..||...
T Consensus 129 ~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 129 RAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred CcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999875432221 11122335667999999888889999999999999999999 78888533
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
..... .. .. ........+..++..+.+++.+|++.+|++||+++++++.|+.+
T Consensus 208 ~~~~~---~~---~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 208 VNREV---LD---QV-----------ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ChHHH---HH---HH-----------hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 21100 00 00 00001112345677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=239.38 Aligned_cols=221 Identities=24% Similarity=0.403 Sum_probs=162.3
Q ss_pred CCCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|++++||||+++++++... ...++||||+++++|.+++.. ....+++..++.++.|++.+|+|||+++ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H 132 (284)
T cd05079 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVH 132 (284)
T ss_pred HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 36788999999999998775 578999999999999999854 3346889999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|+++..|.
T Consensus 133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999999999999999999999998754332221 1122344566799999998888999999999999999999977654
Q ss_pred cccCccCccchhhh-chhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 158 DLSKGQGEQNLVSW-SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 158 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
.............. ...... .....+........+..++..+.+++.+||+.+|++|||++++++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 213 SSPMTLFLKMIGPTHGQMTVT---RLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccchhhhhcccccccccHH---HHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 21110000000000 000000 00000111111122344677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=246.24 Aligned_cols=147 Identities=27% Similarity=0.392 Sum_probs=127.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++|+|++. ++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 182 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRD 182 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 3678999999999999999999999999995 588888864 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++.++.++|+|||++...... .......|+..|+|||++.+..++.++|+||||+++|+|+++..++
T Consensus 183 lkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999999999999999998743211 1222345789999999999989999999999999999999865544
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=244.98 Aligned_cols=202 Identities=30% Similarity=0.391 Sum_probs=160.1
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
||++++|||||+++++..+ .+.+|||+|||..|.+...- ..+. +++.++++++..++.+|.|||.++ |+
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---ii 232 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQG---II 232 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcC---ee
Confidence 5889999999999999876 56899999999988775433 3444 999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCC---CCcceeeecccccceeCCcccccCC----CcccCCeeehHHHHHHH
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVG---DNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~~ 150 (267)
||||||+|+|++++|.+||+|||.+..+... +....-....||+.|+|||...++. -+.+.|||++|+++|-|
T Consensus 233 HRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCl 312 (576)
T KOG0585|consen 233 HRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCL 312 (576)
T ss_pred ccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHh
Confidence 9999999999999999999999998765222 2222233478999999999887632 35789999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
+.|+.||..... .....++++..+..+...+....+.++|.++|++||..|.++.+|..-
T Consensus 313 lfG~~PF~~~~~----------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 313 LFGQLPFFDDFE----------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred hhccCCcccchH----------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 999999963321 111222333333333334567889999999999999999999998753
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=236.82 Aligned_cols=205 Identities=31% Similarity=0.454 Sum_probs=160.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++. ....+++|||+++++|.+++... ....+++..+..++.+++.|+.|||+++ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 367899999999999875 45688999999999999998652 2345889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||++......... ......++..|+|||.+....++.++|+||||+++|+|++ |.+||..
T Consensus 128 i~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 128 LRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred CccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999998754222111 1111234567999999888889999999999999999998 8888864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
..... .... +........+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 207 ~~~~~---~~~~--------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 207 MNNRE---VLEQ--------------VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHH---HHHH--------------HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 32111 0000 00011112234556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=244.25 Aligned_cols=195 Identities=28% Similarity=0.372 Sum_probs=154.4
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++++++...+.+|+||||+++++|..++.. ...+++..+..++.|++.||+|||+++ ++|+||||+|
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~N 126 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDN 126 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 699999999999999999999999999999988854 457899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
|+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 127 ili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~ 204 (327)
T cd05617 127 VLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204 (327)
T ss_pred EEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc
Confidence 999999999999999986422111 122345688999999999999999999999999999999999999964332221
Q ss_pred cchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.......... .... ....|...+..+.+++.+||..+|++|+++
T Consensus 205 ~~~~~~~~~~---------~~~~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 205 MNTEDYLFQV---------ILEK--PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred cccHHHHHHH---------HHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1111110000 0001 011244456778999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=229.10 Aligned_cols=200 Identities=22% Similarity=0.224 Sum_probs=160.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
.+.|+||||+++.+.+.+++..|+|+|+++|+.|..-+-. +..+++..+--.+.||++++.|+|.++ |+|||+
T Consensus 64 C~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDv 136 (355)
T KOG0033|consen 64 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDL 136 (355)
T ss_pred HHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccC
Confidence 4679999999999999999999999999999999877754 467888888999999999999999999 999999
Q ss_pred CCCcEEEc---CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||.|+++. ...-+||+|||++.... ....-....|++.|++||++...+|+..+|||+.|+++|-++.|.+||.
T Consensus 137 kP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~ 213 (355)
T KOG0033|consen 137 KPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 213 (355)
T ss_pred ChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCC
Confidence 99999994 34468999999998654 2234455679999999999999999999999999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+.+..... .+.++.-....++..+++++||..||++|.|+.|.++
T Consensus 214 ~~~~~rlye~I~~g~y--------------d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 214 DEDQHRLYEQIKAGAY--------------DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CccHHHHHHHHhcccc--------------CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 4322111111110000 0001111345678999999999999999999998764
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=236.08 Aligned_cols=205 Identities=30% Similarity=0.438 Sum_probs=160.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||++++++++. .+..+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecc
Confidence 367889999999999875 45688999999999999999652 2345788999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||++++++.++|+|||++......... ......++..|++||...+..++.++|+||||+++|+|++ |..||..
T Consensus 128 l~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 128 LRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998754222111 1112234567999999888889999999999999999998 8888864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
...... ... ... ......+...+..+.+++.+||..+|++||++++|++.|++
T Consensus 207 ~~~~~~---~~~----------~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 207 MVNREV---LEQ----------VER----GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCHHHH---HHH----------HHc----CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 321110 000 000 00011233456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=238.89 Aligned_cols=211 Identities=24% Similarity=0.308 Sum_probs=155.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++.++||||+++++.+.....+++||||+++++|.+++...... ....++..+..++.|++.|++|||+++ ++|+|
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSD 125 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---Eeccc
Confidence 46789999999999999999999999999999999999763321 233567788899999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-------CCCcccCCeeehHHHHHHHHh-
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~Dv~slG~i~~~~l~- 152 (267)
|||+||+++.++.++|+|||++................++..|+|||++.. ..++.++|+||||+++|+|++
T Consensus 126 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 999999999999999999999864322211111222334667999998643 356789999999999999998
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
|..||......... . ... .........+. .+..++..+.+++..|+ .+|++|||+++|++.|.
T Consensus 206 ~~~p~~~~~~~~~~---~---~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 206 ADQPYPDLSDEQVL---K---QVV--REQDIKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCCCcCCHHHHH---H---HHh--hccCccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 77888533211100 0 000 00000111111 23345667788999998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=248.26 Aligned_cols=198 Identities=23% Similarity=0.302 Sum_probs=152.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++|+||+++++++..++.+++||||+++++|.... ...+..+..++.|++.||.|||+++ ++|+|
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 193 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRD 193 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 367899999999999999999999999999999885432 3456778899999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHhCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|||+||+++.++.++|+|||++....... .......|+..|+|||++.. ...+.++||||||+++|+|++|..
T Consensus 194 lkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 194 IKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred CCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999987542211 11233467899999998743 234568999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||............... ........+..++.++.++|.+||..+|++|||++|+++
T Consensus 272 pf~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 272 PFGVGRQGDWASLMCAI--------------CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCCccHHHHHHHH--------------hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99732211110000000 000001123455778999999999999999999999996
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=247.76 Aligned_cols=217 Identities=24% Similarity=0.327 Sum_probs=155.5
Q ss_pred CCCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|++++||||+++++++... ..+|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+++
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--- 123 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN--- 123 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36789999999999988543 25899999995 689888854 456899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHh
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.. ..++.++||||||+++|+|++
T Consensus 124 ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999998753222111 11223457899999998875 578999999999999999999
Q ss_pred CCCCccccCccCccchhhhc--hh------hhh--cccccccccCCcCCCCCc---HHHHHHHHHHHHhhcccCCCCCCC
Q 024460 153 GRKAMDLSKGQGEQNLVSWS--RP------FLK--DQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~--~~------~~~--~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
|.+||...........+... .+ ... ........+.+....... ..++..+.+++.+||+.+|++|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 99999644321110000000 00 000 000000000000000000 123567899999999999999999
Q ss_pred HHHHHH
Q 024460 220 INDIVV 225 (267)
Q Consensus 220 ~~ev~~ 225 (267)
++|+++
T Consensus 284 ~~e~l~ 289 (338)
T cd07859 284 AEEALA 289 (338)
T ss_pred HHHHhc
Confidence 999997
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=249.14 Aligned_cols=207 Identities=25% Similarity=0.389 Sum_probs=179.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+++.||||++++|+|+++ ..|+|||.++-|.|..|++. ....++......++.|++.|++|||+.. +||||
T Consensus 444 iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRD 516 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRD 516 (974)
T ss_pred HHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhh
Confidence 57899999999999999765 78999999999999999987 5678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|..+|||+.....+||+|||+++.......+... ...-..-|+|||-+....++.++|||.||+.+||++. |..||..
T Consensus 517 IAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 517 IAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 9999999999999999999999987655544333 4455778999999999999999999999999999976 8889874
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
.+ +..+--.++..-+-+.|.+||+.+..++.+||..+|.+||++.++...|..+.+
T Consensus 596 vk-----------------NsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 596 VK-----------------NSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cc-----------------ccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 43 333333444555556789999999999999999999999999999998876666
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=239.34 Aligned_cols=222 Identities=28% Similarity=0.390 Sum_probs=160.3
Q ss_pred CCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++.. ...+++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~ 132 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHR 132 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 578899999999998743 3468999999999999999964 3456889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcce-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||++........... .....+...|+|||.+.+..++.++|+||||+++|+|++|..++.
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9999999999999999999999876433221111 111223456999999988889999999999999999999876653
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
............... .......+...+.....-..+..++.++.+++.+||..+|++|||+++|++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 213 SPPAEFMRMMGNDKQ-GQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred Ccchhhhhhcccccc-cccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 221110000000000 00000000001111111112344567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=235.89 Aligned_cols=206 Identities=29% Similarity=0.440 Sum_probs=161.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++. .+..+++|||+.+++|.+++.. ..+..+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~d 127 (260)
T cd05067 54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127 (260)
T ss_pred HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccc
Confidence 367889999999999874 4578999999999999999865 23457888999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||++........ .......++..|+|||.+....++.++|+||||+++|++++ |..||..
T Consensus 128 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 128 LRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred ccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875432111 11122334668999999988889999999999999999998 9999963
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .. .+........+..++.++.+++.+||+.+|++|||++++++.|+.+
T Consensus 207 ~~~~~~---~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 207 MTNPEV---IQ--------------NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CChHHH---HH--------------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 321110 00 0000011112334567799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=233.79 Aligned_cols=204 Identities=28% Similarity=0.331 Sum_probs=161.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++||||+++++++..++.+|++|||+.+++|.+++.. ....+++..+..++.|++.++.|||+++ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 126 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRD 126 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecC
Confidence 36789999999999999999999999999999999998865 3367889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC---CCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|+|+||+++.++.++|+|||.+....... .......++..|++||.+... .++.++|+||||+++|+|++|.+||
T Consensus 127 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~ 204 (262)
T cd06613 127 IKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204 (262)
T ss_pred CChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999987532211 112234567789999998776 7889999999999999999999998
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............. .. ...... ...+..++.++.+++++||..+|.+|||+++|+.
T Consensus 205 ~~~~~~~~~~~~~--------~~---~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 205 FDLHPMRALFLIS--------KS---NFPPPK--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCHHHHHHHHH--------hc---cCCCcc--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6433111100000 00 000001 1123456788999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=241.06 Aligned_cols=210 Identities=26% Similarity=0.381 Sum_probs=163.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++... ..++++||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~di 135 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDL 135 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eecccc
Confidence 5678999999999998654 56799999999999999865 3446888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||+++...............++..|++||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 136 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999975432222111222334668999999988899999999999999999997 88888533
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
........ .. ....-..+..++..+.+++.+|+..+|++||+++++++.|+++.....
T Consensus 216 ~~~~~~~~-------~~----------~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (303)
T cd05110 216 PTREIPDL-------LE----------KGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ 273 (303)
T ss_pred CHHHHHHH-------HH----------CCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence 21111000 00 000001123345678999999999999999999999999998765543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=235.55 Aligned_cols=195 Identities=23% Similarity=0.348 Sum_probs=152.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..+...+++|||+++++|..++.. ....+++..++.++.|++.|++|||+++ ++|+||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 131 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNV 131 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCC
Confidence 5678999999999999999999999999999999988864 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc-------eEEeccCCcccCCCCCCcceeeecccccceeCCcccc-cCCCcccCCeeehHHHHHHHH-h
Q 024460 82 KSANILLDNDFN-------PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELI-T 152 (267)
Q Consensus 82 ~~~nili~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~~l-~ 152 (267)
+|+||+++.++. ++++|||++...... ....++..|+|||.+. ...++.++||||||+++|+|+ .
T Consensus 132 kp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 132 CTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999976553 899999988643211 1234567799999886 467889999999999999997 5
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
|..|+......... .... ... ......+.++.+++.+||+.+|.+||++++|++.+
T Consensus 206 ~~~p~~~~~~~~~~-------~~~~----------~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 206 GEIPLKDKTLAEKE-------RFYE----------GQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCCCcchhHHH-------HHHh----------cCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 77777533211100 0000 000 00112246789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=247.33 Aligned_cols=200 Identities=22% Similarity=0.258 Sum_probs=156.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++.+|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++ ++|+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDL 168 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDV 168 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 5678999999999999999999999999999999999953 35788999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC----CCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+||+++.++.+||+|||++....... ........|++.|+|||++... .++.++|+||||+++|+|++|..||
T Consensus 169 Kp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 169 KPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 9999999999999999999987542221 1122345689999999998754 3788999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCc--HHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 226 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~~ 226 (267)
......... ..+......-.++ ...+..+.+++..||..++.+ |++++|+++.
T Consensus 248 ~~~~~~~~~----------------~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 248 YADSLVGTY----------------SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCHHHHH----------------HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 643321110 0011100000111 234677899999999866544 8999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=248.55 Aligned_cols=217 Identities=23% Similarity=0.246 Sum_probs=161.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..|++||++. ++|.+++. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrD 210 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRD 210 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678999999999999999999999999995 58888883 3567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++................|+..|+|||++....++.++|+||||+++|+|++|..||...
T Consensus 211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999987543332222233456899999999999889999999999999999999999998654
Q ss_pred CccCccchhhhchhhh----------------hcccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 161 KGQGEQNLVSWSRPFL----------------KDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
................ ....+......+..... ....++.++.++|.+||..+|++|||+.
T Consensus 291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~ 370 (392)
T PHA03207 291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370 (392)
T ss_pred CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence 3322111000000000 00000000000000000 0012356788999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|++.
T Consensus 371 e~l~ 374 (392)
T PHA03207 371 DILS 374 (392)
T ss_pred HHhh
Confidence 9995
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=248.95 Aligned_cols=211 Identities=26% Similarity=0.362 Sum_probs=163.2
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------------------------------
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------------------------------ 44 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------------------------------ 44 (267)
|.++. ||||+++++++..++..++||||+.+|+|.++++....
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 55676 99999999999999999999999999999999964221
Q ss_pred ----------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 024460 45 ----------------------------------------------------------DQEPLSWNTRMKIAVGAARGLE 66 (267)
Q Consensus 45 ----------------------------------------------------------~~~~~~~~~~~~~~~~l~~~l~ 66 (267)
....+++..++.++.|++.||.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 1123567778899999999999
Q ss_pred HhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHH
Q 024460 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 146 (267)
Q Consensus 67 ~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 146 (267)
|||+.+ ++|+||||+||+++.++.++|+|||++................++..|++||.+....++.++|+||||++
T Consensus 254 ~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 254 FLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred HHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 999998 99999999999999999999999999875322221111222345778999999988889999999999999
Q ss_pred HHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 147 LLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 147 ~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|+|++ |..||......... ...+.....-..+..++.++.+++.+||..+|.+||++++|++
T Consensus 331 l~e~l~~g~~P~~~~~~~~~~----------------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 331 LWEIFTLGGTPYPELPMNEQF----------------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCCCCCCchHHH----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 88888533211100 0000000011123345678999999999999999999999999
Q ss_pred HHHHhh
Q 024460 226 ALDYLV 231 (267)
Q Consensus 226 ~l~~l~ 231 (267)
.|+.+.
T Consensus 395 ~L~~~~ 400 (401)
T cd05107 395 LVGDLL 400 (401)
T ss_pred HHHHHh
Confidence 998874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=235.44 Aligned_cols=204 Identities=27% Similarity=0.390 Sum_probs=160.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++......+++|||+++++|.+++.. ....+++..+..++.+++.++++||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~d 125 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999865 3356788999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++++|||.+....... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 126 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999887432211 111122234568999999988889999999999999999998 8888863
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
...... ... ... ......+...+..+.+++.+||..+|++|||++++++.|+
T Consensus 205 ~~~~~~---~~~----------~~~----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 205 RSNSEV---VET----------INA----GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCHHHH---HHH----------HhC----CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 321110 000 000 0000112234577999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=237.93 Aligned_cols=217 Identities=24% Similarity=0.323 Sum_probs=163.1
Q ss_pred CCCCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|+.++|+||+.+.+++.. -+.+|+|+|+| +.+|...++. +..++...+..++.|++.|++|+|+.+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn--- 145 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN--- 145 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---
Confidence 3678899999999999865 34789999999 5599999954 555999999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|||+||.|++++.+..+|++|||+++...........+....|.||+|||++.. ..|+.+.||||+|||+.||++|+
T Consensus 146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence 99999999999999999999999999997543322223344557999999998864 57999999999999999999999
Q ss_pred CCccccCccCccchhhhchhhh--------h--cccccccccCCcCCCCCc---HHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFL--------K--DQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~--------~--~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+.|.+.+...-...+....... . ......+.+...-+..+. .+..+...+++++||..||.+|+|++
T Consensus 226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~ 305 (359)
T KOG0660|consen 226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE 305 (359)
T ss_pred CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence 9997665443322111100000 0 000011111111111111 14467789999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|.++
T Consensus 306 eAL~ 309 (359)
T KOG0660|consen 306 EALA 309 (359)
T ss_pred HHhc
Confidence 9987
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=249.87 Aligned_cols=218 Identities=21% Similarity=0.271 Sum_probs=158.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+||||+++++++..++..++|||++. ++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 285 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRD 285 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECc
Confidence 4678999999999999999999999999995 688888854 3347899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc-c
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD-L 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~-~ 159 (267)
|||+|||++.++.++|+|||+++...............|+..|+|||++.+..++.++||||||+++|||++|..++. .
T Consensus 286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 999999999999999999999875433222222233568999999999999999999999999999999999876542 2
Q ss_pred cCccCcc----chhhhchh---hhhcccc-----cc--------cccCCcCCC-CCc--HHHHHHHHHHHHhhcccCCCC
Q 024460 160 SKGQGEQ----NLVSWSRP---FLKDQKK-----FV--------HLVDPLLHG-RYP--RRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 160 ~~~~~~~----~~~~~~~~---~~~~~~~-----~~--------~~~~~~~~~-~~~--~~~~~~l~~li~~cl~~~p~~ 216 (267)
....... .+...... ....... +. ....+.... .+. .....++.++|.+||+.||.+
T Consensus 366 ~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~ 445 (461)
T PHA03211 366 SRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGAR 445 (461)
T ss_pred CcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhh
Confidence 2111110 01110000 0000000 00 000000000 000 122457899999999999999
Q ss_pred CCCHHHHHH
Q 024460 217 RPLINDIVV 225 (267)
Q Consensus 217 Rpt~~ev~~ 225 (267)
|||++|+++
T Consensus 446 RPsa~elL~ 454 (461)
T PHA03211 446 RPSAAELLR 454 (461)
T ss_pred CcCHHHHhh
Confidence 999999995
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=247.85 Aligned_cols=202 Identities=23% Similarity=0.281 Sum_probs=158.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++.+++.+|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~D 126 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRD 126 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 36678999999999999999999999999999999999854 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcc------------------------------------eeeeccccccee
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTH------------------------------------VSTRVMGTYGYC 124 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~ 124 (267)
|||+||+++.++.++|+|||++.......... ......|++.|+
T Consensus 127 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred CCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc
Confidence 99999999999999999999886432111000 001235889999
Q ss_pred CCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCcc-chhhhchhhhhcccccccccCCcCCCCCcHHHHHHHH
Q 024460 125 APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 203 (267)
Q Consensus 125 aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 203 (267)
|||++....++.++|+|||||++|+|++|.+||......... .+..+. ..+.......++.++.
T Consensus 207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~ 271 (364)
T cd05599 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWK---------------ETLQFPDEVPLSPEAK 271 (364)
T ss_pred CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCC---------------CccCCCCCCCCCHHHH
Confidence 999999999999999999999999999999999644321110 000000 0000000113466789
Q ss_pred HHHHhhcccCCCCCCC---HHHHHH
Q 024460 204 AVTAMCLNEEANFRPL---INDIVV 225 (267)
Q Consensus 204 ~li~~cl~~~p~~Rpt---~~ev~~ 225 (267)
++|++|+. +|.+|++ ++++++
T Consensus 272 ~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 272 DLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred HHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99999996 9999998 888887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=235.37 Aligned_cols=198 Identities=25% Similarity=0.322 Sum_probs=161.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.++.+||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl 127 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDI 127 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCC
Confidence 5678999999999999999999999999999999999853 45788899999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... .......++..|.|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 128 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred ChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9999999999999999999987543221 11223356778999999988889999999999999999999999986433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
...... .+........+..++..+.+++.+||+.+|++||+++++++.
T Consensus 206 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 206 PMRVLF-----------------LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHhHhh-----------------hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 211100 000011112345678889999999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=251.10 Aligned_cols=211 Identities=26% Similarity=0.376 Sum_probs=177.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.++|||+|++.++|+.+..+|||+|||..|+|.+|++.. ....++....+.++.||..|+.||..++ ++|||
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRD 390 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRD 390 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhh
Confidence 578899999999999999999999999999999999999862 3455677778999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|..+|.|+.++..+||+|||++++.... .+.......-..-|.|||-+-.+.++.++|||+||+++||+.+ |-.||..
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999999975322 2222222233668999999999999999999999999999988 5567752
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
-. ..++..++++..+-.-|..|++.+.++|+.||+.+|++||++.|+.++|+.+.+..
T Consensus 470 id-----------------lSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s 527 (1157)
T KOG4278|consen 470 ID-----------------LSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS 527 (1157)
T ss_pred cc-----------------HHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence 22 34445566666666668899999999999999999999999999999997766544
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=238.73 Aligned_cols=234 Identities=25% Similarity=0.306 Sum_probs=173.5
Q ss_pred CCCCCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
||+++.|||||++.-+|.... ...+||||++. +|.+.++..-..+..++.-.+.-+..||.+|+.|||+.+
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--- 145 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--- 145 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---
Confidence 578899999999998885432 45699999965 999999865455778888899999999999999999999
Q ss_pred eeeCCCCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhC
Q 024460 76 VIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 76 i~h~di~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g 153 (267)
|+||||||+|+|+|.+ |.+||+|||.|...... ..+..-..+..|+|||.+.+. .|+.+.||||.||++.||+.|
T Consensus 146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g 222 (364)
T KOG0658|consen 146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG 222 (364)
T ss_pred cccCCCChheEEEcCCCCeEEeccCCcceeeccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC
Confidence 9999999999999865 89999999999864322 122334567889999998875 799999999999999999999
Q ss_pred CCCccccCccCcc-chhhhch-hh----hhc-----ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 154 RKAMDLSKGQGEQ-NLVSWSR-PF----LKD-----QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 154 ~~p~~~~~~~~~~-~~~~~~~-~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
++.|.+.....-. .++...- +. ..- .....++........+....+++..+++.++|..+|.+|.++.|
T Consensus 223 ~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 223 QPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred CcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 9999765443222 1111100 00 000 01111111111111234566888999999999999999999999
Q ss_pred HHH--HHHHhhhccCCCCCcC
Q 024460 223 IVV--ALDYLVSQRDSHPVSR 241 (267)
Q Consensus 223 v~~--~l~~l~~~~~~~~~~~ 241 (267)
++. .+++++.....-+..+
T Consensus 303 ~l~h~fFdelr~~~~~l~~g~ 323 (364)
T KOG0658|consen 303 ALAHPFFDELRDPNTKLPNGR 323 (364)
T ss_pred HhcchhhHHhhCcCccCcCCC
Confidence 997 6888887744444433
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=248.34 Aligned_cols=203 Identities=22% Similarity=0.249 Sum_probs=156.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrD 126 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRD 126 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 35678999999999999999999999999999999999864 457889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc---------------------------------------------ceee
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT---------------------------------------------HVST 115 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------------------------------~~~~ 115 (267)
|||+||+++.++.++|+|||+++........ ....
T Consensus 127 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (377)
T cd05629 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206 (377)
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence 9999999999999999999998632110000 0001
Q ss_pred ecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCcc-chhhhchhhhhcccccccccCCcCCCCC
Q 024460 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRY 194 (267)
Q Consensus 116 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (267)
...|++.|+|||++.+..++.++|+|||||++|+|++|.+||......... .+..+.. .+.-..
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~ 271 (377)
T cd05629 207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLYFPD 271 (377)
T ss_pred ccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccCCCC
Confidence 135889999999999889999999999999999999999999643321110 0011000 000000
Q ss_pred cHHHHHHHHHHHHhhcccCCCCC---CCHHHHHHH
Q 024460 195 PRRCLNYAVAVTAMCLNEEANFR---PLINDIVVA 226 (267)
Q Consensus 195 ~~~~~~~l~~li~~cl~~~p~~R---pt~~ev~~~ 226 (267)
...++.++.+++.+||. +|.+| +++.++++.
T Consensus 272 ~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 272 DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 11345678999999997 66665 599998873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=255.59 Aligned_cols=225 Identities=22% Similarity=0.286 Sum_probs=160.1
Q ss_pred CCCCCCCCCccceeeEEeeC--------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
+|+.++||||+++++++... ..+++||||+++ +|.+++.........+++..+..++.|++.||+|||+.+
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~ 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46789999999998876432 257799999964 787777654445678999999999999999999999999
Q ss_pred CCCeeeCCCCCCcEEEcCCC-ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHH
Q 024460 73 NPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~ 150 (267)
++||||||+||+++.++ .+||+|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|
T Consensus 191 ---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 191 ---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred ---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999998654 69999999997543221 12234568899999987654 689999999999999999
Q ss_pred HhCCCCccccCccCccc-hhhh-chhhhh----ccccc-----ccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC
Q 024460 151 ITGRKAMDLSKGQGEQN-LVSW-SRPFLK----DQKKF-----VHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~-~~~~-~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
++|.+||.......... +... ..+... ..... .......+...++...+.++.++|.+||+.+|.+|||
T Consensus 265 ltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t 344 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344 (440)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 99999997543221110 1100 000000 00000 0000011111123345678999999999999999999
Q ss_pred HHHHHH--HHHHhhh
Q 024460 220 INDIVV--ALDYLVS 232 (267)
Q Consensus 220 ~~ev~~--~l~~l~~ 232 (267)
+.|+++ .++.+..
T Consensus 345 a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 PIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhCChhHHhhhc
Confidence 999997 4555544
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=236.66 Aligned_cols=195 Identities=24% Similarity=0.349 Sum_probs=152.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++||||+++++|..+++. ..+.+++..+..++.|++.||+|||+++ ++|+||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 143 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNV 143 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCC
Confidence 5788999999999999999999999999999999998864 3467889999999999999999999998 999999
Q ss_pred CCCcEEEcCCC-------ceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHH-h
Q 024460 82 KSANILLDNDF-------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELI-T 152 (267)
Q Consensus 82 ~~~nili~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l-~ 152 (267)
||+||+++..+ .++++|||.+...... ....++..|+|||.+.. ..++.++|+||||+++|+|+ +
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999997543 4799999987532111 11235677999998865 56899999999999999985 6
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
|..||............ . .. ...+......+.+++.+||+.+|++|||+++|++.|
T Consensus 218 g~~p~~~~~~~~~~~~~-------~----------~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 218 GEVPLKERTPSEKERFY-------E----------KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCCccccChHHHHHHH-------H----------hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 88888643221110000 0 00 001112235689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=238.26 Aligned_cols=221 Identities=28% Similarity=0.408 Sum_probs=164.9
Q ss_pred CCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|+.++||||+++++++.. +...+++|||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~ 133 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR---HRDQINLKRLLLFSSQICKGMDYLGSQR---YIHR 133 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHh---CccccCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 578899999999999877 5678999999999999999965 3346899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++++|||.+......... .......+...|++||.+....++.++|+||||+++|+|++|..|+.
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 99999999999999999999998764322111 11112234566999999988889999999999999999999998875
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
.............. ...........+........+..++.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus 214 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 214 SPPAEFLRMIGIAQ--GQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccchhcccccccc--ccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 33221110000000 00000001111111111122345567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=246.66 Aligned_cols=203 Identities=26% Similarity=0.301 Sum_probs=156.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrD 126 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRD 126 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 36788999999999999999999999999999999999864 456888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc---------------------------------------------ceee
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT---------------------------------------------HVST 115 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------------------------------~~~~ 115 (267)
|||+||+++.++.++|+|||++......... ....
T Consensus 127 lKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (381)
T cd05626 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206 (381)
T ss_pred CcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence 9999999999999999999987532100000 0011
Q ss_pred ecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCcc-chhhhchhhhhcccccccccCCcCCCCC
Q 024460 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRY 194 (267)
Q Consensus 116 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (267)
...|+..|+|||++.+..++.++|||||||++|+|++|..||......... .+..+. .......
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~ 271 (381)
T cd05626 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE---------------NTLHIPP 271 (381)
T ss_pred cccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccc---------------cccCCCC
Confidence 235889999999999889999999999999999999999999643321110 000000 0000011
Q ss_pred cHHHHHHHHHHHHhhc--ccCCCCCCCHHHHHH
Q 024460 195 PRRCLNYAVAVTAMCL--NEEANFRPLINDIVV 225 (267)
Q Consensus 195 ~~~~~~~l~~li~~cl--~~~p~~Rpt~~ev~~ 225 (267)
...++.++.+++.+|+ ..++..||+++++++
T Consensus 272 ~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 272 QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 1234677889998854 455566999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=236.10 Aligned_cols=201 Identities=23% Similarity=0.310 Sum_probs=157.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++|+||+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++|+||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl 129 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDL 129 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCC
Confidence 5678999999999999999999999999999999988754 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+|+||+++.++.++++|||++....... .......++..|+|||++. ...++.++|+||+|+++|+|++|.+|
T Consensus 130 kp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 130 KAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred CcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 9999999999999999999986432211 1222345788899999874 34577899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|........ .... .....+. ...+..++.++.+++.+||..+|.+||+++++++
T Consensus 208 ~~~~~~~~~--~~~~-----------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 208 HHELNPMRV--LLKI-----------AKSEPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred ccccCHHHH--HHHH-----------hhcCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 863221100 0000 0000000 0123345678999999999999999999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=235.30 Aligned_cols=200 Identities=27% Similarity=0.383 Sum_probs=160.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++++||+++++|.+++.. .+.+++..+..++.|++.|+++||+++ ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di 132 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDI 132 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccC
Confidence 6788999999999999999999999999999999999964 356888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCC----cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDN----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+|+||+++.++.++|+|||.+........ ........++..|+|||.+.+..++.++|+|+||+++|+|++|..||
T Consensus 133 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 212 (267)
T cd06628 133 KGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212 (267)
T ss_pred CHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCC
Confidence 99999999999999999999875432111 01112234678899999998888999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ....... ....+..++..+.+++++||+.+|.+||++.++++
T Consensus 213 ~~~~~~~~~-------------~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 213 PDCTQLQAI-------------FKIGENA----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCccHHHHH-------------HHHhccC----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 743221100 0000011 11223456778999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=231.74 Aligned_cols=216 Identities=21% Similarity=0.235 Sum_probs=161.8
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
||.+++|||||.+..+... -+.+|+|||||+. +|..++.. -..++....+..+..|++.|++|||.+. |+|
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~---m~q~F~~~evK~L~~QlL~glk~lH~~w---ilH 200 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET---MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILH 200 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh---ccCCCchHHHHHHHHHHHHHHHHHhhce---eEe
Confidence 4678899999999988754 3579999999976 99999976 3478999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+|++|+|++..|.+|++|||+++...... ...+...-|.||+|||++.+. .|+.+.|+||+|||+.||+.+.+.|
T Consensus 201 RDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf 278 (419)
T KOG0663|consen 201 RDLKTSNLLLSHKGILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF 278 (419)
T ss_pred cccchhheeeccCCcEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999754332 222334458999999999875 5899999999999999999999998
Q ss_pred cccCccCccchhhh--------chhhhhc-----ccccccccCCcCCCCCcHH-HHHHHHHHHHhhcccCCCCCCCHHHH
Q 024460 158 DLSKGQGEQNLVSW--------SRPFLKD-----QKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDI 223 (267)
Q Consensus 158 ~~~~~~~~~~~~~~--------~~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rpt~~ev 223 (267)
...........+-. .++.... .....+.--..++.+++.. .+..-.+++..+|..||.+|.|++|.
T Consensus 279 ~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~ 358 (419)
T KOG0663|consen 279 PGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG 358 (419)
T ss_pred CCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence 65543222111100 0000000 0111111111122222211 45678899999999999999999998
Q ss_pred HH
Q 024460 224 VV 225 (267)
Q Consensus 224 ~~ 225 (267)
++
T Consensus 359 L~ 360 (419)
T KOG0663|consen 359 LK 360 (419)
T ss_pred hc
Confidence 86
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=232.84 Aligned_cols=201 Identities=24% Similarity=0.301 Sum_probs=162.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+..+..+|+++||+.+++|.+++.. ....+++..+..++.|++.++.|||+.+ ++|+|+
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl 125 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDI 125 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5778999999999999999999999999999999999864 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++........ ......++..|++||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 126 ~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 126 KAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred CcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999875432221 2223446788999999988889999999999999999999999986432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ......+ ....+..++.++.+++.+||+.+|++|||++++++
T Consensus 204 ~~~~~~~-------------~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 204 PMRAIFM-------------IPNKPPP--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhhhhh-------------hccCCCC--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 2111000 0000000 11123455678999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=243.21 Aligned_cols=192 Identities=28% Similarity=0.371 Sum_probs=153.1
Q ss_pred CCCCCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+.++| ++|+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 126 (324)
T cd05587 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRD 126 (324)
T ss_pred HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 345555 5688999999999999999999999999998854 456888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|..||...
T Consensus 127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 127 LKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986422111 1233456889999999999989999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
...... . .+.. ....++..++.++.+++.+||..+|.+|++.
T Consensus 205 ~~~~~~---~-------------~i~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 205 DEDELF---Q-------------SIME--HNVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHHHHH---H-------------HHHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 211100 0 0000 0011234456778999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=232.96 Aligned_cols=200 Identities=30% Similarity=0.450 Sum_probs=158.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..+ ..+++|||+.+++|.+++... ....+++..++.++.|++.|+.|||+.+ ++|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl 126 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 5788999999999998665 479999999999999999652 2346888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++...... .........|+|||.+.+..++.++|+||||+++|+|++ |..||...
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 999999999999999999998643211 111233567999999988889999999999999999997 88988643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
........ +........+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 202 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 202 SLKEVKEC-----------------VEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHHHHHH-----------------HhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 32111000 00011111233456789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=232.95 Aligned_cols=206 Identities=26% Similarity=0.395 Sum_probs=160.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|+||+++++++.. ...+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~d 127 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 3678999999999999877 7789999999999999999652 3456788889999999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||.+........ .......++..|+|||.+....++.++|+||||+++|++++ |..||..
T Consensus 128 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 128 LRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred cCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999875432211 11122334567999999988889999999999999999998 8999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... .... . .......+...+.++.+++.+|++.+|++||++.++.++|+.+
T Consensus 207 ~~~~~~---~~~~----~----------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 207 MSNPEV---IRAL----E----------RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCHHHH---HHHH----h----------CCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 321110 0000 0 0000011234466799999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=232.64 Aligned_cols=202 Identities=24% Similarity=0.345 Sum_probs=162.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|+||+++++++.+++..+++|||+++++|.+++... ....+++..+..++.|++.++.|||+.+ ++|+|
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 126 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 367889999999999999999999999999999999999752 2456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++++|||++........ ......++..|.|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 127 l~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred CChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999875422221 223345788999999998888899999999999999999999998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
...... . ....... ...+..++.++.+++.+||..+|.+||+++++++.
T Consensus 205 ~~~~~~---~-------------~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 205 NPLNLV---V-------------KIVQGNY-TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CHHHHH---H-------------HHHcCCC-CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 211100 0 0000000 01123456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=238.53 Aligned_cols=199 Identities=24% Similarity=0.315 Sum_probs=159.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..+...|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dL 142 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999843 45788999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+|+||+++|+|++|..||....
T Consensus 143 kp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876432211 11122357788999999988889999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .... .........+...+..+.+++.+||..+|++|||++++++
T Consensus 221 ~~~~~--~~~~-------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 221 PLRAL--YLIA-------------TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHHhH--HHHh-------------cCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 21110 0000 0000000113345677999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=246.29 Aligned_cols=202 Identities=23% Similarity=0.279 Sum_probs=155.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++.+.+++.+|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRD 126 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 36788999999999999999999999999999999999864 356888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCC---------------------------------------------cceee
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDN---------------------------------------------THVST 115 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~---------------------------------------------~~~~~ 115 (267)
|||+|||++.++.++|+|||++........ .....
T Consensus 127 lKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred CCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 999999999999999999998753210000 00001
Q ss_pred ecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCcc-chhhhchhhhhcccccccccCCcCCCCC
Q 024460 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRY 194 (267)
Q Consensus 116 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (267)
...|++.|+|||++.+..++.++|+|||||++|+|++|.+||......... .+..+ ........
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------~~~~~~p~ 271 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW---------------QTSLHIPP 271 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHcc---------------CCCcCCCC
Confidence 235789999999999999999999999999999999999999644321110 00000 00000011
Q ss_pred cHHHHHHHHHHHHhhcccCCCCCCC---HHHHHH
Q 024460 195 PRRCLNYAVAVTAMCLNEEANFRPL---INDIVV 225 (267)
Q Consensus 195 ~~~~~~~l~~li~~cl~~~p~~Rpt---~~ev~~ 225 (267)
....+.+..++|.+|+ .+|.+|++ ++++++
T Consensus 272 ~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 272 QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 1234667888888876 59999997 888775
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=233.96 Aligned_cols=195 Identities=27% Similarity=0.441 Sum_probs=153.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.+.||||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dl 126 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNV 126 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999998999999999999999999965 3346888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc--------eEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHh
Q 024460 82 KSANILLDNDFN--------PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 82 ~~~nili~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~ 152 (267)
||+||+++.++. ++++|||.+..... .....++..|+|||++.+ ..++.++|+||||+++|+|++
T Consensus 127 kp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 200 (258)
T cd05078 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200 (258)
T ss_pred ccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence 999999976654 68999998764321 112346778999999876 457899999999999999999
Q ss_pred CC-CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 153 GR-KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 153 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
|. +|+.......... .... ....+...+.++.+++.+||+.+|++|||++++++.|
T Consensus 201 g~~~~~~~~~~~~~~~-------~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 201 GGDKPLSALDSQKKLQ-------FYED------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred CCCCChhhccHHHHHH-------HHHc------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 85 5554222111000 0000 0112333456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=240.73 Aligned_cols=224 Identities=19% Similarity=0.207 Sum_probs=159.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dl 127 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSV 127 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 56789999999999999999999999999999999998642 2345889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
||+||+++.++.+++.||+........... .......++..|+|||++.. ..++.++|+||||+++|+|++|.
T Consensus 128 kp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 207 (327)
T cd08227 128 KASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 207 (327)
T ss_pred ChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999865432111110 01112235667999999876 45889999999999999999999
Q ss_pred CCccccCccCcc-chhhhchhhh------h------------------cccc---cccccCCcCCCCCcHHHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQ-NLVSWSRPFL------K------------------DQKK---FVHLVDPLLHGRYPRRCLNYAVAVT 206 (267)
Q Consensus 155 ~p~~~~~~~~~~-~~~~~~~~~~------~------------------~~~~---~~~~~~~~~~~~~~~~~~~~l~~li 206 (267)
.||......... .......+.. . .... ................++..+.+++
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 287 (327)
T cd08227 208 VPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFV 287 (327)
T ss_pred CCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHH
Confidence 999643211100 0000000000 0 0000 0000000000112234567899999
Q ss_pred HhhcccCCCCCCCHHHHHH--HHHHh
Q 024460 207 AMCLNEEANFRPLINDIVV--ALDYL 230 (267)
Q Consensus 207 ~~cl~~~p~~Rpt~~ev~~--~l~~l 230 (267)
.+||+.||++|||++++++ .++++
T Consensus 288 ~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 288 EQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HHHHhhCchhcCCHHHHhcChhhhhc
Confidence 9999999999999999997 35443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=233.08 Aligned_cols=203 Identities=32% Similarity=0.458 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..+++|||+++++|.+++.... ...+++..+..++.|++.++++||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl 129 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDL 129 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeeccc
Confidence 567899999999999999999999999999999999996511 122899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++++|||++............ ...++..|++||.+....++.++|+|+||+++|+|++ |.+||...
T Consensus 130 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998764333211111 2335678999999988889999999999999999998 77887642
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
..... ... +........+..++.++.+++.+|+..+|++|||++++++.|
T Consensus 209 ~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 SNEEV---LEY--------------LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CHHHH---HHH--------------HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 21100 000 000000111233577899999999999999999999999764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=248.77 Aligned_cols=195 Identities=24% Similarity=0.375 Sum_probs=158.8
Q ss_pred CCCCCCCCCccceeeEEeeCC--eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|+.|+||||+++|+++.+.. .+.+|+|.+..|+|..|+.. .+......+..|+.||+.+|.|||++ .+||+|
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIH 168 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIH 168 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccc
Confidence 478999999999999997755 48899999999999999965 56788889999999999999999998 577999
Q ss_pred CCCCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||||-+||||+++ |.|||+|+|+|....... .....||+.|||||++. ..|++..||||||+.+.||.|+..||
T Consensus 169 RDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY 243 (632)
T KOG0584|consen 169 RDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY 243 (632)
T ss_pred cccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh
Confidence 9999999999865 899999999998643222 22257999999999876 89999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCc----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... .+++ .+...+..| +--.+++++||.+||.. .++|||+.|+++
T Consensus 244 sEC~n~--AQIY-----------------KKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 244 SECTNP--AQIY-----------------KKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhhCCH--HHHH-----------------HHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 644321 1111 111111111 11146799999999999 999999999997
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=241.67 Aligned_cols=200 Identities=26% Similarity=0.223 Sum_probs=166.7
Q ss_pred CCCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
||+++. ||||+.++++|++...+++|||+|.||.|.+.+... .+++..+..++.|++.+++|||+.+ ++|+
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHr 159 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHR 159 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceec
Confidence 577888 999999999999999999999999999999999763 3999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC----CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 80 DLKSANILLDND----FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 80 di~~~nili~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|+||+|+|+... +.++++|||++..... ........|++.|+|||++....|+..+|+||+|+++|.|++|.+
T Consensus 160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred cCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 999999999533 4799999999986433 345666889999999999999999999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||...........+... +..+....-..++....++|..|+..+|..|+|++++++
T Consensus 237 PF~~~~~~~~~~~i~~~--------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 237 PFWGETEFEIFLAILRG--------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCcCCChhHHHHHHHcC--------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 99754432222111100 001222222456788999999999999999999999997
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=255.30 Aligned_cols=220 Identities=24% Similarity=0.376 Sum_probs=187.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||-++.||||+++.|+.+....+.+|+|||++|+|..|++. ..+.+..-+...++..|+.+++||-+.+ +||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRD 756 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRD 756 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhh
Confidence 57789999999999999999999999999999999999987 5677999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCccee-eecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|.++|||++.+-.+||.|||+++.+......... ....-..+|.|||.+...+++.++||||+|++|||.++ |..||.
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 9999999999999999999999976444322222 11223679999999999999999999999999999887 888886
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 238 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~~ 238 (267)
.+. +-.+.+.++...+-+.|-+||..+.+|+..||+++-.+||++.+|+..|++++.+..+-+
T Consensus 837 dmS-----------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 837 DMS-----------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred ccc-----------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 443 222333445555566688999999999999999999999999999999999999988865
Q ss_pred CcCCC
Q 024460 239 VSRNA 243 (267)
Q Consensus 239 ~~~~~ 243 (267)
.....
T Consensus 900 ~~~~~ 904 (996)
T KOG0196|consen 900 TIAPE 904 (996)
T ss_pred ccCCC
Confidence 44433
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=247.25 Aligned_cols=202 Identities=24% Similarity=0.280 Sum_probs=156.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++.+.+++.+|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRD 126 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 36788999999999999999999999999999999999964 456888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-----------------------------------------ceeeeccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-----------------------------------------HVSTRVMG 119 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-----------------------------------------~~~~~~~~ 119 (267)
|||+||+++.++.++|+|||++......... .......|
T Consensus 127 lkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 206 (376)
T cd05598 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVG 206 (376)
T ss_pred CCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCC
Confidence 9999999999999999999987422100000 00012358
Q ss_pred ccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHH
Q 024460 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRC 198 (267)
Q Consensus 120 ~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (267)
++.|+|||++.+..++.++|||||||++|+|++|..||.......... +..+. ..........+
T Consensus 207 t~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~ 271 (376)
T cd05598 207 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPSQAKL 271 (376)
T ss_pred CccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCCCCCC
Confidence 899999999999999999999999999999999999996543221110 00000 00000111234
Q ss_pred HHHHHHHHHhhcccCCCCCC---CHHHHHH
Q 024460 199 LNYAVAVTAMCLNEEANFRP---LINDIVV 225 (267)
Q Consensus 199 ~~~l~~li~~cl~~~p~~Rp---t~~ev~~ 225 (267)
+.++.+++.+|+ .+|.+|+ ++.++++
T Consensus 272 s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 272 SREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred CHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 667888998876 5999999 8999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=244.18 Aligned_cols=202 Identities=21% Similarity=0.213 Sum_probs=155.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 5678999999999999999999999999999999999854 45788889999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC----CcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+||+++.++.++|+|||++........ .......|++.|+|||++.... ++.++|+||||+++|+|++|..||
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 99999999999999999999875432211 1223456899999999987543 788999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 226 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~~ 226 (267)
......... .... ... ....-.....++..+.++|.+||..++.+ |++++++++.
T Consensus 248 ~~~~~~~~~------~~i~-------~~~-~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 248 YADSLVGTY------SKIM-------NHK-NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCHHHHH------HHHH-------cCC-CcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 643321110 0000 000 00000112245677999999999854443 7899998873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=238.54 Aligned_cols=215 Identities=24% Similarity=0.329 Sum_probs=157.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dl 130 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDL 130 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5688999999999999999999999999975 88888765 3456888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 131 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 131 KPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999874322211 1222346789999998765 46889999999999999999999999654
Q ss_pred CccCccchhhhc--------hhhhhcccccccccCCcCCC----CCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWS--------RPFLKDQKKFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............ .+.............+.... .....++.++.+++.+||+.+|.+|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 332211110000 00000000000000000000 011234677899999999999999999999996
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=235.31 Aligned_cols=197 Identities=26% Similarity=0.341 Sum_probs=159.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.++.|||+++ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl 127 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDI 127 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCC
Confidence 5788999999999999999999999999999999998843 56888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|..|+....
T Consensus 128 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred ChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999987543221 11222356788999999988889999999999999999999999986332
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... . .+........+..++..+.+++.+||..+|++||++.++++
T Consensus 206 ~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 206 PMRVL---F--------------LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hhhHH---h--------------hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11100 0 00000011122345677999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=241.25 Aligned_cols=193 Identities=26% Similarity=0.340 Sum_probs=155.8
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+|++|+++++++..++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 131 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHH
Confidence 689999999999999999999999999999998854 456889999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
|+++.++.++|+|||++...... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||........
T Consensus 132 ill~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 209 (323)
T cd05616 132 VMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209 (323)
T ss_pred eEECCCCcEEEccCCCceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999998642211 1122335678999999999999999999999999999999999999964332111
Q ss_pred cchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 225 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~ev~~ 225 (267)
. . . +... ...++...+.++.+++.+||+.+|.+|++. +++.+
T Consensus 210 ~---~---~----------i~~~--~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 210 F---Q---S----------IMEH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred H---H---H----------HHhC--CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 0 0 0 0000 012234556789999999999999999985 56554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=236.34 Aligned_cols=202 Identities=24% Similarity=0.317 Sum_probs=159.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++.+..+...|+||||+++++|.+++.. ....+++..+..++.|++.++.|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 128 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRD 128 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 36788999999999999999999999999999999999865 3457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|+|+||+++.++.++++|||++....... .......++..|++||.+. ...++.++|+||||+++|+|++|..
T Consensus 129 l~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 129 LKAGNILLTLDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred CChhhEEECCCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999876432211 1222345788899999875 3456789999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||......... ... .....+.+ ..+..++.++.+++.+||+.+|.+||+++++++
T Consensus 207 p~~~~~~~~~~--~~~-----------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 207 PHHELNPMRVL--LKI-----------LKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CcccCCHHHHH--HHH-----------hcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 98643221110 000 00000011 113345678999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=244.49 Aligned_cols=203 Identities=22% Similarity=0.269 Sum_probs=154.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++.+.++..+|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDl 127 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDI 127 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 5678999999999999999999999999999999999964 467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc---------------------------------ceeeecccccceeCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT---------------------------------HVSTRVMGTYGYCAPEY 128 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~aPE~ 128 (267)
||+|||++.++.++|+|||++......... .......|+..|+|||+
T Consensus 128 Kp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 207 (363)
T cd05628 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV 207 (363)
T ss_pred CHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHH
Confidence 999999999999999999998643211000 00122468999999999
Q ss_pred cccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHH
Q 024460 129 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTA 207 (267)
Q Consensus 129 ~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 207 (267)
+.+..++.++|+||||+++|+|++|..||.......... +..+.. .. .+. .....+.++.+++.
T Consensus 208 ~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~----------~~---~~p--~~~~~s~~~~~li~ 272 (363)
T cd05628 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKE----------TL---IFP--PEVPISEKAKDLIL 272 (363)
T ss_pred HcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC----------cc---cCC--CcCCCCHHHHHHHH
Confidence 999999999999999999999999999996433211100 000000 00 000 01123566888888
Q ss_pred hhccc--CCCCCCCHHHHHHH
Q 024460 208 MCLNE--EANFRPLINDIVVA 226 (267)
Q Consensus 208 ~cl~~--~p~~Rpt~~ev~~~ 226 (267)
+++.. ++..||+++||++.
T Consensus 273 ~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 273 RFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHcCChhhcCCCCCHHHHhCC
Confidence 86652 33356899999884
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=221.70 Aligned_cols=196 Identities=24% Similarity=0.352 Sum_probs=165.9
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~ 82 (267)
+.|+||||+++|++|-++...|+++||...|+|...++. ...+++++.....++.|++.|+.|+|..+ ++|||||
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiK 151 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIK 151 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCC
Confidence 578999999999999999999999999999999999975 34677999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 83 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 83 ~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
|+|+|++..+.+|++|||.+-... .....+..||..|.+||...+...+...|+|++|++.||++.|.+||.....
T Consensus 152 penlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~ 227 (281)
T KOG0580|consen 152 PENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH 227 (281)
T ss_pred HHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence 999999999999999999986432 2234557789999999999999999999999999999999999999975442
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......+.. .+-.+|...+.+..++|.+|+..+|.+|.+..|+++
T Consensus 228 ~etYkrI~k------------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 228 SETYKRIRK------------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HHHHHHHHH------------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 111111110 011234566788999999999999999999999986
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=231.35 Aligned_cols=196 Identities=27% Similarity=0.397 Sum_probs=154.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.. +..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 126 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHR---EKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGN 126 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhhCC---eeccc
Confidence 3678999999999999888 778999999999999999975 2337889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCC-------ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHH
Q 024460 81 LKSANILLDNDF-------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 81 i~~~nili~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l 151 (267)
|||+||+++.++ .++++|||++..... .....+...|+|||.+... .++.++|+||||+++|+|+
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999998777 799999999875322 1123356679999998876 7889999999999999999
Q ss_pred h-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 152 T-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
+ |..||.............. . ...+......+.+++.+||..+|.+|||+.++++.|+
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~~-------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQD-------Q------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred hCCCCCcccCCchhHHHHHhc-------C------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 8 5667654321111100000 0 0001111267899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=235.80 Aligned_cols=201 Identities=24% Similarity=0.320 Sum_probs=157.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++..++||||+++++|..++.. ....+++..+..++.|++.++.|||+++ ++|+|+
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 136 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDL 136 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCC
Confidence 5788999999999999999999999999999999888754 3456889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++. ...++.++|+||||+++|+|++|.+|
T Consensus 137 kp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 137 KAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred CcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 9999999999999999999876432211 1122345678899999884 34567899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|........ ... ......+.. ..+..++.++.+++.+||..+|++||+++++++
T Consensus 215 ~~~~~~~~~--~~~-----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 215 HHELNPMRV--LLK-----------IAKSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CccccHHHH--HHH-----------HhcCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 864321110 000 000000000 113345667899999999999999999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=234.48 Aligned_cols=208 Identities=25% Similarity=0.382 Sum_probs=161.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC-----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-----QEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|++++||||+++++++..++..++||||+++++|.+++...... ...+++..+..++.|++.+|+|||+++
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--- 137 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--- 137 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---
Confidence 367899999999999999999999999999999999999753311 126899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
++|+||+|+||+++.++.++++||+++........ .......++..|++||.+.+..++.++|+||||+++|+|++ |.
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998764322111 11122334667999999888888999999999999999998 77
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
.||....... .... ..........+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 217 ~p~~~~~~~~---~~~~-------------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 217 LPFYGLSDEE---VLNR-------------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCccccchHH---HHHH-------------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 7875322111 0110 00001111123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=236.98 Aligned_cols=203 Identities=28% Similarity=0.397 Sum_probs=161.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|+||+++++.+..++..++||||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 367889999999999999999999999999999999988542 2346889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++++|||++....... ......++..|+|||++....++.++|+||+|+++|+|++|..||...
T Consensus 128 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 128 LKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986432211 112245788999999999889999999999999999999999999743
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
........... ... ......+..++.++.+++.+||+.+|++||| ++|+++
T Consensus 205 ~~~~~~~~~~~-------------~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 205 KKKIKREEVER-------------LVK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccchHHHHHh-------------hhh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 32111000000 000 0001123345677899999999999999999 888887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=243.23 Aligned_cols=194 Identities=25% Similarity=0.253 Sum_probs=152.9
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++++.+..+..+|+||||+.+++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||+|
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~N 126 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPEN 126 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 799999999999999999999999999999998854 467899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
|+++.++.++|+|||++....... .......|+..|+|||++.+. .++.++||||||+++|+|++|..||.......
T Consensus 127 ili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~ 204 (330)
T cd05586 127 ILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204 (330)
T ss_pred eEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH
Confidence 999999999999999986432211 122335688999999988754 58899999999999999999999986432111
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC----CHHHHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP----LINDIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp----t~~ev~~ 225 (267)
... .... . ...+ ....++.++.+++++||+.+|++|| +++++++
T Consensus 205 ~~~------~i~~-~-------~~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 205 MYR------NIAF-G-------KVRF---PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHH------HHHc-C-------CCCC---CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000 0000 0 0000 0112466789999999999999998 5666665
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=232.94 Aligned_cols=202 Identities=27% Similarity=0.312 Sum_probs=162.3
Q ss_pred CCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCC
Q 024460 2 LSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANP 74 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-----~~~~~ 74 (267)
|++++||||+++++++.. +...+++|||+++++|.+++.........+++..++.++.|++.++.+|| +.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-- 130 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-- 130 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--
Confidence 678899999999997754 45689999999999999999764444678899999999999999999999 777
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||+|+||+++.++.++++|||++........ ......++..|++||.+....++.++|+|+||+++++|++|.
T Consensus 131 -i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 131 -VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred -ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999886433221 122345788999999998888999999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.||....... ... .+........+..++..+.+++.+|+..+|++|||+++|++
T Consensus 208 ~p~~~~~~~~---~~~--------------~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 208 PPFTARNQLQ---LAS--------------KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CcccCcCHHH---HHH--------------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 9997443110 000 00111111234456788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=236.52 Aligned_cols=214 Identities=22% Similarity=0.291 Sum_probs=159.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~d 80 (267)
|++++||||+++++++..++.+++||||+++++|.+++.. ...+++..+..++.|++.++.|||+ .+ ++|+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~d 125 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRD 125 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECC
Confidence 5678999999999999999999999999999999999964 3568899999999999999999997 57 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++++|||++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 126 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999988643221 122345688999999988888999999999999999999999998543
Q ss_pred CccCccchhhhchhhhhcc----------------ccccc----ccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 161 KGQGEQNLVSWSRPFLKDQ----------------KKFVH----LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~----------------~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
................... ..... .............++.++.+++.+||..+|++|||+
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 281 (308)
T cd06615 202 DAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281 (308)
T ss_pred chhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence 3211111110000000000 00000 000000000011356779999999999999999999
Q ss_pred HHHHHH
Q 024460 221 NDIVVA 226 (267)
Q Consensus 221 ~ev~~~ 226 (267)
+++++.
T Consensus 282 ~~ll~~ 287 (308)
T cd06615 282 KELTKH 287 (308)
T ss_pred HHHhcC
Confidence 999963
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=233.18 Aligned_cols=203 Identities=27% Similarity=0.309 Sum_probs=157.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.++.|||+.+ ++|+|+
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 132 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDI 132 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999998854 456889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||.+. ...++.++|+||+|+++|+|++|..||.
T Consensus 133 ~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 133 KGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999999999999999987542211 1112235678899999874 3457789999999999999999999985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
............ ......+... ....++..+.+++++||..+|++|||++++++.
T Consensus 211 ~~~~~~~~~~~~-----------~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 211 DLHPMRALFLMS-----------KSNFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred ccchhhhheeee-----------cCCCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 332211110000 0000001110 112346789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=240.99 Aligned_cols=201 Identities=22% Similarity=0.264 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|.-...|+||++|-.|.+..++||||||++||++..+|.. ...+++..+..++.+++.||..+|+.| ++|+||
T Consensus 195 L~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDI 267 (550)
T KOG0605|consen 195 LAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDI 267 (550)
T ss_pred hhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccC
Confidence 3445789999999999999999999999999999999954 678999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCC---------------------CCcc-----ee-------------------ee
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVG---------------------DNTH-----VS-------------------TR 116 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~---------------------~~~~-----~~-------------------~~ 116 (267)
||+|+||+..|.+||.|||++.-.... .... .. ..
T Consensus 268 KPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 268 KPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred ChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 999999999999999999998422110 0000 00 02
Q ss_pred cccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc-cchhhhchhhhhcccccccccCCcCCCCCc
Q 024460 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE-QNLVSWSRPFLKDQKKFVHLVDPLLHGRYP 195 (267)
Q Consensus 117 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (267)
..|||-|+|||++.+.+|+..+|.||||||+||||.|.|||........ ..+..|...... +-.
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------P~~ 412 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------PEE 412 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------CCc
Confidence 4689999999999999999999999999999999999999965443322 223333321111 111
Q ss_pred HHHHHHHHHHHHhhcccCCCCCC---CHHHHHH
Q 024460 196 RRCLNYAVAVTAMCLNEEANFRP---LINDIVV 225 (267)
Q Consensus 196 ~~~~~~l~~li~~cl~~~p~~Rp---t~~ev~~ 225 (267)
..+..+..++|.+|++ ||.+|. .++||.+
T Consensus 413 ~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 413 VDLSDEAKDLITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred CcccHHHHHHHHHHhc-CHHHhcCcccHHHHhc
Confidence 2345789999999999 999996 4667664
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=233.31 Aligned_cols=202 Identities=27% Similarity=0.336 Sum_probs=157.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++.++++|||+++++|.+++.. .+.+++..+..++.|++.++.|||+++ ++|+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 132 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDI 132 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999999999999854 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++.++|+|||++...... ........++..|+|||.+. ...++.++|+||||+++|+|++|..||.
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 133 KGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 999999999999999999998653221 11223346788999999874 4458889999999999999999999985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............ . . ....+.... ...++..+.+++.+||..+|++|||+++|++
T Consensus 211 ~~~~~~~~~~~~------~--~---~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 211 DLHPMRALFLMT------K--S---NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccchhhHHhhh------c--c---CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 332211110000 0 0 000011110 1134567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=225.88 Aligned_cols=202 Identities=24% Similarity=0.270 Sum_probs=158.0
Q ss_pred CCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 6 HHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 6 ~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
.|||||.++++|+. ...+.+|||+++||.|...+++ .....+++..+..++.||..|+.|||..+ |.|||+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDl 187 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDL 187 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccC
Confidence 59999999998864 3467899999999999999987 34667999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+|... +..+||+|||++..... ........-|+.|.|||++...+|+...|+||+|+++|-|++|.+||-
T Consensus 188 KpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 188 KPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999999964 45789999999985432 222344567999999999999999999999999999999999999995
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
-+.+..-. - .+..+..... ..+-++. =.+.++...++|+.+|..+|.+|.|++++++
T Consensus 265 S~hg~ais-p-gMk~rI~~gq---y~FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 265 SNHGLAIS-P-GMKRRIRTGQ---YEFPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ccCCccCC-h-hHHhHhhccC---ccCCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 44432110 0 0000000000 0011111 1466788999999999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=232.89 Aligned_cols=204 Identities=25% Similarity=0.349 Sum_probs=162.3
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDL 81 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di 81 (267)
+.++||||+++++++..++..+++|||+++++|.+++.........+++..++.++.|++.++.+||+ .+ ++|+||
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl 140 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDL 140 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCC
Confidence 35799999999999999999999999999999999886543455678999999999999999999995 66 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||||+++|+|++|.+||....
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999999999999999999987543222 2334557888999999998889999999999999999999999985332
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
.... ... ..+..........++..+.+++.+||..+|++||++.|+..++.
T Consensus 218 ~~~~------~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 MLSL------ATK----------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHH------HHH----------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1100 000 00000000011234577999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=240.48 Aligned_cols=213 Identities=28% Similarity=0.385 Sum_probs=160.5
Q ss_pred CCCC-CCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCC-----------------------------------
Q 024460 2 LSLL-HHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEP----------------------------------- 44 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~----------------------------------- 44 (267)
|+++ +||||+++++++.. +...+++|||+++|+|.++++....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 4566 68999999998765 4568999999999999999864211
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEE
Q 024460 45 ----------------------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKL 96 (267)
Q Consensus 45 ----------------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l 96 (267)
....+++..+..++.|++.||.|||+++ ++|+||||+||+++.++.+++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEE
Confidence 0124677888999999999999999999 999999999999999999999
Q ss_pred eccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccchhhhchhh
Q 024460 97 SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPF 175 (267)
Q Consensus 97 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~ 175 (267)
+|||++................++..|+|||.+....++.++|+||||+++|+|++ |..||........ ... .
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~ 294 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----R 294 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----H
Confidence 99999875422222112222334567999999988889999999999999999997 8888864321110 000 0
Q ss_pred hhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 176 LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
.. .......+..++.++.+++..||..+|++|||+.+|++.|+.+.+.
T Consensus 295 ~~----------~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 295 LK----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred Hh----------ccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00 0001111223456789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=233.64 Aligned_cols=198 Identities=26% Similarity=0.305 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..+...++|+||+++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl 124 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDI 124 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5678999999999999999999999999999999999954 37899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... .......++..|++||.+.+..++.++|+|+||+++|+|++|..||....
T Consensus 125 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 125 KAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred CHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 9999999999999999999987543221 12223456778999999988889999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... . .......+... ...++.++.+++.+||..+|++|||++++++
T Consensus 203 ~~~~~---~----------~~~~~~~~~~~---~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 203 PMRVL---F----------LIPKNNPPSLE---GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred hHHHH---H----------HhhhcCCCCCc---ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11100 0 00000111110 0115677999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=237.22 Aligned_cols=199 Identities=25% Similarity=0.352 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++.+++|+||+++++|.+++.. ..+++..+..++.+++.++.+||+++ ++|+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL 141 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDI 141 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5778999999999999999999999999999999998843 46889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||.+....++.++|+||||+++|+|++|..||....
T Consensus 142 ~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998764322211 1223456788999999988889999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ .. . ..+. ...+..++..+.++|++||..+|.+|||+.++++
T Consensus 220 ~~~~~~~~------~~-~------~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 220 PLRALYLI------AT-N------GTPE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHHHHHHH------Hh-c------CCcc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 21110000 00 0 0000 0113345677999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=234.81 Aligned_cols=214 Identities=21% Similarity=0.250 Sum_probs=154.6
Q ss_pred CCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 3 SLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
+.++||||+++++++.. ....+++||++.+ +|.+++... ....+++..+..++.|++.||.|||+.+ ++
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---iv 130 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IV 130 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 45689999999998864 3458999999974 888888642 2345899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|+||||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+||+|+++|+|++|.+||
T Consensus 131 H~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred cCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 99999999999999999999999987543221 112245688899999999889999999999999999999999998
Q ss_pred cccCccCccc-hhhhc----hhhhhccccc-ccccCCcCCC---CCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQN-LVSWS----RPFLKDQKKF-VHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~-~~~~~----~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... +.... ...+...... .....+.... .....++..+.+++.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 6443221110 00000 0000000000 0000000000 011234667899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=260.74 Aligned_cols=211 Identities=23% Similarity=0.298 Sum_probs=158.5
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC----C
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN----P 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~----~ 74 (267)
+|++|+||||++++++|.. ...+|+||||+++++|.+++.........+++..++.++.||+.||.|||..+. .
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 4678999999999998854 457899999999999999997644445679999999999999999999998431 2
Q ss_pred CeeeCCCCCCcEEEcC-----------------CCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc--CCCc
Q 024460 75 PVIYRDLKSANILLDN-----------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLT 135 (267)
Q Consensus 75 ~i~h~di~~~nili~~-----------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~ 135 (267)
+|+|+||||+|||++. .+.++|+|||++...... .......+++.|+|||++.. ..++
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCC
Confidence 3999999999999953 235899999998754222 12233468999999998864 4588
Q ss_pred ccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCC
Q 024460 136 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 215 (267)
Q Consensus 136 ~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 215 (267)
.++|||||||++|+|++|..||........ +.. .+... +.+ ....++.++.+||..||..+|.
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~~~~~q--li~----~lk~~--------p~l---pi~~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKANNFSQ--LIS----ELKRG--------PDL---PIKGKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCcHHH--HHH----HHhcC--------CCC---CcCCCCHHHHHHHHHHhcCChh
Confidence 999999999999999999999964321110 000 00000 000 0123357799999999999999
Q ss_pred CCCCHHHHHH--HHHHhh
Q 024460 216 FRPLINDIVV--ALDYLV 231 (267)
Q Consensus 216 ~Rpt~~ev~~--~l~~l~ 231 (267)
+||++.++++ .++.+.
T Consensus 285 eRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 285 ERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HCcCHHHHhccHHHhhcC
Confidence 9999999985 444443
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=230.43 Aligned_cols=200 Identities=24% Similarity=0.316 Sum_probs=158.5
Q ss_pred CCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++|||++++++.+.. ++.+|++|||+++++|.+++... ....+++..+..++.+++.++.+||+.+ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~d 127 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRD 127 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 578899999999988764 45689999999999999998652 2456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||+|+++++|++|..||...
T Consensus 128 i~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 128 LKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred CCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987542221 1223345788899999999888999999999999999999999998633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
... ........ ... ...+...+..+.+++.+|++.+|.+|||+.++++
T Consensus 206 ~~~------~~~~~~~~------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 206 DMN------SLVYRIIE------GKL-----PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CHH------HHHHHHHh------cCC-----CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 211 00000000 000 1123456678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=230.51 Aligned_cols=201 Identities=22% Similarity=0.283 Sum_probs=160.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++||||+++++++..++..++|+||+.+++|.+++... ....+++..+..++.|++.++.+||+++ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~ 126 (256)
T cd08218 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 367899999999999999999999999999999999988641 2345788999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus 127 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred CCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 999999999999999999999875432211 112234677899999998888999999999999999999999998632
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .. ..+.. .....+..++.++.++|.+||+.+|++||++++|++
T Consensus 205 ~~~~~------~~----------~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 205 NMKNL------VL----------KIIRG-SYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHHHH------HH----------HHhcC-CCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 21100 00 00000 001123455778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=234.44 Aligned_cols=217 Identities=21% Similarity=0.246 Sum_probs=157.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..|+||||+. ++|.+++.... .+..+++..+..++.|++.||.|||+++ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 127 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDL 127 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCC
Confidence 567899999999999999999999999997 58888886532 2467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...
T Consensus 128 ~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 128 KPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999987432221 112223457889999987654 5788999999999999999999999644
Q ss_pred CccCccc-hhh-hchh---hh---hcccccccccCCcC---CCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQN-LVS-WSRP---FL---KDQKKFVHLVDPLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~-~~~-~~~~---~~---~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ... +... .+ .............. .......++.++.++|++||..+|.+|||+++|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 3211100 000 0000 00 00000000000000 00011235677899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=229.20 Aligned_cols=200 Identities=27% Similarity=0.364 Sum_probs=159.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++.+..++..++||||+++++|.+++... ....+++..+..++.+++.++.+||+++ ++|+|
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~d 126 (256)
T cd08220 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRD 126 (256)
T ss_pred HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 367889999999999999999999999999999999999752 2456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|+|+||+++.+ +.++++|||.+....... ......++..|+|||.+....++.++|+||+|+++|+|++|..||..
T Consensus 127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 127 LKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred CCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 99999999754 467999999987543221 12224567889999999888889999999999999999999999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ... . .. ......+..++.++.+++.+||..+|++|||++|+++
T Consensus 204 ~~~~~~---~~~---~----------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 204 ANLPAL---VLK---I----------MS-GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CchHHH---HHH---H----------Hh-cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 332110 000 0 00 0001123345678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=228.24 Aligned_cols=219 Identities=21% Similarity=0.270 Sum_probs=161.8
Q ss_pred CCCCCCCCC-ccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 1 MLSLLHHDN-LVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 1 il~~l~Hpn-iv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+|+.|+|+| |+.+++++..++ .+++||||++. +|..++.........++...+..++.|++.|++|||+++
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~- 140 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG- 140 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 467899999 999999998776 89999999965 999999874332256777899999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHh
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~ 152 (267)
|+||||||+||+|+..|.+|++|||+++........ -.....|.+|+|||++.+. .|+...|+||+|||+.||++
T Consensus 141 --IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 141 --ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred --eecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence 999999999999999999999999999854433222 2334568899999999986 79999999999999999999
Q ss_pred CCCCccccCccCccc-hhhh-ch---hhhhcccccccccCCcCCCCC-cH-------HHHHHHHHHHHhhcccCCCCCCC
Q 024460 153 GRKAMDLSKGQGEQN-LVSW-SR---PFLKDQKKFVHLVDPLLHGRY-PR-------RCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 153 g~~p~~~~~~~~~~~-~~~~-~~---~~~~~~~~~~~~~~~~~~~~~-~~-------~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
+.+.|.......... +... .- ..+......... ...+.... +. ....+..+++.+||+.+|..|.|
T Consensus 217 ~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~-k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S 295 (323)
T KOG0594|consen 217 RRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY-KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS 295 (323)
T ss_pred CCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc-cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC
Confidence 999986554321110 0000 00 000000000000 00111111 11 11247899999999999999999
Q ss_pred HHHHHHH
Q 024460 220 INDIVVA 226 (267)
Q Consensus 220 ~~ev~~~ 226 (267)
++..++.
T Consensus 296 a~~al~h 302 (323)
T KOG0594|consen 296 AKGALTH 302 (323)
T ss_pred HHHHhcC
Confidence 9999874
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=234.91 Aligned_cols=205 Identities=19% Similarity=0.194 Sum_probs=154.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++.+++.+|+||||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ ++|+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 128 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDI 128 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCC
Confidence 4567999999999999999999999999999999999964 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||+||+++.++.++|+|||++........ .......|++.|+|||++.. ..++.++|+||+|+++|+|++|..|
T Consensus 129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 129 KPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred CHHHEEECCCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 99999999999999999999864322211 11223457899999999863 4578899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 226 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~~ 226 (267)
|......... ......... .. +.+ ....++..+.+++++||+..+++ |++++++++.
T Consensus 208 f~~~~~~~~~------~~i~~~~~~-~~-~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 208 FYAESLVETY------GKIMNHKEH-FQ-FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCCHHHHH------HHHHcCCCc-cc-CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9643211100 000000000 00 000 01235677899999988654443 7899999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=232.38 Aligned_cols=203 Identities=27% Similarity=0.386 Sum_probs=160.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|+||+++.+.+..++..+++|||+.+++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+|
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~d 127 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRD 127 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 367889999999999999999999999999999999888642 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 128 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 128 LKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred CCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999886432211 122345789999999998888999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
.......... ...... ...++..++..+.+++..||+.+|++||+ ++++++
T Consensus 205 ~~~~~~~~~~---------~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 205 KEKVKREEVD---------RRVLET-----EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CHHHHHHHHH---------Hhhhcc-----ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 2211100000 000000 01123345667899999999999999999 667776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=237.41 Aligned_cols=199 Identities=24% Similarity=0.344 Sum_probs=158.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+..++..++||||+++++|.+++.. ..+++..+..++.|++.++.|||+++ ++|+||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dl 144 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDI 144 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCC
Confidence 5678999999999999999999999999999999998843 45888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||.+....++.++|+||+|+++|+|++|..||....
T Consensus 145 kp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 145 KSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986432221 11223457889999999988889999999999999999999999986332
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... . .......+.... ...++..+.+++.+||..+|++|||++++++
T Consensus 223 ~~~~~---~----------~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 223 PLQAM---R----------RIRDNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred HHHHH---H----------HHHhcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11100 0 000111111111 1234567899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=231.72 Aligned_cols=201 Identities=25% Similarity=0.320 Sum_probs=154.5
Q ss_pred CCCC-CCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
|+++ +||||+++++++... ..+|++|||+.+++|.+++... ....+++..+..++.|++.+++|||+++
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-- 131 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK-- 131 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3455 699999999998653 4689999999999999998752 2456889999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHH
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~ 149 (267)
++|+|++|+||+++.++.++|+|||++....... .......++..|+|||++. ...++.++|+||+|+++|+
T Consensus 132 -ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 132 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred -CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999987532211 1223345788899999886 3457889999999999999
Q ss_pred HHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 150 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|++|..||............ . .. ......+..++..+.+++.+||..+|.+|||++++++
T Consensus 209 l~~g~~p~~~~~~~~~~~~~-------~-~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLI-------P-RN--------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhCCCCccccCHHHHHHHH-------h-cC--------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 99999998533211110000 0 00 0011112345667999999999999999999999974
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=235.24 Aligned_cols=202 Identities=20% Similarity=0.179 Sum_probs=156.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|+||+++++.+.+++.+|+||||+++|+|.+++.. ....+++..+..++.|++.|+.|||+.+ ++|+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDl 128 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDI 128 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 4678999999999999999999999999999999999965 3457889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||+||+++.++.++|+|||++....... ........|+..|+|||++. ...++.++|+||||+++|+|++|..|
T Consensus 129 kp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 129 KPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred CHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 9999999999999999999986432211 11223346899999999886 34678899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCC--CCCHHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANF--RPLINDIVVA 226 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~~ 226 (267)
|.......... .. ........+ ...++.++.+++++|+..++++ |++++++++.
T Consensus 208 f~~~~~~~~~~------~i----------~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 208 FYAESLVETYG------KI----------MNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCCCHHHHHH------HH----------hCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 96432111100 00 000000011 1245678999999998765554 6899999874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=231.69 Aligned_cols=202 Identities=26% Similarity=0.370 Sum_probs=159.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++|+||+++++++..++..++++||+++++|.+++.. ...+++..+..++.|++.++.|||+.+ ++|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 128 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDI 128 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 5788999999999999999999999999999999999954 346788999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCC----CcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+|+||+++.++.++++|||++....... .........++..|+|||.+.+..++.++|+|+||+++|+|++|..||
T Consensus 129 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 208 (265)
T cd06631 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208 (265)
T ss_pred CHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcc
Confidence 9999999999999999999886432111 111122345788899999998888999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... ... ......+ ..+..++.++.+++++||..+|.+||+++++++
T Consensus 209 ~~~~~~~~~~-------~~~----~~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 209 ASMDRLAAMF-------YIG----AHRGLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccCChHHHHH-------Hhh----hccCCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 6432111100 000 0000011 123345677899999999999999999999984
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=236.13 Aligned_cols=215 Identities=23% Similarity=0.322 Sum_probs=157.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dl 130 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDL 130 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 578899999999999999999999999996 589888865 3456888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 131 kp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 131 KPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999875322211 1122345788999998765 45788999999999999999999999654
Q ss_pred CccCccchh-hh-------chhhhhcccccccccCCcCCCC----CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLV-SW-------SRPFLKDQKKFVHLVDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~-~~-------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... .. ..+.............+..... ....++.++.++|.+||+.+|.+|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 322111000 00 0000000000000000100000 11234667899999999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=229.93 Aligned_cols=205 Identities=26% Similarity=0.364 Sum_probs=159.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++...+..++||||+++++|.++++. .+.+++..+..++.|++.++.+||+++ ++|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 134 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDL 134 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCC
Confidence 6788999999999999999999999999999999999965 357888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC--CcccCCeeehHHHHHHHHhCCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
+|+||+++.++.++++|||++................++..|++||.+.... ++.++|+||||+++|++++|..||..
T Consensus 135 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 135 KADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999987532221111222345678899999887654 78999999999999999999999853
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... .. .. .......+.......++..+.+++.+||..+|++|||+++|++
T Consensus 215 ~~~~~~~--~~-----~~-----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 215 EEAIAAM--FK-----LG-----NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cchHHHH--HH-----hh-----ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 2211100 00 00 0001111111122345778999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=231.29 Aligned_cols=204 Identities=26% Similarity=0.330 Sum_probs=157.0
Q ss_pred CCCC-CCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
++++ +||||+++++++.... .+++||||+++++|.+++......+..+++..+..++.|++.||.|||+.+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-- 133 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-- 133 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--
Confidence 4556 6999999999996644 589999999999999998764434578899999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHH
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~ 149 (267)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.. ..++.++|+||||+++|+
T Consensus 134 -i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 134 -VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred -cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 9999999999999999999999999986532221 12223457888999998754 346788999999999999
Q ss_pred HHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 150 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|++|..||........ .... .....+. ...+..++.++.+++.+||..+|++|||++++++
T Consensus 211 l~~g~~p~~~~~~~~~--~~~~-----------~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 211 LADGKPPLCDMHPMRA--LFKI-----------PRNPPPT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhCCCCccccchHHH--HHHh-----------hccCCCC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999963321111 0000 0000001 1112346778999999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=267.73 Aligned_cols=202 Identities=28% Similarity=0.308 Sum_probs=162.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|..++|||+|++||+=.+.+.++|.||||++|+|.+.++. +...++.....+..|++.|++|||++| |||||
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRD 1359 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRD 1359 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecC
Confidence 35678999999999999999999999999999999999953 445666777788999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCC---CcccCCeeehHHHHHHHHhCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|||.||+++.+|.+|++|||.+..+...... ...+...||+.|||||++.+.. -..++|||||||++.||++|..
T Consensus 1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 9999999999999999999998764333111 1123467999999999998754 4578999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||...+. ..++.-.+...-.-.+|...+.+-.+++..||..||+.|+++.|+++
T Consensus 1440 PW~~~dn----------------e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1440 PWAELDN----------------EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred chhhccc----------------hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 9964332 11111111111112246668899999999999999999999998886
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=232.11 Aligned_cols=202 Identities=26% Similarity=0.312 Sum_probs=156.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
++.++||||+++++++..++..|++|||++ ++|.+++.........+++..++.++.|++.|+.|||++ + ++|+|
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~d 129 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRD 129 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 356789999999999999999999999996 688888865444456799999999999999999999987 7 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc----CCCcccCCeeehHHHHHHHHhCCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|+|+||+++.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+|+||+++|+|++|..|
T Consensus 130 lkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 130 VKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred CCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 9999999999999999999998753221 11222456788999998865 3468899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|........ .....+...........++.++.+++.+||..+|++|||++++++
T Consensus 207 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 207 YDSWKTPFQ---------------QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCccccCHH---------------HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 853211000 000000000000011245678999999999999999999999996
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=234.48 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=159.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.++.|||+.+ ++|+||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL 141 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDI 141 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999843 45788899999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... .......++..|++||.+.+..++.++|+||+|+++|++++|..||....
T Consensus 142 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CHHHEEECCCCCEEECcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999886432221 11223457788999999988889999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... .........+...+..+.+++.+||..+|++||+++++++
T Consensus 220 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 220 PLRALYLIA---------------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cchheeeec---------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 211100000 0000000113345677899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=229.50 Aligned_cols=201 Identities=25% Similarity=0.338 Sum_probs=155.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~--~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+++++|+||+++++++..++..++++||+++++|.+++.. ....+ +...+..++.|++.|+.|||+.+ ++|+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~ 132 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRS---KWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHR 132 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHH---hcccCCCcHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 5688999999999999999999999999999999999975 22334 77888899999999999999998 9999
Q ss_pred CCCCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHHhCCCC
Q 024460 80 DLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 80 di~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||+|+||+++. ++.++|+|||.+....... .......++..|+|||.+... .++.++|+||+|+++|+|++|..|
T Consensus 133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred CCCHHHEEEcCCCCeEEEecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999976 6789999999886432211 112223467889999988654 378899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|......... .+.... ......++..++.++.+++.+||..+|++|||++++++
T Consensus 211 ~~~~~~~~~~---~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 211 FIELGEPQAA---MFKVGM------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CccccChhhh---Hhhhhh------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 8532211100 000000 00111234456678999999999999999999999985
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=239.03 Aligned_cols=211 Identities=22% Similarity=0.308 Sum_probs=152.3
Q ss_pred CCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|+.++||||+++++++...+ .+|+||||+++ +|...+. ..++...+..++.|++.||.|||+++
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~--- 143 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG--- 143 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56889999999999986543 57999999965 6766663 24778889999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++|+||||+||+++.++.++|+|||++...... .......++..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 144 ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred cccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998743211 11223457889999999999999999999999999999999999
Q ss_pred CccccCccCccc------------hhhh----chhhhhccccc-----ccccCCc-CC--CCCcHHHHHHHHHHHHhhcc
Q 024460 156 AMDLSKGQGEQN------------LVSW----SRPFLKDQKKF-----VHLVDPL-LH--GRYPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 156 p~~~~~~~~~~~------------~~~~----~~~~~~~~~~~-----~~~~~~~-~~--~~~~~~~~~~l~~li~~cl~ 211 (267)
||.......... .... ........... .+..... .. .......+..+.+++.+||.
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 300 (359)
T cd07876 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300 (359)
T ss_pred CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence 997443211000 0000 00000000000 0000000 00 00111235678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.+|++|||++|+++
T Consensus 301 ~dP~~R~t~~e~l~ 314 (359)
T cd07876 301 IDPDKRISVDEALR 314 (359)
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=236.18 Aligned_cols=200 Identities=23% Similarity=0.301 Sum_probs=159.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..++++||+++++|.+++. ...+++..++.++.|++.+|.+||+++ ++|+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl 143 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDI 143 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 567899999999999999999999999999999999873 356889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 144 ~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 144 KSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999886432211 11223457889999999988889999999999999999999999986432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
......... ....... ......+..+.+++.+||+.+|++||+++++++.
T Consensus 222 ~~~~~~~~~-------------~~~~~~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 222 PVQAMKRLR-------------DSPPPKL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHh-------------ccCCCCc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 211110000 0000000 1112345678999999999999999999999983
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=230.79 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=155.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|..+. .+++..+..++.|++.|+.|||+.+ ++|+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 121 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDV 121 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCC
Confidence 56789999999999999999999999999999886542 4577888999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 122 kp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred CHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 999999999999999999998743221 1223467889999999998889999999999999999999999986432
Q ss_pred ccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ...... ...+...........+.++.+++.+||+.+|.+||+++++++
T Consensus 198 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 198 KNQGSLMPLQLLQ----------CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred ccccccchHHHHH----------HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111110 000000 000000000111234567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=245.64 Aligned_cols=199 Identities=28% Similarity=0.330 Sum_probs=164.8
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL--SWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~--~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+.|+|+|||++.|.+..++++-+.||-.+||+|.++++..+ +++ .+.++-.+.+||+++|.|||++. |||||
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRD 700 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRD 700 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhcc---eeecc
Confidence 57899999999999999999999999999999999998744 444 67888999999999999999999 99999
Q ss_pred CCCCcEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||.+|+||+ -.|.+||.|||-+..... ...+..+..||.-|||||++.. ..|..++|||||||++.||.+|+|||
T Consensus 701 IKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 701 IKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred ccCCcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 999999996 468899999998875432 2335566789999999999975 46999999999999999999999999
Q ss_pred cccC-ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSK-GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
-... .+-....+- .=..+-.+|...+.+...+|.+|+.++|.+||+++++++
T Consensus 779 ~ElgspqAAMFkVG----------------myKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 779 VELGSPQAAMFKVG----------------MYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred eecCChhHhhhhhc----------------ceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 5322 111111111 111223457888999999999999999999999999997
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=228.94 Aligned_cols=204 Identities=23% Similarity=0.357 Sum_probs=160.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+++..++|+||+.+++|.+++.. .+.+++..+..++.|++.|+.+||+++ ++|+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i 129 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDV 129 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999864 356888999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-ceEEeccCCcccCCCCCC--cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDF-NPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++ .++|+|||.+........ ........++..|+|||.+.+..++.++|+|++|+++|+|++|..||.
T Consensus 130 ~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 130 KGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred CHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999998765 699999999865432211 111223456788999999988889999999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............ ...........+...+.++.+++.+||..+|++|||+.++++
T Consensus 210 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 210 AEKHSNHLALIF-------------KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCcchHHHHH-------------HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 332211111000 000001112234566788999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=232.99 Aligned_cols=203 Identities=32% Similarity=0.441 Sum_probs=160.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++|||++++++|.+++. ....+++..++.++.|++.+|.+||+++ ++|+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~di 124 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDI 124 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSB
T ss_pred ccccccccccccccccccccccccccccccccccccccc----cccccccccccccccccccccccccccc---cccccc
Confidence 456789999999999999999999999999999999996 2567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-cCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||.+... ...........++..|.|||++. ...++.++|+||||+++|+|++|..||...
T Consensus 125 kp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 125 KPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999998643 12222344456788999999988 788999999999999999999999999755
Q ss_pred CccCccchhhhchh-hhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRP-FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.............. ..... . . ........+.+++.+||+.+|++|||++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~------~---~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 203 NSDDQLEIIEKILKRPLPSS------S---Q---QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHHHHHHTHHHHH------T---T---SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhhhhhhhhccccccccc------c---c---ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 21111111110000 00000 0 0 00111378999999999999999999999984
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=232.77 Aligned_cols=205 Identities=27% Similarity=0.321 Sum_probs=155.8
Q ss_pred CCCC-CCCCccceeeEEe-----eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLL-HHDNLVTLIGYCT-----SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
++++ +||||+++++++. .++..++||||+++++|.+++.........+++..+..++.|++.|+.|||+.+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 144 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--- 144 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4556 6999999999873 345789999999999999988643334567889999999999999999999998
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHH
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~ 150 (267)
++|+|++|+||+++.++.++++|||++....... .......++..|+|||.+.. ..++.++|+||+|+++|+|
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9999999999999999999999999987532221 11223457889999998753 4578899999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
++|..||......... .... ....+.. ..+..++.++.+++.+||+.+|++|||++|+++.
T Consensus 223 ~~g~~p~~~~~~~~~~--~~~~-----------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 223 GDGDPPLADLHPMRAL--FKIP-----------RNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred hcCCCCCCCCchhHHH--hhcc-----------ccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 9999998643221110 0000 0000000 1122345679999999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=241.72 Aligned_cols=215 Identities=28% Similarity=0.418 Sum_probs=173.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|.+|+||||+.++++|..++.+++|+||++.|+|.+++.+... ..........++.||+.+++||.+.+ +||||
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd 662 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRD 662 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhcc
Confidence 47889999999999999999999999999999999999976321 22344555779999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH--HhCCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL--ITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~--l~g~~p~~ 158 (267)
+.+.|+|++.++.+||+|||.++.+.............-..+|+|+|.+..++++.++|+|++|+++||+ ++...||.
T Consensus 663 ~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 663 LATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 9999999999999999999999987777777777777778999999999999999999999999999998 45677886
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
....+.. +.-.-.+.... .....-..|..|+.++.++|..||+.+.++||+++++...|.+.
T Consensus 743 ~lt~e~v---ven~~~~~~~~-------~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 743 QLTDEQV---VENAGEFFRDQ-------GRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhHHHH---HHhhhhhcCCC-------CcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 3332111 11111111111 11111224678899999999999999999999999999988754
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=228.92 Aligned_cols=210 Identities=23% Similarity=0.372 Sum_probs=159.3
Q ss_pred CCCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
+|+.++||||+++++++.... ..++++||+.+++|.+++..... ....++...+..++.|++.+++|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 367899999999999886532 24789999999999988753221 2235788899999999999999999998
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||+|+||+++.++.++++|||+++...............+...|++||.+....++.++|+||||+++|+|++
T Consensus 134 ---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 134 ---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred ---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 99999999999999999999999999875432221112222334567999999988889999999999999999998
Q ss_pred -CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 153 -GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
|.+||........ .... .... ....+..++..+.+++.+||..+|++||++.++++.|+++
T Consensus 211 ~g~~p~~~~~~~~~---~~~~----~~~~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 211 RGQTPYAGVENSEI---YNYL----IKGN----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCCHHHH---HHHH----HcCC----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 8888753321110 0000 0000 0011234467899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=235.03 Aligned_cols=203 Identities=27% Similarity=0.269 Sum_probs=158.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++.+..++..|+||||+.+++|.+++.. .....+++..+..++.|++.+|+|||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 129 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDL 129 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999864 23457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcc---------------------------eeeecccccceeCCcccccCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTH---------------------------VSTRVMGTYGYCAPEYAMSGKL 134 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~aPE~~~~~~~ 134 (267)
+|+||+++.++.++|+|||++.......... ......|+..|+|||.+.+..+
T Consensus 130 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred ChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 9999999999999999999876432211100 0012346778999999998889
Q ss_pred cccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCC
Q 024460 135 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA 214 (267)
Q Consensus 135 ~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 214 (267)
+.++|+||||+++|+|++|..||......... .........-......+..+.+++.+||..+|
T Consensus 210 ~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDETF----------------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CchHHHHHHHHHHHHHhhCCCCCCCCchHHHH----------------HHHhcCCccCCCccccCHHHHHHHHHHccCCH
Confidence 99999999999999999999999644321110 00011100001111257789999999999999
Q ss_pred CCCCC----HHHHHH
Q 024460 215 NFRPL----INDIVV 225 (267)
Q Consensus 215 ~~Rpt----~~ev~~ 225 (267)
++||| ++++++
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 777775
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=233.60 Aligned_cols=204 Identities=20% Similarity=0.192 Sum_probs=155.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|+||+++++++..++..|+||||+.+|+|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDl 128 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDI 128 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccC
Confidence 4567999999999999999999999999999999999965 3457889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||+||+++.++.++|+|||++........ .......|+..|+|||++.. ..++.++|+||+|+++|+|++|..|
T Consensus 129 kp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred chHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 99999999999999999999875422211 11223468999999998875 4678899999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~ 225 (267)
|.......... ......... .+.+. ...++.++.+++.+|+...+++ |++++++++
T Consensus 208 f~~~~~~~~~~------~i~~~~~~~--~~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 208 FYAESLVETYG------KIMNHEERF--QFPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ccCCCHHHHHH------HHHcCCCcc--cCCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 96332111000 000000000 00000 1234677999999999876654 468888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=241.73 Aligned_cols=201 Identities=22% Similarity=0.291 Sum_probs=154.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|..++||||+++++.+..++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDL 127 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDI 127 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCC
Confidence 5678999999999999999999999999999999999854 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc---------------------------------ceeeecccccceeCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT---------------------------------HVSTRVMGTYGYCAPEY 128 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~aPE~ 128 (267)
||+||+++.++.++|+|||++......... .......|+..|+|||+
T Consensus 128 kp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 207 (360)
T cd05627 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207 (360)
T ss_pred CHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHH
Confidence 999999999999999999997643211000 00112358899999999
Q ss_pred cccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHH
Q 024460 129 AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTA 207 (267)
Q Consensus 129 ~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 207 (267)
+.+..++.++|+|||||++|+|++|.+||.......... +..+. .. ....+ ....+.++.++|.
T Consensus 208 ~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~-------~~--~~~p~------~~~~s~~~~~li~ 272 (360)
T cd05627 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWK-------ET--LVFPP------EVPISEKAKDLIL 272 (360)
T ss_pred HcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCC-------Cc--eecCC------CCCCCHHHHHHHH
Confidence 999999999999999999999999999996443211110 00000 00 00000 0124567889998
Q ss_pred hhcccCCCCCCC---HHHHHH
Q 024460 208 MCLNEEANFRPL---INDIVV 225 (267)
Q Consensus 208 ~cl~~~p~~Rpt---~~ev~~ 225 (267)
+|+ .+|.+|++ ++++++
T Consensus 273 ~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 273 RFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred Hhc-cChhhcCCCCCHHHHhc
Confidence 876 49999985 667665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=232.01 Aligned_cols=216 Identities=24% Similarity=0.325 Sum_probs=159.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++|+||+++++++..++..+++|||++++.+..+.. ....+++..+..++.|++.++.|||+++ ++|+|+
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 126 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDI 126 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 567899999999999999999999999998866665553 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ .......++..|+|||.+... .++.++|+||||+++|+|++|.+||...
T Consensus 127 ~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 127 KPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999876433322 122234567889999999887 8899999999999999999999998644
Q ss_pred CccCccchhhhch-h-------hhhccc-----ccccccCC-cCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSR-P-------FLKDQK-----KFVHLVDP-LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~-~-------~~~~~~-----~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............. . ...... .......+ .....++..++.++.++|++||..+|++|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 3221110000000 0 000000 00000000 0011123345788999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=231.74 Aligned_cols=200 Identities=25% Similarity=0.301 Sum_probs=153.4
Q ss_pred CCC-CCCCccceeeEEe------eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 3 SLL-HHDNLVTLIGYCT------SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+++ +||||+++++++. .+..+|++|||+.+++|.+++... ....+++..+..++.|++.|+.|||+.+
T Consensus 67 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~--- 141 (282)
T cd06636 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK--- 141 (282)
T ss_pred HHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 444 6999999999984 346789999999999999998752 2345788889999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHH
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~ 150 (267)
++|+|++|+||+++.++.++|+|||++....... .......++..|+|||.+. ...++.++|+||||+++|+|
T Consensus 142 ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el 219 (282)
T cd06636 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219 (282)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHH
Confidence 9999999999999999999999999986432111 1122345778899999875 34678899999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
++|..||........... .............++.++.++|.+||..+|.+|||+.|+++
T Consensus 220 ~~g~~p~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 220 AEGAPPLCDMHPMRALFL----------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhCCCCccccCHHhhhhh----------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 999999853321111100 00000111112345778999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=233.68 Aligned_cols=156 Identities=26% Similarity=0.343 Sum_probs=125.1
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCC-----CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEP-----DQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+|++++||||+++++++.. +..+|++|||+. ++|.+++..... ....+++..+..++.|++.||.|||+++
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 128 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999998854 457899999995 588887753221 2235889999999999999999999999
Q ss_pred CCeeeCCCCCCcEEE----cCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCccccc-CCCcccCCeeehHHHH
Q 024460 74 PPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVL 147 (267)
Q Consensus 74 ~~i~h~di~~~nili----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~ 147 (267)
++|+||||+||++ +..+.+||+|||++......... .......++..|+|||++.+ ..++.++|+||+|+++
T Consensus 129 --ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999999999 45578999999999754322111 11223457889999998876 4589999999999999
Q ss_pred HHHHhCCCCcccc
Q 024460 148 LELITGRKAMDLS 160 (267)
Q Consensus 148 ~~~l~g~~p~~~~ 160 (267)
|+|++|.+||...
T Consensus 207 ~el~~g~~~f~~~ 219 (317)
T cd07868 207 AELLTSEPIFHCR 219 (317)
T ss_pred HHHHhCCCCccCC
Confidence 9999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=228.38 Aligned_cols=200 Identities=28% Similarity=0.324 Sum_probs=160.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+.++...++++||+++++|.+++.. ...++...+..++.|++.++.|||+++ ++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl 119 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDL 119 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5788999999999999999999999999999999999964 345888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... ......++..|++||.+....++.++|+|++|+++|+|++|..||....
T Consensus 120 ~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9999999999999999999987543321 2223456788999999888889999999999999999999999996443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
.... ... ............+...+.++.+++.+||..+|++||+ ++|+++
T Consensus 197 ~~~~-~~~-------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 197 EDPM-EIY-------------NDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCHH-HHH-------------HHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 2100 000 0011001111223344778999999999999999999 777774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=236.01 Aligned_cols=188 Identities=25% Similarity=0.351 Sum_probs=151.6
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+|++|+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~N 131 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDN 131 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 468889999999999999999999999999998854 456899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
|+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|..||........
T Consensus 132 ill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~ 209 (323)
T cd05615 132 VMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209 (323)
T ss_pred eEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999987432111 122334578999999999988899999999999999999999999964332110
Q ss_pred cchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.. .. ... ...++..++.++.+++.+||..+|.+|++.
T Consensus 210 ---~~---~i----------~~~--~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 210 ---FQ---SI----------MEH--NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ---HH---HH----------HhC--CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 00 00 000 011234456778999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=226.42 Aligned_cols=202 Identities=25% Similarity=0.340 Sum_probs=164.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|||++++.+.+..++..++|+|++++++|.+++.........+++..+..++.+++.++.+||+++ ++|+||
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl 129 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDI 129 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 56789999999999999999999999999999999999764434578999999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||.+....... .......++..|+|||......++.++|+|++|+++++|++|..||....
T Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 130 KPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999999999999999987543322 22333467888999999888889999999999999999999999986433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ... .. .......+..++.++.+++++||..+|++|||++++++
T Consensus 208 ~~~~------~~~----------~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 LLEL------ALK----------IL-KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHHH------HHH----------Hh-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1100 000 00 00011223355678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=231.93 Aligned_cols=199 Identities=22% Similarity=0.301 Sum_probs=158.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++++||+++++|.+++.. ..+++..+..++.|++.++.+||+++ ++|+||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 141 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDI 141 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999854 56888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 142 ~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 142 KSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 9999999999999999999876432211 11223457889999999988889999999999999999999999985322
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ......+... .+..++..+.+++.+||..+|++|||++++++
T Consensus 220 ~~~~~~~-------------~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 220 PLQAMKR-------------IRDNLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHH-------------HHhcCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1111000 0000001110 12235678999999999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=228.57 Aligned_cols=208 Identities=25% Similarity=0.312 Sum_probs=159.8
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|++++||||+++++++.. .+.+++||||+++++|.+++.........+++..+..++.|++.+|.|||+.+ ++|
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H 128 (287)
T cd06621 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIH 128 (287)
T ss_pred HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 3678899999999998855 34789999999999999887643334566888999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+||+|+||+++.++.++|+|||++....... .....++..|++||.+.+..++.++|+|+||+++|+|++|..||.
T Consensus 129 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred CCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986432221 112346778999999988899999999999999999999999997
Q ss_pred ccCcc--CccchhhhchhhhhcccccccccCCcCCCCCc--HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQ--GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .......+... .. .+.+..... ...+..+.+++.+||..+|++|||+.|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 205 PEGEPPLGPIELLSYIVN-----MP-----NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred cccCCCCChHHHHHHHhc-----CC-----chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 54321 11111111000 00 001111111 234678999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=232.70 Aligned_cols=215 Identities=19% Similarity=0.220 Sum_probs=154.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++.+++..++++||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl 125 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDL 125 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 567899999999999999999999999996 588887754 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|..|+...
T Consensus 126 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 126 KPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99999999999999999999875322211 11223457889999988764 4789999999999999999988875322
Q ss_pred CccCc-cchh-hh-------chhhhhcccccc--cccCCcC-CCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGE-QNLV-SW-------SRPFLKDQKKFV--HLVDPLL-HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~-~~~~-~~-------~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ...+ .. ............ ....... .......++.++.+++++||..+|.+|||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 204 NDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 21110 0000 00 000000000000 0000000 00011235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=255.13 Aligned_cols=215 Identities=22% Similarity=0.298 Sum_probs=163.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------DQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+++++||||+++++++.+++..|++|||+++++|.+++..... .....+...++.++.|++.||+|||+++
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-- 133 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-- 133 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5678999999999999999999999999999999998864221 1234556778899999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc----------------ceeeecccccceeCCcccccCCCcccC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT----------------HVSTRVMGTYGYCAPEYAMSGKLTLKS 138 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~ 138 (267)
++|+||||+||+++.++.++++|||++......... .......|++.|+|||.+.+..++.++
T Consensus 134 -IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS 212 (932)
T PRK13184 134 -VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST 212 (932)
T ss_pred -ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh
Confidence 999999999999999999999999998754111100 001123589999999999999999999
Q ss_pred CeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 139 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 139 Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
|+||+|+++|+|++|..||.......... . . ....+... .....++..+.+++.+||..+|++||
T Consensus 213 DIWSLGVILyELLTG~~PF~~~~~~ki~~----~-------~---~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRRKKGRKISY----R-------D---VILSPIEV-APYREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhhhhh----h-------h---hccChhhc-cccccCCHHHHHHHHHHccCChhhCc
Confidence 99999999999999999996432211100 0 0 00000000 00124567789999999999999995
Q ss_pred -CHHHHHHHHHHhhhcc
Q 024460 219 -LINDIVVALDYLVSQR 234 (267)
Q Consensus 219 -t~~ev~~~l~~l~~~~ 234 (267)
+++++++.|+.+.+..
T Consensus 278 ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 278 SSVQELKQDLEPHLQGS 294 (932)
T ss_pred CHHHHHHHHHHHHHhcC
Confidence 6777888888776643
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=240.17 Aligned_cols=211 Identities=23% Similarity=0.296 Sum_probs=152.8
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
++.++||||+++++++... ..+|+||||+++ +|.+.+. ..++...+..++.|++.||+|||+++
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~--- 146 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--- 146 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 5678999999999987543 357999999965 7777773 24778889999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++|+||||+||+++.++.++|+|||++...... .......++..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 147 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred eecCCCCHHHEEECCCCcEEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 999999999999999999999999999753221 12233457889999999999999999999999999999999999
Q ss_pred CccccCccCccchh-h-----------hc----hhhhhccccc-----ccccCCc---CCCCCcHHHHHHHHHHHHhhcc
Q 024460 156 AMDLSKGQGEQNLV-S-----------WS----RPFLKDQKKF-----VHLVDPL---LHGRYPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 156 p~~~~~~~~~~~~~-~-----------~~----~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~l~~li~~cl~ 211 (267)
||...........+ . .. .......... ....... ............+.+++.+||+
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 303 (364)
T cd07875 224 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303 (364)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcC
Confidence 99654322111000 0 00 0000000000 0000000 0000111224578999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.||++|||++++++
T Consensus 304 ~dP~~R~t~~e~L~ 317 (364)
T cd07875 304 IDASKRISVDEALQ 317 (364)
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=243.04 Aligned_cols=202 Identities=22% Similarity=0.297 Sum_probs=166.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||..+.||+||++++.|..++.++++.|||.||-+...+-. -+..+.+..+.-+++|++.||.|||+++ |+|+|
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRD 155 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRD 155 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhh
Confidence 57788999999999999999999999999999999888865 5678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHhCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+.|||++-+|.++|+|||.+.. ............||+.|||||+..+ .+|+.++||||||+++.+|..+.|
T Consensus 156 LKAGNiL~TldGdirLADFGVSAK--n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 156 LKAGNILLTLDGDIRLADFGVSAK--NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred ccccceEEEecCcEeeeccccccc--chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 999999999999999999998754 2233344556789999999998865 478999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|-...+...-...+. ..-.|.+ ..|..++..+.+++.+||.+||..||++.++++
T Consensus 234 PHhelnpMRVllKia-------------KSePPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 234 PHHELNPMRVLLKIA-------------KSEPPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CccccchHHHHHHHh-------------hcCCCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 975333211111111 1111111 125677889999999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=239.53 Aligned_cols=211 Identities=22% Similarity=0.295 Sum_probs=152.9
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|+.++||||+++++++... ...|+||||+++ +|.+.+. ..++...+..++.|++.||.|||+++
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g--- 139 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--- 139 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999988643 357999999965 6777663 24778889999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++|+||||+||+++.++.++|+|||+++..... .......++..|+|||++.+..++.++|+||||+++|+|++|..
T Consensus 140 ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred cccCCCChHHEEECCCCCEEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998753221 12223457889999999998899999999999999999999999
Q ss_pred CccccCccCccc-hhh---------------hchhhhhccccccccc-CCcC-------CCCCcHHHHHHHHHHHHhhcc
Q 024460 156 AMDLSKGQGEQN-LVS---------------WSRPFLKDQKKFVHLV-DPLL-------HGRYPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 156 p~~~~~~~~~~~-~~~---------------~~~~~~~~~~~~~~~~-~~~~-------~~~~~~~~~~~l~~li~~cl~ 211 (267)
||.......... ... ................ .... ....+......+.+++.+||.
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 996443211100 000 0000000000000000 0000 000112235678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.||++|||++|+++
T Consensus 297 ~dP~~Rps~~ell~ 310 (355)
T cd07874 297 IDPAKRISVDEALQ 310 (355)
T ss_pred CCchhcCCHHHHhc
Confidence 99999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=226.63 Aligned_cols=201 Identities=26% Similarity=0.354 Sum_probs=154.8
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|++++||||+++++++.. ++..++++||+++++|.+++.. ...+++..++.++.|++.++.|||+.+ ++|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H 129 (266)
T cd06651 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVH 129 (266)
T ss_pred HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3678899999999998865 4678999999999999999864 345788999999999999999999998 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus 130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf 209 (266)
T cd06651 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209 (266)
T ss_pred CCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999998643221111 1112234678899999998888999999999999999999999998
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ............+..+...+.+++ .|+..+|++||+++||++
T Consensus 210 ~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 210 AEYEAMAAI----------------FKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cccchHHHH----------------HHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 633211100 000000011122344566778888 688899999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=236.35 Aligned_cols=200 Identities=23% Similarity=0.273 Sum_probs=155.3
Q ss_pred CCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
.+|+ |.+|++++++-..++.+|+||||-+ .+|...++.. ....+...+..+..|++.|+.++|.++ |||.||
T Consensus 414 ~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDL 486 (677)
T KOG0596|consen 414 NKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDL 486 (677)
T ss_pred HHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCC
Confidence 3443 7899999999989999999999874 5999999762 223333477889999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-----------CcccCCeeehHHHHHHH
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-----------LTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----------~~~~~Dv~slG~i~~~~ 150 (267)
||.|+|+- .|.+||+|||.+..+......-......||..||+||.+.... .+.++||||||||+|+|
T Consensus 487 KPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqM 565 (677)
T KOG0596|consen 487 KPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQM 565 (677)
T ss_pred CcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHH
Confidence 99999986 4689999999998665544444566788999999999987643 45789999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHH-HHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN-YAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+-|.+||..-. .....+..+.+|...-++|.--.. ++.++++.||..||++||++.+|++
T Consensus 566 vYgktPf~~~~---------------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 566 VYGKTPFGQII---------------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HhcCCchHHHH---------------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 99999996111 112233344444333333321111 2999999999999999999999997
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=225.93 Aligned_cols=207 Identities=28% Similarity=0.382 Sum_probs=162.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++|+||+++++.+..++..++++|++++++|.+++..... ...+++..+..++.|++.|+.+||+++ ++|+|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l 128 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDI 128 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999975221 256889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcc--eeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||++++++.++|+|||++.......... ......++..|++||.+... .++.++|+||||+++|+|++|..||.
T Consensus 129 ~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred CHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 9999999999999999999987544332221 22334578899999988766 78899999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCC-CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR-YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........... .. ...+..... ....++..+.+++.+||..+|++|||++++++
T Consensus 209 ~~~~~~~~~~~--~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 209 KYPPMKVLMLT--LQ-----------NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccChhhhHHHH--hc-----------CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 44322111000 00 000011100 01355678999999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=226.23 Aligned_cols=198 Identities=28% Similarity=0.363 Sum_probs=159.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..+..+++++||+++++|.+++.. ...+++..+..++.|++.++.+||+.+ ++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 128 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDI 128 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999964 346888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-CcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||.+....... ......++..|++||.+.... ++.++|+|+||+++|+|++|..||...
T Consensus 129 ~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 129 KGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred CHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 9999999999999999999887532222 233455788899999887766 899999999999999999999998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... .... .. ......+..++.++.+++.+||..+|++||++++++.
T Consensus 206 ~~~~~~--~~~~-----~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 206 EGVAAV--FKIG-----RS---------KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cHHHHH--HHHH-----hc---------ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 311100 0000 00 0001123345677899999999999999999999984
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=232.99 Aligned_cols=205 Identities=21% Similarity=0.247 Sum_probs=157.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..++.+++||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ ++|+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 127 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDL 127 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999954 356889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-------------ceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
+|+||+++.++.++++|||++......... .......++..|+|||.+....++.++|+||||+++|
T Consensus 128 ~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~ 207 (305)
T cd05609 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207 (305)
T ss_pred chHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHH
Confidence 999999999999999999987631111000 0011234677899999998888999999999999999
Q ss_pred HHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 149 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
+|++|..||........ .. .... .....+. ....++.++.+++.+||..+|++||+..++.+.|+
T Consensus 208 el~~g~~pf~~~~~~~~---~~---~~~~-----~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 208 EFLVGCVPFFGDTPEEL---FG---QVIS-----DDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhCCCCCCCCCHHHH---HH---HHHh-----cccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 99999999863321100 00 0000 0000000 01235677999999999999999999665555553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=228.67 Aligned_cols=203 Identities=27% Similarity=0.353 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~d 80 (267)
+++++||||+++++.+..++..++++||+.+++|.+++.. ....+++..+..++.|++.++.|||+ .+ ++|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~d 126 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRD 126 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCC
Confidence 5678899999999999999999999999999999999975 22678899999999999999999999 88 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||.+....... .....++..|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 127 l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 127 VKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred CCHHHEEECCCCCEEEeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999876432111 11155778899999998889999999999999999999999998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ....... .............++.++.++|.+||..+|++|||+.+++.
T Consensus 203 ~~~~~~-~~~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 203 NDPPDG-IFELLQY----------IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cccccc-HHHHHHH----------HhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 221110 0000000 00000000011126778999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=230.69 Aligned_cols=204 Identities=25% Similarity=0.288 Sum_probs=155.4
Q ss_pred CCCC-CCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
++++ +||||+++++++... +..++||||+++++|.+++.........+++..++.++.|++.++.+||+.+
T Consensus 72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 148 (291)
T cd06639 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--- 148 (291)
T ss_pred HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 799999999998653 3689999999999999988654344567899999999999999999999998
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-----CCcccCCeeehHHHHHHH
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~~ 150 (267)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+... .++.++|+||||+++|+|
T Consensus 149 ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el 226 (291)
T cd06639 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226 (291)
T ss_pred eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence 99999999999999999999999999875322211 12223567889999987543 368899999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
++|..||......... .... ....+.. ..+......+.++|.+||..+|++||+++++++
T Consensus 227 ~~g~~p~~~~~~~~~~--~~~~-----------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 227 GDGDPPLFDMHPVKTL--FKIP-----------RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hhCCCCCCCCcHHHHH--HHHh-----------cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999998643221110 0000 0000000 112334567999999999999999999999985
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=230.69 Aligned_cols=194 Identities=29% Similarity=0.362 Sum_probs=158.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+++.||||+++++++..++.+++||||+++++|.+++.. ...+++..+..++.|++.+|.+||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl 127 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDL 127 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 6788999999999999999999999999999999999865 367899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++...... .....++..|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 128 ~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 128 KPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998754322 223357888999999988888999999999999999999999986433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
..... . . .... ...++...+..+.+++.+||..+|.+|+ +++|+++
T Consensus 203 ~~~~~---~---~----------~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 203 PIQIY---E---K----------ILEG--KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHH---H---H----------HhcC--CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11000 0 0 0000 0112334467789999999999999999 7777774
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=227.10 Aligned_cols=200 Identities=26% Similarity=0.336 Sum_probs=163.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++|+||+++++|.+++.........+++..++.++.|++.|+.+||+.+ ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l 129 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDL 129 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 57889999999999999999999999999999999998664434567889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++...... ......++..|++||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998754332 1222446788999999988889999999999999999999999996443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ...........+..++.++.+++.+||..+|++|||+.++++
T Consensus 206 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 206 MQDLR-----------------YKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred HHHHH-----------------HHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 21100 000001111223466788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=229.16 Aligned_cols=208 Identities=24% Similarity=0.382 Sum_probs=162.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~d 80 (267)
++.++||||+++++++...+.+++||||+++++|.+++.. .+.+++..+..++.+++.++.|||+ .+ ++|+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 129 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRD 129 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccC
Confidence 5678999999999999999999999999999999998854 4568899999999999999999996 57 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||+|+++|++++|..||...
T Consensus 130 l~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 130 IKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred CCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999987643111 122345788999999998888999999999999999999999999754
Q ss_pred CccCcc-----chhhhchhhhhcccccccccCCcCCCCCc-HHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 161 KGQGEQ-----NLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 161 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
...... .+........ .... ...+ ..++.++.+++.+||+.+|.+|||++|+++..--++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~----------~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 206 NIDDDGQDDPMGILDLLQQIV----------QEPP-PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred chhhhhhhhhhHHHHHHHHHh----------hccC-CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 332110 0111110000 0000 0111 235678999999999999999999999998644433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=240.73 Aligned_cols=216 Identities=25% Similarity=0.343 Sum_probs=156.4
Q ss_pred CCCCCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|+.++||||+++++++...+ ..|+|+||+. ++|.+.+.. ...+++..+..++.|++.||.|||+++
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 123 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG--- 123 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 367889999999999998776 7899999996 578887743 467899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+||+|+++|+|++|.
T Consensus 124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 202 (372)
T cd07853 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202 (372)
T ss_pred eeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence 99999999999999999999999999875322211 112223467889999998764 5789999999999999999999
Q ss_pred CCccccCccCccchhhhc--hhhhhc----cccccccc-C-----CcCC--CCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 155 KAMDLSKGQGEQNLVSWS--RPFLKD----QKKFVHLV-D-----PLLH--GRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~--~~~~~~----~~~~~~~~-~-----~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.||...........+... .+.... .......+ . +... .......+.++.++|.+||+.||++|||+
T Consensus 203 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 282 (372)
T cd07853 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA 282 (372)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence 999654322111100000 000000 00000000 0 0000 00112336678999999999999999999
Q ss_pred HHHHH
Q 024460 221 NDIVV 225 (267)
Q Consensus 221 ~ev~~ 225 (267)
+|+++
T Consensus 283 ~e~l~ 287 (372)
T cd07853 283 ADALA 287 (372)
T ss_pred HHHhc
Confidence 99987
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=227.69 Aligned_cols=197 Identities=26% Similarity=0.326 Sum_probs=159.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ..+++..+..++.+++.++.+||+.+ ++|+||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl 127 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDI 127 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCC
Confidence 5678999999999999999999999999999999999843 46888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||++....... .......++..|++||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 128 ~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 128 KAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred CHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999886532221 11222356778999999988888999999999999999999999986432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... . ........+..++.++.+++.+||..+|.+||+++++++
T Consensus 206 ~~~~~~~-------~----------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 206 PMKVLFL-------I----------PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred hHHHHHH-------H----------hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1110000 0 000001123345678999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=230.07 Aligned_cols=216 Identities=25% Similarity=0.305 Sum_probs=154.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++||||+++++++..++..++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~d 128 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDD---CGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRD 128 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 36788999999999999999999999999975 89998865 3347889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||..
T Consensus 129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 129 LKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999864322111 1122235778999998865 4588999999999999999999999964
Q ss_pred cCccCccc--hhh-------hchhhhhcccccccccC-----CcCCCCCc-HHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 160 SKGQGEQN--LVS-------WSRPFLKDQKKFVHLVD-----PLLHGRYP-RRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 160 ~~~~~~~~--~~~-------~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
........ ... ...+............. ..+....+ .....++.+++.+||+.+|++|||+++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred CccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 43111100 000 00000000000000000 00000000 01126788999999999999999999987
Q ss_pred H
Q 024460 225 V 225 (267)
Q Consensus 225 ~ 225 (267)
+
T Consensus 287 ~ 287 (291)
T cd07844 287 K 287 (291)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=230.33 Aligned_cols=216 Identities=23% Similarity=0.242 Sum_probs=158.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++|+||+++++++.+++..++||||+ +++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 127 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD---KSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRD 127 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 367889999999999999999999999999 8899999965 2236899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.++|..
T Consensus 128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 128 LKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 999999999999999999999875432211 1122345778999998754 4678999999999999999999888764
Q ss_pred cCccCccchh-hhc----hhhhhcccccccccCCcCC-----CCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLV-SWS----RPFLKDQKKFVHLVDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... ... ................... .......+..+.++|.+||..+|++|||++|+++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 4322111000 000 0000000000000000000 0011234678999999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=228.00 Aligned_cols=203 Identities=27% Similarity=0.355 Sum_probs=159.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++.+...+..|+||||+++++|.+++... ....+++..+..++.|++.++.|||+.+ ++|+|
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 120 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRD 120 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 367889999999999999999999999999999999998652 2246899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||.+...... .......++..|++||.+.+..++.++|+||||+++|+|++|..||...
T Consensus 121 i~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 121 LKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCHHHEEECCCCCEEEccCcchhhhccC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999988753221 1122234677899999998888999999999999999999999999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
.......... .... ......+..++..+.++|.+||+.+|.+|| ++.++++
T Consensus 198 ~~~~~~~~~~-------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 198 KEKVEKEELK-------------RRTL-EMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccccHHHHH-------------hccc-cccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3211110000 0000 001112344577899999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=225.01 Aligned_cols=200 Identities=26% Similarity=0.309 Sum_probs=155.8
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++.+. ..++++|||+++++|.+++.. ...+++..+..++.|++.+|.+||+++ ++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~ 130 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHR 130 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 5788999999999988663 568899999999999999864 345788889999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 131 dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 131 DIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred CCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999988753221111 11122347788999999988889999999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ ............+......+.+++.+|+. +|++||++++|++
T Consensus 211 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 211 EFEAMAAI----------------FKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ccchHHHH----------------HHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 33211110 00000011112345566778999999995 9999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=229.34 Aligned_cols=216 Identities=23% Similarity=0.302 Sum_probs=158.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++|+||+ +++|.+++.. ....+++..+..++.|++.+|.|||+.+ ++|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 125 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDL 125 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCc
Confidence 56789999999999999999999999999 9999999865 3367899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++++|||++........ .......++..|+|||.+... .++.++|+||+|+++|+|++|.++|...
T Consensus 126 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 126 KPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 99999999999999999999875433221 112234578889999988654 4689999999999999999998887543
Q ss_pred CccCccch-hhh-chh---hhhcccc---cccccCCcCC----CCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNL-VSW-SRP---FLKDQKK---FVHLVDPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~-~~~-~~~---~~~~~~~---~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ ... ..+ ....... ......+... .....+.+..+.+++++||..+|.+|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 205 NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 32111100 000 000 0000000 0000000000 0001234578999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=231.79 Aligned_cols=156 Identities=26% Similarity=0.340 Sum_probs=124.1
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+|++++||||+++++++.. +...++||||+.+ +|.+++.... .....+++..+..++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~- 128 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999998853 5678999999964 7877764321 12235888899999999999999999999
Q ss_pred CCeeeCCCCCCcEEE----cCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCccccc-CCCcccCCeeehHHHH
Q 024460 74 PPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVL 147 (267)
Q Consensus 74 ~~i~h~di~~~nili----~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~ 147 (267)
++|+||||+||++ +.++.++|+|||+++........ .......++..|+|||++.+ ..++.++|+||||+++
T Consensus 129 --ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 206 (317)
T cd07867 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence 9999999999999 45678999999999754322111 11223456889999998876 4578999999999999
Q ss_pred HHHHhCCCCcccc
Q 024460 148 LELITGRKAMDLS 160 (267)
Q Consensus 148 ~~~l~g~~p~~~~ 160 (267)
|+|++|.+||...
T Consensus 207 ~el~tg~~~f~~~ 219 (317)
T cd07867 207 AELLTSEPIFHCR 219 (317)
T ss_pred HHHHhCCCCcccc
Confidence 9999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=229.42 Aligned_cols=216 Identities=24% Similarity=0.274 Sum_probs=157.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++||||+++++++..+..+++||||+++++|..++.. ...+++..+..++.|++.+|.|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~d 125 (286)
T cd07847 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRD 125 (286)
T ss_pred HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 35788999999999999999999999999998888777643 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||..
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 126 VKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred CChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999875433221 1222346778999998865 4578899999999999999999999975
Q ss_pred cCccCccchh-hhchh-------hhhcccccccccCCcCCCCC-----cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLV-SWSRP-------FLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... ..... ......-......+...... -...+..+.+++.+||+.+|++|||+.|+++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 4432211100 00000 00000000000000000000 0123577899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=230.25 Aligned_cols=225 Identities=20% Similarity=0.226 Sum_probs=162.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..+++|||+++++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dl 127 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSV 127 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 56789999999999999999999999999999999999752 2346888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
+|+||+++.++.++++||+.+......... .......++..|+|||.+... .++.++|+||+|+++|+|++|.
T Consensus 128 k~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~ 207 (314)
T cd08216 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207 (314)
T ss_pred CcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCC
Confidence 999999999999999999987643221111 111223456789999988753 5889999999999999999999
Q ss_pred CCccccCccCcc-chhhhc-------hhhhhccccccc----ccCC----cCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 155 KAMDLSKGQGEQ-NLVSWS-------RPFLKDQKKFVH----LVDP----LLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 155 ~p~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
.||......... ...... ............ ...+ ............++.+++.+||+.+|++||
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 287 (314)
T cd08216 208 VPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287 (314)
T ss_pred CCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence 999643211100 000000 000000000000 0000 011112345567899999999999999999
Q ss_pred CHHHHHH--HHHHhh
Q 024460 219 LINDIVV--ALDYLV 231 (267)
Q Consensus 219 t~~ev~~--~l~~l~ 231 (267)
|++++++ .++++.
T Consensus 288 t~~~ll~~p~~~~~~ 302 (314)
T cd08216 288 SASQLLNHSFFKQCK 302 (314)
T ss_pred CHHHHhcCchHhhhc
Confidence 9999998 444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=227.88 Aligned_cols=202 Identities=25% Similarity=0.307 Sum_probs=172.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++...|+||++|+.+.....+|+|||||..|++.+.++. .++++.+..+..++..-+.+|+|||... -+|||
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRD 154 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRD 154 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhh
Confidence 57788999999999999888999999999999999999987 6799999999999999999999999998 89999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||..|||++.+|..||+|||.+..+... ........|++.|+|||++..-.|..++||||||++..||.-|.+||..-
T Consensus 155 IKAGNILLNT~G~AKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 155 IKAGNILLNTDGIAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred cccccEEEcccchhhhhhccccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 9999999999999999999999764433 23345577999999999999999999999999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+.-. -.|.+ +-|..++.++-+++++||-++|++|-|+-++++
T Consensus 233 HPMRAIFMIPT~-------------PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 233 HPMRAIFMIPTK-------------PPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred cccceeEeccCC-------------CCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 443333222211 11222 236778899999999999999999999998876
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=236.13 Aligned_cols=211 Identities=23% Similarity=0.335 Sum_probs=152.1
Q ss_pred CCCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||+++++++... ...|++++++ +++|.+++. ...+++..+..++.|++.||.|||+++
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 138 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG-- 138 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36789999999999987543 3578999998 779988874 356899999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++|+||||+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++||||||+++|+|++|
T Consensus 139 -ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (343)
T cd07878 139 -IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212 (343)
T ss_pred -eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence 999999999999999999999999998753221 123457889999999876 5688999999999999999999
Q ss_pred CCCccccCccCccchh-hhc-h---hhhh----c-ccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 154 RKAMDLSKGQGEQNLV-SWS-R---PFLK----D-QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~-~~~-~---~~~~----~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
..||...........+ ... . .... . .......+...-... ........+.+++.+||..+|.+|||+
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~ 292 (343)
T cd07878 213 KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA 292 (343)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence 9999644321110000 000 0 0000 0 000000000000000 001123457899999999999999999
Q ss_pred HHHHH
Q 024460 221 NDIVV 225 (267)
Q Consensus 221 ~ev~~ 225 (267)
+|+++
T Consensus 293 ~ell~ 297 (343)
T cd07878 293 SEALA 297 (343)
T ss_pred HHHhc
Confidence 99996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=230.24 Aligned_cols=215 Identities=23% Similarity=0.297 Sum_probs=157.8
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++... +..|+|+||+++ +|.+++.. ....+++..+..++.|++.||+|||+++ ++|+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~ 130 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMET---MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHR 130 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 5678999999999998877 899999999974 99988865 2346899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+||.
T Consensus 131 dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 131 DLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred cCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999887543321 112223467889999988654 46889999999999999999999996
Q ss_pred ccCccCccchhh----------hchh--h-hhcccccccccCCcCCCCCcHH-HHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 159 LSKGQGEQNLVS----------WSRP--F-LKDQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 159 ~~~~~~~~~~~~----------~~~~--~-~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
..........+. |... . ..................++.. .+..+.++|++||+.+|++|||++|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 443322111100 0000 0 0000000011111111222222 467789999999999999999999998
Q ss_pred H
Q 024460 225 V 225 (267)
Q Consensus 225 ~ 225 (267)
+
T Consensus 289 ~ 289 (293)
T cd07843 289 K 289 (293)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=226.18 Aligned_cols=198 Identities=24% Similarity=0.247 Sum_probs=156.4
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~ 82 (267)
+.++||||+++++++..++..|+|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~ 124 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIK 124 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 356899999999999999999999999999999999954 356889999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 83 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 83 ~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
|+||+++.++.++++|||++..... .....++..|++||.+.+..++.++|+|++|+++|+|++|..||.....
T Consensus 125 p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 125 PENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred HHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999998874322 2233467789999999888889999999999999999999999964322
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
... .. .... . ...........++.++.+++.+||..+|++||++.++.+.+
T Consensus 199 ~~~---~~---~~~~--~------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 199 DAV---FD---NILS--R------RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHH---HH---HHHh--c------ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 110 00 0000 0 00011111224577899999999999999999776555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=227.18 Aligned_cols=201 Identities=27% Similarity=0.332 Sum_probs=159.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++|+||+++++.+..++..++++||+++++|.+++.. ....++...+..++.|++.++.+||+.+ ++|+|+
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl 142 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQ---NFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDI 142 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 5678999999999999999999999999999999999975 2247899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+||+++....... .......++..|++||.+.+..++.++|+|+||+++|+|++|..||....
T Consensus 143 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 143 KSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876432221 11222346778999999988889999999999999999999999986332
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... . .... .......+..++.++.++|.+||+.+|.+|||++++++
T Consensus 221 ~~~~~~--~-----------~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 221 PLRALF--L-----------ITTK--GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HHHHHH--H-----------HHhc--CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 211100 0 0000 00000112235678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=226.62 Aligned_cols=198 Identities=26% Similarity=0.305 Sum_probs=160.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++|+||+.+++|.+++.. ...+++..+..++.|++.++.|||+++ ++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl 126 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDI 126 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5788999999999999999999999999999999999954 357889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||.+....... ......++..|+|||.+....++.++|+|+||+++|+|++|..||....
T Consensus 127 ~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 127 KPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred CHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543221 2233557888999999988889999999999999999999999997444
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH--HHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI--NDIV 224 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~--~ev~ 224 (267)
......... .... .....+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 204 ~~~~~~~~~--------------~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 204 RTIRDQIRA--------------KQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccHHHHHHH--------------Hhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 321111100 0000 1112334556889999999999999999999 6655
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=224.92 Aligned_cols=201 Identities=25% Similarity=0.341 Sum_probs=161.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~d 80 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.++.+||+ .+ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~ 125 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRD 125 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCC
Confidence 5678899999999999999999999999999999999965 3678999999999999999999999 98 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|+|+||+++.++.++|+|||.+........ ......++..|+|||.+....++.++|+|+||+++|+|++|..||...
T Consensus 126 l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 126 IKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCHHHEEECCCCCEEEccCccceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999875432221 112344678899999998888999999999999999999999998644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHH-HHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR-CLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........... . .....+ ..+.. ++..+.+++++||..+|++||+++++++
T Consensus 204 ~~~~~~~~~~~---~-------~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 204 GQPSFFELMQA---I-------CDGPPP----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCHHHHHHH---H-------hcCCCC----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 32000000000 0 000001 11223 6778999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=227.91 Aligned_cols=196 Identities=24% Similarity=0.280 Sum_probs=156.9
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
..+||||+.+++.+..++..++||||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.+ ++|+||+|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp 125 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKP 125 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCH
Confidence 45799999999999999999999999999999998854 456899999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-cCCCcccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 84 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 84 ~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
+||+++.++.++++|||++....... .....++..|+|||.+. +..++.++|+||+|+++|+|++|..||.....
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred HHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 99999999999999999986432211 12235788999999886 45688999999999999999999999964432
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
.......... .......+..++.++.+++.+||..+|++|| +++++++
T Consensus 202 ~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 202 KDKHEIDRMT---------------LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCHHHHHHHh---------------hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1111000000 0011123445678899999999999999999 6999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=244.86 Aligned_cols=220 Identities=20% Similarity=0.208 Sum_probs=154.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++++++..++..|+|++++. ++|.+++..... .........+..++.|++.||.|||+++ ++|+
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHr 291 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHR 291 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 3678899999999999999999999999995 577777654211 1223445677889999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC-Ccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~-p~~ 158 (267)
||||+|||++.++.++|+|||++........ .......|+..|+|||++.+..++.++||||||+++|+|++|.. |+.
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999999999975432211 12223468999999999999999999999999999999999875 443
Q ss_pred ccCccCccchhhhchh-------hhhcccccccccCCc----CCCCC-----cHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 159 LSKGQGEQNLVSWSRP-------FLKDQKKFVHLVDPL----LHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~----~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
.........+...... +..........+... ..... ....+.++.+++.+||+.||++|||++|
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e 450 (501)
T PHA03210 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE 450 (501)
T ss_pred CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence 2221111111110000 000000000000000 00000 0123456888999999999999999999
Q ss_pred HHH
Q 024460 223 IVV 225 (267)
Q Consensus 223 v~~ 225 (267)
+++
T Consensus 451 lL~ 453 (501)
T PHA03210 451 LLA 453 (501)
T ss_pred Hhh
Confidence 986
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=231.45 Aligned_cols=227 Identities=21% Similarity=0.250 Sum_probs=160.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||++++++|..++..++|+||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDl 127 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNI 127 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 45689999999999999999999999999999999998763 2346888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-c----eeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-H----VSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~----~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
||+||+++.++.++++||+.+......... . ......++..|++||++.+. .++.++|+||+|+++|+|++|.
T Consensus 128 kp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred CHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999754321111100 0 01112235569999998763 4789999999999999999999
Q ss_pred CCccccCccCcc-chhh------hchhh--------------hhc---cccc-----ccccCCcCCCCCcHHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQ-NLVS------WSRPF--------------LKD---QKKF-----VHLVDPLLHGRYPRRCLNYAVAV 205 (267)
Q Consensus 155 ~p~~~~~~~~~~-~~~~------~~~~~--------------~~~---~~~~-----~~~~~~~~~~~~~~~~~~~l~~l 205 (267)
.||......... .... +.... ... .... ............+..++..+.++
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 287 (328)
T cd08226 208 VPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNL 287 (328)
T ss_pred CCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHH
Confidence 999643211100 0000 00000 000 0000 00111111222234567889999
Q ss_pred HHhhcccCCCCCCCHHHHHH--HHHHhhhc
Q 024460 206 TAMCLNEEANFRPLINDIVV--ALDYLVSQ 233 (267)
Q Consensus 206 i~~cl~~~p~~Rpt~~ev~~--~l~~l~~~ 233 (267)
+++||+.+|++|||++++++ .++.+...
T Consensus 288 i~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 288 VELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred HHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 99999999999999999987 45655554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=227.35 Aligned_cols=202 Identities=26% Similarity=0.349 Sum_probs=157.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~d 80 (267)
|++++||||+++++.+..++..++||||+++++|..++.... ....+++..+..++.|++.++.|||+ .+ ++|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 128 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRD 128 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCC
Confidence 567899999999999999999999999999999999886421 23478999999999999999999996 47 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC------CcccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|+|+||+++.++.++|+|||++...... ......++..|+|||.+.... ++.++|+||||+++|+|++|.
T Consensus 129 l~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 204 (286)
T cd06622 129 VKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204 (286)
T ss_pred CCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence 9999999999999999999998643211 122234677899999885543 478999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.||.......... ....... ......+..++.++.+++.+||..+|++||+++++++
T Consensus 205 ~pf~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 205 YPYPPETYANIFA-------------QLSAIVD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCcchhhHHH-------------HHHHHhh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 9996332111100 0000010 0111224457788999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=227.44 Aligned_cols=199 Identities=26% Similarity=0.355 Sum_probs=159.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+..++..|+|+||+++++|.+++.. ..+++..+..++.|++.++.|||+++ ++|+|+
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL 141 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccC
Confidence 5788999999999999999999999999999999999853 45788899999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++........ ......++..|++||.+....++.++|+||+|+++|++++|..||....
T Consensus 142 ~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 142 KSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred CHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999998764322211 1222357788999999988889999999999999999999999996443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... . -.+.+ ..+...+..+.+++.+||..+|.+||++++++.
T Consensus 220 ~~~~~~~~~~-------~------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 220 PLRALYLIAT-------N------GTPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred hhhheeehhc-------C------CCCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2111100000 0 00001 112345667999999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=236.66 Aligned_cols=141 Identities=27% Similarity=0.323 Sum_probs=123.8
Q ss_pred CccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 024460 9 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 88 (267)
Q Consensus 9 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili 88 (267)
|+|+++++|...++.|+|+|.+. .+|++++... .-.+++...+..++.||+.+|.+||+.+ |||+||||+|||+
T Consensus 249 n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL 322 (586)
T KOG0667|consen 249 NIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILL 322 (586)
T ss_pred eEEEeeeccccccceeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheee
Confidence 89999999999999999999995 5999999873 3446899999999999999999999999 9999999999999
Q ss_pred cCC--CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 89 DND--FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 89 ~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
.+. ..+||+|||.+++...... ....+..|+|||++.+.+|+.+.|+||||||++||++|.+.|.+.
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 643 4799999999986432222 344577899999999999999999999999999999999988654
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-33 Score=241.20 Aligned_cols=196 Identities=29% Similarity=0.406 Sum_probs=164.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+|||++.+.++|--+...|+||||| -|+-.|++.- ..+++-+..+..+..+.+.||+|||+++ .+|+|
T Consensus 79 FL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRD 151 (948)
T KOG0577|consen 79 FLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRD 151 (948)
T ss_pred HHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhh
Confidence 478999999999999999999999999999 4588888865 6789999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||..|||+++.|.|||+|||.+.... ......||+.|||||++.. +.|+.++||||||++..++.-..||+
T Consensus 152 iKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPl 225 (948)
T KOG0577|consen 152 IKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 225 (948)
T ss_pred ccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCc
Confidence 99999999999999999999987532 2334679999999999864 57999999999999999999999998
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..++..... .-+.+.-.|.+. ...++..|..++..||++-|.+|||.++++.
T Consensus 226 FnMNAMSAL-------------YHIAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 226 FNMNAMSAL-------------YHIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred cCchHHHHH-------------HHHHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 755533221 111122222222 3577889999999999999999999998765
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=256.91 Aligned_cols=219 Identities=32% Similarity=0.566 Sum_probs=167.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||++++++|.+++..|+||||+++|+|.++++ .+++..+..++.|++.|++|||.....+++|+|+
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 678899999999999999999999999999999999994 3778899999999999999999543334999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++..++. ++....... .....++..|+|||++.+..++.++||||+|+++|||++|..||+...
T Consensus 810 kp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 810 SPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 9999999988777764 544332111 112246788999999998899999999999999999999999985433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCC--CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
.. ......|.+.... .......+++..... .+.....++.+++.+||+.+|++|||++|++++|+++.+....
T Consensus 883 ~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~~ 957 (968)
T PLN00113 883 GV-HGSIVEWARYCYS-DCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSSS 957 (968)
T ss_pred CC-CCcHHHHHHHhcC-ccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccccc
Confidence 22 2233334332222 122233344444332 2345567789999999999999999999999999988765544
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=224.21 Aligned_cols=200 Identities=24% Similarity=0.300 Sum_probs=157.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++.+..+...++|+||+++++|.+++... ....+++..+..++.|++.++.|||+.+ ++|+|+
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl 127 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDI 127 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccC
Confidence 57889999999999999999999999999999999998652 2345789999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||++++++ .++++||+.+....... .......++..|+|||.+....++.++|+||||+++++|++|..||...
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 128 KSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred CHHHEEEcCCCCeEEecccccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99999998775 56999999887543221 1222345788899999988888999999999999999999999998633
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .. ....... ...+...+.++.+++.+|+..+|++|||++++++
T Consensus 206 ~~~~~------~~----------~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 206 NLHQL------VL----------KICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred cHHHH------HH----------HHhcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 21110 00 0000000 0112234567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=237.25 Aligned_cols=189 Identities=24% Similarity=0.300 Sum_probs=157.6
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
-+||||+++.+.+.++...|+|||.++++-+.+.+.. .......+..|+.+|+.|+.|||.++ ++|||+||+
T Consensus 373 ~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~ 444 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPG 444 (612)
T ss_pred cCCCcceeecceecCCceeeeeehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChh
Confidence 4799999999999999999999999999999888854 22333777789999999999999999 999999999
Q ss_pred cEEE-cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCcc
Q 024460 85 NILL-DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 163 (267)
Q Consensus 85 nili-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~ 163 (267)
|||+ ++.+.++|+|||.+...... .....-+..|.|||++....|++++|+||||+++|+||+|..||......
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 9999 58889999999998864332 22345578899999999999999999999999999999999999755432
Q ss_pred CccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.++.......++....+...++++.+||+.+|.+||++.++..
T Consensus 520 -------------------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 520 -------------------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------------------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1122222223334677888999999999999999999999985
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=224.43 Aligned_cols=194 Identities=27% Similarity=0.344 Sum_probs=153.8
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
.|||++++++++..+...++||||+++++|.++++. ..+++..++.++.|++.++.|||+.+ ++|+||+|+|
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~n 131 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAAN 131 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHH
Confidence 499999999999999999999999999999999854 36889999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
|+++.++.++++|||++....... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||.......
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 132 ILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred EEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 999999999999999987543322 11223457888999998764 457899999999999999999999996432211
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ......+.+. ...++.++.+++.+||+.+|++||++.+++.
T Consensus 210 ~~~~-------------~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 210 AMML-------------IPKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred hhhc-------------cccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1000 0000001110 1124667999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=221.95 Aligned_cols=202 Identities=27% Similarity=0.326 Sum_probs=163.1
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+++++||||+++++.+... ..+++++||+++++|.+++.. ...+++..++.++.|++.+++|||+.+ ++|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~ 125 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHR 125 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5788999999999999888 899999999999999999965 338899999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|++|+||+++.++.++|+|||.+................++..|.+||.+....++.++|+|+||+++|+|++|..||..
T Consensus 126 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred CCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998754333221123345678899999999888899999999999999999999999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ..............+...+..+.+++.+|+..+|++||++.++++
T Consensus 206 ~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 206 LGNPMA---------------ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCchHH---------------HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 431000 000011111112234455788999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=226.82 Aligned_cols=195 Identities=28% Similarity=0.365 Sum_probs=154.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++|+||+. +++.+++.. ....+++..+..++.|++.++.|||+.+ ++|+||
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl 141 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDI 141 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 577899999999999999999999999996 577777754 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++.++|+|||++...... ....++..|+|||++. ...++.++|+||||+++|+|++|.+||.
T Consensus 142 ~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 142 KAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999988643211 2234677899999874 3568889999999999999999999985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............ ........+..++..+.+++.+||..+|++||++++++.
T Consensus 216 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 216 NMNAMSALYHIA----------------QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CccHHHHHHHHh----------------cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 332111100000 000000112346678999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.3e-32 Score=225.26 Aligned_cols=212 Identities=20% Similarity=0.233 Sum_probs=153.7
Q ss_pred CCCC-CCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLL-HHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
++++ .||||+++++++.++ +..++||||++ ++|.+.+.. ....+++..+..++.|++.||.|||+.+ ++|
T Consensus 51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H 123 (282)
T cd07831 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFH 123 (282)
T ss_pred HhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 3455 499999999999887 88999999996 588888754 3357899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||+|+||+++. +.++|+|||++........ .....++..|+|||.+.. ..++.++|+||+|+++|+|++|.+||
T Consensus 124 ~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~ 199 (282)
T cd07831 124 RDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199 (282)
T ss_pred cccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC
Confidence 999999999999 9999999999875432211 122346788999997654 55788999999999999999999999
Q ss_pred cccCccCccchhh-hc---hh----hhhcccccccccCCcCCC----CCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVS-WS---RP----FLKDQKKFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~-~~---~~----~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............. .. .. ....... .....+.... .....++.++.++|.+||..+|++|||++++++
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 200 PGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH-MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCCHHHHHHHHHHHcCCCCHHHHHhhccccc-ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 6543221110000 00 00 0000000 0000000000 001245788999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=220.32 Aligned_cols=200 Identities=29% Similarity=0.384 Sum_probs=159.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++++||+++++|.+++.. ....+++..+..++.|++.++.+||..+ ++|+||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl 124 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS---TNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCC
Confidence 5678999999999999999999999999999999999865 2357899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||.+........ .....++..|++||.+....++.++|+|+||+++|+|++|..||....
T Consensus 125 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 125 KAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred CHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999875432221 233457888999999988888999999999999999999999986432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ . ....+.. ..+..++..+.+++.+||+.+|++|||++++++
T Consensus 202 ~~~~~~~~---------~----~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 202 PMKALFKI---------A----TNGPPGL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hHHHHHHH---------H----hcCCCCc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110000 0 0000000 011223677999999999999999999999984
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.5e-33 Score=237.64 Aligned_cols=195 Identities=28% Similarity=0.352 Sum_probs=167.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||+.|+|||||+++.+.+.+..+|+||||+.+|.+.+++.. +++..+..+...+.|++.|++|||+++ |+|+|
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrd 180 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRD 180 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccc
Confidence 47789999999999999999999999999999999999964 667777889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
||++|++++.+-++||+|||++.++. .....+...|++.|.|||++.+..| .+.+|+|++|+++|-+++|..||+.
T Consensus 181 Lk~eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 181 LKAENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred cchhhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999998654 3345667889999999999998776 5889999999999999999999985
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCC--CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... +-.+.+.++ ++.-.+.++.++|+++|-.+|..|++.+++.+
T Consensus 258 ~~lk~--------------------Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 258 QNLKE--------------------LRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ccccc--------------------ccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 54322 222222222 23444677999999999999999999999987
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=227.77 Aligned_cols=216 Identities=21% Similarity=0.246 Sum_probs=155.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+. ++|..++.. .....+++..+..++.|++.|++|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~--~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l 126 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDA--SPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDL 126 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 578899999999999999999999999995 589888865 23456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-CcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++++|||++........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...
T Consensus 127 ~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 127 KPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred CHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999875322211 112234577899999876644 588899999999999999999998643
Q ss_pred CccCcc-chhhhchh-------hhhcccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQ-NLVSWSRP-------FLKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~-~~~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ........ ................... .....+.++.++|.+||+.+|++|||++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 205 SEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 321110 00000000 0000000000000000000 01234567889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=227.50 Aligned_cols=215 Identities=24% Similarity=0.338 Sum_probs=157.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..++|+||+++++|.++... ...+++..+..++.|++.++.|||+.+ ++|+|+
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l 126 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDI 126 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999888877643 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 127 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 127 KPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999987543222 11222346788999998865 34778999999999999999999988643
Q ss_pred CccCcc-chhhhchhhh-------hcccccccccCCcCCCC-----CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQ-NLVSWSRPFL-------KDQKKFVHLVDPLLHGR-----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~-~~~~~~~~~~-------~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... .......... ...........+..... ....++..+.+++.+||..+|.+||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 321110 0000000000 00000000000000000 11245678999999999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=224.79 Aligned_cols=201 Identities=27% Similarity=0.349 Sum_probs=157.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+..++..|+++||+++++|.+++.. ...+++..+..++.|++.+|+|||+.+ ++|+||
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di 119 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDL 119 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCC
Confidence 5678999999999999999999999999999999999965 247899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCC------cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDN------THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||+++.++.++++|||++........ ........++..|++||......++.++|+|+||+++|++++|..
T Consensus 120 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred CHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999998875322211 011223446778999999988888999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHH--HHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR--CLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
||............ .... ...+.. .+..+.+++.+||+.+|++|||+.++.+.|
T Consensus 200 p~~~~~~~~~~~~~----------------~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 200 PFHGETPEEIFQNI----------------LNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CCCCCCHHHHHHHH----------------hcCC--cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 98644321110000 0000 001112 267789999999999999999995555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-32 Score=227.24 Aligned_cols=199 Identities=23% Similarity=0.305 Sum_probs=157.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+..++..+++|||+++++|.+++.. ..+++..+..++.|++.+++|||+.+ ++|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl 142 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDI 142 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999999999998743 45788999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||.+....... .......++..|++||.+....++.++|+||+|+++|+|++|..||....
T Consensus 143 ~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 143 KSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred CHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999876432211 11223456788999999888888999999999999999999999986322
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ..... ......+. ....++..+.+++.+||..+|.+||++.++++
T Consensus 221 ~~~~---~~~~~----------~~~~~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 221 PLKA---MKMIR----------DNLPPKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHH---HHHHH----------hhCCcccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 1111 00000 00111110 11234567899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=227.86 Aligned_cols=221 Identities=22% Similarity=0.265 Sum_probs=156.5
Q ss_pred CCCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
+|++++||||+++++++... ..+++||||+++ +|.+++...... ...+++..++.++.|++.|+.|||+.+ ++
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 130 (316)
T cd07842 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VL 130 (316)
T ss_pred HHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 35788999999999999888 789999999965 777776543222 237899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcC----CCceEEeccCCcccCCCCCC-cceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHH
Q 024460 78 YRDLKSANILLDN----DFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 78 h~di~~~nili~~----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l 151 (267)
|+||+|+||+++. ++.++++|||++........ ........++..|+|||++.+ ..++.++|+||||+++|+|+
T Consensus 131 h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999998 89999999999875432221 111223346788999998765 45789999999999999999
Q ss_pred hCCCCccccCccCccc-------hhhh----c------hhhhhcccccccccCCcCCCCCc---------H--HHHHHHH
Q 024460 152 TGRKAMDLSKGQGEQN-------LVSW----S------RPFLKDQKKFVHLVDPLLHGRYP---------R--RCLNYAV 203 (267)
Q Consensus 152 ~g~~p~~~~~~~~~~~-------~~~~----~------~~~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~l~ 203 (267)
+|.+||.......... .... . +.....................+ . .....+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 9999996544332100 0000 0 00000000000000000000011 1 3345789
Q ss_pred HHHHhhcccCCCCCCCHHHHHH
Q 024460 204 AVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 204 ~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+++.+||..+|++|||++|+++
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-32 Score=221.34 Aligned_cols=203 Identities=28% Similarity=0.380 Sum_probs=157.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|+||+++++++...+.+++|+||+++++|.+++.. ...+++..+..++.+++.++.|||+.+ ++|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl 125 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDI 125 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5788999999999999999999999999999999999864 345788899999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcce--eeecccccceeCCcccccCC---CcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHV--STRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+|+||+++.++.++|+|||++........... .....++..|++||.+.... ++.++|+|++|++++++++|..|
T Consensus 126 ~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred CHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 99999999999999999999875433222111 11245678899999988766 88999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|........ .... . .. ...+.+. ....++..+.+++.+||+.+|.+|||+++++.
T Consensus 206 f~~~~~~~~---~~~~--~---~~----~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 206 WSELDNEFQ---IMFH--V---GA----GHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccCCcchHH---HHHH--H---hc----CCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 963321100 0000 0 00 0000010 01133677899999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=238.88 Aligned_cols=203 Identities=25% Similarity=0.408 Sum_probs=173.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|-+|+|||++++||+..+ ...-+|||.++.|+|.+.++. .....+.....+.++.||+.|+.||..+. +||||+
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDL 238 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDL 238 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhh
Confidence 568999999999999876 678899999999999999987 45678889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCccee-eecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS-TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
..+|+++.....|||+|||+.+-+.......+. ....-...|+|||.+....|+.++|||++|+++|||++ |+.||..
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 999999999999999999999976554444332 22334668999999999999999999999999999998 6788864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
.. ..++.+.++..-+-..|..|++++.++++.||..+|.+|||+.+|.+.+
T Consensus 319 ~~-----------------g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 319 CR-----------------GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CC-----------------HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 44 3444455555555556889999999999999999999999999998654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=223.35 Aligned_cols=196 Identities=25% Similarity=0.285 Sum_probs=156.6
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
...||||+++.+.+..++..++||||+.+++|.+++.. .+.+++..+..++.|++.|+.|||+.+ ++|+||+|
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p 125 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKP 125 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCH
Confidence 45799999999999999999999999999999998854 457999999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 84 ANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 84 ~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
+||+++.++.++++|||++...... ......++..|+|||.+... .++.++|+||+|+++|+|++|..||.....
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999998643221 11234578899999998744 688999999999999999999999964322
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
......... ... ..-..+..++.++.+++.+||..+|.+|| +++++++
T Consensus 202 ~~~~~~~~~-----------~~~----~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 202 KDKHEIDRM-----------TLT----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cchHHHHHH-----------hhc----cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111100000 000 01112334567899999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=220.68 Aligned_cols=193 Identities=24% Similarity=0.306 Sum_probs=155.5
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++++.+..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.+||+.+ ++|+||+|+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 139 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLEN 139 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 699999999999999999999999999999999964 347899999999999999999999999 9999999999
Q ss_pred EEEcCCC-ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 86 ILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 86 ili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
|+++.++ .++++|||++...... ....++..|+|||++....++.++|+||+|+++|+|++|..||.......
T Consensus 140 il~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 140 VLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred EEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 9999888 9999999988753221 12346788999999988889999999999999999999999997333211
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-~~ev~~ 225 (267)
.....+.. .... ....+..++..+.+++.+||+.+|.+||+ ++++++
T Consensus 214 -~~~~~~~~-----------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 -LDLESLLK-----------RQQK--KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -hhHHHHHH-----------hhcc--cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00111100 0000 00112356778999999999999999996 698883
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=223.33 Aligned_cols=201 Identities=26% Similarity=0.330 Sum_probs=160.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++|+||+++++|.+++.........+++..++.++.|++.|+.|||+.+ ++|+|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l 132 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDL 132 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 56789999999999999999999999999999999988754445567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++. +.++++|||.+....... .......++..|++||......++.++|+|++|+++|+|++|..||....
T Consensus 133 ~~~nili~~-~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 133 KAKNIFLKN-NLLKIGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred ChhheEeec-CCEeecccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999975 569999999886542221 12223456788999999888888999999999999999999999985322
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... .. .......+ ..+..++.++.++|.+||..+|++||++.++++
T Consensus 210 ~~~~------~~-------~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 FLSV------VL-------RIVEGPTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHHH------HH-------HHHcCCCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1000 00 00000011 124566788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=225.07 Aligned_cols=205 Identities=26% Similarity=0.324 Sum_probs=153.4
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhccc-CCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeee
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIY 78 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h 78 (267)
|+++. ||||+++++++..++..+++|||+.. ++.++.... ......+++..+..++.|++.|++|||+. + ++|
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H 131 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIH 131 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eec
Confidence 34554 99999999999999999999999854 665544321 11346789999999999999999999974 7 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC---CCcccCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||+|+||+++.++.++|+|||++....... ......++..|+|||++... .++.++|+||+|+++|+|++|..
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 9999999999999999999999986432221 12223567889999998766 68899999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||..... ..... ........+.+....+..++.++.+++.+||..+|++|||+++|++
T Consensus 209 p~~~~~~-----~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 209 PYPKWNS-----VFDQL-------TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred Cchhcch-----HHHHH-------hhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9864320 00000 0000000111111122346778999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=224.89 Aligned_cols=200 Identities=27% Similarity=0.350 Sum_probs=155.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++|||++++++++..++..++||||+.+ +|.+.+.. ....+++..+..++.+++.++.|||+++ ++|+||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL 151 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDI 151 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5778999999999999999999999999964 77777754 3456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.++|+||+|+++|+|++|..||.
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 152 KAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999998764321 12235678899999874 3568899999999999999999999985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
.......... .............++..+.+++.+||+.+|.+||++.++++..-.+
T Consensus 226 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 226 NMNAMSALYH----------------IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CccHHHHHHH----------------HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 3221110000 0000000011234567799999999999999999999999854433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=236.55 Aligned_cols=223 Identities=19% Similarity=0.261 Sum_probs=156.8
Q ss_pred CCCCccceeeEEeeC-CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCC
Q 024460 6 HHDNLVTLIGYCTSG-DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKS 83 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di~~ 83 (267)
.|.++++++++|..+ +.+|+|||++ +++|.+++.. ...+++..+..++.|++.||.|||. .+ |+|+||||
T Consensus 189 ~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP 260 (467)
T PTZ00284 189 DRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKP 260 (467)
T ss_pred cCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCH
Confidence 456788999988764 5789999998 6788888854 4578999999999999999999997 48 99999999
Q ss_pred CcEEEcCCC----------------ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHH
Q 024460 84 ANILLDNDF----------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 84 ~nili~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 147 (267)
+|||++.++ .+||+|||.+.... .......++..|+|||++.+..++.++|||||||++
T Consensus 261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred HHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 999997654 49999999875321 112335678999999999999999999999999999
Q ss_pred HHHHhCCCCccccCccCccchhh---------hch--------hhhhcccccccccCC-----cCCCC-C-cHHHHHHHH
Q 024460 148 LELITGRKAMDLSKGQGEQNLVS---------WSR--------PFLKDQKKFVHLVDP-----LLHGR-Y-PRRCLNYAV 203 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~~~~~---------~~~--------~~~~~~~~~~~~~~~-----~~~~~-~-~~~~~~~l~ 203 (267)
|||++|.+||...........+. |.. .............++ ..... . .......+.
T Consensus 336 ~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (467)
T PTZ00284 336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC 415 (467)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence 99999999997544221111100 000 000000000000000 00000 0 001135678
Q ss_pred HHHHhhcccCCCCCCCHHHHHH--HHHHhhhccCCCCCcC
Q 024460 204 AVTAMCLNEEANFRPLINDIVV--ALDYLVSQRDSHPVSR 241 (267)
Q Consensus 204 ~li~~cl~~~p~~Rpt~~ev~~--~l~~l~~~~~~~~~~~ 241 (267)
+||.+||+.||++|||++|+++ .|..........|...
T Consensus 416 dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~~~~ 455 (467)
T PTZ00284 416 DLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQHPNYP 455 (467)
T ss_pred HHHHHhCCcChhhCCCHHHHhcCccccccCCccccCCCCC
Confidence 9999999999999999999997 5666655555555544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=223.85 Aligned_cols=195 Identities=28% Similarity=0.392 Sum_probs=153.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|||++++++++.++...|+||||+. ++|.+++.. ....+++..+..++.|++.++.|||+++ ++|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl 147 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDI 147 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 578899999999999999999999999995 578777754 3456888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.++|+||||+++|+|++|.+||.
T Consensus 148 ~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 148 KAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999998764211 12345678899999874 3568889999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............ ... .+ ......++..+.+++.+||+.+|.+||++++++.
T Consensus 222 ~~~~~~~~~~~~--------~~~-----~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 222 NMNAMSALYHIA--------QND-----SP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCChHHHHHHHH--------hcC-----CC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 433211110000 000 00 0112234566899999999999999999999995
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=223.07 Aligned_cols=214 Identities=22% Similarity=0.263 Sum_probs=158.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++|+||+++ +|.+++.. ....+++..+..++.|++.++.+||+++ ++|+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 124 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDL 124 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCc
Confidence 5678999999999999999999999999965 88888865 3367899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++++|||.+....... .......++..|++||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 125 ~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 125 KPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred CHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999887543222 112223467789999988776 7889999999999999999999998644
Q ss_pred CccCccchhh-h-chh---hhhc--------ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVS-W-SRP---FLKD--------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~-~-~~~---~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... . ... .... ............ ......++.++.++|.+||..+|.+||++++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 203 SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 3221110000 0 000 0000 000000000000 0112346788999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=217.68 Aligned_cols=198 Identities=29% Similarity=0.367 Sum_probs=160.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++|||++++++++..++..+++|||+++++|.+++.. ...+++..+..++.|++.++.+||+.+ ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 125 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDI 125 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5678999999999999999999999999999999999864 367899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||.+........ ......++..|++||......++.++|+|++|+++|+|++|..||....
T Consensus 126 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 126 KAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred CHHHEEECCCCCEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999875433221 1233457888999999888788999999999999999999999986332
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .. . . .......+...+..+.+++.+||..+|++|||+++++.
T Consensus 204 ~~~~~--~~----~-------~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 PMAAL--FR----I-------V----QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHH--HH----H-------h----ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11000 00 0 0 00111223445678999999999999999999999984
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=223.78 Aligned_cols=216 Identities=21% Similarity=0.221 Sum_probs=155.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..+++|||++ ++|.+++... ....+++..+..++.|++.+|.|||+++ ++|+||
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl 125 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDL 125 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCC
Confidence 567899999999999999999999999995 6899988652 1246899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...
T Consensus 126 ~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 126 KPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999865322211 11222457789999987654 5788999999999999999999998644
Q ss_pred CccCccc-hhhhchh-------hhhcccccccccCCc---CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQN-LVSWSRP-------FLKDQKKFVHLVDPL---LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~-~~~~~~~-------~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... +...... ............... ........++..+.+++.+||+.+|.+|||++|+++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 204 SEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 3221110 0000000 000000000000000 000011234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=217.25 Aligned_cols=182 Identities=24% Similarity=0.223 Sum_probs=148.2
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
..||||+++++++..++..+++|||+++++|.+++.. ...+++..+..++.|++.|+.|||+.+ ++|+||+|+
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~ 114 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPN 114 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH
Confidence 4699999999999999999999999999999999864 345889999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
||+++.++.++++|||.+...... .....++..|+|||......++.++|+||+|+++|+|++|..|+.......
T Consensus 115 Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~ 189 (237)
T cd05576 115 NILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189 (237)
T ss_pred HEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc
Confidence 999999999999999987643221 112334667999999888888999999999999999999998765321100
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.....-..+..++..+.+++.+||+.||++||++
T Consensus 190 ----------------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 190 ----------------------NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ----------------------ccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 0000011233456778999999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=223.09 Aligned_cols=215 Identities=22% Similarity=0.271 Sum_probs=152.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++|+||+++++++..++..|+||||+. ++|.+++.. ....+.+..+..++.|++.||.|||+.+ ++|+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 129 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDL 129 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 577899999999999999999999999995 677777644 3356778888999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 130 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 130 KPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999998875322211 1122345788999998865 45788999999999999999999999644
Q ss_pred CccCccchhhhch---h------hhhcccccc-cccCCcCCCCC-----cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSR---P------FLKDQKKFV-HLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~---~------~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+.. + ......... ........... ....+..+.+++.+|+..+|++|||++|++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 208 SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 3211100000000 0 000000000 00000000000 0011457889999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=223.45 Aligned_cols=196 Identities=28% Similarity=0.362 Sum_probs=153.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++|||++++.+++..++..++||||+. ++|.+.+.. ....+++..+..++.|++.++.|||+.+ ++|+||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl 141 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 141 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 678899999999999999999999999996 588777754 3456888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++.++++|||++..... .....++..|+|||.+. ...++.++|+||||+++|+|++|..||.
T Consensus 142 ~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 142 KAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999998864321 12234677899999874 3457889999999999999999999985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
........ . ...........+..++..+.++|.+||..+|++||+++++++.
T Consensus 216 ~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 216 NMNAMSAL--Y--------------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cccHHHHH--H--------------HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 32211000 0 0000000011123456779999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=224.52 Aligned_cols=217 Identities=25% Similarity=0.306 Sum_probs=151.9
Q ss_pred CCCCCCCCccceeeEEeeCC--------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD--------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~--------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+++++||||+++++++.... ..++||||+. ++|.+.+.. ....+++..++.++.|++.|++|||+++
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~- 139 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK- 139 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 57889999999999986543 4599999996 488887754 3457899999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHH
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~ 150 (267)
++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||+|+++|+|
T Consensus 140 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el 217 (310)
T cd07865 140 --ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217 (310)
T ss_pred --eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHH
Confidence 999999999999999999999999998754322211 111223457789999987654 478899999999999999
Q ss_pred HhCCCCccccCccCccchhhhch-----hhhhcccc---ccccc-CCc----CCCC-CcHHHHHHHHHHHHhhcccCCCC
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSR-----PFLKDQKK---FVHLV-DPL----LHGR-YPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~---~~~~~-~~~----~~~~-~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
++|.+||................ ........ ..... ... .... .+......+.++|.+||..+|.+
T Consensus 218 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~ 297 (310)
T cd07865 218 WTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297 (310)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhh
Confidence 99999986443221111100000 00000000 00000 000 0000 01112345789999999999999
Q ss_pred CCCHHHHHH
Q 024460 217 RPLINDIVV 225 (267)
Q Consensus 217 Rpt~~ev~~ 225 (267)
|||++++++
T Consensus 298 R~t~~e~l~ 306 (310)
T cd07865 298 RIDADTALN 306 (310)
T ss_pred ccCHHHHhc
Confidence 999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=222.47 Aligned_cols=217 Identities=22% Similarity=0.294 Sum_probs=156.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++ +|.+++.... ....+++..+..++.|++.|+.|||+.+ ++|+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl 126 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDL 126 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCC
Confidence 5678999999999999999999999999975 8888886522 2356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||++++++.++++|||++........ ......++..|++||.+.+ ..++.++|+|+||+++|+|++|.+||...
T Consensus 127 ~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 127 KPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred CHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999874322111 1122345778999998765 45788999999999999999999998644
Q ss_pred CccCccc-hhhhc-hh------hhhcccccccccCCc---CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQN-LVSWS-RP------FLKDQKKFVHLVDPL---LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~-~~~~~-~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ..... .+ ............... ....+...++..+.+++.+|++.+|.+||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 205 NNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 3221110 00000 00 000000000000000 000011234677899999999999999999999984
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=228.78 Aligned_cols=211 Identities=24% Similarity=0.307 Sum_probs=153.9
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+++++||||+++++++... ...|+||||+. ++|.+.+.. .++...+..++.|++.||.|||+++
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g--- 138 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG--- 138 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999988643 35799999995 588888743 2888899999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999999987532211 1222346788999999999999999999999999999999999
Q ss_pred CccccCccCccc-hhh-----------h----chhhhhccc-----ccccccC----CcCCCCCcHHHHHHHHHHHHhhc
Q 024460 156 AMDLSKGQGEQN-LVS-----------W----SRPFLKDQK-----KFVHLVD----PLLHGRYPRRCLNYAVAVTAMCL 210 (267)
Q Consensus 156 p~~~~~~~~~~~-~~~-----------~----~~~~~~~~~-----~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl 210 (267)
||.......... +.. . ......... ....... +......+...+..+.+++.+||
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 986443211100 000 0 000000000 0000000 00000112234667899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 024460 211 NEEANFRPLINDIVV 225 (267)
Q Consensus 211 ~~~p~~Rpt~~ev~~ 225 (267)
+.+|++|||++|+++
T Consensus 296 ~~dP~~R~t~~eiL~ 310 (353)
T cd07850 296 VIDPEKRISVDDALQ 310 (353)
T ss_pred CCChhhCcCHHHHhc
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=224.39 Aligned_cols=214 Identities=24% Similarity=0.282 Sum_probs=154.1
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++|+||+++++++... +.+++||||+.+ +|.+++.. ....+++..+..++.|++.+++|||+.+ ++|+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 132 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN---MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHR 132 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5788999999999998765 568999999964 88888865 2367899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.
T Consensus 133 dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875432211 1112234677999998865 567899999999999999999999996
Q ss_pred ccCccCccch-hhhch----hhhhccccc---ccc-cC----CcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNL-VSWSR----PFLKDQKKF---VHL-VD----PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~-~~~~~----~~~~~~~~~---~~~-~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... ..... ......... ... .. ...... ....+..+.++|.+||+.||++|||+++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 4432221110 00000 000000000 000 00 000000 0123667889999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=220.45 Aligned_cols=208 Identities=14% Similarity=0.146 Sum_probs=153.0
Q ss_pred CCCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 3 SLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+.+.|+||+++++.+.... ..++++|++. .++.+.+.. ....++..+..++.|++.|+.|||+.+ ++|
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 149 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4678999999998765543 4578888874 477776643 234567888999999999999999998 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g 153 (267)
|||||+||+++.++.++|+|||+++........ .......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999998754321111 112234589999999999999999999999999999999999
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
..||......... ........ ...+..... ....++.++.+++..|+..+|++||+++++++.|+
T Consensus 230 ~~P~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 230 KLPWKGFGHNGNL--IHAAKCDF-----IKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred CCCCCccccchHH--HHHhHHHH-----HHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999754321111 00000000 000000000 01234678999999999999999999999998763
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=216.82 Aligned_cols=200 Identities=25% Similarity=0.304 Sum_probs=156.6
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+++++||||+++++++.+. +.+++++||+++++|.+++.. .+.+++..+..++.|++.|+.|||+++ ++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~ 130 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHR 130 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 5788999999999998663 568899999999999999854 345888999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCC-cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++|+||||+++|++++|..||.
T Consensus 131 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred CCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999875422111 111122347788999999988889999999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ..+..........+......+.+++.+||. +|..||++.+++.
T Consensus 211 ~~~~~~~----------------~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 211 EYEAMAA----------------IFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ccCHHHH----------------HHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 3321110 011111111122355667889999999999 5799999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=222.42 Aligned_cols=218 Identities=20% Similarity=0.220 Sum_probs=152.6
Q ss_pred CCCC-CCCCccceeeEEeeCCe-----eEEEEecCCCCCHHHHhcccCCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQ-----RLLVYEYMPMGSLEDHLYDLEPD-QEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
++++ +||||+++++++...+. .|+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+++
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-- 130 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-- 130 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4556 46999999999877665 8999999975 888887653222 456899999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHh
Q 024460 75 PVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 75 ~i~h~di~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||+|+||+++. ++.++|+|||++......... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 131 -i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 131 -VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred -eeecCCChHHEEEecCCCeEEEeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 999999999999998 889999999988743222111 112245778999998765 457899999999999999999
Q ss_pred CCCCccccCccCccc-hhhhch-h---hhhccccccccc-CCcCC----CCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 153 GRKAMDLSKGQGEQN-LVSWSR-P---FLKDQKKFVHLV-DPLLH----GRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 153 g~~p~~~~~~~~~~~-~~~~~~-~---~~~~~~~~~~~~-~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
|.+||.......... +..... + ............ -+... ......++..+.++|.+||..+|.+||+++|
T Consensus 208 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~e 287 (295)
T cd07837 208 KQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKA 287 (295)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHH
Confidence 999986433221110 000000 0 000000000000 00000 0001235677899999999999999999999
Q ss_pred HHH
Q 024460 223 IVV 225 (267)
Q Consensus 223 v~~ 225 (267)
++.
T Consensus 288 il~ 290 (295)
T cd07837 288 ALT 290 (295)
T ss_pred Hhc
Confidence 984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=217.19 Aligned_cols=194 Identities=31% Similarity=0.375 Sum_probs=156.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++.+..++..+++|||+.+++|.+++.. ...+++..+..++.|++.++.+||+.+ ++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l 119 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDL 119 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5688999999999999999999999999999999999964 346889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||.+....... .......++..|++||...+...+.++|+|+||+++|++++|..||....
T Consensus 120 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 120 KPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999987543221 12333456788999999988888999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
... ... .... ....++...+..+.+++++||..+|++||++.+
T Consensus 198 ~~~---~~~-------------~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 198 RKE---IYE-------------KILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHH---HHH-------------HHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 200 000 0000 011223344677899999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=217.61 Aligned_cols=214 Identities=21% Similarity=0.256 Sum_probs=155.4
Q ss_pred CCCCCCCccceeeEEeeCCe-----eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 3 SLLHHDNLVTLIGYCTSGDQ-----RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
+.++||||+++++++...+. .+++|||+.+ +|.+++... ....+++..++.++.|++.||.+||+.+ ++
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~ 129 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHR---IV 129 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 45679999999999988776 9999999964 898888652 2246899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|+|++|+||+++.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|.+||
T Consensus 130 h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred eccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 999999999999999999999999875432211 11223577899999999889999999999999999999999998
Q ss_pred cccCccCccc-hhhhchh-h----hhcccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQN-LVSWSRP-F----LKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~-~~~~~~~-~----~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... +...... . .................. .....+..+.+++++||+.+|++||+++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 207 RGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 6443221110 0000000 0 000000000000000000 11234577899999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=220.60 Aligned_cols=216 Identities=25% Similarity=0.281 Sum_probs=156.9
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+++++|||++++++++... +..++|+||+++ +|.+++.. ....+++..++.++.|++.|+.+||+.+ ++|+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~ 124 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHR 124 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 5678999999999999888 899999999975 88888854 2357899999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||++++++.++++|||.+......... ......++..|+|||.+.+ ..++.++|+|+||+++|+|++|..||.
T Consensus 125 dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 125 DIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred cCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998754333211 1222345778999997765 467899999999999999999999986
Q ss_pred ccCccCccchh-hhch-hh---hhcccc--------cccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLV-SWSR-PF---LKDQKK--------FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~-~~~~-~~---~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+ .... .. ...... ........+...+...++..+.+++++||..+|.+||+++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 204 GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 44422111000 0000 00 000000 00000000101111123678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=224.80 Aligned_cols=196 Identities=29% Similarity=0.368 Sum_probs=163.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++++.|+||.+--.|++.+.+|+|+..|+||+|.-.|.+ ..+..+++..+.-++.+|+.+|.+||... ||+||
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn--~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRD 312 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYN--HGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRD 312 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeec--cCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeecc
Confidence 57788999999999999999999999999999999999977 34578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+||+|||+|+.|.++|.|+|++..+... .......||.+|||||++.+..|+...|.|+|||++|+|+.|+.||...
T Consensus 313 LKPeNILLDd~GhvRISDLGLAvei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 313 LKPENILLDDHGHVRISDLGLAVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CChhheeeccCCCeEeeccceEEecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 9999999999999999999999864333 2334447999999999999999999999999999999999999999744
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
+...+..-+ .+... ....+++...+++..++.+..|.+||++|.
T Consensus 390 KeKvk~eEv--drr~~------------~~~~ey~~kFS~eakslc~~LL~Kdp~~RL 433 (591)
T KOG0986|consen 390 KEKVKREEV--DRRTL------------EDPEEYSDKFSEEAKSLCEGLLTKDPEKRL 433 (591)
T ss_pred hhhhhHHHH--HHHHh------------cchhhcccccCHHHHHHHHHHHccCHHHhc
Confidence 432221000 00000 111235677789999999999999999985
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=221.58 Aligned_cols=216 Identities=22% Similarity=0.241 Sum_probs=153.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..+...++||||++ ++|.+++... ....+++..+..++.|++.||+|||+++ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl 128 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDL 128 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 678899999999999999999999999996 5888877541 2334678888999999999999999998 999999
Q ss_pred CCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 82 KSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
+|+||+++. ++.++++|||++....... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.+||..
T Consensus 129 ~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 129 KPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred CcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999985 5579999999987532211 11122345778999998765 4578999999999999999999999964
Q ss_pred cCccCccch-hhhc-hh---hhhcccccccc--cCCcCCCC----CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNL-VSWS-RP---FLKDQKKFVHL--VDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~-~~~~-~~---~~~~~~~~~~~--~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... .... .+ .+.....+... ..+..... .....+.++.+++.+|++.+|++||+++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 432211100 0000 00 00000000000 00000000 01234567899999999999999999999996
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=225.99 Aligned_cols=217 Identities=21% Similarity=0.292 Sum_probs=155.1
Q ss_pred CCCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
+|++++||||+++++++.. ...+++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+++ +
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 128 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---V 128 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 3678899999999998753 356899999995 589888854 455899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g 153 (267)
+|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.. ..++.++|+||||+++|+|++|
T Consensus 129 vH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g 208 (334)
T cd07855 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR 208 (334)
T ss_pred ecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence 99999999999999999999999998654322211 11123457888999998765 4688999999999999999999
Q ss_pred CCCccccCccCccchhhh--chhh--hh---cccccccccC---CcCCC---CCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 154 RKAMDLSKGQGEQNLVSW--SRPF--LK---DQKKFVHLVD---PLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~--~~~~--~~---~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.+||...........+.. ..+. .. .......... ..... ......+.++.++|++||+.+|.+|||+
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 288 (334)
T cd07855 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288 (334)
T ss_pred CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999964332111000000 0000 00 0000000000 00000 0012346789999999999999999999
Q ss_pred HHHHH
Q 024460 221 NDIVV 225 (267)
Q Consensus 221 ~ev~~ 225 (267)
+++++
T Consensus 289 ~~~l~ 293 (334)
T cd07855 289 EQALQ 293 (334)
T ss_pred HHHHh
Confidence 99987
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=212.53 Aligned_cols=196 Identities=30% Similarity=0.388 Sum_probs=155.5
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ni 86 (267)
.|+||+++|+|..+..+++.||.|.. -+..++++ -.+++++..+-++...++.||.||.++. +++|||+||+||
T Consensus 150 cpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNI 223 (391)
T KOG0983|consen 150 CPYIVQCFGYFITNTDVFICMELMST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNI 223 (391)
T ss_pred CCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccce
Confidence 59999999999999999999999843 55566654 4567999999999999999999998543 399999999999
Q ss_pred EEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC---CCcccCCeeehHHHHHHHHhCCCCccccCcc
Q 024460 87 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG---KLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 163 (267)
Q Consensus 87 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~ 163 (267)
|+++.|++|++|||.+... -.........|.+.|||||-+... +|+-++||||||+.++|+.+|+.||...+.+
T Consensus 224 LlDe~GniKlCDFGIsGrl---vdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td 300 (391)
T KOG0983|consen 224 LLDERGNIKLCDFGISGRL---VDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD 300 (391)
T ss_pred EEccCCCEEeeccccccee---ecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc
Confidence 9999999999999998743 233445667899999999988764 5788999999999999999999999865543
Q ss_pred CccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ..+.....|.+... ...++.+.+++..||++|+.+||.+.++++
T Consensus 301 Fe~l------------tkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 301 FEVL------------TKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred HHHH------------HHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2210 00001111222222 126788999999999999999999999997
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=218.05 Aligned_cols=214 Identities=26% Similarity=0.286 Sum_probs=155.6
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++ ||||+++++++..++..++||||+ +++|.+++... ....+++..+..++.|++.++.|||+++ ++|+|
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~d 124 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRD 124 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 45677 999999999999999999999999 77999888652 2357899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-cCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||.+........ .....++..|+|||++. ...++.++|+||||+++++|++|.+||..
T Consensus 125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 125 LKPENLLVSGPEVVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred CChhhEEEcCCCCEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 999999999999999999999875432211 12234677899999875 45678999999999999999999999864
Q ss_pred cCccCccch-hhhchh----hhhcccccccccCCc--------CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNL-VSWSRP----FLKDQKKFVHLVDPL--------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ...... ............... .....+ ..+.++.+++++||+.+|++|||++|++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 202 SSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 432211100 000000 000000000000000 000011 12567999999999999999999999974
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=219.91 Aligned_cols=205 Identities=28% Similarity=0.337 Sum_probs=158.3
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+++ +||||+++.+.+..+...++||||+.+++|.+++.. ...+++..+..++.|++.+|.|||+.+ ++|+|
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~d 130 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRD 130 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 4566 599999999999999999999999999999999854 356888999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC--CcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|+|+||+++.++.++++|||++......... ......++..|++||.+.+.. .+.++|+|+||+++|+|++|..||.
T Consensus 131 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 131 IKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CCHHHeEECCCCCEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 9999999999999999999998754322211 122234688899999887654 7889999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
........ ......... . ....+..++..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 210 ~~~~~~~~--~~~~~~~~~-------~-----~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 210 VDGEQNSQ--SEISRRILK-------S-----KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred cCcccchH--HHHHHHHHc-------c-----CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 33211110 000000000 0 01123345677899999999999999999888877654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=224.11 Aligned_cols=219 Identities=25% Similarity=0.310 Sum_probs=156.0
Q ss_pred CCCC-CCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLL-HHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
++++ +||||+++++++... ...++||||++ ++|..++.. ..+.+..+..++.|++.+|.|||+.+ ++|
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H 130 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIH 130 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 4577 999999999998653 36899999996 599988854 37788888999999999999999998 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCc---ceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT---HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.. ..++.++|+||||+++|+|++|.
T Consensus 131 ~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~ 210 (337)
T cd07852 131 RDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210 (337)
T ss_pred CCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence 999999999999999999999998754332211 12223456888999998765 45788999999999999999999
Q ss_pred CCccccCccCccch-hhhchh-h------h--hcccccccccC----CcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 155 KAMDLSKGQGEQNL-VSWSRP-F------L--KDQKKFVHLVD----PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 155 ~p~~~~~~~~~~~~-~~~~~~-~------~--~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.||........... ...... . . ........... ..... ....++.++.++|.+||+.+|++|||+
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDE-LLPKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhh-hccCCCHHHHHHHHHhccCCcccccCH
Confidence 99864332211100 000000 0 0 00000000000 00000 011256789999999999999999999
Q ss_pred HHHHHH--HHHh
Q 024460 221 NDIVVA--LDYL 230 (267)
Q Consensus 221 ~ev~~~--l~~l 230 (267)
.++++. ++.+
T Consensus 290 ~~il~~~~~~~~ 301 (337)
T cd07852 290 EEALEHPYVAQF 301 (337)
T ss_pred HHHhhChhhhhh
Confidence 999973 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=217.47 Aligned_cols=198 Identities=27% Similarity=0.322 Sum_probs=166.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+..+||++..+.-.|..++++|+||||..||.|.-.+.+ ...+++.....+...|+.||.|||+++ |++||
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRD 293 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRD 293 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeee
Confidence 46788999999999999999999999999999999988854 567889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|.+|++++.+|.+||+|||++.. ............|++.|+|||++....|..+.|.|.+|+++|||+||..||-..
T Consensus 294 lKLENLlLDkDGHIKitDFGLCKE--~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 294 LKLENLLLDKDGHIKITDFGLCKE--EIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred chhhhheeccCCceEeeecccchh--cccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 999999999999999999999986 333334566789999999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........+-. . .-++|...+++...++...|.++|++|. .++||..
T Consensus 372 dh~kLFeLIl~----------------e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 372 DHEKLFELILM----------------E--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred chhHHHHHHHh----------------h--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 32221111110 0 1135777888999999999999999994 4555554
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=217.94 Aligned_cols=214 Identities=26% Similarity=0.296 Sum_probs=157.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++...+..++|+||++ ++|.+++.. ....+++..+..++.|++.+|.+||+++ ++|+||
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l 124 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDK---RPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDL 124 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999999999999999997 599999965 2257899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ ......++..|+|||.+... .++.++|+|+||+++|+|++|.+||...
T Consensus 125 ~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 125 KPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999875432211 11223346779999988766 7889999999999999999999998654
Q ss_pred CccCccc-hhhhch----hhhhccccc---ccccCCc----CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQN-LVSWSR----PFLKDQKKF---VHLVDPL----LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~-~~~~~~----~~~~~~~~~---~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... +..... ......... ....... ..... ...+..+.+++++||..+|++||++++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 3221110 000000 000000000 0000000 00011 122667999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=220.15 Aligned_cols=199 Identities=26% Similarity=0.348 Sum_probs=159.2
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++ ||||+++++++..++..++|||++++++|.+++.. ...+++..++.++.|++.++.+||+.+ ++|+|
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~d 127 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRD 127 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 45677 99999999999999999999999999999999965 347999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc------------------ceeeecccccceeCCcccccCCCcccCCeee
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT------------------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYS 142 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s 142 (267)
|+|+||+++.++.++++|||++......... .......++..|++||......++.++|+|+
T Consensus 128 l~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 207 (280)
T cd05581 128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207 (280)
T ss_pred CCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHH
Confidence 9999999999999999999998754332211 1122234678899999988888999999999
Q ss_pred hHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH--
Q 024460 143 FGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-- 220 (267)
Q Consensus 143 lG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-- 220 (267)
||++++++++|..||......... .... ......+...+..+.+++++||+.+|++||++
T Consensus 208 lG~~l~~l~~g~~p~~~~~~~~~~----------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 208 LGCIIYQMLTGKPPFRGSNEYLTF----------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred HHHHHHHHHhCCCCCCCccHHHHH----------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999999999999999744311000 0000 01112234446779999999999999999999
Q ss_pred --HHHHH
Q 024460 221 --NDIVV 225 (267)
Q Consensus 221 --~ev~~ 225 (267)
+++++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 77763
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=224.59 Aligned_cols=218 Identities=23% Similarity=0.305 Sum_probs=157.2
Q ss_pred CCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|+.++||||+++++++... ...|+++||+. ++|.+++.. ...+++..+..++.|++.|+.|||+++ +
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 129 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---V 129 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5678999999999988654 35899999995 689888854 467999999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.. ..++.++|+||||+++|+|++|.+
T Consensus 130 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred ecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999987543221 11223346788999998765 468899999999999999999999
Q ss_pred CccccCccCccchhh-hchh-h---h--hcccccc---ccc----CCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 156 AMDLSKGQGEQNLVS-WSRP-F---L--KDQKKFV---HLV----DPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 156 p~~~~~~~~~~~~~~-~~~~-~---~--~~~~~~~---~~~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
||............. .... . . ....... ..+ .+.... ....++.++.+++++||+.+|++|||++
T Consensus 208 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 208 LFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred CCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 996543211110000 0000 0 0 0000000 000 000000 1124567789999999999999999999
Q ss_pred HHHHH--HHHh
Q 024460 222 DIVVA--LDYL 230 (267)
Q Consensus 222 ev~~~--l~~l 230 (267)
++++- ++.+
T Consensus 287 ell~h~~~~~~ 297 (337)
T cd07858 287 EALAHPYLASL 297 (337)
T ss_pred HHHcCcchhhh
Confidence 99974 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=223.73 Aligned_cols=226 Identities=25% Similarity=0.293 Sum_probs=163.7
Q ss_pred CCCCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++.+++...+ ..|++|||+. ++|.+++.. ...+++..+..++.+++.||.+||+.+ +
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i 124 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---V 124 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 57789999999999987765 7899999997 488888854 347899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
+|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.
T Consensus 125 ~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~ 204 (330)
T cd07834 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204 (330)
T ss_pred ecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999998764332210 112234567889999999887 8899999999999999999999
Q ss_pred CCccccCccCccchhhh-chh----hh--hcccccccccC---CcC---CCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLVSW-SRP----FL--KDQKKFVHLVD---PLL---HGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~-~~~----~~--~~~~~~~~~~~---~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+||...........+.. ... .. .........+. ... ........+.++.+++.+||+.+|.+|||++
T Consensus 205 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 284 (330)
T cd07834 205 PLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284 (330)
T ss_pred CCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 99965443211100000 000 00 00000000000 000 0001123467799999999999999999999
Q ss_pred HHHH--HHHHhhhccC
Q 024460 222 DIVV--ALDYLVSQRD 235 (267)
Q Consensus 222 ev~~--~l~~l~~~~~ 235 (267)
++++ .|+.++....
T Consensus 285 ~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 285 EALAHPYLAQLHDPED 300 (330)
T ss_pred HHHhCccHHhhccccc
Confidence 9998 4666655433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=223.94 Aligned_cols=216 Identities=22% Similarity=0.236 Sum_probs=156.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++..++..++||||+. ++|.+++.. ...+++..+..++.|++.|+.+||+.+ ++|+||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl 145 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDL 145 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 578899999999999999999999999996 589988854 456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCC------------cceeeecccccceeCCcccccC-CCcccCCeeehHHHHH
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDN------------THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLL 148 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~ 148 (267)
+|+||+++.++.++++|||++........ ........++..|+|||.+.+. .++.++|+||||+++|
T Consensus 146 ~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 225 (335)
T PTZ00024 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225 (335)
T ss_pred cHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999875431110 0111122357789999988754 4688999999999999
Q ss_pred HHHhCCCCccccCccCccc-hhhhchhh----hhcccccc--cccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 149 ELITGRKAMDLSKGQGEQN-LVSWSRPF----LKDQKKFV--HLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
+|++|.+||.......... +....... +....... .......... ....++..+.+++.+||+.+|++||
T Consensus 226 el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 305 (335)
T PTZ00024 226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305 (335)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence 9999999996444321110 00000000 00000000 0000000000 0123356789999999999999999
Q ss_pred CHHHHHH
Q 024460 219 LINDIVV 225 (267)
Q Consensus 219 t~~ev~~ 225 (267)
|++|++.
T Consensus 306 s~~~~l~ 312 (335)
T PTZ00024 306 SAKEALK 312 (335)
T ss_pred CHHHHhc
Confidence 9999995
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=218.27 Aligned_cols=197 Identities=27% Similarity=0.405 Sum_probs=150.3
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSA 84 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di~~~ 84 (267)
.||||+++++++..+...|++|||+. ++|.+++.. ....+++..+..++.|++.+++|||+ .+ ++|+||+|+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~ 144 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPS 144 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHH
Confidence 59999999999999999999999985 477777754 34578889999999999999999997 47 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC----CcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+++.++.++|+|||++....... ......++..|+|||.+.... ++.++|+||||+++|+|++|..||...
T Consensus 145 nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 145 NILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HEEEcCCCCEEECccccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999986432211 122234677899999887553 788999999999999999999998642
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
..... ... ...... .+.. .....++.++.+++.+||..+|++||+++++++.
T Consensus 222 ~~~~~--~~~---~~~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 222 KTEFE--VLT---KILQEE-------PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hhHHH--HHH---HHhcCC-------CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 21100 000 000000 0000 0111356779999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=217.45 Aligned_cols=215 Identities=26% Similarity=0.277 Sum_probs=153.4
Q ss_pred CCCCCCCCccceeeEEeeCC----------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 024460 2 LSLLHHDNLVTLIGYCTSGD----------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 71 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~----------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 71 (267)
+++++||||+++++++.+.. .+++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+.
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 135 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK 135 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999887654 78999999975 77777754 345789999999999999999999999
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHH
Q 024460 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 72 ~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~ 150 (267)
+ ++|+||+|+||++++++.++|+|||++......... ......++..|++||.+.. ..++.++|+|+||+++|+|
T Consensus 136 ~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 136 N---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred C---eecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 9 999999999999999999999999998754322211 1111234667999998764 3578899999999999999
Q ss_pred HhCCCCccccCccCccchhhhc--hhhhhcccccc-----------cccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCC
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWS--RPFLKDQKKFV-----------HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 217 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 217 (267)
++|.+||...........+... .+......... .......... ...++..+.+++.+||..+|.+|
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R 290 (302)
T cd07864 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKR 290 (302)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhC
Confidence 9999999644322211111100 00000000000 0000000000 11236779999999999999999
Q ss_pred CCHHHHHH
Q 024460 218 PLINDIVV 225 (267)
Q Consensus 218 pt~~ev~~ 225 (267)
||++++++
T Consensus 291 p~~~~il~ 298 (302)
T cd07864 291 CTAEEALN 298 (302)
T ss_pred CCHHHHhc
Confidence 99999984
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=215.98 Aligned_cols=202 Identities=28% Similarity=0.347 Sum_probs=155.1
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+++ +|+||+++++.+..++..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~d 130 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRD 130 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4566 589999999999999999999999999999999864 456888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|+|+||+++.++.++|+|||++........ .......++..|++||.+... .++.++|+|+||+++|+|++|..||.
T Consensus 131 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CCHHHeEECCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999999875322211 111234467889999988653 46789999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........ ......... . ...++..++..+.+++++||..+|++|| +++++++
T Consensus 210 ~~~~~~~~--~~~~~~~~~--------~----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 210 VDGEKNSQ--AEISRRILK--------S----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCccccH--HHHHHHhhc--------c----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 43221110 000000000 0 0112344567789999999999999997 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=222.12 Aligned_cols=216 Identities=21% Similarity=0.294 Sum_probs=152.5
Q ss_pred CCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++++++... ...|+++||+. ++|.+.+. ...+++..+..++.|++.||.+||+.+ +
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~---i 127 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSAN---V 127 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5788999999999987544 35799999996 48888774 357899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
+|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus 128 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~ 207 (336)
T cd07849 128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207 (336)
T ss_pred eccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999998754222111 11122456888999998654 56889999999999999999999
Q ss_pred CCccccCccCccc-hhhhchh-hhh--------cccccccccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQN-LVSWSRP-FLK--------DQKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~-~~~~~~~-~~~--------~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+||.......... +...... ... ................. ....+.++.+++.+||+.+|++|||+.
T Consensus 208 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 287 (336)
T cd07849 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVE 287 (336)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHH
Confidence 9996443211100 0000000 000 00000000000000000 012356789999999999999999999
Q ss_pred HHHHH
Q 024460 222 DIVVA 226 (267)
Q Consensus 222 ev~~~ 226 (267)
++++.
T Consensus 288 e~l~h 292 (336)
T cd07849 288 EALAH 292 (336)
T ss_pred HHhcC
Confidence 99974
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=225.61 Aligned_cols=154 Identities=31% Similarity=0.359 Sum_probs=133.1
Q ss_pred CCCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
||++|+|||||+++++=++.. ...+|||||.+|+|...++..+ +..++++..++.++..++.|+.|||+++
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~-- 140 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENG-- 140 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 588999999999998855433 4689999999999999998744 5568999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEc----CCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHH
Q 024460 75 PVIYRDLKSANILLD----NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 75 ~i~h~di~~~nili~----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~ 149 (267)
|+||||||.||++. +.-..||+|||.++.+... .......||+.|++||++.. +.|+...|.||||+++|+
T Consensus 141 -IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 141 -IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred -ceeccCCCCcEEEeecCCCceEEeeecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHH
Confidence 99999999999994 2335799999999965433 35666889999999999984 899999999999999999
Q ss_pred HHhCCCCccccC
Q 024460 150 LITGRKAMDLSK 161 (267)
Q Consensus 150 ~l~g~~p~~~~~ 161 (267)
+.||..||....
T Consensus 217 caTG~lPF~p~~ 228 (732)
T KOG4250|consen 217 CATGELPFIPFG 228 (732)
T ss_pred HhccCCCCCcCC
Confidence 999999995443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-30 Score=232.63 Aligned_cols=209 Identities=25% Similarity=0.387 Sum_probs=169.3
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC---C-------CC--CCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE---P-------DQ--EPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---~-------~~--~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
-+||||+.+.++|..++.+++|+||+..|+|..+++..+ . .. ..+.....+.++.||+.++.||++..
T Consensus 359 g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~ 438 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP 438 (609)
T ss_pred cCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC
Confidence 369999999999999999999999999999999998754 0 01 23888999999999999999999998
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeec-ccccceeCCcccccCCCcccCCeeehHHHHHHHH
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV-MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l 151 (267)
++|||+..+|||+..+..+|++|||+++.............. .-...|+|||.+....|+.++||||+|+++|||+
T Consensus 439 ---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 439 ---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred ---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 999999999999999999999999999864443333222111 1355699999999999999999999999999998
Q ss_pred h-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 152 T-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
+ |..||..... ...+.+.+.+..+-..|..|+.++.++|+.||+.+|++||++.++.+.|...
T Consensus 516 sLG~~PYp~~~~----------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 516 TLGGTPYPGIPP----------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hCCCCCCCCCCc----------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 8 7788863110 1111223334444455778899999999999999999999999999999875
Q ss_pred hh
Q 024460 231 VS 232 (267)
Q Consensus 231 ~~ 232 (267)
.+
T Consensus 580 l~ 581 (609)
T KOG0200|consen 580 LQ 581 (609)
T ss_pred HH
Confidence 33
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=216.11 Aligned_cols=217 Identities=24% Similarity=0.273 Sum_probs=151.5
Q ss_pred CCCCCCCCccceeeEEeeC--------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|++++||||+++++++... ..+++|+||+.+ +|...+.. ....+++..+..++.|++.||.|||+++
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~- 135 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH- 135 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5788999999999887443 347999999964 77777754 3457999999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcce---------eeecccccceeCCccccc-CCCcccCCeeeh
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---------STRVMGTYGYCAPEYAMS-GKLTLKSDIYSF 143 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~sl 143 (267)
++|+||+|+||+++.++.++++|||++........... .....++..|+|||.+.+ ..++.++|+|||
T Consensus 136 --i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 213 (311)
T cd07866 136 --ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213 (311)
T ss_pred --eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHH
Confidence 99999999999999999999999999875432211111 111235678999998765 457899999999
Q ss_pred HHHHHHHHhCCCCccccCccCccchh-hhchh----hhhcccccccccCCcCCCCCc-------HHHHHHHHHHHHhhcc
Q 024460 144 GVVLLELITGRKAMDLSKGQGEQNLV-SWSRP----FLKDQKKFVHLVDPLLHGRYP-------RRCLNYAVAVTAMCLN 211 (267)
Q Consensus 144 G~i~~~~l~g~~p~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~cl~ 211 (267)
|+++|+|++|.+||...........+ ..... ....................+ ......+.+++.+||.
T Consensus 214 G~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 293 (311)
T cd07866 214 GCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293 (311)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcc
Confidence 99999999999998654432211110 00000 000000000000000000000 1223678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.+|++|||+.+++.
T Consensus 294 ~~p~~R~t~~ell~ 307 (311)
T cd07866 294 LDPYKRLTASDALE 307 (311)
T ss_pred cCcccCcCHHHHhc
Confidence 99999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=225.90 Aligned_cols=199 Identities=28% Similarity=0.308 Sum_probs=167.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||...+.|+||++|..|.++.++|++||-|-||.|+..+++ .+.+.......++..+++|+.|||.++ |++||
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRD 545 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRD 545 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceecc
Confidence 35566789999999999999999999999999999999975 678888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+||+|.+++.+|-+||.|||++..+.... ..-+..||+.|.|||++.+..-+.++|.|+||+++||+++|.+||...
T Consensus 546 LKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 546 LKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred CChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999998654333 344578999999999999999999999999999999999999999866
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
++......+-..... -.+|........++|++....+|.+|.- +.+|.+
T Consensus 623 dpmktYn~ILkGid~----------------i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 623 DPMKTYNLILKGIDK----------------IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred chHHHHHHHHhhhhh----------------hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 654443222211111 1246677778899999999999999965 555544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=218.45 Aligned_cols=211 Identities=23% Similarity=0.336 Sum_probs=152.9
Q ss_pred CCCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++.++|.. +...++++||+ +++|..++. ...++...+..++.|++.||.|||+.+ ++|+
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~ 132 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHR 132 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 3678899999999998865 56789999999 568988884 346788888999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++++|||.+...... .....++..|++||.+.+ ..++.++|+|+||+++|+|++|.+||.
T Consensus 133 dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 133 DLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred CCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998743211 122345778999998765 568899999999999999999999996
Q ss_pred ccCccCccchh-hhchh-------hhhcccccccccCC-cCCCCCc-----HHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 159 LSKGQGEQNLV-SWSRP-------FLKDQKKFVHLVDP-LLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 159 ~~~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
........... ..... ...... ....... ......+ ..++..+.++|++||+.+|++|||+++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 208 GKDHVNQFSIITDLLGTPPDDVINTICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 54322111000 00000 000000 0000000 0000111 12457899999999999999999999998
Q ss_pred HH
Q 024460 225 VA 226 (267)
Q Consensus 225 ~~ 226 (267)
..
T Consensus 287 ~~ 288 (328)
T cd07856 287 AH 288 (328)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-30 Score=205.30 Aligned_cols=204 Identities=22% Similarity=0.323 Sum_probs=157.0
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
-|+||+.++++|+++..+|+|||.+.||+|...+.. ++.+.+..+..+.+.|+.||.|||++| |.|||+||+|
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPEN 206 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPEN 206 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccc
Confidence 499999999999999999999999999999999964 778999999999999999999999999 9999999999
Q ss_pred EEEcCCCc---eEEeccCCcccCCCCCCc-----ceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHh
Q 024460 86 ILLDNDFN---PKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 86 ili~~~~~---~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~ 152 (267)
||-...+. +||+||++..-....... ..-..+.|...|||||+..- ..|+.+.|+||||+++|-||+
T Consensus 207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 99965543 799999986532111111 11234668889999997743 368899999999999999999
Q ss_pred CCCCccccCccCc----cchhhhchhhhhcccccccccCCcCCC--CCcH----HHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 153 GRKAMDLSKGQGE----QNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPR----RCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 153 g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
|.+||...-+..- -.........+. ..+..+ .+|. .++.+..+++...|..++.+|.++.+
T Consensus 287 GYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF---------esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~ 357 (463)
T KOG0607|consen 287 GYPPFVGHCGADCGWDRGEVCRVCQNKLF---------ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQ 357 (463)
T ss_pred CCCCccCccCCcCCccCCCccHHHHHHHH---------HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhh
Confidence 9999976654321 111111111111 111111 1333 34667899999999999999999999
Q ss_pred HHH
Q 024460 223 IVV 225 (267)
Q Consensus 223 v~~ 225 (267)
+++
T Consensus 358 vln 360 (463)
T KOG0607|consen 358 VLN 360 (463)
T ss_pred ccC
Confidence 886
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=222.40 Aligned_cols=210 Identities=23% Similarity=0.327 Sum_probs=153.3
Q ss_pred CCCCCCCCccceeeEEeeCCe------eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQ------RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+++++||||+++.+++..++. .++|+||+ +++|.+++.. ..+++..+..++.|++.++.|||+.+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g--- 138 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG--- 138 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 578899999999998866554 89999999 6699998843 57899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.. ..++.++|+||||+++|+|++|.
T Consensus 139 i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998754221 122346778999998765 46789999999999999999999
Q ss_pred CCccccCccCccch-hhhch---hhh-h-----cccccccccCCcCCCCCc---HHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNL-VSWSR---PFL-K-----DQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~-~~~~~---~~~-~-----~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
.||........... ..... ... . ........+....+..+. ..++..+.+++.+||+.+|++|||++
T Consensus 214 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 99964432211100 00000 000 0 000000000011111111 12367899999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
+|++
T Consensus 294 ell~ 297 (343)
T cd07851 294 EALA 297 (343)
T ss_pred HHhc
Confidence 9985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-30 Score=216.64 Aligned_cols=221 Identities=21% Similarity=0.242 Sum_probs=153.2
Q ss_pred CCCC-CCCCccceeeEEeeC----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLL-HHDNLVTLIGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
++++ +||||+++++.+... ..+++++|++. ++|.+++.. ...+++..+..++.|++.||.|||+++ +
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---i 126 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---V 126 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 3455 599999999875432 45789999985 689888853 567899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g 153 (267)
+|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus 127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred ccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999998754322111 11122457888999998765 4688999999999999999999
Q ss_pred CCCccccCccCccch-hhhc--------hhhhhc-ccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 154 RKAMDLSKGQGEQNL-VSWS--------RPFLKD-QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~-~~~~--------~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.+||........... .... ...... ............... ....++..+.+++.+||+.+|++|||+
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 286 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 999864432110000 0000 000000 000000000000000 011235679999999999999999999
Q ss_pred HHHHH--HHHHh
Q 024460 221 NDIVV--ALDYL 230 (267)
Q Consensus 221 ~ev~~--~l~~l 230 (267)
+++++ .++.+
T Consensus 287 ~~ll~~~~~~~~ 298 (332)
T cd07857 287 EEALEHPYLAIW 298 (332)
T ss_pred HHHhcChhhhhh
Confidence 99986 34444
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=217.90 Aligned_cols=218 Identities=24% Similarity=0.364 Sum_probs=154.2
Q ss_pred CCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|++++||||+++++++.... .+++|+||+.. +|...+ +..+++..+..++.|++.|++|||+++
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~--- 137 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG--- 137 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999986542 46999999954 776655 246888999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998743211 112345778999998865 46889999999999999999999
Q ss_pred CCccccCccCccchhhhch----h-hhh--cc---cccccccCCcCCCCCc---HHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLVSWSR----P-FLK--DQ---KKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~----~-~~~--~~---~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
.||................ + ... .. ...........+.... ...+..+.+++.+||+.+|++||+++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9997543211110000000 0 000 00 0000000000000000 12346688999999999999999999
Q ss_pred HHHH--HHHHhhhcc
Q 024460 222 DIVV--ALDYLVSQR 234 (267)
Q Consensus 222 ev~~--~l~~l~~~~ 234 (267)
+++. .++.++...
T Consensus 293 e~l~h~~f~~~~~~~ 307 (342)
T cd07879 293 EALEHPYFDSFRDAD 307 (342)
T ss_pred HHhcCcchhhccccc
Confidence 9996 477666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=207.67 Aligned_cols=155 Identities=28% Similarity=0.337 Sum_probs=129.7
Q ss_pred CCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccC-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|-|+||||+.+..+|.. +..+++++||.+. +|+..++-.+ .....++...+..+++||+.++.|||++= ++||
T Consensus 81 ~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHR 156 (438)
T KOG0666|consen 81 LRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHR 156 (438)
T ss_pred HHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeec
Confidence 577899999999998866 8899999999976 8888776322 23457888999999999999999999998 9999
Q ss_pred CCCCCcEEEcCC----CceEEeccCCcccCCCCCCcc-eeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhC
Q 024460 80 DLKSANILLDND----FNPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 80 di~~~nili~~~----~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g 153 (267)
|+||.|||+..+ |+|||+|+|+++.+...-... ......-|.||+|||++.+. .|+.+.|+|++|||+.||++.
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 999999999776 899999999999765433322 12234458999999999875 699999999999999999999
Q ss_pred CCCcccc
Q 024460 154 RKAMDLS 160 (267)
Q Consensus 154 ~~p~~~~ 160 (267)
.+.|...
T Consensus 237 ~PlF~g~ 243 (438)
T KOG0666|consen 237 EPLFKGR 243 (438)
T ss_pred Cccccch
Confidence 9888544
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=219.30 Aligned_cols=216 Identities=25% Similarity=0.320 Sum_probs=150.2
Q ss_pred CCCCCCCCCccceeeEEeeC--------------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE 66 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~ 66 (267)
+|++++||||+++++++... ...|+||||++ ++|.+++. ...+++..+..++.|++.|+.
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~ 128 (342)
T cd07854 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLK 128 (342)
T ss_pred HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHH
Confidence 36788999999999876543 35799999996 58988884 346889999999999999999
Q ss_pred HhhhcCCCCeeeCCCCCCcEEEc-CCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCccccc-CCCcccCCeeeh
Q 024460 67 YLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSF 143 (267)
Q Consensus 67 ~lH~~~~~~i~h~di~~~nili~-~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~sl 143 (267)
|||+.+ ++|+||+|+||+++ .++.++++|||.+......... .......++..|+|||.+.. ..++.++|+|||
T Consensus 129 ~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred HHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 999999 99999999999997 4567899999998753221111 11122346778999997654 568889999999
Q ss_pred HHHHHHHHhCCCCccccCccCccchhhhchhhhh--ccc----ccccccC-CcCCCC-----CcHHHHHHHHHHHHhhcc
Q 024460 144 GVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK--DQK----KFVHLVD-PLLHGR-----YPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 144 G~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~-~~~~~~-----~~~~~~~~l~~li~~cl~ 211 (267)
|+++|+|++|..||................+... ... ....... ...... .....+.++.+++.+||+
T Consensus 206 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 285 (342)
T cd07854 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT 285 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhC
Confidence 9999999999999964432211100000000000 000 0000000 000000 011345678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.+|.+|||++++++
T Consensus 286 ~dP~~R~t~~ell~ 299 (342)
T cd07854 286 FNPMDRLTAEEALM 299 (342)
T ss_pred CCchhccCHHHHhC
Confidence 99999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9e-30 Score=205.89 Aligned_cols=198 Identities=32% Similarity=0.378 Sum_probs=157.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++|+||+++++++......++++|++.+++|.+++.. ...++...++.++.+++.++.+||+.+ ++|+||
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i 113 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDL 113 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCc
Confidence 4678999999999999999999999999999999999865 223888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++++|||.+....... ......+...|++||.+....++.++|+|++|++++++++|..||....
T Consensus 114 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 190 (244)
T smart00220 114 KPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD 190 (244)
T ss_pred CHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543221 2233456788999999988888999999999999999999999986421
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCc-H-HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP-R-RCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ... .+......... . .++.++.+++.+|+..+|++||++.++++
T Consensus 191 ~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 191 QLLE--LFK--------------KIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cHHH--HHH--------------HHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1100 000 00000000000 0 15678999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=217.10 Aligned_cols=216 Identities=24% Similarity=0.319 Sum_probs=155.2
Q ss_pred CCCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||+++++++..+. .+++||||+ +++|.+++. ...+++..+..++.|++.|+.|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~g-- 138 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAG-- 138 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367889999999999987654 458999999 679988884 356899999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++|+||+|+||+++.++.++++|||++...... .....++..|++||.+.+ ..++.++|+||||+++|++++|
T Consensus 139 -i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 212 (343)
T cd07880 139 -IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212 (343)
T ss_pred -eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998753221 122345778999998875 4578899999999999999999
Q ss_pred CCCccccCccCccc-hhhhchh---h----hhc--ccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 154 RKAMDLSKGQGEQN-LVSWSRP---F----LKD--QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 154 ~~p~~~~~~~~~~~-~~~~~~~---~----~~~--~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.+||.......... ....... . ... .......+....... ....++..+.+++.+||+.+|++|||+
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~ 292 (343)
T cd07880 213 KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA 292 (343)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH
Confidence 99996443211110 0000000 0 000 000000000000000 112345678999999999999999999
Q ss_pred HHHHH--HHHHh
Q 024460 221 NDIVV--ALDYL 230 (267)
Q Consensus 221 ~ev~~--~l~~l 230 (267)
.+++. .++.+
T Consensus 293 ~~~l~~~~~~~~ 304 (343)
T cd07880 293 AEALAHPYFEEF 304 (343)
T ss_pred HHHhcCccHhhh
Confidence 99995 45444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=209.21 Aligned_cols=205 Identities=27% Similarity=0.360 Sum_probs=159.3
Q ss_pred CCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
-+.|.||-||++|++|.- .+.+|-|.|||+|.+|.-|+. .++.+++..+..++.||+.||.||.+. .+||+|.|
T Consensus 521 HKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYD 595 (775)
T KOG1151|consen 521 HKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYD 595 (775)
T ss_pred hhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeec
Confidence 467899999999999964 567899999999999999995 478899999999999999999999987 56799999
Q ss_pred CCCCcEEEc---CCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccC----CCcccCCeeehHHHHH
Q 024460 81 LKSANILLD---NDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSG----KLTLKSDIYSFGVVLL 148 (267)
Q Consensus 81 i~~~nili~---~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~----~~~~~~Dv~slG~i~~ 148 (267)
+||.|||+- ..|.+||+|||++.+....... .......||+||++||.+.-. +.+.+.||||+|+|+|
T Consensus 596 LKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 596 LKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred cCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhh
Confidence 999999994 4578999999999876543332 334567899999999988643 4678999999999999
Q ss_pred HHHhCCCCccccCccCccchhhhchhhhhcccccccccCC-cCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 149 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP-LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
.++-|..||.....+... +..+ .++.. .+..+.....+.+..++|++||...-.+|....++.
T Consensus 676 QClYGrKPFGhnqsQQdI---------LqeN----TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQQDI---------LQEN----TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhccCCCCCCchhHHHH---------Hhhh----chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 999999999644332221 0000 01111 011111234567889999999999999998887765
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=215.78 Aligned_cols=210 Identities=23% Similarity=0.326 Sum_probs=150.7
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+++++||||+++++++... ...|++++++ +++|.+++.. ..+++..+..++.|++.|++|||+.+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--- 140 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 140 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5788999999999988643 3478888887 7799888743 46889999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998753211 122356788999998766 46888999999999999999999
Q ss_pred CCccccCccCccchh-hhc---hhhh----hc--ccccccccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLV-SWS---RPFL----KD--QKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~~---~~~~----~~--~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
.||...........+ ... .... .. .......+.......+ ....+.++.++|.+||+.+|.+||++.
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 998643321111000 000 0000 00 0000000000000000 012356789999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
+++.
T Consensus 296 e~l~ 299 (345)
T cd07877 296 QALA 299 (345)
T ss_pred HHhc
Confidence 9996
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=226.37 Aligned_cols=210 Identities=26% Similarity=0.391 Sum_probs=179.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|.+|.|||++++++++.... +-||++|++.|+|.++++. ++..+.....+.|..||++|+.|||++. ++|||
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrd 823 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRD 823 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhh
Confidence 367899999999999997765 7899999999999999987 6778888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|-.+|+||..-..+|+.|||+++...............-.+.|+|-|.+....|+.++|||++|+++||++| |..|++.
T Consensus 824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 999999999999999999999987654443333333445778999999999999999999999999999988 8888874
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.. ...+..++....+-..|..|+.++.-++.+||..|++.||+++++...+..+-...
T Consensus 904 i~-----------------~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 904 IP-----------------AEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CC-----------------HHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 43 34445555555556678899999999999999999999999999999987765544
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=207.15 Aligned_cols=204 Identities=19% Similarity=0.210 Sum_probs=150.9
Q ss_pred ccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc
Q 024460 10 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD 89 (267)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~ 89 (267)
++.+.++|+..++.|+|+|.+ |.|+.+++.. ..-.+++...+..++.|++.++++||+.+ ++|.|+||+||++.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfv 226 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFV 226 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEe
Confidence 466678899999999999999 6699999975 24567889999999999999999999999 99999999999992
Q ss_pred C--------------------CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHH
Q 024460 90 N--------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 90 ~--------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 149 (267)
+ +..++|+|||.++.... .......|..|+|||++.+-+|+..+||||+|||++|
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE 301 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence 1 23489999999985321 2234456889999999999999999999999999999
Q ss_pred HHhCCCCccccCccCccch-----hhhchhhhhccccccc-----ccC---CcCCC--------C--------CcHHHHH
Q 024460 150 LITGRKAMDLSKGQGEQNL-----VSWSRPFLKDQKKFVH-----LVD---PLLHG--------R--------YPRRCLN 200 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-----~~~---~~~~~--------~--------~~~~~~~ 200 (267)
+.+|...|+.........+ ......+..... ..+ -++ ....+ . .......
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~-~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~ 380 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTR-KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV 380 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhh-hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence 9999999977663332111 111111111000 000 000 00000 0 0123355
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 201 YAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 201 ~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.+.+|+++||..||.+|+|+.|+++
T Consensus 381 ~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 381 QLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHHHccCccccccHHHHhc
Confidence 7999999999999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=221.72 Aligned_cols=199 Identities=26% Similarity=0.351 Sum_probs=165.6
Q ss_pred CCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 5 LHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 5 l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
-.|||++.++++|.- ++.+|||||||.+||..|++.... +.++.+..+..++..++.++.+||.+. ++|+
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHR 147 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHR 147 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeee
Confidence 368999999998853 568999999999999999998744 788999999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-----CCcccCCeeehHHHHHHHHhCC
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|||-.|||++.++.||++|||.+...... .....+..|++.|||||++... .|+..+|+||||++..||.-|.
T Consensus 148 DikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~ 225 (953)
T KOG0587|consen 148 DIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGA 225 (953)
T ss_pred cccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCC
Confidence 99999999999999999999998764332 2334556799999999998754 4677899999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|+-.+........+. -+|.....-+.+.+.++.++|..||.+|...||++.++++
T Consensus 226 PPl~DmHPmraLF~Ip---------------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 226 PPLCDMHPMRALFLIP---------------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCccCcchhhhhccCC---------------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 9987665433322221 2233333346788999999999999999999999999886
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=207.87 Aligned_cols=186 Identities=28% Similarity=0.370 Sum_probs=157.2
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+-|+++++...|.+-+++|+||||+.||+|...+++ -+.+.+..+.-++..|+-+|-+||+++ |++||+|.+|
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDN 480 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 480 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccc
Confidence 457899999999999999999999999999999965 567888889999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
|+++.+|.+||+|||++.... -......+..||+.|+|||++...+|+...|.|++|+++|||+.|++||+.......
T Consensus 481 vmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred eEeccCCceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 999999999999999998632 223345668899999999999999999999999999999999999999985443221
Q ss_pred cchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
. ..+.+... .+|.-.+.+..++++..|.++|..|.
T Consensus 559 F----------------~aI~ehnv--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 F----------------QAIMEHNV--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred H----------------HHHHHccC--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 11111111 35677788899999999999999994
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=201.22 Aligned_cols=213 Identities=23% Similarity=0.303 Sum_probs=171.6
Q ss_pred CCCCCCCCccceeeEEeeC-CeeEEEEecCCCCCHHHHhcccCCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSG-DQRLLVYEYMPMGSLEDHLYDLEPD----QEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|.-+.|||++.+.+++.++ ...+.+++++..|+|..+++..+.. ...++......++.|++.|+.|||+++ +
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---V 417 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---V 417 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 4457899999999988654 5788999999999999999843321 234556677899999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~ 155 (267)
+|.||..+|.+|++.-.+|++|=.+++.....+..-..........||+||.+....|+.++|+||||+++|||++ |+.
T Consensus 418 iHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 418 IHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred ccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986644444433444456778999999999999999999999999999988 778
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
|+..-++ ..+...+....+-..|.+||.++..++.-||...|++||+++++..-|+++-.+.
T Consensus 498 PyaeIDP-----------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 498 PYAEIDP-----------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred CccccCH-----------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 8752221 1222233333344457799999999999999999999999999999998876553
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=202.79 Aligned_cols=228 Identities=28% Similarity=0.398 Sum_probs=164.3
Q ss_pred CCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------C
Q 024460 4 LLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------N 73 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~------~ 73 (267)
.++|+||+++++.-.... .+++|++|.+.|+|.+++. ...+++....+++..++.+|+|||+.- +
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~K 334 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHK 334 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCC
Confidence 479999999998865544 7999999999999999995 478999999999999999999999632 5
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-Cc-----ccCCeeehHHHH
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LT-----LKSDIYSFGVVL 147 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-----~~~Dv~slG~i~ 147 (267)
++|+|||||.+||||.++..+.|+|||++..+.........-...||.+|||||++.+.- +. .+.||||+|+++
T Consensus 335 p~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 335 PPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred CccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 589999999999999999999999999998765333332333477999999999998752 22 358999999999
Q ss_pred HHHHhCCCCccc-cCccCccchhhh--chhhhhc--ccccccccCCcCCCCC-cHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 148 LELITGRKAMDL-SKGQGEQNLVSW--SRPFLKD--QKKFVHLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 148 ~~~l~g~~p~~~-~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
|||++.....+. ..+....-+... ..+.+.+ ...+.+-..|.+.+.+ ......-+.+.+..||..||+-|.|+.
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 999997654431 111111111100 0000000 0111111222222111 123356689999999999999999999
Q ss_pred HHHHHHHHhhhccCC
Q 024460 222 DIVVALDYLVSQRDS 236 (267)
Q Consensus 222 ev~~~l~~l~~~~~~ 236 (267)
=+.+.+.++.-..+.
T Consensus 495 Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 495 CVEERMAELMMLWED 509 (534)
T ss_pred HHHHHHHHHhccCCc
Confidence 999999888766554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=214.57 Aligned_cols=200 Identities=23% Similarity=0.282 Sum_probs=161.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++++||+||.+...|++.+.+++|||.+.|.-|+..+.. +.+++++.....++.||+.||.|||-++ |+|+|
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCD 689 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKN---IVHCD 689 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcc---eeecc
Confidence 68899999999999999999999999999976555555543 6789999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDND---FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||+|||+... ..+||+|||+++++ ..........||+.|+|||++....|...-|+||.|+|+|.-++|..||
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiI---gEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARII---GEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeec---chhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC
Confidence 99999999643 57999999999964 3344555678999999999999999999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......+. .+-..++=|.. + =.+.+.+..++|...|+..-..|.+.+.-+.
T Consensus 767 NEdEdIndQ-------------IQNAaFMyPp~--P-W~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 767 NEDEDINDQ-------------IQNAAFMYPPN--P-WSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCccchhHH-------------hhccccccCCC--c-hhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 755433221 11111111100 0 0355677899999999999999999887553
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-29 Score=193.93 Aligned_cols=218 Identities=26% Similarity=0.366 Sum_probs=157.4
Q ss_pred CCCCCCCCCccceeeEEee--------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 1 MLSLLHHDNLVTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
||+.|+|+|++.++++|.. ...+|+||.+|+. +|.-++.+ ...+++...+.+++.++..+|.|+|...
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k 144 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK 144 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 4778999999999988743 2348999999976 88888854 3468999999999999999999999999
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcce--eeecccccceeCCccccc-CCCcccCCeeehHHHHHH
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV--STRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~ 149 (267)
|+|||+|+.|+||+.++.++|+|||+++.+........ -+...-|.+|++||.+.+ ..|++..|+|..||++.+
T Consensus 145 ---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimae 221 (376)
T KOG0669|consen 145 ---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAE 221 (376)
T ss_pred ---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHH
Confidence 99999999999999999999999999975432221111 111234889999998876 579999999999999999
Q ss_pred HHhCCCCccccCccCccchhh--------hchhhhhcccccccc-cCCcCCCCC--------cHHHHHHHHHHHHhhccc
Q 024460 150 LITGRKAMDLSKGQGEQNLVS--------WSRPFLKDQKKFVHL-VDPLLHGRY--------PRRCLNYAVAVTAMCLNE 212 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~-~~~~~~~~~--------~~~~~~~l~~li~~cl~~ 212 (267)
|+++.+.++....+.....+. ..++....-.-...+ +.|...+.. |..-..+..+++.+++..
T Consensus 222 Mwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 222 MWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL 301 (376)
T ss_pred HHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence 999999887654333221111 111111111111111 011111111 111134678999999999
Q ss_pred CCCCCCCHHHHHH
Q 024460 213 EANFRPLINDIVV 225 (267)
Q Consensus 213 ~p~~Rpt~~ev~~ 225 (267)
||.+|++++++++
T Consensus 302 DP~kR~~ad~aln 314 (376)
T KOG0669|consen 302 DPTKRIDADQALN 314 (376)
T ss_pred CcccCcchHhhhc
Confidence 9999999999886
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=198.98 Aligned_cols=222 Identities=26% Similarity=0.337 Sum_probs=162.0
Q ss_pred CCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCC
Q 024460 4 LLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-----CKANP 74 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-----~~~~~ 74 (267)
.|||+||+.+++.-..+. .+|+|++|.+.|||.||+. ..+++....++++..++.+|++|| ++|++
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence 479999999998754332 5899999999999999994 478999999999999999999999 46788
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCC-CC-cceeeecccccceeCCcccccCC----C--cccCCeeehHHH
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG-DN-THVSTRVMGTYGYCAPEYAMSGK----L--TLKSDIYSFGVV 146 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~-~~-~~~~~~~~~~~~~~aPE~~~~~~----~--~~~~Dv~slG~i 146 (267)
.|.|||||+.||||..++.+-|+|+|++-..... +. ........||.+|||||++...- + -..+||||+|++
T Consensus 336 aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred hhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 9999999999999999999999999998543211 11 11233467899999999987532 2 146999999999
Q ss_pred HHHHHhC----------CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCC-cHHHHHHHHHHHHhhcccCCC
Q 024460 147 LLELITG----------RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEAN 215 (267)
Q Consensus 147 ~~~~l~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~ 215 (267)
+||++-. ++||-...+... .+..+. ...-.+.+.|.+..++ ...+...+.++|+.||..||.
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DP-s~eeMr------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPSDP-SFEEMR------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCCCC-CHHHHh------cceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCch
Confidence 9999762 334421111000 000000 0011112222222222 356678899999999999999
Q ss_pred CCCCHHHHHHHHHHhhhccCCC
Q 024460 216 FRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 216 ~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
-|.|+-.+.+.|.++.+..+..
T Consensus 489 aRltALriKKtl~~l~~~~ek~ 510 (513)
T KOG2052|consen 489 ARLTALRIKKTLAKLSNSDEKI 510 (513)
T ss_pred hhhHHHHHHHHHHHHhcChhhh
Confidence 9999999999999998655443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=181.22 Aligned_cols=215 Identities=21% Similarity=0.251 Sum_probs=157.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.|+|+|||+++++.-.++.+.+|+|||+. +|..++.. -++.++...+..++.|++.++.++|+++ ++|+|
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrd 126 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRD 126 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhcc
Confidence 36788999999999999999999999999954 88888865 6788999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
+||+|.+|+.+|.+|++|||+++-+...- ..-....-+.+|.+|.++.+. -|+...|+||.|||+.|+.. |.+.|.
T Consensus 127 lkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 127 LKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred CCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 99999999999999999999998654332 223334458899999999876 58899999999999999977 445554
Q ss_pred ccCccCccchhhhchhhhhccccccc---ccC----CcCCC-----CCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVH---LVD----PLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+-+..... ...++.. +-+ |...- .+-.+....-++++++.|.-+|.+|.++++.++
T Consensus 205 g~dvddqlkrif~~lg~p-~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLLGTP-TEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcHHHHHHHHHHHhCCC-ccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 443221111111110000 0111110 000 00000 001233445689999999999999999998775
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=228.30 Aligned_cols=198 Identities=16% Similarity=0.202 Sum_probs=140.2
Q ss_pred CCCCCC-CCccceeeEE-------eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHH-DNLVTLIGYC-------TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~-------~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
++.++| +||+.+++.| .....++.++|++ +++|.+++.. ....+++..+..++.||+.||.|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 356788 7999999987 2334678889988 5699999964 3456899999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCc-------------------eEEeccCCcccCCCCCC--------------cceeeecccc
Q 024460 74 PPVIYRDLKSANILLDNDFN-------------------PKLSDFGLAKLGPVGDN--------------THVSTRVMGT 120 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~-------------------~~l~d~~~~~~~~~~~~--------------~~~~~~~~~~ 120 (267)
|+||||||+|||++..+. +|++|||+++....... ........++
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999965444 45555555542110000 0000113468
Q ss_pred cceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHH
Q 024460 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLN 200 (267)
Q Consensus 121 ~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (267)
++|+|||++.+..++.++|||||||++|||+++.+|+...... ..... ...+.+.. .....
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~----------~~~~~~~~-----~~~~~ 239 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLR----------HRVLPPQI-----LLNWP 239 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHH----------HhhcChhh-----hhcCH
Confidence 8899999999999999999999999999999988876421100 00000 00011100 11133
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 201 YAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 201 ~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...+++.+||..+|.+||+++|+++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 4568899999999999999999976
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=221.39 Aligned_cols=95 Identities=34% Similarity=0.420 Sum_probs=88.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++...+.+|+||||+.+++|.+++.. .+.+++..++.++.||+.||.|||.++ |+|+||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDL 130 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDL 130 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCc
Confidence 4678999999999999999999999999999999999864 356888999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~ 103 (267)
||+|||++.++.++|+|||+++
T Consensus 131 KP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 131 KPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred cHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=220.40 Aligned_cols=203 Identities=25% Similarity=0.285 Sum_probs=158.1
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ni 86 (267)
.+=|+.++-.|.++.++|+||||++||+|..++.. .. .+++..+..++..|+.||.-+|+.| +|||||||+||
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk---~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNv 206 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSK---FD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNV 206 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhh---cC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCccee
Confidence 34577777888999999999999999999999965 33 8999999999999999999999999 99999999999
Q ss_pred EEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 87 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 87 li~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
|++..|.+||+|||.+-.... +.........|||-|.+||++.. +.|++.+|.||+|+++|||+.|..||-...
T Consensus 207 Lld~~GHikLADFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 207 LLDKSGHIKLADFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred EecccCcEeeccchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 999999999999998765432 33345666789999999999863 468899999999999999999999994222
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCc--HHHHHHHHHHHHhhcccCCCCCCC---HHHHHHHHHHhhhccCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP--RRCLNYAVAVTAMCLNEEANFRPL---INDIVVALDYLVSQRDS 236 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~~p~~Rpt---~~ev~~~l~~l~~~~~~ 236 (267)
... ...++++-.-.-.+| ...+.+..++|++.++ +|..|.. ++++. .
T Consensus 286 lve----------------TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik-----------~ 337 (1317)
T KOG0612|consen 286 LVE----------------TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK-----------N 337 (1317)
T ss_pred HHH----------------HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH-----------h
Confidence 111 111222221111233 3467889999998876 5667776 88887 4
Q ss_pred CCCcCCCCC
Q 024460 237 HPVSRNAGA 245 (267)
Q Consensus 237 ~~~~~~~~~ 245 (267)
+|.....+|
T Consensus 338 HpFF~g~~W 346 (1317)
T KOG0612|consen 338 HPFFEGIDW 346 (1317)
T ss_pred CccccCCCh
Confidence 555555555
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.5e-28 Score=193.74 Aligned_cols=194 Identities=26% Similarity=0.375 Sum_probs=157.7
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
-+||++|-+..+|.++..+++|.||.+||+|.-.+++ ...+++..+..+...|+.||.|||+.| |+++|+|.+
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkld 380 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLD 380 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeecccc
Confidence 4799999999999999999999999999999888865 456888999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
|+|++..|.+|++|+|.+.... .......+..||+.|.|||++.+..|....|.|+||++++||+.|..||+...-.+
T Consensus 381 nvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred ceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 9999999999999999998632 33345667889999999999999999999999999999999999999997443222
Q ss_pred ccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 165 EQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 165 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
... ..+... .-++++.+ ++|.-.+.....+++.-|++||++|.
T Consensus 459 ~d~ntedylf---------qvilekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 459 PDMNTEDYLF---------QVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccchhHHHH---------HHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 211 111110 11122222 34555566678899999999999984
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-29 Score=198.23 Aligned_cols=207 Identities=26% Similarity=0.284 Sum_probs=156.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcc-cCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD-LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++.-+-||||++||.+..++..|+.||.|+- +|..+... ...+...+++..+-.+....+.||.||.+.-+ ++|||
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRD 193 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRD 193 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhcc
Confidence 3445679999999999999999999999954 66654432 22356789999999999999999999986543 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+||+|||++..|.+||+|||.+..+ ...-..+...|...|+|||-+... .|+-++|+||||+++||+.+|..|+.
T Consensus 194 vKPSNILldr~G~vKLCDFGIcGqL---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr 270 (361)
T KOG1006|consen 194 VKPSNILLDRHGDVKLCDFGICGQL---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR 270 (361)
T ss_pred CChhheEEecCCCEeeecccchHhH---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence 9999999999999999999998643 222234456788899999988753 58999999999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCC-cHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
......+. -.++..--.|.+.... ...++..+..+|..||.++-+.||.+.++.+.
T Consensus 271 ~w~svfeq------------l~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 271 KWDSVFEQ------------LCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred hHHHHHHH------------HHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 54432111 0111111111111111 12457789999999999999999999999873
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-28 Score=213.37 Aligned_cols=199 Identities=29% Similarity=0.364 Sum_probs=148.6
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++|+.-.+..+.|+..|.|. .+|.+++............-..+.++.|++.|+++||+.+ |+||||||+|
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQN 636 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQN 636 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCce
Confidence 79999999999888999999999995 5999999762111111111334778999999999999999 9999999999
Q ss_pred EEEcC---C--CceEEeccCCcccCCCCCC-cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC-CCCcc
Q 024460 86 ILLDN---D--FNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMD 158 (267)
Q Consensus 86 ili~~---~--~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g-~~p~~ 158 (267)
|||+. + .+++|.|||++........ ........|+.+|.|||++.....+.+.|+|+|||++||.++| ..||.
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99965 2 4679999999987654322 2334557899999999999998888899999999999999886 78985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..-.. ....+.....+..+- + ...+ +..++|.+|++.+|..||++.+|+.
T Consensus 717 d~~~R--------~~NIl~~~~~L~~L~-~------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 717 DSLER--------QANILTGNYTLVHLE-P------LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred chHHh--------hhhhhcCccceeeec-c------CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 22110 001111111111111 0 1122 7899999999999999999999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=203.03 Aligned_cols=149 Identities=26% Similarity=0.321 Sum_probs=128.1
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
-.+-||++|-.|.+++.+|+||+|++||++..++.+ .+.|.+..+..++..+..|+.+.|+.| ++||||||+|
T Consensus 687 Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDN 759 (1034)
T KOG0608|consen 687 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDN 759 (1034)
T ss_pred CCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccc
Confidence 456789999999999999999999999999999864 678899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCC--CCCccee--------------------------------------eecccccceeC
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPV--GDNTHVS--------------------------------------TRVMGTYGYCA 125 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~--~~~~~~~--------------------------------------~~~~~~~~~~a 125 (267)
|||+.+|.+||+|||++.=+.. ...+... ....|++.|+|
T Consensus 760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 9999999999999999863211 1111000 02457999999
Q ss_pred CcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 126 PEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 126 PE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||++....|+..+|.|+.|+|+|+|+.|++||-...
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhhCCCCccCCC
Confidence 999999999999999999999999999999995443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=180.90 Aligned_cols=169 Identities=24% Similarity=0.177 Sum_probs=125.3
Q ss_pred CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcc
Q 024460 33 GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 112 (267)
Q Consensus 33 ~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~ 112 (267)
|+|.+++.. .+..+++..++.++.|++.||.|||+++ ||+||+++.++.+++ ||.+......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999965 3567999999999999999999999775 999999999999998 9988753221
Q ss_pred eeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCC
Q 024460 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHG 192 (267)
Q Consensus 113 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (267)
...++..|+|||++.+..++.++||||||+++|+|++|..||......... ........ . ...+.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~-------~-~~~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGM-------P-ADDPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHh-------c-cCCccc-c
Confidence 124789999999999999999999999999999999999998643221110 00000000 0 000000 0
Q ss_pred CCcHHHHH--HHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 193 RYPRRCLN--YAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 193 ~~~~~~~~--~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
..+..... ++.+++.+||..+|.+||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11223333 69999999999999999999999998766654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=215.36 Aligned_cols=181 Identities=25% Similarity=0.305 Sum_probs=131.6
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
-.+||-||||+..++.+++++.. -.-.....|+++.+|++||.|+|++| ++||||||.||+++.++.|||+|||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~N~---~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRRNH---FNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHhcc---cchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccc
Confidence 46899999999877777775511 11146788999999999999999999 9999999999999999999999999
Q ss_pred CcccCC----C------------CCCcceeeecccccceeCCcccccCC---CcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 101 LAKLGP----V------------GDNTHVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 101 ~~~~~~----~------------~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
++.... . .......+...||.-|+|||++.+.. |+.|+|+||||++++||+. ||....
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM 819 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM 819 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH
Confidence 998611 0 01111234567899999999998754 9999999999999999975 343221
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCC--CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR--YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
. . ...+..+-+..+... +..+-...-..+|++|++.||++|||+.|+++
T Consensus 820 E--R-------------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 E--R-------------ASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred H--H-------------HHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0 0 111111111111111 11122334578999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=184.99 Aligned_cols=197 Identities=20% Similarity=0.327 Sum_probs=143.3
Q ss_pred CCCCccceee-EEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 6 HHDNLVTLIG-YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 6 ~Hpniv~~~~-~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.|.||+..|+ .|+..+.+++++||++.|+|.+-+. ..++.+....+++.|+++||.|||+++ +||||||.+
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~e 150 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAE 150 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccc
Confidence 5889998886 4678889999999999999999884 477888999999999999999999999 999999999
Q ss_pred cEEEcC--CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-----CCcccCCeeehHHHHHHHHhCCCCc
Q 024460 85 NILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 85 nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||||.. .-++||+|||..+..... .........|.+||+.... ...+.+|+|+||+++|++++|.+||
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred eEEEecCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 999953 348999999998743211 1122235568999976543 2357799999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCC---CCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---pt~~ev~~ 225 (267)
+....... ....|.. ..+-.++.+...+ ...++.+..++++-|..++++| .+.+....
T Consensus 226 Qka~~~d~-~Y~~~~~--------w~~rk~~~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 226 QKASIMDK-PYWEWEQ--------WLKRKNPALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred hhhhccCc-hHHHHHH--------HhcccCccCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 84433222 2222211 1111112221111 1235668889999999999999 55554444
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=189.60 Aligned_cols=211 Identities=25% Similarity=0.332 Sum_probs=152.8
Q ss_pred CCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+..++|+||++++.+|.-.. ..|+|||++. .+|...+. -.++-..+..++.|++.|+++||+.+
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~--- 138 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG--- 138 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---
Confidence 45789999999999996543 5799999995 59988884 34556788999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|+|||+||+||++..+..+||.|||+++. .+.....+....+..|+|||++.+-.+.+.+||||+||++.||+.|..
T Consensus 139 IihRdLkPsnivv~~~~~lKi~dfg~ar~---e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V 215 (369)
T KOG0665|consen 139 IIHRDLKPSNIVVNSDCTLKILDFGLART---EDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV 215 (369)
T ss_pred eeecccCcccceecchhheeeccchhhcc---cCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE
Confidence 99999999999999999999999999984 222233444556888999999999889999999999999999999998
Q ss_pred CccccCccCc------------cchh----hhchhhhhcc-----cccccc-cCCcCCCCC--cHHHHHHHHHHHHhhcc
Q 024460 156 AMDLSKGQGE------------QNLV----SWSRPFLKDQ-----KKFVHL-VDPLLHGRY--PRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 156 p~~~~~~~~~------------~~~~----~~~~~~~~~~-----~~~~~~-~~~~~~~~~--~~~~~~~l~~li~~cl~ 211 (267)
.|.+...... ..+. .-++.+.... ....+. -+..+.... +.-...-..+++.+||.
T Consensus 216 lf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv 295 (369)
T KOG0665|consen 216 LFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV 295 (369)
T ss_pred EecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc
Confidence 8763321110 0000 0111111100 000000 011111110 11223457899999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.+|++|.++++++.
T Consensus 296 i~pe~Risv~daL~ 309 (369)
T KOG0665|consen 296 IDPEKRISVDDALR 309 (369)
T ss_pred cChhhcccHHHHhc
Confidence 99999999999986
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=206.97 Aligned_cols=200 Identities=21% Similarity=0.172 Sum_probs=128.5
Q ss_pred eeCCeeEEEEecCCCCCHHHHhcccCC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 18 TSGDQRLLVYEYMPMGSLEDHLYDLEP----------------DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 18 ~~~~~~~lv~e~~~~~sL~~~l~~~~~----------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
..+..+++|+||+.+++|.+++..... .........+..++.|++.+|.|||+++ |+|+||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 355679999999999999999864210 0011123446689999999999999998 999999
Q ss_pred CCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC----------------------CCcccC
Q 024460 82 KSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG----------------------KLTLKS 138 (267)
Q Consensus 82 ~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~ 138 (267)
||+|||++. ++.+||+|||++........ .......+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 57899999999975432211 122334678899999966432 234567
Q ss_pred CeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCC------CcHHHHHHHHHHHHhhccc
Q 024460 139 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR------YPRRCLNYAVAVTAMCLNE 212 (267)
Q Consensus 139 Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~ 212 (267)
||||+||++|+|+++..+++.........+.... .+...+.....+..... ..........+||.+||+.
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRND----YDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcC----CcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999876554311100000000000 00000001111110000 0011123456899999999
Q ss_pred CCCCCCCHHHHHH
Q 024460 213 EANFRPLINDIVV 225 (267)
Q Consensus 213 ~p~~Rpt~~ev~~ 225 (267)
||++|||++++++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999999996
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=176.98 Aligned_cols=168 Identities=38% Similarity=0.546 Sum_probs=145.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|++|+++++++......++++|++.+++|.+++.. ....++...+..++.+++.++.+||+.+ ++|+||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl 118 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDL 118 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5678999999999999999999999999998999999965 1246888999999999999999999998 999999
Q ss_pred CCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 82 KSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
+|.||+++. ++.++++||+.+........ ......+...|.+||..... .++.++|+|++|+++++|
T Consensus 119 ~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred CHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 999999998 89999999999875432221 12234567789999988877 888999999999999998
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
..+.+++.+|+..+|++||+++++++.
T Consensus 188 ----------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 337899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-27 Score=176.11 Aligned_cols=151 Identities=27% Similarity=0.345 Sum_probs=129.1
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~ 82 (267)
+..-.|++|.+||.+..++.+++.||.|+. ||..+.+..-..++.+++..+-+++..++.|+.|||++-. ++|||+|
T Consensus 100 r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvK 176 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVK 176 (282)
T ss_pred cCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCC
Confidence 444569999999999999999999999954 8888877666688999999999999999999999998764 9999999
Q ss_pred CCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc----CCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 83 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 83 ~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|+|||++..|.+|++|||.+..+.. .-..+...|...|+|||.+.. ..|+-++||||||+.+.||.++..||+
T Consensus 177 PsNiLIn~~GqVKiCDFGIsG~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 177 PSNILINYDGQVKICDFGISGYLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred cceEEEccCCcEEEcccccceeehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 9999999999999999999864322 222334567888999998765 368899999999999999999999986
Q ss_pred c
Q 024460 159 L 159 (267)
Q Consensus 159 ~ 159 (267)
.
T Consensus 254 ~ 254 (282)
T KOG0984|consen 254 S 254 (282)
T ss_pred c
Confidence 3
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=190.08 Aligned_cols=206 Identities=19% Similarity=0.141 Sum_probs=135.7
Q ss_pred ccceeeEEee--------CCeeEEEEecCCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHHH
Q 024460 10 LVTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVGA 61 (267)
Q Consensus 10 iv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~~~~~~l 61 (267)
+++++++|.. ++..++||||+.+++|.+++..... ....+++..+..++.|+
T Consensus 239 ~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql 318 (507)
T PLN03224 239 CAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQV 318 (507)
T ss_pred hhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHH
Confidence 3566666643 3568999999999999999864211 01234567788999999
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-------
Q 024460 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL------- 134 (267)
Q Consensus 62 ~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~------- 134 (267)
+.++.|||+.+ ++|+||||+||+++.++.++|+|||++........ ........++.|++||++.....
T Consensus 319 ~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~ 394 (507)
T PLN03224 319 LTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAP 394 (507)
T ss_pred HHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccchh
Confidence 99999999998 99999999999999999999999999864322111 11112234788999998754221
Q ss_pred ---------------cccCCeeehHHHHHHHHhCCC-CccccCccCcc-chhhhchhhhhcccccccccCCcCCCCCcHH
Q 024460 135 ---------------TLKSDIYSFGVVLLELITGRK-AMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRR 197 (267)
Q Consensus 135 ---------------~~~~Dv~slG~i~~~~l~g~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (267)
..+.|+||+|+++|+|+++.. |+......... .........+ .........-.....
T Consensus 395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~------r~~~~~~~~~~~~d~ 468 (507)
T PLN03224 395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW------RMYKGQKYDFSLLDR 468 (507)
T ss_pred hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH------HhhcccCCCcccccc
Confidence 134699999999999999874 55422111000 0000000000 000000000011234
Q ss_pred HHHHHHHHHHhhcccCC---CCCCCHHHHHH
Q 024460 198 CLNYAVAVTAMCLNEEA---NFRPLINDIVV 225 (267)
Q Consensus 198 ~~~~l~~li~~cl~~~p---~~Rpt~~ev~~ 225 (267)
.+....+++.+||..+| .+|+|++|+++
T Consensus 469 ~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 469 NKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 46778999999999866 68999999984
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-25 Score=191.64 Aligned_cols=146 Identities=25% Similarity=0.356 Sum_probs=126.0
Q ss_pred CCCCCC---CCCccceeeEEeeCCeeEEEEecC-CCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLH---HDNLVTLIGYCTSGDQRLLVYEYM-PMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~---Hpniv~~~~~~~~~~~~~lv~e~~-~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
||..|+ |+||++++++|++++++|++||.. ++-+|.+++. ..+.+++..+..+++|++.++++||+++ |
T Consensus 619 Ila~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---i 691 (772)
T KOG1152|consen 619 ILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---I 691 (772)
T ss_pred HHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---c
Confidence 345566 999999999999999999999985 4557889884 5789999999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCc-ccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|||||-+|+.++.+|-+||+|||.+...... .-....||..|.|||++.+.+|- ..-|||+||+++|-+.-...
T Consensus 692 vhrdikdenvivd~~g~~klidfgsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 692 VHRDIKDENVIVDSNGFVKLIDFGSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred eecccccccEEEecCCeEEEeeccchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 99999999999999999999999998643222 22345689999999999998885 55899999999998887777
Q ss_pred Cc
Q 024460 156 AM 157 (267)
Q Consensus 156 p~ 157 (267)
||
T Consensus 768 py 769 (772)
T KOG1152|consen 768 PY 769 (772)
T ss_pred CC
Confidence 76
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-25 Score=192.37 Aligned_cols=203 Identities=27% Similarity=0.329 Sum_probs=159.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++..+||||+.+++.+-..+.+++.||||.+|+|.+..+ ..+.+++.++..+.+..+.+++|||+.+ -+|||
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~g---k~hRd 137 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRD 137 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCC---ccccc
Confidence 4677899999999999999999999999999999998774 3678999999999999999999999999 89999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||-.||++++.+.+|++|||.+-.+... ........|++.|+|||+.. ...|...+|+|++|+..-|+--.++|.
T Consensus 138 iKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 138 IKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred ccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 9999999999999999999987653222 22334567999999999874 357889999999999999998878775
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........... +.....+ .+.+++ +....+.+.++++.||..+|+.|||++.+++
T Consensus 216 fdlhpmr~l~L------mTkS~~q-----pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 216 FDLHPMRALFL------MTKSGFQ-----PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccchHHHHHH------hhccCCC-----CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 42222111100 0000111 111111 2356778999999999999999999998876
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-26 Score=178.54 Aligned_cols=217 Identities=23% Similarity=0.298 Sum_probs=155.7
Q ss_pred CCCCCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|..++|.|++...++..-.+ .+|+++|.+. .+|...+. ....++...+.-++.||+.+|+|||+.+
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA~--- 176 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTAN--- 176 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhcc---
Confidence 466789999999988875432 4688999985 48887773 5778888999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|+||||||.|.|++.+..+|++|||+++...... ....+...-+..|+|||++++. .|+.+.||||.|||+.|++...
T Consensus 177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr 255 (449)
T KOG0664|consen 177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK 255 (449)
T ss_pred hhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence 9999999999999999999999999998643222 2222334457889999999875 7999999999999999999988
Q ss_pred CCccccCccCccchhhhchh------hhhc-ccccccccCCcCCCC---------CcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 155 KAMDLSKGQGEQNLVSWSRP------FLKD-QKKFVHLVDPLLHGR---------YPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
..|+..........+..... +-.. .+....++....+.. .+..-..+-..+..++|..+|..|.
T Consensus 256 ILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri 335 (449)
T KOG0664|consen 256 ILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI 335 (449)
T ss_pred hhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc
Confidence 88876554433322211100 0000 011111111111111 0122334677888999999999999
Q ss_pred CHHHHHHH
Q 024460 219 LINDIVVA 226 (267)
Q Consensus 219 t~~ev~~~ 226 (267)
+.++.+.-
T Consensus 336 s~~~A~~~ 343 (449)
T KOG0664|consen 336 SVEEALQH 343 (449)
T ss_pred cHhhhccc
Confidence 98888763
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-24 Score=184.69 Aligned_cols=143 Identities=24% Similarity=0.265 Sum_probs=120.8
Q ss_pred CccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 024460 9 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 88 (267)
Q Consensus 9 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili 88 (267)
|+++++-.|.+.+++|||||-+. -+|.+.+..+. .+-.+....+..++.|+.-||..|-..+ ++|+||||+||||
T Consensus 495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLV 569 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILV 569 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEe
Confidence 77888999999999999999985 49999997643 4556778889999999999999999999 9999999999999
Q ss_pred cCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 89 DND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 89 ~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
++. ..+||||||.+....... . +...-...|.|||++.+.+|+...|+||+||.+||+.+|+..|.+.
T Consensus 570 NE~k~iLKLCDfGSA~~~~ene---i-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 570 NESKNILKLCDFGSASFASENE---I-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccCcceeeeccCcccccccccc---c-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 865 567999999997543222 1 1122356799999999999999999999999999999999988544
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=165.98 Aligned_cols=211 Identities=17% Similarity=0.273 Sum_probs=151.2
Q ss_pred CCCCCC-CCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 1 MLSLLH-HDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 1 il~~l~-Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
||+.|. ||||++++++..+ .....+|+||.+..+...+. ..++.-.+...+.+++.||.|+|+.| |.
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---Im 154 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IM 154 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cc
Confidence 466777 9999999999865 45678999999886666555 55777889999999999999999999 99
Q ss_pred eCCCCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCC
Q 024460 78 YRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 78 h~di~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|||+||.|++|+.. ..++|+|||++.+.-... .-.....+..|-.||++.. ..|+-.-|+|||||++..|+....
T Consensus 155 HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrke 231 (338)
T KOG0668|consen 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 231 (338)
T ss_pred cccCCcceeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccC
Confidence 99999999999854 579999999998642222 2223445777899998875 467888999999999999999999
Q ss_pred CccccCccCccchhhhchh--------h-----hhcccccccccCCcCCCCCc--------HHHHHHHHHHHHhhcccCC
Q 024460 156 AMDLSKGQGEQNLVSWSRP--------F-----LKDQKKFVHLVDPLLHGRYP--------RRCLNYAVAVTAMCLNEEA 214 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~p 214 (267)
||......... .+..+.- . ..-..+...++....+..+. .-..++..+++.+.|..|-
T Consensus 232 pFFhG~dN~DQ-LVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 232 PFFHGHDNYDQ-LVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred cccCCCCCHHH-HHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 98644433221 1111000 0 00011111111111111110 1124678999999999999
Q ss_pred CCCCCHHHHHH
Q 024460 215 NFRPLINDIVV 225 (267)
Q Consensus 215 ~~Rpt~~ev~~ 225 (267)
.+|+|++|.+.
T Consensus 311 qeRlTakEam~ 321 (338)
T KOG0668|consen 311 QERLTAKEAMA 321 (338)
T ss_pred ccccchHHHhc
Confidence 99999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=192.54 Aligned_cols=206 Identities=22% Similarity=0.211 Sum_probs=160.3
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~ 82 (267)
+.|+|||++.....+.+.....-+||||+. +|..++.. ...+....+..+++|++.++.|||..| +.|+|+|
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK 447 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLK 447 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCc
Confidence 468999998888877776666666999998 99999854 357888899999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCCCcc-cCCeeehHHHHHHHHhCCCCccc
Q 024460 83 SANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTL-KSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 83 ~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
++|+++..++.+|++|||.+..+...... .......|...|+|||++.+..|.+ ..||||.|+++..|.+|+.||..
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 99999999999999999998754433332 4455677899999999999998875 58999999999999999999976
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+.......... ......-.......+....+...+.+|.+||+.+|.+|.|+++|++
T Consensus 528 a~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 528 AKKSDNSFKTN---------NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccchhhh---------ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 65443321000 0000000000011122455778899999999999999999999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=169.58 Aligned_cols=76 Identities=26% Similarity=0.393 Sum_probs=67.5
Q ss_pred CCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 8 DNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 8 pniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
.+||++++.|.. +.++|||+|++ |.+|..+|.. .....++...+..++.||+.+|.|||.... |+|.||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCc
Confidence 579999999975 44899999999 7799999976 467789999999999999999999998653 99999999
Q ss_pred CcEEE
Q 024460 84 ANILL 88 (267)
Q Consensus 84 ~nili 88 (267)
+|||+
T Consensus 217 ENvLl 221 (590)
T KOG1290|consen 217 ENVLL 221 (590)
T ss_pred ceeee
Confidence 99999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-22 Score=162.50 Aligned_cols=151 Identities=36% Similarity=0.389 Sum_probs=128.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++|+|++++++++......++++|++++++|.+++... ...+++..+..++.+++.++.+||+.+ ++|+|+
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di 124 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDL 124 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 45679999999999999999999999999999999999652 122788999999999999999999998 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccc-ccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA-MSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
++.||+++.++.++++|||.+........ .......+...|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus 125 ~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 125 KPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999998875432210 012234567789999988 666788899999999999999999999963
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7e-22 Score=163.73 Aligned_cols=210 Identities=23% Similarity=0.305 Sum_probs=149.9
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
-+.||+++.+++..++.+++|+||++...-.++... ++...+..++..++.||.++|.+| |+||||||.|
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsN 162 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSN 162 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccc
Confidence 367999999999999999999999999888888743 557889999999999999999999 9999999999
Q ss_pred EEEcC-CCceEEeccCCcccCCCCC------C------------------------------------cceeeecccccc
Q 024460 86 ILLDN-DFNPKLSDFGLAKLGPVGD------N------------------------------------THVSTRVMGTYG 122 (267)
Q Consensus 86 ili~~-~~~~~l~d~~~~~~~~~~~------~------------------------------------~~~~~~~~~~~~ 122 (267)
++.+. .+...|+|||++....... . ........||++
T Consensus 163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G 242 (418)
T KOG1167|consen 163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG 242 (418)
T ss_pred cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence 99974 4678899999987210000 0 000113568999
Q ss_pred eeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccccCccCcc--chh-------------------hhchhh----h
Q 024460 123 YCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLV-------------------SWSRPF----L 176 (267)
Q Consensus 123 ~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~--~~~-------------------~~~~~~----~ 176 (267)
|+|||++... ..+.+.|+||.|+|+..++++..||......-.. .+. -|.+.. .
T Consensus 243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~ 322 (418)
T KOG1167|consen 243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP 322 (418)
T ss_pred CCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence 9999998764 5678999999999999999999998554333211 000 011000 0
Q ss_pred hcccccccc-cCCc--------CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 177 KDQKKFVHL-VDPL--------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 177 ~~~~~~~~~-~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... .... .........+..+.+++.+||..||.+|.|+++.++
T Consensus 323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000000011 0111 111122334568999999999999999999999997
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=166.25 Aligned_cols=219 Identities=27% Similarity=0.377 Sum_probs=166.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-eeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV-IYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i-~h~d 80 (267)
|+.+.|.|+.++++.+..+..++.|.+||..|+|.|.+.. ..-.++......+...++.++.|+|... + .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 6889999999999999999999999999999999999976 4567778888999999999999999776 5 9999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-------CcccCCeeehHHHHHHHHhC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-------LTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~Dv~slG~i~~~~l~g 153 (267)
++..|.+++....+|+.|||+.....................|.|||.+.... .+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987543211112222333566899999987742 35679999999999999999
Q ss_pred CCCccccCccCcc-chhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 154 RKAMDLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 154 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
..||......... .++..... .......|.+... ...++++..+++.||..+|.+||+++++-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999764433332 22222111 0111111111100 1344579999999999999999999999998877665
Q ss_pred cc
Q 024460 233 QR 234 (267)
Q Consensus 233 ~~ 234 (267)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 44
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=157.68 Aligned_cols=197 Identities=21% Similarity=0.179 Sum_probs=139.6
Q ss_pred CCCCCccceeeEEee---------------------------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHH
Q 024460 5 LHHDNLVTLIGYCTS---------------------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI 57 (267)
Q Consensus 5 l~Hpniv~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~ 57 (267)
-+|||||.+.++|.+ +..+|+||..++. +|..++- ....+.....-+
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~ 346 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVI 346 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHH
Confidence 479999999887632 2357999999955 9999994 345566777789
Q ss_pred HHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc----CCCceEEeccCCcccCCCCC----CcceeeecccccceeCCccc
Q 024460 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLD----NDFNPKLSDFGLAKLGPVGD----NTHVSTRVMGTYGYCAPEYA 129 (267)
Q Consensus 58 ~~~l~~~l~~lH~~~~~~i~h~di~~~nili~----~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~~aPE~~ 129 (267)
+.|+++|+.|||.++ +.|+|+|.+|||+. .-..+.|+|||++--..... ...-.-...|.-..+|||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 999999999999999 99999999999993 33467899999874221110 00111224567789999987
Q ss_pred ccCC------CcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHH
Q 024460 130 MSGK------LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 203 (267)
Q Consensus 130 ~~~~------~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 203 (267)
...+ .-.++|.|+.|.+.||+++...||-... +.... .....+.-.| .+|..+++.+.
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~-----------~r~Yqe~qLP----alp~~vpp~~r 487 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLD-----------TRTYQESQLP----ALPSRVPPVAR 487 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheec-----------hhhhhhhhCC----CCcccCChHHH
Confidence 6432 2368999999999999999999985311 10000 0001111111 23567788999
Q ss_pred HHHHhhcccCCCCCCCHHHHHHH
Q 024460 204 AVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 204 ~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
+++...|+.+|++|++..-..+.
T Consensus 488 qlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred HHHHHHhcCCccccCCccHHHhH
Confidence 99999999999999987644443
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-20 Score=154.99 Aligned_cols=217 Identities=20% Similarity=0.167 Sum_probs=162.6
Q ss_pred CCccceeeEE-eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 024460 8 DNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 8 pniv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ni 86 (267)
+++..+++.+ ..+...|+||+.+ |.+|.++..... ...++..++..++.|++.+|.+||+.| ++||||||.|+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~ 153 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENF 153 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHe
Confidence 5888899888 5788899999998 779999886532 578999999999999999999999999 99999999999
Q ss_pred EEcCC-----CceEEeccCCcccCC--CCCCc----c-e-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC
Q 024460 87 LLDND-----FNPKLSDFGLAKLGP--VGDNT----H-V-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 87 li~~~-----~~~~l~d~~~~~~~~--~~~~~----~-~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++... ..++++|||+++... ..... . . .....||..|.++....+...+.+.|+||++.++.+++.|
T Consensus 154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 99754 468999999998322 11111 1 1 1234589999999999999999999999999999999999
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
..||.................. ..... .....+.++.++...+-..+..++|.+..+...|++....
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~--------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRK--------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred CCCCccccccchHHHHHHHhhh--------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 9999644432221111100000 00000 1223356677888888889999999999999999888877
Q ss_pred cCCCCCcCCC
Q 024460 234 RDSHPVSRNA 243 (267)
Q Consensus 234 ~~~~~~~~~~ 243 (267)
.......+..
T Consensus 301 ~~~~~~~~~d 310 (322)
T KOG1164|consen 301 EGSKEDSPFD 310 (322)
T ss_pred cCCCCCCCCc
Confidence 7554443333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.5e-21 Score=152.69 Aligned_cols=202 Identities=21% Similarity=0.342 Sum_probs=154.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.+.||||+++++.|.....+.++..|++.|+|+..+.. ...-..+..++.+++.+++.+++|||+.... +.--.+
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep~-ipr~~l 317 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYL 317 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhc
Confidence 5778999999999999999999999999999999999975 2334566788999999999999999988632 455578
Q ss_pred CCCcEEEcCCCceEE--eccCCcccCCCCCCcceeeecccccceeCCcccccCCC---cccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKL--SDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL---TLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l--~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+...++|+++-..++ +|--++. ......-.+.|++||.+...+- -.++|+|||++++||+.+...|
T Consensus 318 ns~hvmidedltarismad~kfsf---------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 318 NSKHVMIDEDLTARISMADTKFSF---------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred ccceEEecchhhhheecccceeee---------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccc
Confidence 899999998765554 3332221 1122334678999999887643 3679999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
|........ -.++....++-.+|...+..+.+++..|.+.||.+||.++.++-.|+.++
T Consensus 389 fadlspmec----------------gmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 389 FADLSPMEC----------------GMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCchhh----------------hhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 964433221 11222233334456677888999999999999999999999998887654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.1e-20 Score=148.43 Aligned_cols=222 Identities=17% Similarity=0.149 Sum_probs=176.4
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ni 86 (267)
-++|..+|-|...+.+..+|+|.+ |.+|+|++.- -+..|+..+++.++.|++.-++++|++. +|+|||||+|+
T Consensus 83 ~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNF 155 (449)
T KOG1165|consen 83 TEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNF 155 (449)
T ss_pred CCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccce
Confidence 489999999988888999999999 7799998854 4668999999999999999999999999 99999999999
Q ss_pred EEc-----CCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 87 LLD-----NDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 87 li~-----~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||. ....+.++|||++......... .......||.+||+-....+...+.+.|+-+||=+++++|-|..|
T Consensus 156 LIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLP 235 (449)
T KOG1165|consen 156 LIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 235 (449)
T ss_pred eecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCc
Confidence 995 3356899999999875443222 334456789999999999999999999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
|+..+...-..... ++-+...... +-...|.++..-+.-.-..+..+-|+++-+...|..+..+
T Consensus 236 WQGLKA~tnK~kYe-------------KIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 236 WQGLKADTNKEKYE-------------KIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cccccCcchHHHHH-------------HhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 98665433221111 1111111000 0123477888888888899999999999999999999998
Q ss_pred cCCCCCcCCCCCCCC
Q 024460 234 RDSHPVSRNAGARGV 248 (267)
Q Consensus 234 ~~~~~~~~~~~~~~~ 248 (267)
..-+.-..++|...+
T Consensus 303 ~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 303 LGETDDGEYDWMGLN 317 (449)
T ss_pred cCCcccccccccccC
Confidence 888877777777555
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-20 Score=172.22 Aligned_cols=198 Identities=23% Similarity=0.208 Sum_probs=147.0
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
..+|||++++..+.+.+..-|+|-+|... +|+|.+. .+.-+..-+...++.|++.|+..+|+.| ++|||||.
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKs 148 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKS 148 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---cccccccc
Confidence 46899999999888888888999999855 9999884 4566777788889999999999999999 99999999
Q ss_pred CcEEEcCCCceEEeccCCcccCCCCC-Cc----ceeeecccccceeCCcccccC----------C-CcccCCeeehHHHH
Q 024460 84 ANILLDNDFNPKLSDFGLAKLGPVGD-NT----HVSTRVMGTYGYCAPEYAMSG----------K-LTLKSDIYSFGVVL 147 (267)
Q Consensus 84 ~nili~~~~~~~l~d~~~~~~~~~~~-~~----~~~~~~~~~~~~~aPE~~~~~----------~-~~~~~Dv~slG~i~ 147 (267)
+||||+.=+.+.|+||...+-+.... .. ..-.+.....+|.|||-+... + .+++=||||+||++
T Consensus 149 ENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVi 228 (1431)
T KOG1240|consen 149 ENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVI 228 (1431)
T ss_pred ceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHH
Confidence 99999999999999998875433221 11 112233456699999987652 1 45678999999999
Q ss_pred HHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 148 LELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 148 ~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
.|+++ |.++|.....-.- ......+.++..+.++ ...+++++..|++.+|+.|.++++.++.
T Consensus 229 aELf~Eg~PlF~LSQL~aY------r~~~~~~~e~~Le~Ie-----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 229 AELFLEGRPLFTLSQLLAY------RSGNADDPEQLLEKIE-----------DVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHhcCCCcccHHHHHhH------hccCccCHHHHHHhCc-----------CccHHHHHHHHHccCchhccCHHHHHHh
Confidence 99977 6888864431111 0000000111111111 2248899999999999999999999997
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.4e-18 Score=142.90 Aligned_cols=215 Identities=33% Similarity=0.418 Sum_probs=156.5
Q ss_pred CCCCCCC-CccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHD-NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hp-niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++.+.|+ +|+++++++......+++++++.++++.+++...... ..+.......++.|++.++.++|..+ ++|+|
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd 126 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRD 126 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4567777 7999999998777889999999999999777541111 37888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-ceEEeccCCcccCCCCCCcc----eeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHh
Q 024460 81 LKSANILLDNDF-NPKLSDFGLAKLGPVGDNTH----VSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 81 i~~~nili~~~~-~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~ 152 (267)
+||+||+++..+ .++++|||.+.......... ......++..|++||.+.. ..++...|+|++|+++++++.
T Consensus 127 ~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred CCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999888 79999999987443332221 2355678999999999987 578899999999999999999
Q ss_pred CCCCccccCcc-CccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 153 GRKAMDLSKGQ-GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 153 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
|..|+...... ......... ...... .................+.+++..|+..+|..|.+..+....
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKII---LELPTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCCCCCccccHHHHHHHH---HhcCCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 99996544321 000000000 000000 000000000001223578899999999999999998887764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.9e-20 Score=155.64 Aligned_cols=173 Identities=25% Similarity=0.321 Sum_probs=128.9
Q ss_pred eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCC
Q 024460 22 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101 (267)
Q Consensus 22 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~ 101 (267)
++|+.|++|+..+|.++++..+ .....+....+.++.|++.++.| ++ .+|+|+||.||+...+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5789999999999999997543 34567778899999999999999 77 99999999999999998999999999
Q ss_pred cccCCCCC----CcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccchhhhchhhh
Q 024460 102 AKLGPVGD----NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 176 (267)
Q Consensus 102 ~~~~~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~ 176 (267)
........ .....+...|+.+|++||.+.+..|+.++|||+||++++|++. -...+......
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------------- 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------------- 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-------------
Confidence 87543333 1223456779999999999999999999999999999999987 22222110000
Q ss_pred hcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 177 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
...-...+.+.+....| +-..|+++++...|.+||++.
T Consensus 470 --~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 470 --TDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --hhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 00001111112211222 235899999999999999443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.7e-19 Score=136.69 Aligned_cols=212 Identities=20% Similarity=0.159 Sum_probs=157.3
Q ss_pred CCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 5 LHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 5 l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
|+| .+|..+..++.+..+..+||+.+ |.+|+++++- -...++..+++.++-|++.-++|+|.++ ++|+||||
T Consensus 67 L~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKP 139 (341)
T KOG1163|consen 67 LQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKP 139 (341)
T ss_pred hccCCCCchhhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCc
Confidence 444 46677777888888999999999 7799998864 3567999999999999999999999999 99999999
Q ss_pred CcEEEc---CCCceEEeccCCcccCCCCCC-----cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 84 ANILLD---NDFNPKLSDFGLAKLGPVGDN-----THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 84 ~nili~---~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+|+. ....+.++|||++........ ........||.+|.+-....+...+.+.|+-|+|.++.++.-|..
T Consensus 140 dNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~L 219 (341)
T KOG1163|consen 140 DNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSL 219 (341)
T ss_pred cceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCC
Confidence 999995 346799999999976433211 122344568999999888888888999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
||+......+.+........- ....-..+. ...|.++.-.+.-|-....++-|+..-+.+.++-|...
T Consensus 220 PWQglka~tk~QKyEkI~EkK------~s~~ie~LC----~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 220 PWQGLKAATKKQKYEKISEKK------MSTPIEVLC----KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred cccccchhhHHHHHHHHHHhh------cCCCHHHHh----CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 998665544432222111110 000000011 23366778888888888899999998888877654433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-18 Score=151.50 Aligned_cols=178 Identities=25% Similarity=0.265 Sum_probs=147.9
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||+++++...+..+...+++.++..+|.|...+. ....+.+.....+...++.++.++|+.+ ++|+|+|++|
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~en 127 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLEN 127 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccc
Confidence 38999999999999999999999999999987774 4567778888889999999999999999 9999999999
Q ss_pred EEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCc
Q 024460 86 ILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGE 165 (267)
Q Consensus 86 ili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~ 165 (267)
|+++.+|.+++.|||+.+..-.... ..|+..|+|||++. ....++|-|++|+++++|++|..||..
T Consensus 128 illd~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------ 193 (612)
T KOG0603|consen 128 VLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------ 193 (612)
T ss_pred eeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------
Confidence 9999999999999999875322211 17899999999887 678899999999999999999999973
Q ss_pred cchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.....++... -.+|...+....+++..++..+|..|.-.
T Consensus 194 --------------~~~~~Il~~~--~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 194 --------------DTMKRILKAE--LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --------------HHHHHHhhhc--cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1111111111 13467888999999999999999999644
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-18 Score=140.52 Aligned_cols=164 Identities=23% Similarity=0.305 Sum_probs=107.1
Q ss_pred eEEEEecCCCCCHHHHhcccC---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEecc
Q 024460 23 RLLVYEYMPMGSLEDHLYDLE---PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDF 99 (267)
Q Consensus 23 ~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~ 99 (267)
.+++|+-+ .++|.+++.... .............+..|++..+++||..| ++|+||+|+|++++.+|.++|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 47888988 458888765311 11223334455677799999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCCcceeeecccccceeCCcccccC--------CCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhh
Q 024460 100 GLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 171 (267)
Q Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~ 171 (267)
+..... +.. ... ...+..|.+||..... .++.+.|.|+||+++|.|+|+..||...........
T Consensus 190 ~~~~r~---g~~-~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRA---GTR-YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEET---TEE-EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeec---Cce-eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 887632 111 111 2334668889876442 467889999999999999999999975543322211
Q ss_pred chhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCC
Q 024460 172 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR 217 (267)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 217 (267)
.+ +... +.++.+..+|..+|+.+|.+|
T Consensus 262 -----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 -----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 01 1223 678889999999999999887
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=134.13 Aligned_cols=115 Identities=19% Similarity=0.088 Sum_probs=84.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|+|+++.+.. .+..|+||||+++++|.. +.. .. ...++.+++.+|.|||+++ ++|+|
T Consensus 74 iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~~---~~-------~~~~~~~i~~aL~~lH~~g---IiHrD 136 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-ARP---HG-------DPAWFRSAHRALRDLHRAG---ITHND 136 (365)
T ss_pred HHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-hCc---cc-------hHHHHHHHHHHHHHHHHCC---CeeCC
Confidence 4678999999863322 246899999999999963 211 11 1467889999999999999 99999
Q ss_pred C-CCCcEEEcCCCceEEeccCCcccCCCCCCcce------eeecccccceeCCcccccC
Q 024460 81 L-KSANILLDNDFNPKLSDFGLAKLGPVGDNTHV------STRVMGTYGYCAPEYAMSG 132 (267)
Q Consensus 81 i-~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~~ 132 (267)
| ||+||+++.++.++|+|||+++.......... -....++..|.+||.+...
T Consensus 137 L~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 137 LAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9 99999999889999999999986543221111 0223456678999987653
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.6e-16 Score=126.19 Aligned_cols=120 Identities=15% Similarity=0.221 Sum_probs=90.0
Q ss_pred CCCCCCCCccceeeEEeeC--------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+.+++|+||..+.+++... +..+++|||++|.+|.+... +++ ....+++.++..+|..+
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g- 155 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG- 155 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-
Confidence 4577899999999886543 35789999999999977641 222 24568999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHH
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l 151 (267)
++|+|++|.|++++.++ ++++|||............ .......+..++|+|+||+++....
T Consensus 156 --i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 156 --MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred --CccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 99999999999999888 9999999886432111100 0233345667899999998876553
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.2e-15 Score=136.20 Aligned_cols=196 Identities=18% Similarity=0.202 Sum_probs=141.7
Q ss_pred CccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEE
Q 024460 9 NLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL 88 (267)
Q Consensus 9 niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili 88 (267)
.|..+.......+.-++|+||.+.|+|.++++ ..+.+++..+.-+..|++..+..||..+ |||+||||+|+++
T Consensus 755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll 827 (974)
T KOG1166|consen 755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLL 827 (974)
T ss_pred chHHHHHHHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEe
Confidence 45555555666778899999999999999996 4678899999999999999999999999 9999999999999
Q ss_pred c-------CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 89 D-------NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 89 ~-------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
. +...++|+|||.+.-.........-...+++..+-.+|...+++|+..+|.|.|+.+++-||.|...- ..+
T Consensus 828 ~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~ 906 (974)
T KOG1166|consen 828 RREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKN 906 (974)
T ss_pred ecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcC
Confidence 3 34568999999876433222222334466788999999999999999999999999999999987532 000
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
+. ...+...++.-+..+. +.+++..+|+.+...=|...++...|++.-.+.
T Consensus 907 ------------------g~-~~~~~~~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 907 ------------------GS-SWMVKTNFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ------------------Cc-ceeccccchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 00 0001111110111222 445666677766666688888888877665544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-15 Score=117.60 Aligned_cols=139 Identities=22% Similarity=0.205 Sum_probs=99.5
Q ss_pred CCCCCCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++|.| ++|++++++ +..+++|||+.|.+|...+.. . ...++.|++.++.++|.+| ++|+
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHr 115 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHN 115 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccC
Confidence 3667854 789999886 346999999999888654311 1 1357789999999999999 9999
Q ss_pred CC-CCCcEEEcCCCceEEeccCCcccCCCCCCc----c---e----eeecccccceeCCcccccC-CCc-ccCCeeehHH
Q 024460 80 DL-KSANILLDNDFNPKLSDFGLAKLGPVGDNT----H---V----STRVMGTYGYCAPEYAMSG-KLT-LKSDIYSFGV 145 (267)
Q Consensus 80 di-~~~nili~~~~~~~l~d~~~~~~~~~~~~~----~---~----~~~~~~~~~~~aPE~~~~~-~~~-~~~Dv~slG~ 145 (267)
|| ||.||+++.++.++|+|||++......... . . +.....++.+++|+...-. ..+ .+.+.++.|.
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 99 799999999999999999999854332211 0 0 1112245566666644321 233 4566778999
Q ss_pred HHHHHHhCCCCc
Q 024460 146 VLLELITGRKAM 157 (267)
Q Consensus 146 i~~~~l~g~~p~ 157 (267)
.+|.++|+..+.
T Consensus 196 ~~~~~~~~~~~~ 207 (218)
T PRK12274 196 PVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHhccCCc
Confidence 999999988765
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.5e-16 Score=125.68 Aligned_cols=199 Identities=26% Similarity=0.334 Sum_probs=139.2
Q ss_pred CCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 4 LLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
++-|.|||+++.++.+.. ...+++||+..|++..++++.....+.+......+|+.||+.||.|||+. .++++|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppiih 201 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIH 201 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcccc
Confidence 457899999999886543 57899999999999999998777788899999999999999999999988 467999
Q ss_pred CCCCCCcEEEcCCCceEEeccCC--cccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 79 RDLKSANILLDNDFNPKLSDFGL--AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~--~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+++..+.|++..++-+|++.-.- ....-............+.++|.+||.=...+.+.++|||++|+...+|..+...
T Consensus 202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 99999999999888888742211 1100011111223344567889999964445667889999999999999876643
Q ss_pred ccccC--ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSK--GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
-.... .+....+ ...+..+-++. =+.++.+|++..|..||++.+++-
T Consensus 282 ~tnseS~~~~ee~i----------a~~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 282 STNSESKVEVEENI----------ANVIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred cCCCcceeehhhhh----------hhheeeccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 21110 0000000 00000001111 246788999999999999998753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.55 E-value=7.8e-15 Score=114.61 Aligned_cols=92 Identities=15% Similarity=0.102 Sum_probs=70.3
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeeCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-H~~~~~~i~h~di 81 (267)
+++.++++.....+ ... ..++||||++++++..... ....++...+..++.|++.++.++ |..+ ++|+||
T Consensus 74 ~~l~~~~v~~p~~~-~~~-~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDl 144 (190)
T cd05147 74 KRLVTAGIPCPEPI-LLK-SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADL 144 (190)
T ss_pred HHHHHCCCCCCcEE-Eec-CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 34455555333222 222 2389999998877665432 235788899999999999999999 7888 999999
Q ss_pred CCCcEEEcCCCceEEeccCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~ 104 (267)
||+||+++ ++.++|+|||++..
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEE-CCcEEEEEcccccc
Confidence 99999998 47899999999874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.8e-15 Score=136.71 Aligned_cols=201 Identities=26% Similarity=0.278 Sum_probs=155.0
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeeCCCCCCc
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDLKSAN 85 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~~i~h~di~~~n 85 (267)
|+|++.+++........+++.++..++++.+.+.. ......+....-..+.|+..++.|+| ..+ +.|+|++|+|
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n 154 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSN 154 (601)
T ss_pred cccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCcc
Confidence 99999999999999999999999999999888832 23335666777889999999999999 888 9999999999
Q ss_pred EEEcCCC-ceEEeccCCcccCCC-CCCcceeeeccc-ccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 86 ILLDNDF-NPKLSDFGLAKLGPV-GDNTHVSTRVMG-TYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 86 ili~~~~-~~~l~d~~~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
.+++..+ .++..||+++..... ...........| +..|.|||...+. ...+..|+||+|+++..+++|..||+...
T Consensus 155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 9999998 999999999987665 444444455667 9999999998874 55688999999999999999999997554
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........... .. ..+.............+++.+++..+|..|.+.+++..
T Consensus 235 ~~~~~~~~~~~------~~-------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 235 RKDGRYSSWKS------NK-------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccceeecc------cc-------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 43321110000 00 00001111233445778899999999999999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.2e-14 Score=112.37 Aligned_cols=87 Identities=15% Similarity=0.156 Sum_probs=69.0
Q ss_pred CCCCccceeeEEeeCC---eeE-EEEec--CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeee
Q 024460 6 HHDNLVTLIGYCTSGD---QRL-LVYEY--MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL-EYLHCKANPPVIY 78 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~---~~~-lv~e~--~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l-~~lH~~~~~~i~h 78 (267)
.||||++++++++++. .++ +|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---Ivh 128 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVT 128 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---Eee
Confidence 6899999999998874 434 78999 557899999954 235555 35677777777 9999999 999
Q ss_pred CCCCCCcEEEcC----CCceEEeccCCc
Q 024460 79 RDLKSANILLDN----DFNPKLSDFGLA 102 (267)
Q Consensus 79 ~di~~~nili~~----~~~~~l~d~~~~ 102 (267)
+||||+||+++. +..++|+|++-+
T Consensus 129 rDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 129 MELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999999963 347999995443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.8e-14 Score=110.95 Aligned_cols=93 Identities=17% Similarity=0.104 Sum_probs=71.8
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDL 81 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di 81 (267)
.++.|++|.....+.... .++||||++++++..... ....++...+..++.|++.++.++|. .+ ++|+||
T Consensus 74 ~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDl 144 (190)
T cd05145 74 KRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDL 144 (190)
T ss_pred HHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 445677764443333222 489999998875544321 23457778899999999999999999 88 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLG 105 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~ 105 (267)
||+||+++ ++.++|+|||++...
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceec
Confidence 99999998 789999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.50 E-value=6.6e-15 Score=134.89 Aligned_cols=139 Identities=25% Similarity=0.313 Sum_probs=105.8
Q ss_pred HHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc------------ce-eeecccccceeCCc
Q 024460 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT------------HV-STRVMGTYGYCAPE 127 (267)
Q Consensus 61 l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~------------~~-~~~~~~~~~~~aPE 127 (267)
++.+++|||..+ |+|+|+||+|.+|+.-|.+|++|||+.......... ++ .....|++.|.|||
T Consensus 152 mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPe 228 (1205)
T KOG0606|consen 152 MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPE 228 (1205)
T ss_pred hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChh
Confidence 378999999999 999999999999999999999999988652211110 11 13457899999999
Q ss_pred ccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHH
Q 024460 128 YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVT 206 (267)
Q Consensus 128 ~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 206 (267)
++....|....|.|++|+|+|+++-|..||.....+.... ++.... .+.+- ....+.+.++++
T Consensus 229 VilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-------~wpE~---------dea~p~Ea~dli 292 (1205)
T KOG0606|consen 229 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-------EWPEE---------DEALPPEAQDLI 292 (1205)
T ss_pred hhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-------ccccc---------CcCCCHHHHHHH
Confidence 9999999999999999999999999999998664433221 111111 11000 134467899999
Q ss_pred HhhcccCCCCCC
Q 024460 207 AMCLNEEANFRP 218 (267)
Q Consensus 207 ~~cl~~~p~~Rp 218 (267)
.+.|+.+|.+|-
T Consensus 293 ~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 293 EQLLRQNPLCRL 304 (1205)
T ss_pred HHHHHhChHhhc
Confidence 999999999994
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6.7e-13 Score=117.07 Aligned_cols=137 Identities=18% Similarity=0.211 Sum_probs=106.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.+|||||+++++.++.++..|+|+|.+. .|..++.+ +....+..-+.||+.||.|||..++ ++|+++
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv 131 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNV 131 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccE
Confidence 678999999999999999999999999983 67777744 2256677778999999999985543 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g 153 (267)
+-+.|+|+..|.-+|++|.++........ ..........|..|+.+.... -..|.|.||+++++++.|
T Consensus 132 ~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 132 CKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999998864322221 112222334466676554333 346999999999999998
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.3e-13 Score=105.02 Aligned_cols=91 Identities=23% Similarity=0.345 Sum_probs=77.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|++|.....++...+..+++|||++|++|.+.+.. .. . ....++.+++.++.++|..+ ++|+|+
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~----~~---~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl 121 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINS----NG---M-EELELSREIGRLVGKLHSAG---IIHGDL 121 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHh----cc---H-HHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 3456788887777777777788999999999999998853 11 1 77889999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~ 104 (267)
+|.||+++ ++.++++|||.+..
T Consensus 122 ~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 122 TTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccEEEE-CCCEEEEECCcccC
Confidence 99999999 78899999998863
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=118.12 Aligned_cols=87 Identities=25% Similarity=0.326 Sum_probs=76.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++|++++....++......++||||+++++|.+++. ....++.+++.++.+||+.+ ++|+|+
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDl 454 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDL 454 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCC
Confidence 567899999888777777777899999999999999883 34678999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~ 104 (267)
||+||++ .++.++|+|||+++.
T Consensus 455 kp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 455 TTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ChHHEEE-ECCcEEEEeCccccc
Confidence 9999999 577899999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.8e-12 Score=102.18 Aligned_cols=88 Identities=27% Similarity=0.367 Sum_probs=72.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|+++.....++...+..++||||++|++|.+.+.. ... .++.+++.++.+||..+ ++|+|+
T Consensus 51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl 116 (199)
T TIGR03724 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDL 116 (199)
T ss_pred HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCC
Confidence 3456677765555555666778999999999999988743 110 78999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~ 104 (267)
+|.||+++ ++.++++|||++..
T Consensus 117 ~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 117 TTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CcceEEEE-CCcEEEEECCCCcC
Confidence 99999999 78999999998863
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.9e-12 Score=103.70 Aligned_cols=91 Identities=26% Similarity=0.207 Sum_probs=70.3
Q ss_pred CCCCCCCCc--cceeeEEeeCC----eeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLLHHDNL--VTLIGYCTSGD----QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l~Hpni--v~~~~~~~~~~----~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+.+|+|++| +..+++...+. ..++|||++++ .+|.+++.. ..++.. .+.+++.++.+||..|
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G-- 162 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG-- 162 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC--
Confidence 445677775 56666544322 23599999997 689888743 334443 3578999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCccc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~ 104 (267)
++|+||+|.|||++.++.++|+|||.+..
T Consensus 163 -I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 163 -VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred -CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999888999999999874
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1e-10 Score=98.68 Aligned_cols=207 Identities=16% Similarity=0.159 Sum_probs=140.7
Q ss_pred eeEEEEecCCCC-CHHHHhcc--cCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEec
Q 024460 22 QRLLVYEYMPMG-SLEDHLYD--LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 98 (267)
Q Consensus 22 ~~~lv~e~~~~~-sL~~~l~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d 98 (267)
...++|+.+.+- .+.++++- .+.....+.+...+..+..++.+.+-||+.| .+-+|++++|+|+++++.+.|+|
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVd 160 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVD 160 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEc
Confidence 367888887654 23333321 1224456778899999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCcceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHHhC-CCCccccCccC------cc
Q 024460 99 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITG-RKAMDLSKGQG------EQ 166 (267)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l~g-~~p~~~~~~~~------~~ 166 (267)
-+...... ......-..|...|.+||...- ..-+...|.|.||+++++++.| ..||..-.... +.
T Consensus 161 sDsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 161 SDSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred ccceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 88766432 2222333567889999997652 2345779999999999999876 88985332111 11
Q ss_pred chhhhchhhhhcccccccccCCcCCCCCc-HHHHHHHHHHHHhhccc--CCCCCCCHHHHHHHHHHhhhccCCCC
Q 024460 167 NLVSWSRPFLKDQKKFVHLVDPLLHGRYP-RRCLNYAVAVTAMCLNE--EANFRPLINDIVVALDYLVSQRDSHP 238 (267)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~--~p~~Rpt~~ev~~~l~~l~~~~~~~~ 238 (267)
.+......+ ..+...-..+.- ..+| ...++.+..++.+|+.. ++.-|||++-++.+|.++.++...+-
T Consensus 238 ~Ia~g~f~y---a~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 238 DIAHGRFAY---ASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred hhhcceeee---chhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 111111101 111111111111 1122 35578899999999987 46789999999999999998876654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.2e-11 Score=107.94 Aligned_cols=195 Identities=26% Similarity=0.261 Sum_probs=143.2
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeeCCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----GLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~----~l~~lH~~~~~~i~h~di 81 (267)
.|+|.++.+..++..+..|+-+|.|. .+|..+... -...++...++..+.+... |+.++|..+ ++|.|+
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~ 248 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDL 248 (524)
T ss_pred ccccccccCcccccCCcceeeecccc-chhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---cccccc
Confidence 48888998889999999999999994 688888865 3455777778888888888 999999999 999999
Q ss_pred CCCcEEEcCC-CceEEeccCCcccCCCCC---CcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDND-FNPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~-~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+|.||+...+ ..++++||++...+.... ...+.....+...|++||.. ..-++.+.|+|++|.++.+..++....
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999988 889999999987654332 22233344778899999964 567889999999999998887776554
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... +..+.++-...+..++-......+...+..|++.+|-.|++.+.+..
T Consensus 328 ~~g~-----------------~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 328 SVGK-----------------NSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCCC-----------------CCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 3221 11111111111111111122445666899999999999998887665
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-11 Score=99.97 Aligned_cols=76 Identities=16% Similarity=0.145 Sum_probs=62.8
Q ss_pred eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCC
Q 024460 22 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101 (267)
Q Consensus 22 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~ 101 (267)
..++||||+++.+|..... .........+..++.|++.++.+||..+. ++|+||+|+||+++ ++.++|+|||.
T Consensus 122 ~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~ 194 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQ 194 (237)
T ss_pred CceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChh
Confidence 3589999999988876542 23345566678999999999999997763 99999999999999 78899999999
Q ss_pred ccc
Q 024460 102 AKL 104 (267)
Q Consensus 102 ~~~ 104 (267)
+..
T Consensus 195 a~~ 197 (237)
T smart00090 195 SVE 197 (237)
T ss_pred hhc
Confidence 874
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-11 Score=94.63 Aligned_cols=71 Identities=18% Similarity=0.118 Sum_probs=60.6
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
+..++||||+++++|...... .....++.+++.++.++|..+ ++|+||+|.||+++.++.++|+|||
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECC
Confidence 456899999999988765421 234678899999999999998 9999999999999999999999999
Q ss_pred Cccc
Q 024460 101 LAKL 104 (267)
Q Consensus 101 ~~~~ 104 (267)
.+..
T Consensus 171 ~~~~ 174 (198)
T cd05144 171 QMVS 174 (198)
T ss_pred cccc
Confidence 9864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.2e-10 Score=86.92 Aligned_cols=90 Identities=23% Similarity=0.200 Sum_probs=73.5
Q ss_pred CCCCC--CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 3 SLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 3 ~~l~H--pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+.++| .++++++.++..++..+++|||++++.+..+ +......++.+++.+++.+|.....+++|+|
T Consensus 46 ~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~D 114 (155)
T cd05120 46 QLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114 (155)
T ss_pred HHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecC
Confidence 34444 5888888888888889999999988766443 4456677889999999999985333499999
Q ss_pred CCCCcEEEcCCCceEEeccCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~ 103 (267)
++|.||+++..+.++++||+.+.
T Consensus 115 l~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 115 LHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred CCcceEEEECCcEEEEEeccccc
Confidence 99999999988899999999886
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-09 Score=94.03 Aligned_cols=179 Identities=17% Similarity=0.189 Sum_probs=125.7
Q ss_pred CCCCCCCCccceeeEEee----CCeeEEEEecCCCC-CHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMG-SLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGL 65 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~-sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~l~~~l 65 (267)
.+++.|+|||++.++|.. +..+++|++|+++. +|.++...... .+...++..+|.++.|+..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 467899999999998863 44689999998754 67776654322 234577889999999999999
Q ss_pred HHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHH
Q 024460 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 145 (267)
Q Consensus 66 ~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 145 (267)
.++|+.| +..+-+.+.+|+++++.++++..+|....+...... .+. -..+-|.-.||.
T Consensus 407 ~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~~----------------~le---~~Qq~D~~~lG~ 464 (655)
T KOG3741|consen 407 YSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPTE----------------PLE---SQQQNDLRDLGL 464 (655)
T ss_pred HHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCCCc----------------chh---HHhhhhHHHHHH
Confidence 9999999 999999999999999889999888876543211100 000 123458889999
Q ss_pred HHHHHHhCCCCc-cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 146 VLLELITGRKAM-DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 146 i~~~~l~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
++..+.+|..-- ...... +. -...+-..++.++++++.-....++.+ -++++++
T Consensus 465 ll~aLAt~~~ns~~~d~~~--------------------~s----~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 465 LLLALATGTENSNRTDSTQ--------------------SS----HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred HHHHHhhcccccccccchH--------------------HH----HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 999999986421 100000 00 000112466778888888888888887 5788887
Q ss_pred HHH
Q 024460 225 VAL 227 (267)
Q Consensus 225 ~~l 227 (267)
.++
T Consensus 520 p~~ 522 (655)
T KOG3741|consen 520 PMI 522 (655)
T ss_pred HHH
Confidence 753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.8e-10 Score=99.67 Aligned_cols=153 Identities=20% Similarity=0.253 Sum_probs=106.8
Q ss_pred HHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceee-------ecccccceeCCccc
Q 024460 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-------RVMGTYGYCAPEYA 129 (267)
Q Consensus 57 ~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~-------~~~~~~~~~aPE~~ 129 (267)
=+.+++.|+.++|...+ +||++|.|++|.++.++..|+..|+.+-.......+.... .......|.+||.+
T Consensus 104 nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34556689999997654 9999999999999999999999999875433322221111 11235589999999
Q ss_pred ccCCCcccCCeeehHHHHHHHH-hCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHh
Q 024460 130 MSGKLTLKSDIYSFGVVLLELI-TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM 208 (267)
Q Consensus 130 ~~~~~~~~~Dv~slG~i~~~~l-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 208 (267)
.....+.++|+||+|+++|.+. .|+..+........ .......+..-...++.+.+.++.+-+.+
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~--------------~~~~~~~~~~~~~~~s~~~p~el~~~l~k 247 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS--------------YSFSRNLLNAGAFGYSNNLPSELRESLKK 247 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhccCCcch--------------hhhhhcccccccccccccCcHHHHHHHHH
Confidence 9888899999999999999998 44444432221111 11111111111122346778899999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 024460 209 CLNEEANFRPLINDIVV 225 (267)
Q Consensus 209 cl~~~p~~Rpt~~ev~~ 225 (267)
++..++.-||++.++..
T Consensus 248 ~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 248 LLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HhcCCcccCcchhhhhc
Confidence 99999999998887765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.4e-09 Score=100.75 Aligned_cols=192 Identities=24% Similarity=0.224 Sum_probs=133.9
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ni 86 (267)
||.++...-.+......+++++|+.+++|...++. -+..++.-....+..+..+.++||... +.|+|++|.|+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSL 935 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccch---hhcccccccch
Confidence 45555444444456678999999999999999865 223444445556677888999999988 99999999999
Q ss_pred EEcCCCceEEeccCCcccCCCC----CC-------------------------cceeeecccccceeCCcccccCCCccc
Q 024460 87 LLDNDFNPKLSDFGLAKLGPVG----DN-------------------------THVSTRVMGTYGYCAPEYAMSGKLTLK 137 (267)
Q Consensus 87 li~~~~~~~l~d~~~~~~~~~~----~~-------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~ 137 (267)
++...+...+.+|+........ +. ........+++.|.+||...+..-...
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 9999999999998732211100 00 001223567899999999999999999
Q ss_pred CCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCC-CcHHHHHHHHHHHHhhcccCCCC
Q 024460 138 SDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR-YPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 138 ~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
+|.|++|+.+++.++|.+||.-...+.... .+++....-. -+...+....+++...+..+|.+
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na~tpq~~f~----------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNAETPQQIFE----------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCCcchhhhhh----------------ccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 999999999999999999996443322210 0000000000 02344566888999999999999
Q ss_pred CCCHH
Q 024460 217 RPLIN 221 (267)
Q Consensus 217 Rpt~~ 221 (267)
|-.+.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 97766
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=98.87 E-value=5.1e-09 Score=81.53 Aligned_cols=73 Identities=22% Similarity=0.186 Sum_probs=57.7
Q ss_pred eeEEEEecCCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCcEEEcCCCceEEecc
Q 024460 22 QRLLVYEYMPMGSLED-HLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDF 99 (267)
Q Consensus 22 ~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di~~~nili~~~~~~~l~d~ 99 (267)
..++||||++++++.. .+.. .... ..+..++.+++.++.++|. .+ ++|+|++|+||+++ ++.++++||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~-----~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKD-----VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhh-----hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEEC
Confidence 4589999998854321 1111 0001 5678899999999999999 88 99999999999999 889999999
Q ss_pred CCccc
Q 024460 100 GLAKL 104 (267)
Q Consensus 100 ~~~~~ 104 (267)
|.+..
T Consensus 159 g~a~~ 163 (187)
T cd05119 159 PQAVE 163 (187)
T ss_pred ccccc
Confidence 99874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.6e-09 Score=92.67 Aligned_cols=191 Identities=20% Similarity=0.170 Sum_probs=134.5
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
.|.+++.++..+......|+--|||+++++..... -...+.+..++.+..|++.++.++|+.. ++|.|++|+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psn 396 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSN 396 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccc
Confidence 57788888888888888889999999998877662 2456777888999999999999999999 9999999999
Q ss_pred EEEcCC-CceEEeccCCcccCCCCCCcceeeeccccccee--CCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 86 ILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC--APEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 86 ili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~--aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
|++..+ +..+++||++..-+... ........++. ++.......+..++|+++||+-+.+.+++.+.-....
T Consensus 397 i~i~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~- 470 (524)
T KOG0601|consen 397 ILISNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV- 470 (524)
T ss_pred eeeccchhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-
Confidence 999875 77789999987532111 11122233334 4444445678899999999999999988775432111
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
.|. .+....-+. .......+..+.+.+...++..||.+.++......
T Consensus 471 -------~~~--------~i~~~~~p~-----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 -------QSL--------TIRSGDTPN-----LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -------cce--------eeecccccC-----CCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 000 000000111 11223668888999999999999999887765443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.5e-08 Score=77.76 Aligned_cols=76 Identities=14% Similarity=0.093 Sum_probs=57.6
Q ss_pred CeeEEEEecCCCCCHHH-HhcccCCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeeCCCCCCcEEEcCCCceEEec
Q 024460 21 DQRLLVYEYMPMGSLED-HLYDLEPDQEPLSWNTRMKIAVGAARGLEYL-HCKANPPVIYRDLKSANILLDNDFNPKLSD 98 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~-~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l-H~~~~~~i~h~di~~~nili~~~~~~~l~d 98 (267)
..-++||||+.+..+.. .+. ...++......+..+++.++..| |..+ ++|+|+++.||++. ++.++++|
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iID 167 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFID 167 (197)
T ss_pred cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEE
Confidence 45679999997643321 222 22344456677889999999998 8888 99999999999997 46799999
Q ss_pred cCCcccC
Q 024460 99 FGLAKLG 105 (267)
Q Consensus 99 ~~~~~~~ 105 (267)
|+.+-..
T Consensus 168 F~qav~~ 174 (197)
T cd05146 168 VSQSVEP 174 (197)
T ss_pred CCCceeC
Confidence 9987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=7e-08 Score=79.23 Aligned_cols=77 Identities=21% Similarity=0.212 Sum_probs=63.8
Q ss_pred eeEEEEecCCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC-------CCc
Q 024460 22 QRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-------DFN 93 (267)
Q Consensus 22 ~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~-------~~~ 93 (267)
.-++|+|++++. +|.+++.... ....+......++.+++..+..||..| ++|+|+++.|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 468999999876 7988885421 234456677889999999999999999 999999999999974 467
Q ss_pred eEEeccCCcc
Q 024460 94 PKLSDFGLAK 103 (267)
Q Consensus 94 ~~l~d~~~~~ 103 (267)
+.++||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 8999999885
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.5e-08 Score=77.49 Aligned_cols=78 Identities=23% Similarity=0.175 Sum_probs=57.1
Q ss_pred cceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCcEEE
Q 024460 11 VTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYRDLKSANILL 88 (267)
Q Consensus 11 v~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~~i~h~di~~~nili 88 (267)
++++.+.. ...++||||+++.++...- ......+.+++.+++.||..+ ...++|+|++|.||++
T Consensus 56 P~~~~~~~--~~~~lv~e~i~G~~l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~ 121 (170)
T cd05151 56 PKLYYFDP--ETGVLITEFIEGSELLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL 121 (170)
T ss_pred CceEEEeC--CCCeEEEEecCCCcccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE
Confidence 44454432 3357999999998775420 011345678999999999887 2235999999999999
Q ss_pred cCCCceEEeccCCcc
Q 024460 89 DNDFNPKLSDFGLAK 103 (267)
Q Consensus 89 ~~~~~~~l~d~~~~~ 103 (267)
+ ++.++++||+.+.
T Consensus 122 ~-~~~~~liDf~~a~ 135 (170)
T cd05151 122 D-DGRLWLIDWEYAG 135 (170)
T ss_pred E-CCeEEEEeccccc
Confidence 8 6689999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.2e-08 Score=74.49 Aligned_cols=74 Identities=30% Similarity=0.424 Sum_probs=60.1
Q ss_pred EEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceE
Q 024460 16 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK 95 (267)
Q Consensus 16 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~ 95 (267)
+..+.+...++|||++|..|.+.+... ...++..+=..+.-||..+ |+|+|+.++||.+.+.+ +.
T Consensus 67 ~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~ 131 (204)
T COG3642 67 YDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IY 131 (204)
T ss_pred EEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EE
Confidence 444566678999999999999888541 1456666777789999999 99999999999998664 99
Q ss_pred EeccCCccc
Q 024460 96 LSDFGLAKL 104 (267)
Q Consensus 96 l~d~~~~~~ 104 (267)
++|||+...
T Consensus 132 ~IDfGLg~~ 140 (204)
T COG3642 132 FIDFGLGEF 140 (204)
T ss_pred EEECCcccc
Confidence 999999873
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.68 E-value=4.1e-08 Score=86.39 Aligned_cols=77 Identities=25% Similarity=0.197 Sum_probs=58.9
Q ss_pred CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHH-HHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEec
Q 024460 20 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR-GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 98 (267)
Q Consensus 20 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~-~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d 98 (267)
....++||||++|++|.+..... ..... ...++..++. .+..+|..| ++|+|++|.||+++.++.++++|
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liD 300 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALD 300 (437)
T ss_pred cCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEe
Confidence 34578999999999998876431 11122 2345555555 467889888 99999999999999999999999
Q ss_pred cCCcccC
Q 024460 99 FGLAKLG 105 (267)
Q Consensus 99 ~~~~~~~ 105 (267)
||++...
T Consensus 301 fG~~~~l 307 (437)
T TIGR01982 301 FGIVGRL 307 (437)
T ss_pred CCCeeEC
Confidence 9998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=74.58 Aligned_cols=87 Identities=26% Similarity=0.308 Sum_probs=69.5
Q ss_pred cceeeEEeeCC----eeEEEEecCCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 11 VTLIGYCTSGD----QRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 11 v~~~~~~~~~~----~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
++.+++.+... .-++|+|++++. +|.+++... ...+......++.+++..+.-||..| ++|+|+++.|
T Consensus 76 P~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~N 148 (206)
T PF06293_consen 76 PEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSN 148 (206)
T ss_pred CcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCccc
Confidence 44455555422 358999999874 799988652 22556677889999999999999999 9999999999
Q ss_pred EEEcCCC---ceEEeccCCccc
Q 024460 86 ILLDNDF---NPKLSDFGLAKL 104 (267)
Q Consensus 86 ili~~~~---~~~l~d~~~~~~ 104 (267)
||++.++ .+.++||+.++.
T Consensus 149 ILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 149 ILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EEEeCCCCceeEEEEcchhcee
Confidence 9998776 799999998774
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=8.6e-07 Score=67.34 Aligned_cols=85 Identities=22% Similarity=0.273 Sum_probs=63.0
Q ss_pred eEEeeCCeeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC-
Q 024460 15 GYCTSGDQRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF- 92 (267)
Q Consensus 15 ~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~- 92 (267)
-++.+...-.++|||++| .++.+++.... ...........++..+=..+.-||.++ ++|+|+..+||++...+
T Consensus 77 l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~ 151 (229)
T KOG3087|consen 77 LIFIDTYGGQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGN 151 (229)
T ss_pred EEEEecCCCeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCC
Confidence 345566677899999976 36777776521 122222333778888999999999999 99999999999995443
Q ss_pred --ceEEeccCCccc
Q 024460 93 --NPKLSDFGLAKL 104 (267)
Q Consensus 93 --~~~l~d~~~~~~ 104 (267)
.+.++|||++..
T Consensus 152 ~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 152 QITPILIDFGLSSV 165 (229)
T ss_pred cCceEEEeecchhc
Confidence 358999999863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.6e-07 Score=83.99 Aligned_cols=76 Identities=17% Similarity=0.090 Sum_probs=53.2
Q ss_pred CCeeEEEEecCCCCCHHHHhc--ccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----c
Q 024460 20 GDQRLLVYEYMPMGSLEDHLY--DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----N 93 (267)
Q Consensus 20 ~~~~~lv~e~~~~~sL~~~l~--~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~----~ 93 (267)
....++||||++|+.+.+.-. ......+.+.+..+..++.|+ ...| ++|+|++|.||+++.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCe
Confidence 445679999999999987432 100011124344444455554 3467 99999999999998887 8
Q ss_pred eEEeccCCcccC
Q 024460 94 PKLSDFGLAKLG 105 (267)
Q Consensus 94 ~~l~d~~~~~~~ 105 (267)
++++|||++...
T Consensus 303 i~llDFGivg~l 314 (537)
T PRK04750 303 YIALDFGIVGSL 314 (537)
T ss_pred EEEEecceEEEC
Confidence 999999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.32 E-value=5e-07 Score=70.09 Aligned_cols=81 Identities=23% Similarity=0.232 Sum_probs=50.5
Q ss_pred ccceeeEEeeCCeeEEEEecCC--CCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeeCCCCCCcE
Q 024460 10 LVTLIGYCTSGDQRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY-LHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~--~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~-lH~~~~~~i~h~di~~~ni 86 (267)
+++.+++- ..++||||++ |..+..+... .+.......++.+++..+.. +|..| ++|+|+.+.||
T Consensus 72 vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NI 138 (188)
T PF01163_consen 72 VPKPYDYN----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNI 138 (188)
T ss_dssp S--EEEEE----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSE
T ss_pred CCcEEEEe----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhE
Confidence 45555442 3469999998 5445443322 11123456677777775555 57888 99999999999
Q ss_pred EEcCCCceEEeccCCccc
Q 024460 87 LLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 87 li~~~~~~~l~d~~~~~~ 104 (267)
+++.+ .+.++||+.+..
T Consensus 139 lv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 139 LVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EEETT-CEEE--GTTEEE
T ss_pred Eeecc-eEEEEecCccee
Confidence 99877 999999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.7e-06 Score=68.98 Aligned_cols=91 Identities=24% Similarity=0.309 Sum_probs=65.4
Q ss_pred CccceeeEEeeC---CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-------------
Q 024460 9 NLVTLIGYCTSG---DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA------------- 72 (267)
Q Consensus 9 niv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~------------- 72 (267)
.+.+++.+.... +..++||||++|.++.+.+. ...++......++.+++.++..||+..
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~ 132 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPG 132 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCC
Confidence 456677776553 36789999999988776542 134555566666777777777776421
Q ss_pred ----------------------------------------CCCeeeCCCCCCcEEEcC--CCceEEeccCCccc
Q 024460 73 ----------------------------------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAKL 104 (267)
Q Consensus 73 ----------------------------------------~~~i~h~di~~~nili~~--~~~~~l~d~~~~~~ 104 (267)
...++|+|+.+.||+++. ++.+.++||+.+..
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 133 GYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred chHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999988 56789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.26 E-value=2e-06 Score=67.75 Aligned_cols=68 Identities=19% Similarity=0.239 Sum_probs=52.9
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
...+++|||++|..|.+... +++ .+...++.++..+|+.| +.|+|++|.|++++++ .++++|++
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECc
Confidence 45679999999987766432 221 24456778899999999 9999999999999855 59999998
Q ss_pred Cccc
Q 024460 101 LAKL 104 (267)
Q Consensus 101 ~~~~ 104 (267)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.23 E-value=4.8e-06 Score=78.85 Aligned_cols=221 Identities=19% Similarity=0.145 Sum_probs=139.3
Q ss_pred CCCCCCCCccceeeEEeeCCe----eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQ----RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
+.++.|+|++.++.+...... ..+..++|...++...++ .-...+......+..++.+++.++|... ..
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~ 308 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSLS---LE 308 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHhc---cc
Confidence 467899999999988754432 345567888888888884 3567888889999999999999999886 66
Q ss_pred eCCCCCC---cEEEcCCCceEEe--ccCCcccCCCCCCcceeeecccccceeCCcccccCCCc--ccCCeeehHHHHHHH
Q 024460 78 YRDLKSA---NILLDNDFNPKLS--DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT--LKSDIYSFGVVLLEL 150 (267)
Q Consensus 78 h~di~~~---nili~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~Dv~slG~i~~~~ 150 (267)
|.-+... +.-++..+.+... ||+.......... .........+.++|........ ...|+|++|.....+
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6555444 3334455556655 7877764433221 1122234557777776655544 447999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH-HHH
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA-LDY 229 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~-l~~ 229 (267)
..|..+-.... .....+.. .+.....+...+|+..++++|+++.+++.. +..
T Consensus 386 ~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~ 438 (1351)
T KOG1035|consen 386 SQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTHPFLR 438 (1351)
T ss_pred hhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence 88776532111 11111111 111146788899999999999999999984 344
Q ss_pred hhhccCCCCCcCCCCCCCCCCcCCCCCcCC
Q 024460 230 LVSQRDSHPVSRNAGARGVPTSASDVSQGS 259 (267)
Q Consensus 230 l~~~~~~~~~~~~~~~~~~~~~~s~~~~~~ 259 (267)
........+.....+...+.--.+.++..+
T Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~r~~~~~s 468 (1351)
T KOG1035|consen 439 FPTDNESSEFAPNDETSVPQFRLRFSGAMS 468 (1351)
T ss_pred cccccccccccCccccccCccCCCCccccC
Confidence 444444433333333333333333333333
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.13 E-value=8e-06 Score=63.55 Aligned_cols=98 Identities=29% Similarity=0.328 Sum_probs=75.2
Q ss_pred CCCCCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+.+++ +++++++|+| ..+++.||...+++....... .+--..++..+.+++.++++.+.+++....+.+.-+|
T Consensus 13 l~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcD 87 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCD 87 (188)
T ss_pred HHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence 455666 5999999998 346789999766654211000 0123467899999999999999999975545589999
Q ss_pred CCCCcEEEcCCCceEEeccCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~ 104 (267)
++++|+-+++++.++++|.+.+..
T Consensus 88 v~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 88 VSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cchHHeEEeCCCcEEEEechhcch
Confidence 999999999999999999997754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=2e-05 Score=61.86 Aligned_cols=78 Identities=18% Similarity=0.109 Sum_probs=63.0
Q ss_pred eeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCc--eEEec
Q 024460 22 QRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFN--PKLSD 98 (267)
Q Consensus 22 ~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~--~~l~d 98 (267)
.-+||+|-+++ -+|.+++... .-.+.+......++.+++.++.-||..+ +.|+|+.+.||+++.++. +.++|
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 35799997753 4788887541 2235567777899999999999999999 999999999999986666 89999
Q ss_pred cCCccc
Q 024460 99 FGLAKL 104 (267)
Q Consensus 99 ~~~~~~ 104 (267)
|..++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 988764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.85 E-value=5e-05 Score=61.49 Aligned_cols=72 Identities=19% Similarity=0.148 Sum_probs=54.2
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
+.-.+|||+++|..|...- +.....-.++..|+..+..+...| ++|+|+++-||+++++|.+.++||-
T Consensus 180 nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCc
Confidence 4567999999886554322 122334555666666666666777 9999999999999999999999998
Q ss_pred Cccc
Q 024460 101 LAKL 104 (267)
Q Consensus 101 ~~~~ 104 (267)
.+..
T Consensus 248 Q~v~ 251 (304)
T COG0478 248 QAVP 251 (304)
T ss_pred cccc
Confidence 8763
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=4e-06 Score=74.84 Aligned_cols=144 Identities=20% Similarity=0.139 Sum_probs=102.5
Q ss_pred CCCCCCCCC-ccceeeEEeeCCeeEEEEecCCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDN-LVTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpn-iv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|.+++||| .+..++-++.+...++.++++.++ +....+.. ....+..-........-...++++|+.. =+|
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~ 359 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVH 359 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccC
Confidence 467899999 777777777788999999999776 22222211 2223333344455555667889999775 577
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+| ||+..+ +..+.++|+......... ......+++.+++||+...+.+..+.|.|++|.-..+|.-|.+|-.
T Consensus 360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 360 RD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 77 666554 578899999876543332 3344678999999999999999999999999987777777777653
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0023 Score=51.45 Aligned_cols=28 Identities=14% Similarity=0.148 Sum_probs=25.4
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.|.|+++++++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 479999999999999877 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0016 Score=52.90 Aligned_cols=30 Identities=23% Similarity=0.142 Sum_probs=26.5
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
+.++|+|+.+.||++++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 358999999999999987778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.00092 Score=53.68 Aligned_cols=74 Identities=22% Similarity=0.222 Sum_probs=54.4
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCcEEEcCCCceEEeccCC
Q 024460 23 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDLKSANILLDNDFNPKLSDFGL 101 (267)
Q Consensus 23 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di~~~nili~~~~~~~l~d~~~ 101 (267)
..+||||+.... ........-.+.......+..+++..+.-|.. .+ +||+|++.-|||+. ++.+.++|++.
T Consensus 141 nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~Q 212 (268)
T COG1718 141 NVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQ 212 (268)
T ss_pred CeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEECcc
Confidence 469999985531 11111122333333577788888888888887 66 99999999999999 78999999998
Q ss_pred ccc
Q 024460 102 AKL 104 (267)
Q Consensus 102 ~~~ 104 (267)
+-.
T Consensus 213 aV~ 215 (268)
T COG1718 213 AVT 215 (268)
T ss_pred ccc
Confidence 864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0032 Score=49.35 Aligned_cols=82 Identities=22% Similarity=0.222 Sum_probs=58.9
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCC------CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMG------SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~------sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
..+.+|.+++|+.+++....+|+|.+.+. +|.+++.. +.++. ... ..+-+-..+|-.+. |+.
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~---~~L~~f~~~l~~~~---Iv~ 141 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELR---QALDEFKRYLLDHH---IVI 141 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHH---HHHHHHHHHHHHcC---Cee
Confidence 35788999999999999999999985432 68888833 44554 333 34444566777777 999
Q ss_pred CCCCCCcEEEcCC--C--ceEEec
Q 024460 79 RDLKSANILLDND--F--NPKLSD 98 (267)
Q Consensus 79 ~di~~~nili~~~--~--~~~l~d 98 (267)
+|++|.||++... + .+.|+|
T Consensus 142 ~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 142 RDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cCCCcccEEEEecCCCceEEEEEe
Confidence 9999999999532 2 455555
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.0026 Score=57.12 Aligned_cols=80 Identities=21% Similarity=0.182 Sum_probs=55.3
Q ss_pred eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEe
Q 024460 18 TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 97 (267)
Q Consensus 18 ~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~ 97 (267)
+..+...++|||++|-.+.+.... .....+...+...+.++. +..+-..| +.|+|.+|.||+++.++.+.+.
T Consensus 236 e~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~ia~~~~~~f--~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~l 307 (517)
T COG0661 236 EYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKELAELLVRAF--LRQLLRDG---FFHADPHPGNILVRSDGRIVLL 307 (517)
T ss_pred hccCCcEEEEEeeCCEecccHHHH---HhcCCCHHHHHHHHHHHH--HHHHHhcC---ccccCCCccceEEecCCcEEEE
Confidence 445567899999999888887432 123444333333222221 23333357 9999999999999999999999
Q ss_pred ccCCcccC
Q 024460 98 DFGLAKLG 105 (267)
Q Consensus 98 d~~~~~~~ 105 (267)
|||.....
T Consensus 308 DfGi~g~l 315 (517)
T COG0661 308 DFGIVGRL 315 (517)
T ss_pred cCcceecC
Confidence 99998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0032 Score=56.44 Aligned_cols=77 Identities=23% Similarity=0.171 Sum_probs=51.7
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC----CCceEE
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN----DFNPKL 96 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~----~~~~~l 96 (267)
....++|||++|..+.|.-.- ....++...+..-+.+...-.-+ ..| ++|+|-.|.||++.. +..+.+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf--~~G---ffHaDPHPGNilv~~~~~~~~~ivl 346 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF--KTG---FFHADPHPGNILVRPNPEGDEEIVL 346 (538)
T ss_pred cceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH--hcC---CccCCCCCCcEEEecCCCCCccEEE
Confidence 457899999999877765332 23445545444443333222222 346 999999999999983 567899
Q ss_pred eccCCcccC
Q 024460 97 SDFGLAKLG 105 (267)
Q Consensus 97 ~d~~~~~~~ 105 (267)
.|||+....
T Consensus 347 lDhGl~~~i 355 (538)
T KOG1235|consen 347 LDHGLYAVI 355 (538)
T ss_pred Ecccccccc
Confidence 999998743
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0067 Score=58.11 Aligned_cols=30 Identities=17% Similarity=0.344 Sum_probs=24.3
Q ss_pred CeeeCCCCCCcEEEcC-CCc-eEEeccCCccc
Q 024460 75 PVIYRDLKSANILLDN-DFN-PKLSDFGLAKL 104 (267)
Q Consensus 75 ~i~h~di~~~nili~~-~~~-~~l~d~~~~~~ 104 (267)
.++|+|+++.|++++. ++. .-|+||..+..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 4999999999999974 333 57999988764
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.011 Score=50.26 Aligned_cols=73 Identities=23% Similarity=0.197 Sum_probs=56.3
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
-+.|++|++. |+++.. .+.....++..++++.+..+.-+..+- ++-|+++..+||+|+ +|++.|+||.
T Consensus 299 ~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence 4567888876 445532 233445778889999888887777554 489999999999999 8999999999
Q ss_pred CcccC
Q 024460 101 LAKLG 105 (267)
Q Consensus 101 ~~~~~ 105 (267)
+++..
T Consensus 367 lsRl~ 371 (488)
T COG5072 367 LSRLS 371 (488)
T ss_pred eeecc
Confidence 99853
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.43 E-value=7.3e-05 Score=73.17 Aligned_cols=152 Identities=14% Similarity=0.019 Sum_probs=107.6
Q ss_pred CCCCCCccceeeEEe--eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeC
Q 024460 4 LLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVIYR 79 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~~i~h~ 79 (267)
...|+++.....=.. ++...+..++++.+|.+...+...-.....+...-+...-.+.+.+..-.|... ...-+|.
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 457777766655442 344678999999999999998764444444444444444444355555555433 2346899
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
++++-|.+|..+-.++++++|+.+. ........+...+++.|+.|++...-.++.++|+|..|+.+|....|.++|
T Consensus 1365 ~Lkf~lpmIVtny~v~~gk~gLdKI--knp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKI--KNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhccceecCCcccccccccccc--cCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999999999999999999873 122222333445677888888877778888899999999999998888776
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.41 E-value=0.014 Score=47.04 Aligned_cols=29 Identities=24% Similarity=0.306 Sum_probs=25.4
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.|+++++++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 48999999999999877666799999876
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.0015 Score=57.70 Aligned_cols=40 Identities=33% Similarity=0.438 Sum_probs=31.8
Q ss_pred CCCCCCCCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcc
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYD 41 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~ 41 (267)
+|+.+.|+|...+.++-.... ...+|+|++. -+|++.+..
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~ 75 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKT 75 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHh
Confidence 467889999999998876543 5789999994 599998854
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.85 E-value=0.0084 Score=50.31 Aligned_cols=71 Identities=15% Similarity=0.057 Sum_probs=52.6
Q ss_pred CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 21 DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 21 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
+.-++|||++.+..|...-.- .. ...+...+...|..|..+| ++|+|++-=||++.+++.++++||-
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v-------~d---~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHV-------ED---PPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred cceeeHHHhhcccceeeeeec-------CC---hHHHHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeech
Confidence 356899999988777543311 11 2334455556677788888 9999999999999999999999997
Q ss_pred Cccc
Q 024460 101 LAKL 104 (267)
Q Consensus 101 ~~~~ 104 (267)
..-.
T Consensus 248 QmvS 251 (465)
T KOG2268|consen 248 QMVS 251 (465)
T ss_pred Hhhc
Confidence 6543
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.25 Score=41.40 Aligned_cols=29 Identities=17% Similarity=0.165 Sum_probs=22.2
Q ss_pred CCCeeeCCCCCCcEEEcCC-Cc-eEEeccCC
Q 024460 73 NPPVIYRDLKSANILLDND-FN-PKLSDFGL 101 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~-~~-~~l~d~~~ 101 (267)
.+.++|+|+.+.|++++.+ +. +.++|...
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa~ 222 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPGL 222 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECchH
Confidence 3469999999999999854 33 56777663
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.1 Score=44.08 Aligned_cols=31 Identities=26% Similarity=0.479 Sum_probs=27.7
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCccc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~ 104 (267)
..++|+|+++.|++++.++-+-|+||+.+..
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 3689999999999999888899999999874
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.084 Score=44.23 Aligned_cols=30 Identities=37% Similarity=0.317 Sum_probs=26.6
Q ss_pred CCeeeCCCCCCcEEEcCC----CceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLDND----FNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~----~~~~l~d~~~~~ 103 (267)
..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 358999999999999874 789999999886
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.082 Score=42.47 Aligned_cols=29 Identities=28% Similarity=0.329 Sum_probs=26.1
Q ss_pred CeeeCCCCCCcEEEcC-CCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDN-DFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~-~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++. ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 4999999999999997 5789999999876
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.09 E-value=0.12 Score=42.73 Aligned_cols=49 Identities=27% Similarity=0.175 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCccc
Q 024460 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 55 ~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~ 104 (267)
.+.+..+-.++.-.+... ..++|+|+.|.|++.++.+.++|+||..+..
T Consensus 135 ~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 334444445555555440 2389999999999999989999999998863
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.078 Score=42.16 Aligned_cols=30 Identities=40% Similarity=0.480 Sum_probs=20.8
Q ss_pred CCeeeCCCCCCcEEEc-CCCceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLD-NDFNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~-~~~~~~l~d~~~~~ 103 (267)
..++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 3499999999999999 55666899998875
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=93.62 E-value=0.13 Score=43.36 Aligned_cols=30 Identities=37% Similarity=0.367 Sum_probs=26.6
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.+++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 359999999999999988777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.21 Score=41.91 Aligned_cols=28 Identities=25% Similarity=0.277 Sum_probs=24.7
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
+++|+|+.+.|++++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4899999999999987 568899999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.27 E-value=0.082 Score=40.97 Aligned_cols=28 Identities=18% Similarity=0.234 Sum_probs=25.0
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
..+|+|+.|.|+++++++ ++++||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 479999999999998776 8899999886
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.27 E-value=0.099 Score=41.67 Aligned_cols=40 Identities=23% Similarity=0.126 Sum_probs=33.9
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCc
Q 024460 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102 (267)
Q Consensus 62 ~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~ 102 (267)
+.+|...|+.. .+.+|+|..|+||+-+..|.+|+.|-+..
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 46788889543 34999999999999999999999998865
|
The function of this family is unknown. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.24 E-value=0.065 Score=45.28 Aligned_cols=29 Identities=34% Similarity=0.360 Sum_probs=25.5
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
+++|+|+.+.||+++++...-|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 59999999999999876666899999876
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.95 E-value=0.075 Score=42.06 Aligned_cols=29 Identities=38% Similarity=0.455 Sum_probs=20.9
Q ss_pred CeeeCCCCCCcEEE-cCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILL-DNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili-~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||++ +.++.++++||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 48999999999999 788899999999886
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.95 E-value=0.16 Score=42.97 Aligned_cols=40 Identities=20% Similarity=0.007 Sum_probs=26.4
Q ss_pred HHHHHHHHHHHHHHHHhhhcC-CCCeeeCCCCCCcEEEcCC
Q 024460 52 NTRMKIAVGAARGLEYLHCKA-NPPVIYRDLKSANILLDND 91 (267)
Q Consensus 52 ~~~~~~~~~l~~~l~~lH~~~-~~~i~h~di~~~nili~~~ 91 (267)
.-+.-++.|++.-.-...+.. ...++|.||||+|||+.+.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 334566777776654443322 3349999999999999543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=92.90 E-value=0.17 Score=42.19 Aligned_cols=29 Identities=38% Similarity=0.372 Sum_probs=26.1
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
+++|+|+.|.|+++++++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 49999999999999987777899999876
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.2 Score=42.49 Aligned_cols=51 Identities=22% Similarity=0.114 Sum_probs=31.7
Q ss_pred HHHHHHHHHHHHHHhhhc-CCCCeeeCCCCCCcEEEcCCC------------------ceEEeccCCccc
Q 024460 54 RMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLDNDF------------------NPKLSDFGLAKL 104 (267)
Q Consensus 54 ~~~~~~~l~~~l~~lH~~-~~~~i~h~di~~~nili~~~~------------------~~~l~d~~~~~~ 104 (267)
+.-++.|++.-.--..+. +...++|.||||+|||+.+.. .++|.||++++.
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 445566665544223222 123499999999999994322 256777777764
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=92.63 E-value=0.1 Score=42.64 Aligned_cols=28 Identities=21% Similarity=0.258 Sum_probs=25.1
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||++++++ +.++||..+.
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 489999999999998876 7899999886
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.24 E-value=0.28 Score=41.38 Aligned_cols=31 Identities=16% Similarity=0.216 Sum_probs=27.8
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCccc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~ 104 (267)
.+++|+|+.++|+++++++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999888999999998863
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.44 Score=41.09 Aligned_cols=75 Identities=19% Similarity=0.136 Sum_probs=54.4
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCc
Q 024460 23 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102 (267)
Q Consensus 23 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~ 102 (267)
-.|||+|+.. +=+..= ......++...+..+-.+++.-+.-|..... +||.||.--|+|+. +|.++++|.+.+
T Consensus 239 hVLVM~FlGr-dgw~aP---kLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh-dG~lyiIDVSQS 311 (520)
T KOG2270|consen 239 HVLVMEFLGR-DGWAAP---KLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH-DGKLYIIDVSQS 311 (520)
T ss_pred ceEeeeeccC-CCCcCc---ccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE-CCEEEEEEcccc
Confidence 3699999853 221111 1134566777788888888888888876654 99999999999997 458999999876
Q ss_pred cc
Q 024460 103 KL 104 (267)
Q Consensus 103 ~~ 104 (267)
-.
T Consensus 312 VE 313 (520)
T KOG2270|consen 312 VE 313 (520)
T ss_pred cc
Confidence 53
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.23 E-value=0.39 Score=41.22 Aligned_cols=29 Identities=24% Similarity=0.344 Sum_probs=25.6
Q ss_pred CeeeCCCCCCcEEEcC-CCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDN-DFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~-~~~~~l~d~~~~~ 103 (267)
.++|+|+++.||++++ ++.+.++||..+.
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 4899999999999976 4679999999876
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=90.94 E-value=0.68 Score=39.45 Aligned_cols=28 Identities=36% Similarity=0.553 Sum_probs=25.2
Q ss_pred eeeCCCCCCcEEEcCCCc-eEEeccCCcc
Q 024460 76 VIYRDLKSANILLDNDFN-PKLSDFGLAK 103 (267)
Q Consensus 76 i~h~di~~~nili~~~~~-~~l~d~~~~~ 103 (267)
++|+|+.++||+++.+.. +-++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999998874 8899999875
|
|
| >PRK14559 putative protein serine/threonine phosphatase; Provisional | Back alignment and domain information |
|---|
Probab=90.79 E-value=0.86 Score=42.36 Aligned_cols=87 Identities=14% Similarity=0.059 Sum_probs=65.8
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
++.||..+|+++..++.-++++|+... .+|.+.- .....+....+.|+.||+.--.-|...+ ++..=+.++
T Consensus 178 ~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w-----~~~~~~~l~~l~Wl~q~~~LW~~l~~~~---~~~sll~~~ 249 (645)
T PRK14559 178 FPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLW-----QDQTLPTLQILYWLNQMTQLWKALEPWG---CCQSLLELE 249 (645)
T ss_pred ccccCcchheeecCCCCcEEEeCCCCCCchHHHHh-----hhcCCcHHHHHHHHHHHHHHHHHHHhcC---eehhccchh
Confidence 445699999999888877888888632 1233322 2234566788999999999999999998 999999999
Q ss_pred cEEEcCCCceEEeccC
Q 024460 85 NILLDNDFNPKLSDFG 100 (267)
Q Consensus 85 nili~~~~~~~l~d~~ 100 (267)
|+.|+++..+.|..|.
T Consensus 250 nlrv~~~~~~~l~~l~ 265 (645)
T PRK14559 250 NLRVDEDQTLGLQQLY 265 (645)
T ss_pred heeeCCCceehHhhhh
Confidence 9999876666665553
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=90.72 E-value=0.23 Score=38.82 Aligned_cols=29 Identities=31% Similarity=0.352 Sum_probs=24.9
Q ss_pred CeeeCCCCCCcEEEcCCC-----ceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDF-----NPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~-----~~~l~d~~~~~ 103 (267)
.++|||+.+.|+++..++ .+.++||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 589999999999997543 58999999886
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.56 E-value=0.25 Score=41.00 Aligned_cols=30 Identities=33% Similarity=0.483 Sum_probs=25.2
Q ss_pred CeeeCCCCCCcEEEcCCCc-eEEeccCCccc
Q 024460 75 PVIYRDLKSANILLDNDFN-PKLSDFGLAKL 104 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~-~~l~d~~~~~~ 104 (267)
.++|+|+++.||+++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999987454 56999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=88.15 E-value=0.47 Score=40.42 Aligned_cols=29 Identities=24% Similarity=0.312 Sum_probs=25.5
Q ss_pred CeeeCCCCCCcEEEcC-CCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDN-DFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~-~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||++++ ++.++++||..+.
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 4799999999999974 4689999999886
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.47 E-value=1.3 Score=37.68 Aligned_cols=27 Identities=30% Similarity=0.409 Sum_probs=23.4
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
+++|+|+.+.||+++ + .+.++||+-+.
T Consensus 197 ~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 197 LRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred cceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 489999999999995 3 57899999876
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=87.29 E-value=1.4 Score=33.96 Aligned_cols=66 Identities=17% Similarity=0.166 Sum_probs=43.4
Q ss_pred EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC--CcEEEcCCCceEEeccCC
Q 024460 24 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS--ANILLDNDFNPKLSDFGL 101 (267)
Q Consensus 24 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~--~nili~~~~~~~l~d~~~ 101 (267)
++.|||++|-.|.+.-.. . +.. -+..+++..--|...| |-|+.+.- .||++. ++.+.|+||..
T Consensus 88 ~i~me~i~G~~L~~~~~~-----~--~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~-~~~~~iIDFd~ 152 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-----G--DRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVN-DRDVYIIDFDS 152 (201)
T ss_pred hhhhhhhcCcchhhhhhc-----c--cHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEec-CCcEEEEEccc
Confidence 456999988888776532 1 222 2334555555556666 99998874 455554 44899999999
Q ss_pred ccc
Q 024460 102 AKL 104 (267)
Q Consensus 102 ~~~ 104 (267)
+++
T Consensus 153 At~ 155 (201)
T COG2112 153 ATF 155 (201)
T ss_pred hhh
Confidence 874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=87.11 E-value=1.6 Score=43.25 Aligned_cols=30 Identities=43% Similarity=0.437 Sum_probs=24.9
Q ss_pred CeeeCCCCCCcEEEcCCC--ceE-EeccCCccc
Q 024460 75 PVIYRDLKSANILLDNDF--NPK-LSDFGLAKL 104 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~--~~~-l~d~~~~~~ 104 (267)
.++|+|+++.||+++.++ .+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999998764 454 999998763
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=85.21 E-value=1.8 Score=37.95 Aligned_cols=28 Identities=21% Similarity=0.367 Sum_probs=24.6
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|||+.+.||++..+ .++++||..+.
T Consensus 224 ~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 224 ALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred ceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 49999999999999765 68999998775
|
|
| >KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=84.17 E-value=3.6 Score=35.07 Aligned_cols=74 Identities=15% Similarity=0.083 Sum_probs=54.4
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCc
Q 024460 23 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102 (267)
Q Consensus 23 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~ 102 (267)
-.+||-|+...-+. ..+.....++.......-.|+..+++.|..... +||.|+.--|+|...+ .+.++|...+
T Consensus 358 hvLVMsFiGd~~~a----APkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~--LVHADlSEyN~Lw~~g-Kvw~IDVsQs 430 (531)
T KOG2269|consen 358 HVLVMSFIGDQGLA----APKLKNVELTDDERRNAYDQVQSIMCRLYKECL--LVHADLSEYNLLWTPG-KVWVIDVSQS 430 (531)
T ss_pred ceEEEEeecCCCCC----CccccccccChHHHHHHHHHHHHHHHHHHHhhh--eeecchhhhhheecCC-ceEEEechhc
Confidence 35899998543332 222234557777888888889888888875543 9999999999999866 8999998766
Q ss_pred c
Q 024460 103 K 103 (267)
Q Consensus 103 ~ 103 (267)
-
T Consensus 431 v 431 (531)
T KOG2269|consen 431 V 431 (531)
T ss_pred c
Confidence 4
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=84.17 E-value=3.4 Score=36.35 Aligned_cols=61 Identities=20% Similarity=0.102 Sum_probs=45.2
Q ss_pred eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcC
Q 024460 23 RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDN 90 (267)
Q Consensus 23 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~ 90 (267)
..++=+|..|-++..++ ..+..++....+++.-.+.|+-.|--.++ ++|.|+.|.||++..
T Consensus 320 ~vl~E~~~~Gl~v~~~v-----~~~~~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFV-----KWKSQPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhh-----hcccChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEEe
Confidence 45666678888888888 34556666777777777777766664433 999999999999953
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 267 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-45 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-44 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-36 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-34 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-13 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-13 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 7e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 8e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 9e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-11 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-11 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-11 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 9e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-10 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-10 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-10 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-10 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-10 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-10 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-10 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-10 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-10 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 8e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 7e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 9e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 8e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-05 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 6e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-147
Identities = 94/232 (40%), Positives = 133/232 (57%), Gaps = 8/232 (3%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+++ H+NLV L+G+ + GD LVY YMP GSL D L L+ PLSW+ R KIA G
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQG 141
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AA G+ +LH I+RD+KSANILLD F K+SDFGLA+ T +++R++GT
Sbjct: 142 AANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y APE + G++T KSDIYSFGVVLLE+ITG A+D + Q L+ ++K
Sbjct: 199 TAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIKEEIEDEEK 255
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232
+D + + +V + CL+E+ N RP I + L + +
Sbjct: 256 TIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 403 bits (1039), Expect = e-143
Identities = 95/237 (40%), Positives = 138/237 (58%), Gaps = 4/237 (1%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
LS H +LV+LIG+C ++ +L+Y+YM G+L+ HLY + +SW R++I +G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
AARGL YLH +I+RD+KS NILLD +F PK++DFG++K G D TH+ST V GT
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
GY PEY + G+LT KSD+YSFGVVL E++ R A+ S + NL W+
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NG 263
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237
+ +VDP L + L CL + RP + D++ L+Y + ++S
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-139
Identities = 99/230 (43%), Positives = 142/230 (61%), Gaps = 4/230 (1%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+S+ H NL+ L G+C + +RLLVY YM GS+ L + Q PL W R +IA+G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+ARGL YLH +P +I+RD+K+ANILLD +F + DFGLAKL D THV+T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGT 198
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ--NLVSWSRPFLKD 178
G+ APEY +GK + K+D++ +GV+LLELITG++A DL++ + L+ W + LK+
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
KK LVD L G Y + + V +C RP ++++V L+
Sbjct: 259 -KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 4e-75
Identities = 65/256 (25%), Positives = 101/256 (39%), Gaps = 26/256 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
L + H+N++ IG G L+ + GSL D L +SWN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 57 IAVGAARGLEYLH-------CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 109
IA ARGL YLH P + +RD+KS N+LL N+ ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 110 NTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164
+ + +GT Y APE L+ D+Y+ G+VL EL + A D +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 165 EQNLVS--WSRPFLKDQKKFV--HLVDPLLHGRYPRRCLNYAVAVTAM-CLNEEANFRPL 219
P L+D ++ V P+L + + + T C + +A R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 220 INDIVVALDYLVSQRD 235
+ + + +
Sbjct: 306 AGCVGERITQMQRLTN 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-58
Identities = 69/244 (28%), Positives = 102/244 (41%), Gaps = 32/244 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H N+V +G T +V EY+ GSL L+ +E L R+ +A
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYD 145
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A+G+ YLH + NPP+++R+LKS N+L+D + K+ DFGL++L S GT
Sbjct: 146 VAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGT 202
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQNLVSWSRP 174
+ APE KSD+YSFGV+L EL T + + G + R
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK----RL 258
Query: 175 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234
+ PR A+ C E RP I+ L L+
Sbjct: 259 EI------------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
Query: 235 DSHP 238
P
Sbjct: 301 VPPP 304
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 6e-58
Identities = 60/272 (22%), Positives = 103/272 (37%), Gaps = 41/272 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 55
+ L+ HDN+ I + LLV EY P GSL +L W +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSC 114
Query: 56 KIAVGAARGLEYLH------CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK------ 103
++A RGL YLH P + +RDL S N+L+ ND +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 104 LGPVGDNTHVSTRVMGTYGYCAPEYAMS-------GKLTLKSDIYSFGVVLLELITGRKA 156
L G+ + + +GT Y APE + D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 157 MDLSKGQGEQNL----VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAM---- 208
+ + E + + P +D + V ++P ++AV ++
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 209 --CLNEEANFRPLINDIVVALDYLVSQRDSHP 238
C +++A R + L+ + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 4e-54
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++S L+H N+V L G + +V E++P G L L D P+ W+ ++++ +
Sbjct: 76 IMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAKLGPVGDNTHVST 115
A G+EY+ + NPP+++RDL+S NI L + K++DFGL++ + H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 116 RVMGTYGYCAPE--YAMSGKLTLKSDIYSFGVVLLELITGRK--------AMDLSKGQGE 165
++G + + APE A T K+D YSF ++L ++TG + E
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE 244
Query: 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225
+ L RP + P C V +C + + RP + IV
Sbjct: 245 EGL----RPTI------------------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
Query: 226 ALDYL 230
L L
Sbjct: 283 ELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 7e-54
Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
LS ++H N+V L G C + LV EY GSL + L+ EP + M +
Sbjct: 54 QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFN-PKLSDFGLAKLGPVGDNTHVSTRVMG 119
++G+ YLH +I+RDLK N+LL K+ DFG A D T G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKG 165
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155
+ + APE + K D++S+G++L E+IT RK
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 3e-53
Identities = 53/240 (22%), Positives = 96/240 (40%), Gaps = 45/240 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L + H N++ ++G C S + +MP GSL + L++ + + +K A
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFA 117
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ ARG+ +LH P + L S ++++D D ++S + + S M
Sbjct: 118 LDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRM 169
Query: 119 GTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQNL 168
+ APE A+ K +D++SF V+L EL+T M++ + L
Sbjct: 170 YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL 228
Query: 169 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
RP + P + + +C+NE+ RP + IV L+
Sbjct: 229 ----RPTI------------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 9e-53
Identities = 63/242 (26%), Positives = 100/242 (41%), Gaps = 45/242 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ ++L H N++ L G C LV E+ G L L + + + + AV
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQ 113
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--------KLSDFGLAKLGPVGDNTH 112
ARG+ YLH +A P+I+RDLKS+NIL+ K++DFGLA+ T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT 170
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR------KAMDLSKGQGEQ 166
+ G Y + APE + + SD++S+GV+L EL+TG + ++ G
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
Query: 167 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226
L + P C + C N + + RP +I+
Sbjct: 230 KL----ALPI------------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
Query: 227 LD 228
L
Sbjct: 268 LT 269
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-50
Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L H N++ +GY T Q +V ++ SL HL+ E + IA
Sbjct: 73 VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASET---KFEMKKLIDIARQ 128
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
ARG++YLH K +I+RDLKS NI L D K+ DFGLA +H ++ G+
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 121 YGYCAPE---YAMSGKLTLKSDIYSFGVVLLELITGR 154
+ APE S + +SD+Y+FG+VL EL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 4e-50
Identities = 57/249 (22%), Positives = 96/249 (38%), Gaps = 33/249 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H N++ IG + + EY+ G+L + ++ W+ R+ A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKD 116
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL------------GPVG 108
A G+ YLH +I+RDL S N L+ + N ++DFGLA+L
Sbjct: 117 IASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
+ V+G + APE K D++SFG+VL E+I A +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP--------DY 225
Query: 169 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
+ + F + + F+ P C +T C + + RP + L+
Sbjct: 226 LPRTMDFGLNVRGFLDR--YC-----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
Query: 229 YLVSQRDSH 237
L H
Sbjct: 279 TLRMHLAGH 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 2e-49
Identities = 57/256 (22%), Positives = 98/256 (38%), Gaps = 26/256 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
L+ H+N++ I G Q L+ +Y GSL D+L L + +K
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLK 138
Query: 57 IAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
+A + GL +LH + P + +RDLKS NIL+ + ++D GLA N
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 112 H--VSTRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG- 162
+GT Y PE + + +D+YSFG++L E+ + + +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 163 QGEQNLVSWSRPFLKDQKKFVHLVD---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219
Q + + S P +D ++ V + + CL + C R
Sbjct: 259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
Query: 220 INDIVVALDYLVSQRD 235
+ L + +D
Sbjct: 319 ALRVKKTLAKMSESQD 334
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-48
Identities = 38/166 (22%), Positives = 63/166 (37%), Gaps = 19/166 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
H+N+V +G C S ++ +L + D + L N +IA
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQE 138
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL---GPVGDNTHVSTRV 117
+G+ YLH K ++++DLKS N+ DN ++DFGL + G
Sbjct: 139 IVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 118 MGTYGYCAPEYAMSGKL---------TLKSDIYSFGVVLLELITGR 154
G + APE + SD+++ G + EL
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-48
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 22/170 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
+L H+N++ I + Q L+ Y MGSL D+L L + ++
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLR 109
Query: 57 IAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
I + A GL +LH + P + +RDLKS NIL+ + ++D GLA + N
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 112 HV--STRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITG 153
+ +GT Y APE + DI++FG+VL E+
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-46
Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
+L H+N++ I + Q LV +Y GSL D+L ++ ++ +K
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIK 143
Query: 57 IAVGAARGLEYLH-----CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
+A+ A GL +LH + P + +RDLKS NIL+ + ++D GLA +T
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 112 H--VSTRVMGTYGYCAPEYAMSGKL-------TLKSDIYSFGVVLLELITG 153
+GT Y APE + + ++DIY+ G+V E+
Sbjct: 204 IDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 44/150 (29%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H N+V LIG CT +V E + G L + L T +++ AA G
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAG 225
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY- 123
+EYL K I+RDL + N L+ K+SDFG+++ D + ++ +
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQVPVK 280
Query: 124 -CAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
APE G+ + +SD++SFG++L E +
Sbjct: 281 WTAPEALNYGRYSSESDVWSFGILLWETFS 310
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-30
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTS---GDQRLLVY-EYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
ML L H N+V S G + +++ E M G+L+ +L + +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRS 133
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVST 115
+GL++LH + PP+I+RDLK NI + + K+ D GLA L +
Sbjct: 134 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAK 188
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V+GT + APE K D+Y+FG+ +LE+ T
Sbjct: 189 AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 49/240 (20%), Positives = 91/240 (37%), Gaps = 38/240 (15%)
Query: 1 MLSLLHHDNLVTLIGYC----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
M L +H N++ L+ YC + + L+ + G+L + + L+ L+ + +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+ +G RGLE +H +RDLK NILL ++ P L D G +
Sbjct: 139 LLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 117 VM-------GTYGYCAPE------YAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQ 163
+ T Y APE + + + ++D++S G VL ++ G D+ +
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
G+ L Q + R+ + + + + RP I +
Sbjct: 253 GDSVA-------LAVQNQL----SIPQSPRHSSALWQ----LLNSMMTVDPHQRPHIPLL 297
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-30
Identities = 45/149 (30%), Positives = 80/149 (53%), Gaps = 8/149 (5%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
+ H NLV L+G CT ++ E+M G+L D+L + + +S + +A +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSA 330
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG-TYGY 123
+EYL K I+R+L + N L+ + K++DFGL++L + +T+ + +
Sbjct: 331 MEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKFPIKW 385
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
APE K ++KSD+++FGV+L E+ T
Sbjct: 386 TAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 56/159 (35%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L HDN+V G C S +R L+ EY+P GSL D+L +E + ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 120
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+G+EYL K I+RDL + NIL++N+ K+ DFGL K+ P
Sbjct: 121 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK--- 174
Query: 119 GTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
G + APE K ++ SD++SFGVVL EL T
Sbjct: 175 -EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-29
Identities = 72/247 (29%), Positives = 111/247 (44%), Gaps = 32/247 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L HDN+V G C S +R L+ EY+P GSL D+L +E + ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 151
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+G+EYL K I+RDL + NIL++N+ K+ DFGL K+ P +
Sbjct: 152 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK--- 205
Query: 119 GTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 173
G + APE K ++ SD++SFGVVL EL T + + + + +
Sbjct: 206 -EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI--GND 262
Query: 174 PFLKDQKKFVHLVDPLLHGR---YPRRCLN--YAVAVTAM--CLNEEANFRPLINDIVVA 226
Q HL++ L + P C + Y + M C N N RP D+ +
Sbjct: 263 KQ--GQMIVFHLIELLKNNGRLPRPDGCPDEIYMI----MTECWNNNVNQRPSFRDLALR 316
Query: 227 LDYLVSQ 233
+D + Q
Sbjct: 317 VDQIRDQ 323
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L+H+N+V G CT L+ E++P GSL+++L ++ ++ ++K A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYA 132
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
V +G++YL + ++RDL + N+L++++ K+ DFGL K +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK--- 186
Query: 119 GTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE M K + SD++SFGV L EL+T
Sbjct: 187 -DDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 29/247 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L+H++++ G C LV EY+P+GSL D+L + + + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFA 140
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
G+ YLH + I+RDL + N+LLDND K+ DFGLAK P G + +
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----V 193
Query: 119 GTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWS 172
G + APE K SD++SFGV L EL+T + E +
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI--- 250
Query: 173 RPFLKDQKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229
Q + L + L G P +C + C EA+FRP +++ L
Sbjct: 251 -AQ--GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
Query: 230 LVSQRDS 236
+ +
Sbjct: 308 VHEKYQG 314
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+++ + ++ +T G T+ D+ ++YEYM S+ + + +++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 61 AAR----GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+ Y+H + N + +RD+K +NIL+D + KLSDFG ++ + +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG- 209
Query: 117 VMGTYGYCAPEYAMSGKLT---LKSDIYSFGVVLLELITGR 154
GTY + PE S + + K DI+S G+ L +
Sbjct: 210 SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 40/155 (25%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
+ + ++ L+G C L+ + MP G L D++ + ++ + + V A+G
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKG 129
Query: 65 LEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
+ YL ++RDL + N+L+ + K++DFGLAKL + + +
Sbjct: 130 MNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ A E + T +SD++S+GV + EL+T G K
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-29
Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L LH D +V G ++ LV EY+P G L D L L + + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR---LDASRLLLYS 133
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+G+EYL + ++RDL + NIL++++ + K++DFGLAKL P+ + +V
Sbjct: 134 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR--- 187
Query: 119 GTYG-----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
G + APE + +SD++SFGVVL EL T
Sbjct: 188 -EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 57/230 (24%), Positives = 91/230 (39%), Gaps = 29/230 (12%)
Query: 1 MLSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L H N+V + L +V EY G L + +++ L +++
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 59 VGAARGLEYLHCKANPP--VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
L+ H +++ V++RDLK AN+ LD N KL DFGLA++ + +T +
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKT 175
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 176
+GT Y +PE KSDI+S G +L EL PF
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPF- 216
Query: 177 KDQKKFVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 223
L + G++ R Y + LN + RP + +I
Sbjct: 217 -TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 265
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-28
Identities = 43/155 (27%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H LV G C+ +V EY+ G L ++L + L + +++ G
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEG 116
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ +L I+RDL + N L+D D K+SDFG+ + V D+ + +GT
Sbjct: 117 MAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPV 169
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE K + KSD+++FG+++ E+ + G+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 10/151 (6%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H N+V++I D LV EY+ +L +++ PLS +T + G
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDG 123
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGY 123
+++ H +++RD+K NIL+D++ K+ DFG+AK + + + T V+GT Y
Sbjct: 124 IKHAH-DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQY 178
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+PE A +DIYS G+VL E++ G
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 51/155 (32%), Positives = 71/155 (45%), Gaps = 13/155 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H NL+ L G +V E P+GSL D L Q T + AV A G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 133
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL K I+RDL + N+LL K+ DFGL + P D+ +V +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+CAPE + + SD + FGV L E+ T G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-28
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H LV L G C LV E+M G L D+L + + T + + + G
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEG 116
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL VI+RDL + N L+ + K+SDFG+ + V D+ + T GT
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPV 169
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ +PE + + KSD++SFGV++ E+ + G+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 47/151 (31%), Positives = 81/151 (53%), Gaps = 12/151 (7%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
+ H NLV L+G CT ++ E+M G+L D+L + + +S + +A +
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSA 123
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+EYL K I+RDL + N L+ + K++DFGL++L + +T+ + G
Sbjct: 124 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPI 176
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE K ++KSD+++FGV+L E+ T
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 25/168 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL----------YDLEPDQEPLS 50
M L H+N+V L+G CT G L++ EY G L + L S
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 51 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 110
+ + A+G+ +L K I+RD+ + N+LL N K+ DFGLA+ N
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 111 THVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
V + M APE T++SD++S+G++L E+ +
Sbjct: 220 YIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-28
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H+ LV L + + +V EYM GSL D L + L + +A
Sbjct: 232 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQ 288
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ Y+ ++RDL++ANIL+ + K++DFGLA+L + T
Sbjct: 289 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFP 344
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE A+ G+ T+KSD++SFG++L EL T
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 48/155 (30%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L HD LV L T + ++ E+M GSL D L + + +
Sbjct: 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQ 292
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ ++ + I+RDL++ANIL+ K++DFGLA++ + DN + T G
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGA 345
Query: 121 ---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE G T+KSD++SFG++L+E++T
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-28
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 27/226 (11%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L+H N++ ++ +V E G L + + + + T K V
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
LE++H + V++RD+K AN+ + KL D GL + T + ++GT
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 200
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKK 181
Y +PE KSDI+S G +L E+ + PF D+
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMN 242
Query: 182 FVHLVDPLLHGRYPRRCLNY----AVAVTAMCLNEEANFRPLINDI 223
L + YP ++ + MC+N + RP + +
Sbjct: 243 LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV 288
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-28
Identities = 44/155 (28%), Positives = 81/155 (52%), Gaps = 12/155 (7%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H N++ L G + +++ EYM G+L+ L + + + S + + G A G
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAG 159
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
++YL ++RDL + NIL++++ K+SDFGL+++ + D+ + G
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPI 214
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE K T SD++SFG+V+ E++T G +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-28
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H LV L T + ++ EYM GSL D L P L+ N + +A
Sbjct: 61 LMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQ 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ ++ + I+RDL++ANIL+ + + K++DFGLA+L + DN + T G
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGA 170
Query: 121 ---YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE G T+KSD++SFG++L E++T
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 12/155 (7%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H N++ L G T G ++V EYM GSL+ L + + + G G
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAG 163
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+ YL ++RDL + N+L+D++ K+SDFGL+++ + D+ + G
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPI 218
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE + SD++SFGVV+ E++ G +
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 45/151 (29%), Positives = 77/151 (50%), Gaps = 13/151 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H+ LV L G CT ++ EYM G L ++L ++ +++
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEA 132
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
+EYL K ++RDL + N L+++ K+SDFGL++ V D+ + T +G+
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPV 185
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ PE M K + KSDI++FGV++ E+ +
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H ++V L+G C G LV +Y+P+GSL DH+ + L + V A+G
Sbjct: 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKG 127
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+ YL +++R+L + N+LL + +++DFG+A L P D + + +
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
A E GK T +SD++S+GV + EL+T G +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H+ LV L + + +V EYM GSL D L + L + +A
Sbjct: 315 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQ 371
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ Y+ ++RDL++ANIL+ + K++DFGLA+L + T
Sbjct: 372 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFP 427
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE A+ G+ T+KSD++SFG++L EL T
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 19/157 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+++ L H NLV L+G L +V EYM GSL D+L + L + +K ++
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSL 296
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV-- 117
+EYL ++RDL + N+L+ D K+SDFGL K +T + ++
Sbjct: 297 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 350
Query: 118 --MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
APE K + KSD++SFG++L E+ +
Sbjct: 351 KWT------APEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H N++ L G T ++V EYM GSL+ L + + + + G A G
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASG 159
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
++YL ++RDL + NIL++++ K+SDFGL ++ + D+ + G
Sbjct: 160 MKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPI 214
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ +PE K T SD++S+G+VL E+++ G +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 40/152 (26%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
+ + ++ L+G C L+ + MP G L D++ + ++ + + V A+G
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKG 129
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+ YL + +++RDL + N+L+ + K++DFGLAKL + + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
A E + T +SD++S+GV + EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-27
Identities = 50/172 (29%), Positives = 77/172 (44%), Gaps = 29/172 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------YDLEPDQ 46
+ L +H N+V L+G CT G L++ EY G L + L +E D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 106
L + + A+G+ +L K I+RDL + NILL + K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 107 VGDNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
N V + M APE + T +SD++S+G+ L EL +
Sbjct: 197 NDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-27
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEP 48
M + H N++ L+G CT ++ EY G+L ++L +E
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
+++ + ARG+EYL + I+RDL + N+L+ + K++DFGLA+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 109 DNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D +T + M APE T +SD++SFGV++ E+ T
Sbjct: 211 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------YDLEPDQEPLSWNTR 54
++ + ++V L+G + G L++ E M G L+ +L P P S +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+++A A G+ YL+ ++RDL + N ++ DF K+ DFG+ + D
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 115 TRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ M +PE G T SD++SFGVVL E+ T
Sbjct: 198 GKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 25/161 (15%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L + +V LIG C + +LV E G L L +E + + ++ + G
Sbjct: 67 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMG 122
Query: 65 LEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
++YL + ++RDL + N+LL N K+SDFGL+K D+ + +
Sbjct: 123 MKYLEEKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS----- 171
Query: 122 G------YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE K + +SD++S+GV + E ++ G+K
Sbjct: 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-27
Identities = 51/173 (29%), Positives = 76/173 (43%), Gaps = 33/173 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------P 48
+L+ L H+++V G C GD ++V+EYM G L L PD
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 49 LSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 105
L + + IA A G+ YL H ++RDL + N L+ + K+ DFG+++
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 106 PVGDNTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D V M PE M K T +SD++SFGV+L E+ T
Sbjct: 184 YSTDYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEP 48
M + H N++ L+G CT ++ EY G+L ++L +E
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
+++ + ARG+EYL + I+RDL + N+L+ + K++DFGLA+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 109 DNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D +T + M APE T +SD++SFGV++ E+ T
Sbjct: 257 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-27
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 26/161 (16%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L + +V +IG C + +LV E +G L +L + +++ + G
Sbjct: 75 LDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMG 129
Query: 65 LEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121
++YL + ++RDL + N+LL K+SDFGL+K +N + +
Sbjct: 130 MKYLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT----- 178
Query: 122 G------YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE K + KSD++SFGV++ E + G+K
Sbjct: 179 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 49/170 (28%), Positives = 74/170 (43%), Gaps = 30/170 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEP 48
+ L HH N++ L+G C L EY P G+L D L
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
LS + A ARG++YL K I+RDL + NIL+ ++ K++DFGL++
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR---GQ 192
Query: 109 DNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ T R M A E T SD++S+GV+L E+++
Sbjct: 193 EVYVKKTMGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 53/172 (30%), Positives = 77/172 (44%), Gaps = 32/172 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE-----------PL 49
+L++L H ++V G CT G L+V+EYM G L L PD + PL
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 50 SWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 106
+ +A A G+ YL H ++RDL + N L+ K+ DFG+++
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 107 VGDNTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D V R M PE + K T +SD++SFGVVL E+ T
Sbjct: 210 STDYYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-26
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L H ++V LIG + ++ E P G L +L + L T + ++ +
Sbjct: 70 LDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKA 125
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-- 122
+ YL ++RD+ NIL+ + KL DFGL++ + D +
Sbjct: 126 MAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTR 175
Query: 123 ----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ +PE + T SD++ F V + E+++ G++
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 50/161 (31%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+++ L H NLV L+G L +V EYM GSL D+L + L + +K ++
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 124
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV-- 117
+EYL ++RDL + N+L+ D K+SDFGL K +T + ++
Sbjct: 125 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 178
Query: 118 --MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
APE K + KSD++SFG++L E+ + GR
Sbjct: 179 KWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-26
Identities = 44/158 (27%), Positives = 69/158 (43%), Gaps = 11/158 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ L +V L G G + E + GSL + + E + +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----LYYLGQ 158
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTHVSTR-- 116
A GLEYLH + +++ D+K+ N+LL +D + L DFG A L P G + T
Sbjct: 159 ALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ GT + APE M K DI+S ++L ++ G
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 47/173 (27%), Positives = 75/173 (43%), Gaps = 33/173 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------P 48
+ + L H N+V L+G T +++ Y G L + L P +
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 49 LSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLG 105
L + + A G+EYL H +++DL + N+L+ + N K+SD GL +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 106 PVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D + R M APE M GK ++ SDI+S+GVVL E+ +
Sbjct: 179 YAADYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL------------YDLEPDQEP 48
M + H N++ L+G CT ++ EY G+L ++L +E
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
LS + A ARG+EYL K I+RDL + N+L+ D K++DFGLA+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 109 DNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
D +T + M APE T +SD++SFGV+L E+ T
Sbjct: 245 DYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKI 57
++S +H N+V IG R ++ E M G L+ L + P L+ + +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 58 AVGAARGLEYL---HCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNT 111
A A G +YL H I+RD+ + N LL K+ DFG+A+
Sbjct: 146 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
M + PE M G T K+D +SFGV+L E+ +
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 27/164 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
++ L+H N++ LIG + ++ YM G L + + + + + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN---PTVKDLISFGL 131
Query: 60 GAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
ARG+EYL ++RDL + N +LD F K++DFGLA+ + D + S +
Sbjct: 132 QVARGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQ 183
Query: 117 VMG--------TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
T A E + + T KSD++SFGV+L EL+T
Sbjct: 184 QHRHARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 47/223 (21%), Positives = 71/223 (31%), Gaps = 30/223 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ H V L G L E SL+ H L
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRD 165
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
L +LH + +++ D+K ANI L KL DFGL +G + G
Sbjct: 166 TLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GD 219
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y APE + G +D++S G+ +LE+ + G+G Q L Q
Sbjct: 220 PRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLR---------QG 267
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
L + + +V M L + R +
Sbjct: 268 Y--------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL 302
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-26
Identities = 50/226 (22%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L+ + H N+V +V +Y G L + + + + V
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK--GVLFQEDQILDWFVQ 133
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
L+++H + +++RD+KS NI L D +L DFG+A++ + ++ +GT
Sbjct: 134 ICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGT 188
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y +PE + KSDI++ G VL EL T + F +
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLK------------------HAF--EAG 228
Query: 181 KFVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDI 223
+LV ++ G +P L+Y ++ + RP +N I
Sbjct: 229 SMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 35/178 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL--------------------Y 40
+L ++H +++ L G C+ LL+ EY GSL L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 41 DLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100
PD+ L+ + A ++G++YL +++RDL + NIL+ K+SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFG 195
Query: 101 LAKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
L++ D+ + + M A E T +SD++SFGV+L E++T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 40/151 (26%), Positives = 58/151 (38%), Gaps = 10/151 (6%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L ++V + + Q + + L L Q PL+ + I
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSA 146
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST-RVMGTYGY 123
L+ H A +RD+K NIL+ D L DFG+A D +GT Y
Sbjct: 147 LDAAH-AAG--ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYY 201
Query: 124 CAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE T ++DIY+ VL E +TG
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-26
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H ++V LIG T + ++ E +G L L + L + + A +
Sbjct: 73 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTA 128
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-- 122
L YL K ++RD+ + N+L+ ++ KL DFGL++ + D+T+
Sbjct: 129 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGK 178
Query: 123 ----YCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE + T SD++ FGV + E++ G K
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 8e-26
Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 13/155 (8%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
L + +V LIG C + +LV E G L L + +E + + ++ + G
Sbjct: 393 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL--VGKREE-IPVSNVAELLHQVSMG 448
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT---Y 121
++YL K ++R+L + N+LL N K+SDFGL+K D+ + +
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPL 503
Query: 122 GYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRK 155
+ APE K + +SD++S+GV + E ++ G+K
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-26
Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 16/157 (10%)
Query: 5 LHHDNLVTL--IGYCTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L+H +V + G + L +V EY+ +L D ++ + P++ +++
Sbjct: 69 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIAD 124
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR---V 117
A + L + H + +I+RD+K ANI++ K+ DFG+A+ + D+ + T+ V
Sbjct: 125 ACQALNFSH-QNG--IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAV 179
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+GT Y +PE A + +SD+YS G VL E++TG
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 50/177 (28%), Positives = 82/177 (46%), Gaps = 34/177 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHL-------------------YD 41
M L H+N+V L+G CT L++EY G L ++L +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 42 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101
E D L++ + A A+G+E+L K+ ++RDL + N+L+ + K+ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 102 AKLGPVGDNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
A+ N V + M APE G T+KSD++S+G++L E+ +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 48/174 (27%), Positives = 74/174 (42%), Gaps = 22/174 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR-------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 53
M L H N+V + G + L+ + G L + L +E + PLS +T
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDT 137
Query: 54 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---KLGPVGDN 110
+KI R ++++H + PP+I+RDLK N+LL N KL DFG A P
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 111 THVSTRVM-------GTYGYCAPE--YAMSGK-LTLKSDIYSFGVVLLELITGR 154
+ ++ T Y PE S + K DI++ G +L L +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 28/171 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQ-RLLVYEYMPMGSLEDHL------------YDLEPDQE 47
++ + HH N+V L+G CT +++ E+ G+L +L + ++
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 48 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 107
L+ + + A+G+E+L + I+RDL + NILL K+ DFGLA+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 108 GDNTHVST------RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ + M APE T++SD++SFGV+L E+ +
Sbjct: 201 DPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 45/161 (27%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE---PLSWNTRMKI 57
++S +H N+V IG R ++ E M G L+ L + P L+ + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 58 AVGAARGLEYL---HCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNT 111
A A G +YL H I+RD+ + N LL K+ DFG+A+
Sbjct: 187 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
M + PE M G T K+D +SFGV+L E+ +
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 39/169 (23%), Positives = 68/169 (40%), Gaps = 29/169 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEP--LSWN 52
+ H ++ L+G + +++ +M G L L + P L
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 53 TRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD 109
T ++ V A G+EYL + I+RDL + N +L D ++DFGL++ GD
Sbjct: 138 TLVRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 110 NTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ A E T+ SD+++FGV + E++T
Sbjct: 192 YYRQGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-25
Identities = 55/240 (22%), Positives = 87/240 (36%), Gaps = 48/240 (20%)
Query: 1 MLSLLHHDNLVTLIGY---------------CTSGDQRL-LVYEYMPMGSLEDHLYDLEP 44
L+ L H N+V G S + L + E+ G+LE +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR- 115
Query: 45 DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104
E L +++ +G++Y+H K +I RDLK +NI L + K+ DFGL
Sbjct: 116 -GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT- 170
Query: 105 GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQ 163
N TR GT Y +PE S + D+Y+ G++L EL+ A + SK
Sbjct: 171 --SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-- 226
Query: 164 GEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
L G + L+++ RP ++I
Sbjct: 227 ---------------------FFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI 265
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 28/168 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
M+S L H +LV G C GD+ +LV E++ GSL+ +L ++ ++ ++++A
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQ 121
Query: 61 AARGLEYL---HCKANPPVIYRDLKSANILLDNDFNP--------KLSDFGLAKLGPVGD 109
A + +L I+ ++ + NILL + + KLSD G++ V
Sbjct: 122 LAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLP 173
Query: 110 NTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELIT-GRK 155
+ R+ PE + K L +D +SFG L E+ + G K
Sbjct: 174 KDILQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 52/226 (23%), Positives = 84/226 (37%), Gaps = 46/226 (20%)
Query: 1 MLSLLHHDNLVTLIG-YCTSGDQRL------------LVYEYMPMGSLEDHLYDL-EPDQ 46
+L+ L+H +V + + + EY G+L D ++ Q
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 47 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL-- 104
W +I L Y+H + +I+RDLK NI +D N K+ DFGLAK
Sbjct: 115 RDEYWRLFRQIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 105 -----------GPVGDNTHVSTRVMGTYGYCAPE-YAMSGKLTLKSDIYSFGVVLLELIT 152
G + ++++ + GT Y A E +G K D+YS G++ E+I
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226
Query: 153 G-RKAMDLSK-----GQGEQNLVSW-SRPFLKDQKKFVHL---VDP 188
M+ +K +KK + L DP
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-25
Identities = 39/153 (25%), Positives = 69/153 (45%), Gaps = 18/153 (11%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
H ++V LIG T + ++ E +G L L + L + + A +
Sbjct: 448 FDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTA 503
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYG-- 122
L YL K ++RD+ + N+L+ ++ KL DFGL++ + D+T+ G
Sbjct: 504 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKL 554
Query: 123 ---YCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ APE + T SD++ FGV + E++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 28/168 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR-----LLVYEYMPMGSLEDHLYDLEPDQEP--LSWNT 53
+ H N++ L+G C + +++ +M G L +L + P + T
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 54 RMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 110
+K V A G+EYL + ++RDL + N +L +D ++DFGL+K GD
Sbjct: 149 LLKFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 111 THVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
+ A E T KSD+++FGV + E+ T
Sbjct: 203 YRQGRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-24
Identities = 45/154 (29%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ S L H N++ L GY + L+ EY P+G++ L L E +
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT----ATYITE 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A L Y H K VI+RD+K N+LL + K++DFG + P + GT
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGT 170
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y PE K D++S GV+ E + G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-24
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 15/160 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED---HLYDLEPDQEPLSWNTRMKI 57
+ L H N+V +G + + E +P GSL + D E +I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTR 116
GL+YLH +++RD+K N+L++ K+SDFG +K + +
Sbjct: 132 ----LEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTET 182
Query: 117 VMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
GT Y APE G +DI+S G ++E+ TG+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 37/155 (23%), Positives = 60/155 (38%), Gaps = 22/155 (14%)
Query: 5 LHHDNLVTLIGYCTSGDQRL-----LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+ H ++V + + D+ +V EY+ SL+ + L + +
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLL 189
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
L YLH + ++Y DLK NI+L + KL D G + + G
Sbjct: 190 EILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINS----FGYLYG 239
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T G+ APE T+ +DIY+ G L L
Sbjct: 240 TPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDL 273
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-24
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
++ H N+++L+G C + L+V YM G L + + + + + + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 135
Query: 60 GAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
A+G++YL ++RDL + N +LD F K++DFGLA+ + V +
Sbjct: 136 QVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 117 VMG------TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
A E + K T KSD++SFGV+L EL+T
Sbjct: 190 TGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 2e-24
Identities = 35/285 (12%), Positives = 73/285 (25%), Gaps = 52/285 (18%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM-------GSLEDHLYDLEPDQEPLSWNTR 54
L+ +I ++ + + + L + L + R
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+++ + R L LH +++ L+ +I+LD L+ F G S
Sbjct: 214 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----S 264
Query: 115 TRVMGTYGYCAPEY----------AMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164
G+ PE +T D ++ G+ + +
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD---------- 314
Query: 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHG--RYPRRCLNYAVAVTAMCLNEEANFRPLIND 222
P D + + + P+ A+ L R L
Sbjct: 315 --------LPNTDDAA--LGGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQ 360
Query: 223 IVVALDYLVSQRDSHPVSRNAGARGVPTSASDVSQGSNSRRSSSA 267
+ +Y + + G PT S+ +
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAG 405
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 4e-24
Identities = 36/164 (21%), Positives = 65/164 (39%), Gaps = 17/164 (10%)
Query: 3 SLLHHDNLVTLIGYCTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+ + +G ++ +Y + +L+D + ++ + I +
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR-EHGVCLHIFI 171
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK----------LGPVGD 109
A +E+LH K +++RDLK +NI D K+ DFGL +
Sbjct: 172 QIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 228
Query: 110 NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
T +GT Y +PE + K DI+S G++L EL+
Sbjct: 229 AYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-24
Identities = 64/245 (26%), Positives = 100/245 (40%), Gaps = 57/245 (23%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN-TRMKIAV 59
+S HH N+V+ D+ LV + + GS+ D + + E S IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 60 ---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVST 115
GLEYLH I+RD+K+ NILL D + +++DFG+ A L GD T
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 116 R--VMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR---------KAMDL---- 159
R +GT + APE + K+DI+SFG+ +EL TG K + L
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242
Query: 160 ------SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 213
+ Q ++ L + + F +K + ++CL ++
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSF----RKMI-----------------------SLCLQKD 275
Query: 214 ANFRP 218
RP
Sbjct: 276 PEKRP 280
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.5 bits (245), Expect = 5e-24
Identities = 23/169 (13%), Positives = 52/169 (30%), Gaps = 24/169 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM----GSLEDHLYDLEPDQEPLSWNTRMK 56
++ ++ + + Y M + + L + L + R++
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
+ + R L LH +++ L+ +I+LD L+ F G
Sbjct: 211 LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----RVV 261
Query: 117 VMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLELITGR 154
+ G+ PE +T D ++ G+V+ +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 6e-24
Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 23/162 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
++ H N+++L+G C + L+V YM G L + + + + + + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 199
Query: 60 GAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
A+G+++L ++RDL + N +LD F K++DFGLA+ + V +
Sbjct: 200 QVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 253
Query: 117 VMG------TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152
A E + K T KSD++SFGV+L EL+T
Sbjct: 254 TGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 50/156 (32%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-A 58
+L+ +H +V+L Y L LV M G + H+Y+++ D R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYT 295
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
GLE+LH + +IYRDLK N+LLD+D N ++SD GLA G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA- 350
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT G+ APE + + D ++ GV L E+I R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-23
Identities = 49/247 (19%), Positives = 85/247 (34%), Gaps = 51/247 (20%)
Query: 2 LSLLHHDNLVTLIGY---------CTSGDQRLLVY---EYMPMGSLEDHLYDLEPDQEPL 49
L+ L H +V ++ +Y + +L+D + +E
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER- 115
Query: 50 SWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL----- 104
+ + I + A +E+LH K +++RDLK +NI D K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 105 -----GPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159
T +GT Y +PE + K DI+S G++L EL+
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------- 225
Query: 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANF 216
PF ++ L D + + ++P + L+
Sbjct: 226 --------------PFSTQMERVRTLTD-VRNLKFPPLFTQKYPCEYVMVQDMLSPSPME 270
Query: 217 RPLINDI 223
RP +I
Sbjct: 271 RPEAINI 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 41/181 (22%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------------- 47
+++ + N+V L+G C G L++EYM G L + L + P
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 48 -------PLSWNTRMKIAVGAARGLEYL---HCKANPPVIYRDLKSANILLDNDFNPKLS 97
PLS ++ IA A G+ YL ++RDL + N L+ + K++
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIA 216
Query: 98 DFGLAKLGPVGDNTHVSTRV------MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151
DFGL++ D M PE + T +SD++++GVVL E+
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 152 T 152
+
Sbjct: 271 S 271
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 42/159 (26%), Positives = 68/159 (42%), Gaps = 12/159 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ + VT G + E M SL+ + + + + KIAV
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMG 119
+ LE+LH K + VI+RD+K +N+L++ K+ DFG+ L + G
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAG 171
Query: 120 TYGYCAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE ++KSDI+S G+ ++EL R
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-23
Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAV 59
+L + +V G S + + E+M GSL+ L E L K+++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSI 138
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA-KLGPVGDNTHVSTRVM 118
+GL YL K +++RD+K +NIL+++ KL DFG++ +L ++ ++ V
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV- 191
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y +PE +++SDI+S G+ L+E+ GR
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 5e-23
Identities = 62/231 (26%), Positives = 92/231 (39%), Gaps = 53/231 (22%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
+LS + G + ++ EY+ GS D L + P E +IA
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDET-------QIATI 124
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
+GL+YLH + I+RD+K+AN+LL KL+DFG+A G + D
Sbjct: 125 LREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTF 179
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGEQNL 168
+GT + APE K+DI+S G+ +EL G K + L L
Sbjct: 180 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTL 239
Query: 169 VS-WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218
+S+P K+FV CLN+E +FRP
Sbjct: 240 EGNYSKPL----KEFV-----------------------EACLNKEPSFRP 263
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 5e-23
Identities = 18/137 (13%), Positives = 36/137 (26%), Gaps = 12/137 (8%)
Query: 22 QRLLVYEYMP--MGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79
LL+ + L L + + + R L K +++
Sbjct: 162 NYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHG 218
Query: 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL--TLK 137
N+ + D L D VG S+ Y E+ + T
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHA 273
Query: 138 SDIYSFGVVLLELITGR 154
+ + G+ + +
Sbjct: 274 LNAWQLGLSIYRVWCLF 290
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 6e-23
Identities = 38/166 (22%), Positives = 63/166 (37%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD--QEPLSWNTRMKIA 58
+ L +H N+V + ++ +V +M GS +D + D E IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IA 131
Query: 59 V---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG-LAKLGPVGDNTHV- 113
G + L+Y+H ++R +K+++IL+ D LS + G V
Sbjct: 132 YILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 114 ---STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
+ + +PE KSDIYS G+ EL G
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 8e-23
Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQ--EPLSWNTRMKI 57
+L ++ +V+L Y L LV M G L+ H+Y + E R
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVF 290
Query: 58 -AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
A GLE LH + ++YRDLK NILLD+ + ++SD GLA P G R
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR 345
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V GT GY APE + + T D ++ G +L E+I G+
Sbjct: 346 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 8e-23
Identities = 25/166 (15%), Positives = 52/166 (31%), Gaps = 15/166 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-EPDQEPLSWNTRMKIAV 59
L + + +LV E G+L + + ++ + + A+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-----------KLSDFGLAKLGPVG 108
+E +H +I+ D+K N +L N F L D G + +
Sbjct: 180 RMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ T T G+ E + + D + + ++ G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-23
Identities = 40/154 (25%), Positives = 59/154 (38%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ S L H N++ + Y + L+ E+ P G L L E S
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS----ATFMEE 122
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A L Y H + VI+RD+K N+L+ K++DFG + P GT
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GT 175
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y PE K D++ GV+ E + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 43/159 (27%), Positives = 67/159 (42%), Gaps = 11/159 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ +V G + E M + + Y + + KI +
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVMG 119
+ L +L +I+RD+K +NILLD N KL DFG+ +L ++ TR G
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAG 187
Query: 120 TYGYCAPE----YAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE A ++SD++S G+ L EL TGR
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 4e-22
Identities = 49/148 (33%), Positives = 67/148 (45%), Gaps = 16/148 (10%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 67
+V + Y +L + + M G L HL E M+ A GLE+
Sbjct: 254 IVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILGLEH 307
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPE 127
+H + V+YRDLK ANILLD + ++SD GLA H V GT+GY APE
Sbjct: 308 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYMAPE 360
Query: 128 YAMSGKLTLKS-DIYSFGVVLLELITGR 154
G S D +S G +L +L+ G
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 6e-22
Identities = 38/167 (22%), Positives = 63/167 (37%), Gaps = 22/167 (13%)
Query: 1 MLSLL--HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L+ L H D ++ L Y + +V E L L ++ + R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 133
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ +H +++ DLK AN L+ + KL DFG+A + V +
Sbjct: 134 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 119 GTYGYCAPE-----------YAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y PE K++ KSD++S G +L + G+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 6e-22
Identities = 38/167 (22%), Positives = 63/167 (37%), Gaps = 22/167 (13%)
Query: 1 MLSLL--HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L+ L H D ++ L Y + +V E L L ++ + R
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 114
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ +H +++ DLK AN L+ + KL DFG+A + V +
Sbjct: 115 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 170
Query: 119 GTYGYCAPE-----------YAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y PE K++ KSD++S G +L + G+
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 48/163 (29%), Positives = 66/163 (40%), Gaps = 16/163 (9%)
Query: 1 MLSLLHHDNLVTLI------GYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
++ L+H N+V+ D LL EY G L +L E + L
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPI 123
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD---NDFNPKLSDFGLAKLGPVGDNT 111
+ + L YLH +I+RDLK NI+L K+ D G AK +
Sbjct: 124 RTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGE 178
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ V GT Y APE K T+ D +SFG + E ITG
Sbjct: 179 LCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-21
Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 41/209 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
++ + N+V + GD+ +V EY+ GSL D + E +IA
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEG-------QIAAV 121
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVS 114
+ LE+LH VI+RD+KS NILL D + KL+DFG A++ P +T V
Sbjct: 122 CRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 177
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE 165
GT + APE K DI+S G++ +E+I G +A+ L G
Sbjct: 178 ----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 166 ---QNLVSWSRPFLKDQKKFVHL---VDP 188
QN S F + F++ +D
Sbjct: 234 PELQNPEKLSAIF----RDFLNRCLEMDV 258
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-21
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 22/167 (13%)
Query: 1 MLSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L+ L D ++ L Y + +V E L L ++ + R
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 161
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ +H +++ DLK AN L+ + KL DFG+A + V +
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 119 GTYGYCAPE-----------YAMSGKLTLKSDIYSFGVVLLELITGR 154
G Y PE K++ KSD++S G +L + G+
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-21
Identities = 44/161 (27%), Positives = 66/161 (40%), Gaps = 18/161 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP-LSWNTRMKIAV 59
+L +V G + + E M + + P E L K+ V
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTV 131
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTRVM 118
+ L YL K VI+RD+K +NILLD KL DFG+ +L + R
Sbjct: 132 AIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSA 185
Query: 119 GTYGYCAPE-----YAMSGKLTLKSDIYSFGVVLLELITGR 154
G Y APE +++D++S G+ L+EL TG+
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-21
Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 41/209 (19%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
++ H N+V + G++ ++ E++ G+L D + E +IA
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEE-------QIATV 146
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR 116
+ L YLH + VI+RD+KS +ILL D KLSDFG A++ + V R
Sbjct: 147 CEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQI-----SKDVPKR 198
Query: 117 --VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR---------KAMDLSKGQGE 165
++GT + APE + DI+S G++++E++ G +AM +
Sbjct: 199 KSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP 258
Query: 166 ---QNLVSWSRPFLKDQKKFVHL---VDP 188
+N S + F+ DP
Sbjct: 259 PKLKNSHKVSPVL----RDFLERMLVRDP 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-21
Identities = 40/168 (23%), Positives = 65/168 (38%), Gaps = 21/168 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L+H N+V L R L+ E+ P GSL L + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVL 118
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVS 114
G+ +L +++R++K NI+ D KL+DFG A+ + D+
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173
Query: 115 TRVMGTYGYCAPE--------YAMSGKLTLKSDIYSFGVVLLELITGR 154
+ GT Y P+ K D++S GV TG
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-21
Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
++ ++V G +V EY GS+ D + L L T +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNK--TL---TEDEIATI 130
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGD--NTHVS 114
+GLEYLH I+RD+K+ NILL+ + + KL+DFG+ +L NT +
Sbjct: 131 LQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI- 186
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT + APE +DI+S G+ +E+ G
Sbjct: 187 ----GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-21
Identities = 40/168 (23%), Positives = 69/168 (41%), Gaps = 21/168 (12%)
Query: 1 MLSLLHHDNLVTLIGY--CTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L+H N+V L T+ ++L+ E+ P GSL L + + L + + +
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVL 118
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVS 114
G+ +L +++R++K NI+ D KL+DFG A+ + D+
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173
Query: 115 TRVMGTYGYCAPE--------YAMSGKLTLKSDIYSFGVVLLELITGR 154
+ GT Y P+ K D++S GV TG
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 8e-21
Identities = 44/155 (28%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-V 59
++S L H V L ++ Y G L ++ + E TR A +
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC---TRFYTAEI 139
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
+A LEYLH K +I+RDLK NILL+ D + +++DFG AK+ + +G
Sbjct: 140 VSA--LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T Y +PE SD+++ G ++ +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-20
Identities = 37/162 (22%), Positives = 62/162 (38%), Gaps = 16/162 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ H N++ + + E +L++++ + L + +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQ 126
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDN-----DFNPKLSDFGLAK-LGPVGDNTHVS 114
GL +LH +++RDLK NIL+ +SDFGL K L +
Sbjct: 127 TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 115 TRVMGTYGYCAPEY---AMSGKLTLKSDIYSFGVVLLELITG 153
+ V GT G+ APE T DI+S G V +I+
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-20
Identities = 41/164 (25%), Positives = 75/164 (45%), Gaps = 25/164 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
+L+ H +V L+G + ++ E+ P G+++ + L T +I V
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM---LELDRGL---TEPQIQVV 122
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR- 116
L +LH K +I+RDLK+ N+L+ + + +L+DFG++ N +
Sbjct: 123 CRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQKR 174
Query: 117 --VMGTYGYCAPEYAMSGKLT-----LKSDIYSFGVVLLELITG 153
+GT + APE M + K+DI+S G+ L+E+
Sbjct: 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 7e-20
Identities = 31/174 (17%), Positives = 55/174 (31%), Gaps = 29/174 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L H ++V D L+ EY GSL D + + + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-------------------KLSDFGL 101
RGL Y+H + +++ D+K +NI + P K+ D G
Sbjct: 124 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 102 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ V G + A E K+DI++ + ++
Sbjct: 181 VT---RISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 11/154 (7%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L H ++V G+ D +V E SL + + EP +
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQI 150
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GT 120
G +YLH VI+RDLK N+ L+ D K+ DFGLA +V+ GT
Sbjct: 151 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGT 204
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE + + D++S G ++ L+ G+
Sbjct: 205 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 2e-19
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 11/154 (7%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L H ++V G+ D +V E SL + + EP +
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQI 124
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GT 120
G +YLH VI+RDLK N+ L+ D K+ DFGLA +V+ GT
Sbjct: 125 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGT 178
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE + + D++S G ++ L+ G+
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 3e-19
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAVG 60
L H +++ L Y + LV E G + +L + P E + + +I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII-- 122
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
G+ YLH +++RDL +N+LL + N K++DFGLA + H T + GT
Sbjct: 123 --TGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGT 175
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y +PE A L+SD++S G + L+ GR
Sbjct: 176 PNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 41/179 (22%), Positives = 65/179 (36%), Gaps = 31/179 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
+ H N++ T+ + E +L+D + E L
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDN-------------DFNPKLSDFGLAKL 104
A G+ +LH +I+RDLK NIL+ + +SDFGL K
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 105 ---GPVGDNTHVSTRVMGTYGYCAPE-------YAMSGKLTLKSDIYSFGVVLLELITG 153
G T+++ GT G+ APE +LT DI+S G V +++
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-18
Identities = 63/236 (26%), Positives = 88/236 (37%), Gaps = 62/236 (26%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV- 59
L L H N + G LV EY GS D LE ++PL ++IA
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPL---QEVEIAAV 159
Query: 60 --GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL-AKLGPVGDNTHVSTR 116
GA +GL YLH +I+RD+K+ NILL KL DFG + + P N+
Sbjct: 160 THGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANS----- 209
Query: 117 VMGTYGYCAPEYAMSGKLT---LKSDIYSFGVVLLELITGR---------KAMDLSKGQG 164
+GT + APE ++ K D++S G+ +EL + A+
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 165 EQNLVS--WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218
L S WS F + FV CL + RP
Sbjct: 270 SPALQSGHWSEYF----RNFV-----------------------DSCLQKIPQDRP 298
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-18
Identities = 60/246 (24%), Positives = 87/246 (35%), Gaps = 68/246 (27%)
Query: 1 MLSLLHHDNLVTLIG-----YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
+ HH N+ T G D +L LV E+ GS+ D L L
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGN-TL---KE 128
Query: 55 MKIAV---GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
IA RGL +LH VI+RD+K N+LL + KL DFG++
Sbjct: 129 EWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS-----AQLD 180
Query: 112 HVSTR---VMGTYGYCAPEYAMSGKLT-----LKSDIYSFGVVLLELITGR--------- 154
R +GT + APE + KSD++S G+ +E+ G
Sbjct: 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM 240
Query: 155 KAMDLSKGQGEQNLVS--WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNE 212
+A+ L L S WS+ F + F+ CL +
Sbjct: 241 RALFLIPRNPAPRLKSKKWSKKF----QSFI-----------------------ESCLVK 273
Query: 213 EANFRP 218
+ RP
Sbjct: 274 NHSQRP 279
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-18
Identities = 48/159 (30%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA- 58
++ L H LV L Y ++ + +V + + G L HL +E ++ I
Sbjct: 68 IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---VKLFICE 123
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ A L+YL + +I+RD+K NILLD + ++DF +A + P T +
Sbjct: 124 LVMA--LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMA 175
Query: 119 GTYGYCAPEYAMSGKLTLKS---DIYSFGVVLLELITGR 154
GT Y APE S K S D +S GV EL+ GR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N++ L LV E+ G L + + + E + N MK +
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-MKQILS 157
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRV 117
+ YLH +++RD+K NILL+N N K+ DFGL+ +
Sbjct: 158 G---ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLRDR 208
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+GT Y APE + K K D++S GV++ L+ G
Sbjct: 209 LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 5e-18
Identities = 53/155 (34%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AV 59
L H L L Y RL V EY G L HL E R +
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA 255
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
L+YLH + N V+YRDLK N++LD D + K++DFGL K G + D + T G
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCG 311
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T Y APE D + GVV+ E++ GR
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L LL H N++ L + LV E G L D + + + I
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQ 144
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRV 117
G+ YLH +++RDLK N+LL++ D K+ DFGL+ + + + R+
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERL 199
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE + K K D++S GV+L L+ G
Sbjct: 200 -GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 42/157 (26%), Positives = 72/157 (45%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N++ L + LV E G L D + + E + ++ +
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-IRQVLS 137
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRV 117
+ Y+H +++RDLK N+LL++ D N ++ DFGL+ + +
Sbjct: 138 G---ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDK 188
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+GT Y APE + G K D++S GV+L L++G
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 1e-17
Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 23/160 (14%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK---- 56
L ++H +V L Y + +L L+ +++ G L L E +K
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA 133
Query: 57 -IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+A+ L++LH +IYRDLK NILLD + + KL+DFGL+K +
Sbjct: 134 ELALA----LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---A 183
Query: 116 RVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE T +D +SFGV++ E++TG
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-17
Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-V 59
+L ++ LV L +V EY+ G + HL + EP R A +
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQI 150
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
EYLH +IYRDLK N+L+D +++DFG AK V T T + G
Sbjct: 151 VLT--FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTW--T-LCG 200
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T APE +S D ++ GV++ E+ G
Sbjct: 201 TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-17
Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 29/163 (17%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
+ +L+H N+V L + L+ EY G + D+L + RMK
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----------HGRMKEKE-- 115
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
AR ++Y H K +++RDLK+ N+LLD D N K++DFG + +
Sbjct: 116 ARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKL 170
Query: 114 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
G Y APE GK + D++S GV+L L++G
Sbjct: 171 DAFC-GAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-17
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
+L+H+N+V G+ G+ + L EY G L D + + M
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD-- 106
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
A+ G+ YLH + +RD+K N+LLD N K+SDFGLA + + +
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 114 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
++ GT Y APE + + D++S G+VL ++ G
Sbjct: 164 LNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 33/126 (26%), Positives = 59/126 (46%), Gaps = 3/126 (2%)
Query: 27 YEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86
E + +E+ + ++ L+ + + A+G+E+L + I+RDL + NI
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 87 LLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 146
LL K+ DFGLA+ + + APE T++SD++SFGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 147 LLELIT 152
L E+ +
Sbjct: 285 LWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 8e-05
Identities = 14/50 (28%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 1 MLSLLHHDNLVTLIGYCT-SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPL 49
++ + HH N+V L+G CT G +++ E+ G+L +L + P
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 2e-17
Identities = 48/163 (29%), Positives = 66/163 (40%), Gaps = 29/163 (17%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L + H +V LI Y +L L+ EY+ G L L E
Sbjct: 75 LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT----------- 122
Query: 61 AAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 112
A L +LH K +IYRDLK NI+L++ + KL+DFGL K
Sbjct: 123 -ACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV- 177
Query: 113 VSTRVM-GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T GT Y APE M D +S G ++ +++TG
Sbjct: 178 --THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 17/159 (10%)
Query: 2 LSLLHHDNLVTLIG-YCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
L L H N+V L+ + L +V+E + G + + P +PLS +
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPLSEDQARFYFQ 144
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
+G+EYLH + +I+RD+K +N+L+ D + K++DFG++ G + +S V G
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSNTV-G 199
Query: 120 TYGYCAPEYAMSGKLTL----KSDIYSFGVVLLELITGR 154
T + APE ++S + D+++ GV L + G+
Sbjct: 200 TPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-17
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 26/165 (15%)
Query: 2 LSLLHHDNLVTL--IGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
L L H N++ L + Y + +V EY G E + D P++ R +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ 110
Query: 60 GAAR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
A GLEYLH + ++++D+K N+LL K+S G+A+
Sbjct: 111 --AHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 112 HVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
G+ + PE A K DI+S GV L + TG
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-17
Identities = 51/156 (32%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AV 59
L H L L Y RL V EY G L HL E R +
Sbjct: 59 LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA 112
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM- 118
LEYLH + V+YRD+K N++LD D + K++DFGL K G T +
Sbjct: 113 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 166
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE D + GVV+ E++ GR
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-17
Identities = 49/153 (32%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 6 HHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-VGAAR 63
LVTL Y + +L L+ +Y+ G L HL E E ++ + + A
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHE---VQIYVGEIVLA- 171
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGY 123
LE+LH +IYRD+K NILLD++ + L+DFGL+K + GT Y
Sbjct: 172 -LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226
Query: 124 CAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
AP+ G D +S GV++ EL+TG
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 4e-17
Identities = 50/199 (25%), Positives = 83/199 (41%), Gaps = 38/199 (19%)
Query: 2 LSLLHHDNLVTLIGYCTS-GDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKI 57
L L H N+++L S D+++ L+++Y +H DL S + +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYA------EH--DLWHIIKFHRASKANKKPV 123
Query: 58 AVGAA----------RGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAK 103
+ G+ YLH V++RDLK ANIL+ + K++D G A+
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 104 L--GPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLS 160
L P+ + V+ T+ Y APE + + T DI++ G + EL+T
Sbjct: 181 LFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF--- 236
Query: 161 KGQGEQNLVSWSRPFLKDQ 179
Q + S P+ DQ
Sbjct: 237 --HCRQEDIKTSNPYHHDQ 253
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-17
Identities = 40/159 (25%), Positives = 65/159 (40%), Gaps = 28/159 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTR 54
+ + H N++ L + LV++ M G L D L E + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS--EKETRKI----- 129
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
M+ + + LH +++RDLK NILLD+D N KL+DFG + + +
Sbjct: 130 MRALLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR 181
Query: 115 TRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVL 147
GT Y APE + D++S GV++
Sbjct: 182 EVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 4e-17
Identities = 43/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
LS + H N++ ++ + LV E G L+ L+ + + R+ +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSG-LD--LFAF------IDRHPRLDEPL-- 131
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
A + YL K +I+RD+K NI++ DF KL DFG A G +
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 114 STRVMGTYGYCAPEYAMSGKLTL--KSDIYSFGVVLLELITGR 154
GT YCAPE + G + +++S GV L L+
Sbjct: 189 FC---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-17
Identities = 45/163 (27%), Positives = 73/163 (44%), Gaps = 26/163 (15%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
+L+H+N+V G+ G+ + L EY G L D + + M
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----------DIGMPEPD-- 106
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
A+ G+ YLH + +RD+K N+LLD N K+SDFGLA + + +
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163
Query: 114 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
++ GT Y APE + + D++S G+VL ++ G
Sbjct: 164 LNKMCGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-17
Identities = 46/164 (28%), Positives = 69/164 (42%), Gaps = 28/164 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
ML L H NLV L+ + LV+EY L++L+ Q + + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH----TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRV 117
+ + + H I+RD+K NIL+ KL DFG A+L GP V+TR
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 118 MGTYGYCAPEYAMSGKLTLKS-------DIYSFGVVLLELITGR 154
Y +PE L + D+++ G V EL++G
Sbjct: 167 ----WYRSPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 16/156 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA- 58
MLS++ H ++ + Q++ ++ +Y+ G L L + P+ + A
Sbjct: 59 MLSIVTHPFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPV---AKFYAAE 114
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
V A LEYLH K +IYRDLK NILLD + + K++DFG AK V D T+ T +
Sbjct: 115 VCLA--LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LC 164
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE + D +SFG+++ E++ G
Sbjct: 165 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 46/197 (23%), Positives = 67/197 (34%), Gaps = 47/197 (23%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ LHH N+ L LV E G L D L D +K +
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 61 -----------------------------AAR-------GLEYLHCKANPPVIYRDLKSA 84
+ L YLH + + +RD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 85 NILL--DNDFNPKLSDFGLAKL---GPVGDNTHVSTRVMGTYGYCAPE--YAMSGKLTLK 137
N L + F KL DFGL+K G+ ++T+ GT + APE + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPK 256
Query: 138 SDIYSFGVVLLELITGR 154
D +S GV+L L+ G
Sbjct: 257 CDAWSAGVLLHLLLMGA 273
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 39/163 (23%), Positives = 60/163 (36%), Gaps = 20/163 (12%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA-- 58
L + L + + L LV EY G L L ++ P R +A
Sbjct: 115 LVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEM-ARFYLAEI 171
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
V A ++ +H ++RD+K NILLD + +L+DFG V
Sbjct: 172 VMA---IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV- 224
Query: 119 GTYGYCAPEYAMSGKLTLKSDIY-------SFGVVLLELITGR 154
GT Y +PE + + Y + GV E+ G+
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 49/166 (29%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR-------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNT 53
L++LHH N+V L Y + +R +V EY+P +L + Q
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 54 RMKIAVGAARGLEYLHCK-ANPPVIYRDLKSANILLD-NDFNPKLSDFGLAK-LGPVGDN 110
R + LH N V +RD+K N+L++ D KL DFG AK L P N
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 111 TH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ +R Y Y APE + T DI+S G + E++ G
Sbjct: 189 VAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-16
Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
++ ++ H N+V L + S + LV EY+P ++ ++ +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTH 112
R L Y+H + +RD+K N+LLD KL DFG AK L N
Sbjct: 144 KLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 113 -VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ +R Y Y APE T DI+S G V+ EL+ G+
Sbjct: 201 YICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
++ L H N+V L + S ++ LV +Y+P ++ ++ L
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAK-LGPVGDNTH 112
R L Y+H + +RD+K N+LLD D KL DFG AK L N
Sbjct: 159 KLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 113 -VSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ +R Y Y APE T D++S G VL EL+ G+
Sbjct: 216 YICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPM---GSLEDHLYDLEPDQEPLSWNTRMKI 57
++ L H+N+V L + ++ LV+E+M ++ P L N
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYF 113
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVST 115
+GL + H +++RDLK N+L++ KL DFGLA+ PV +
Sbjct: 114 QWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS--- 167
Query: 116 RVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
V+ T Y AP+ M + + DI+S G +L E+ITG+
Sbjct: 168 EVV-TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 16/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN---TRMKI 57
+L L H N++ + +V E G L + + + + LS MK
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVS 114
+ A L Y H + V+++DLK NIL + K+ DFGLA+L + H +
Sbjct: 133 MMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHST 184
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT Y APE +T K DI+S GVV+ L+TG
Sbjct: 185 NAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 29/163 (17%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H +++ L ++ +V EY+ G L D++ + R++
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI----------CKHGRVEEME-- 112
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
AR ++Y H V++RDLK N+LLD N K++DFGL+ + G+
Sbjct: 113 ARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169
Query: 114 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
S G+ Y APE +SG+L + DI+S GV+L L+ G
Sbjct: 170 SC---GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 49/148 (33%), Positives = 68/148 (45%), Gaps = 15/148 (10%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 67
L + + L V EY+ G L H+ R A GL++
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQF 133
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 126
LH K ++YRDLK NILLD D + K++DFG+ K +GD T GT Y AP
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAP 187
Query: 127 EYAMSGKLTLKSDIYSFGVVLLELITGR 154
E + K D +SFGV+L E++ G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 45/164 (27%), Positives = 68/164 (41%), Gaps = 28/164 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H+NLV L+ C + LV+E++ L DLE L + K
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH----TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VSTRV 117
G+ + H +I+RD+K NIL+ KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 118 MGTYGYCAPE-------YAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE Y + D+++ G ++ E+ G
Sbjct: 189 ----WYRAPELLVGDVKYGKA------VDVWAIGCLVTEMFMGE 222
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 48/148 (32%), Positives = 65/148 (43%), Gaps = 15/148 (10%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 67
L L C RL V E++ G L H+ E R + A L +
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMF 139
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 126
LH K +IYRDLK N+LLD++ + KL+DFG+ K G T T GT Y AP
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193
Query: 127 EYAMSGKLTLKSDIYSFGVVLLELITGR 154
E D ++ GV+L E++ G
Sbjct: 194 EILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-16
Identities = 49/148 (33%), Positives = 64/148 (43%), Gaps = 15/148 (10%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 67
LV L + +L V +Y+ G L HL EP R + A A L Y
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGY 154
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 126
LH ++YRDLK NILLD+ + L+DFGL K ++T T GT Y AP
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAP 208
Query: 127 EYAMSGKLTLKSDIYSFGVVLLELITGR 154
E D + G VL E++ G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 44/162 (27%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA- 58
+L + TL Y D L LV +Y G L L E D+ P R +A
Sbjct: 127 VLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEM-ARFYLAE 183
Query: 59 -VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
V A ++ +H ++RD+K NIL+D + + +L+DFG S V
Sbjct: 184 MVIA---IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV 237
Query: 118 MGTYGYCAPEYAMSGKLTLKS-----DIYSFGVVLLELITGR 154
GT Y +PE + + D +S GV + E++ G
Sbjct: 238 -GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 48/148 (32%), Positives = 69/148 (46%), Gaps = 15/148 (10%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKI-AVGAARGLEY 67
L L C RL V EY+ G L H+ + +EP A A GL +
Sbjct: 83 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAIGLFF 136
Query: 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAP 126
L K +IYRDLK N++LD++ + K++DFG+ K T T+ GT Y AP
Sbjct: 137 LQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAP 190
Query: 127 EYAMSGKLTLKSDIYSFGVVLLELITGR 154
E D ++FGV+L E++ G+
Sbjct: 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H N++ L +V E G L D + + E + +K
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-IKQVFSG 133
Query: 62 ARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
+ Y+H +++RDLK NILL++ D + K+ DFGL+ NT + R+
Sbjct: 134 ---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRI- 184
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT Y APE + G K D++S GV+L L++G
Sbjct: 185 GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 3e-16
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 28/159 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTR 54
+ + H +++TLI S LV++ M G L D L E + +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALS--EKETRSI----- 205
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
M+ + A + +LH +++RDLK NILLD++ +LSDFG + + +
Sbjct: 206 MRSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLR 257
Query: 115 TRVMGTYGYCAPE------YAMSGKLTLKSDIYSFGVVL 147
GT GY APE + D+++ GV+L
Sbjct: 258 ELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 3e-16
Identities = 48/147 (32%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 68
L L C RL V EY+ G L H+ + +EP A A GL +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH---AVFYAA-EIAIGLFFL 458
Query: 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE 127
K +IYRDLK N++LD++ + K++DFG+ K T T+ GT Y APE
Sbjct: 459 QSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE 512
Query: 128 YAMSGKLTLKSDIYSFGVVLLELITGR 154
D ++FGV+L E++ G+
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 6e-16
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 14/160 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L S + LV+E+ L+ + L
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQ 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVM 118
+GL + H + V++RDLK N+L++ + KL++FGLA+ PV + V+
Sbjct: 110 LLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV 163
Query: 119 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAM 157
T Y P+ KL + D++S G + EL + +
Sbjct: 164 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-16
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L+H ++ + + + D +V E M G L D + + +E ++
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-- 249
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
++YLH +I+RDLK N+LL + D K++DFG +K+ +G+ + + T
Sbjct: 250 --LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC 302
Query: 118 MGTYGYCAPE---YAMSGKLTLKSDIYSFGVVLLELITG 153
GT Y APE + D +S GV+L ++G
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 7e-16
Identities = 49/155 (31%), Positives = 68/155 (43%), Gaps = 29/155 (18%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAAR----- 63
LV L C + RL V EY+ G L H+ E AR
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------------HARFYSAE 118
Query: 64 ---GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-G 119
L YLH + +IYRDLK N+LLD++ + KL+D+G+ K G +T T G
Sbjct: 119 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 172
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T Y APE D ++ GV++ E++ GR
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-16
Identities = 35/160 (21%), Positives = 67/160 (41%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ ++ L + + +L+ EY G + L E +S +
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC--LPELAEMVS----ENDVIR 135
Query: 61 AAR----GLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHV 113
+ G+ YLH +++ DLK NILL + + K+ DFG+++ +G +
Sbjct: 136 LIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACEL 190
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+ GT Y APE +T +D+++ G++ L+T
Sbjct: 191 REIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 22/160 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKI 57
L L H N+VTL + LV+EY+ DL + ++ +
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLDK--------DLKQYLDDCGNIINMHNVKLF 105
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVST 115
RGL Y H + V++RDLK N+L++ KL+DFGLA+ P +
Sbjct: 106 LFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN--- 159
Query: 116 RVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
V+ T Y P+ + + + D++ G + E+ TGR
Sbjct: 160 EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 38/152 (25%), Positives = 64/152 (42%), Gaps = 14/152 (9%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWN---TRMKIA 58
+L H ++V L+ +S +V+E+M L + S M+
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ A L Y H +I+RD+K +LL +N KL FG+A +G++ V+
Sbjct: 140 LEA---LRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAG 191
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
+GT + APE D++ GV+L
Sbjct: 192 GRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-15
Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L LHH N+V+LI S LV+E+M L+ L + + L +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQ 127
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVM 118
RG+ + H +++RDLK N+L+++D KL+DFGLA+ PV TH V+
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV 181
Query: 119 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
T Y AP+ M K + DI+S G + E+ITG+
Sbjct: 182 -TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 1e-15
Identities = 45/157 (28%), Positives = 75/157 (47%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L + + +LV+E++ L+ L + L T +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVC---EGGLESVTAKSFLLQ 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRVM 118
G+ Y H + V++RDLK N+L++ + K++DFGLA+ PV TH ++
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV 162
Query: 119 GTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
T Y AP+ M K + DI+S G + E++ G
Sbjct: 163 -TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 21/162 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHL--YDLEPDQEPLSWNTRMKI 57
+++ + +V L Y D+ L +V EYMP G L + + YD+ R
Sbjct: 122 IMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW------ARFYT 174
Query: 58 A-VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
A V A L+ +H I+RD+K N+LLD + KL+DFG T
Sbjct: 175 AEVVLA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 229
Query: 117 VMGTYGYCAPEYAMS----GKLTLKSDIYSFGVVLLELITGR 154
V GT Y +PE S G + D +S GV L E++ G
Sbjct: 230 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 49/147 (33%), Positives = 69/147 (46%), Gaps = 13/147 (8%)
Query: 10 LVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 68
LV L C + RL V EY+ G L H+ E R A + L YL
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH---ARFYSAE-ISLALNYL 169
Query: 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM-GTYGYCAPE 127
H + +IYRDLK N+LLD++ + KL+D+G+ K G +T T GT Y APE
Sbjct: 170 HERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE 223
Query: 128 YAMSGKLTLKSDIYSFGVVLLELITGR 154
D ++ GV++ E++ GR
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 29/163 (17%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L L H +++ L ++ +V EY+ G L D++ N R+
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI----------CKNGRLDEKE-- 117
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
+R G++Y H V++RDLK N+LLD N K++DFGL+ + G+
Sbjct: 118 SRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174
Query: 114 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
S G+ Y APE +SG+L + DI+S GV+L L+ G
Sbjct: 175 SC---GSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 43/155 (27%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMK 56
+L H N++TL G +V E M G L D + E + + +
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV-----LF 123
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTH 112
+EYLH + V++RDLK +NIL N + ++ DFG AK +N
Sbjct: 124 TITKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGL 176
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
+ T T + APE DI+S GV+L
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-15
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 25/163 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDL-EPDQEPLSWNT 53
++ ++H N+++L+ T LV E M +L + Q L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--------NLCQVIQMELDHER 165
Query: 54 RMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-- 111
+ G+++LH A +I+RDLK +NI++ +D K+ DFGLA+
Sbjct: 166 MSYLLYQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+V TR Y APE + DI+S G ++ E++ +
Sbjct: 223 YVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-15
Identities = 37/161 (22%), Positives = 71/161 (44%), Gaps = 23/161 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL------EDHLYDLEPDQEPLSWNTR 54
+++ LHH L+ L + +L+ E++ G L ED+ E +
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS-EAEVINY----- 154
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTH 112
M+ A GL+++H + +++ D+K NI+ + K+ DFGLA + +
Sbjct: 155 MRQACE---GLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEI 206
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
V T + APE + +D+++ GV+ L++G
Sbjct: 207 VKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-15
Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKI 57
L L H N++ L+ LV+++M DL + + L+ +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET--------DLEVIIKDNSLVLTPSHIKAY 117
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTH-VS 114
+ +GLEYLH +++RDLK N+LLD + KL+DFGLAK P TH V
Sbjct: 118 MLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 115 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
TR Y APE ++ + D+++ G +L EL+
Sbjct: 175 TR-----WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 41/172 (23%), Positives = 69/172 (40%), Gaps = 43/172 (25%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----LYDL 42
++ ++H N++ L+ T +V E M M + LY +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQM 136
Query: 43 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102
G+++LH A +I+RDLK +NI++ +D K+ DFGLA
Sbjct: 137 -------------------LCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 103 KLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ + T + T Y APE + DI+S G ++ E+I G
Sbjct: 175 ---RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-15
Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMKI 57
L L H N++ L +V E G L D + E D + +K
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-----IKQ 129
Query: 58 AVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ Y+H +++RDLK NILL + D + K+ DFGL+ NT +
Sbjct: 130 VFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
R+ GT Y APE + G K D++S GV+L
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-15
Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 21/154 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N++ L + + LV E + G L D + + E + A
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAAD 152
Query: 61 AAR----GLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHV 113
A + + YLH +++RDLK N+L D K++DFGL+K+ V +
Sbjct: 153 AVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLM 207
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
T GT GYCAPE + D++S G++
Sbjct: 208 KTVC-GTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-15
Identities = 41/150 (27%), Positives = 61/150 (40%), Gaps = 14/150 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H N++ L LV E G L + + +E + MK +
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-MKDVLS 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRV 117
A + Y H V +RDLK N L D KL DFGLA + T+V
Sbjct: 118 A---VAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV 169
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
GT Y +P+ + G + D +S GV++
Sbjct: 170 -GTPYYVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-15
Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 20/154 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMK 56
+ H N+V L LV E + G L + + E + + M+
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MR 113
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHV 113
V A + ++H V++RDLK N+L +++ K+ DFG A+L P DN +
Sbjct: 114 KLVSA---VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPL 166
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
T T Y APE D++S GV+L
Sbjct: 167 KTPC-FTLHYAAPELLNQNGYDESCDLWSLGVIL 199
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-15
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 30/163 (18%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L LL H +++ L T+ ++V EY G L D++ RM
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYI----------VEKKRMTEDE-- 109
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113
R +EY H +++RDLK N+LLD++ N K++DFGL+ + G+
Sbjct: 110 GRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166
Query: 114 STRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
S G+ Y APE ++GKL + D++S G+VL ++ GR
Sbjct: 167 SC---GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 8e-15
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 22/154 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMK 56
+L + H+N+VTL S LV + + G L D + + E D + ++
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQ 113
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHV 113
+ A ++YLH +++RDLK N+L + + ++DFGL+K + N +
Sbjct: 114 QVLSA---VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIM 164
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
ST GT GY APE + D +S GV+
Sbjct: 165 STAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 9e-15
Identities = 47/161 (29%), Positives = 71/161 (44%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H N++TL + +L+ E + G L D L E E + A
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATS 119
Query: 61 AAR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTH 112
+ G+ YLH K + + DLK NI+L + P KL DFGLA + D
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVE 174
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT + APE L L++D++S GV+ L++G
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-14
Identities = 47/160 (29%), Positives = 70/160 (43%), Gaps = 22/160 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L + H N++TL + +L+ E + G L D L E E + A
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE--------EEATSF 120
Query: 62 AR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHV 113
+ G+ YLH K + + DLK NI+L + P KL DFGLA + D
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT + APE L L++D++S GV+ L++G
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-14
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 22/160 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L + H N++TL + +L+ E + G L D L + E E A
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE--------DEATQF 113
Query: 62 AR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHV 113
+ G+ YLH K + + DLK NI+L + P KL DFG+A +
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF 168
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT + APE L L++D++S GV+ L++G
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 18/159 (11%)
Query: 2 LSLLHHD--NLVTLIGYCTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
L + ++ L+ + D +L+ E P+ L D + + QE L+ R
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---R-SFF 155
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRV 117
+ + H V++RD+K NIL+D N KL DFG L +T +
Sbjct: 156 WQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD 209
Query: 118 MGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
GT Y PE+ + + ++S G++L +++ G
Sbjct: 210 -GTRVYSPPEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-14
Identities = 40/153 (26%), Positives = 60/153 (39%), Gaps = 21/153 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L H N+V L LV++ + G L + + E E A
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 110
Query: 62 AR----GLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ + Y H +++R+LK N+LL KL+DFGLA V D+
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH 165
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
GT GY +PE + DI++ GV+L
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+S+L H LV L ++ +++YE+M G L + + D + +S AV
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMS----EDEAVE 259
Query: 61 AAR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVS 114
R GL ++H ++ DLK NI+ + KL DFGL + V
Sbjct: 260 YMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVK 314
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT + APE A + +D++S GV+ L++G
Sbjct: 315 VTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 40/153 (26%), Positives = 60/153 (39%), Gaps = 21/153 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L H N+V L LV++ + G L + + E E A
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 133
Query: 62 AR----GLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ + Y H +++R+LK N+LL KL+DFGLA V D+
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH 188
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
GT GY +PE + DI++ GV+L
Sbjct: 189 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 29/159 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLED------HLYDLEPDQEPLSWNTR 54
+L L+H ++ + + + D +V E M G L D L E +
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK--EATCKLY----- 119
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNT 111
+ A ++YLH +I+RDLK N+LL + D K++DFG +K+ +G+ +
Sbjct: 120 FYQMLLA---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETS 171
Query: 112 HVSTRVMGTYGYCAPE---YAMSGKLTLKSDIYSFGVVL 147
+ T GT Y APE + D +S GV+L
Sbjct: 172 LMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 41/169 (24%), Positives = 72/169 (42%), Gaps = 26/169 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL--------LVYEYMPMGSLEDHLYDL----EPDQEP 48
+L LL H+N+V LI C + LV+++ +H DL
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EH--DLAGLLSNVLVK 120
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GP 106
+ + ++ GL Y+H +++RD+K+AN+L+ D KL+DFGLA+
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 107 VGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ T + T Y PE + + D++ G ++ E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 23/161 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSL------EDHLYDLEPDQEPLSWNTR 54
+++ L H NL+ L S + +LV EY+ G L E + E D
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-ELDTILF----- 192
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTH 112
MK G+ ++H +++ DLK NIL N K+ DFGLA+
Sbjct: 193 MKQICE---GIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREK 244
Query: 113 VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+ GT + APE ++ +D++S GV+ L++G
Sbjct: 245 LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-14
Identities = 41/165 (24%), Positives = 62/165 (37%), Gaps = 31/165 (18%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L H N+V + ++ EY G L + + + R
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----------AGRFSEDE-- 117
Query: 62 AR--------GLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNT 111
AR G+ Y H + +RDLK N LLD P K+ DFG +K +
Sbjct: 118 ARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 112 HVSTRVMGTYGYCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
+ V GT Y APE + + +D++S GV L ++ G
Sbjct: 175 K--STV-GTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 37/164 (22%), Positives = 62/164 (37%), Gaps = 26/164 (15%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIA 58
L L H N++ L + L++EY DL+ +S
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAEN--------DLKKYMDKNPDVSMRVIKSFL 138
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAKL--GPVGDNT 111
G+ + H + ++RDLK N+LL K+ DFGLA+ P+ T
Sbjct: 139 YQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 112 HVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
H ++ T Y PE + + + DI+S + E++
Sbjct: 196 H---EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-14
Identities = 35/159 (22%), Positives = 62/159 (38%), Gaps = 26/159 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-- 54
++V ++ + L++ E M G L + + + ++ R
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFTEREA 130
Query: 55 ---MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVG 108
M+ A +++LH + +RD+K N+L + D KL+DFG AK
Sbjct: 131 AEIMRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ET 181
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
+ T T Y APE K D++S GV++
Sbjct: 182 TQNALQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 6e-14
Identities = 27/163 (16%), Positives = 65/163 (39%), Gaps = 29/163 (17%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL-----EPDQEPLSWNTRMK 56
L++ H N++ L S ++ ++++E++ + + + E +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE----------- 103
Query: 57 IAVGAAR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDN 110
V L++LH + + D++ NI+ + K+ +FG A+ +
Sbjct: 104 -IVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPG 157
Query: 111 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
+ Y APE ++ +D++S G ++ L++G
Sbjct: 158 DNFRLLF-TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-14
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 30/165 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-----M 55
+ H N++ LI + D+ LV+E M GS+ H+ + +N +
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI------HKRRHFNELEASVVV 117
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK-LGPVGDNT 111
+ A L++LH K + +RDLK NIL + K+ DF L + GD +
Sbjct: 118 QDVASA---LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171
Query: 112 HVSTRVM----GTYGYCAPE-----YAMSGKLTLKSDIYSFGVVL 147
+ST + G+ Y APE + + D++S GV+L
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 13/134 (9%)
Query: 25 LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84
++ EY+P +L L + N R + ++H + +RD+K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LG--ICHRDIKPQ 170
Query: 85 NILLD-NDFNPKLSDFGLAK-LGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKL-TLKSDI 140
N+L++ D KL DFG AK L P + + +R + Y APE + T D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDL 225
Query: 141 YSFGVVLLELITGR 154
+S G V ELI G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 9e-14
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 14/159 (8%)
Query: 1 MLSLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRM 55
L H N+V L+ T + ++ LV+E++ L +L L T
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP--PPGLPAETIK 123
Query: 56 KIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVST 115
+ RGL++LH +++RDLK NIL+ + KL+DFGLA+ ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V+ T Y APE + D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-14
Identities = 43/167 (25%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYMPMGSLEDHLYDLE----PDQEPLSW 51
+L+ HH N++ L ++ LV E M DL + +S
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR--------TDLAQVIHDQRIVIS- 132
Query: 52 NTRMK-IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 110
++ GL LH +A V++RDL NILL ++ + + DF LA+ N
Sbjct: 133 PQHIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 111 T--HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154
+V+ R Y APE M T D++S G V+ E+ +
Sbjct: 190 KTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 44/160 (27%), Positives = 69/160 (43%), Gaps = 22/160 (13%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGA 61
L + H N++TL + +L+ E + G L D L + E E + A
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE--------EEATEF 119
Query: 62 AR----GLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHV 113
+ G+ YLH + + DLK NI+L + P K+ DFGLA +
Sbjct: 120 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEF 174
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153
GT + APE L L++D++S GV+ L++G
Sbjct: 175 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 24/164 (14%)
Query: 1 MLSLLHHDNLVTLI----GYCTSGDQRL-LVYEYMPMGSLEDHLYDLEP--DQEPLSWNT 53
L H N+V L T + +L LV+E++ D DL D+ P
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQ--DLTTYLDKVPEPGVP 118
Query: 54 RMKIAVGAA---RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN 110
I RGL++LH V++RDLK NIL+ + KL+DFGLA+
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQ 173
Query: 111 THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+++ V+ T Y APE + D++S G + E+ +
Sbjct: 174 MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 38/154 (24%), Positives = 62/154 (40%), Gaps = 20/154 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL----EPDQEPLSWNTRMK 56
+ LL H N+V L + L+++ + G L + + E D ++
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQ 117
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHV 113
+ A + + H V++R+LK N+LL KL+DFGLA V
Sbjct: 118 QILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQA 169
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
GT GY +PE D+++ GV+L
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 45/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
+L + H+N++ L+ T + LV +M L L + L +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHE-KLGEDRI 130
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ +GL Y+H A +I+RDLK N+ ++ D K+ DFGLA+ +V
Sbjct: 131 QFLVYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187
Query: 115 TRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154
TR Y APE ++ + T DI+S G ++ E+ITG+
Sbjct: 188 TRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-13
Identities = 39/159 (24%), Positives = 64/159 (40%), Gaps = 25/159 (15%)
Query: 1 MLSLLHHDNLVTLIG-YCTSGDQR---LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR-- 54
++V ++ Y R L+V E + G L + D + ++ R
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREA 163
Query: 55 ---MKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAKLGPVG 108
MK A ++YLH + +RD+K N+L + KL+DFG AK
Sbjct: 164 SEIMKSIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TT 215
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147
+ ++T T Y APE K D++S GV++
Sbjct: 216 SHNSLTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-13
Identities = 26/94 (27%), Positives = 46/94 (48%), Gaps = 11/94 (11%)
Query: 64 GLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRVMGTYG 122
+++ H + V++RD+K NIL+D KL DFG L + + GT
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD-GTRV 203
Query: 123 YCAPEYAMSGKL--TLKSDIYSFGVVLLELITGR 154
Y PE+ +S L + ++S G++L +++ G
Sbjct: 204 YSPPEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-13
Identities = 49/174 (28%), Positives = 77/174 (44%), Gaps = 42/174 (24%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYMP--------MGSL-EDH----LYDL 42
+L H+N++ + + +V + M L DH LY +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 43 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102
RGL+Y+H AN V++RDLK +N+LL+ + K+ DFGLA
Sbjct: 138 -------------------LRGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 103 K-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ P D+T T + T Y APE ++ K T DI+S G +L E+++ R
Sbjct: 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 46/173 (26%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMP--------MGSLEDH----LYDL 42
+L + H+N++ L+ T LV +M + E+ +Y +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQM 135
Query: 43 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102
+GL+Y+H A V++RDLK N+ ++ D K+ DFGLA
Sbjct: 136 L-------------------KGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDFGLA 173
Query: 103 KLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154
+ +V TR Y APE +S DI+S G ++ E++TG+
Sbjct: 174 RHADAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL------LVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
+L + H+N++ L+ T LV M L ++ Q L+ +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQ-KLTDDHV 134
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ RGL+Y+H A+ +I+RDLK +N+ ++ D K+ DFGLA+ +V+
Sbjct: 135 QFLIYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA 191
Query: 115 TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
TR Y APE ++ DI+S G ++ EL+TGR
Sbjct: 192 TRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-12
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 49/181 (27%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYMP--------MGSL-EDH----LYDL 42
+L H+N++T+ ++ E M L +DH +Y
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 43 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA 102
R ++ LH +N VI+RDLK +N+L++++ + K+ DFGLA
Sbjct: 122 -------------------LRAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 103 ----KLGPVGDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITG 153
+ M + Y APE ++ + D++S G +L EL
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219
Query: 154 R 154
R
Sbjct: 220 R 220
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-11
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 52/184 (28%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL--------------LVYEYMP--------MGSL-ED 37
++ L HDN+V + +L +V EYM G L E+
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 38 H----LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDF 92
H +Y L RGL+Y+H AN V++RDLK AN+ ++ D
Sbjct: 121 HARLFMYQL-------------------LRGLKYIH-SAN--VLHRDLKPANLFINTEDL 158
Query: 93 NPKLSDFGLAK-LGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLEL 150
K+ DFGLA+ + P + + + T Y +P +S T D+++ G + E+
Sbjct: 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218
Query: 151 ITGR 154
+TG+
Sbjct: 219 LTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-11
Identities = 25/99 (25%), Positives = 51/99 (51%), Gaps = 12/99 (12%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGD--NTHVSTRVMG 119
+ L+Y H +++RD+K N+++D++ +L D+GLA+ G N V++R
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 120 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGRKAM 157
+ PE + ++ S D++S G +L +I ++
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-11
Identities = 19/150 (12%), Positives = 37/150 (24%), Gaps = 38/150 (25%)
Query: 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARG 64
+ + ++ + L+V E++ GSL++ S ++ A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA------DTSPSPVGAIRAMQSLAAA 141
Query: 65 LEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+ H V + + + D G L
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSID--------GDVVLA--------------YPATM 176
Query: 125 APEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ DI G L L+ R
Sbjct: 177 PDA-------NPQDDIRGIGASLYALLVNR 199
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 51/237 (21%), Positives = 78/237 (32%), Gaps = 80/237 (33%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYM----------PMGSLEDH----LYD 41
+L+ L D ++ L D +V E P+ E+H LY+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 42 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101
L L G ++H ++ +I+RDLK AN LL+ D + K+ DFGL
Sbjct: 138 L------L-------------LGENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGL 175
Query: 102 AKLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYAMSGKL-T 135
A+ +T HV TR Y APE + + T
Sbjct: 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYT 230
Query: 136 LKSDIYSFGVVLLELITGRKAMDLS--------KGQGEQNLVSWSRPFLKDQKKFVH 184
DI+S G + EL+ ++ G L +K
Sbjct: 231 KSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 28/112 (25%), Positives = 53/112 (47%), Gaps = 23/112 (20%)
Query: 63 RGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLA---------------KLGPV 107
+ ++YLH +++RD+K +NILL+ + + K++DFGL+ +
Sbjct: 120 KVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 108 GDNTHVSTRVMGTY----GYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+N ++ Y Y APE + T D++S G +L E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 3e-09
Identities = 44/209 (21%), Positives = 73/209 (34%), Gaps = 67/209 (32%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-----LVYEYMPM---------GSL-EDH----LYD 41
+L+ L+HD++V ++ D +V E L E H LY+
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 42 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101
L G++Y+H A +++RDLK AN L++ D + K+ DFGL
Sbjct: 165 L-------------------LVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGL 202
Query: 102 AKLGPVGDNTHVSTRVMGTYG-------------------------YCAPEYAMSGKL-T 135
A+ +N + + Y APE + + T
Sbjct: 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYT 262
Query: 136 LKSDIYSFGVVLLELITGRKAMDLSKGQG 164
D++S G + EL+ K
Sbjct: 263 EAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 33/138 (23%), Positives = 60/138 (43%), Gaps = 20/138 (14%)
Query: 25 LVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
+V+E +G +L L + + + +I+ GL+Y+H + +I+ D+K
Sbjct: 107 MVFE--VLGE---NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIK 159
Query: 83 SANILLD------NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL 136
N+L++ N K++D G A + TR Y +PE +
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGC 214
Query: 137 KSDIYSFGVVLLELITGR 154
+DI+S ++ ELITG
Sbjct: 215 GADIWSTACLIFELITGD 232
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 7e-08
Identities = 36/180 (20%), Positives = 53/180 (29%), Gaps = 61/180 (33%)
Query: 25 LVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83
+V+E +G L + PL KI +GL+YLH K +I+ D+K
Sbjct: 122 MVFE--VLGHHLLKWIIKSNYQGLPLP--CVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 84 ANILL-------------------------------------------------DNDFNP 94
NILL
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 95 KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
K++D G A + TR Y + E + +DI+S + EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 39/134 (29%), Positives = 58/134 (43%), Gaps = 15/134 (11%)
Query: 25 LVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
LV+E L +LYDL + +S N K A L +L +I+ DLK
Sbjct: 133 LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLK 186
Query: 83 SANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 140
NILL N K+ DFG + ++ +R Y +PE + L D+
Sbjct: 187 PENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEVLLGMPYDLAIDM 241
Query: 141 YSFGVVLLELITGR 154
+S G +L+E+ TG
Sbjct: 242 WSLGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-07
Identities = 37/134 (27%), Positives = 59/134 (44%), Gaps = 17/134 (12%)
Query: 25 LVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82
+ +E L +LY+L + + S K A + L+ LH +I+ DLK
Sbjct: 176 MTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLK 227
Query: 83 SANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 140
NILL K+ DFG + T++ +R Y APE + + + D+
Sbjct: 228 PENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAPEVILGARYGMPIDM 282
Query: 141 YSFGVVLLELITGR 154
+S G +L EL+TG
Sbjct: 283 WSLGCILAELLTGY 296
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 5e-07
Identities = 25/116 (21%), Positives = 41/116 (35%), Gaps = 24/116 (20%)
Query: 1 MLSLLHHDNLVTLIG-YCTSGDQRLLVY---EYMPMGSLED------HLYDLEPDQEPLS 50
++V ++ Y R + E + G L E + +
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI- 122
Query: 51 WNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILL---DNDFNPKLSDFGLAK 103
MK A ++YLH + +RD+K N+L + KL+DFG AK
Sbjct: 123 ----MKSIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 3e-06
Identities = 32/187 (17%), Positives = 56/187 (29%), Gaps = 23/187 (12%)
Query: 19 SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78
DQ +V E+ G + + + S T I L +
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEASLR--FEH 185
Query: 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAP--EYAMSGKLTL 136
RDL N+LL KL K + + + G +Y +S
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGK-----------SSTIPSCGLQVSIIDYTLSRLERD 234
Query: 137 KSDIYSFGVVLLELITGRKAM--DLSKGQGEQNLVSWSRPFLKDQKKFVH-LVDPLLHGR 193
++ + +L TG D+ + ++N W ++H L D +L
Sbjct: 235 GIVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM 294
Query: 194 YPRRCLN 200
+ N
Sbjct: 295 TFKTKCN 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 3e-06
Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 19/153 (12%)
Query: 13 LIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 72
+ + G +LV + + SLED L DL + S T A ++ +H K+
Sbjct: 71 VYYFGQEGLHNVLVIDLLGP-SLED-LLDLCGRK--FSVKTVAMAAKQMLARVQSIHEKS 126
Query: 73 NPPVIYRDLKSANILLDNDFNPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGTYG 122
++YRD+K N L+ + + DFG+ K H+ R + GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 123 YCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
Y G+ + + D+ + G V + + G
Sbjct: 184 Y-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 19/153 (12%)
Query: 12 TLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC 70
T+ GD ++V E + G SLED L++ + S T + +A +EY+H
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLED-LFNFCSRK--FSLKTVLLLADQMISRIEYIHS 123
Query: 71 KANPPVIYRDLKSANILLDNDFNPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTYG 122
K I+RD+K N L+ + DFGLAK + H+ R + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 123 YCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
Y A G + + D+ S G VL+ G
Sbjct: 181 Y-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-06
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 21/154 (13%)
Query: 13 LIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 71
+ + G +V E + G SLED L+DL S T + IA+ +EY+H K
Sbjct: 70 VYYFGPCGKYNAMVLELL--GPSLED-LFDLCDRT--FSLKTVLMIAIQLISRMEYVHSK 124
Query: 72 ANPPVIYRDLKSANILLDNDFNPK-----LSDFGLAKL-GPVGDNTHVSTR----VMGTY 121
+IYRD+K N L+ N + DF LAK H+ R + GT
Sbjct: 125 N---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTA 181
Query: 122 GYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
Y GK + + D+ + G + + + G
Sbjct: 182 RY-MSINTHLGKEQSRRDDLEALGHMFMYFLRGS 214
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.2 bits (109), Expect = 5e-06
Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 17/152 (11%)
Query: 12 TLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 71
+ + GD +LV + + SLED L++ LS T + +A +E++H K
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLED-LFNFCS--RKLSLKTVLMLADQMINRVEFVHSK 122
Query: 72 ANPPVIYRDLKSANILLDNDFNPK---LSDFGLAKL-GPVGDNTHVSTR----VMGTYGY 123
+ ++RD+K N L+ + DFGLAK + H+ R + GT Y
Sbjct: 123 S---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 124 CAPEYAMSGK-LTLKSDIYSFGVVLLELITGR 154
A G + + D+ S G VL+ + G
Sbjct: 180 -ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 24/106 (22%), Positives = 45/106 (42%), Gaps = 11/106 (10%)
Query: 2 LSLLHHDNLVTLIGY-CTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAV 59
L + T +G+ R LV + G SL+ D+ P LS + +++A
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKH-VLSERSVLQVAC 166
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPK--LSDFGLAK 103
LE+LH ++ ++ + NI +D + + L+ +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 32/155 (20%), Positives = 63/155 (40%), Gaps = 27/155 (17%)
Query: 16 YCTSGDQRLLVYEYMPM---G-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK 71
D+ Y +M M G L+ +Y+ + S T +++++ LEY+H
Sbjct: 115 GSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAKR--FSRKTVLQLSLRILDILEYIHEH 171
Query: 72 ANPPVIYRDLKSANILLDNDFNPK--LSDFGLAKL-GPVGDNTHVSTR----VMGTYGYC 124
++ D+K++N+LL+ + L D+GLA P G + + GT
Sbjct: 172 E---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGT---- 224
Query: 125 APEYA-----MSGKLTLKSDIYSFGVVLLELITGR 154
E+ + + D+ G +++ +TG
Sbjct: 225 -IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 5/90 (5%)
Query: 16 YCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75
+ + Y +M M L L + +T +++ + LEY+H
Sbjct: 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE--- 171
Query: 76 VIYRDLKSANILLDNDFNPK--LSDFGLAK 103
++ D+K+AN+LL + L+D+GL+
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 267 | |||
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.84 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.6 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.33 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.09 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.71 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.39 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.76 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.67 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.65 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.55 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.32 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.57 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.25 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.19 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.05 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 90.24 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.08 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.55 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.52 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 87.86 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 87.66 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 87.63 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 87.23 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.36 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.42 |
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=329.46 Aligned_cols=214 Identities=21% Similarity=0.208 Sum_probs=173.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+|||||+++++|.+++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+++ |+|||
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 175 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGD 175 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 58899999999999999999999999999999999999965 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-ceEEeccCCcccCCCCCCc---ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 81 LKSANILLDNDF-NPKLSDFGLAKLGPVGDNT---HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 81 i~~~nili~~~~-~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..|+.++|||||||++|+|++|.+|
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999887 6999999999864322211 112235699999999999999999999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
|...........+... ... ...++..++.++.++|.+||..||++|||++||++.|..+.+....
T Consensus 256 f~~~~~~~~~~~i~~~------~~~---------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 256 WTQYFRGPLCLKIASE------PPP---------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp STTTCCSCCHHHHHHS------CCG---------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred CCCCCHHHHHHHHHcC------CCC---------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 9754332211111100 000 0112456678899999999999999999999999999877766554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=334.26 Aligned_cols=214 Identities=29% Similarity=0.463 Sum_probs=169.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-----------CCCCCCHHHHHHHHHHHHHHHHHhh
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-----------DQEPLSWNTRMKIAVGAARGLEYLH 69 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-----------~~~~~~~~~~~~~~~~l~~~l~~lH 69 (267)
+|++|+|||||+++++|.+++.+|+|||||++|+|.++++.... ....+++..++.++.|++.|++|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999999976332 2356899999999999999999999
Q ss_pred hcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHH
Q 024460 70 CKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 70 ~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~ 149 (267)
+++ |+||||||+|||++.++.+||+|||+++...............|++.|+|||++.+..++.++||||||+++||
T Consensus 176 ~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 999 99999999999999999999999999986544433334455678999999999999999999999999999999
Q ss_pred HHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 150 LIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 150 ~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
|++ |..||........ ... .. ...+-..|..++.++.+++.+||+.||++|||++||++.|+
T Consensus 253 llt~G~~Pf~~~~~~~~---~~~----i~----------~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNTEA---IDC----IT----------QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHTTSCCTTCSSCHHHH---HHH----HH----------HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HHcCCCCCCCCCCHHHH---HHH----HH----------cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 998 8999964432111 100 00 01111235677889999999999999999999999999999
Q ss_pred Hhhhcc
Q 024460 229 YLVSQR 234 (267)
Q Consensus 229 ~l~~~~ 234 (267)
.+.+..
T Consensus 316 ~l~~~p 321 (329)
T 4aoj_A 316 ALAQAP 321 (329)
T ss_dssp HHHHSC
T ss_pred HHhhCC
Confidence 998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=328.71 Aligned_cols=213 Identities=28% Similarity=0.462 Sum_probs=166.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++.. +.+|+|||||++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+|||
T Consensus 85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRD 157 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRD 157 (307)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCc
Confidence 4789999999999999864 568999999999999999975 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+ ..|+.++|||||||++|||++|..||
T Consensus 158 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp CCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 999999999999999999999986543333333445679999999999864 35899999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
......... . ..... ....+.. ...+..++.++.+++.+||+.+|++|||++||++.|+.++.
T Consensus 238 ~~~~~~~~~--~----~~~~~-----~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 238 SHINNRDQI--I----FMVGR-----GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TTCCCHHHH--H----HHHHT-----TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCChHHHH--H----HHHhc-----CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 743321110 0 00000 0111111 12345678889999999999999999999999999998864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-50 Score=333.43 Aligned_cols=214 Identities=28% Similarity=0.434 Sum_probs=175.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC---------CCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE---------PDQEPLSWNTRMKIAVGAARGLEYLHCK 71 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~---------~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 71 (267)
+|++|+|||||+++++|.+++.+|+|||||++|+|.++++... .....+++..++.++.|++.|++|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4789999999999999999999999999999999999997522 1345799999999999999999999999
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHH
Q 024460 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 72 ~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l 151 (267)
+ ++||||||+|||++.++.+||+|||+++...............|++.|+|||++.+..|+.++||||||+++|||+
T Consensus 148 ~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 148 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999997543332222233345899999999999999999999999999999999
Q ss_pred h-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 152 T-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
+ |..||....... +... +.....-..|..++.++.+++.+||+.+|++|||+++|++.|+.+
T Consensus 225 t~G~~Pf~~~~~~~---~~~~--------------i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 225 TYGKQPWYQLSNNE---VIEC--------------ITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp TTTCCTTTTSCHHH---HHHH--------------HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHH---HHHH--------------HHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 8 899997443211 1110 000011123567788999999999999999999999999999988
Q ss_pred hhcc
Q 024460 231 VSQR 234 (267)
Q Consensus 231 ~~~~ 234 (267)
....
T Consensus 288 ~~~~ 291 (299)
T 4asz_A 288 AKAS 291 (299)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 7643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-49 Score=330.48 Aligned_cols=210 Identities=28% Similarity=0.422 Sum_probs=173.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
+|++|+|||||+++++|..++.+++|||||++|+|.+++..... ....+++..++.++.|++.|++||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999965321 134689999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++||||||+|||+++++.+||+|||+++...............|++.|+|||++.+..|+.++||||||+++|
T Consensus 162 H~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 9999 9999999999999999999999999998643333333344467899999999999999999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
||++ |..||....... +.. .+.....-..|..++.++.+++.+||+.+|++|||++||++.|
T Consensus 239 El~t~g~~Pf~~~~~~~---~~~--------------~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQD---VVE--------------MIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHTTTCCTTTTCCHHH---HHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHH---HHH--------------HHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 899996443211 111 1111111234667888999999999999999999999999999
Q ss_pred HHh
Q 024460 228 DYL 230 (267)
Q Consensus 228 ~~l 230 (267)
+++
T Consensus 302 ~a~ 304 (308)
T 4gt4_A 302 RAW 304 (308)
T ss_dssp HTS
T ss_pred Hhc
Confidence 865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=331.24 Aligned_cols=201 Identities=22% Similarity=0.286 Sum_probs=166.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+|||||++++++.+++.+|+|||||++|+|.+++.. .....+++..++.++.||+.||.|||+++ |+|||
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~--~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 150 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA--QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRD 150 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETT
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH--cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 46789999999999999999999999999999999999975 23456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||+++.... .........||+.|+|||++.+..|+.++|||||||++|+|++|.+||...
T Consensus 151 lKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 151 IKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp CCGGGEEECTTCCEEECSTTEESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHEEECCCCCEEEcccccceeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999985321 112223456999999999999999999999999999999999999999744
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ..... ... ...+..++.++.++|.+||+.||++|||++|+++
T Consensus 229 ~~~~~~------~~i~~----------~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 229 SMKNLV------LKIIS----------GSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SHHHHH------HHHHH----------TCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHH------HHHHc----------CCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 321110 00000 000 0123456788999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=326.10 Aligned_cols=199 Identities=23% Similarity=0.310 Sum_probs=167.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+|||||+++++|++++.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+|||
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 157 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRD 157 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 47899999999999999999999999999999999999965 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|+|||||++|+|++|.+||...
T Consensus 158 lKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654333333445567999999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
..... .. ...... -.+|..++.++.++|.+||..||++|||++|++
T Consensus 238 ~~~~~---~~---~i~~~~------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 238 NEGLI---FA---KIIKLE------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp SHHHH---HH---HHHHTC------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CHHHH---HH---HHHcCC------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 31111 00 001000 013445677899999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=327.55 Aligned_cols=200 Identities=22% Similarity=0.295 Sum_probs=166.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||+++++|.+++.+|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+|||
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 195 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 195 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 46789999999999999999999999999999999999954 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||++....... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||...
T Consensus 196 lKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 196 IKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999998643222 2334567999999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+ .....+. ...+..++.++.++|.+||..||++|||++|+++
T Consensus 274 ~~~~~~~~i-------------~~~~~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 274 PPLKAMKMI-------------RDNLPPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHH-------------HHSSCCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHH-------------HcCCCCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 321111100 0001111 1123456788999999999999999999999985
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=318.86 Aligned_cols=198 Identities=26% Similarity=0.309 Sum_probs=163.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++.+++.+|+|||||+||+|.+++.. .+.+++..+..++.|++.||+|||+++ |+|||
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 151 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 151 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 58899999999999999999999999999999999999965 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|+|||||++|+|++|.+||...
T Consensus 152 lKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 152 LKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp CCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999997532221 2233467999999999999999999999999999999999999999743
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~ev~~ 225 (267)
...... . .... .. -.+|..+++++.++|.+||+.||++|||+ +|+++
T Consensus 230 ~~~~~~---~---~i~~----------~~--~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 230 DRKETM---T---MILK----------AK--LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SHHHHH---H---HHHH----------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CHHHHH---H---HHHc----------CC--CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 321110 0 0000 00 12345567889999999999999999984 67663
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=329.10 Aligned_cols=200 Identities=22% Similarity=0.309 Sum_probs=165.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
||++++|||||+++++|.+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||+|||+++ |+|||
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRD 272 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 272 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 46789999999999999999999999999999999999954 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||++....... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||...
T Consensus 273 iKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 273 IKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp CSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999998643222 2234467999999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+ .....+.+ .....++.++.+||.+||..||++|||++|+++
T Consensus 351 ~~~~~~~~i-------------~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 351 PPLKAMKMI-------------RDNLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CHHHHHHHH-------------HHSCCCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHH-------------HcCCCCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 321111100 00111111 112345778999999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=325.35 Aligned_cols=215 Identities=26% Similarity=0.359 Sum_probs=174.0
Q ss_pred CCCCCC-CCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 024460 2 LSLLHH-DNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEY 67 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~ 67 (267)
|++++| ||||+++++|.. ++.+++|||||++|+|.++++.... ....+++..+..++.|++.|++|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 456655 999999999876 4578999999999999999975321 23458899999999999999999
Q ss_pred hhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHH
Q 024460 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 68 lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 147 (267)
||+++ ++||||||+|||++.++.+||+|||+++...............|++.|+|||++.+..|+.++|||||||++
T Consensus 201 LH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999 999999999999999999999999999875444444444456789999999999999999999999999999
Q ss_pred HHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 148 LELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 148 ~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
|||++ |..||........ +. ..+....+-..|..+++++.++|.+||+.||++|||++||++.
T Consensus 278 ~El~t~G~~Pf~~~~~~~~--~~--------------~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDEE--FC--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHTTTSCCSSTTCCCSHH--HH--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHH--HH--------------HHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99998 8999974432111 00 0111111123456678889999999999999999999999999
Q ss_pred HHHhhhccC
Q 024460 227 LDYLVSQRD 235 (267)
Q Consensus 227 l~~l~~~~~ 235 (267)
|+.+.+...
T Consensus 342 L~~llq~~~ 350 (353)
T 4ase_A 342 LGNLLQANA 350 (353)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHHhh
Confidence 998876543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=312.10 Aligned_cols=196 Identities=25% Similarity=0.324 Sum_probs=154.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+||||| +|+|.+++.. .+.+++..+..++.|++.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 137 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRD 137 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 367899999999999999999999999999 6799999865 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+||+|||+++.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||..
T Consensus 138 iKP~NILl~~~~~vkl~DFGla~~~~~---~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 138 LKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CChHHeEECCCCCEEEeecCCCeecCC---CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999975322 223344679999999999998876 5799999999999999999999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ... ...... -.++..++.++.++|.+||+.||++|||++|+++
T Consensus 215 ~~~~~---~~~---~i~~~~------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 215 ESIPV---LFK---NISNGV------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp SSHHH---HHH---HHHHTC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHH---HHH---HHHcCC------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 32111 000 000000 0123455778999999999999999999999987
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=311.85 Aligned_cols=200 Identities=26% Similarity=0.398 Sum_probs=158.6
Q ss_pred CCCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
+|++|+|||||+++++|.+ ++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+++ ++|
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~I 152 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 4678999999999999865 3468999999999999999965 467999999999999999999999875 349
Q ss_pred eeCCCCCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||||||+|||++. ++.+||+|||+++.... .......||+.|+|||++.+ .|+.++|||||||++|+|++|.+
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999999999974 78999999999975322 22345679999999998864 69999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||........ +.. . +........++..+++++.++|.+||..||++|||++|+++
T Consensus 228 Pf~~~~~~~~--~~~----~---------i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 228 PYSECQNAAQ--IYR----R---------VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTTCSSHHH--HHH----H---------HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCcHHH--HHH----H---------HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9964321111 000 0 00000001123344567999999999999999999999984
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=308.30 Aligned_cols=228 Identities=25% Similarity=0.320 Sum_probs=166.1
Q ss_pred CCCCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----
Q 024460 2 LSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----- 72 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----- 72 (267)
+.+++|||||++++++..++ .+|+|||||++|+|.++++. ..+++..+..++.|++.||+|||++.
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~ 125 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccC
Confidence 56899999999999997654 57999999999999999964 46889999999999999999999871
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccC------CCcccCCeeehH
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSFG 144 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~slG 144 (267)
.++|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||
T Consensus 126 ~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 123999999999999999999999999998754322211 112235689999999998764 367899999999
Q ss_pred HHHHHHHhCCCCccccCccCccc--hhhh--chhhhhcccccccccCCcCCCCC-cHHHHHHHHHHHHhhcccCCCCCCC
Q 024460 145 VVLLELITGRKAMDLSKGQGEQN--LVSW--SRPFLKDQKKFVHLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 145 ~i~~~~l~g~~p~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
|++|||++|.+|+.......... .... ...... .......+.+.+.... +..++..+.+++.+||+.||++|||
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt 284 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH-HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHHHCCCCCCccccccccchhcccccchHHHHH-HHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC
Confidence 99999999998875443221110 0000 000000 0001111222221111 2356788999999999999999999
Q ss_pred HHHHHHHHHHhhhccC
Q 024460 220 INDIVVALDYLVSQRD 235 (267)
Q Consensus 220 ~~ev~~~l~~l~~~~~ 235 (267)
++||++.|+++.++++
T Consensus 285 ~~ei~~~L~~l~~~~~ 300 (303)
T 3hmm_A 285 ALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHHHHHHcC
Confidence 9999999999988764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=295.41 Aligned_cols=199 Identities=23% Similarity=0.305 Sum_probs=147.8
Q ss_pred CCCCCCCCCccceeeEEeeCC------------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD------------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~------------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
+|++|+|||||+++++|.+.+ .+|+|||||++|+|.+++.... ......+..++.++.|++.||+||
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~yl 134 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFL 134 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHH
Confidence 478999999999999987544 3799999999999999997522 223345677889999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc----------ceeeecccccceeCCcccccCCCcccC
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT----------HVSTRVMGTYGYCAPEYAMSGKLTLKS 138 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~ 138 (267)
|+++ |+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..|+.++
T Consensus 135 H~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~ 211 (299)
T 4g31_A 135 HSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211 (299)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHH
T ss_pred HHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHH
Confidence 9999 999999999999999999999999999864332111 111234699999999999999999999
Q ss_pred CeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCc---HHHHHHHHHHHHhhcccCCC
Q 024460 139 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEAN 215 (267)
Q Consensus 139 Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~ 215 (267)
|||||||++|||++ ||..... ... .+.... ...+| ...++...++|.+||+.||+
T Consensus 212 DiwSlGvilyell~---Pf~~~~~-----~~~----------~~~~~~----~~~~p~~~~~~~~~~~~li~~~L~~dP~ 269 (299)
T 4g31_A 212 DIFSLGLILFELLY---PFSTQME-----RVR----------TLTDVR----NLKFPPLFTQKYPCEYVMVQDMLSPSPM 269 (299)
T ss_dssp HHHHHHHHHHHHHS---CCSSHHH-----HHH----------HHHHHH----TTCCCHHHHHHCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHcc---CCCCccH-----HHH----------HHHHHh----cCCCCCCCcccCHHHHHHHHHHcCCChh
Confidence 99999999999996 5532110 000 000000 11112 23445678999999999999
Q ss_pred CCCCHHHHHH
Q 024460 216 FRPLINDIVV 225 (267)
Q Consensus 216 ~Rpt~~ev~~ 225 (267)
+|||++|+++
T Consensus 270 ~Rps~~eil~ 279 (299)
T 4g31_A 270 ERPEAINIIE 279 (299)
T ss_dssp GSCCHHHHHT
T ss_pred HCcCHHHHhc
Confidence 9999999985
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=287.30 Aligned_cols=231 Identities=41% Similarity=0.725 Sum_probs=192.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+|
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 164 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRD 164 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCC
Confidence 478899999999999999999999999999999999999764444457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++................|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999987543332222333455789999999998889999999999999999999999999765
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
..........+.... .........+++......+..++..+.+++.+||..+|++|||++|+++.|+.+....+
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 245 LPREMVNLAEWAVES-HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSSSCCCHHHHTHHH-HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CcHHHHHHHHHhhhc-cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 544444444443322 22344555666666667788999999999999999999999999999999998876544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=307.58 Aligned_cols=198 Identities=25% Similarity=0.273 Sum_probs=163.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++|||||+++++|.+++.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDL 318 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDL 318 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 4678999999999999999999999999999999999965 467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-cCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-SGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+|||++.+|.+||+|||++....... .....||+.|+|||++. +..|+.++|+|||||++|+|++|.+||...
T Consensus 319 KPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 319 KPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred chHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998643221 23457999999999996 458999999999999999999999999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
.......+.. ..... .-.+|..++.++.++|.+||+.||++|++ ++||++
T Consensus 395 ~~~~~~~i~~---~i~~~------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 395 KTKDKHEIDR---MTLTM------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp GCCCHHHHHH---HHHHC------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ChHHHHHHHH---hhcCC------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 3222111111 00000 01234556788999999999999999998 688776
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=307.41 Aligned_cols=202 Identities=22% Similarity=0.279 Sum_probs=165.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++|+|||||+++++|.+++.+|+|||||+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+|||
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRD 280 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 280 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 46789999999999999999999999999999999999965 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC--CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDND--FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+..|+.++|+|||||++|+|++|.+||.
T Consensus 281 lKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CCGGGEEESSSSCCCEEECCCSSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CChhhccccCCCCCCEEEeeccceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999754 78999999999864322 23345679999999999999999999999999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+. . .+..+.......++.++.+||.+||..||.+|||++|+++
T Consensus 358 ~~~~~~~~~~i~------~--------~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 358 GENDDETLRNVK------S--------CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSSHHHHHHHHH------T--------TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcCHHHHHHHHH------h--------CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 443211110000 0 0001111112345678999999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=289.16 Aligned_cols=149 Identities=26% Similarity=0.353 Sum_probs=126.6
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+.+ +||||++++++|.+++.+|+|||||++|+|.+++ +.+++..+..++.|++.||+|||+++ |+|||
T Consensus 73 l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRD 142 (361)
T 4f9c_A 73 LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRD 142 (361)
T ss_dssp HHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCc
Confidence 4445 6999999999999999999999999999999998 24889999999999999999999999 99999
Q ss_pred CCCCcEEEcCC-CceEEeccCCcccCCCCCCc--------------------------ceeeecccccceeCCcccccC-
Q 024460 81 LKSANILLDND-FNPKLSDFGLAKLGPVGDNT--------------------------HVSTRVMGTYGYCAPEYAMSG- 132 (267)
Q Consensus 81 i~~~nili~~~-~~~~l~d~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~~~~- 132 (267)
|||+|||++.+ +.+||+|||+++........ .......||+.|+|||++.+.
T Consensus 143 iKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 143 VKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred CCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99999999876 79999999999754321110 111234689999999998875
Q ss_pred CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 133 KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 133 ~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
.|+.++|+||+||++|+|++|..||...
T Consensus 223 ~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 223 NQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 5899999999999999999999999543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=293.32 Aligned_cols=217 Identities=21% Similarity=0.275 Sum_probs=158.8
Q ss_pred CCCCCCCCCccceeeEEee------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++|+|||||++++++.. .+.+|+|||||+ |+|.+++.. .+.+++..+..++.||+.||.|||+++
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~-- 178 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ-- 178 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 4678999999999998754 367899999996 689999954 568999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCC--CcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHH
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD--NTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l 151 (267)
|+||||||+|||++.++.+|++|||+++...... .........||+.|+|||++.+. .++.++||||+||++|+|+
T Consensus 179 -iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 179 -VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp -CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred -CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 9999999999999999999999999998643221 11223346799999999998875 5799999999999999999
Q ss_pred hCCCCccccCccCccchhhhchhh--hhc-----ccc---cccccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCCCC
Q 024460 152 TGRKAMDLSKGQGEQNLVSWSRPF--LKD-----QKK---FVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~--~~~-----~~~---~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
+|.+||...........+...... ... ... ....+.+.....+ ....+.++.+||.+||..||++||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 337 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI 337 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence 999999754322211111000000 000 000 0000001000000 012356789999999999999999
Q ss_pred CHHHHHH
Q 024460 219 LINDIVV 225 (267)
Q Consensus 219 t~~ev~~ 225 (267)
|++|+++
T Consensus 338 ta~e~L~ 344 (398)
T 4b99_A 338 SAAAALR 344 (398)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=279.17 Aligned_cols=227 Identities=43% Similarity=0.708 Sum_probs=186.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc---CCCCee
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK---ANPPVI 77 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~~i~ 77 (267)
+|++++||||+++++++..++..++||||+++++|.+++.........+++..+..++.|++.||.|||++ + ++
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---iv 156 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---II 156 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EE
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eE
Confidence 46789999999999999999999999999999999999987655566799999999999999999999999 7 99
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|+||||+||+++.++.++|+|||++....... ........|++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999997653322 22334455899999999998888999999999999999999999999
Q ss_pred cccCccC--ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 158 DLSKGQG--EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 158 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
....... ......+..... .........+.......+..++..+.+++.+||+.+|++|||++||++.|+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLL-KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTT-SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred cccccccccchhHHHHHHHHh-hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 6432221 112222322222 2344455566666667788899999999999999999999999999999986433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=282.29 Aligned_cols=214 Identities=26% Similarity=0.384 Sum_probs=171.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 176 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRD 176 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 36789999999999999999999999999999999999965 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 177 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999865432221 12223345778999999998999999999999999999999 999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
........ ..+........+..++..+.+++.+||..+|++|||+++|++.|+.+....++.
T Consensus 257 ~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~ 318 (325)
T 3kul_A 257 NMTNRDVI-----------------SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL 318 (325)
T ss_dssp TSCHHHHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred cCCHHHHH-----------------HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence 43321110 001111112234566788999999999999999999999999999998876654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.39 Aligned_cols=214 Identities=26% Similarity=0.401 Sum_probs=173.1
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|+++ +||||+++++++..++.+|+||||+++|+|.+++..... ....+++..++.++.|++.||.||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999976331 124688999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|
T Consensus 220 H~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999997543332222233345678899999999999999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||......... ..+........+..++.++.++|.+||..+|.+|||++|+++.|
T Consensus 297 ellt~g~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEELF-----------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHHTTSCCSSTTCCGGGHH-----------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHHHH-----------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 99999643321110 00111111223456678899999999999999999999999999
Q ss_pred HHhhhccC
Q 024460 228 DYLVSQRD 235 (267)
Q Consensus 228 ~~l~~~~~ 235 (267)
+.+.+...
T Consensus 360 ~~il~~~~ 367 (370)
T 2psq_A 360 DRILTLTT 367 (370)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhc
Confidence 99876544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=280.01 Aligned_cols=226 Identities=27% Similarity=0.360 Sum_probs=170.7
Q ss_pred CCCCCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK----- 71 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----- 71 (267)
+|++++||||+++++++.... .+++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~ 145 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLK 145 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 478899999999999998744 47999999999999999965 4589999999999999999999998
Q ss_pred -----CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-----CCcccCCee
Q 024460 72 -----ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-----KLTLKSDIY 141 (267)
Q Consensus 72 -----~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~Dv~ 141 (267)
+ ++|+||||+||+++.++.+||+|||++................+++.|+|||++.+. .++.++|||
T Consensus 146 ~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 222 (322)
T 3soc_A 146 DGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222 (322)
T ss_dssp TEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHH
T ss_pred cccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhH
Confidence 8 999999999999999999999999999754333322223335689999999998863 456788999
Q ss_pred ehHHHHHHHHhCCCCccccCccCccchhhhchh--hhhc--ccccccccCCcCCCC-CcHHHHHHHHHHHHhhcccCCCC
Q 024460 142 SFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP--FLKD--QKKFVHLVDPLLHGR-YPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 142 slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
|||+++|+|++|..||................. .... .........+..... ....++.++.+++.+||+.||++
T Consensus 223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (322)
T 3soc_A 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302 (322)
T ss_dssp HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhh
Confidence 999999999999999975543322211110000 0000 000001111111111 12356778999999999999999
Q ss_pred CCCHHHHHHHHHHhhhcc
Q 024460 217 RPLINDIVVALDYLVSQR 234 (267)
Q Consensus 217 Rpt~~ev~~~l~~l~~~~ 234 (267)
|||++||++.|+++....
T Consensus 303 Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 303 RLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SCCHHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHHHHh
Confidence 999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=275.58 Aligned_cols=215 Identities=26% Similarity=0.358 Sum_probs=172.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+|
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~d 133 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRD 133 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 36789999999999999999999999999999999999976 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcce------------eeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV------------STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|||+||+++.++.++|+|||++........... .....|++.|+|||++.+..++.++||||||+++|
T Consensus 134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 213 (310)
T 3s95_A 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213 (310)
T ss_dssp CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence 999999999999999999999976432221110 11346899999999999999999999999999999
Q ss_pred HHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 149 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
+|++|..|+............... ..... ..+..++..+.+++.+||..+|++|||++++++.|+
T Consensus 214 el~~g~~~~~~~~~~~~~~~~~~~-----------~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 214 EIIGRVNADPDYLPRTMDFGLNVR-----------GFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHHHTCCSSTTTSCBCTTSSBCHH-----------HHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCCCcchhhhHHHHhhhhh-----------ccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 999999998643322211110000 00000 113345667899999999999999999999999999
Q ss_pred HhhhccCC
Q 024460 229 YLVSQRDS 236 (267)
Q Consensus 229 ~l~~~~~~ 236 (267)
+++.....
T Consensus 279 ~l~~~~~~ 286 (310)
T 3s95_A 279 TLRMHLAG 286 (310)
T ss_dssp HHHHHHHH
T ss_pred HHHHhccC
Confidence 98876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=289.16 Aligned_cols=211 Identities=27% Similarity=0.374 Sum_probs=170.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++|+|.++++. .+..+++..++.++.|++.|++|||+++ ++|+|
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 238 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcc
Confidence 36789999999999999999999999999999999999975 3456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.+||+|||++................++..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875322211111112234678999999998899999999999999999998 9999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
...... ...+....+-..+..++..+.++|.+||..+|++|||+++|++.|+.+..+.
T Consensus 319 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 319 LSNQQT-----------------REFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp SCHHHH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 432111 0111111112234556788999999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=280.77 Aligned_cols=211 Identities=22% Similarity=0.375 Sum_probs=165.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..+. .++|+|++.+++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 70 ~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 142 (327)
T 3lzb_A 70 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 142 (327)
T ss_dssp HHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCC
Confidence 367899999999999998764 7889999999999999976 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 143 ikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 143 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp CCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999986543333333334456788999999999999999999999999999999 9999974
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
....... ..+........+..++.++.+++.+||..+|.+|||++|+++.|+.+.....
T Consensus 223 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 281 (327)
T 3lzb_A 223 IPASEIS-----------------SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281 (327)
T ss_dssp CCGGGHH-----------------HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHH
T ss_pred CCHHHHH-----------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcC
Confidence 4322111 1111111122344567789999999999999999999999999999886543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=277.12 Aligned_cols=213 Identities=26% Similarity=0.389 Sum_probs=172.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHH
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVG 60 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~~~~~~ 60 (267)
+|++++||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|
T Consensus 79 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 158 (314)
T 2ivs_A 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQ 158 (314)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHH
T ss_pred HHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHH
Confidence 36789999999999999999999999999999999999976332 1234889999999999
Q ss_pred HHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCe
Q 024460 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 140 (267)
Q Consensus 61 l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv 140 (267)
++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||
T Consensus 159 i~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 235 (314)
T 2ivs_A 159 ISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235 (314)
T ss_dssp HHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHH
T ss_pred HHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhH
Confidence 999999999999 99999999999999999999999999876543332222333456788999999998889999999
Q ss_pred eehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC
Q 024460 141 YSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 141 ~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
||||+++|+|++ |..||.......... .+........+..++.++.+++.+||..+|.+|||
T Consensus 236 ~slG~il~el~t~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 236 WSFGVLLWEIVTLGGNPYPGIPPERLFN-----------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCGGGHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999 999996443211110 00011111234456788999999999999999999
Q ss_pred HHHHHHHHHHhhhc
Q 024460 220 INDIVVALDYLVSQ 233 (267)
Q Consensus 220 ~~ev~~~l~~l~~~ 233 (267)
++++++.|+++...
T Consensus 299 ~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 299 FADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999988765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=276.67 Aligned_cols=216 Identities=30% Similarity=0.401 Sum_probs=163.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ .+++|+||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Di 165 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNL 165 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTC
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCC
Confidence 567899999999999999999999999999999999996511 1124899999999999999999999875 34999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 166 kp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 166 KSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp CGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998743221 122334568999999999999999999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
....... ..........+..++..+.++|.+||..+|.+|||++++++.|+.+.......
T Consensus 244 ~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 244 PAQVVAA----------------VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp HHHHHHH----------------HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred HHHHHHH----------------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 2111000 00011112234566788999999999999999999999999999998765544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=279.00 Aligned_cols=209 Identities=27% Similarity=0.437 Sum_probs=167.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++. ++..++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 69 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Di 141 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNL 141 (325)
T ss_dssp HHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCcc
Confidence 46789999999999986 4568999999999999999975 3467888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 142 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp SSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred chheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999987544433333444567789999999999999999999999999999999 99999744
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
........+ ........+..++.++.+++.+||..+|.+|||++++++.|+.+....
T Consensus 222 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 222 RLAEVPDLL-----------------EKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp CTTHHHHHH-----------------HTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred CHHHHHHHH-----------------HcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 321111110 011111123344556889999999999999999999999999886554
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=283.51 Aligned_cols=221 Identities=29% Similarity=0.402 Sum_probs=176.6
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|+++ +||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||.||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 3455 899999999999999999999999999999999976331 124699999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|
T Consensus 208 H~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred HhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9999 9999999999999999999999999998654333323333455678999999999999999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........ ...+........+..++.++.+++.+||..+|++|||++||++.|
T Consensus 285 ellt~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVEEL-----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHTTSCCSSTTCCHHHH-----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHH-----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 9999964332111 001111111122345677899999999999999999999999999
Q ss_pred HHhhhccCCCCCcCC
Q 024460 228 DYLVSQRDSHPVSRN 242 (267)
Q Consensus 228 ~~l~~~~~~~~~~~~ 242 (267)
+.+.......+....
T Consensus 348 ~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 348 DRIVALTSNQEMGYY 362 (382)
T ss_dssp HHHHHHSCSCC----
T ss_pred HHHHHHHhcCCCCCC
Confidence 999988776654433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=270.56 Aligned_cols=208 Identities=25% Similarity=0.366 Sum_probs=169.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+++ ++|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~di 132 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCc
Confidence 6789999999999999999999999999999999999965 4567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 133 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 133 AARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999987532211 111223445778999999998999999999999999999999 99999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
...... . .+........+..++..+.+++.+||+.+|++|||++++++.|+++...
T Consensus 212 ~~~~~~---~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 212 SNSEVV---E--------------DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CHHHHH---H--------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHHHH---H--------------HHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 321110 0 0000111122344567799999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=281.76 Aligned_cols=213 Identities=27% Similarity=0.400 Sum_probs=162.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 172 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRD 172 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 36789999999999999999999999999999999999975 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcc-eeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 173 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp CCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred CCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987643222111 1122234678999999999999999999999999999998 999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
....... . ..+........+..++..+.+++.+||+.+|++||++++|++.|+.+......
T Consensus 253 ~~~~~~~---~--------------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 313 (373)
T 2qol_A 253 EMSNQDV---I--------------KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGS 313 (373)
T ss_dssp TCCHHHH---H--------------HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGGG
T ss_pred CCCHHHH---H--------------HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCccc
Confidence 4321110 0 00011111122345677899999999999999999999999999999876544
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=280.13 Aligned_cols=215 Identities=25% Similarity=0.410 Sum_probs=169.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC--------------------CCCCCHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD--------------------QEPLSWNTRMKIAVGA 61 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~--------------------~~~~~~~~~~~~~~~l 61 (267)
|++++||||+++++++..++..++||||+++++|.+++...... ...+++..++.++.|+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 57889999999999999999999999999999999999763211 2678999999999999
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCee
Q 024460 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 141 (267)
Q Consensus 62 ~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 141 (267)
+.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|+|
T Consensus 184 ~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 184 AAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 99999999999 999999999999999999999999998754322222233445678899999999989999999999
Q ss_pred ehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 142 SFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 142 slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
|||+++|+|++ |..||......... . ... . ......+..++..+.+++.+||..+|++|||+
T Consensus 261 slG~il~el~t~g~~p~~~~~~~~~~---~----~~~---------~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAHEEVI---Y----YVR---------D-GNILACPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHHHH---H----HHH---------T-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhcCCCcCCCCChHHHH---H----HHh---------C-CCcCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 99999999998 99998643211100 0 000 0 00112344567789999999999999999999
Q ss_pred HHHHHHHHHhhhccCC
Q 024460 221 NDIVVALDYLVSQRDS 236 (267)
Q Consensus 221 ~ev~~~l~~l~~~~~~ 236 (267)
+++++.|+++.++...
T Consensus 324 ~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 324 CSIHRILQRMCERAEG 339 (343)
T ss_dssp HHHHHHHHHTTC----
T ss_pred HHHHHHHHHHHhhhhh
Confidence 9999999998876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=275.19 Aligned_cols=218 Identities=21% Similarity=0.334 Sum_probs=161.7
Q ss_pred CCCCCCCCccceeeEEeeCCee------EEEEecCCCCCHHHHhcccCC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEP--DQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|++++||||+++++++...... ++||||+++++|.+++..... ....+++..++.++.|++.||.|||+++
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~- 157 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 6789999999999999877655 999999999999999965321 2236899999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 158 --ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 158 --FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp --CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 99999999999999999999999999976433333333334556788999999999999999999999999999999
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
|..||............ ........+..++.++.+++.+||..+|++|||++++++.|+++..
T Consensus 236 g~~p~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 236 GQTPYAGIENAEIYNYL-----------------IGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp SCCTTTTCCGGGHHHHH-----------------HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccccChHHHHHHH-----------------hcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 89999744321111000 0000112234566789999999999999999999999999999988
Q ss_pred ccCCCCC
Q 024460 233 QRDSHPV 239 (267)
Q Consensus 233 ~~~~~~~ 239 (267)
.......
T Consensus 299 ~~~~~~~ 305 (323)
T 3qup_A 299 HLSVLST 305 (323)
T ss_dssp C------
T ss_pred HhhhcCC
Confidence 7765543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=275.62 Aligned_cols=216 Identities=26% Similarity=0.383 Sum_probs=168.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 173 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDL 173 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 5688999999999999999999999999999999999975 4567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 174 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp CGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999998764322111 11222345778999999998999999999999999999998 9999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 239 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~~~ 239 (267)
...... . ..+........+..++..+.+++.+||..+|++||+++++++.|+++.........
T Consensus 254 ~~~~~~---~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~~~~ 316 (333)
T 1mqb_A 254 LSNHEV---M--------------KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316 (333)
T ss_dssp CCHHHH---H--------------HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGGGGS
T ss_pred CCHHHH---H--------------HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhh
Confidence 321110 0 00000111122345677899999999999999999999999999998877666443
Q ss_pred c
Q 024460 240 S 240 (267)
Q Consensus 240 ~ 240 (267)
.
T Consensus 317 ~ 317 (333)
T 1mqb_A 317 L 317 (333)
T ss_dssp B
T ss_pred h
Confidence 3
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=269.88 Aligned_cols=209 Identities=23% Similarity=0.340 Sum_probs=168.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 130 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDL 130 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSC
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCc
Confidence 5678999999999999999999999999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 131 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp SGGGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 9999999999999999999987543322 112233445678999999998899999999999999999998 99999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
......... ........+..++..+.+++.+||+.+|++|||++++++.|+.++.+.
T Consensus 210 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 210 TNSEVVLKV-----------------SQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CHHHHHHHH-----------------HTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred ChHHHHHHH-----------------HcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 321110000 000011123344677999999999999999999999999999987653
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=272.60 Aligned_cols=199 Identities=25% Similarity=0.312 Sum_probs=163.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ ++|+||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dl 142 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCC
Confidence 5678999999999999999999999999999999999964 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543222 22334568999999999999999999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ... .. ......+..++..+.+++.+||..||++|||++|+++
T Consensus 221 ~~~~~~~------~~~-------~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 221 PLRALYL------IAT-------NG--TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHHHHHH------HHH-------HC--SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHHHH------HHh-------CC--CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 2111000 000 00 0011124456778999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=267.15 Aligned_cols=223 Identities=41% Similarity=0.623 Sum_probs=176.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 159 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDI 159 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCC
Confidence 567899999999999999999999999999999999987522 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++................++..|+|||.+.+ .++.++|+||||+++|+|++|.+||....
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999999999876543333333344568999999998764 58899999999999999999999997554
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
...... .+..........+...+++.. ...+..++..+.+++.+||..+|++|||+++|++.|+++.+
T Consensus 239 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 239 EPQLLL--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSSBTT--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chHHHH--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 332211 111111111222223333333 23456788999999999999999999999999999998864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=276.74 Aligned_cols=209 Identities=22% Similarity=0.374 Sum_probs=168.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..+. .++|+|++.+|+|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Di 143 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDL 143 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCC
Confidence 56789999999999998764 7889999999999999976 4567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 144 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 99999999999999999999876433333333334556789999999999999999999999999999999 99999744
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
..... ...+........+..++.++.+++.+||+.+|.+|||++++++.|+.+....
T Consensus 224 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 224 PASEI-----------------SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp CGGGH-----------------HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred CHHHH-----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 32111 1111111112234456778999999999999999999999999999887643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=270.45 Aligned_cols=209 Identities=24% Similarity=0.368 Sum_probs=170.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.+|.|||+++ ++|+||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 146 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 146 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSC
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5688999999999999999999999999999999999965 3467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp SGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999987532211 111222345678999999998999999999999999999998 99999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
....... .+........+..++..+.+++.+||+.+|.+|||++++++.|+++...+
T Consensus 226 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 226 TNSETAE-----------------HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp CHHHHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ChhHHHH-----------------HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 3211100 00011111223444678999999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.28 Aligned_cols=215 Identities=26% Similarity=0.352 Sum_probs=171.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|++++||||+++++++..++..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ ++|
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 204 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 204 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence 5678999999999999999999999999999999999976432 2356899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC---ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 79 RDLKSANILLDNDF---NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 79 ~di~~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
+||||+|||++.++ .+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999998544 599999999864322222222333556889999999999999999999999999999998 99
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.||......... ..+........+..++..+.+++.+||+.+|.+|||+++|++.|+.+.+..
T Consensus 285 ~pf~~~~~~~~~-----------------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 285 MPYPSKSNQEVL-----------------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp CSSTTCCHHHHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCCCHHHHH-----------------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 999644321110 000011111224456778999999999999999999999999999888766
Q ss_pred CC
Q 024460 235 DS 236 (267)
Q Consensus 235 ~~ 236 (267)
+.
T Consensus 348 ~~ 349 (367)
T 3l9p_A 348 DV 349 (367)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=270.09 Aligned_cols=208 Identities=22% Similarity=0.332 Sum_probs=158.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 70 l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 142 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDI 142 (281)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 56889999999999984 5678999999999999999975 3457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++........ .......+++.|+|||++....++.++|+||||+++|+|++ |..||...
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 143 AARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp SGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cHHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 99999999999999999999875432211 12223445778999999998999999999999999999996 99999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
........+ ........+..++..+.+++.+||..+|++|||++++++.|+++...+
T Consensus 222 ~~~~~~~~i-----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 222 KNNDVIGRI-----------------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CGGGHHHHH-----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHH-----------------HcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 321110000 000111234566788999999999999999999999999999887654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=272.09 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=162.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dl 131 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 131 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 5678999999999999999999999999999999999854 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++................|++.|+|||++.+..+ +.++||||||+++|+|++|..||...
T Consensus 132 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred chHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999975432222222334578999999999987765 78899999999999999999999644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ...+. ...........++..+.+++.+||..||++|||++|+++
T Consensus 212 ~~~~~~-~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 212 SDSCQE-YSDWK--------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp CTTSHH-HHHHH--------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chHHHH-HHHHh--------------cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 322110 00000 000000112345677899999999999999999999986
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=276.39 Aligned_cols=196 Identities=26% Similarity=0.341 Sum_probs=162.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDl 140 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDL 140 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCC
Confidence 5678999999999999999999999999999999999965 356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCc-ccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLT-LKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++....... ......|++.|+|||++.+..+. .++||||||+++|+|++|..||...
T Consensus 141 kp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 141 KAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp CGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987543221 22345689999999999887765 7899999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... .... . ....|..++.++.+++.+||..||.+|||++|+++
T Consensus 218 ~~~~~~~------~i~~----------~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 218 NLKELRE------RVLR----------G--KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp SHHHHHH------HHHH----------C--CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CHHHHHH------HHHh----------C--CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3211100 0000 0 01123445678999999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=276.12 Aligned_cols=215 Identities=25% Similarity=0.379 Sum_probs=169.2
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC-------------------CCCCCHHHHHHHHHHH
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD-------------------QEPLSWNTRMKIAVGA 61 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~-------------------~~~~~~~~~~~~~~~l 61 (267)
|+++ +||||+++++++..++..++||||+++++|.+++...... ...+++..++.++.|+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 4566 8999999999999999999999999999999999763211 1347899999999999
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCee
Q 024460 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 141 (267)
Q Consensus 62 ~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 141 (267)
+.||.|||+++ ++|+||||+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||
T Consensus 182 ~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999999 999999999999999999999999999754333333333345567889999999989999999999
Q ss_pred ehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 142 SFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 142 slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
|||+++|+|++ |..||......... ...+........+..++.++.+++.+||..+|.+|||+
T Consensus 259 slG~il~el~t~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVDANF----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHcCCCCCcccCCcHHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 99999999998 99999644321110 00111111112244557889999999999999999999
Q ss_pred HHHHHHHHHhhhccC
Q 024460 221 NDIVVALDYLVSQRD 235 (267)
Q Consensus 221 ~ev~~~l~~l~~~~~ 235 (267)
++|++.|+.+.....
T Consensus 323 ~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 323 PNLTSFLGCQLADAE 337 (344)
T ss_dssp HHHHHHHHHHC----
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999998876544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=268.99 Aligned_cols=214 Identities=25% Similarity=0.340 Sum_probs=166.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..|+||||+++++|.+++.. .+.+++..++.++.|++.||.|||+++ ++|+||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dl 137 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDI 137 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5789999999999999999999999999999999999965 357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 138 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 138 KPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp CGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997543221 112233568999999999999999999999999999999999999996443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHHhhhccCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRDS 236 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-t~~ev~~~l~~l~~~~~~ 236 (267)
..... ..... ... +......+..++..+.+++.+||..+|.+|| +++++.+.|+.+......
T Consensus 217 ~~~~~------~~~~~------~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 217 AVSIA------IKHIQ------DSV-PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp HHHHH------HHHHS------SCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred hHHHH------HHHhh------ccC-CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 21110 00000 000 0000011234567899999999999999998 999999999887665544
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=272.94 Aligned_cols=226 Identities=29% Similarity=0.415 Sum_probs=167.6
Q ss_pred CCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++.. ...+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 138 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHR 138 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccC
Confidence 678999999999999854 3568999999999999999976 3456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 139 Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp CCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 99999999999999999999999864322211 22233456778999999999999999999999999999999999885
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
................... .......+........+..++.++.+++.+||..+|++|||++|+++.|+++....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 219 SPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp SHHHHHHHHHCTTCCTHHH-HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred CChHHHHhhhcCccccchh-HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 3321100000000000000 00111111112222335567888999999999999999999999999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=270.33 Aligned_cols=213 Identities=28% Similarity=0.393 Sum_probs=170.8
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|+++ +||||+++++++..++..++||||+++++|.+++.... .....+++..++.++.|++.||.||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5678 89999999999999999999999999999999997632 2235789999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||||+||+++.++.++|+|||++.... .........++..|+|||++.+..++.++|+||||+++|
T Consensus 159 H~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 159 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccc---ccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 9999 9999999999999999999999999987321 111222344577899999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||......... ..+........+..++..+.+++.+||..+|.+|||++++++.|
T Consensus 233 ellt~g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAELY-----------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp HHHTTSCCTTTTCCHHHHH-----------------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCcHHHHH-----------------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9998 99999643321100 00001111122345677899999999999999999999999999
Q ss_pred HHhhhccCCC
Q 024460 228 DYLVSQRDSH 237 (267)
Q Consensus 228 ~~l~~~~~~~ 237 (267)
+.+.......
T Consensus 296 ~~~~~~~~~~ 305 (327)
T 1fvr_A 296 NRMLEERKTY 305 (327)
T ss_dssp HHHHHSSSCS
T ss_pred HHHHHhhcCc
Confidence 9988876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=272.35 Aligned_cols=215 Identities=27% Similarity=0.392 Sum_probs=172.2
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHH
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLE 66 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~ 66 (267)
|+++ +||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4556 899999999999999999999999999999999976321 1235899999999999999999
Q ss_pred HhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHH
Q 024460 67 YLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 146 (267)
Q Consensus 67 ~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 146 (267)
|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||++
T Consensus 160 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999999 99999999999999999999999999986544433333334456788999999999999999999999999
Q ss_pred HHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 147 LLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 147 ~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|+|++ |..||......... .. .+........+..++..+.+++.+||..+|.+|||++++++
T Consensus 237 l~ellt~g~~p~~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSKF--YK--------------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHHH--HH--------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCcccchhHH--HH--------------HhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999998 99998644321110 00 00001111123455678999999999999999999999999
Q ss_pred HHHHhhhccC
Q 024460 226 ALDYLVSQRD 235 (267)
Q Consensus 226 ~l~~l~~~~~ 235 (267)
.|+++.+...
T Consensus 301 ~L~~~~~~~~ 310 (313)
T 1t46_A 301 LIEKQISEST 310 (313)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHHHhh
Confidence 9998876543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=267.39 Aligned_cols=221 Identities=18% Similarity=0.177 Sum_probs=173.1
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+++ +||||+++++++..++..++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrD 130 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDL---CDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRD 130 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4566 8999999999999999999999999 8999999975 3568999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCc-----eEEeccCCcccCCCCCCcc-----eeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 81 LKSANILLDNDFN-----PKLSDFGLAKLGPVGDNTH-----VSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 81 i~~~nili~~~~~-----~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
|||+||+++.++. ++|+|||++.......... ......|++.|+|||++.+..++.++|+||||+++|+|
T Consensus 131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHH
Confidence 9999999998876 9999999997543222111 12345689999999999999999999999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
++|..||.................... .... ... ...++ ++.+++..||..+|.+||++++|.+.|+.+
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKIGDTKR-ATPI-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHHHHHHH-HSCH-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hcCCCCccccccccHHHHHHHHHhhhc-cCCH-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 999999975543222111111100000 0000 000 01234 899999999999999999999999999988
Q ss_pred hhccCCCCCc
Q 024460 231 VSQRDSHPVS 240 (267)
Q Consensus 231 ~~~~~~~~~~ 240 (267)
..+.......
T Consensus 280 ~~~~~~~~~~ 289 (330)
T 2izr_A 280 FDRKGYMFDY 289 (330)
T ss_dssp HHHTTCCCSC
T ss_pred HHHcCCCCCC
Confidence 8877655433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.20 Aligned_cols=213 Identities=26% Similarity=0.362 Sum_probs=168.9
Q ss_pred CCCC-CCCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcccCCC----------------------------------
Q 024460 2 LSLL-HHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPD---------------------------------- 45 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~---------------------------------- 45 (267)
|+++ +||||+++++++...+ ..++||||+++|+|.+++......
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 3455 7999999999998755 489999999999999999763211
Q ss_pred ----------------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEe
Q 024460 46 ----------------------------QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLS 97 (267)
Q Consensus 46 ----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~ 97 (267)
...+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEE
Confidence 122889999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccccCccCccchhhhchhhh
Q 024460 98 DFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFL 176 (267)
Q Consensus 98 d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~ 176 (267)
|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......... .
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~------- 306 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--C------- 306 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--H-------
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--H-------
Confidence 9999986544333334445567889999999999999999999999999999998 99999644321110 0
Q ss_pred hcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 177 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
..+........+..++.++.+++.+||..+|.+|||++|+++.|+++.+.
T Consensus 307 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 307 -------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 00000111122345567899999999999999999999999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=274.30 Aligned_cols=214 Identities=26% Similarity=0.387 Sum_probs=163.0
Q ss_pred CCCCCCCCCccceeeEEe-eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCT-SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++++++. .++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 216 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 216 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 578999999999999865 45688999999999999999975 4567889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCC
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKA 156 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p 156 (267)
||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |.+|
T Consensus 217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 99999999999999999999999754322111 11233456788999999999999999999999999999999 6778
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
|............. .......+..++..+.+++.+||..+|++|||++++++.|+++......
T Consensus 297 ~~~~~~~~~~~~~~-----------------~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 297 YPDVNTFDITVYLL-----------------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp CTTSCSSCHHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred CCCCCHHHHHHHHH-----------------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 76443221110000 0001112345677899999999999999999999999999999877654
Q ss_pred C
Q 024460 237 H 237 (267)
Q Consensus 237 ~ 237 (267)
.
T Consensus 360 ~ 360 (373)
T 3c1x_A 360 E 360 (373)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=267.63 Aligned_cols=211 Identities=26% Similarity=0.381 Sum_probs=172.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. .....+++..++.++.|++.+|.|||+++ ++|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~di 137 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH--CCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHh--cccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5678999999999999999999999999999999999975 23456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 138 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 138 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997643222 222333445778999999998999999999999999999999 99998644
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
..... ...+........+..++..+.+++.+||..+|.+|||++++++.|+.+.+...
T Consensus 217 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 217 DLSQV-----------------YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CGGGH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CHHHH-----------------HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 32111 11111111222344567889999999999999999999999999998877644
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=271.77 Aligned_cols=201 Identities=16% Similarity=0.221 Sum_probs=162.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+.+.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dl 128 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 5678999999999999999999999999999999999965 3457999999999999999999999999 999999
Q ss_pred CCCcEEEcC--CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 82 KSANILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
||+||+++. ++.++|+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|.+||..
T Consensus 129 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 129 RPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 999999986 789999999999864322 233445689999999999988899999999999999999999999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ....... ........++.++.+++.+||..+|.+|||++|+++
T Consensus 206 ~~~~~~~~~------i~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 206 ETNQQIIEN------IMNAEYT--------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SSHHHHHHH------HHHTCCC--------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHH------HHcCCCC--------CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 332111000 0000000 000001234678999999999999999999999998
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=274.41 Aligned_cols=230 Identities=15% Similarity=0.124 Sum_probs=175.4
Q ss_pred CCCCCCCCccceeeEEeeC----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 2 LSLLHHDNLVTLIGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
++.++||||+++++++... ...|+||||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 4678999999999998764 4589999999 9999999976 4567999999999999999999999999 99
Q ss_pred eCCCCCCcEEEc--CCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 78 YRDLKSANILLD--NDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 78 h~di~~~nili~--~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
|+||||+|||++ .++.++|+|||++......... .......|+..|+|||++.+..++.++||||||+++|+|
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999998 8899999999999754322111 111234489999999999999999999999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
++|..||......... ........ .......+++.+. +..++.++.+++..||..+|.+||++++|++.|+.+
T Consensus 255 ~~g~~Pf~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 255 LTGHLPWEDNLKDPKY--VRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHSCCTTGGGTTCHHH--HHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCCccccccCHHH--HHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 9999999743322111 11010000 1111112211111 123467899999999999999999999999999999
Q ss_pred hhccCCCCCcCCCCC
Q 024460 231 VSQRDSHPVSRNAGA 245 (267)
Q Consensus 231 ~~~~~~~~~~~~~~~ 245 (267)
............+++
T Consensus 328 ~~~~~~~~~~~~dw~ 342 (364)
T 3op5_A 328 LKAIGSKDDGKLDLS 342 (364)
T ss_dssp HHHTTCCCCCCCCC-
T ss_pred HHHcCCCcCCccceE
Confidence 888776644444433
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=281.59 Aligned_cols=207 Identities=28% Similarity=0.387 Sum_probs=168.0
Q ss_pred CCCCCCCCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++++++.... .+++||||+++|+|.+++... ....+++..++.++.|++.|+.|||+++ ++|+
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHr 313 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 367899999999999987665 799999999999999999762 2334789999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
||||+|||++.++.+||+|||+++..... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 314 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 314 DLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998743211 122346788999999999999999999999999999998 999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
........ . .+....+-..+..++..+.++|.+||..+|.+|||++++++.|+.+...+
T Consensus 389 ~~~~~~~~---~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 389 RIPLKDVV---P--------------RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp TSCTTTHH---H--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCHHHHH---H--------------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 44322111 0 00111112235567888999999999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=287.62 Aligned_cols=209 Identities=25% Similarity=0.383 Sum_probs=170.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++.+++||||+++|+|.++++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDl 344 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL 344 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 56789999999999999999999999999999999999752 3456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+|||++.++.+||+|||+++...... ........++..|+|||++....++.++||||||+++|+|++ |..||...
T Consensus 345 kp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 345 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp SGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643221 111222345678999999998999999999999999999999 99999744
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
..... ...+....+...+..++..+.++|.+||+.+|++|||+++|++.|+.+.+.
T Consensus 424 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 424 DLSQV-----------------YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CGGGH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CHHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 32111 111111122233556778899999999999999999999999999987644
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=271.16 Aligned_cols=197 Identities=27% Similarity=0.335 Sum_probs=163.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++...+.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 131 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 131 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcC
Confidence 5788999999999999999999999999999999999964 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 132 kp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 132 KLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 9999999999999999999987532221 22334568999999999999999999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
..... ..... . .-.++..++.++.++|.+||..+|++|| +++|+++
T Consensus 210 ~~~~~------~~i~~----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 210 HERLF------ELILM----------E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHH------HHHHH----------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHHH------HHHHc----------C--CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11100 00000 0 0123445677899999999999999999 8999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=266.29 Aligned_cols=212 Identities=27% Similarity=0.391 Sum_probs=167.6
Q ss_pred CCCCCCCCccceeeEE-eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++++||||+++++++ ..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~d 153 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 153 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 6789999999999985 456688999999999999999975 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~ 157 (267)
|||+||+++.++.++|+|||++......... .......+++.|+|||.+.+..++.++|+||||+++|+|++ +.+||
T Consensus 154 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp CSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999754332211 12233456788999999999999999999999999999999 56666
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
............. .......+..++..+.+++.+||..+|++|||++++++.|+++......
T Consensus 234 ~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 234 PDVNTFDITVYLL-----------------QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp TTSCTTTHHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ccCCHHHHHHHHh-----------------cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 5333211110000 0001112344567899999999999999999999999999998876554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=264.90 Aligned_cols=214 Identities=25% Similarity=0.337 Sum_probs=169.8
Q ss_pred CCCCCCCCccceeeEEeeCCee-EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQR-LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~-~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++++||||+++++++...+.. ++||||+.+++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 149 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRD 149 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 5788999999999999776554 999999999999999975 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCC--cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCC-CCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR-KAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~-~p~ 157 (267)
|||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|+|++|. +||
T Consensus 150 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 150 LAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp CSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 999999999999999999999975432211 11223345688999999999999999999999999999999955 444
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
......... ..+........+..++..+.+++.+||..+|.+|||++++++.|+++..+....
T Consensus 230 ~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 230 RHIDPFDLT-----------------HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp TTSCGGGHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ccCCHHHHH-----------------HHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 422211110 000001111223455678999999999999999999999999999998877654
Q ss_pred C
Q 024460 238 P 238 (267)
Q Consensus 238 ~ 238 (267)
.
T Consensus 293 ~ 293 (298)
T 3pls_A 293 H 293 (298)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.20 Aligned_cols=201 Identities=26% Similarity=0.302 Sum_probs=162.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 140 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFD 140 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 36789999999999999999999999999999999999954 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC----ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 81 LKSANILLDNDF----NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 81 i~~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||+||+++.++ .++|+|||++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|.+|
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999998776 79999999997643221 22345689999999999998999999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|...........+. .... .+.......++..+.++|.+||..||++|||++|+++
T Consensus 218 f~~~~~~~~~~~i~------~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 218 FLGDTKQETLANIT------AVSY--------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSHHHHHHHHH------TTCC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHHHHHHH------hcCC--------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 96433211110000 0000 0000011234677999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=266.42 Aligned_cols=213 Identities=29% Similarity=0.473 Sum_probs=157.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++ ..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~D 145 (289)
T 3og7_A 73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145 (289)
T ss_dssp HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 36789999999999965 55678999999999999999965 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++.++.++|+|||++................+++.|+|||++. ...++.++||||||+++|+|++|..||
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999987543322222333456899999999986 567889999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
......... ... .. .. ...+. .......++..+.+++.+||..+|.+|||++++++.|+++..
T Consensus 226 ~~~~~~~~~--~~~----~~-~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 226 SNINNRDQI--IEM----VG-RG----SLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCCCHHHH--HHH----HH-HT----SCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccchHHHH--HHH----hc-cc----ccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 643321110 000 00 00 00010 111234567889999999999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.85 Aligned_cols=213 Identities=23% Similarity=0.351 Sum_probs=163.0
Q ss_pred CCCCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
|++++||||+++++++...+ ..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 167 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57889999999999997654 3599999999999999985422 24567999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-C
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-G 153 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g 153 (267)
++|+||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 168 -ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 168 -FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp -CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999875433322223334556788999999999999999999999999999999 8
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
..||........... +........+..++..+.+++.+||..+|.+|||++++++.|+.+...
T Consensus 247 ~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 247 MTPYPGVQNHEMYDY-----------------LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCSSTTCCGGGHHHH-----------------HHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHH-----------------HHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 889864432111000 000011122445677899999999999999999999999999988765
Q ss_pred c
Q 024460 234 R 234 (267)
Q Consensus 234 ~ 234 (267)
.
T Consensus 310 l 310 (313)
T 3brb_A 310 L 310 (313)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=263.77 Aligned_cols=204 Identities=30% Similarity=0.450 Sum_probs=158.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++..++..++||||+++++|.+++. ...+++..++.++.|++.|+.|||+++..+++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 467899999999999999999999999999999999984 467999999999999999999999987445889999
Q ss_pred CCCcEEEcC--------CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC
Q 024460 82 KSANILLDN--------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 82 ~~~nili~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g 153 (267)
||+||+++. ++.++|+|||++...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred chHHEEEecccccccccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999985 678999999998753222 12234689999999999999999999999999999999999
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
..||......... ............+..++..+.+++.+||..+|.+|||++|+++.|+.+
T Consensus 211 ~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 211 EVPFRGIDGLAVA----------------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCTTTTSCHHHHH----------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCCHHHHH----------------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9999643321110 001111111223455678899999999999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=270.34 Aligned_cols=196 Identities=25% Similarity=0.337 Sum_probs=161.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++...+..++||||+ +|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 62 ~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~D 133 (336)
T 3h4j_B 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRD 133 (336)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 367899999999999999999999999999 6799988864 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.++|+|||++...... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 134 lkp~NIll~~~~~~kl~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 134 LKPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp CSTTTEEECTTCCEEECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CchhhEEEcCCCCEEEEEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999754322 22234568999999999988776 6899999999999999999999974
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... +.. .....+..++.++.+++.+||..||.+|||++|+++
T Consensus 211 ~~~~~~~~~-----------------i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 211 EFIPNLFKK-----------------VNS-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSSTTCBCC-----------------CCS-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ccHHHHHHH-----------------HHc-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 332111100 000 011234456778999999999999999999999987
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=264.54 Aligned_cols=208 Identities=25% Similarity=0.354 Sum_probs=168.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 130 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSC
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5688999999999999999999999999999999999976 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++...... .........++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 131 ~p~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 131 AARNCLVGENQVIKVSDFGMTRFVLDD-QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCH-HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chheEEECCCCCEEEcccccccccccc-cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 999999999999999999998753221 1111223445778999999998899999999999999999999 89998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
...... . .. ........+..++..+.+++.+||..+|++|||++++++.|+++...
T Consensus 210 ~~~~~~---~----~i----------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 210 SNSEVV---E----DI----------STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CHHHHH---H----HH----------HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHHHH---H----HH----------hcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 211100 0 00 00011112344567899999999999999999999999999998763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=272.01 Aligned_cols=216 Identities=26% Similarity=0.407 Sum_probs=171.5
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|+++ +||||+++++++..++..++||||+++++|.+++...... ...+++..++.++.|++.||.||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3455 8999999999999999999999999999999999763321 23588999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|
T Consensus 174 H~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999997654333222233345678899999998888999999999999999
Q ss_pred HHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
+|++ |..||........ .. ... .......+..++..+.+++.+||..+|.+|||++++++.|
T Consensus 251 ellt~g~~p~~~~~~~~~---~~----~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPVEEL---FK----LLK----------EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHTTSCCSSTTCCHHHH---HH----HHH----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCcCcCCHHHH---HH----HHh----------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999 9999864321110 00 000 0011122345677899999999999999999999999999
Q ss_pred HHhhhccCCC
Q 024460 228 DYLVSQRDSH 237 (267)
Q Consensus 228 ~~l~~~~~~~ 237 (267)
+.+.+.....
T Consensus 314 ~~l~~~~~~~ 323 (334)
T 2pvf_A 314 DRILTLTTNE 323 (334)
T ss_dssp HHHHHHHC--
T ss_pred HHHHhccccC
Confidence 9998766543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=273.71 Aligned_cols=204 Identities=22% Similarity=0.236 Sum_probs=161.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++.+|+||||+++++|.+++......+..+++..+..++.|++.||.|||+++ ++|+||
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDl 156 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDV 156 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccC
Confidence 56789999999999999999999999999999999888653334556899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc---eEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFN---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++.++. ++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 157 KPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp SGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 999999976544 9999999997643322 12334568999999999999999999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ... ........ ..+. ....++.++.++|.+||..||++|||++++++
T Consensus 235 ~~~~~----~~~---~i~~~~~~----~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 235 GTKER----LFE---GIIKGKYK----MNPR----QWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SSHHH----HHH---HHHHTCCC----CCHH----HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CcHHH----HHH---HHHcCCCC----CCcc----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 43210 000 00000000 0000 00234677999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=265.26 Aligned_cols=212 Identities=25% Similarity=0.348 Sum_probs=171.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++ ..+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 64 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 136 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDL 136 (287)
T ss_dssp HHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCC
Confidence 5678999999999999 55678999999999999999965 4567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++ |..||..
T Consensus 137 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999765332221 11223345788999999988889999999999999999998 9999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
....... . .+........+..++.++.+++.+||..+|++|||++++++.|+++.......
T Consensus 217 ~~~~~~~---~--------------~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 217 MKGPEVM---A--------------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp CCTHHHH---H--------------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCHHHHH---H--------------HHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 4321110 0 00001111234566788999999999999999999999999999887766554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=261.51 Aligned_cols=221 Identities=16% Similarity=0.143 Sum_probs=172.6
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++ +|+|++++++++..+...++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dl 132 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDI 132 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 445 7999999999999999999999999 8999999975 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc-----eEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHH
Q 024460 82 KSANILLDNDFN-----PKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 82 ~~~nili~~~~~-----~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l 151 (267)
||+||+++.++. ++|+|||++......... .......|+..|+|||++.+..++.++||||||+++|+|+
T Consensus 133 kp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 212 (298)
T 1csn_A 133 KPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 212 (298)
T ss_dssp CGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHH
Confidence 999999977665 999999999764332221 1223456899999999999999999999999999999999
Q ss_pred hCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 152 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
+|..||.................... ...... ....++.++.+++.+||..+|++|||+++|++.|+++.
T Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 213 RGSLPWQGLKAATNKQKYERIGEKKQ-STPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp HSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCCCCcchhhccccHHHHHHHHhhcc-CccHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 99999975433222111111000000 000000 01234678999999999999999999999999999998
Q ss_pred hccCCCCCc
Q 024460 232 SQRDSHPVS 240 (267)
Q Consensus 232 ~~~~~~~~~ 240 (267)
.+.......
T Consensus 283 ~~~~~~~~~ 291 (298)
T 1csn_A 283 ERLNTTEDE 291 (298)
T ss_dssp HHTTCCSCS
T ss_pred HhcCCCCCC
Confidence 877665433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=268.73 Aligned_cols=222 Identities=24% Similarity=0.380 Sum_probs=169.8
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++..+ ..+++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ ++|+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 150 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHR 150 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccC
Confidence 5788999999999999876 678999999999999999965 3466999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++|..|+.
T Consensus 151 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999999999999999999999765433221 22334567888999999999999999999999999999999999864
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
.............. ...........+........+..++..+.+++.+||..+|.+|||+++++++|+++.
T Consensus 231 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 231 SPMALFLKMIGPTH--GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SHHHHHHHHHCSCC--GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhhHHhhccCCcc--cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 22110000000000 000001111111122222334566788999999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.60 Aligned_cols=212 Identities=26% Similarity=0.401 Sum_probs=169.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++. ++..++||||+.+|+|.++++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 309 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 309 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 368899999999999986 56789999999999999999652 2236888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|||+|||++.++.+||+|||+++...... ........++..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 310 lkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 310 LRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997542211 111122345678999999998999999999999999999999 9999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
...... .. .+....+...+..++.++.++|.+||..+|++|||+++|++.|+.+.....+
T Consensus 389 ~~~~~~---~~--------------~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~ 448 (454)
T 1qcf_A 389 MSNPEV---IR--------------ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448 (454)
T ss_dssp CCHHHH---HH--------------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred CCHHHH---HH--------------HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence 332111 00 0001111123456778899999999999999999999999999988765543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=265.10 Aligned_cols=199 Identities=23% Similarity=0.305 Sum_probs=162.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 167 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDI 167 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 678999999999999999999999999999999999984 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543221 12334568999999999999999999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... .. .+.....+.. ..+..++..+.+++.+||..+|++|||++++++
T Consensus 246 ~~~~---~~----------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 246 PVQA---MK----------RLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHH---HH----------HHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHH---HH----------HHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2111 00 0000011111 112345678999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=270.03 Aligned_cols=226 Identities=29% Similarity=0.435 Sum_probs=173.8
Q ss_pred CCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++... ..+++||||+++++|.+++.. ..+++..++.++.|++.+|.|||+.+ ++|+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~ 158 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHR 158 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 5678999999999999874 678999999999999999954 45899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 159 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 99999999999999999999999865433221 22334557888999999999899999999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
........ ...+..... ........+........+..++.++.+++.+||..+|++|||++++++.|+.+..+...+
T Consensus 239 ~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 239 SPPTKFLE-LIGIAQGQM-TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp SHHHHHHH-HHCSCCHHH-HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccchhhhh-hhcccccch-hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 43211000 000000000 011112222222233345567788999999999999999999999999999988776554
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=276.23 Aligned_cols=201 Identities=20% Similarity=0.193 Sum_probs=162.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+++..|+||||+++|+|.+.+.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDl 136 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNL 136 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999865 467999999999999999999999999 999999
Q ss_pred CCCcEEEc---CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++ .++.+||+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|.+||.
T Consensus 137 Kp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 137 KPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp SSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99999998 45789999999997543222 22234568999999999999899999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+. .... .+.......++.++.++|.+||..||++|||++|+++
T Consensus 215 ~~~~~~~~~~i~------~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 215 DEDQHRLYQQIK------AGAY--------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CSSHHHHHHHHH------HTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CccHHHHHHHHH------hCCC--------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 433211100000 0000 0000111245678999999999999999999999997
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=275.13 Aligned_cols=214 Identities=26% Similarity=0.367 Sum_probs=169.1
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC----------CCCCCCHHHHHHHHHHHHHHHHHhhh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP----------DQEPLSWNTRMKIAVGAARGLEYLHC 70 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~----------~~~~~~~~~~~~~~~~l~~~l~~lH~ 70 (267)
|+++ +||||+++++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4566 899999999999999999999999999999999875211 13468899999999999999999999
Q ss_pred cCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 71 KANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 71 ~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|
T Consensus 183 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 183 KN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp TT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999754333222233334567889999999999999999999999999999
Q ss_pred Hh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 151 IT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
++ |..||......... .. .+........+..++..+.+++.+||..+|.+|||+++|++.|++
T Consensus 260 ~t~g~~p~~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSKF--YK--------------LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp TTTSCCSSTTCCSSHHH--HH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHHH--HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 98 88998643321110 00 000011111233456789999999999999999999999999988
Q ss_pred hhhcc
Q 024460 230 LVSQR 234 (267)
Q Consensus 230 l~~~~ 234 (267)
+....
T Consensus 324 ~~~~~ 328 (333)
T 2i1m_A 324 QAQED 328 (333)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 76543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=265.96 Aligned_cols=219 Identities=21% Similarity=0.248 Sum_probs=164.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 162 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDI 162 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCC
Confidence 57889999999999999999999999999999999998754334667899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 163 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999987532221 12233457889999999999999999999999999999999999986432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCCCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 239 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~~~ 239 (267)
... ........ ...........++.++.+++.+||..||.+|||+++|++.|+++......++.
T Consensus 241 ~~~----~~~~~~~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~ 304 (310)
T 2wqm_A 241 MNL----YSLCKKIE----------QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304 (310)
T ss_dssp CCH----HHHHHHHH----------TTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred hhH----HHHHHHhh----------cccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence 110 00000000 00000011234567899999999999999999999999999999998877653
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=270.21 Aligned_cols=212 Identities=25% Similarity=0.407 Sum_probs=168.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||+++++++..++..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 158 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3678999999999999999999999999999999999986521 11246788999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-C
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-G 153 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g 153 (267)
++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |
T Consensus 159 -i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 159 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999875322221112223345788999999998999999999999999999999 8
Q ss_pred CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 154 RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
..||......... . .. ... .....+..++..+.+++.+||..+|.+|||++|+++.|+++..
T Consensus 238 ~~p~~~~~~~~~~---~----~~---------~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 238 EQPYQGLSNEQVL---R----FV---------MEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCTTTTSCHHHHH---H----HH---------HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCccccCCHHHHH---H----HH---------HcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 8898643211100 0 00 000 0011234567789999999999999999999999999987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=285.96 Aligned_cols=212 Identities=25% Similarity=0.345 Sum_probs=168.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.. +.+++||||+.+|+|.+++.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrD 461 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRN 461 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCc
Confidence 4678999999999999976 568999999999999999965 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+|||++.++.+||+|||+++........ .......++..|+|||++....++.++||||||+++|||++ |..||.
T Consensus 462 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp CSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999864322211 11222334678999999999999999999999999999998 999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
........ ..+....+-..+..++.++.++|.+||..+|++|||+++|++.|+.+......
T Consensus 542 ~~~~~~~~-----------------~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 542 KMKGPEVM-----------------AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp TCCSHHHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCHHHHH-----------------HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 54322111 01111111223556788899999999999999999999999999987665544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=270.21 Aligned_cols=200 Identities=25% Similarity=0.329 Sum_probs=162.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||++++++|.+.+.+|+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 140 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRD 140 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 36788999999999999999999999999999999999964 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++.++.++|+|||++...... .......|++.|+|||++.. ..++.++|+||||+++|+|++|..||
T Consensus 141 lkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 141 MKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 9999999999999999999999754322 22344678999999999864 45899999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-HHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-~~ev~~ 225 (267)
............... .. ....++..++..+.++|.+||..+|.+||+ ++++++
T Consensus 218 ~~~~~~~~~~~~~~~---~~------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 218 HIRSSTSSKEIVHTF---ET------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHH---HH------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCccHHHHHHHH---hh------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 644332221111110 00 001234456778999999999999999998 777765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=263.14 Aligned_cols=209 Identities=24% Similarity=0.370 Sum_probs=167.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++ ..+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~di 143 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDL 143 (291)
T ss_dssp HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCC
Confidence 5688999999999999 56678999999999999999965 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||..
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999998764332221 11222345688999999988889999999999999999999 9999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
....... ..+........+..++..+.+++.+||..+|++|||++++++.|+.+-....
T Consensus 224 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 224 MKGSEVT-----------------AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCHHHHH-----------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCHHHHH-----------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 4321110 0000011112344567889999999999999999999999999998866543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=261.07 Aligned_cols=219 Identities=25% Similarity=0.308 Sum_probs=164.2
Q ss_pred CCCCCCCccceeeEEeeC----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-------
Q 024460 3 SLLHHDNLVTLIGYCTSG----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK------- 71 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~------- 71 (267)
..++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||++
T Consensus 86 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~ 160 (337)
T 3mdy_A 86 VLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160 (337)
T ss_dssp TTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB
T ss_pred HhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 346999999999999887 789999999999999999954 4689999999999999999999988
Q ss_pred -CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcce--eeecccccceeCCcccccCCCccc------CCeee
Q 024460 72 -ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV--STRVMGTYGYCAPEYAMSGKLTLK------SDIYS 142 (267)
Q Consensus 72 -~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~------~Dv~s 142 (267)
+ ++|+||||+||+++.++.+||+|||++........... .....|+..|+|||++.+..+... +||||
T Consensus 161 ~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diws 237 (337)
T 3mdy_A 161 PA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237 (337)
T ss_dssp CC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHH
T ss_pred CC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHH
Confidence 7 99999999999999999999999999875432221111 123468999999999987766655 99999
Q ss_pred hHHHHHHHHhCCC----------CccccCccCccchhhhchhhhhcccccccccCCcCCCC-CcHHHHHHHHHHHHhhcc
Q 024460 143 FGVVLLELITGRK----------AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR-YPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 143 lG~i~~~~l~g~~----------p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~ 211 (267)
||+++|+|++|.. ||.......... . ..... .......+..... .+..++.++.+++.+||.
T Consensus 238 lG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~--~----~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 310 (337)
T 3mdy_A 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY--E----DMREI-VCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310 (337)
T ss_dssp HHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH--H----HHHHH-HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHhccCcccccccccccHhhhcCCCCch--h----hhHHH-HhhhccCccccccchhhHHHHHHHHHHHHhhh
Confidence 9999999999944 443221111100 0 00000 0000111111111 124788999999999999
Q ss_pred cCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 212 EEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
.+|++|||+++|++.|+.+.+..+.
T Consensus 311 ~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 311 HNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hChhhCCCHHHHHHHHHHHHhhccc
Confidence 9999999999999999999887653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=258.86 Aligned_cols=206 Identities=23% Similarity=0.332 Sum_probs=164.1
Q ss_pred CCCCCCCCCccceeeEEeeC--CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSG--DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~--~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|++++||||+++++++... +..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+++ .+++|
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H 136 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPR 136 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS--CSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTT
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh--cccCCCCHHHHHHHHHHHHHHHHHHhcCC-Cceec
Confidence 47889999999999999877 788999999999999999976 22336899999999999999999999865 34999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcc---cCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTL---KSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~Dv~slG~i~~~~l~g~~ 155 (267)
+||+|+||+++.++.+++.||++...... ....+++.|+|||++.+..++. ++||||||+++|+|++|..
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred CCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999998887653211 1235688999999998765544 7999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
||........ .............+..++..+.+++.+||+.+|++|||++++++.|+++..
T Consensus 210 p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 210 PFADLSNMEI----------------GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TTTTSCHHHH----------------HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CccccChHHH----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9964321110 000111111122344567789999999999999999999999999998864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=271.51 Aligned_cols=228 Identities=26% Similarity=0.353 Sum_probs=170.2
Q ss_pred CCCCCCCCccceeeEEe--eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCT--SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~--~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++. .++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~ 151 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHR 151 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 67889999999999886 45678999999999999999975 2356899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||||+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999865333221 12233457888999999999899999999999999999999999985
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
............ . ............+........+..++..+.+++.+||..+|++|||++++++.|+.+.......
T Consensus 232 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~ 308 (327)
T 3lxl_A 232 SPSAEFLRMMGC-E-RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308 (327)
T ss_dssp SHHHHHHHHCC------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-------
T ss_pred cccchhhhhccc-c-cccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCc
Confidence 332211000000 0 0000001111122222223345567788999999999999999999999999999987766554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=263.40 Aligned_cols=208 Identities=21% Similarity=0.312 Sum_probs=164.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..+ ..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 67 l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 139 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDI 139 (281)
T ss_dssp HHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999998654 56899999999999999975 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 140 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 140 AVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp SGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 99999999999999999999875432221 12233456788999999998999999999999999999998 99999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.......... .......+..++..+.+++.+||..+|++|||++++++.|+.+.+.+
T Consensus 219 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 275 (281)
T 3cc6_A 219 ENKDVIGVLE-----------------KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275 (281)
T ss_dssp CGGGHHHHHH-----------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHh-----------------cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhh
Confidence 3211110000 00011123445678999999999999999999999999999887654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=281.01 Aligned_cols=212 Identities=28% Similarity=0.413 Sum_probs=166.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.. +..++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 232 ~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrD 305 (452)
T 1fmk_A 232 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 305 (452)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999876 6789999999999999999641 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.+||+|||+++...... ........++..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 306 lkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 306 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp CSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997543221 112223445778999999998999999999999999999999 8999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
...... . ..+....+...+..++..+.++|.+||..+|++|||+++|++.|+.+......
T Consensus 385 ~~~~~~---~--------------~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 385 MVNREV---L--------------DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCHHHH---H--------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCHHHH---H--------------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 332110 0 00111111223456788899999999999999999999999999988765544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=258.26 Aligned_cols=198 Identities=25% Similarity=0.347 Sum_probs=143.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 138 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDL 138 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSC
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5788999999999999999999999999999999999975 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 139 ~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 139 TLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 9999999999999999999987543221 12223467899999999998889999999999999999999999997443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ...... -..+..++.++.+++.+||..+|++|||++++++
T Consensus 217 ~~~~~~----------------~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 217 VKNTLN----------------KVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC---------------------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHH----------------HHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 221110 000000 1123445678999999999999999999999985
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=269.59 Aligned_cols=202 Identities=20% Similarity=0.250 Sum_probs=163.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++.+++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 174 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 36789999999999999999999999999999999999965 3457899999999999999999999999 99999
Q ss_pred CCCCcEEEcC--CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+||+++. .+.++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 175 IKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cchHHeEEecCCCCceEEEecccceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 9999999974 467999999999864322 22334568999999999999999999999999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... ... ............++.++.++|.+||..||++|||++|+++
T Consensus 252 ~~~~~~~~~~------i~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 252 GEDDLETLQN------VKR--------CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSHHHHHHH------HHH--------CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHH------HHh--------CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 4432111000 000 0000111112345678999999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=262.02 Aligned_cols=198 Identities=22% Similarity=0.298 Sum_probs=157.2
Q ss_pred CCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++.. ++.+|+||||+++++|.+++ ....+++..+..++.|++.||.|||+++ ++|+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 578899999999999986 56899999999999998765 3467999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC---CcccCCeeehHHHHHHHHhCCCC
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||||+||+++.++.++|+|||++....... .......+++.|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999999999999999987543221 2233456899999999987655 37889999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|........ ...... ..........++.++.++|.+||..||++|||++|+++
T Consensus 240 f~~~~~~~~------~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERIMCL------HSKIKS----------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSHHHH------HHHHHH----------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHHHH------HHHHhc----------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 964321100 000000 00000111245677999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=271.21 Aligned_cols=200 Identities=21% Similarity=0.216 Sum_probs=160.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+++..|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dl 154 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNL 154 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999999854 467899999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDND---FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++.+ +.+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|.+||.
T Consensus 155 kp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 155 KPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred chHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999764 459999999997543221 2234568999999999999899999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ . ...... ..........++.++.++|.+||..||++|||++++++
T Consensus 232 ~~~~~~~~---~---~i~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 232 DEDQHRLY---A---QIKAGA--------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CSSHHHHH---H---HHHHTC--------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCHHHHH---H---HHHhCC--------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 43321100 0 000000 00001111345678999999999999999999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=267.83 Aligned_cols=216 Identities=27% Similarity=0.363 Sum_probs=169.5
Q ss_pred CCCC-CCCCccceeeEEeeCC-eeEEEEecCCCCCHHHHhcccCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 024460 2 LSLL-HHDNLVTLIGYCTSGD-QRLLVYEYMPMGSLEDHLYDLEPD------------QEPLSWNTRMKIAVGAARGLEY 67 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~-~~~lv~e~~~~~sL~~~l~~~~~~------------~~~~~~~~~~~~~~~l~~~l~~ 67 (267)
|+++ +||||+++++++...+ .+++||||+++++|.+++...... ...+++..++.++.|++.||.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 3445 7999999999987754 589999999999999999763321 2238899999999999999999
Q ss_pred hhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHH
Q 024460 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 68 lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 147 (267)
||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|+||||+++
T Consensus 164 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99999 999999999999999999999999999865443333333445568899999999999999999999999999
Q ss_pred HHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 148 LELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 148 ~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
|+|++ |..||......... .. ... .......+..++..+.+++.+||..+|.+|||++++++.
T Consensus 241 ~~l~t~g~~p~~~~~~~~~~--~~----~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDEEF--CR----RLK----------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTTSCCSSTTCCCSHHH--HH----HHH----------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCcccchhHHH--HH----Hhc----------cCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99998 99999643321110 00 000 000111233456789999999999999999999999999
Q ss_pred HHHhhhccCC
Q 024460 227 LDYLVSQRDS 236 (267)
Q Consensus 227 l~~l~~~~~~ 236 (267)
|+.+.+....
T Consensus 305 L~~~~~~~~~ 314 (316)
T 2xir_A 305 LGNLLQANAQ 314 (316)
T ss_dssp HHHHHHHHC-
T ss_pred HHHHHhhhcc
Confidence 9998876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=266.42 Aligned_cols=200 Identities=27% Similarity=0.322 Sum_probs=161.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dl 140 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDL 140 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCC
Confidence 5678999999999999999999999999999999999954 567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDF----NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+||+++.++ .++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 141 kp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp CGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 99999998777 79999999997643222 223356899999999999899999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...........+. . ............++..+.++|.+||..+|++|||++|+++
T Consensus 218 ~~~~~~~~~~~~~------~--------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 218 LGDTKQETLANVS------A--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCSSHHHHHHHHH------H--------TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHH------h--------cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 6432211100000 0 0000000011234677899999999999999999999997
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=260.36 Aligned_cols=213 Identities=24% Similarity=0.288 Sum_probs=159.8
Q ss_pred CCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hc
Q 024460 4 LLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CK 71 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------~~ 71 (267)
+++||||+++++++.. ....++||||+++|+|.++++ ...+++..++.++.|++.||.||| +.
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 4899999999998654 346899999999999999994 357999999999999999999999 88
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcc--eeeecccccceeCCcccccC------CCcccCCeeeh
Q 024460 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSF 143 (267)
Q Consensus 72 ~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~sl 143 (267)
+ ++|+||||+||+++.++.+||+|||++.......... ......|++.|+|||++.+. .++.++|||||
T Consensus 133 ~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 133 A---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp E---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 8 9999999999999999999999999986532222111 12234689999999999876 45578999999
Q ss_pred HHHHHHHHhC----------CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccC
Q 024460 144 GVVLLELITG----------RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 213 (267)
Q Consensus 144 G~i~~~~l~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 213 (267)
|+++|+|++| ..||.......... .... ...... ...........+..++..+.+++.+||..+
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~-~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 283 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF-EDMR-KVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQN 283 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HHHH-HHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcch-hhhh-HHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcC
Confidence 9999999999 66664332211110 0000 000000 000000011123467889999999999999
Q ss_pred CCCCCCHHHHHHHHHHh
Q 024460 214 ANFRPLINDIVVALDYL 230 (267)
Q Consensus 214 p~~Rpt~~ev~~~l~~l 230 (267)
|++|||+++|++.|+++
T Consensus 284 P~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 284 PSARLTALRIKKTLTKI 300 (301)
T ss_dssp GGGSCCHHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHhcc
Confidence 99999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=259.04 Aligned_cols=223 Identities=20% Similarity=0.222 Sum_probs=167.6
Q ss_pred CCCCCCCCccceeeEEeeCC--eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++.... ..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 136 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 56789999999999998755 7899999999999999997632 2234899999999999999999999999 9999
Q ss_pred CCCCCcEEE----cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc--------cCCCcccCCeeehHHHH
Q 024460 80 DLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--------SGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 80 di~~~nili----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Dv~slG~i~ 147 (267)
||||+||++ +.++.+||+|||++....... ......++..|+|||++. +..++.++||||||+++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp CCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred CCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 999999999 777789999999997643322 223356899999999886 46789999999999999
Q ss_pred HHHHhCCCCccccCccCcc-chhh-hchhhhhcc-ccccc--------ccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC
Q 024460 148 LELITGRKAMDLSKGQGEQ-NLVS-WSRPFLKDQ-KKFVH--------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~-~~~~-~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
|+|++|..||......... .... ......... ..... .-.......++..++..+.+++++||+.||++
T Consensus 214 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~ 293 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293 (319)
T ss_dssp HHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhh
Confidence 9999999999644332211 1111 000000000 00000 00111122345788899999999999999999
Q ss_pred CCCHHHHHHHHHHhh
Q 024460 217 RPLINDIVVALDYLV 231 (267)
Q Consensus 217 Rpt~~ev~~~l~~l~ 231 (267)
|||++|+++....-.
T Consensus 294 R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 294 CWGFDQFFAETSDIL 308 (319)
T ss_dssp SCCHHHHHHHHHHHT
T ss_pred hccHHHhhhccHHHh
Confidence 999999999776443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.08 Aligned_cols=194 Identities=27% Similarity=0.393 Sum_probs=162.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||+++++++.+++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 132 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDL 132 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999965 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++..... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 133 kp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 133 KPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999975322 1233568999999999999999999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
..... .... ... -.++..++.++.+++.+||..+|++|| +++++++
T Consensus 208 ~~~~~------~~i~----------~~~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 208 TMKTY------EKIL----------NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp HHHHH------HHHH----------HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred HHHHH------HHHH----------hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 21110 0000 000 112345567899999999999999999 8999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=265.77 Aligned_cols=218 Identities=23% Similarity=0.335 Sum_probs=167.7
Q ss_pred CCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 2 LSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
+++++||||+++++++.. ....++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 156 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YA 156 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 578899999999999863 34789999999999999999765445678999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcc-------eeeecccccceeCCcccccCC---CcccCCeeehHHHH
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH-------VSTRVMGTYGYCAPEYAMSGK---LTLKSDIYSFGVVL 147 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~---~~~~~Dv~slG~i~ 147 (267)
|+||+|+||+++.++.++|+|||++.......... ......++..|+|||++.... ++.++||||||+++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999887432111000 001234588999999987654 68899999999999
Q ss_pred HHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 148 LELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
|+|++|..||........... ...........+..++..+.+++.+||+.+|.+|||++++++.|
T Consensus 237 ~el~~g~~p~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGDSVA---------------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHSSCTTHHHHHTTSCHH---------------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhhhcccchhh---------------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 999999999963221111000 00000111111234567899999999999999999999999999
Q ss_pred HHhhhccCCC
Q 024460 228 DYLVSQRDSH 237 (267)
Q Consensus 228 ~~l~~~~~~~ 237 (267)
+++.+....+
T Consensus 302 ~~~~~~~~~~ 311 (317)
T 2buj_A 302 EALQPPAPGQ 311 (317)
T ss_dssp HHTCCCCCC-
T ss_pred hhcCCCCCCC
Confidence 9987665554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=272.39 Aligned_cols=196 Identities=26% Similarity=0.348 Sum_probs=157.5
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+.+ +||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 78 ~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 150 (353)
T 3txo_A 78 SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDL 150 (353)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCC
Confidence 344 799999999999999999999999999999999965 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+|||++.++.++|+|||++...... ........|++.|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 151 kp~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 228 (353)
T 3txo_A 151 KLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228 (353)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEECCCCCEEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998742221 222344568999999999998889999999999999999999999996443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~------~ev~~ 225 (267)
..... ..... . .-.++..++.++.++|.+||..+|.+||++ +++++
T Consensus 229 ~~~~~------~~i~~----------~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 229 EDDLF------EAILN----------D--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HHHHH------HHHHH----------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred HHHHH------HHHHc----------C--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 21110 00000 0 011234456779999999999999999998 77776
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=275.21 Aligned_cols=198 Identities=29% Similarity=0.344 Sum_probs=163.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~ 79 (267)
+|++++||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHr 273 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYR 273 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCC
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEEC
Confidence 57889999999999999999999999999999999999965 4578999999999999999999998 88 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
||||+|||++.++.++|+|||++...... ........|++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 99999999999999999999998753222 2223446789999999999999999999999999999999999999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
......... ... . ...++..++.++.++|.+||..||.+|| +++|+++
T Consensus 352 ~~~~~~~~~------i~~----------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 352 QDHEKLFEL------ILM----------E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SSHHHHHHH------HHH----------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHHHH------HHh----------C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 332111000 000 0 0113445577899999999999999999 9999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.68 Aligned_cols=218 Identities=16% Similarity=0.125 Sum_probs=165.8
Q ss_pred CCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 024460 2 LSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVI 77 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~ 77 (267)
++.++||||+++++++.. +...|+||||+ +++|.+++.. .+.+++..++.++.|++.||.|||+++ ++
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 173 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YV 173 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 457899999999999987 77899999999 9999999965 337999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCC--ceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 78 YRDLKSANILLDNDF--NPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 78 h~di~~~nili~~~~--~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
|+||||+||+++.++ .++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|
T Consensus 174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999998776 9999999999754221111 111334689999999999999999999999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
++|..||......... .......... .....+.... ....++.++.+++.+||..+|++|||+++|++.|+.+
T Consensus 254 l~g~~pf~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 254 LCGKLPWEQNLKDPVA-VQTAKTNLLD---ELPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHSSCTTGGGTTCHHH-HHHHHHHHHH---TTTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HhCCCCccccccccHH-HHHHHHhhcc---cccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 9999999632211110 0000000000 0000000000 0114566899999999999999999999999999887
Q ss_pred hhcc
Q 024460 231 VSQR 234 (267)
Q Consensus 231 ~~~~ 234 (267)
.-..
T Consensus 327 ~~~~ 330 (345)
T 2v62_A 327 GIPL 330 (345)
T ss_dssp CCCC
T ss_pred CCcc
Confidence 6533
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=262.42 Aligned_cols=210 Identities=29% Similarity=0.395 Sum_probs=160.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh---cCCCCeee
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC---KANPPVIY 78 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~~i~h 78 (267)
|++++||||+++++++. +..++||||+++++|.+++.... ....++...++.++.|++.||.|||+ ++ ++|
T Consensus 55 l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH 128 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIH 128 (307)
T ss_dssp HHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCC
T ss_pred HhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eec
Confidence 56789999999999876 34899999999999999997522 22357889999999999999999999 66 999
Q ss_pred CCCCCCcEEEcCCCc-eEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFN-PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||||+||+++.++. +||+|||++...... .....++..|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 129 ~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp CCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred CCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999999999988776 799999998743211 22345899999999999999999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
......... ..+. . . .......+..++..+.+++.+||..+|++|||++++++.|+.+.+.....
T Consensus 204 ~~~~~~~~~--~~~~--~-------~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 204 DEIGGPAFR--IMWA--V-------H----NGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp TTTCSSHHH--HHHH--H-------H----TTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred hhhCccHHH--HHHH--H-------h----cCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 643221100 0000 0 0 00011123455678999999999999999999999999999988766543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=257.81 Aligned_cols=204 Identities=29% Similarity=0.522 Sum_probs=161.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.... ++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+++ .+++|+||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~di 150 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDL 150 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCC
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCC
Confidence 67889999999999987665 699999999999998865 4567999999999999999999999875 34999999
Q ss_pred CCCcEEEcCCCc-----eEEeccCCcccCCCCCCcceeeecccccceeCCcccc--cCCCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFN-----PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM--SGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
||+||+++.++. ++|+|||++..... ......+++.|+|||++. ...++.++|+||||+++|+|++|.
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999987765 99999999874221 233456899999999984 456789999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
.||........... . ...........+..++..+.+++.+||..+|.+|||++++++.|+++
T Consensus 226 ~pf~~~~~~~~~~~-~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 226 GPFDEYSYGKIKFI-N-------------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CTTTTCCCCHHHHH-H-------------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCccccccHHHHH-H-------------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 99964332111000 0 00011111223456678899999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=269.45 Aligned_cols=202 Identities=21% Similarity=0.248 Sum_probs=151.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++.+++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dl 142 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDL 142 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCC
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999864 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc--eEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCccc-CCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFN--PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLK-SDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++.++. +||+|||++..... ........|++.|+|||++.+..++.+ +||||||+++|+|++|..||.
T Consensus 143 kp~Nill~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 143 KLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEcCCCCceEEEeecCccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 999999987655 99999999873221 122334568999999999988777655 899999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... .... .............++.++.++|.+||..+|++|||++|+++
T Consensus 220 ~~~~~~~~~~--~~~~----------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 220 DPEEPRDYRK--TIQR----------ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp ----CCCHHH--HHHH----------HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCccHHHHHH--HHHH----------HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 5433221110 0000 00111111111234677899999999999999999999997
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=264.21 Aligned_cols=215 Identities=22% Similarity=0.307 Sum_probs=157.5
Q ss_pred CCCCCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
++++++||||+++++++.... ..|+||||+++++|.+++.. ...+++..++.++.|++.+|.|||+++ +
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---I 137 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 478899999999999987654 34999999999999999965 356899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||||+||+++.++.++|+|||++......... .......|++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999998754322211 12233457999999999999999999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHH-HHHHHhhhcc
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV-VALDYLVSQR 234 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~-~~l~~l~~~~ 234 (267)
||......... ......... .+ ......++.++.+++.+||..||.+||+..+++ ..|..+....
T Consensus 218 pf~~~~~~~~~------~~~~~~~~~-----~~---~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 218 PFTGDSPVSVA------YQHVREDPI-----PP---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp SCCCSSHHHHH------HHHHHCCCC-----CH---HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred CCCCCChHHHH------HHHhcCCCC-----Cc---ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 99643321110 000000000 00 000123567799999999999999999666555 4666655444
Q ss_pred CC
Q 024460 235 DS 236 (267)
Q Consensus 235 ~~ 236 (267)
..
T Consensus 284 ~~ 285 (311)
T 3ork_A 284 PP 285 (311)
T ss_dssp CC
T ss_pred CC
Confidence 33
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=261.82 Aligned_cols=212 Identities=27% Similarity=0.417 Sum_probs=166.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++. ++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 62 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 135 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135 (279)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999986 45689999999999999999641 1236899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||||+++|+|++ |..||...
T Consensus 136 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 136 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999987543221 111222345678999999988889999999999999999999 89998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
..... .. .+........+..++.++.+++.+||..+|++|||++++++.|+.+......+
T Consensus 215 ~~~~~---~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 215 TNPEV---IQ--------------NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp CHHHH---HH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred CHHHH---HH--------------HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 22110 00 00000111223456778999999999999999999999999999887765543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=267.68 Aligned_cols=195 Identities=25% Similarity=0.266 Sum_probs=162.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++.+++.+|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 166 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36789999999999999999999999999999999999965 356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.++|+||||+++|+|++|.+||...
T Consensus 167 lkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 9999999999999999999999754222 22346899999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
..... ...... . .-.++..++.++.++|.+||+.+|.+||+ ++++++
T Consensus 242 ~~~~~------~~~i~~----------~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 242 QPIQI------YEKIVS----------G--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SHHHH------HHHHHH----------C--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHH------HHHHHc----------C--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 21110 000000 0 01234456778999999999999999998 888876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=270.31 Aligned_cols=194 Identities=27% Similarity=0.278 Sum_probs=159.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
++.++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 165 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 165 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5778999999999999999999999999999999999965 457889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.+||+|||++...... ........|++.|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 166 kp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 166 KPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999998742211 112334568999999999999999999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
.... ...... .. -.++..++.++.++|.+||+.+|.+||++.+
T Consensus 244 ~~~~------~~~i~~----------~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 244 TAEM------YDNILN----------KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp HHHH------HHHHHH----------SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred HHHH------HHHHHh----------cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1110 000110 00 0123345678999999999999999999853
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=262.11 Aligned_cols=213 Identities=21% Similarity=0.196 Sum_probs=158.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 160 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDV 160 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCC
Confidence 6788999999999999999999999999999999999965 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 161 KPENILVSADDFAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp CGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ChHHEEEcCCCCEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 99999999999999999999875432211 12233467899999999998899999999999999999999999996432
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHHhhhccCCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-t~~ev~~~l~~l~~~~~~~ 237 (267)
.... ....... .. .....+..++.++.+++.+||..+|++|| +++++++.|+++.......
T Consensus 240 ~~~~-------~~~~~~~------~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 240 LSVM-------GAHINQA------IP--RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp HHHH-------HHHHHSC------CC--CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred HHHH-------HHHhccC------CC--CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 1100 0000000 00 00012334567799999999999999999 9999999999876665544
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=261.09 Aligned_cols=206 Identities=28% Similarity=0.389 Sum_probs=161.1
Q ss_pred CCCCCCCCccceeeEEeeC-CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG-DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++++||||+++++++... +..++||||+++++|.+++... ....+++..++.++.|++.|+.|||+++ ++|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 142 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 142 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 6789999999999987544 5789999999999999999651 1223788999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|+|+||+++.++.++|+|||++...... .....++..|+|||++.+..++.++|+||||+++|+|++ |..||..
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998743221 122346788999999998999999999999999999998 9999864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
....... ..+........+..++..+.+++.+||..+|++|||++++++.|+++...+
T Consensus 218 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 218 IPLKDVV-----------------PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp SCGGGHH-----------------HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCHHHHH-----------------HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 3321110 001111111234456788999999999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=262.62 Aligned_cols=215 Identities=25% Similarity=0.283 Sum_probs=159.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Di 145 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDL 145 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999975 88888865 4567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++...... ........+++.|+|||++.+ ..++.++||||||+++|+|++|..||...
T Consensus 146 kp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 146 KPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999754322 122333467999999999876 56899999999999999999999999754
Q ss_pred CccCccchhhh-c-hh---hhhcccccc-------cccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSW-S-RP---FLKDQKKFV-------HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~-~-~~---~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+.. . .+ ......... ..............++.++.++|.+||+.||++|||++|+++
T Consensus 224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 43322111100 0 00 000000000 000000000011234567899999999999999999999995
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=266.09 Aligned_cols=205 Identities=22% Similarity=0.272 Sum_probs=142.3
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++++ ||||+++++++.+++..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 131 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRD 131 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecC
Confidence 34565 99999999999999999999999999999999965 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC---ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDF---NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++.++ .++|+|||++...... ........+++.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp CCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHEEEecCCCcccEEEeccccceecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 999999997655 7999999999754322 12233456789999999999999999999999999999999999999
Q ss_pred cccCccCcc-chhhhchhhhhcccccccccCCcC--CCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQ-NLVSWSRPFLKDQKKFVHLVDPLL--HGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ....... .+..... .......++.++.++|.+||..||++|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 210 QSHDRSLTCTSAVEIMK----------KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C-------CCCHHHHHH----------HHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCccccccccHHHHHH----------HHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 754322111 0000000 0000000 00011245678999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=262.64 Aligned_cols=191 Identities=25% Similarity=0.323 Sum_probs=160.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCC-CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMG-SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~-sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++++++..++.+++||||+.+| +|.+++.. ...+++..+..++.|++.||.|||+++ ++|+
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 154 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHR 154 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEe
Confidence 367899999999999999999999999998766 99999864 457999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||||+||+++.++.++|+|||++....... ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.
T Consensus 155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 155 DIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 999999999999999999999997543222 2233568999999999988776 789999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ..... ..+..++.++.+++.+||..+|++|||++++++
T Consensus 232 ~~~~~----------------------~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 232 ELEET----------------------VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp SGGGG----------------------TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHHHH----------------------Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 32110 00000 112335677999999999999999999999997
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=270.40 Aligned_cols=225 Identities=19% Similarity=0.215 Sum_probs=162.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++.+|+||||+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDl 154 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSV 154 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 56789999999999999999999999999999999999762 3466999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
||+||+++.++.++|+|||.+......... .......++..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 155 kp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 234 (389)
T 3gni_B 155 KASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234 (389)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 999999999999999999987543211110 11122367889999999987 57899999999999999999999
Q ss_pred CCccccCccCccch-hhhchhhhhcc------------------ccccccc---------CCcCCCCCcHHHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQNL-VSWSRPFLKDQ------------------KKFVHLV---------DPLLHGRYPRRCLNYAVAVT 206 (267)
Q Consensus 155 ~p~~~~~~~~~~~~-~~~~~~~~~~~------------------~~~~~~~---------~~~~~~~~~~~~~~~l~~li 206 (267)
.||........... .....+..... ......+ ........+..++..+.++|
T Consensus 235 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 314 (389)
T 3gni_B 235 VPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFV 314 (389)
T ss_dssp CTTTTCCSTTHHHHC--------------------------------------------------------CCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHH
Confidence 99965432221100 00000000000 0000000 00000112344567899999
Q ss_pred HhhcccCCCCCCCHHHHHHH--HHHhh
Q 024460 207 AMCLNEEANFRPLINDIVVA--LDYLV 231 (267)
Q Consensus 207 ~~cl~~~p~~Rpt~~ev~~~--l~~l~ 231 (267)
.+||+.||++|||++|+++- |+.+.
T Consensus 315 ~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 315 EQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp HHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred HHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 99999999999999999963 55443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=267.27 Aligned_cols=215 Identities=26% Similarity=0.361 Sum_probs=168.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|++++||||+++++++..++..|+||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ ++|
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H 163 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 163 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eec
Confidence 5678999999999999999999999999999999999986332 1245889999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CC
Q 024460 79 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GR 154 (267)
Q Consensus 79 ~di~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~ 154 (267)
+||+|+||+++. +..++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 243 (327)
T 2yfx_A 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243 (327)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999984 44699999999864322222222334556889999999998999999999999999999998 88
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.||........ .. .+........+..++..+.+++.+||..+|.+|||++++++.|..+....
T Consensus 244 ~p~~~~~~~~~---~~--------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 244 MPYPSKSNQEV---LE--------------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp CSSTTCCHHHH---HH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred CCCCCcCHHHH---HH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 99864321110 00 00000011123456778999999999999999999999999999887766
Q ss_pred CC
Q 024460 235 DS 236 (267)
Q Consensus 235 ~~ 236 (267)
..
T Consensus 307 ~~ 308 (327)
T 2yfx_A 307 DV 308 (327)
T ss_dssp HH
T ss_pred HH
Confidence 54
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=275.46 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=162.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++...+.+|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 141 (476)
T 2y94_A 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRD 141 (476)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCccc
Confidence 36789999999999999999999999999999999999954 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.+||+|||++...... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 142 Lkp~NIll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 142 LKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccHHHEEEecCCCeEEEeccchhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999864322 22334568999999999988765 6899999999999999999999974
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... . . +..... ..+..++.++.++|.+||..||++|||++|+++
T Consensus 219 ~~~~~~~---~---~----------i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 219 DHVPTLF---K---K----------ICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp SSSHHHH---H---H----------HHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHH---H---H----------HhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 3321110 0 0 000000 123345677999999999999999999999997
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=265.50 Aligned_cols=207 Identities=25% Similarity=0.371 Sum_probs=160.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 139 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNV 139 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCc
Confidence 5788999999999999999999999999999999999976 3445899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc--------eEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHh
Q 024460 82 KSANILLDNDFN--------PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 82 ~~~nili~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~ 152 (267)
||+||+++.++. ++|+|||++..... .....++..|+|||++.+ ..++.++||||||+++|+|++
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 999999987776 99999999864311 122346788999999987 678999999999999999999
Q ss_pred CC-CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 153 GR-KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 153 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
|. +|+........... .... ...+..++.++.+++.+||+.+|++|||++++++.|+.+.
T Consensus 214 g~~~~~~~~~~~~~~~~-------~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 214 GGDKPLSALDSQRKLQF-------YEDR------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTCCTTTTSCHHHHHHH-------HHTT------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred CCCCCccccchHHHHHH-------hhcc------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 54 45543221110000 0000 0112222455889999999999999999999999999998
Q ss_pred hccCCCCC
Q 024460 232 SQRDSHPV 239 (267)
Q Consensus 232 ~~~~~~~~ 239 (267)
+-..+.+.
T Consensus 275 ~p~~~~~~ 282 (289)
T 4fvq_A 275 TPDLVPRG 282 (289)
T ss_dssp --------
T ss_pred CCCCCCCC
Confidence 86665543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=270.11 Aligned_cols=201 Identities=28% Similarity=0.390 Sum_probs=160.2
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.+||||++++++|.+++.+|+||||+++|+|..++.. ...+++..+..++.|++.||.|||+++ ++||||||+
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~ 182 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 182 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHH
Confidence 3899999999999999999999999999999999965 457999999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
|||++.++.+||+|||++...... ........|++.|+|||++.+..++.++|+||||+++|+|++|.+||.......
T Consensus 183 NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 183 NVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred HEEECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 999999999999999999752222 223344678999999999999999999999999999999999999996432211
Q ss_pred cc--chhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 024460 165 EQ--NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 225 (267)
Q Consensus 165 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~------~ev~~ 225 (267)
.. ......... +... .-.+|..++.++.++|++||+.||++||++ +|+++
T Consensus 261 ~~~~~~~~~~~~~---------i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 261 NPDQNTEDYLFQV---------ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----CCHHHHHHH---------HHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccchhhHHHHHHH---------Hhcc--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 10 000000000 0000 112345567789999999999999999985 56665
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=268.94 Aligned_cols=202 Identities=23% Similarity=0.267 Sum_probs=162.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 212 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLD 212 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36789999999999999999999999999999999998865 3457899999999999999999999999 99999
Q ss_pred CCCCcEEE--cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILL--DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+||++ +.++.++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 213 lkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 213 LKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999 566789999999998543222 2233468999999999988889999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ....... .........++.++.++|.+||..+|.+|||++|+++
T Consensus 290 ~~~~~~~~~------~i~~~~~--------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 290 GDNDAETLN------NILACRW--------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSSHHHHHH------HHHHTCC--------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHH------HHHhccC--------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 443211100 0000000 0000111245678999999999999999999999998
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=262.19 Aligned_cols=214 Identities=21% Similarity=0.251 Sum_probs=160.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 155 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 46789999999999999999999999999999999999965 3457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCC---CcceeeecccccceeCCccccc---------CCCcccCCeeehHHHHH
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGD---NTHVSTRVMGTYGYCAPEYAMS---------GKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~Dv~slG~i~~ 148 (267)
|+|+||+++ ++.++|+|||++....... .........++..|+|||++.. ..++.++||||||+++|
T Consensus 156 lkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp CCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred CChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 999999998 6799999999976532111 1112233457899999999874 35788999999999999
Q ss_pred HHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHH
Q 024460 149 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~ 228 (267)
+|++|..||.......... .. .....+. ..+..++.++.+++.+||..+|.+|||++++++.|+
T Consensus 235 el~~g~~p~~~~~~~~~~~------~~-------~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 235 ELHAREWPFKTQPAEAIIW------QM-------GTGMKPN---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp HHHHSSCSSSSCCHHHHHH------HH-------HTTCCCC---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred HHHhCCCCCCCCCHHHHHH------Hh-------ccCCCCC---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 9999999996433211100 00 0000010 011234566899999999999999999999999999
Q ss_pred HhhhccCCC
Q 024460 229 YLVSQRDSH 237 (267)
Q Consensus 229 ~l~~~~~~~ 237 (267)
.+.......
T Consensus 299 ~l~~~~~~~ 307 (319)
T 2y4i_B 299 KLPKRNRRL 307 (319)
T ss_dssp TC-------
T ss_pred HHHHhhccC
Confidence 988775443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=257.87 Aligned_cols=216 Identities=19% Similarity=0.228 Sum_probs=158.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++..++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~d 126 (292)
T 3o0g_A 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 36789999999999999999999999999975 66666654 3567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-CcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.++|+|||++...... ........++..|+|||++.+.. ++.++|+||||+++|+|++|..|+..
T Consensus 127 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 127 LKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 9999999999999999999999754322 12233456799999999987765 79999999999999999988877532
Q ss_pred cCccCcc-c-hhhhc-hhhhhccccccc---------ccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQ-N-LVSWS-RPFLKDQKKFVH---------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~-~-~~~~~-~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... . +.... .+.......... .............++..+.+++.+||+.||++|||++|+++
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 2211110 0 00000 000000000000 00000001112345678999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=258.96 Aligned_cols=216 Identities=22% Similarity=0.302 Sum_probs=157.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 125 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 47889999999999999999999999999975 99998865 3467899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.+||+|||++....... .......+++.|+|||++.+. .++.++|+||||+++|+|++|.+||..
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 126 LKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999987532211 122334578999999998764 589999999999999999999999965
Q ss_pred cCccCccc-hhhh-chh---hhhccccccc------ccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQN-LVSW-SRP---FLKDQKKFVH------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~-~~~~-~~~---~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ +... ... .......... ...+.........++.++.+++.+||..||++|||++|+++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 43211110 0000 000 0000000000 00000000112345678899999999999999999999985
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=255.15 Aligned_cols=220 Identities=19% Similarity=0.208 Sum_probs=169.5
Q ss_pred CCCCCCCCccceeeEE-eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++|++++..+..+ ..++..++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 130 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4566777766665554 6778899999999 8899999975 3467999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 81 LKSANILL---DNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 81 i~~~nili---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
|||+||++ +.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 131 lkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 4hgt_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp CSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc
Confidence 99999999 78889999999999764332221 12234568999999999999999999999999999999999
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
|..||...................... .. +. ....++.++.+++.+||+.+|++|||+++|++.|+++..
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 211 GSLPWQGLKAATKRQKYERISEKKMST-PI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHHHS-CH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCcccchhhhhhhhhhhhcccccc-hh-----hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 999997654433322211111000000 00 00 012336789999999999999999999999999999998
Q ss_pred ccCCCC
Q 024460 233 QRDSHP 238 (267)
Q Consensus 233 ~~~~~~ 238 (267)
......
T Consensus 281 ~~~~~~ 286 (296)
T 4hgt_A 281 RQGFSY 286 (296)
T ss_dssp HHTCCT
T ss_pred HhCCCc
Confidence 877654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=255.80 Aligned_cols=202 Identities=26% Similarity=0.360 Sum_probs=161.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 131 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 131 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5678999999999999999999999999999999999854 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++................++..|+|||++.+..+ +.++|+||||+++|+|++|..||...
T Consensus 132 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred ChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999875432222222334568899999999987665 78899999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ...+. ...........++..+.+++.+||..+|++|||++|+++
T Consensus 212 ~~~~~~-~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 212 SDSCQE-YSDWK--------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CTTSHH-HHHHH--------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chHHHH-HHHhh--------------hcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 321110 00000 000000112345678999999999999999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.16 Aligned_cols=201 Identities=23% Similarity=0.294 Sum_probs=153.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+++ ++|+||
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 174 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDL 174 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 5678999999999999999999999999999999999954 456899999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++. ++.++|+|||++...... .......|++.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 175 kp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp CGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CcccEEEecCCCCCCEEEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999975 789999999998753221 12234568999999999999899999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... .. ....... ..........++.++.++|.+||..||++|||++|+++
T Consensus 252 ~~~~~~~--~~---~~i~~~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 252 DERGDQF--MF---RRILNCE--------YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTCHHH--HH---HHHHTTC--------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccHH--HH---HHHHhCC--------CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4332110 00 0000000 00011112345678999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=260.15 Aligned_cols=202 Identities=27% Similarity=0.321 Sum_probs=156.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++...+..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~di 150 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDL 150 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCC
Confidence 67889999999999999999999999999999999998653334577999999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||++ +.++.++|+|||++..... ........++..|+|||++. ..++.++|+||||+++|+|++|..||.
T Consensus 151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 151 KPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp SGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCCEEEEeeecceecCC---cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 9999999 4457899999999975322 22234456899999999875 578899999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............. ..+... .....++.++.+++.+||..+|++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~--------------~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 227 GTSLEEVQQKATY--------------KEPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CSSHHHHHHHHHH--------------CCCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHhhhcc--------------CCcccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4432111100000 000000 001123567899999999999999999999984
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=265.56 Aligned_cols=197 Identities=26% Similarity=0.340 Sum_probs=160.8
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+.+ +||||+++++++.+.+.+|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+|
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 146 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 146 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 4445 799999999999999999999999999999999965 356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|.+||...
T Consensus 147 lkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 147 LKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987532211 2234456899999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
..... . ..... .. -.++..++.++.++|.+||..+|.+||+ ++++++
T Consensus 225 ~~~~~---~---~~i~~----------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 225 DEDEL---F---QSIME----------HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SHHHH---H---HHHHH----------CC--CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CHHHH---H---HHHHh----------CC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 21110 0 00000 00 1134456778999999999999999995 577765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=286.30 Aligned_cols=207 Identities=25% Similarity=0.383 Sum_probs=165.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.. +..++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++|+|
T Consensus 423 il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrD 494 (635)
T 4fl3_A 423 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 494 (635)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCC
Confidence 3567899999999999965 468899999999999999964 467899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCC-cceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+|||++.++.+||+|||++........ ........++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 495 Lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 495 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp CSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999876433221 122233445788999999999999999999999999999998 999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
....... ...+........+..++.++.++|.+||..+|++|||+++|++.|+.+..
T Consensus 575 ~~~~~~~-----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 575 GMKGSEV-----------------TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp TCCHHHH-----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHHHH-----------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 4432111 11111111223355678889999999999999999999999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=266.12 Aligned_cols=225 Identities=29% Similarity=0.425 Sum_probs=168.6
Q ss_pred CCCCCCCCccceeeEEeeCC--eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++...+ ..++||||+++++|.+++.. ....+++..++.++.|++.||.+||+++ ++|+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 169 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHR 169 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 57889999999999986644 78999999999999999976 3456899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 170 dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred CCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999865332221 11223446778999999998889999999999999999999999875
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
................... ...+...+........+..++.++.++|.+||..+|++|||+++|++.|++++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 250 SPPAEFMRMIGNDKQGQMI-VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp SHHHHHHHHHCTTCCTHHH-HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHhhccccchhhh-HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 3211000000000000000 0001111111111223456678899999999999999999999999999998765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=265.36 Aligned_cols=197 Identities=27% Similarity=0.320 Sum_probs=158.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dl 147 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDL 147 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccC
Confidence 5678999999999999999999999999999999999965 456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 148 kp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 148 KPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CHHHeEECCCCcEEEEeCCcccccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999998743211 112334568999999999998899999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
..... ..... . ...++..++.++.++|.+||..+|.+|| +++++++
T Consensus 226 ~~~~~------~~i~~----------~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 226 RKKTI------DKILK----------C--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHHHH------HHHHH----------T--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HHHHH------HHHHh----------C--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 21100 00000 0 0112345567899999999999999999 7888876
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=259.55 Aligned_cols=191 Identities=22% Similarity=0.213 Sum_probs=152.9
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.+||||+++++++..++.+++||||+ +++|.+++.. .+..+++..++.++.|++.||.|||+++ ++|+||||+
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 186 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPA 186 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH
Confidence 48999999999999999999999999 6699998876 3567999999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
||+++.++.+||+|||++..... ........|++.|+|||++.+ .++.++||||||+++|+|++|..++.....
T Consensus 187 NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-- 260 (311)
T 3p1a_A 187 NIFLGPRGRCKLGDFGLLVELGT---AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-- 260 (311)
T ss_dssp GEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--
T ss_pred HEEECCCCCEEEccceeeeeccc---CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--
Confidence 99999999999999999875422 222334568999999998875 789999999999999999999765532110
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...+........++..++.++.+++.+||+.+|++|||++|+++
T Consensus 261 -----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 -----------------WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----------------HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----------------HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 00000111111112345678999999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=260.08 Aligned_cols=224 Identities=24% Similarity=0.297 Sum_probs=160.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 125 (324)
T 3mtl_A 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRD 125 (324)
T ss_dssp HHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred HHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 3678999999999999999999999999997 599998876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+||+++.++.++|+|||++...... ........++..|+|||++.+ ..++.++||||||+++|+|++|.+||..
T Consensus 126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 126 LKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp CCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998753222 112233467999999999876 5689999999999999999999999975
Q ss_pred cCccCccchhhhc--------hhhhhcccccccccCCcCCCC----CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--
Q 024460 160 SKGQGEQNLVSWS--------RPFLKDQKKFVHLVDPLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV-- 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~-- 225 (267)
.........+... .+.............+..... ....++.++.+++.+||+.||++|||++|+++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 283 (324)
T 3mtl_A 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283 (324)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence 4322111100000 000000000000000000000 01234677899999999999999999999997
Q ss_pred HHHHhhhc
Q 024460 226 ALDYLVSQ 233 (267)
Q Consensus 226 ~l~~l~~~ 233 (267)
.|..+..+
T Consensus 284 ~f~~~~~~ 291 (324)
T 3mtl_A 284 FFLSLGER 291 (324)
T ss_dssp GGGGGCST
T ss_pred hhhhcccc
Confidence 45544433
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=255.78 Aligned_cols=195 Identities=26% Similarity=0.415 Sum_probs=159.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dl 135 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDI 135 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCC
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 6788999999999999999999999999999999999965 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 136 kp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 136 KPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp CGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 999999999999999999988643221 2233567899999999999999999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......+ .. .....+..++..+.+++.+||..+|.+|||++|+++
T Consensus 212 ~~~~~~~~------~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 212 YQETYKRI------SR------------VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp HHHHHHHH------HH------------TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHH------Hh------------CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 21110000 00 011123445677999999999999999999999998
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=260.22 Aligned_cols=210 Identities=28% Similarity=0.361 Sum_probs=164.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++ .++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 147 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDL 147 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 56789999999999988765 8899999999999999975 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
+|+||+++.++.++|+|||++......... .......++..|+|||++.+..++.++|+||||+++|+|++ |..||..
T Consensus 148 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 148 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999998765333221 12223456778999999998889999999999999999999 9999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
....... . ...........+..++.++.+++.+||..+|.+|||++++++.|+++.+..
T Consensus 228 ~~~~~~~---~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 228 LNGSQIL---H-------------KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp CCHHHHH---H-------------HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCHHHHH---H-------------HHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 4321100 0 000001111223456788999999999999999999999999999887644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=253.57 Aligned_cols=222 Identities=19% Similarity=0.198 Sum_probs=169.5
Q ss_pred CCCCCCCCccceeeEE-eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~-~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++|++++..+..+ ..++..++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 130 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 4567787766555554 6678899999999 8899999974 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 81 LKSANILLD---NDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 81 i~~~nili~---~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
|||+||+++ .++.++|+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 131 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh
Confidence 999999994 7889999999998764332221 11234568999999999999999999999999999999999
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
|..||.................... .... +. ....++.++.+++.+||+.+|++|||+++|++.|+++..
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~-----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 211 GSLPWQGLKAATKRQKYERISEKKM-STPI-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHH-HSCH-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcCchhhhhhhhhhccccc-CCch-----HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 9999975443322221111110000 0000 00 012346779999999999999999999999999999988
Q ss_pred ccCCCCCc
Q 024460 233 QRDSHPVS 240 (267)
Q Consensus 233 ~~~~~~~~ 240 (267)
........
T Consensus 281 ~~~~~~~~ 288 (296)
T 3uzp_A 281 RQGFSYDY 288 (296)
T ss_dssp HTTCCSSC
T ss_pred hcCCcccc
Confidence 87765443
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=259.33 Aligned_cols=205 Identities=25% Similarity=0.346 Sum_probs=164.3
Q ss_pred CCCCCCCCccceeeEEee----------------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVTLIGYCTS----------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~----------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l 65 (267)
|++++||||+++++++.. ...+++||||+++++|.+++... ....+++..++.++.|++.||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l 135 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGV 135 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHH
Confidence 567899999999998864 44589999999999999999752 245789999999999999999
Q ss_pred HHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHH
Q 024460 66 EYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGV 145 (267)
Q Consensus 66 ~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~ 145 (267)
.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......+++.|+|||++.+..++.++|+||||+
T Consensus 136 ~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (284)
T 2a19_B 136 DYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209 (284)
T ss_dssp HHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred HHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence 9999999 9999999999999999999999999987543222 223345889999999999999999999999999
Q ss_pred HHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 146 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 146 i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
++|+|++|..|+..... .. ..... ...+..++..+.+++.+||..+|.+|||++|+++
T Consensus 210 il~~l~~~~~~~~~~~~------------~~------~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 210 ILAELLHVCDTAFETSK------------FF------TDLRD----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp HHHHHHSCCSSHHHHHH------------HH------HHHHT----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCcchhHHH------------HH------HHhhc----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999988742110 00 00001 1122344667899999999999999999999999
Q ss_pred HHHHhhhccCC
Q 024460 226 ALDYLVSQRDS 236 (267)
Q Consensus 226 ~l~~l~~~~~~ 236 (267)
.|..+....+.
T Consensus 268 ~l~~~~~~~~~ 278 (284)
T 2a19_B 268 TLTVWKKSPEK 278 (284)
T ss_dssp HHHHHTC----
T ss_pred HHHHHhhCCCc
Confidence 99988765543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=266.48 Aligned_cols=204 Identities=21% Similarity=0.229 Sum_probs=154.3
Q ss_pred CCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 3 SLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+..+||||+++++++.. ++.+|+||||+++|+|.+++.. .....+++..+..++.|++.||.|||+++ ++|
T Consensus 110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 184 (400)
T 1nxk_A 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 184 (400)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC--C---CCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH--hCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 34689999999999876 5678999999999999999975 22356999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||||+|||++. ++.+||+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCcceEEEecCCCCccEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999987 788999999999754321 12234567999999999999999999999999999999999999
Q ss_pred CccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||.......... ..... ..... .+.......++.++.++|.+||..||++|||++|+++
T Consensus 262 pf~~~~~~~~~~~~~~~i---~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTRI---RMGQY--------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp SCCCCTTCSSCCSHHHHH---HHTCC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCccccccHHHHHHH---HcCcc--------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 997544322110 00000 00000 0000011345678999999999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.69 Aligned_cols=204 Identities=20% Similarity=0.183 Sum_probs=161.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||++++++|.+++.+|+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++||||
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDL 201 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDI 201 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccc
Confidence 4568999999999999999999999999999999999975 3567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||+|||++.++.+||+|||++....... ........|++.|+|||++. ...++.++|+||||+++|+|++|.+|
T Consensus 202 Kp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 202 KPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 9999999999999999999997543222 22233457899999999987 45789999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~ 225 (267)
|...........+. .... ...-+. ....++.++.++|++||+.+|++ ||+++|+++
T Consensus 281 f~~~~~~~~~~~i~------~~~~---~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 281 FYAESLVETYGKIM------NHKE---RFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp TCCSSHHHHHHHHH------THHH---HCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred CCCCChhHHHHhhh------hccc---cccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 97433211110000 0000 000000 01235677999999999988888 999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=262.08 Aligned_cols=227 Identities=24% Similarity=0.309 Sum_probs=163.5
Q ss_pred CCCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----
Q 024460 2 LSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK----- 71 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----- 71 (267)
++.++||||+++++.+.. ...+++||||+++|+|.+++.. ...++..++.++.|++.||.|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~ 135 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGD 135 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence 456899999999986532 3367899999999999999965 3458889999999999999999998
Q ss_pred ----CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCC------cceeeecccccceeCCccccc-------CCC
Q 024460 72 ----ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN------THVSTRVMGTYGYCAPEYAMS-------GKL 134 (267)
Q Consensus 72 ----~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~~ 134 (267)
+ ++|+||||+||+++.++.+||+|||++........ ........|+..|+|||++.+ ..+
T Consensus 136 ~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 212 (336)
T 3g2f_A 136 HYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212 (336)
T ss_dssp GCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH
T ss_pred ccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc
Confidence 8 99999999999999999999999999976432211 111223468999999999876 356
Q ss_pred cccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhh---chhhhhc--ccccccccCCcCCCC--CcHHHHHHHHHHH
Q 024460 135 TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW---SRPFLKD--QKKFVHLVDPLLHGR--YPRRCLNYAVAVT 206 (267)
Q Consensus 135 ~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~---~~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~l~~li 206 (267)
+.++||||||+++|+|++|..|+.......... .... ..+.... .........+.+... ....++..+.++|
T Consensus 213 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (336)
T 3g2f_A 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHH
Confidence 678999999999999999977664332222111 0000 0000000 000000111111111 1235778899999
Q ss_pred HhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 207 AMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 207 ~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
.+||..+|++|||++|+++.|+++...-..
T Consensus 293 ~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 293 EDCWDQDAEARLTAQXAEERMAELMMIWER 322 (336)
T ss_dssp HHHSCSSGGGSCCHHHHHHHHHHHHHCCCC
T ss_pred HHHhcCChhhCcchHHHHHHHHHHHHHHHh
Confidence 999999999999999999999998866554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=271.12 Aligned_cols=201 Identities=21% Similarity=0.236 Sum_probs=160.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||++++++|.+++.+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++ ++||||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDL 194 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 194 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999999954 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC----CcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK----LTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+|||++.++.+||+|||++....... ........|++.|+|||++.... ++.++|+||||+++|+|++|.+||
T Consensus 195 Kp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 195 KPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 9999999999999999999997543222 11233467899999999998765 789999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC--CCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF--RPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--Rpt~~ev~~ 225 (267)
...........+ ...... ..-.....++.++.++|.+||+.+|++ ||+++||++
T Consensus 274 ~~~~~~~~~~~i------~~~~~~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 274 YADSLVGTYSKI------MNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp CCSSHHHHHHHH------HTHHHH--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred CCCChhhHHHHH------Hhcccc--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 643321111000 000000 000011234677999999999999988 999999997
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.35 Aligned_cols=219 Identities=21% Similarity=0.281 Sum_probs=160.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC--CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE--PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+|++++||||+++++++..++..++||||++ ++|.+++.... .....+++..+..++.|++.||.|||+++ ++|
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH 131 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILH 131 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 3678999999999999999999999999997 59999886522 12346889999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+||||+||+++.++.+||+|||++....... .......+++.|+|||++.+ ..++.++||||||+++|+|++|.+||
T Consensus 132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987543221 12233467899999999876 46899999999999999999999999
Q ss_pred cccCccCccchh-hhc-------hhhhhcccccccccCCcC--------CCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 158 DLSKGQGEQNLV-SWS-------RPFLKDQKKFVHLVDPLL--------HGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 158 ~~~~~~~~~~~~-~~~-------~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
...........+ ... .+...........+.... ....+..++.++.+++.+||+.||++|||++
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 289 (317)
T 2pmi_A 210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAK 289 (317)
T ss_dssp CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 654332111100 000 000000000000000000 0001123456799999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 290 e~l~ 293 (317)
T 2pmi_A 290 QALH 293 (317)
T ss_dssp HHTT
T ss_pred HHhC
Confidence 9984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=283.52 Aligned_cols=212 Identities=28% Similarity=0.410 Sum_probs=169.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.. +..|+||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ ++|+|
T Consensus 315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrD 388 (535)
T 2h8h_A 315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 388 (535)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999876 6789999999999999999641 2346889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|||+|||++.++.+||+|||+++..... .........++..|+|||++....++.++||||||+++|+|++ |..||..
T Consensus 389 lkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 389 LRAANILVGENLVCKVADFGLARLIEDN-EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CSGGGEEECGGGCEEECCTTSTTTCCCH-HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCHhhEEEcCCCcEEEcccccceecCCC-ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999754321 1111222345678999999999999999999999999999999 8999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
...... .. .+....+...+..++..+.++|.+||..+|++|||+++|++.|+.+......
T Consensus 468 ~~~~~~---~~--------------~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 468 MVNREV---LD--------------QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp CCHHHH---HH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCHHHH---HH--------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 332110 00 0111111223456778899999999999999999999999999988765544
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=265.04 Aligned_cols=194 Identities=28% Similarity=0.393 Sum_probs=159.8
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
++||||+++++++.+++.+|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||||+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 147 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD 147 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChh
Confidence 4899999999999999999999999999999999965 357899999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccC
Q 024460 85 NILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQG 164 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~ 164 (267)
||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|.+||.......
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999987532221 22344578999999999999999999999999999999999999996433211
Q ss_pred ccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 024460 165 EQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 225 (267)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-ev~~ 225 (267)
.. . .... .. ..++..++.++.++|.+||..+|++||++. ++++
T Consensus 226 ~~---~---~i~~--------~~----~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 226 LF---H---SIRM--------DN----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HH---H---HHHH--------CC----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HH---H---HHHh--------CC----CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 10 0 0000 00 112344567899999999999999999998 6654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=261.90 Aligned_cols=203 Identities=27% Similarity=0.385 Sum_probs=160.1
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++ +||||+++++++.+++.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 64 ~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 136 (345)
T 3a8x_A 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDL 136 (345)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 344 899999999999999999999999999999999965 357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 137 kp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 137 KLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp CGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred CHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 9999999999999999999987532221 22344578999999999999999999999999999999999999996432
Q ss_pred ccCccc--hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH------HHHHH
Q 024460 162 GQGEQN--LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI------NDIVV 225 (267)
Q Consensus 162 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~------~ev~~ 225 (267)
...... ........ +... .-.++..++.++.++|.+||+.+|++||++ +|+++
T Consensus 215 ~~~~~~~~~~~~~~~~---------i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQV---------ILEK--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp C-------CHHHHHHH---------HHHC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred cccccccccHHHHHHH---------HHcC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 211100 00000000 0000 012344567789999999999999999996 56665
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.08 Aligned_cols=214 Identities=25% Similarity=0.304 Sum_probs=148.8
Q ss_pred CCCCC-CCCccceeeEEe--------eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 2 LSLLH-HDNLVTLIGYCT--------SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~--------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
|+++. ||||+++++++. ....+++||||+. |+|.+++.... ....+++..++.++.|++.||.|||+++
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34554 999999999984 3445899999995 69998886422 3456999999999999999999999874
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcc----------eeeecccccceeCCccc---ccCCCcccCC
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH----------VSTRVMGTYGYCAPEYA---MSGKLTLKSD 139 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~---~~~~~~~~~D 139 (267)
.+++|+||||+||+++.++.++|+|||++.......... ......+++.|+|||++ .+..++.++|
T Consensus 157 -~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D 235 (337)
T 3ll6_A 157 -PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235 (337)
T ss_dssp -SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHH
T ss_pred -CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh
Confidence 239999999999999999999999999997643322111 11134578899999998 5667899999
Q ss_pred eeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC
Q 024460 140 IYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 140 v~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
|||||+++|+|++|..||....... ..........+..++..+.+++.+||+.+|.+|||
T Consensus 236 v~slG~il~el~~g~~p~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 295 (337)
T 3ll6_A 236 IWALGCILYLLCFRQHPFEDGAKLR--------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLS 295 (337)
T ss_dssp HHHHHHHHHHHHHSSCCC--------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHHHHhCCCCCcchhHHH--------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcC
Confidence 9999999999999999996332110 11111111112233445889999999999999999
Q ss_pred HHHHHHHHHHhhhccCCCC
Q 024460 220 INDIVVALDYLVSQRDSHP 238 (267)
Q Consensus 220 ~~ev~~~l~~l~~~~~~~~ 238 (267)
++|+++.|+.+.......+
T Consensus 296 ~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 296 IAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp HHHHHHHHHHHHHHTTCCT
T ss_pred HHHHHHHHHHHHhccCCCC
Confidence 9999999999988765543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=259.45 Aligned_cols=200 Identities=26% Similarity=0.289 Sum_probs=160.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~di 141 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDL 141 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999964 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDF----NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+|+||+++.++ .++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 142 kp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp SGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred ChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 99999998877 79999999987543221 223346899999999999899999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........... ..... ..........++..+.++|.+||..+|++|||++|+++
T Consensus 219 ~~~~~~~~~~~------i~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 219 LGDTKQETLAN------ITSVS--------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCSSHHHHHHH------HHTTC--------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHH------HHhcc--------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 64322111000 00000 00000011234567999999999999999999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=263.67 Aligned_cols=200 Identities=24% Similarity=0.315 Sum_probs=158.3
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++++++.+++..|+||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+||||+|
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~N 146 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSN 146 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHH
Confidence 799999999999999999999999999999999964 457999999999999999999999999 9999999999
Q ss_pred EEEcCC----CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 86 ILLDND----FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 86 ili~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
|++... +.++|+|||++....... .......+++.|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 147 Il~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 147 ILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp EEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred EEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 998533 359999999987543222 12334567999999999988889999999999999999999999997433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......+... ..... ..+.......++.++.++|.+||..||++|||++++++
T Consensus 225 ~~~~~~~~~~---i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 225 DDTPEEILAR---IGSGK--------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TSCHHHHHHH---HHHCC--------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHH---HccCC--------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 2211111110 00000 00111122345778999999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=264.18 Aligned_cols=200 Identities=24% Similarity=0.326 Sum_probs=153.9
Q ss_pred CCCCCC--CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHH--DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~H--pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++| |||+++++++..++..++|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHr 132 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 132 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 445665 9999999999999999999995 57899999975 467899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----------CCCcccCCeeehHHHHH
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~i~~ 148 (267)
||||+||+++ ++.++|+|||++................|++.|+|||++.+ ..++.++||||||+++|
T Consensus 133 Dikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ 211 (343)
T 3dbq_A 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211 (343)
T ss_dssp CCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHH
T ss_pred CCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHH
Confidence 9999999997 57899999999986543333223345578999999999865 67889999999999999
Q ss_pred HHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 149 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|++|..||...... .......+++.....++...+.++.+++.+||..+|.+|||++|+++
T Consensus 212 ell~g~~pf~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 212 YMTYGKTPFQQIINQ---------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHSSCTTTTCCSH---------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCcchhhhhH---------------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 999999999632210 01111122222223334445677999999999999999999999987
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=259.43 Aligned_cols=201 Identities=21% Similarity=0.231 Sum_probs=157.7
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++ +||||+++++++..++..++||||+++++|.+++.. .....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 83 ~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Di 157 (327)
T 3lm5_A 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDL 157 (327)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcC
Confidence 344 579999999999999999999999999999999854 23567999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++. ++.++|+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 158 kp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp CGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHHEEEecCCCCCcEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999987 789999999999754322 12233568999999999999999999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+. .............++..+.++|.+||..+|.+|||++++++
T Consensus 235 ~~~~~~~~~~i~--------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 235 GEDNQETYLNIS--------------QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CSSHHHHHHHHH--------------HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCchHHHHHHH--------------hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 433211100000 00001111122345677999999999999999999999985
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=262.67 Aligned_cols=213 Identities=23% Similarity=0.179 Sum_probs=158.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCC------------------------------------
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPD------------------------------------ 45 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~------------------------------------ 45 (267)
|++++||||+++++++.+++..++||||+++++|.+++......
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 56789999999999999999999999999999999998631111
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC--ceEEeccCCcccCCCCC--Ccceeeeccccc
Q 024460 46 QEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF--NPKLSDFGLAKLGPVGD--NTHVSTRVMGTY 121 (267)
Q Consensus 46 ~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~--~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 121 (267)
...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||++....... .........+++
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 122356778899999999999999999 99999999999998766 89999999987532211 111234456899
Q ss_pred ceeCCccccc--CCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHH
Q 024460 122 GYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCL 199 (267)
Q Consensus 122 ~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (267)
.|+|||++.+ ..++.++||||||+++|+|++|..||.......... ...... ..........++
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~~~~~~--------~~~~~~~~~~~~ 304 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTIS------QVLNKK--------LCFENPNYNVLS 304 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCC--------CCTTSGGGGGSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHH------HHHhcc--------cccCCcccccCC
Confidence 9999999865 678899999999999999999999996443211110 000000 000001112356
Q ss_pred HHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhh
Q 024460 200 NYAVAVTAMCLNEEANFRPLINDIVV--ALDYLV 231 (267)
Q Consensus 200 ~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~ 231 (267)
..+.++|.+||..+|.+|||++++++ .++.+.
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 78999999999999999999999997 455443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=252.78 Aligned_cols=195 Identities=22% Similarity=0.250 Sum_probs=158.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.|+.|||+++ ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 132 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDL 132 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5788999999999999999999999999999999998865 456899999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||++ +.++.++|+|||++...... .......+++.|+|||++.+ .++.++|+||||+++|+|++|..||.
T Consensus 133 kp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCcEEEEecccceeccCc---cchhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCC
Confidence 9999999 77889999999998754322 22334568999999998765 48999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcH----HHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPR----RCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+. . ... ..+. .++..+.+++.+||+.+|++|||+.++++
T Consensus 209 ~~~~~~~~~~~~------~----------~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 209 APTDSEVMLKIR------E----------GTF--TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp CSSHHHHHHHHH------H----------CCC--CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCHHHHHHHHH------h----------CCC--CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 433211100000 0 000 0111 34678999999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=257.10 Aligned_cols=198 Identities=27% Similarity=0.343 Sum_probs=162.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 145 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEK---KIHRDI 145 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 567899999999999999999999999999999999994 357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 146 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 146 KAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 9999999999999999999987543221 12234567899999999999999999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
....... .. ....+ ..+..++..+.+++.+||..+|.+|||++++++.
T Consensus 224 ~~~~~~~-------~~------~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 224 PMKVLFL-------IP------KNNPP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHH-------HH------HSCCC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHHHH-------hh------cCCCC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2111000 00 00011 1233456779999999999999999999999973
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=253.73 Aligned_cols=200 Identities=21% Similarity=0.218 Sum_probs=160.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+++ ++|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 131 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNL 131 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCC
Confidence 5678999999999999999999999999999999988865 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc---eEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFN---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.++. ++|+|||++...... .......+++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 132 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 132 KPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCcEEEeeceeeEEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 999999976554 999999998754322 22233568999999999999999999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+. .... .........++.++.+++.+||+.+|++|||++|+++
T Consensus 209 ~~~~~~~~~~~~------~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 209 DEDQHRLYAQIK------AGAY--------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CSSHHHHHHHHH------HTCC--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCchhHHHHHHH------hccc--------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 433211100000 0000 0000111345677999999999999999999999997
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=255.13 Aligned_cols=191 Identities=17% Similarity=0.195 Sum_probs=153.9
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
+||||+++++++..++..++||||+++++|.+++.........+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~N 145 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSN 145 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHH
Confidence 8999999999999999999999999999999999763333467899999999999999999999999 9999999999
Q ss_pred EEEcC-------------------CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHH
Q 024460 86 ILLDN-------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGV 145 (267)
Q Consensus 86 ili~~-------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~ 145 (267)
|+++. ...++|+|||.+...... ....++..|+|||++.+. .++.++||||||+
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALAL 219 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHH
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHH
Confidence 99984 347999999998754322 123488999999998765 6678999999999
Q ss_pred HHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 146 VLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 146 i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
++|+|++|.+++..... .. .. ... .....+..++.++.+++.+||..+|++|||++++++
T Consensus 220 il~~l~~~~~~~~~~~~-----~~-----~~------~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 220 TVVCAAGAEPLPRNGDQ-----WH-----EI------RQG----RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHTTCCCCCSSSHH-----HH-----HH------HTT----CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCCCcchhH-----HH-----HH------HcC----CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 99999999887642210 00 00 000 001223455678999999999999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=263.56 Aligned_cols=229 Identities=17% Similarity=0.160 Sum_probs=171.9
Q ss_pred CCCCCCCCccc---------------eeeEEee-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVT---------------LIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65 (267)
Q Consensus 2 l~~l~Hpniv~---------------~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l 65 (267)
|++++||||++ +++++.. ++..|+||||+ +++|.+++... ....+++..++.++.|++.||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L 172 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDAL 172 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHH
Confidence 45567777776 6777776 77899999999 89999999752 246799999999999999999
Q ss_pred HHhhhcCCCCeeeCCCCCCcEEEcCCC--ceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccC
Q 024460 66 EYLHCKANPPVIYRDLKSANILLDNDF--NPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKS 138 (267)
Q Consensus 66 ~~lH~~~~~~i~h~di~~~nili~~~~--~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~ 138 (267)
.|||+++ ++|+||||+||+++.++ .++|+|||++......... .......+++.|+|||++.+..++.++
T Consensus 173 ~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (352)
T 2jii_A 173 EFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS 249 (352)
T ss_dssp HHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH
T ss_pred HHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchh
Confidence 9999999 99999999999999888 8999999999754322111 111234689999999999998999999
Q ss_pred CeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 139 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 139 Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
||||||+++|+|++|..||........ .+......... ......... .....++.++.+++.+||..+|++||
T Consensus 250 Di~slG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 250 DLQSLGYCMLKWLYGFLPWTNCLPNTE-DIMKQKQKFVD---KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCHH-HHHHHHHHHHH---SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred hHHHHHHHHHHHHhCCCCcccCCcCHH-HHHHHHHhccC---Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCC
Confidence 999999999999999999975432111 11111110100 000111100 00123467899999999999999999
Q ss_pred CHHHHHHHHHHhhhccCCCCCcCCC
Q 024460 219 LINDIVVALDYLVSQRDSHPVSRNA 243 (267)
Q Consensus 219 t~~ev~~~l~~l~~~~~~~~~~~~~ 243 (267)
|+++|++.|+++..........+..
T Consensus 323 s~~~l~~~L~~~~~~~~~~~~~~~d 347 (352)
T 2jii_A 323 PYAMLRNNLEALLQDLRVSPYDPIG 347 (352)
T ss_dssp CHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred CHHHHHHHHHHHHHhcCCCcCcccc
Confidence 9999999999999888766544433
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=256.81 Aligned_cols=181 Identities=22% Similarity=0.258 Sum_probs=138.3
Q ss_pred eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCC
Q 024460 22 QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101 (267)
Q Consensus 22 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~ 101 (267)
..++|||||++++|.+++.... ......+..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 210 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRC-SLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL 210 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEEecCCCCHHHHHhccc-CccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCc
Confidence 3899999999999999997633 2334566778999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCCc----------ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhh
Q 024460 102 AKLGPVGDNT----------HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 171 (267)
Q Consensus 102 ~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~ 171 (267)
+......... .......+++.|+|||++.+..++.++||||||+++|+|++|..|+.....
T Consensus 211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--------- 281 (332)
T 3qd2_B 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--------- 281 (332)
T ss_dssp CEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH---------
T ss_pred ccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH---------
Confidence 8764332211 112334689999999999999999999999999999999998776531100
Q ss_pred chhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 172 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... .......+..+.+++.+||..+|++|||++|+++
T Consensus 282 ---------~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 282 ---------IITDVRNLKF-PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ---------HHHHHHTTCC-CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ---------HHHHhhccCC-CcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0000000000 0012345677899999999999999999999985
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=264.28 Aligned_cols=226 Identities=19% Similarity=0.206 Sum_probs=169.4
Q ss_pred CCCCCCCCccceeeEEeeCC--eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++...+ ..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++ ++|+
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 136 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEC
Confidence 56789999999999998755 7899999999999999997532 2234999999999999999999999999 9999
Q ss_pred CCCCCcEEE----cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc--------CCCcccCCeeehHHHH
Q 024460 80 DLKSANILL----DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--------GKLTLKSDIYSFGVVL 147 (267)
Q Consensus 80 di~~~nili----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~ 147 (267)
||||+||++ +.++.+||+|||++...... .......++..|+|||++.+ ..++.++||||||+++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp CCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 999999999 77778999999999754322 12233568999999998865 4678899999999999
Q ss_pred HHHHhCCCCccccCccCcc-chhhhchhhh-hc---------ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC
Q 024460 148 LELITGRKAMDLSKGQGEQ-NLVSWSRPFL-KD---------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~-~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
|+|++|..||......... .......... .. ...+.-.-.......++..++..+.+++++||..||++
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~ 293 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEK 293 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTT
T ss_pred HHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhh
Confidence 9999999999644322211 1110000000 00 00000000011122345788899999999999999999
Q ss_pred CCCHHHHHHHHHHhhhcc
Q 024460 217 RPLINDIVVALDYLVSQR 234 (267)
Q Consensus 217 Rpt~~ev~~~l~~l~~~~ 234 (267)
|||++++++.++.+..+.
T Consensus 294 R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 294 CWGFDQFFAETSDILHRM 311 (396)
T ss_dssp SCCHHHHHHHHHHHHTCE
T ss_pred hccHHHHHHHHHHHhhce
Confidence 999999999998876653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=255.57 Aligned_cols=201 Identities=24% Similarity=0.299 Sum_probs=163.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 151 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDI 151 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCc
Confidence 5688999999999999999999999999999999999864 3567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 152 KAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543221 12234568899999999999899999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... ... ....+ ....+..++..+.+++.+||..+|.+|||++++++
T Consensus 230 ~~~~~~-------~~~------~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 230 PMRAIF-------MIP------TNPPP--TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HHHHHH-------HHH------HSCCC--CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hHHHHH-------HHh------cCCCc--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 211100 000 00000 11123455778999999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=262.38 Aligned_cols=195 Identities=28% Similarity=0.365 Sum_probs=157.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dl 180 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 180 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 567899999999999999999999999996 588888864 3467899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
||+||+++.++.++|+|||++..... .....|++.|+|||++. ...++.++||||||+++|+|++|.+||.
T Consensus 181 kp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 181 KAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999875321 12346899999999885 4678999999999999999999999986
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ ..... ...+ ...+..++..+.++|.+||..+|++|||++++++
T Consensus 255 ~~~~~~~~------~~~~~-------~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 255 NMNAMSAL------YHIAQ-------NESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp TSCHHHHH------HHHHH-------SCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCChHHHH------HHHHh-------cCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 43321110 00000 0001 1112345677999999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=257.62 Aligned_cols=215 Identities=22% Similarity=0.256 Sum_probs=157.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dl 128 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDV 128 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 5678999999999999999999999999999999888754 466899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+||||+++|+|++|.+||...
T Consensus 129 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 129 KPENILITKHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChhhEEEcCCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999997643222 22234567899999999876 57899999999999999999999999654
Q ss_pred CccCccchhhhc--------hhhhhccccccc--ccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWS--------RPFLKDQKKFVH--LVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~--------~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
............ ............ ..++...... ...++..+.+++.+||..||++|||++|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 432221111000 000000000000 0000000000 0234667899999999999999999999996
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=273.71 Aligned_cols=203 Identities=28% Similarity=0.392 Sum_probs=164.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+||||+++|+|.+++... ....+++..+..++.||+.||.|||+++ ++|+|
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrD 311 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRD 311 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccC
Confidence 356789999999999999999999999999999999999752 2345999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.+||+|||++...... .......|++.|+|||++.+..++.++|+||||+++|+|++|.+||...
T Consensus 312 LKPeNILld~~g~vKL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 312 LKPENILLDDHGHIRISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred CchheEEEeCCCCeEEEecccceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999999754322 1233457899999999999989999999999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
........+. ..... ....++..++.++.++|.+||+.||.+|| +++|+++
T Consensus 389 ~~~~~~~~i~--~~i~~------------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 389 KKKIKREEVE--RLVKE------------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SSCCCHHHHH--HHHHH------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccchhHHHHH--HHhhc------------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 3221110000 00000 01122345577899999999999999999 7888886
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=265.97 Aligned_cols=200 Identities=24% Similarity=0.316 Sum_probs=153.7
Q ss_pred CCCCC--CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLH--HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++ ||||+++++++..++.+|+||| +.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHr 179 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCC
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 34454 5999999999999999999999 557899999975 357888999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----------CCCcccCCeeehHHHHH
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~i~~ 148 (267)
||||+|||++ ++.+||+|||++................|++.|+|||++.+ ..++.++||||||+++|
T Consensus 180 Dlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ 258 (390)
T 2zmd_A 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258 (390)
T ss_dssp CCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence 9999999995 57899999999986433322222344568999999999865 36889999999999999
Q ss_pred HHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 149 ELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 149 ~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|++|.+||....... ..+...+++.....++...+.++.++|.+||..+|++|||++|+++
T Consensus 259 ell~G~~Pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 259 YMTYGKTPFQQIINQI---------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHSSCTTTTCCCHH---------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCcchhhhHHH---------------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 9999999996322110 0111112222222233344677999999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.76 Aligned_cols=205 Identities=26% Similarity=0.385 Sum_probs=165.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++...+.+|+||||+++|+|.+++.........+++..+..++.||+.||.|||+++ ++|+||
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDL 315 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDL 315 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCC
Confidence 56789999999999999999999999999999999999764444567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.+||+|||++....... .......|++.|+|||++.+..++.++|+||||+++|+|++|.+||....
T Consensus 316 KP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 316 KPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999997643222 12233478999999999999999999999999999999999999997543
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~ev~~ 225 (267)
...... ........ . ...++..++.++.++|.+||..+|++||++ +++++
T Consensus 394 ~~~~~~--~~~~~i~~----------~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 394 EKVENK--ELKQRVLE----------Q--AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCHH--HHHHHHHH----------C--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cchhHH--HHHHHHhh----------c--ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 211110 00000110 0 012344567889999999999999999975 66664
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=257.34 Aligned_cols=207 Identities=24% Similarity=0.270 Sum_probs=153.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
++.++||||+++++++..++..++||||++ ++|.+++.........+++..++.++.|++.||.|||++ + ++|+|
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 135 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRD 135 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCC
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 567899999999999999999999999997 488887765434567899999999999999999999998 8 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccc----ccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||+||+++.++.++|+|||++...... .......+++.|+|||++ ....++.++|+||||+++|+|++|..|
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999998753222 223334688999999996 456788999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHh
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 230 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l 230 (267)
|........ . .............+..++.++.+++.+||..+|++|||++|+++ .++..
T Consensus 213 ~~~~~~~~~----~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 213 YDSWGTPFQ----Q-----------LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp SCCCSCHHH----H-----------HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ccccCchHH----H-----------HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 963221100 0 00000011111112345678999999999999999999999997 44443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=252.44 Aligned_cols=210 Identities=25% Similarity=0.309 Sum_probs=164.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 134 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDL 134 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5678999999999999999999999999999999999964 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 82 KSANILLDNDF----NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 82 ~~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
+|+||+++.++ .++|+|||++....... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 135 ~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 135 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp SGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 99999998776 79999999987543221 223345889999999999889999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhhhccC
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVSQRD 235 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~~~~~ 235 (267)
...........+. . ............++..+.+++.+||..+|++|||++++++ .++++..+..
T Consensus 212 ~~~~~~~~~~~~~------~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~ 277 (283)
T 3bhy_A 212 LGETKQETLTNIS------A--------VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277 (283)
T ss_dssp CCSSHHHHHHHHH------T--------TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCCC
T ss_pred CCcchHHHHHHhH------h--------cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHhh
Confidence 6433211100000 0 0000000011234567999999999999999999999998 5777765543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=255.58 Aligned_cols=197 Identities=24% Similarity=0.334 Sum_probs=162.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.|+.|||+++ ++|+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 141 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 141 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5688999999999999999999999999999999998864 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 142 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 142 KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643222 12333567899999999998889999999999999999999999996443
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... .. ... ....+..++..+.+++.+||+.+|++|||++++++
T Consensus 220 ~~~~~~------~~----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 220 LKETYL------RI----------KKN--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp HHHHHH------HH----------HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHH------HH----------hhc--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 211100 00 000 01123445677999999999999999999999997
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=261.30 Aligned_cols=197 Identities=25% Similarity=0.340 Sum_probs=162.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.+++..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dl 167 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 167 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCC
Confidence 5788999999999999999999999999999999998864 357899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 168 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 168 KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999999999999999999987643222 12334568899999999999899999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... .... . ....+..++..+.++|.+||+.||++|||++|+++
T Consensus 246 ~~~~~~------~~~~-~-----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 246 LKETYL------RIKK-N-----------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp HHHHHH------HHHH-T-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred HHHHHH------HHhc-C-----------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 211100 0000 0 00123345677899999999999999999999997
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=254.31 Aligned_cols=213 Identities=21% Similarity=0.236 Sum_probs=157.7
Q ss_pred CCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 4 LLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
.++||||+++++++.... .+++||||+. ++|.+++... ....+++..+..++.|++.||+|||+++ ++|
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH 143 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVH 143 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 346999999999998765 5899999996 5999999762 2345999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+||||+||+++.++.++|+|||++...... .......+++.|+|||++.+..++.++||||||+++|+|++|.+||.
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999754222 22334567999999999999999999999999999999999999996
Q ss_pred ccCccCccchh-hhchh----hhhcccccc-cccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLV-SWSRP----FLKDQKKFV-HLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~-~~~~~----~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+ ..... .+....... ....+..... ....++..+.++|.+||+.||++|||++|+++
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 221 GNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 54322111100 00000 000000000 0000000000 01234678899999999999999999999984
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=256.16 Aligned_cols=217 Identities=25% Similarity=0.306 Sum_probs=164.4
Q ss_pred CCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh--------hc
Q 024460 4 LLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--------CK 71 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--------~~ 71 (267)
.++||||+++++++...+ ..++||||+++++|.+++.. ..+++..++.++.|++.||.||| +.
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 166 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence 379999999999998776 78999999999999999964 46899999999999999999999 78
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcc--eeeecccccceeCCcccccC------CCcccCCeeeh
Q 024460 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMSG------KLTLKSDIYSF 143 (267)
Q Consensus 72 ~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~Dv~sl 143 (267)
+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++.+. .++.++|||||
T Consensus 167 ~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 243 (342)
T 1b6c_B 167 A---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 243 (342)
T ss_dssp E---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHH
T ss_pred C---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHH
Confidence 8 9999999999999999999999999987533222111 12334689999999998765 23478999999
Q ss_pred HHHHHHHHhC----------CCCccccCccCccchhhhchhhhhcccccccccCCcCCCC-CcHHHHHHHHHHHHhhccc
Q 024460 144 GVVLLELITG----------RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR-YPRRCLNYAVAVTAMCLNE 212 (267)
Q Consensus 144 G~i~~~~l~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~ 212 (267)
|+++|+|++| ..||......... ...+.... ......+.+... ....++..+.+++.+||..
T Consensus 244 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 316 (342)
T 1b6c_B 244 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS-VEEMRKVV------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316 (342)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHHHHH------TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHhccCcCCcccccccCccccCcCccc-HHHHHHHH------HHHHhCCCCcccccchhHHHHHHHHHHHHhcc
Confidence 9999999999 5565432211110 00000000 001111111111 1236778999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhhhccC
Q 024460 213 EANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 213 ~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
+|++|||+++|++.|+.+.++..
T Consensus 317 dp~~Rps~~~i~~~L~~i~~~~~ 339 (342)
T 1b6c_B 317 NGAARLTALRIKKTLSQLSQQEG 339 (342)
T ss_dssp SGGGSCCHHHHHHHHHHHHHTTC
T ss_pred ChhhCCCHHHHHHHHHHHHHHhc
Confidence 99999999999999999988764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=280.86 Aligned_cols=208 Identities=22% Similarity=0.336 Sum_probs=164.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++. ++..|+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||
T Consensus 445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDi 517 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDI 517 (656)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 56789999999999985 4568999999999999999975 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 518 kp~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 518 AARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp SGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999986432221 12223446788999999998999999999999999999997 99998643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
..... ... . ........+..++..+.+++.+||..+|++|||+++|++.|+.+...+
T Consensus 597 ~~~~~---~~~---i-----------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 597 KNNDV---IGR---I-----------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp CHHHH---HHH---H-----------HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHH---HHH---H-----------HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 32111 000 0 000111234566788999999999999999999999999999886543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=258.31 Aligned_cols=207 Identities=25% Similarity=0.299 Sum_probs=160.2
Q ss_pred CCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCee
Q 024460 2 LSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPVI 77 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~~i~ 77 (267)
|++++||||+++++++.. ++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+++
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv 138 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 138 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence 567899999999998743 67899999999999999999764434556999999999999999999999876 23499
Q ss_pred eCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 78 YRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 78 h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus 139 H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp CCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999987532221 1122345788999999999889999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
........ .. .... ......+..++.++.+++.+||..+|.+|||++||++.+
T Consensus 217 ~~~~~~~~---~~---~i~~-----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 217 TAFSQKEL---AG---KIRE-----------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCSSHHHH---HH---HHHH-----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cccCHHHH---HH---HHhh-----------cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 74431110 00 0000 000122345677899999999999999999999999754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=258.18 Aligned_cols=215 Identities=17% Similarity=0.197 Sum_probs=153.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++.+++||||++ ++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~D 157 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRD 157 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCC
Confidence 3678999999999999999999999999997 499999965 456899999999999999999999999 99999
Q ss_pred CCCCcEEEc-----CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLD-----NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|||+||+++ ..+.++|+|||++...... ........++..|+|||++.+. .++.++||||||+++|+|++|.
T Consensus 158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 235 (329)
T 3gbz_A 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235 (329)
T ss_dssp CCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999994 4556999999998753221 1122334568999999998874 5899999999999999999999
Q ss_pred CCccccCccCccchhhhc--h------hhhhcccccccccCCcCCC----CCcHHHHHHHHHHHHhhcccCCCCCCCHHH
Q 024460 155 KAMDLSKGQGEQNLVSWS--R------PFLKDQKKFVHLVDPLLHG----RYPRRCLNYAVAVTAMCLNEEANFRPLIND 222 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 222 (267)
+||...........+... . ................... ..+..++.++.++|.+||+.||++|||++|
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 315 (329)
T 3gbz_A 236 PLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKN 315 (329)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHH
Confidence 999654322111000000 0 0000000000000000000 011224678999999999999999999999
Q ss_pred HHH
Q 024460 223 IVV 225 (267)
Q Consensus 223 v~~ 225 (267)
+++
T Consensus 316 ~l~ 318 (329)
T 3gbz_A 316 ALE 318 (329)
T ss_dssp HHT
T ss_pred HhC
Confidence 983
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=265.45 Aligned_cols=203 Identities=21% Similarity=0.183 Sum_probs=159.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||++++++|.+++.+|+||||+++|+|.+++.. .+..+++..+..++.|++.||.|||+++ ++||||
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDL 188 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDI 188 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence 4568999999999999999999999999999999999975 3457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-------cCCCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-------SGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
||+|||++.++.+||+|||++........ .......|++.|+|||++. ...++.++|+||||+++|+|++|.
T Consensus 189 Kp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 189 KPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 99999999999999999999975432221 1223357899999999987 356899999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCC---CCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR---PLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---pt~~ev~~ 225 (267)
+||...........+ ..... ....+. .+..++.++.++|++||+ +|.+| |+++|+++
T Consensus 268 ~Pf~~~~~~~~~~~i------~~~~~---~~~~p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 268 TPFYADSTAETYGKI------VHYKE---HLSLPL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp CTTCCSSHHHHHHHH------HTHHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred CCCCCCCHHHHHHHH------Hhccc---CcCCCc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 999644321111000 00000 000010 123456789999999999 99998 59999986
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=253.49 Aligned_cols=195 Identities=23% Similarity=0.327 Sum_probs=161.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.|+.|||+++ ++|+||
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 140 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDI 140 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5688999999999999999999999999999999999965 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||||+++|+|++|..||....
T Consensus 141 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 141 KPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999998643221 1233567899999999999999999999999999999999999996433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ... ... ...++..++.++.+++.+||..+|.+|||++++++
T Consensus 217 ~~~~~------~~~----------~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 217 HTETH------RRI----------VNV--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp HHHHH------HHH----------HTT--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhHHH------HHH----------hcc--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 21110 000 000 01123445678999999999999999999999997
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=251.47 Aligned_cols=196 Identities=24% Similarity=0.325 Sum_probs=153.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 137 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDL 137 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCC
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999965 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++...... .......+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...
T Consensus 138 ~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 138 KPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChhhEEECCCCCEEEeecccccccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998754322 12233467889999999987765 68999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .. .... . ....+..++..+.+++.+||+.+|++|||++++++
T Consensus 215 ~~~~~---~~---~~~~-~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 215 HVPTL---FK---KIRG-G-----------VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SHHHH---HH---HHHH-C-----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cHHHH---HH---Hhhc-C-----------cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 21110 00 0000 0 00123345677999999999999999999999997
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=256.94 Aligned_cols=207 Identities=15% Similarity=0.128 Sum_probs=166.8
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-DQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
..|+||+++++++..++..|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||+++ ++|+||||
T Consensus 124 ~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp 200 (365)
T 3e7e_A 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKP 200 (365)
T ss_dssp GGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSG
T ss_pred hhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCH
Confidence 3499999999999999999999999999999999974322 3567999999999999999999999999 99999999
Q ss_pred CcEEEcC-----------CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 84 ANILLDN-----------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 84 ~nili~~-----------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
+|||++. ++.+||+|||++................|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 201 ~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt 280 (365)
T 3e7e_A 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280 (365)
T ss_dssp GGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred HHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 9999988 88999999999964332233334455678999999999999999999999999999999999
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCC-CCHHHHHHHHHHhh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFR-PLINDIVVALDYLV 231 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-pt~~ev~~~l~~l~ 231 (267)
|..||....... .. +...+... .....+.+++..||+.+|.+| |+++++.+.|+.+.
T Consensus 281 g~~pf~~~~~~~---------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 281 GTYMKVKNEGGE---------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp SSCCCEEEETTE---------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCccccCCCCc---------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 999985322100 00 11111111 125568899999999999999 68888999998877
Q ss_pred hccCC
Q 024460 232 SQRDS 236 (267)
Q Consensus 232 ~~~~~ 236 (267)
+....
T Consensus 339 ~~~~~ 343 (365)
T 3e7e_A 339 QQHYT 343 (365)
T ss_dssp HHHTT
T ss_pred HHhhh
Confidence 76543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.62 Aligned_cols=200 Identities=25% Similarity=0.285 Sum_probs=158.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++...+.+|+|||||.+++|.+.+.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~D 146 (486)
T 3mwu_A 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146 (486)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 36778999999999999999999999999999999998865 457999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++ .++.++|+|||++...... .......|++.|+|||++.+ .++.++||||||+++|+|++|.+||
T Consensus 147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CchHHEEEecCCCCCCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999995 4567999999998753222 22334568999999999875 5899999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...........+. . .. ..........++.++.++|.+||..+|.+|||++++++
T Consensus 223 ~~~~~~~~~~~i~------~--~~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 223 YGKNEYDILKRVE------T--GK------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CCSSHHHHHHHHH------H--TC------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHH------h--CC------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 6433211100000 0 00 00000111345678999999999999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=255.14 Aligned_cols=214 Identities=26% Similarity=0.358 Sum_probs=159.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE----PDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
+|++++||||+++++++..++..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++ +
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 142 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---Q 142 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 4778999999999999999999999999999999999986421 12456899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCC---cceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHh
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN---THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~ 152 (267)
+|+||+|+||+++.++.++|+|||++........ ........+++.|+|||++.. ..++.++|+||||+++|+|++
T Consensus 143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999865432211 111233467899999998875 568999999999999999999
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|..||........... ... ..................++.++.+++.+||..+|.+|||++++++
T Consensus 223 g~~pf~~~~~~~~~~~------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 223 GAAPYHKYPPMKVLML------TLQ--NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SSCTTTTSCGGGHHHH------HHT--SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCccCchhhHHHH------Hhc--cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999975432211100 000 0000000000011122345677999999999999999999999996
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=261.11 Aligned_cols=215 Identities=23% Similarity=0.378 Sum_probs=158.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dl 150 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDI 150 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCc
Confidence 5678999999999999999999999999999888887643 457999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+. .++.++||||||+++|+|++|.+||...
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 151 KPENILVSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChheEEEcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987532221 223345678999999998875 7899999999999999999999999754
Q ss_pred CccCccchhh-h-------chhhhhcccccccccCCcCCCCCc-----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVS-W-------SRPFLKDQKKFVHLVDPLLHGRYP-----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~-~-------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........+. . ................+......+ ..++..+.+++.+||..||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 4322111000 0 000000011111111111111111 245678999999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=262.02 Aligned_cols=214 Identities=22% Similarity=0.296 Sum_probs=160.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~ 79 (267)
+|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.++.|||+. + ++|+
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~ 156 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHR 156 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcC
Confidence 46789999999999999999999999999999999999965 35689999999999999999999985 8 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
||||+||+++.++.++|+|||++.... ........+++.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 157 dlkp~Nil~~~~~~~kl~Dfg~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 157 DVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHH----HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CccHHHEEECCCCCEEEEECCCCcccc----cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986321 1122334678999999999999999999999999999999999999964
Q ss_pred cCccCccchhhhc----------------hh------hhhcc----cccccccCCcCCCCCcHHHHHHHHHHHHhhcccC
Q 024460 160 SKGQGEQNLVSWS----------------RP------FLKDQ----KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 213 (267)
Q Consensus 160 ~~~~~~~~~~~~~----------------~~------~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 213 (267)
............. .. ..... ...............+..++.++.++|.+||..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence 3321110000000 00 00000 0000000001111112335678999999999999
Q ss_pred CCCCCCHHHHHH
Q 024460 214 ANFRPLINDIVV 225 (267)
Q Consensus 214 p~~Rpt~~ev~~ 225 (267)
|++|||++|+++
T Consensus 313 P~~Rpt~~ell~ 324 (360)
T 3eqc_A 313 PAERADLKQLMV 324 (360)
T ss_dssp TTTSCCHHHHHT
T ss_pred hhhCCCHHHHhh
Confidence 999999999997
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=270.34 Aligned_cols=205 Identities=24% Similarity=0.276 Sum_probs=161.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++...+.+|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 161 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRD 161 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 36789999999999999999999999999999999998864 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDND---FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++.. +.+||+|||++...... .......|++.|+|||++. ..++.++||||||+++|+|++|.+||
T Consensus 162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChhhEEEeCCCCCCcEEEEECCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99999999754 45999999998754322 2233456899999999876 57999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHh
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYL 230 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l 230 (267)
...........+... .. .... .....++..+.++|.+||..+|.+|||++++++ -++..
T Consensus 238 ~~~~~~~~~~~i~~~------~~---~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 238 GGQTDQEILRKVEKG------KY---TFDS-----PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp CCSSHHHHHHHHHHT------CC---CCCS-----GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCCCHHHHHHHHHhC------CC---CCCc-----hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 754321111000000 00 0000 011244677999999999999999999999997 35444
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=252.88 Aligned_cols=203 Identities=25% Similarity=0.311 Sum_probs=159.4
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 148 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDI 148 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCC
Confidence 567899999999999999999999999999999999997622 2345678889999999999999999999 999999
Q ss_pred CCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC--CcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++. ++.++|+|||++....... .......++..|+|||++.+.. ++.++|+||||+++|+|++|..||.
T Consensus 149 ~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 149 KGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp SGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred ChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 999999987 8899999999987543221 1223456789999999987643 7899999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ ... . . .. ......+..++.++.+++.+||..+|++|||++++++
T Consensus 227 ~~~~~~~~-~~~--~-~-------~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 227 ELGEPQAA-MFK--V-G-------MF----KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp GGSSHHHH-HHH--H-H-------HH----CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred CCCchhHH-HHh--h-c-------cc----cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 43211100 000 0 0 00 0111224456778999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=250.90 Aligned_cols=200 Identities=23% Similarity=0.259 Sum_probs=157.0
Q ss_pred CCCCCCCCccceeeEE--eeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYC--TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~--~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
|++++||||+++++++ ..++..++||||++++ |.+++... ....+++..+..++.|++.||.|||+++ ++|+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~ 133 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHK 133 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 6789999999999998 4456889999999875 77777652 3567999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC--CcccCCeeehHHHHHHHHhCCCCc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||+|+||+++.++.++|+|||++................++..|+|||++.+.. ++.++||||||+++|+|++|..||
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999997654333333344566899999999987644 377999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ..... . .-..+..++..+.+++.+||..||.+|||++|+++
T Consensus 214 ~~~~~~~~~------~~i~~-~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 214 EGDNIYKLF------ENIGK-G-----------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCSSHHHHH------HHHHH-C-----------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCchHHHHH------HHHhc-C-----------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 743211100 00000 0 00123455678999999999999999999999997
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=264.32 Aligned_cols=199 Identities=23% Similarity=0.301 Sum_probs=149.9
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++.. +..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+||
T Consensus 194 l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDl 265 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDL 265 (419)
T ss_dssp HHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 567899999999999864 468999999999999998854 567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC---ceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCC
Q 024460 82 KSANILLDNDF---NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 82 ~~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
||+||+++.++ .+||+|||++..... ........|++.|+|||++.. ..++.++|+||||+++|+|++|.+
T Consensus 266 kp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 266 KPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp CGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred ChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999997544 599999999985432 222334568999999999853 578899999999999999999999
Q ss_pred CccccCccCccc-hhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQN-LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||.......... .+... ... .. + .....++..+.+++.+||..+|++|||++|+++
T Consensus 343 pf~~~~~~~~~~~~i~~~------~~~---~~-~----~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSG------KYN---FI-P----EVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp SSCCCSSSCCHHHHHHTT------CCC---CC-H----HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcchHHHHHHHhcC------CCC---CC-c----hhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 997443221110 00000 000 00 0 001234677999999999999999999999986
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=250.02 Aligned_cols=200 Identities=26% Similarity=0.393 Sum_probs=156.7
Q ss_pred CCCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
+|++++||||+++++++.. +..+++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ .++
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i 152 (290)
T 1t4h_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 3678999999999999865 4568999999999999999965 366889999999999999999999875 239
Q ss_pred eeCCCCCCcEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||+|+||+++ .++.++|+|||++...... ......+++.|+|||++. ..++.++|+||||+++|+|++|..
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~ 227 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999997 7889999999998753222 223456899999999876 468999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||......... .. ...........+..++.++.+++.+||..+|++|||++++++
T Consensus 228 pf~~~~~~~~~--~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 228 PYSECQNAAQI--YR-------------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTTCSSHHHH--HH-------------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcCcHHHH--HH-------------HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99643221110 00 000000001122334567999999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=272.09 Aligned_cols=200 Identities=25% Similarity=0.296 Sum_probs=160.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++...+.+|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 151 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRD 151 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 36789999999999999999999999999999999998864 467999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||++ +.++.++|+|||++....... ......|++.|+|||++.+ .++.++||||||+++|+|++|.+||
T Consensus 152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp CCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 99999999 467889999999987543221 2233568999999998875 6899999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...........+. . .. ..........++.++.++|.+||..+|++|||++|+++
T Consensus 228 ~~~~~~~~~~~i~------~--~~------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 228 NGANEYDILKKVE------K--GK------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCSSHHHHHHHHH------H--CC------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCHHHHHHHHH------c--CC------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 7443211110000 0 00 00000111345778999999999999999999999997
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.78 Aligned_cols=200 Identities=25% Similarity=0.295 Sum_probs=159.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++.+|+|||||++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 99 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 171 (504)
T 3q5i_A 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRD 171 (504)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 36788999999999999999999999999999999998865 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC---ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDF---NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||+++.++ .++|+|||++...... .......|++.|+|||++. ..++.++||||||+++|+|++|.+||
T Consensus 172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf 247 (504)
T 3q5i_A 172 IKPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247 (504)
T ss_dssp CSGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CcHHHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCC
Confidence 999999998765 6999999999754322 1233456899999999876 56899999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...........+.... ..........++.++.++|.+||..+|.+|||++|+++
T Consensus 248 ~~~~~~~~~~~i~~~~--------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 248 GGQNDQDIIKKVEKGK--------------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCSSHHHHHHHHHHCC--------------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHHHcCC--------------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 7543211110000000 00000001234677999999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=264.89 Aligned_cols=216 Identities=19% Similarity=0.205 Sum_probs=167.3
Q ss_pred CCCCCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++.|+| ++|..+..++..++..++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+++ ++|+|
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 128 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRD 128 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 455666 66777777778888999999999 8899999975 3567999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 81 LKSANILL---DNDFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 81 i~~~nili---~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
|||+|||+ +.++.++|+|||++......... .......|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 129 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt 208 (483)
T 3sv0_A 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR 208 (483)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 99999999 57889999999999764332221 11224568999999999999999999999999999999999
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
|..||................... ....+. .+...++.++.+++..||..+|++||++++|++.|+.+..
T Consensus 209 G~~Pf~~~~~~~~~~~~~~i~~~~-----~~~~~~-----~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 209 GSLPWQGLKAGTKKQKYEKISEKK-----VATSIE-----ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp SSCTTSSCCCSSHHHHHHHHHHHH-----HHSCHH-----HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCCccccchhHHHHHHHHhhcc-----ccccHH-----HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 999997654332222111111000 000000 0012346789999999999999999999999999998865
Q ss_pred cc
Q 024460 233 QR 234 (267)
Q Consensus 233 ~~ 234 (267)
..
T Consensus 279 ~~ 280 (483)
T 3sv0_A 279 RE 280 (483)
T ss_dssp HT
T ss_pred Hc
Confidence 44
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=257.33 Aligned_cols=215 Identities=23% Similarity=0.218 Sum_probs=160.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 138 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDL 138 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCC
Confidence 5678999999999999999999999999975 89888865 4457888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|.+||...
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 139 KPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999997543221 223345679999999998654 5899999999999999999999998654
Q ss_pred CccCccch-hhh-chh---hhhcccccccccCCcCCCCC-----cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNL-VSW-SRP---FLKDQKKFVHLVDPLLHGRY-----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~-~~~-~~~---~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ ... ..+ .+.........+........ ...++.++.++|.+||..||++|||++|+++
T Consensus 217 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 217 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 32211100 000 000 00000000000000000000 1234578999999999999999999999996
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=254.87 Aligned_cols=211 Identities=23% Similarity=0.281 Sum_probs=153.3
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
++||||+++++++..++.+|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ ++|+||||+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 140 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE 140 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHH
Confidence 5799999999999999999999999999999999965 356899999999999999999999999 999999999
Q ss_pred cEEEcCCCc---eEEeccCCcccCCCCCCc-----ceeeecccccceeCCccccc-----CCCcccCCeeehHHHHHHHH
Q 024460 85 NILLDNDFN---PKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 85 nili~~~~~---~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Dv~slG~i~~~~l 151 (267)
||+++.++. ++|+|||++......... .......++..|+|||++.. ..++.++||||||+++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999987765 999999998754322111 11123458999999999875 45788999999999999999
Q ss_pred hCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCc----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 152 TGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|..||.................... ............ .++ ..++..+.+++.+||..||++|||++|+++
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQ-NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHH-HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCcccccccccccccccchhHH-HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 99999975443221100000000000 000000000000 111 134677999999999999999999999996
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=253.44 Aligned_cols=199 Identities=22% Similarity=0.304 Sum_probs=160.6
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++ ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~di 132 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDL 132 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSC
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999864 356899999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILL---DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||++ +.++.++|+|||++...... ......+++.|+|||++.+..++.++|+||||+++|+|++|..||.
T Consensus 133 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 133 KPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999 67889999999998743211 1223457899999999999999999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... .. ...... ..........++..+.+++.+||..+|++|||++++++
T Consensus 209 ~~~~~~~---~~---~i~~~~--------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 209 EETESKL---FE---KIKEGY--------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TSCHHHH---HH---HHHHCC--------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCHHHH---HH---HHHcCC--------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4321110 00 000000 00111122345678999999999999999999999987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.30 Aligned_cols=215 Identities=24% Similarity=0.334 Sum_probs=154.8
Q ss_pred CCCCC-CCCccceeeEEeeCC--eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLH-HDNLVTLIGYCTSGD--QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~--~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|+++. ||||+++++++..++ .+|+||||++ ++|..++.. ..+++..+..++.|++.||+|||+.+ ++|
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH 132 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLH 132 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEe
Confidence 45566 999999999997644 7899999997 589999854 57889999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCC-------------------CcceeeecccccceeCCccccc-CCCcccC
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGD-------------------NTHVSTRVMGTYGYCAPEYAMS-GKLTLKS 138 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~ 138 (267)
+||||+||+++.++.+||+|||+++...... .........++++|+|||++.+ ..++.++
T Consensus 133 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 212 (388)
T 3oz6_A 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212 (388)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHH
T ss_pred CCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChh
Confidence 9999999999999999999999997542210 0111233568999999999876 6789999
Q ss_pred CeeehHHHHHHHHhCCCCccccCccCccchhhhc-----------------hhhhhcccccccccCCcCCCCC-------
Q 024460 139 DIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWS-----------------RPFLKDQKKFVHLVDPLLHGRY------- 194 (267)
Q Consensus 139 Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~------- 194 (267)
|||||||++|+|++|.+||...........+... .....................+
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLL 292 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhc
Confidence 9999999999999999999754422211110000 0000000000000000000000
Q ss_pred -----cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 195 -----PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 195 -----~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+..++.++.+++.+||..||++|||++|+++
T Consensus 293 ~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 293 LKINPKADCNEEALDLLDKLLQFNPNKRISANDALK 328 (388)
T ss_dssp HHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC
Confidence 0134567999999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=255.65 Aligned_cols=215 Identities=22% Similarity=0.247 Sum_probs=161.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHH------hcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDH------LYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANP 74 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~------l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ 74 (267)
|++++||||+++++++..++..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ ++
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-- 172 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC--
Confidence 6789999999999999999999999999999999998 432 225789999999999999999999999 88
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcc-cCCeeehHHHHHHHHh
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTL-KSDIYSFGVVLLELIT 152 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~Dv~slG~i~~~~l~ 152 (267)
++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+. .++. ++|+||||+++|+|++
T Consensus 173 -i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 173 -ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred -EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999998753222 33445689999999999877 6666 9999999999999999
Q ss_pred CCCCccccCccCcc-chhhhc-hhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 153 GRKAMDLSKGQGEQ-NLVSWS-RPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 153 g~~p~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|..||......... ..+... ...............+.........++.++.+++.+||..+|.+|||++|+++
T Consensus 248 g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 248 NVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999754331110 000000 00000000000000000000111345678999999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=254.76 Aligned_cols=146 Identities=28% Similarity=0.363 Sum_probs=128.9
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
++||||+++++++...+..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 45999999999999999999999999 88999999762 3346899999999999999999999999 999999999
Q ss_pred cEEEcC-------------------------CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCC
Q 024460 85 NILLDN-------------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSD 139 (267)
Q Consensus 85 nili~~-------------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D 139 (267)
||+++. ++.++|+|||++...... .....+++.|+|||++.+..++.++|
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccc
Confidence 999975 788999999999753221 22356799999999999999999999
Q ss_pred eeehHHHHHHHHhCCCCccccC
Q 024460 140 IYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 140 v~slG~i~~~~l~g~~p~~~~~ 161 (267)
|||||+++|+|++|..||....
T Consensus 242 iwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHHHHHHCCCCCCCCc
Confidence 9999999999999999996543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=263.91 Aligned_cols=199 Identities=16% Similarity=0.176 Sum_probs=152.6
Q ss_pred CCCCCCCCcccee-------eEEeeCC-----------------eeEEEEecCCCCCHHHHhcccCC---CCCCCCHHHH
Q 024460 2 LSLLHHDNLVTLI-------GYCTSGD-----------------QRLLVYEYMPMGSLEDHLYDLEP---DQEPLSWNTR 54 (267)
Q Consensus 2 l~~l~Hpniv~~~-------~~~~~~~-----------------~~~lv~e~~~~~sL~~~l~~~~~---~~~~~~~~~~ 54 (267)
|++++||||++++ +++...+ ..|+||||+ +|+|.+++..... ....+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 6678999999998 6666553 278999999 6799999975211 1122334788
Q ss_pred HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC--
Q 024460 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-- 132 (267)
Q Consensus 55 ~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-- 132 (267)
+.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||++.... .......| +.|+|||++.+.
T Consensus 209 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhccccc
Confidence 889999999999999999 9999999999999999999999999997421 12334456 899999999887
Q ss_pred ---------CCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHH
Q 024460 133 ---------KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAV 203 (267)
Q Consensus 133 ---------~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 203 (267)
.++.++||||||+++|+|++|..||........... ... ....++.++.
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~----------------~~~------~~~~~~~~~~ 337 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW----------------IFR------SCKNIPQPVR 337 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGG----------------GGS------SCCCCCHHHH
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhh----------------hhh------hccCCCHHHH
Confidence 899999999999999999999999964332211100 000 0123467799
Q ss_pred HHHHhhcccCCCCCCCHHHHHH--HHHHhhh
Q 024460 204 AVTAMCLNEEANFRPLINDIVV--ALDYLVS 232 (267)
Q Consensus 204 ~li~~cl~~~p~~Rpt~~ev~~--~l~~l~~ 232 (267)
++|.+||..||++|||++++++ .++.+..
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 368 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred HHHHHHcCCCchhCCCHHHHhhChHHHHHHH
Confidence 9999999999999999999997 4555544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=276.69 Aligned_cols=196 Identities=26% Similarity=0.330 Sum_probs=162.1
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
..+ +||||+++++++.+.+.+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||
T Consensus 396 ~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDL 468 (674)
T 3pfq_A 396 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDL 468 (674)
T ss_dssp TCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCC
T ss_pred HhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccC
Confidence 444 799999999999999999999999999999999975 357999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+|||++.++.+||+|||++....... .......|++.|+|||++.+..++.++|+||||+++|||++|.+||....
T Consensus 469 Kp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 469 KLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999987532222 22344678999999999999999999999999999999999999997433
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH-----HHHHH
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI-----NDIVV 225 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~-----~ev~~ 225 (267)
..... ..++... ..+|..++.++.++|.+||+.||++||++ +||++
T Consensus 547 ~~~~~----------------~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 547 EDELF----------------QSIMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHHHH----------------HHHHSSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHHHH----------------HHHHhCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 21110 0111111 12345667889999999999999999997 77765
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=265.78 Aligned_cols=211 Identities=23% Similarity=0.284 Sum_probs=151.9
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|+.++||||+++++++... ..+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~--- 184 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--- 184 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999654 357999999975 5777763 24889999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++||||||+|||++.++.+||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|+|++|.+
T Consensus 185 iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp CCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975322 122334568999999999999999999999999999999999999
Q ss_pred CccccCccCccchh-h-----------h----chhhhhccc-----ccccccCCcC-C--CCCcHHHHHHHHHHHHhhcc
Q 024460 156 AMDLSKGQGEQNLV-S-----------W----SRPFLKDQK-----KFVHLVDPLL-H--GRYPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 156 p~~~~~~~~~~~~~-~-----------~----~~~~~~~~~-----~~~~~~~~~~-~--~~~~~~~~~~l~~li~~cl~ 211 (267)
||...........+ . . ......... .........+ . .......+.++.++|.+||.
T Consensus 262 pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 341 (464)
T 3ttj_A 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341 (464)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence 99754322111000 0 0 000000000 0000000000 0 00112236789999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.||++|||++|+++
T Consensus 342 ~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 342 IDPAKRISVDDALQ 355 (464)
T ss_dssp SSTTTSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=261.67 Aligned_cols=225 Identities=23% Similarity=0.289 Sum_probs=160.4
Q ss_pred CCCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|+.++||||+++++++...+ .+++||||+++ ++.+.+.........+++..+..++.|++.||.|||+++
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-- 161 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-- 161 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 367899999999999985533 38899999976 555444332224678999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHh
Q 024460 75 PVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 75 ~i~h~di~~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||||+||+++ .++.+||+|||++....... ......+++.|+|||++.+. .++.++||||||+++|+|++
T Consensus 162 -ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 162 -ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999998 78999999999997542221 22335678999999988764 58999999999999999999
Q ss_pred CCCCccccCccCccc-hhhhc-hh---hh-hcccccccccCCcCC-----CCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 153 GRKAMDLSKGQGEQN-LVSWS-RP---FL-KDQKKFVHLVDPLLH-----GRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 153 g~~p~~~~~~~~~~~-~~~~~-~~---~~-~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
|.+||.......... +.... .+ .. ..........-+... ..++..++.++.+++.+||..+|++|||++
T Consensus 238 g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (394)
T 4e7w_A 238 GQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317 (394)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence 999997544221110 11000 00 00 000000000000000 011233567899999999999999999999
Q ss_pred HHHH--HHHHhhh
Q 024460 222 DIVV--ALDYLVS 232 (267)
Q Consensus 222 ev~~--~l~~l~~ 232 (267)
|+++ .++.+..
T Consensus 318 e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 318 EALCHPFFDELRT 330 (394)
T ss_dssp HHHTSGGGSTTTS
T ss_pred HHhcChhhhhhcc
Confidence 9997 3555544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=262.22 Aligned_cols=225 Identities=22% Similarity=0.319 Sum_probs=164.3
Q ss_pred CCCCCCCCCccceeeEEee--------------------------------------CCeeEEEEecCCCCCHHHHhccc
Q 024460 1 MLSLLHHDNLVTLIGYCTS--------------------------------------GDQRLLVYEYMPMGSLEDHLYDL 42 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--------------------------------------~~~~~lv~e~~~~~sL~~~l~~~ 42 (267)
+|+.++||||+++++++.. +..+++||||++ ++|.+.+...
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH
Confidence 3678999999999999843 345899999997 5888777654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEc-CCCceEEeccCCcccCCCCCCcceeeeccccc
Q 024460 43 EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTY 121 (267)
Q Consensus 43 ~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 121 (267)
...+..+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||++....... ......++.
T Consensus 132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~ 205 (383)
T 3eb0_A 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSR 205 (383)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCS
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCC
Confidence 345678999999999999999999999999 99999999999997 67899999999997543222 223346788
Q ss_pred ceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccccCccCccc-hhhh-chh----hhhccccccc-----ccCCc
Q 024460 122 GYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN-LVSW-SRP----FLKDQKKFVH-----LVDPL 189 (267)
Q Consensus 122 ~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~-~~~~-~~~----~~~~~~~~~~-----~~~~~ 189 (267)
.|+|||++.+. .++.++||||+|+++|+|++|.+||.......... ++.. ..+ .......... .....
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (383)
T 3eb0_A 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD 285 (383)
T ss_dssp SCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCC
T ss_pred CccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCccc
Confidence 99999988765 58999999999999999999999997543222110 0000 000 0000000000 01111
Q ss_pred CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhhh
Q 024460 190 LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLVS 232 (267)
Q Consensus 190 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~~ 232 (267)
+...++..++.++.+++.+||..+|++|||++|+++ .++.+..
T Consensus 286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 111123446778999999999999999999999997 4666554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=256.64 Aligned_cols=199 Identities=25% Similarity=0.334 Sum_probs=157.3
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++ +||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||
T Consensus 154 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dl 226 (365)
T 2y7j_A 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDL 226 (365)
T ss_dssp HHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 445 799999999999999999999999999999999964 457899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc------CCCcccCCeeehHHHHHHHHhCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||+++.++.++|+|||++....... ......|++.|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 227 kp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~ 303 (365)
T 2y7j_A 227 KPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303 (365)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCC
Confidence 9999999999999999999987543222 2234568999999998863 358889999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||......... . ........ ...+ ....++..+.+++.+||..+|++|||++++++
T Consensus 304 pf~~~~~~~~~---~---~i~~~~~~---~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 304 PFWHRRQILML---R---MIMEGQYQ---FSSP-----EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SSCCSSHHHHH---H---HHHHTCCC---CCHH-----HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHH---H---HHHhCCCC---CCCc-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99643211100 0 00000000 0000 00133567999999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-36 Score=263.65 Aligned_cols=145 Identities=27% Similarity=0.368 Sum_probs=119.6
Q ss_pred CCCCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|++++||||+++++++.. .+.+|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+++
T Consensus 105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 176 (458)
T 3rp9_A 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG--- 176 (458)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3677899999999999843 35789999998 5699998864 467999999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-------------------------ceeeecccccceeCCccc-
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-------------------------HVSTRVMGTYGYCAPEYA- 129 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE~~- 129 (267)
++||||||+|||++.++.+||+|||+++........ .......|+++|+|||++
T Consensus 177 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 999999999999999999999999999864322110 112334679999999976
Q ss_pred ccCCCcccCCeeehHHHHHHHHhC
Q 024460 130 MSGKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 130 ~~~~~~~~~Dv~slG~i~~~~l~g 153 (267)
....++.++|||||||++|+|++|
T Consensus 257 ~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 257 LQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCcHhHHHHHHHHHHHHHHh
Confidence 456799999999999999999983
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=253.84 Aligned_cols=201 Identities=21% Similarity=0.302 Sum_probs=156.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 143 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 143 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCC
Confidence 5678999999999999999999999999999999998865 3467999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+|+||+++.++.++|+|||++.... ..........++..|+|||++. ...++.++|+||||+++|+|++|..|
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 144 KAGNVLMTLEGDIRLADFGVSAKNL--KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp SGGGEEECTTSCEEECCCHHHHHHH--HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHEEECCCCCEEEEECCCCcccc--ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999864211 0111122345789999999883 56788999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|......... ..... ...+ ....+..++..+.+++.+||..+|++|||++++++
T Consensus 222 ~~~~~~~~~~------~~~~~-------~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 222 HHELNPMRVL------LKIAK-------SDPP--TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp TTTSCHHHHH------HHHHH-------SCCC--CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccCCHHHHH------HHHhc-------cCCc--ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9643321100 00000 0000 01124456778999999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.23 Aligned_cols=201 Identities=26% Similarity=0.333 Sum_probs=152.2
Q ss_pred CCCC-CCCCccceeeEEee------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 2 LSLL-HHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
|+++ +||||+++++++.. ++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+++
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 149 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK-- 149 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3445 79999999999977 56899999999999999999752 2457899999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHH
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~ 149 (267)
++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++. ...++.++||||||+++|+
T Consensus 150 -ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 150 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp -CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred -ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 999999999999999999999999998753221 11223346899999999987 4568899999999999999
Q ss_pred HHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 150 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|++|..||........... ... ...+ ...+..++..+.++|.+||..+|.+|||++++++
T Consensus 227 l~~g~~p~~~~~~~~~~~~------~~~-------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRALFL------IPR-------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHHSSCTTTTSCHHHHHHH------HHH-------SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhCCCCCCCCcHHHHHHH------hhc-------Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 9999999964332111000 000 0000 0112344677999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=249.48 Aligned_cols=213 Identities=22% Similarity=0.277 Sum_probs=158.4
Q ss_pred CCCCCCccceeeEEe-----eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 4 LLHHDNLVTLIGYCT-----SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~-----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
.++||||+++++++. .+...++||||++ ++|.+++... ....+++..+..++.|++.||.|||+++ ++|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H 143 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVH 143 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 358999999999987 4567899999997 5999998762 2345899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+||+|+||+++.++.++|+|||++..... ........++..|+|||++.+..++.++||||||+++|+|++|.+||.
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999875321 112234567899999999999899999999999999999999999997
Q ss_pred ccCccCccch-hhhc-h---hhhhcccccc-cccC---CcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNL-VSWS-R---PFLKDQKKFV-HLVD---PLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~-~~~~-~---~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.......... .... . ..+....... .... ..........++..+.+++.+||..+|++|||++|+++
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 221 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 5432211100 0000 0 0000000000 0000 00001122345678999999999999999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=256.50 Aligned_cols=203 Identities=28% Similarity=0.341 Sum_probs=159.4
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+++ +||||+++++++..++.+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 184 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 184 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 3445 699999999999999999999999999999999965 356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+||+++.++.++|+|||++....... ........|++.|+|||++.+ ..++.++||||||+++|+|++|..||.
T Consensus 185 lkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 185 IKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999999987542221 112233568999999999885 347899999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVVA 226 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~~ 226 (267)
......... ........ . ...++..++..+.++|.+||..+|.+|| |++|+++.
T Consensus 264 ~~~~~~~~~--~~~~~~~~--------~----~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 264 VDGEKNSQA--EISRRILK--------S----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CTTSCCCHH--HHHHHHHH--------C----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred cCCccchHH--HHHHHHhc--------c----CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 443222111 11111110 0 0112345567799999999999999999 99999873
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=252.38 Aligned_cols=216 Identities=24% Similarity=0.319 Sum_probs=157.2
Q ss_pred CCCCCCCCccceeeEEee--------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 2 LSLLHHDNLVTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
|++++||||+++++++.. ++.+++||||+++ +|.+.+.. ....+++..+..++.|++.||.|||+++
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 144 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK- 144 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 567899999999999977 4568999999975 77777765 4467999999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCC--cceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHH
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN--THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~ 150 (267)
++|+||||+||+++.++.++|+|||++........ ........+++.|+|||++.+ ..++.++||||||+++|+|
T Consensus 145 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 145 --ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred --eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence 99999999999999999999999999876432211 112233567999999998876 4589999999999999999
Q ss_pred HhCCCCccccCccCccchhhhc--------hhhhhcccccccccCCcCC--CCCcHH-----HHHHHHHHHHhhcccCCC
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWS--------RPFLKDQKKFVHLVDPLLH--GRYPRR-----CLNYAVAVTAMCLNEEAN 215 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~--~~~~~~-----~~~~l~~li~~cl~~~p~ 215 (267)
++|.+||...........+... .+... .......+..... ...... .+..+.++|.+||..||+
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 301 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 301 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG-GCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGG
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhccccc-cchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChh
Confidence 9999999754322111111000 00000 0000000000000 001111 145689999999999999
Q ss_pred CCCCHHHHHH
Q 024460 216 FRPLINDIVV 225 (267)
Q Consensus 216 ~Rpt~~ev~~ 225 (267)
+|||++|+++
T Consensus 302 ~R~t~~e~l~ 311 (351)
T 3mi9_A 302 QRIDSDDALN 311 (351)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhC
Confidence 9999999995
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=254.76 Aligned_cols=211 Identities=23% Similarity=0.298 Sum_probs=150.1
Q ss_pred CCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|+.++||||+++++++...+ ..|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||+++
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~--- 147 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG--- 147 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999997665 78999999965 7888884 34888999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++|+||||+||+++.++.+||+|||++..... ........++..|+|||++.+..++.++||||||+++|+|++|..
T Consensus 148 ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCHHHEEEcCCCCEEEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975322 112233567899999999999999999999999999999999999
Q ss_pred CccccCccCccchh-hh-----------ch----hhhhcc-----cccccccCCcC---CCCCcHHHHHHHHHHHHhhcc
Q 024460 156 AMDLSKGQGEQNLV-SW-----------SR----PFLKDQ-----KKFVHLVDPLL---HGRYPRRCLNYAVAVTAMCLN 211 (267)
Q Consensus 156 p~~~~~~~~~~~~~-~~-----------~~----~~~~~~-----~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~ 211 (267)
||...........+ .. .. ...... ........... ....+...+..+.+++.+||.
T Consensus 225 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp SSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 99654321110000 00 00 000000 00000000000 000123447789999999999
Q ss_pred cCCCCCCCHHHHHH
Q 024460 212 EEANFRPLINDIVV 225 (267)
Q Consensus 212 ~~p~~Rpt~~ev~~ 225 (267)
.||++|||++|+++
T Consensus 305 ~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 305 IDASKRISVDEALQ 318 (371)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCCCHHHHhC
Confidence 99999999999998
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=252.71 Aligned_cols=200 Identities=23% Similarity=0.267 Sum_probs=155.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++ .|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 140 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDL 140 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999987665 8999999999999999854 567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCc---eEEeccCCcccCCCCCCcceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHHhCCC
Q 024460 82 KSANILLDNDFN---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 82 ~~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||+++.++. ++|+|||++...... .......++..|+|||++. ...++.++|+||||+++|+|++|..
T Consensus 141 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 141 KPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp SGGGEEESSSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEecCCCCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999986654 999999998754221 1222345789999999874 4678899999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||......... .... ...... ..+. ....++..+.+++.+||..+|++|||++++++
T Consensus 218 pf~~~~~~~~~--~~~~---~~~~~~----~~~~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 218 PFSEHRTQVSL--KDQI---TSGKYN----FIPE----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSCSTTCSSCH--HHHH---HHTCCC----CCHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccchHHHH--HHHH---HhCccc----cCch----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 99744322111 0000 000000 0000 01234677999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=248.33 Aligned_cols=200 Identities=26% Similarity=0.278 Sum_probs=159.2
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+++ .||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+|
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 149 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRD 149 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 3455 499999999999999999999999999999999965 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc------cCCCcccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM------SGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|+|+||+++.++.++|+|||++....... ......++..|+|||++. ...++.++|+||||+++|+|++|.
T Consensus 150 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 150 LKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 99999999999999999999987543221 223356789999999885 456889999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.||......... ....... ..........++..+.+++.+||..+|.+|||++++++
T Consensus 227 ~p~~~~~~~~~~------~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 227 PPFWHRKQMLML------RMIMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CSSCCSSHHHHH------HHHHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCcCccHHHHH------HHHhcCC--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 999643321100 0000000 00011112356778999999999999999999999985
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=260.54 Aligned_cols=148 Identities=28% Similarity=0.344 Sum_probs=123.0
Q ss_pred CCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++++++... +.+|+||||++ ++|.+++.. ...+++..+..++.||+.||.|||+++ +
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---i 150 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---I 150 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 5778999999999999766 57899999996 599999964 467999999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--------------------ceeeecccccceeCCccc-ccCCCc
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--------------------HVSTRVMGTYGYCAPEYA-MSGKLT 135 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~~~~~~ 135 (267)
+|+||||+|||++.++.+||+|||+++........ .......++++|+|||++ ....++
T Consensus 151 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 230 (432)
T 3n9x_A 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230 (432)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCC
T ss_pred CCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCC
Confidence 99999999999999999999999999864322111 112445689999999986 456799
Q ss_pred ccCCeeehHHHHHHHHhCCCCc
Q 024460 136 LKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 136 ~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
.++|||||||++|+|++|..||
T Consensus 231 ~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 231 KSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp THHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccchHHHHHHHHHhccccc
Confidence 9999999999999999865555
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=250.46 Aligned_cols=205 Identities=24% Similarity=0.299 Sum_probs=142.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE-PDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYR 79 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~ 79 (267)
++.++||||+++++++..++..++||||+++ +|.+++.... .....+++..+..++.|++.||.|||+. + ++|+
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~ 150 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHR 150 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCS
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeEC
Confidence 5678999999999999999999999999975 8887775311 1356789999999999999999999998 8 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccc----ccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----MSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
||+|+||+++.++.++|+|||++...... .......++..|+|||++ .+..++.++||||||+++|+|++|..
T Consensus 151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 151 DIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEcCCCCEEEccCCCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999998754222 122334688999999998 45678999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||......... .........+.+.......++..+.+++.+||..+|.+|||++++++
T Consensus 228 pf~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 228 PYPKWNSVFDQ------------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CSSCC-------------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcchHHHH------------HHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99643211100 00000001111111122345678999999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=257.07 Aligned_cols=207 Identities=11% Similarity=-0.014 Sum_probs=144.1
Q ss_pred CCCCCCCcccee-------eEEeeC-----------------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHH----
Q 024460 3 SLLHHDNLVTLI-------GYCTSG-----------------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR---- 54 (267)
Q Consensus 3 ~~l~Hpniv~~~-------~~~~~~-----------------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~---- 54 (267)
+. +||||++++ +++... ..+|+||||++ ++|.+++... +..+....+
T Consensus 120 ~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~ 194 (371)
T 3q60_A 120 LG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGIL 194 (371)
T ss_dssp HC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHH
T ss_pred cc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhh
Confidence 44 799988755 444433 33899999998 7999999752 233444555
Q ss_pred --HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-
Q 024460 55 --MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS- 131 (267)
Q Consensus 55 --~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~- 131 (267)
..++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||++.... .......+++.|+|||++.+
T Consensus 195 vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~ 266 (371)
T 3q60_A 195 ALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNAS 266 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCS
T ss_pred hHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCC
Confidence 677799999999999999 9999999999999999999999999998532 12224556799999999987
Q ss_pred -CCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhc
Q 024460 132 -GKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCL 210 (267)
Q Consensus 132 -~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 210 (267)
..++.++||||||+++|+|++|..||............. ..................++..+.++|.+||
T Consensus 267 ~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 337 (371)
T 3q60_A 267 TATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL 337 (371)
T ss_dssp EEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHT
T ss_pred CCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHc
Confidence 679999999999999999999999997553221110000 0000000111111112355778999999999
Q ss_pred ccCCCCCCCHHHHHH--HHHHhh
Q 024460 211 NEEANFRPLINDIVV--ALDYLV 231 (267)
Q Consensus 211 ~~~p~~Rpt~~ev~~--~l~~l~ 231 (267)
+.||++|||++++++ .++.+.
T Consensus 338 ~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 338 NFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp CSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CCChhhCCCHHHHhcCHHHHHHH
Confidence 999999999999986 344443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=260.14 Aligned_cols=224 Identities=24% Similarity=0.273 Sum_probs=159.7
Q ss_pred CCCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||++++++|... ..+++||||+++ +|.+.+.........+++..+..++.|++.||.|||+++
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-- 176 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 176 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36789999999999988432 246799999975 777666543334678999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHh
Q 024460 75 PVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 75 ~i~h~di~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||||+|||++.+ +.+||+|||+++...... ......+++.|+|||++.+. .++.++|||||||++|+|++
T Consensus 177 -ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 177 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999854 678999999998543221 12334679999999998764 78999999999999999999
Q ss_pred CCCCccccCccCcc-chhhhc-h---hhhh-cccccccccCCcCCC-----CCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 153 GRKAMDLSKGQGEQ-NLVSWS-R---PFLK-DQKKFVHLVDPLLHG-----RYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 153 g~~p~~~~~~~~~~-~~~~~~-~---~~~~-~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
|.+||......... .++... . ..+. .........-+.... .++...+.++.++|.+||..||.+|||++
T Consensus 253 G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~ 332 (420)
T 1j1b_A 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332 (420)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHH
Confidence 99999754322111 011000 0 0000 000000110111100 01234467899999999999999999999
Q ss_pred HHHH--HHHHhh
Q 024460 222 DIVV--ALDYLV 231 (267)
Q Consensus 222 ev~~--~l~~l~ 231 (267)
|+++ .++.+.
T Consensus 333 e~l~hp~f~~~~ 344 (420)
T 1j1b_A 333 EACAHSFFDELR 344 (420)
T ss_dssp HHHTSGGGGGGG
T ss_pred HHhCCHhhcccc
Confidence 9987 455544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.93 Aligned_cols=210 Identities=25% Similarity=0.361 Sum_probs=157.9
Q ss_pred CCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|++++||||+++++++..++ .+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~--- 148 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG--- 148 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999997653 469999999 7899999854 56899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||||+||+++.++.+||+|||+++..... .....++.+|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus 149 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999854321 223467899999999887 67999999999999999999999
Q ss_pred CCccccCccCccchh-hhc-hh---hhhc-----ccccccccCCcCCC---CCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLV-SWS-RP---FLKD-----QKKFVHLVDPLLHG---RYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~~-~~---~~~~-----~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+||...........+ ... .+ .... .......+...... ......+..+.+++.+||..||++|||++
T Consensus 224 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 999754322111000 000 00 0000 00000000000000 11134467899999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 304 e~l~ 307 (367)
T 1cm8_A 304 EALA 307 (367)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 9987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=251.09 Aligned_cols=211 Identities=17% Similarity=0.216 Sum_probs=157.1
Q ss_pred CCCCC-CCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLH-HDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|++++ ||||+++++++.. ....++||||+++++|.+++. .+++..+..++.|++.||.|||+++ ++|
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH 153 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMH 153 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 45565 9999999999987 668899999999999999883 3788999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC-ceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCC
Q 024460 79 RDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 79 ~di~~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+||||+||+++.++ .++|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus 154 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 230 (330)
T 3nsz_A 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230 (330)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred CCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999998666 89999999997543222 2233467889999999877 6789999999999999999999999
Q ss_pred ccccCccCccc--hhhh-chhhh----hc-------------ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCC
Q 024460 157 MDLSKGQGEQN--LVSW-SRPFL----KD-------------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 157 ~~~~~~~~~~~--~~~~-~~~~~----~~-------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
|.......... +... ..... .. ................+..++.++.++|.+||+.||++
T Consensus 231 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 310 (330)
T 3nsz_A 231 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310 (330)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGG
T ss_pred cccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCccc
Confidence 85332211100 0000 00000 00 00000011111122223346788999999999999999
Q ss_pred CCCHHHHHH
Q 024460 217 RPLINDIVV 225 (267)
Q Consensus 217 Rpt~~ev~~ 225 (267)
|||++|+++
T Consensus 311 Rpta~e~l~ 319 (330)
T 3nsz_A 311 RLTAREAME 319 (330)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999995
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=250.82 Aligned_cols=204 Identities=20% Similarity=0.227 Sum_probs=139.2
Q ss_pred CCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 3 SLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+.++||||+++++++.. +...++||||+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH 151 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAH 151 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 45789999999999876 45689999999999999999752 3357999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||||+||+++. ++.++|+|||++...... ......+++.|+|||++....++.++||||||+++|+|++|..
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999976 445999999998753221 2233457899999999988889999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||.............. .. ..............++.++.+++.+||..+|++|||++|+++
T Consensus 228 pf~~~~~~~~~~~~~~--~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 228 PFYSNTGQAISPGMKR--RI--------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CC-------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCccchhhhhhHHH--hh--------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9964432211000000 00 000000011111345678999999999999999999999998
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=244.40 Aligned_cols=202 Identities=23% Similarity=0.334 Sum_probs=150.2
Q ss_pred CCCCCCCCccceeeEEee-------------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLLHHDNLVTLIGYCTS-------------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-------------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|++++||||+++++++.. .+..|+||||+++++|.+++.. ....+++..++.++.|++.||.||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L 132 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYI 132 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHH
Confidence 678999999999998855 3568999999999999999975 345678899999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCC------------cceeeecccccceeCCcccccC-CCc
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN------------THVSTRVMGTYGYCAPEYAMSG-KLT 135 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~ 135 (267)
|+++ ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||++.+. .++
T Consensus 133 H~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 209 (303)
T 1zy4_A 133 HSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209 (303)
T ss_dssp HHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCC
T ss_pred HhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc
Confidence 9999 99999999999999999999999999875432110 1112334578899999998764 689
Q ss_pred ccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCC
Q 024460 136 LKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEAN 215 (267)
Q Consensus 136 ~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 215 (267)
.++|+||||+++|+|++ ||..... ...... .. ..........++..++..+.+++.+||..||.
T Consensus 210 ~~~Di~slG~il~~l~~---p~~~~~~--~~~~~~---~~--------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (303)
T 1zy4_A 210 EKIDMYSLGIIFFEMIY---PFSTGME--RVNILK---KL--------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273 (303)
T ss_dssp THHHHHHHHHHHHHHHS---CCSSHHH--HHHHHH---HH--------HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred chhhHHHHHHHHHHHHh---ccCCchh--HHHHHH---hc--------cccccccCccccccchHHHHHHHHHHHhcCcc
Confidence 99999999999999998 3321100 000000 00 00111112223445567789999999999999
Q ss_pred CCCCHHHHHH
Q 024460 216 FRPLINDIVV 225 (267)
Q Consensus 216 ~Rpt~~ev~~ 225 (267)
+|||++++++
T Consensus 274 ~Rps~~~ll~ 283 (303)
T 1zy4_A 274 KRPGARTLLN 283 (303)
T ss_dssp GSCCHHHHHH
T ss_pred cCcCHHHHhC
Confidence 9999999996
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=244.69 Aligned_cols=205 Identities=23% Similarity=0.272 Sum_probs=159.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 147 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDL 147 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5688999999999999999999999999999999998864 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 82 KSANILLDND---FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 82 ~~~nili~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
+|+||+++.+ +.++|+|||++....... ......++..|+|||++.+ .++.++|+||||+++|+|++|..||.
T Consensus 148 ~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 9999999754 469999999987532221 1223457889999998765 48899999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLV 231 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~ 231 (267)
....... .. .... . .. .........++.++.+++.+||..+|++|||++++++ .+++..
T Consensus 224 ~~~~~~~---~~---~~~~-~-~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 224 GKNEYDI---LK---RVET-G-KY------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp CSSHHHH---HH---HHHH-C-CC------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CCCHHHH---HH---HHHc-C-CC------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 4332110 00 0000 0 00 0000001244677999999999999999999999998 455543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=248.98 Aligned_cols=199 Identities=23% Similarity=0.310 Sum_probs=151.4
Q ss_pred CCCC--CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 3 SLLH--HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 3 ~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++++ ||||+++++++..++..++||| +.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+|
T Consensus 81 ~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~d 152 (313)
T 3cek_A 81 NKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSD 152 (313)
T ss_dssp HHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 4455 5999999999999999999999 557899999965 457899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-----------CCCcccCCeeehHHHHHH
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-----------GKLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~Dv~slG~i~~~ 149 (267)
|+|+||++++ +.++|+|||++................++..|+|||++.+ ..++.++||||||+++|+
T Consensus 153 lkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~e 231 (313)
T 3cek_A 153 LKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231 (313)
T ss_dssp CCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHH
T ss_pred CCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHH
Confidence 9999999964 7999999999976433322222334568999999999875 468889999999999999
Q ss_pred HHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 150 LITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|++|..||....... ......+++.....++..++.++.+++.+||..+|++|||++|+++
T Consensus 232 l~~g~~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 232 MTYGKTPFQQIINQI---------------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHSSCTTTTCCSHH---------------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCchhhHHHHH---------------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 999999996332110 0011112222222233444677999999999999999999999997
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=255.99 Aligned_cols=214 Identities=22% Similarity=0.216 Sum_probs=151.2
Q ss_pred CCCCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++++++.. ...+|+||||++ ++|.+++.. ....+++..+..++.|++.||.|||+++ +
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 155 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---V 155 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 567899999999999854 346899999997 588888865 4567999999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+|+||||+||+++.++.++|+|||++..... ........++..|+|||++.+ ..++.++||||||+++|+|++|..
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCChHHEEEcCCCCEEEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 9999999999999999999999999974322 222334567889999998876 678999999999999999999999
Q ss_pred CccccCccCccchh-hhc-hhhh-----hcccccccccCCcCCC-------CCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 156 AMDLSKGQGEQNLV-SWS-RPFL-----KDQKKFVHLVDPLLHG-------RYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 156 p~~~~~~~~~~~~~-~~~-~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
||...........+ ... .+.. .........+...... .....++..+.+++.+||..+|++|||++
T Consensus 233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 312 (362)
T 3pg1_A 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312 (362)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 99754322111000 000 0000 0000000000000000 01123456799999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 313 ell~ 316 (362)
T 3pg1_A 313 QALR 316 (362)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 9996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=255.76 Aligned_cols=147 Identities=23% Similarity=0.272 Sum_probs=128.5
Q ss_pred CCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCC
Q 024460 4 LLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKS 83 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~ 83 (267)
..+|+||+++++++...+.+++||||+. ++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp 228 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKP 228 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSG
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 3478999999999999999999999995 6999998762 3345899999999999999999999999 99999999
Q ss_pred CcEEEcCCCc--eEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 84 ANILLDNDFN--PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 84 ~nili~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
+|||++.++. +||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|.+||....
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999998877 999999998753221 223467899999999999999999999999999999999999996543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-35 Score=249.57 Aligned_cols=223 Identities=24% Similarity=0.254 Sum_probs=157.9
Q ss_pred CCCCCCCCccceeeEEeeCCe-------eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh--hcC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQ-------RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH--CKA 72 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~-------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~ 72 (267)
|+.++||||+++++++...+. +++||||+++ +|.+.+.........+++..+..++.|++.|+.||| +++
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ 151 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN 151 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 345799999999999865332 8899999976 665555433335677899999999999999999999 888
Q ss_pred CCCeeeCCCCCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHH
Q 024460 73 NPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~ 150 (267)
++|+||||+||+++. ++.++|+|||++....... ......++..|+|||++.+. .++.++||||||+++|+|
T Consensus 152 ---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 225 (360)
T 3e3p_A 152 ---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225 (360)
T ss_dssp ---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999986 8899999999998543222 23345679999999998655 489999999999999999
Q ss_pred HhCCCCccccCccCccch-hhhc----hhhhhc---ccccccccCC------cCCCCCcHHHHHHHHHHHHhhcccCCCC
Q 024460 151 ITGRKAMDLSKGQGEQNL-VSWS----RPFLKD---QKKFVHLVDP------LLHGRYPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~-~~~~----~~~~~~---~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
++|..||........... .... ...... .......... ......+..++.++.+++.+||+.||.+
T Consensus 226 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 999999975432211110 0000 000000 0000000000 0000112235788999999999999999
Q ss_pred CCCHHHHHH--HHHHhh
Q 024460 217 RPLINDIVV--ALDYLV 231 (267)
Q Consensus 217 Rpt~~ev~~--~l~~l~ 231 (267)
|||++|+++ .|+.+.
T Consensus 306 Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 306 RMKPYEALCHPYFDELH 322 (360)
T ss_dssp SCCHHHHTTSGGGGGGG
T ss_pred cCCHHHHhcCccccccC
Confidence 999999996 344443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=254.25 Aligned_cols=202 Identities=22% Similarity=0.258 Sum_probs=147.5
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|+.+ +||||+++++++.+++..|+|||||. |+|.+++.. .........++.++.|++.||.|||+++ ++|+|
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 143 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQ---KDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRD 143 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHS---SSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHh---cCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCC
Confidence 4455 79999999999999999999999996 599999976 2334444566789999999999999999 99999
Q ss_pred CCCCcEEEcC-----CCceEEeccCCcccCCCCCC-cceeeecccccceeCCcccc---cCCCcccCCeeehHHHHHHHH
Q 024460 81 LKSANILLDN-----DFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAM---SGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 81 i~~~nili~~-----~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~---~~~~~~~~Dv~slG~i~~~~l 151 (267)
|||+||+++. ...++|+|||++........ ........|++.|+|||++. ...++.++||||||+++|+|+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 9999999953 23578999999976432211 12233456899999999987 356778999999999999999
Q ss_pred h-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 152 T-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+ |..||......... ....... . . ........+..+.++|.+||+.||++|||++++++
T Consensus 224 t~g~~pf~~~~~~~~~--------~~~~~~~----~-~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 224 SEGSHPFGKSLQRQAN--------ILLGACS----L-D--CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCBTTBSTTTHHHH--------HHTTCCC----C-T--TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCcchhhHHHHH--------HHhccCC----c-c--ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9 88898532211000 0000000 0 0 00112355677899999999999999999999994
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=255.26 Aligned_cols=157 Identities=26% Similarity=0.342 Sum_probs=121.9
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccC-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLE-----PDQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~-----~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+|++++||||+++++++.. +..+|+||||+. ++|.+++.... .....+++..++.++.||+.||.|||+++
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 148 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 148 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678899999999999954 678999999996 48888775321 12235899999999999999999999999
Q ss_pred CCeeeCCCCCCcEEE----cCCCceEEeccCCcccCCCCCC-cceeeecccccceeCCcccccC-CCcccCCeeehHHHH
Q 024460 74 PPVIYRDLKSANILL----DNDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVL 147 (267)
Q Consensus 74 ~~i~h~di~~~nili----~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~ 147 (267)
++|+||||+|||+ +.++.++|+|||++........ ........+++.|+|||++.+. .++.++||||||+++
T Consensus 149 --ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 149 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp --CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred --EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 9999999999999 6678999999999986432211 1222345679999999998874 589999999999999
Q ss_pred HHHHhCCCCccccC
Q 024460 148 LELITGRKAMDLSK 161 (267)
Q Consensus 148 ~~~l~g~~p~~~~~ 161 (267)
|+|++|.+||....
T Consensus 227 ~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 227 AELLTSEPIFHCRQ 240 (405)
T ss_dssp HHHHHSSCTTCCCC
T ss_pred HHHHhCCCCCCCcc
Confidence 99999999996443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-34 Score=241.95 Aligned_cols=209 Identities=18% Similarity=0.231 Sum_probs=157.3
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCc
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSAN 85 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~n 85 (267)
.|++|+++++++..++..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||||+|
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 148 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPEN 148 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 4567999999999999999999999 78999999762 2346889999999999999999999999 9999999999
Q ss_pred EEEcC-------------------CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHH
Q 024460 86 ILLDN-------------------DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 146 (267)
Q Consensus 86 ili~~-------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 146 (267)
|+++. ++.++|+|||++...... .....++..|+|||++.+..++.++||||||++
T Consensus 149 il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 223 (339)
T 1z57_A 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223 (339)
T ss_dssp EEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHH
T ss_pred EEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHH
Confidence 99987 567999999998753221 223467999999999999999999999999999
Q ss_pred HHHHHhCCCCccccCccCccchhhhch-----hhhhcccc--------------------cccccCCc-CCCCCcHHHHH
Q 024460 147 LLELITGRKAMDLSKGQGEQNLVSWSR-----PFLKDQKK--------------------FVHLVDPL-LHGRYPRRCLN 200 (267)
Q Consensus 147 ~~~~l~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~--------------------~~~~~~~~-~~~~~~~~~~~ 200 (267)
+|+|++|..||................ ........ ......+. .....+..++.
T Consensus 224 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303 (339)
T ss_dssp HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence 999999999997543322111100000 00000000 00000000 00112346688
Q ss_pred HHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 201 YAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 201 ~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.+.+++.+||..||.+|||++|+++
T Consensus 304 ~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 304 RLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHhCcCcccccCHHHHhc
Confidence 8999999999999999999999985
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=255.91 Aligned_cols=204 Identities=22% Similarity=0.273 Sum_probs=147.0
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCC---CCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEP---LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
.+||||+++++++.+++..|+|||||+ |+|.+++......... ..+..++.++.|++.||.|||+++ ++|+||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDL 141 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDL 141 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 489999999999999999999999995 6999999763221111 123345789999999999999999 999999
Q ss_pred CCCcEEEcCC-------------CceEEeccCCcccCCCCCCcc--eeeecccccceeCCccccc-------CCCcccCC
Q 024460 82 KSANILLDND-------------FNPKLSDFGLAKLGPVGDNTH--VSTRVMGTYGYCAPEYAMS-------GKLTLKSD 139 (267)
Q Consensus 82 ~~~nili~~~-------------~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-------~~~~~~~D 139 (267)
||+||+++.+ +.++|+|||++.......... ......|++.|+|||++.+ ..++.++|
T Consensus 142 kp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 221 (434)
T 2rio_A 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221 (434)
T ss_dssp SGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred ChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence 9999999653 479999999998653322111 1233568999999999875 56889999
Q ss_pred eeehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC
Q 024460 140 IYSFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218 (267)
Q Consensus 140 v~slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 218 (267)
|||||+++|+|++ |..||....... .. ....... .+......+..++.++.++|.+||+.+|++||
T Consensus 222 iwSlG~il~ellt~g~~Pf~~~~~~~-~~-------i~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (434)
T 2rio_A 222 IFSMGCVFYYILSKGKHPFGDKYSRE-SN-------IIRGIFS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288 (434)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSTTTHH-HH-------HHHTCCC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred hHhHHHHHHHHHhCCCCCCCCchhhH-HH-------HhcCCCC-----cccccccccccchHHHHHHHHHHhhCChhhCC
Confidence 9999999999998 899986332111 00 0000000 01111122456788999999999999999999
Q ss_pred CHHHHHH
Q 024460 219 LINDIVV 225 (267)
Q Consensus 219 t~~ev~~ 225 (267)
|++++++
T Consensus 289 s~~eil~ 295 (434)
T 2rio_A 289 TAMKVLR 295 (434)
T ss_dssp CHHHHHT
T ss_pred CHHHHHh
Confidence 9999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=251.12 Aligned_cols=215 Identities=22% Similarity=0.278 Sum_probs=157.0
Q ss_pred CCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++++++... ...|+||||++ ++|.+++.. ..+++..++.++.|++.||.|||+++ +
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---i 149 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---V 149 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999998654 46899999996 599999854 46899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
+|+||||+||+++.++.++|+|||++......... .......+++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 150 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999754322111 11233468999999998654 55899999999999999999999
Q ss_pred CCccccCccCccchhhhc--hhh---hhc-----ccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLVSWS--RPF---LKD-----QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~--~~~---~~~-----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+||...........+... .+. ... ............... ....++.++.++|.+||..||++|||++
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999755432221111000 000 000 000000000000000 0123457799999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 310 e~l~ 313 (364)
T 3qyz_A 310 QALA 313 (364)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=249.96 Aligned_cols=209 Identities=20% Similarity=0.208 Sum_probs=155.4
Q ss_pred CCCCccceeeEEe----eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 6 HHDNLVTLIGYCT----SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 6 ~Hpniv~~~~~~~----~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
+||||+++++++. .+..+|+||||+ +++|.+++.. .....+++..+..++.|++.||.|||++ + ++|+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrD 172 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK--SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTD 172 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh--cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 3889999999987 456899999999 5577666654 1346799999999999999999999998 8 99999
Q ss_pred CCCCcEEEcCCC-------------------------------------------------ceEEeccCCcccCCCCCCc
Q 024460 81 LKSANILLDNDF-------------------------------------------------NPKLSDFGLAKLGPVGDNT 111 (267)
Q Consensus 81 i~~~nili~~~~-------------------------------------------------~~~l~d~~~~~~~~~~~~~ 111 (267)
|||+|||++.++ .++|+|||++......
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--- 249 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--- 249 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---
Confidence 999999998765 7999999998754321
Q ss_pred ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhh----------------
Q 024460 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF---------------- 175 (267)
Q Consensus 112 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~---------------- 175 (267)
.....++..|+|||++.+..++.++||||||+++|+|++|..||..................
T Consensus 250 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 250 --FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp --SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred --CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 22346799999999999999999999999999999999999999754433221100000000
Q ss_pred -----hhcccccccccCCc---------CCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 176 -----LKDQKKFVHLVDPL---------LHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 176 -----~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.............. .....+...+..+.++|.+||+.||++|||++|+++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000000000 001235677889999999999999999999999984
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-34 Score=245.75 Aligned_cols=209 Identities=18% Similarity=0.242 Sum_probs=153.5
Q ss_pred CCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 6 HHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
.||||+++++++...+ .+++|||++ +++|.+++... ....+++..+..++.|++.||.|||++ + ++|+|
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~D 157 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTD 157 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSC
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 4899999999997654 789999999 88999999762 345689999999999999999999998 8 99999
Q ss_pred CCCCcEEEc------CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLD------NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~------~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|||+||+++ ..+.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999994 3447999999998754221 22346799999999999999999999999999999999999
Q ss_pred CCccccCccCccchhhhchh---------------------hhhcccccccccCC---------cCCCCCcHHHHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRP---------------------FLKDQKKFVHLVDP---------LLHGRYPRRCLNYAVA 204 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~ 204 (267)
.||................. .............. .....++..++.++.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 99975442211100000000 00000000000000 0011245678899999
Q ss_pred HHHhhcccCCCCCCCHHHHHH
Q 024460 205 VTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 205 li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+|.+||+.||++|||++|+++
T Consensus 313 li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHHhccCccccCCHHHHhh
Confidence 999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=249.87 Aligned_cols=209 Identities=23% Similarity=0.335 Sum_probs=152.9
Q ss_pred CCCCCCCCccceeeEEeeCCee------EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~------~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|++++||||+++++++...+.. |+||||+. ++|.+.+. ..+++..+..++.|++.||.|||+++
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--- 164 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG--- 164 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999877654 99999996 58888773 34899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||||+||+++.++.++|+|||++..... ......+++.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 165 ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999874321 1233567899999999887 68899999999999999999999
Q ss_pred CCccccCccCccchh-hhc-hh---hhhc-----ccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLV-SWS-RP---FLKD-----QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~~-~~---~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
.||...........+ ... .+ .... .......+....... ....++..+.++|.+||+.+|++|||++
T Consensus 240 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 319 (371)
T 4exu_A 240 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319 (371)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence 999754322111000 000 00 0000 000000000000000 0123467899999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 320 ell~ 323 (371)
T 4exu_A 320 QALT 323 (371)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=251.93 Aligned_cols=210 Identities=24% Similarity=0.362 Sum_probs=144.6
Q ss_pred CCCCCCCCccceeeEEeeC------CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSG------DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|+.++||||+++++++... ..+|+|+|++ +++|.+++.. ..+++..+..++.|++.||.|||+++
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--- 152 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 152 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999998654 5689999999 6799888843 57999999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||||+||+++.++.+||+|||+++.... ......++..|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 153 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227 (367)
T ss_dssp CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred eeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975321 1233467999999999876 67899999999999999999999
Q ss_pred CCccccCccCccchh-hh-chh---hhhc-----ccccccccCCcCCCCCc---HHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLV-SW-SRP---FLKD-----QKKFVHLVDPLLHGRYP---RRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~-~~~---~~~~-----~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+||...........+ .. ..+ .... .......+...-...+. ...+..+.+++.+||..||++|||++
T Consensus 228 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~ 307 (367)
T 2fst_X 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307 (367)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH
Confidence 999754422111100 00 000 0000 00000000000000000 12356789999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 308 e~L~ 311 (367)
T 2fst_X 308 QALA 311 (367)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-35 Score=248.41 Aligned_cols=215 Identities=20% Similarity=0.250 Sum_probs=155.2
Q ss_pred CCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 2 LSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
|++++||||+++++++..+ ...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+++ +
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---i 133 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---V 133 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999988654 67899999996 599998854 56899999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcc--------eeeecccccceeCCccccc-CCCcccCCeeehHHHH
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH--------VSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVL 147 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~ 147 (267)
+|+||||+||+++.++.++|+|||++.......... ......|+..|+|||++.. ..++.++|+||||+++
T Consensus 134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred ecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 999999999999999999999999987643221111 1122457999999998764 6789999999999999
Q ss_pred HHHHhCCCCccccCccCccchhhh--chhhhhc------cccccc---ccCCcCCCC---CcHHHHHHHHHHHHhhcccC
Q 024460 148 LELITGRKAMDLSKGQGEQNLVSW--SRPFLKD------QKKFVH---LVDPLLHGR---YPRRCLNYAVAVTAMCLNEE 213 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~~ 213 (267)
|+|++|.+||...........+.. ..+.... ...... .+....... ....++.++.+++.+||..|
T Consensus 214 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 999999999975432111000000 0000000 000000 000000000 01245678999999999999
Q ss_pred CCCCCCHHHHHH
Q 024460 214 ANFRPLINDIVV 225 (267)
Q Consensus 214 p~~Rpt~~ev~~ 225 (267)
|++|||++|+++
T Consensus 294 P~~Rpt~~ell~ 305 (353)
T 2b9h_A 294 PAKRITAKEALE 305 (353)
T ss_dssp GGGSCCHHHHHT
T ss_pred cccCCCHHHHhc
Confidence 999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-35 Score=244.26 Aligned_cols=206 Identities=26% Similarity=0.320 Sum_probs=150.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCCeeeCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK-ANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~~i~h~d 80 (267)
++.++||||+++++++..++..++||||+ ++.+..+... ....+++..+..++.|++.||.|||++ + ++|+|
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~d 150 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRD 150 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCC
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCC
Confidence 45789999999999999999999999999 5566665543 346789999999999999999999985 8 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|+|+||+++.++.++|+|||++...... .......++..|+|||++. ...++.++||||||+++|+|++|..
T Consensus 151 lkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 151 VKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEEECCCchhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 9999999999999999999998753221 1223346789999999984 4568889999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH--HHHHhh
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV--ALDYLV 231 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~--~l~~l~ 231 (267)
||........ .. ...... ..+.. .....++.++.+++.+||..+|.+|||++++++ .++.+.
T Consensus 228 pf~~~~~~~~--~~---~~~~~~-------~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 228 PYKNCKTDFE--VL---TKVLQE-------EPPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp TTTTCCSHHH--HH---HHHHHS-------CCCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCccHH--HH---HHHhcc-------CCCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 9964321110 00 000000 00000 011235677999999999999999999999997 344443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=241.87 Aligned_cols=215 Identities=24% Similarity=0.309 Sum_probs=154.1
Q ss_pred CCCCCCCCccceeeEEe--------------eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHH
Q 024460 2 LSLLHHDNLVTLIGYCT--------------SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEY 67 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~--------------~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 67 (267)
|++++||||+++++++. ..+..++||||++ ++|.+++. ...+++..++.++.|++.||.|
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~ 135 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKY 135 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHH
Confidence 57889999999999873 4467899999997 59999994 3568999999999999999999
Q ss_pred hhhcCCCCeeeCCCCCCcEEEc-CCCceEEeccCCcccCCCCCC-cceeeecccccceeCCccccc-CCCcccCCeeehH
Q 024460 68 LHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFG 144 (267)
Q Consensus 68 lH~~~~~~i~h~di~~~nili~-~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG 144 (267)
||+++ ++|+||||+||+++ .++.++|+|||++........ ........++..|+|||++.. ..++.++|+||||
T Consensus 136 lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 212 (320)
T 2i6l_A 136 IHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212 (320)
T ss_dssp HHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHH
T ss_pred HHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHH
Confidence 99999 99999999999997 567899999999975432111 111233456888999998865 6789999999999
Q ss_pred HHHHHHHhCCCCccccCccCccchhhhchhh--hhcccccccc----cCCcCC---CC---CcHHHHHHHHHHHHhhccc
Q 024460 145 VVLLELITGRKAMDLSKGQGEQNLVSWSRPF--LKDQKKFVHL----VDPLLH---GR---YPRRCLNYAVAVTAMCLNE 212 (267)
Q Consensus 145 ~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~---~~---~~~~~~~~l~~li~~cl~~ 212 (267)
+++|+|++|..||...........+....+. .......... +..... .. ....++.++.++|.+||+.
T Consensus 213 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (320)
T 2i6l_A 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292 (320)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence 9999999999999754422111100000000 0000000000 000000 00 1123567899999999999
Q ss_pred CCCCCCCHHHHHH
Q 024460 213 EANFRPLINDIVV 225 (267)
Q Consensus 213 ~p~~Rpt~~ev~~ 225 (267)
||++|||++|+++
T Consensus 293 dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 293 SPMDRLTAEEALS 305 (320)
T ss_dssp SGGGSCCHHHHHT
T ss_pred CccccCCHHHHhC
Confidence 9999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=243.94 Aligned_cols=208 Identities=22% Similarity=0.303 Sum_probs=152.9
Q ss_pred CCCCCCCCccceeeEEeeCCe------eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQ------RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~------~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|++++||||+++++++...+. +|+||||+. ++|.+++. ..+++..+..++.|++.||.|||+++
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~--- 146 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG--- 146 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999999987654 499999996 58887762 35899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||+|+||+++.++.++|+|||++..... ......++..|+|||++.+ ..++.++|+||||+++|+|++|.
T Consensus 147 ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875321 1223467899999999876 67899999999999999999999
Q ss_pred CCccccCccCccchh-hhc-h---hhhhc---------ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 155 KAMDLSKGQGEQNLV-SWS-R---PFLKD---------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~~-~---~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.||...........+ ... . ..... .........+.+ ......++.++.+++.+||..||++|||+
T Consensus 222 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 300 (353)
T 3coi_A 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTA 300 (353)
T ss_dssp CSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence 999754322111000 000 0 00000 000000000011 11123557889999999999999999999
Q ss_pred HHHHH
Q 024460 221 NDIVV 225 (267)
Q Consensus 221 ~ev~~ 225 (267)
+++++
T Consensus 301 ~e~l~ 305 (353)
T 3coi_A 301 AQALT 305 (353)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=245.98 Aligned_cols=208 Identities=16% Similarity=0.188 Sum_probs=153.5
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcE
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANI 86 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ni 86 (267)
|.+++.+++++...+..++||||+ +++|.+++.. .....+++..+..++.|++.||.|||+++ ++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NI 154 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKE--NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENI 154 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH--TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGE
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 344999999999999999999999 5677777755 13357899999999999999999999999 99999999999
Q ss_pred EE-------------------cCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHH
Q 024460 87 LL-------------------DNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 87 li-------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 147 (267)
++ +.++.++|+|||++...... .....++..|+|||++.+..++.++|+||||+++
T Consensus 155 ll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp EESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 99 56788999999998753221 2334689999999999999999999999999999
Q ss_pred HHHHhCCCCccccCccCccchhhhch-----hhhhcccc--------------------cccccCC-cCCCCCcHHHHHH
Q 024460 148 LELITGRKAMDLSKGQGEQNLVSWSR-----PFLKDQKK--------------------FVHLVDP-LLHGRYPRRCLNY 201 (267)
Q Consensus 148 ~~~l~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~--------------------~~~~~~~-~~~~~~~~~~~~~ 201 (267)
|+|++|..||................ ........ ......+ ..........+..
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 99999999997543221111000000 00000000 0000000 0000112355678
Q ss_pred HHHHHHhhcccCCCCCCCHHHHHH
Q 024460 202 AVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 202 l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
+.++|.+||..||++|||++|+++
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHhcCChhhCcCHHHHhc
Confidence 999999999999999999999985
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=242.56 Aligned_cols=185 Identities=22% Similarity=0.311 Sum_probs=153.2
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
.||||+++++++..++..++|+|++.+ ++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 178 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE 178 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHH
Confidence 369999999999999999999999976 899999965 457899999999999999999999999 999999999
Q ss_pred cEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 85 NILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 85 nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
||+++ .++.++|+|||++...... ......++..|+|||++.+..+ +.++|+||||+++|+|++|..||.....
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 254 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 254 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred HEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh
Confidence 99998 7789999999998754322 1223458999999999887665 6889999999999999999999963211
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... ...+..++.++.++|.+||..+|++|||++++++
T Consensus 255 ------------~~~~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 255 ------------IIRGQ------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ------------HHHCC------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------------hhccc------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 0112344677999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=256.36 Aligned_cols=226 Identities=26% Similarity=0.241 Sum_probs=162.0
Q ss_pred CCCCCCCCccceeeEEee------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 2 LSLLHHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
|++++||||+++++++.. ++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g--- 141 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR--- 141 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999998765 677899999999999999997632 2346888999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCc---eEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 76 VIYRDLKSANILLDNDFN---PKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 76 i~h~di~~~nili~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 142 IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 999999999999986654 8999999998643222 2334568999999999999999999999999999999999
Q ss_pred CCCCccccCccCcc-chh-hhchhh--hhc--ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHH----
Q 024460 153 GRKAMDLSKGQGEQ-NLV-SWSRPF--LKD--QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIND---- 222 (267)
Q Consensus 153 g~~p~~~~~~~~~~-~~~-~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e---- 222 (267)
|..||......... ... ...... ... ...................++..+.+++.+||..||++|||+++
T Consensus 219 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred CCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 99999643111000 000 000000 000 00000000001112234567899999999999999999999988
Q ss_pred -HHHHHHHhhhcc
Q 024460 223 -IVVALDYLVSQR 234 (267)
Q Consensus 223 -v~~~l~~l~~~~ 234 (267)
+.+.++.+....
T Consensus 299 p~F~~l~~iL~~k 311 (676)
T 3qa8_A 299 GCFQALDSILSLK 311 (676)
T ss_dssp TTHHHHHHHHCCC
T ss_pred HHHHHHHHHHhcc
Confidence 445555555444
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=240.37 Aligned_cols=185 Identities=24% Similarity=0.403 Sum_probs=149.8
Q ss_pred CCCCccceeeEEeeCCeeEEEEec-CCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEY-MPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~-~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
+||||+++++++..++..++|+|+ +.+++|.+++.. ...+++..++.++.|++.||.|||+++ ++|+||+|+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 168 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE 168 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGG
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChh
Confidence 899999999999999999999999 788999999965 346899999999999999999999999 999999999
Q ss_pred cEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 85 NILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 85 nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
||+++ .++.++|+|||++....... .....++..|+|||++.+..+ +.++|+||||+++|+|++|..||.....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 244 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE 244 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred hEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH
Confidence 99998 78899999999987543221 233457899999999887666 4589999999999999999999963210
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.... ...++..++..+.++|.+||..+|++|||++|+++
T Consensus 245 ------------~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ------------ILEA------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------------HHHT------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------Hhhh------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 00123445677999999999999999999999996
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-33 Score=239.25 Aligned_cols=144 Identities=26% Similarity=0.272 Sum_probs=123.8
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh--cCCCCeeeCCCCCC
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC--KANPPVIYRDLKSA 84 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~--~~~~~i~h~di~~~ 84 (267)
|++|+++++++..++..|+||||+. ++|.+++... ....+++..+..++.|++.||.|||. .+ ++|+||||+
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~ 188 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPE 188 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGG
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcc
Confidence 3469999999999999999999996 5999999762 23568999999999999999999994 56 999999999
Q ss_pred cEEEc--CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 85 NILLD--NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 85 nili~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+++ .++.+||+|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++|.+||....
T Consensus 189 NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 189 NILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99995 4678999999999754221 223567899999999999999999999999999999999999997543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-33 Score=257.32 Aligned_cols=190 Identities=22% Similarity=0.292 Sum_probs=150.3
Q ss_pred CCCCCCCCCccceeeEEeeCCe-----eEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQ-----RLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~-----~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|++++||||+++++++...+. .|+||||+++++|.+++. ..+++..++.++.|++.+|.|||+++
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g--- 202 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG--- 202 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4778999999999999987655 799999999999988763 26899999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
++|+||||+||+++.+ .+||+|||++...... ....|++.|+|||++.+. ++.++||||||+++|+|++|.+
T Consensus 203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCC
T ss_pred CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCC
Confidence 9999999999999875 8999999998754322 334689999999988765 4889999999999999999998
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-HHHHHHHHHHhh
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-INDIVVALDYLV 231 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-~~ev~~~l~~l~ 231 (267)
|+........ .........+..+.++|.+||..+|++||+ ++++.+.|..+.
T Consensus 275 ~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 275 TRNGRYVDGL------------------------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp EETTEECSSC------------------------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCcccccccc------------------------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 8753211000 000112234577999999999999999995 666666665543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-33 Score=228.95 Aligned_cols=184 Identities=14% Similarity=0.086 Sum_probs=142.0
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||+++++++..++..|+||||+++++|.+++.. + .....+..++.|++.||.|||+++ ++|+||
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Di 155 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSID 155 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999943 2 355678899999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~ 161 (267)
||+||+++.++.++|++++ |++ .++.++||||||+++|+|++|..||....
T Consensus 156 kp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 156 HPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp SGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 9999999999999987433 222 36889999999999999999999997544
Q ss_pred ccCccchhhhchhhhhcccccccccCCcCC--CCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCCC
Q 024460 162 GQGEQNLVSWSRPFLKDQKKFVHLVDPLLH--GRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSH 237 (267)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~~ 237 (267)
......... ..+..... ......++.++.+++.+||..||++| |++|+++.|+++.......
T Consensus 207 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~~~ 270 (286)
T 3uqc_A 207 VRSGLAPAE-------------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVADRT 270 (286)
T ss_dssp BCCCSEECC-------------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-----
T ss_pred cchhhHHHH-------------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCCcc
Confidence 322110000 00000000 00113456789999999999999999 9999999999988776544
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-32 Score=229.58 Aligned_cols=180 Identities=20% Similarity=0.271 Sum_probs=141.2
Q ss_pred CCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 3 SLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+.++||||+++++++.. ++.+++||||+++++|.+++.. .....+++..++.++.|++.||.|||+++ ++|
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H 140 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 140 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHH--CTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 45689999999999987 6789999999999999999976 23457999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||||+||+++. ++.++|+|||++.... +..++.++|+||||+++|+|++|..
T Consensus 141 ~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999987 7889999999986321 2456789999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCc----HHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYP----RRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||........... ......... ...+ ..++.++.+++.+||..+|.+|||++|+++
T Consensus 197 pf~~~~~~~~~~~------------~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 197 PFYSNHGLAISPG------------MKTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SCCC-------CC------------SCCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCcchhhhHH------------HHHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9964332111000 000000000 0111 245678999999999999999999999997
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=236.05 Aligned_cols=172 Identities=17% Similarity=0.196 Sum_probs=133.5
Q ss_pred eeEEEEecCCCCCHHHHhccc---CCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEec
Q 024460 22 QRLLVYEYMPMGSLEDHLYDL---EPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSD 98 (267)
Q Consensus 22 ~~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d 98 (267)
.++++|+++ +++|.+++... ...+..+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEe
Confidence 467888877 57999888521 123556778889999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCcceeeecccccceeCCccc----------ccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccch
Q 024460 99 FGLAKLGPVGDNTHVSTRVMGTYGYCAPEYA----------MSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168 (267)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~ 168 (267)
||++..... ......| +.|+|||++ ....++.++||||||+++|+|++|..||.........
T Consensus 255 FG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-- 326 (413)
T 3dzo_A 255 FEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-- 326 (413)
T ss_dssp GGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS--
T ss_pred ccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH--
Confidence 999874321 1334456 899999999 5556888999999999999999999999644321111
Q ss_pred hhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 169 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...+. . ...++.++.++|.+||..+|++|||+.++++
T Consensus 327 --------------~~~~~----~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 327 --------------EWIFR----S--CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp --------------GGGGS----S--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------------HHHHh----h--cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00111 0 0133577999999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-30 Score=219.43 Aligned_cols=174 Identities=15% Similarity=0.049 Sum_probs=130.0
Q ss_pred CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCCeeeCCCCCCcEEEcCCC------
Q 024460 20 GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKANPPVIYRDLKSANILLDNDF------ 92 (267)
Q Consensus 20 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~~~i~h~di~~~nili~~~~------ 92 (267)
++.+|+||||+++|++.+.+. ...+++..+..++.|++.||.||| +++ ++||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~ 205 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHY 205 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEE
T ss_pred cCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceee
Confidence 678999999999997777663 256899999999999999999999 899 99999999999998876
Q ss_pred --------------ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHH-HHHHHhCCCCc
Q 024460 93 --------------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV-LLELITGRKAM 157 (267)
Q Consensus 93 --------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i-~~~~l~g~~p~ 157 (267)
.+||+|||+++.... ....|++.|+|||++.+.. +.++|||||+++ .+++++|..||
T Consensus 206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp EETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred eccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 899999999975321 1246899999999998766 889999998766 77788899988
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~ 224 (267)
.... |......... .............+..++.++.++|++||+.+ |++|++
T Consensus 278 ~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 278 SNVL---------WLHYLTDKML-KQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHH---------HHHHHHHHHH-HTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cchh---------hhhHHHHhhh-hhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 5210 0000000000 00000111111123567899999999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-29 Score=224.33 Aligned_cols=143 Identities=19% Similarity=0.151 Sum_probs=104.9
Q ss_pred CCCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|+++ .|+||+++++++++++..||||||++|++|.+++.. .+.+++. .++.||+.||+|+|++| |+||
T Consensus 294 ~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHR 363 (569)
T 4azs_A 294 FLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHD 363 (569)
T ss_dssp HHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEES
T ss_pred HHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceec
Confidence 36677 799999999999999999999999999999999965 4556654 47899999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+ .+..++|+|++|++++.+.++..+
T Consensus 364 DIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 364 DVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999999999999999999999998643221 12334568999999998875 466789999999988877655444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1e-22 Score=182.22 Aligned_cols=139 Identities=19% Similarity=0.228 Sum_probs=113.8
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++..++..++..|+||||+++++|.+++.. +..++.|++.+|.|||+++ ++|+||
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDi 457 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDL 457 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTC
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCC
Confidence 5678999999766666677788999999999999999943 5689999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcc-----eeeecccccceeCCccccc--CCCcccCCeeehHHHHHHHHhCC
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTH-----VSTRVMGTYGYCAPEYAMS--GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
||+||+++. .+||+|||+++......... ......|++.|+|||++.. ..|+...|+|+..+-..+..-+.
T Consensus 458 Kp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 458 TTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp CTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred CHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 999999998 99999999998653221111 1234568999999999987 67888999999988777776655
Q ss_pred CCc
Q 024460 155 KAM 157 (267)
Q Consensus 155 ~p~ 157 (267)
.+|
T Consensus 536 ~rY 538 (540)
T 3en9_A 536 ARY 538 (540)
T ss_dssp SCC
T ss_pred ccc
Confidence 544
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=8.1e-17 Score=132.67 Aligned_cols=83 Identities=12% Similarity=0.115 Sum_probs=68.3
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++ | +++.+++.. +..|+||||+++++|.+ +.. .....++.|++.|+.+||+++ ++|+||
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDl 219 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDL 219 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCC
Confidence 34455 4 666666544 45699999999999988 521 124569999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcc
Q 024460 82 KSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~ 103 (267)
||+||+++ ++.++|+|||++.
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~ 240 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSV 240 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCE
T ss_pred CHHHEEEE-CCcEEEEECCCCe
Confidence 99999999 9999999999986
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=3.6e-13 Score=109.36 Aligned_cols=87 Identities=17% Similarity=0.144 Sum_probs=65.7
Q ss_pred CCCCCCCCc--cceeeEEeeCCeeEEEEecCCC-C----CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCC
Q 024460 2 LSLLHHDNL--VTLIGYCTSGDQRLLVYEYMPM-G----SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLH-CKAN 73 (267)
Q Consensus 2 l~~l~Hpni--v~~~~~~~~~~~~~lv~e~~~~-~----sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH-~~~~ 73 (267)
|++++|+|+ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.++.+|| +.+
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 344566654 333332 356899999942 3 67766532 123457889999999999999 998
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCccc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~ 104 (267)
++|+||||.|||++. .++|+|||++..
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999988 899999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.09 E-value=1.2e-11 Score=105.34 Aligned_cols=68 Identities=13% Similarity=0.085 Sum_probs=55.9
Q ss_pred EEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCC----------c
Q 024460 24 LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDF----------N 93 (267)
Q Consensus 24 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~----------~ 93 (267)
++||||++|++|.++... .....++.|++.++.+||+.+ ++|+||||.|||++.++ .
T Consensus 187 ~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~~ 253 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITLT 253 (397)
T ss_dssp EEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEEE
T ss_pred eEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCcccccccccc
Confidence 699999999888665421 123567899999999999999 99999999999997665 3
Q ss_pred eEEeccCCccc
Q 024460 94 PKLSDFGLAKL 104 (267)
Q Consensus 94 ~~l~d~~~~~~ 104 (267)
+.|+||+.+-.
T Consensus 254 ~~iID~~Q~V~ 264 (397)
T 4gyi_A 254 PIIIXFPQMVS 264 (397)
T ss_dssp EEECCCTTCEE
T ss_pred eEEEEeCCccc
Confidence 88999997753
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=3.3e-08 Score=79.95 Aligned_cols=88 Identities=14% Similarity=0.058 Sum_probs=69.1
Q ss_pred CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------
Q 024460 7 HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------- 72 (267)
Q Consensus 7 Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------------- 72 (267)
+..+.++++++...+..|+|||+++|.+|.+.... ......++.+++.++..||...
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 139 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRL 139 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHH
Confidence 56788899999999999999999999999876421 1123467788999999999811
Q ss_pred ------------------------------------------CCCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 73 ------------------------------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 73 ------------------------------------------~~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 140 AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1238999999999999876566799999775
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.46 E-value=4.3e-07 Score=76.89 Aligned_cols=92 Identities=15% Similarity=0.204 Sum_probs=70.9
Q ss_pred CCCccceeeEEeeC---CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------
Q 024460 7 HDNLVTLIGYCTSG---DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------- 72 (267)
Q Consensus 7 Hpniv~~~~~~~~~---~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----------- 72 (267)
+..+++++.++.+. +..|+||||++|..+.+.. ...++......++.+++.+|..||...
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 34578888888766 4589999999987764422 234677788889999999999999731
Q ss_pred --------------------------------------------CCCeeeCCCCCCcEEEcCCC--ceEEeccCCccc
Q 024460 73 --------------------------------------------NPPVIYRDLKSANILLDNDF--NPKLSDFGLAKL 104 (267)
Q Consensus 73 --------------------------------------------~~~i~h~di~~~nili~~~~--~~~l~d~~~~~~ 104 (267)
...++|+|+++.||+++.++ .+.|+||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 13499999999999998664 368999998863
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.39 E-value=3.3e-07 Score=73.63 Aligned_cols=82 Identities=18% Similarity=0.141 Sum_probs=60.8
Q ss_pred ccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------
Q 024460 10 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------------- 72 (267)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----------------- 72 (267)
+.++++++..++..++||||++|.+|. ... .. ...++.+++..+..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~ 144 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERA 144 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Confidence 566888888888899999999998873 211 11 1245667777777777642
Q ss_pred --------------------------------------CCCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 73 --------------------------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 73 --------------------------------------~~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
...++|+|++|.||++++++.+.|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 145 RTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877666799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.08 E-value=2.4e-07 Score=76.57 Aligned_cols=138 Identities=20% Similarity=0.205 Sum_probs=82.1
Q ss_pred ccceeeEEeeCC---eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--------------
Q 024460 10 LVTLIGYCTSGD---QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA-------------- 72 (267)
Q Consensus 10 iv~~~~~~~~~~---~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-------------- 72 (267)
+.+++.....++ ..|+||++++|.+|.+... ..++......++.+++..+..||...
T Consensus 75 vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~ 148 (304)
T 3sg8_A 75 IPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFRE 148 (304)
T ss_dssp CCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHH
T ss_pred CCceEeecCCCCCCCcceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHH
Confidence 344444443333 3489999999988765331 23555666777777777777777511
Q ss_pred -----------------------------------------CCCeeeCCCCCCcEEEcC--CCceEEeccCCcccCCCCC
Q 024460 73 -----------------------------------------NPPVIYRDLKSANILLDN--DFNPKLSDFGLAKLGPVGD 109 (267)
Q Consensus 73 -----------------------------------------~~~i~h~di~~~nili~~--~~~~~l~d~~~~~~~~~~~ 109 (267)
...++|+|+++.||+++. +..+.|+||+.+......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~- 227 (304)
T 3sg8_A 149 KINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD- 227 (304)
T ss_dssp HHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-
T ss_pred HHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-
Confidence 124799999999999987 556789999987632110
Q ss_pred Ccceeeec-----cc-------ccce--eC-CcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 110 NTHVSTRV-----MG-------TYGY--CA-PEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 110 ~~~~~~~~-----~~-------~~~~--~a-PE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
....... .+ ...| .. |+.... .....+.|+++.++|.+.+|.++|
T Consensus 228 -~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 228 -NDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp -HHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred -HHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000000 00 0011 11 111100 011257899999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00011 Score=59.19 Aligned_cols=86 Identities=20% Similarity=0.150 Sum_probs=60.4
Q ss_pred ccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------
Q 024460 10 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------------- 72 (267)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----------------- 72 (267)
+.+++.++.+++..|+|||+++|.++.+..... ......+..++...+..||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 677888999999999999999998877654320 0112234444555555555321
Q ss_pred --------------------------------------CCCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 73 --------------------------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 73 --------------------------------------~~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
...++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1137899999999999987777799999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.65 E-value=0.00019 Score=55.59 Aligned_cols=142 Identities=13% Similarity=0.034 Sum_probs=90.4
Q ss_pred CHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcce
Q 024460 34 SLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV 113 (267)
Q Consensus 34 sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~ 113 (267)
+|.+.++. .+.++.+.++|.++.|.+.++.-+-.... -...=+.+..|++..+|.|.+.+ ....
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 78998886 67899999999999999999877622111 11222346888998888887643 1110
Q ss_pred eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCC
Q 024460 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGR 193 (267)
Q Consensus 114 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (267)
.....+.+||... ...+.+.-||+||+++|.-+-...|-+
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~----------------------------------- 137 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN----------------------------------- 137 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-----------------------------------
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-----------------------------------
Confidence 1133467888653 455677789999999998876443321
Q ss_pred CcHHHHHHHHHHHHhhccc-------------------------CCCCCCCHHHHHHHHHHhh
Q 024460 194 YPRRCLNYAVAVTAMCLNE-------------------------EANFRPLINDIVVALDYLV 231 (267)
Q Consensus 194 ~~~~~~~~l~~li~~cl~~-------------------------~p~~Rpt~~ev~~~l~~l~ 231 (267)
.+.+.++.+.+||..|... .+..|.++++|++....-.
T Consensus 138 eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl 200 (229)
T 2yle_A 138 EERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHL 200 (229)
T ss_dssp EEECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTS
T ss_pred cchhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhc
Confidence 1233456677787777655 3468889999988765433
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00023 Score=58.73 Aligned_cols=88 Identities=18% Similarity=0.172 Sum_probs=56.9
Q ss_pred ccceeeEEe-eCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhc-----------------
Q 024460 10 LVTLIGYCT-SGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCK----------------- 71 (267)
Q Consensus 10 iv~~~~~~~-~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~----------------- 71 (267)
+.+++.++. ..+..++|||+++|.++.+..- ..++......++.++...+..||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~ 147 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKN 147 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHH
Confidence 556666664 4556789999999988866321 1123334444444444444444432
Q ss_pred ----------------------------------------CCCCeeeCCCCCCcEEEcC---CCc-eEEeccCCcc
Q 024460 72 ----------------------------------------ANPPVIYRDLKSANILLDN---DFN-PKLSDFGLAK 103 (267)
Q Consensus 72 ----------------------------------------~~~~i~h~di~~~nili~~---~~~-~~l~d~~~~~ 103 (267)
....++|+|+++.||+++. ++. +.|+||+.+.
T Consensus 148 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 148 KILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1224799999999999987 344 5899999876
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00043 Score=58.16 Aligned_cols=30 Identities=17% Similarity=0.351 Sum_probs=25.5
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
..++|+|+.+.||+++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 359999999999999865457899999876
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.57 E-value=0.019 Score=47.37 Aligned_cols=30 Identities=20% Similarity=0.258 Sum_probs=26.7
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
..++|+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 349999999999999877889999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.25 E-value=0.045 Score=45.08 Aligned_cols=27 Identities=15% Similarity=0.149 Sum_probs=23.0
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccC
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFG 100 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~ 100 (267)
.+.++|+|+.+.|++++.++ +.|+|+.
T Consensus 206 ~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 206 KPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 45699999999999998876 8888874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.19 E-value=0.052 Score=46.54 Aligned_cols=29 Identities=17% Similarity=0.311 Sum_probs=25.6
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCccc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKL 104 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~ 104 (267)
.++|+|+++.||+++.++ +.|+||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 399999999999998776 99999998863
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.05 E-value=0.14 Score=41.63 Aligned_cols=28 Identities=18% Similarity=0.112 Sum_probs=24.1
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+ ..++.+.++||..+.
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~ 201 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSG 201 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence 4899999999999 556678999999876
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.53 E-value=0.18 Score=41.51 Aligned_cols=31 Identities=29% Similarity=0.311 Sum_probs=26.4
Q ss_pred CCeeeCCCCCCcEEEcCC----CceEEeccCCccc
Q 024460 74 PPVIYRDLKSANILLDND----FNPKLSDFGLAKL 104 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~----~~~~l~d~~~~~~ 104 (267)
..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999864 6789999998763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.63 E-value=0.064 Score=43.97 Aligned_cols=29 Identities=34% Similarity=0.280 Sum_probs=25.2
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 49999999999999877666899999775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.44 E-value=0.22 Score=40.85 Aligned_cols=27 Identities=30% Similarity=0.393 Sum_probs=24.0
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+++.||+++ + .+.|+||+.+.
T Consensus 196 ~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 196 LRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp EECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred eeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 489999999999998 4 88999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=90.24 E-value=0.26 Score=40.91 Aligned_cols=29 Identities=17% Similarity=0.269 Sum_probs=26.1
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++.++.+.++||+.+.
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 49999999999999877789999998775
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.08 E-value=0.21 Score=41.85 Aligned_cols=28 Identities=29% Similarity=0.358 Sum_probs=23.7
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++.+. +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 489999999999997654 8999998875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.55 E-value=1 Score=34.61 Aligned_cols=85 Identities=13% Similarity=0.101 Sum_probs=59.6
Q ss_pred CCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCC
Q 024460 5 LHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 5 l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~~~ 84 (267)
..||+.++. .+-+.++.+.+.++.-+.+.=...+ ...+....+.++.+|+....+++ . -+|--++|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~--~---r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNR--T---RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGG--S---SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhc--C---ceEEEEecc
Confidence 367888876 5556667766666654322212223 45667888999999888775554 3 567889999
Q ss_pred cEEEcCCCceEEeccCCc
Q 024460 85 NILLDNDFNPKLSDFGLA 102 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~ 102 (267)
|++++.++.++++-.|+.
T Consensus 109 NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GEEECTTSCEEESCCEET
T ss_pred eEEEcCCCCEEEEEccCc
Confidence 999999999999766654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.52 E-value=1.8 Score=33.44 Aligned_cols=84 Identities=10% Similarity=0.055 Sum_probs=58.4
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeeCCCCCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLE-YLHCKANPPVIYRDLKSA 84 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~-~lH~~~~~~i~h~di~~~ 84 (267)
.||++ + ..+-.+++.+.+.++.-+++.=...+ ...+....+.++.+|+.... +++ . -+|--+.|+
T Consensus 48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCPE 113 (219)
T ss_dssp SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCGG
T ss_pred cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeCc
Confidence 56777 3 33446677777777765343333334 34667888999999887666 443 3 578889999
Q ss_pred cEEEcCCCceEEeccCCcc
Q 024460 85 NILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 85 nili~~~~~~~l~d~~~~~ 103 (267)
|++++.++.++++-.|+-.
T Consensus 114 NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GEEECTTCCEEESCCEETT
T ss_pred eEEEeCCCcEEEEEcCCcc
Confidence 9999999999997776543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=87.86 E-value=0.23 Score=42.75 Aligned_cols=17 Identities=35% Similarity=0.466 Sum_probs=14.8
Q ss_pred CeeeCCCCCCcEEEcCC
Q 024460 75 PVIYRDLKSANILLDND 91 (267)
Q Consensus 75 ~i~h~di~~~nili~~~ 91 (267)
.++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 58999999999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=87.66 E-value=0.64 Score=39.23 Aligned_cols=28 Identities=25% Similarity=0.322 Sum_probs=24.3
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++.+ .+.++||..+.
T Consensus 228 ~L~HGDl~~~Nil~~~~-~~~lID~e~a~ 255 (397)
T 2olc_A 228 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 255 (397)
T ss_dssp EEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred ceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence 49999999999999865 48899998775
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=87.63 E-value=0.31 Score=42.30 Aligned_cols=15 Identities=33% Similarity=0.268 Sum_probs=14.1
Q ss_pred CeeeCCCCCCcEEEc
Q 024460 75 PVIYRDLKSANILLD 89 (267)
Q Consensus 75 ~i~h~di~~~nili~ 89 (267)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.97 E-value=0.33 Score=41.01 Aligned_cols=29 Identities=28% Similarity=0.325 Sum_probs=25.8
Q ss_pred CeeeCCCCCCcEEEcCC----CceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDND----FNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~----~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999876 688999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=85.42 E-value=0.47 Score=40.33 Aligned_cols=29 Identities=28% Similarity=0.314 Sum_probs=24.6
Q ss_pred CeeeCCCCCCcEEE------cCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILL------DNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili------~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||++ +....+.++||..+.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 36899999999999 345679999999876
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 267 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-50 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-48 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-48 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-47 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-47 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-47 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-47 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-47 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-46 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-44 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-37 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-33 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-32 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-30 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-28 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-26 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-25 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-23 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-61
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 22/233 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L H N++ +GY T Q +V ++ SL HL+ +E + IA
Sbjct: 57 VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQ 112
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A+G++YLH K +I+RDLKS NI L D K+ DFGLA + +H ++ G+
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 121 YGYCAPEYAM---SGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 177
+ APE + +SD+Y+FG+VL EL+TG+ + + +
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 178 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230
D K C + A CL ++ + RPL I+ +++ L
Sbjct: 230 DLSKV------------RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 4e-51
Identities = 60/256 (23%), Positives = 101/256 (39%), Gaps = 26/256 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
+L H+N++ I + Q LV +Y GSL D+L ++ ++ +K
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIK 104
Query: 57 IAVGAARGLEYLHCKA-----NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT 111
+A+ A GL +LH + P + +RDLKS NIL+ + ++D GLA +T
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 112 --HVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGRKAMDLSK-G 162
+GT Y APE + ++DIY+ G+V E+ + +
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 163 QGEQNLVSWSRPFLKDQKKFV--HLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPL 219
Q + S P +++ +K V + P + R+ L + C R
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284
Query: 220 INDIVVALDYLVSQRD 235
I L L Q
Sbjct: 285 ALRIKKTLSQLSQQEG 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-50
Identities = 57/249 (22%), Positives = 96/249 (38%), Gaps = 41/249 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-------------------D 41
M L H+N+V L+G CT L++EY G L ++L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 42 LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGL 101
E D L++ + A A+G+E+L K ++RDL + N+L+ + K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 102 AKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSK 161
A+ N V + APE G T+KSD++S+G++L E+ +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV------ 264
Query: 162 GQGEQNLVSWSRPF--LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219
P+ + F L+ P + C ++ RP
Sbjct: 265 -----------NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS 313
Query: 220 INDIVVALD 228
++ L
Sbjct: 314 FPNLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-50
Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 32/247 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD--------------LEPDQ 46
+ L +H N+V L+G CT G L++ EY G L + L +E D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 EPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGP 106
L + + A+G+ +L K I+RDL + NILL + K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 107 VGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 166
N V + APE + T +SD++S+G+ L EL + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-------- 248
Query: 167 NLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226
P + KF ++ P + C + + RP IV
Sbjct: 249 -------PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 227 LDYLVSQ 233
++ +S+
Sbjct: 302 IEKQISE 308
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 6e-50
Identities = 41/154 (26%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + +V G S + + E+M GSL+ L + K+++
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GL YL K +++RD+K +NIL+++ KL DFG++ ++ +GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 166
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y +PE +++SDI+S G+ L+E+ GR
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 9e-50
Identities = 60/230 (26%), Positives = 99/230 (43%), Gaps = 27/230 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H LV L T + ++ EYM GSL D L P L+ N + +A
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ ++ + I+RDL++ANIL+ + + K++DFGLA+L +
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFP 173
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA--MDLSKGQGEQNLVSWSRPFLKD 178
+ APE G T+KSD++SFG++L E++T + ++ + QNL R
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-- 231
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
P C + +C E RP + + L+
Sbjct: 232 ----------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-49
Identities = 57/231 (24%), Positives = 88/231 (38%), Gaps = 29/231 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLL--VYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+L L H N+V L V EY G L + +++ L +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 59 VGAARGLEYLHCK--ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTR 116
L+ H + V++RDLK AN+ LD N KL DFGLA++ + +T +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 176
+GT Y +PE KSDI+S G +L EL PF
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------------------PPF- 214
Query: 177 KDQKKFVHLVDPLLHGRYPRRCLNY---AVAVTAMCLNEEANFRPLINDIV 224
L + G++ R Y + LN + RP + +I+
Sbjct: 215 -TAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-49
Identities = 52/228 (22%), Positives = 91/228 (39%), Gaps = 25/228 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H+ LV L G CT ++ EYM G L ++L + +++
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKD 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+EYL K ++RDL + N L+++ K+SDFGL++ D S
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFP 164
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQ 179
+ PE M K + KSDI++FGV++ E+ + K P+
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK-----------------MPYERFTN 207
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
+ + L P + C +E+A+ RP ++ +
Sbjct: 208 SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (403), Expect = 4e-48
Identities = 53/240 (22%), Positives = 102/240 (42%), Gaps = 27/240 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ H N++ L G T +++ E+M GSL+ L + + + + G
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRG 136
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRV--- 117
A G++YL ++RDL + NIL++++ K+SDFGL++ + T
Sbjct: 137 IAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL- 176
+ APE K T SD++S+G+V+ E+++ + RP+
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWD 236
Query: 177 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236
+ ++ ++ P C + + C ++ N RP IV LD ++ +S
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 6e-48
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 22/235 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ + H NLV L+G CT ++ E+M G+L D+L E +++ +S + +A
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQ 123
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+ +EYL K I+RDL + N L+ + K++DFGL++L GD
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
+ APE K ++KSD+++FGV+L E+ T + D
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLS 223
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235
+ L++ P C + C + RP +I A + + +
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-48
Identities = 54/231 (23%), Positives = 91/231 (39%), Gaps = 23/231 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H LV L G C LV+E+M G L D+L + + T + + +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLD 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
G+ YL VI+RDL + N L+ + K+SDFG+ + D ST
Sbjct: 110 VCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFP 165
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
+ +PE + + KSD++SFGV++ E+ + K ++ E
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------------- 211
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231
V + PR + + C E RP + ++ L +
Sbjct: 212 --VEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 9e-48
Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 29/232 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL-LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+++ L H NLV L+G L +V EYM GSL D+L + L + +K ++
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 110
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
+EYL ++RDL + N+L+ D K+SDFGL K +T
Sbjct: 111 DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKL 162
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK-D 178
+ APE K + KSD++SFG++L E+ + + P+ +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----------------VPYPRIP 205
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230
K V V+ P C V C + +A RP + L+++
Sbjct: 206 LKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-47
Identities = 53/251 (21%), Positives = 94/251 (37%), Gaps = 41/251 (16%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD------------------- 41
+++ + N+V L+G C G L++EYM G L + L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 42 -LEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFG 100
P PLS ++ IA A G+ YL ++RDL + N L+ + K++DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 101 LAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160
L++ D + PE + T +SD++++GVVL E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL----- 240
Query: 161 KGQGEQNLVSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219
+P+ ++ ++ V P C + +C ++ RP
Sbjct: 241 ------------QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 288
Query: 220 INDIVVALDYL 230
I L +
Sbjct: 289 FCSIHRILQRM 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-47
Identities = 53/232 (22%), Positives = 92/232 (39%), Gaps = 36/232 (15%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR----LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
ML L H N+V S + +LV E M G+L+ +L + +
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRS 116
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVST 115
+GL++LH + PP+I+RDLK NI + + K+ D GLA L +
Sbjct: 117 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 175
V+GT + APE K D+Y+FG+ +LE+ T P+
Sbjct: 172 AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE------------------YPY 212
Query: 176 LKDQKK---FVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224
+ Q + + + + + + + C+ + + R I D++
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 4e-47
Identities = 48/229 (20%), Positives = 91/229 (39%), Gaps = 27/229 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L + +V +IG C + + +LV E +G L +L + +++
Sbjct: 61 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQ 115
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMG 119
+ G++YL ++RDL + N+LL K+SDFGL+K L + T
Sbjct: 116 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KD 178
+ APE K + KSD++SFGV++ E + + +P+
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMK 215
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
+ +++ P C + +C + RP + + L
Sbjct: 216 GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-47
Identities = 58/250 (23%), Positives = 97/250 (38%), Gaps = 36/250 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYD------------LEPDQEP 48
+ L HH N++ L+G C L EY P G+L D L
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
LS + A ARG++YL I+RDL + NIL+ ++ K++DFGL++ V
Sbjct: 124 LSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
T + A E T SD++S+GV+L E+++
Sbjct: 181 VKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------------- 224
Query: 169 VSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
P+ + + P C + + C E+ RP I+V+L
Sbjct: 225 ----TPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280
Query: 228 DYLVSQRDSH 237
+ ++ +R ++
Sbjct: 281 NRMLEERKTY 290
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 5e-47
Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 23/224 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ +L+H+N+V G+ G+ + L EY G L D + + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQ 111
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
G+ YLH + +RD+K N+LLD N K+SDFGLA + + + ++ GT
Sbjct: 112 LMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 121 YGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 179
Y APE + D++S G+VL ++ G D ++
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------------- 215
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
+ + + ++ + +A+ L E + R I DI
Sbjct: 216 --YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 6e-47
Identities = 53/243 (21%), Positives = 97/243 (39%), Gaps = 30/243 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQ 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMG 119
+ G++YL K ++RDL + N+LL N K+SDFGL+K LG +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL-KD 178
+ APE K + +SD++S+GV + E ++ + +P+
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----------------KPYKKMK 217
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY----LVSQR 234
+ + ++ P C A+ + C + RP + + L S+
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
Query: 235 DSH 237
+ H
Sbjct: 278 EGH 280
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-46
Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 23/237 (9%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ H N++ L G + +++ EYM G+L+ L + S + + G
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRG 118
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMG 119
A G++YL N ++RDL + NIL++++ K+SDFGL++ L + T+ ++
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQ 179
+ APE K T SD++SFG+V+ E++T + +
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY----------------WELSN 219
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236
+ + ++ P C + + C +E RP DIV LD L+ DS
Sbjct: 220 HEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 5e-46
Identities = 51/226 (22%), Positives = 85/226 (37%), Gaps = 33/226 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ S L H N++ L GY + L+ EY P+G++ L
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITE 114
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A L Y H K VI+RD+K N+LL + K++DFG + P + T + GT
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y PE K D++S GV+ E + G+ PF +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------------------PPF--EAN 207
Query: 181 KFVHLVDPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIV 224
+ + + P A + + L + RP++ +++
Sbjct: 208 TYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-45
Identities = 57/236 (24%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR-LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
++ H N+++L+G C + L+V YM G L + + + + + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 137
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKL--GPVGDNTHVSTRV 117
A+G+++L K ++RDL + N +LD F K++DFGLA+ D+ H T
Sbjct: 138 QVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLK 177
+ A E + K T KSD++SFGV+L EL+T + N + L+
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY-----PDVNTFDITVYLLQ 249
Query: 178 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233
++ P C + V C + +A RP +++V + + S
Sbjct: 250 GRRLL-----------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-45
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 26/234 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ L H+ LV L + + +V EYM GSL D L + L + +A
Sbjct: 65 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 121
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A G+ Y+ ++RDL++ANIL+ + K++DFGLA+L +
Sbjct: 122 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 177
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQ 179
+ APE A+ G+ T+KSD++SFG++L EL T + P+
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-----------------VPYPGMVN 220
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL-DYLVS 232
++ + V+ P C + C +E RP + L DY S
Sbjct: 221 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-45
Identities = 49/229 (21%), Positives = 89/229 (38%), Gaps = 30/229 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L+ H N+V L+ + ++ E+ G+++ + +LE PL+ + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQ 118
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
L YLH +I+RDLK+ NIL D + KL+DFG++ +GT
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGT 173
Query: 121 YGYCAPEYAMS-----GKLTLKSDIYSFGVVLLELITGRKA-MDLSKGQGEQNLVSWSRP 174
+ APE M K+D++S G+ L+E+ +L+ + + P
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 175 FLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
L P R + CL + + R + +
Sbjct: 234 TLA----------------QPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-44
Identities = 46/240 (19%), Positives = 103/240 (42%), Gaps = 25/240 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+++ + + ++ L+G C + +L + + MP G L D++ + ++ + + V
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQ 119
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A+G+ YL + +++RDL + N+L+ + K++DFGLAKL + + +
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF-LKDQ 179
+ A E + T +SD++S+GV + EL+T +P+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGIPA 219
Query: 180 KKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHPV 239
+ +++ P C + C +A+ RP ++++ + + V
Sbjct: 220 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 279
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (376), Expect = 6e-44
Identities = 51/228 (22%), Positives = 84/228 (36%), Gaps = 34/228 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L L H N + G LV EY + + ++PL + G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHG 123
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A +GL YLH +I+RD+K+ NILL KL DFG A + + +GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGT 174
Query: 121 YGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM-DLSKGQGEQNLVSWSRPFL 176
+ APE ++ G+ K D++S G+ +EL + + +++ ++ P L
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 177 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV 224
+ Y CL + RP ++
Sbjct: 235 Q-----------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-42
Identities = 63/245 (25%), Positives = 100/245 (40%), Gaps = 33/245 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEP 48
M + H N++ L+G CT ++ EY G+L ++L P +E
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 49 LSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVG 108
LS + A ARG+EYL + I+RDL + N+L+ D K++DFGLA+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 109 DNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNL 168
D +T + APE T +SD++SFGV+L E+ T
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG------------- 235
Query: 169 VSWSRPFL-KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
P+ ++ L+ P C N + C + + RP +V L
Sbjct: 236 ----SPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 228 DYLVS 232
D +V+
Sbjct: 292 DRIVA 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-42
Identities = 48/240 (20%), Positives = 81/240 (33%), Gaps = 34/240 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++S L H V L ++ Y G L ++
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAE 116
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
LEYLH +I+RDLK NILL+ D + +++DFG AK+ + +GT
Sbjct: 117 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y +PE SD+++ G ++ +L+ G PF
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPF--RAG 213
Query: 181 KFVHLVDPLLHGRY--PRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDSHP 238
+ ++ Y P + A + L +A R ++ +HP
Sbjct: 214 NEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK-----AHP 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 1e-41
Identities = 58/230 (25%), Positives = 86/230 (37%), Gaps = 27/230 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ L H NL+ L G + ++ V E P+GSL D L Q T + AV
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQ 119
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMG 119
A G+ YL + I+RDL + N+LL K+ DFGL + P D+ +V
Sbjct: 120 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF--LK 177
+ +CAPE + + SD + FGV L E+ T + P+ L
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----------------EPWIGLN 219
Query: 178 DQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
+ + P C V C + RP + L
Sbjct: 220 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 1e-41
Identities = 56/244 (22%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYD------------LEPDQE 47
++ + HH N+V L+G CT G +++ E+ G+L +L + ++
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 48 PLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPV 107
L+ + + A+G+E+L + I+RDL + NILL K+ DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 108 GDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 167
+ + APE T++SD++SFGV+L E+ + +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--------- 237
Query: 168 LVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
P +K ++F + R P C + E + RP +++V L
Sbjct: 238 ------PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 228 DYLV 231
L+
Sbjct: 292 GNLL 295
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-41
Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 27/234 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQE------PLSWNTR 54
++ + ++V L+G + G L++ E M G L+ +L L P P S +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+++A A G+ YL+ ++RDL + N ++ DF K+ DFG+ + D
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRP 174
+ + + +PE G T SD++SFGVVL E+ T + +P
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-----------------QP 235
Query: 175 F-LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227
+ ++ + V P C + + MC RP +I+ ++
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 5e-41
Identities = 50/226 (22%), Positives = 90/226 (39%), Gaps = 31/226 (13%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++ + N+V + GD+ +V EY+ GSL D + + + +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRE 124
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+ LE+LH VI+RD+KS NILL D + KL+DFG + + ++GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD-- 178
+ APE K DI+S G++ +E+I G P+L +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------------------PPYLNENP 221
Query: 179 -QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
+ ++ + + P + CL+ + R ++
Sbjct: 222 LRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-39
Identities = 43/233 (18%), Positives = 88/233 (37%), Gaps = 24/233 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ H ++V LIG T + ++ E +G L L + L + + A
Sbjct: 61 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQ 116
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+ L YL + ++RD+ + N+L+ ++ KL DFGL++ + +++
Sbjct: 117 LSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
+ APE + T SD++ FGV + E++ + D
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------------PFQGVKNNDVI 219
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233
+ + L P C ++ C + + RP ++ L ++ +
Sbjct: 220 GRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 132 bits (332), Expect = 5e-37
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+S+L H LV L ++ +++YE+M G L + + D + +S + ++
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQ 132
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVM 118
+GL ++H ++ DLK NI+ + KL DFGL D
Sbjct: 133 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTT 186
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GT + APE A + +D++S GV+ L++G
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-36
Identities = 55/218 (25%), Positives = 83/218 (38%), Gaps = 27/218 (12%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ H L + + + V EY+ G L H+ + A
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAE 111
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
GL++LH K ++YRDLK NILLD D + K++DFG+ K +GD GT
Sbjct: 112 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
Y APE + K D +SFGV+L E++ G+ PF +
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ------------------SPFHGQDE 208
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP 218
+ + + + YPR A + E R
Sbjct: 209 EELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRL 246
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 129 bits (324), Expect = 8e-36
Identities = 47/176 (26%), Positives = 72/176 (40%), Gaps = 12/176 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
++S +V + + D+ + + M G L HL E A
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMR----FYAAE 115
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
GLE++H N V+YRDLK ANILLD + ++SD GLA +GT
Sbjct: 116 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGT 168
Query: 121 YGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPF 175
+GY APE G +D +S G +L +L+ G K + + + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 1e-35
Identities = 29/156 (18%), Positives = 69/156 (44%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L++ H N++ L S ++ ++++E++ + + + L+ +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVM 118
L++LH + + D++ NI+ + K+ +FG A+ GDN + +
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE ++ +D++S G ++ L++G
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (317), Expect = 1e-35
Identities = 46/160 (28%), Positives = 69/160 (43%), Gaps = 16/160 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ + H N++ L + LV++ M G L D+L + + LS KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRA 118
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+ LH +++RDLK NILLD+D N KL+DFG + D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGT 172
Query: 121 YGYCAPEYAMSG------KLTLKSDIYSFGVVLLELITGR 154
Y APE + D++S GV++ L+ G
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 128 bits (322), Expect = 1e-35
Identities = 41/225 (18%), Positives = 82/225 (36%), Gaps = 25/225 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+++ LHH L+ L + +L+ E++ G L D + + +S +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQ 135
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP--KLSDFGLAKLGPVGDNTHVSTRVM 118
A GL+++H +++ D+K NI+ + K+ DFGLA + +
Sbjct: 136 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTT 189
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKD 178
T + APE + +D+++ GV+ L++G ++ +
Sbjct: 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP--------------FAGEDDLE 235
Query: 179 QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
+ V D A L +E R ++D
Sbjct: 236 TLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 122 bits (308), Expect = 6e-34
Identities = 38/154 (24%), Positives = 61/154 (39%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H N+V L SG L+ + + G L D + + + + ++
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQ 115
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
++YLH + LD D +SDFGL+K+ D V + GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGT 172
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
GY APE + D +S GV+ L+ G
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (304), Expect = 1e-33
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
+ L+H +V + + G +V EY+ +L D ++ + P++ ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIE 115
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVST 115
+ A + L + H +I+RD+K ANI++ K+ DFG+A+ + G++ +
Sbjct: 116 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 116 RVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
V+GT Y +PE A + +SD+YS G VL E++TG
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-33
Identities = 48/235 (20%), Positives = 78/235 (33%), Gaps = 19/235 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDL--EPDQEPLSWNTRMKIA 58
L H N+V L CT + ++ L + + + T +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVM 118
RGL++LH V++RDLK NIL+ + KL+DFGLA++ T V+
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 176
Query: 119 GTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNL 168
T Y APE + D++S G + E+ + + G
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 169 VSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
W R ++ F H ++ + CL R
Sbjct: 237 EDWPRDVALPRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (303), Expect = 3e-33
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 12/155 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
MLS++ H ++ + G Q ++ +Y+ L+ L + A
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAE 112
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
LEYLH + +IYRDLK NILLD + + K++DFG AK P V+ + GT
Sbjct: 113 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGT 164
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155
Y APE + D +SFG+++ E++ G
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 2e-32
Identities = 47/234 (20%), Positives = 83/234 (35%), Gaps = 20/234 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N++ L+ LV+++M D ++ + L+ + +
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLM 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GLEYLH +++RDLK N+LLD + KL+DFGLAK G T + T
Sbjct: 109 TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVT 163
Query: 121 YGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMD----------LSKGQGEQNLV 169
Y APE ++ + D+++ G +L EL+ + + + G
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 170 SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
W + + + + R
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 4e-32
Identities = 56/249 (22%), Positives = 92/249 (36%), Gaps = 35/249 (14%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H N++TL + +L+ E + G L+D ++E L+ +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQ 121
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP----KLSDFGLAKLGPVGDNTHVSTR 116
G+ YLH + + + DLK NI+L + P K+ DFGLA D +
Sbjct: 122 ILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKN 175
Query: 117 VMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFL 176
+ GT + APE L L++D++S GV+ L++G Q
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------------- 222
Query: 177 KDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIV-------VALDY 229
+ V V+ Y A L ++ R I D +
Sbjct: 223 -ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281
Query: 230 LVSQRDSHP 238
+S SHP
Sbjct: 282 ALSSAWSHP 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 6e-31
Identities = 41/230 (17%), Positives = 71/230 (30%), Gaps = 25/230 (10%)
Query: 1 MLSLLHHDNLVTLIGYC----TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMK 56
++V ++ L+V E + G L + D + + +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASE 115
Query: 57 IAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP---KLSDFGLAKLGPVGDNTHV 113
I ++YLH + +RD+K N+L + KL+DFG AK ++
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT- 171
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSR 173
T Y APE K D++S GV++ L+ G L
Sbjct: 172 --TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF-----YSNHGLAISPG 224
Query: 174 PFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
+ + +P + L E R I +
Sbjct: 225 MKTRIRMGQYEFPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-31
Identities = 53/238 (22%), Positives = 97/238 (40%), Gaps = 19/238 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L H+N++ + + + Y+ + LY L Q LS +
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQ 117
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK-LGPVGDNTHVSTRVMG 119
RGL+Y+H V++RDLK +N+LL+ + K+ DFGLA+ P D+T T +
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 120 TYGYCAPEYAMSGKLTLKS-DIYSFGVVLLELITGR-------------KAMDLSKGQGE 165
T Y APE ++ K KS DI+S G +L E+++ R + + +
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 166 QNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
++L ++ + + + R + A+ + L + R +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 6e-30
Identities = 40/161 (24%), Positives = 64/161 (39%), Gaps = 13/161 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR------LLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
++ L H N+V L + S ++ LV +Y+P + ++ L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYV 124
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHV 113
R L Y+H + +RD+K N+LLD D KL DFG AK +
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPN 179
Query: 114 STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ + Y + T D++S G VL EL+ G+
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 8e-30
Identities = 30/248 (12%), Positives = 68/248 (27%), Gaps = 27/248 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L + + + G +LV + + L+ S T A
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQ 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-----KLSDFGLAKLGPVGDNT---- 111
++ +H K ++YRD+K N L+ + + DFG+ K
Sbjct: 110 MLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 112 -HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVS 170
+ GT Y + + + + + D+ + G V + + G K +
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY- 225
Query: 171 WSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230
++ N + P + + +
Sbjct: 226 ---------ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276
Query: 231 VSQRDSHP 238
+ + ++
Sbjct: 277 LERLNTTE 284
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (278), Expect = 9e-30
Identities = 42/237 (17%), Positives = 80/237 (33%), Gaps = 26/237 (10%)
Query: 1 MLSLLHHDNLVTLIGYC-TSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAV 59
+ ++ + I +C GD ++V E + + + S T + +A
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLAD 110
Query: 60 GAARGLEYLHCKANPPVIYRDLKSANIL---LDNDFNPKLSDFGLAKLGPVGDNT----- 111
+EY+H K I+RD+K N L + DFGLAK
Sbjct: 111 QMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 112 HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSW 171
+ + GT Y + + + + + D+ S G VL+ G K ++
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK--- 224
Query: 172 SRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALD 228
+ + +K + +L YP Y C + + +P + +
Sbjct: 225 ---YERISEKKMSTPIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-29
Identities = 34/151 (22%), Positives = 59/151 (39%), Gaps = 12/151 (7%)
Query: 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGL 65
++ L+ + D +L+ E L+D ++ L +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAV 123
Query: 66 EYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYC 124
+ H V++RD+K NIL+D N KL DFG L V T GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYS 176
Query: 125 APEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
PE+ + + ++S G++L +++ G
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-28
Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L+H N+V L+ + ++ LV+E++ + + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKK---FMDASALTGIPLPLIKSYLFQ 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GL + H V++RDLK N+L++ + KL+DFGLA+ V + V+
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTL 166
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ + DI+S G + E++T R
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 107 bits (268), Expect = 2e-28
Identities = 45/234 (19%), Positives = 88/234 (37%), Gaps = 19/234 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L + + +LV+E++ + + L T +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQ 108
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
G+ Y H + V++RDLK N+L++ + K++DFGLA+ + + ++
Sbjct: 109 LLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTL 164
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK----------AMDLSKGQGEQNLVS 170
+ S K + DI+S G + E++ G M + + G N +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 171 WSRPF-LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDI 223
W L + +PL + + + + + L + N R
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-28
Identities = 45/154 (29%), Positives = 62/154 (40%), Gaps = 9/154 (5%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L H L L + D+ V EY G L HL E +
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-------RARFY 110
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
A + L + V+YRD+K N++LD D + K++DFGL K G T GT
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGT 168
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
Y APE D + GVV+ E++ GR
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 2e-26
Identities = 40/165 (24%), Positives = 72/165 (43%), Gaps = 18/165 (10%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQR--------LLVYEYMPMGSLEDHLYDLEPDQEPLSWN 52
+L LL H+N+V LI C + LV+++ L + +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117
Query: 53 TRMKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTH 112
++ GL Y+H +++RD+K+AN+L+ D KL+DFGLA+ + N+
Sbjct: 118 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 113 VS--TRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGR 154
+ T + T Y PE + + D++ G ++ E+ T
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 4e-26
Identities = 33/154 (21%), Positives = 65/154 (42%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H+N++ L+ T + ++ + E L + +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GL Y+H +RDLK N+ ++ D K+ DFGLA+ ++ ++ V+
Sbjct: 130 MLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTR 182
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ + T DI+S G ++ E+ITG+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 6e-26
Identities = 40/214 (18%), Positives = 78/214 (36%), Gaps = 8/214 (3%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L L H N+V L S + LV+E+ D + L
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
+GL + H + V++RDLK N+L++ + KL++FGLA+ + S V+
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI-PVRCYSAEVVTL 165
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQNLVSWSRPFLKDQK 180
+ + + D++S G + EL + + +Q + ++
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 181 KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEA 214
++ + + YP ++ LN
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 101 bits (251), Expect = 2e-25
Identities = 42/154 (27%), Positives = 61/154 (39%), Gaps = 12/154 (7%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L ++ LV L +V EY+ G + HL S A
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQ 149
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
EYLH +IYRDLK N+L+D +++DFG AK T + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGT 201
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
APE +S D ++ GV++ E+ G
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 94.9 bits (235), Expect = 2e-23
Identities = 31/169 (18%), Positives = 63/169 (37%), Gaps = 15/169 (8%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRL--LVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIA 58
+ +L N++TL R LV+E++ + + L+
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYM 135
Query: 59 VGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNP-KLSDFGLAKLGPVGDNTHVSTRV 117
+ L+Y H +++RD+K N+++D++ +L D+GLA+ + RV
Sbjct: 136 YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF--YHPGQEYNVRV 190
Query: 118 MGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQ 166
Y D++S G +L +I ++ +Q
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 4e-23
Identities = 48/156 (30%), Positives = 72/156 (46%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+ + LVTL + + L+ +Y+ G L HL +E + +
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGE 137
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
LE+LH +IYRD+K NILLD++ + L+DFGL+K V D T + GT
Sbjct: 138 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGT 193
Query: 121 YGYCAPEYAMSGK--LTLKSDIYSFGVVLLELITGR 154
Y AP+ G D +S GV++ EL+TG
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.2 bits (212), Expect = 4e-20
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTR 54
++ ++H N+++L+ T LV E M + Q L
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERM 121
Query: 55 MKIAVGAARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVS 114
+ G+++LH +I+RDLK +NI++ +D K+ DFGLA+ + +
Sbjct: 122 SYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMM 175
Query: 115 TRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
T + T Y APE + DI+S G ++ E++ +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 86.2 bits (212), Expect = 4e-20
Identities = 32/168 (19%), Positives = 66/168 (39%), Gaps = 4/168 (2%)
Query: 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLY-DLEPDQEPLSWNTRMKIAVG 60
+ ++++ L+ + + + E+ L + + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMG 119
GL+Y+H + +I+ D+K N+L++ D L +A LG T +
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 120 TYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKGQGEQN 167
T Y +PE + +DI+S ++ ELITG + +G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 1e-19
Identities = 34/154 (22%), Positives = 64/154 (41%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
+L + H+N++ L+ T + + L + + L+ + +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGT 120
RGL+Y+H +RDLK +N+ ++ D K+ DFGLA+ + ++ V
Sbjct: 130 ILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATR 182
Query: 121 YGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154
+ DI+S G ++ EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 50.6 bits (120), Expect = 2e-08
Identities = 10/103 (9%), Positives = 30/103 (29%), Gaps = 19/103 (18%)
Query: 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVG 60
L L + + + + ++ E + L ++
Sbjct: 67 ALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-----------RVENPDEVLDM 111
Query: 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAK 103
+ + + +++ DL N+L+ + + DF +
Sbjct: 112 ILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 267 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.54 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.97 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 94.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.15 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 89.77 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 80.15 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-47 Score=317.37 Aligned_cols=213 Identities=24% Similarity=0.391 Sum_probs=166.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++..++.+++|||||++|+|.+++.. ..+.+++..+..++.|++.||.|||+++ ++|||
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrD 153 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRD 153 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCc
Confidence 47889999999999999999999999999999999998865 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcce---eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV---STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKA 156 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p 156 (267)
|||+|||++.++.+||+|||+++.......... .....+++.|+|||.+....++.++||||||+++|||++ |.+|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 999999999999999999999986433221111 122356889999999999999999999999999999998 8999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
|........ .. .+....+-..+..++..+.+++.+||+.+|++|||++||++.|+++.+.+++
T Consensus 234 f~~~~~~~~---~~--------------~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s 296 (299)
T d1jpaa_ 234 YWDMTNQDV---IN--------------AIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS 296 (299)
T ss_dssp TTTCCHHHH---HH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred CCCCCHHHH---HH--------------HHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence 864432111 10 0111111223556788899999999999999999999999999998876554
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=312.81 Aligned_cols=214 Identities=29% Similarity=0.467 Sum_probs=165.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++. ++.+++|||||++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++|||
T Consensus 57 ~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrD 129 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129 (276)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---Eeccc
Confidence 478899999999999875 4568999999999999999975 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+|||++.++.+||+|||+++...............|++.|+|||++.+ ..++.++||||||+++|||++|..||
T Consensus 130 lKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp CCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 999999999999999999999986543333334445678999999999864 35789999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
.......... . ..... ...+. ....+..++.++.+++.+||..+|++|||++||++.|+.+.+.
T Consensus 210 ~~~~~~~~~~--~----~~~~~-----~~~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 210 SNINNRDQII--F----MVGRG-----YLSPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TTCCCHHHHH--H----HHHHT-----SCCCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCChHHHHH--H----HHhcC-----CCCCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 7443211110 0 00000 00110 0122446678899999999999999999999999999988764
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=311.26 Aligned_cols=203 Identities=25% Similarity=0.331 Sum_probs=165.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+++ ++|||
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrD 128 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 128 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCc
Confidence 36789999999999999999999999999999999999954 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+||+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|.+||..
T Consensus 129 iKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986543333333445679999999999988776 6789999999999999999999964
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... . .............++.++.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~~~~~~-~--------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 209 PSDSCQEYS-D--------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SSTTSHHHH-H--------------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHHHHH-H--------------HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 432211100 0 00000011112345678899999999999999999999973
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-47 Score=307.15 Aligned_cols=196 Identities=26% Similarity=0.405 Sum_probs=165.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+++ ++|||
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrD 131 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRD 131 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeee
Confidence 36789999999999999999999999999999999999964 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 9999999999999999999999754322 233467899999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ . ... .-.+|..++.++.++|.+||+.||++|||++|+++
T Consensus 208 ~~~~~~~~------i----------~~~--~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 TYQETYKR------I----------SRV--EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SHHHHHHH------H----------HTT--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHHHHH------H----------HcC--CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 32111000 0 000 01234456788999999999999999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=307.31 Aligned_cols=207 Identities=25% Similarity=0.372 Sum_probs=160.7
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++||||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDl 127 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTC
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeeccc
Confidence 5789999999999999999999999999999999999865 4567889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhC-CCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITG-RKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g-~~p~~~~ 160 (267)
||+||+++.++.+||+|||+++....... .......|+..|+|||++.+..++.++||||||+++|||+++ .+|+...
T Consensus 128 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 128 AARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp SGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred chhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999975432221 222335678999999999999999999999999999999995 5555432
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
... .+... +....+...|..++.++.+++.+||+.+|++|||++||++.|+++.+
T Consensus 207 ~~~---~~~~~--------------i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 207 SNS---EVVED--------------ISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CHH---HHHHH--------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHH---HHHHH--------------HHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 211 01110 00011112345567889999999999999999999999999998865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-46 Score=309.21 Aligned_cols=212 Identities=25% Similarity=0.372 Sum_probs=172.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||+++++|.+++.+++|||||++|+|.+++.. .....+++..+..++.|++.||+|||+++ ++|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrD 140 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 140 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCc
Confidence 36789999999999999999999999999999999999865 24567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 141 LAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CSGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999998643322 22233345788999999999999999999999999999999976655322
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.... .+.+.+....+-..+..++.++.+++.+||+.||++|||++||++.|+.+.++.
T Consensus 220 ~~~~----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~ 277 (287)
T d1opja_ 220 IDLS----------------QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277 (287)
T ss_dssp CCHH----------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred chHH----------------HHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence 1110 011111112222345567788999999999999999999999999998876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=314.40 Aligned_cols=208 Identities=26% Similarity=0.407 Sum_probs=169.0
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC-------------------CCCCCCHHHHHHHHHHH
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP-------------------DQEPLSWNTRMKIAVGA 61 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~-------------------~~~~~~~~~~~~~~~~l 61 (267)
|+++ +|||||++++++.+.+.+|+|||||++|+|.++++.... ....+++..++.++.|+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 3455 899999999999999999999999999999999976321 12458899999999999
Q ss_pred HHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCee
Q 024460 62 ARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIY 141 (267)
Q Consensus 62 ~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~ 141 (267)
+.||+|||+++ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||
T Consensus 174 ~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 99999999999 999999999999999999999999999865444433344456679999999999999999999999
Q ss_pred ehHHHHHHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 142 SFGVVLLELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 142 slG~i~~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
||||++|||++ |.+||........ +...+....+-..|..++.++.++|.+||+.+|++|||+
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDAN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999997 8999964432111 011111112223455678889999999999999999999
Q ss_pred HHHHHHHH
Q 024460 221 NDIVVALD 228 (267)
Q Consensus 221 ~ev~~~l~ 228 (267)
+||++.|.
T Consensus 315 ~ei~~~L~ 322 (325)
T d1rjba_ 315 PNLTSFLG 322 (325)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999885
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=309.39 Aligned_cols=206 Identities=26% Similarity=0.326 Sum_probs=154.9
Q ss_pred CCCCCCCCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA--NPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~~~i 76 (267)
+|++++||||+++++++.+ ++.+|+|||||++|+|.+++......+..+++..++.++.|++.||+|||+.+ ..+|
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 4789999999999999864 45789999999999999998754445678999999999999999999999864 2249
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
+||||||+|||++.++.+||+|||++...... ........||+.|+|||++.+..++.++||||||+++|+|++|.+|
T Consensus 136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~P 213 (269)
T d2java1 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213 (269)
T ss_dssp ----CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCcCchhhcCcCCCCcEEEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence 99999999999999999999999999864322 2223446789999999999999999999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|....... .... . .... ....+..++.++.++|.+||+.||++|||++|+++
T Consensus 214 f~~~~~~~---~~~~---i----------~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 214 FTAFSQKE---LAGK---I----------REGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCSSHHH---HHHH---H----------HHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCHHH---HHHH---H----------HcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 96432211 1000 0 0000 01234556788999999999999999999999984
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=307.66 Aligned_cols=208 Identities=25% Similarity=0.363 Sum_probs=169.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++..+ .+|+|||||++|+|.+++.. ....+++..+..++.|++.||+|||+++ ++|||
T Consensus 62 il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrD 134 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRD 134 (285)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCc
Confidence 36789999999999998754 68999999999999999864 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+||+++.++.+||+|||+++........ .......+++.|+|||++....++.++||||||+++|||++ |..||.
T Consensus 135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865433222 22233457899999999999999999999999999999998 899997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
...... +.. .+....+-..|..++.++.++|.+||..+|++|||+.+|.+.|+.+..
T Consensus 215 ~~~~~~---~~~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 215 KMKGPE---VMA--------------FIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp TCCTHH---HHH--------------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHH---HHH--------------HHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 443211 111 011111123456678899999999999999999999999999886554
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=306.82 Aligned_cols=200 Identities=24% Similarity=0.313 Sum_probs=165.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. ..+++..+..++.|++.||+|||+++ ++|||
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrD 141 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 36789999999999999999999999999999999998854 56999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 142 iKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 99999999999999999999998643222 2334456899999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
...... . .... . ....-..+..++.++.++|.+||..||++|||++|+++
T Consensus 220 ~~~~~~---~---~~~~-~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 220 NPLRAL---Y---LIAT-N--------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHH---H---HHHH-H--------CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHH---H---HHHh-C--------CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 321110 0 0000 0 00011224566788999999999999999999999984
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=304.87 Aligned_cols=205 Identities=25% Similarity=0.392 Sum_probs=166.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||+++++|..+ ..++|||||++|+|.+++.. ...+++..++.++.|++.||+|||+++ ++|||
T Consensus 61 il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrD 132 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCC
Confidence 46789999999999998654 57899999999999999965 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+|||++.++.++++|||+++........ .......|++.|+|||++.+..++.++||||||+++|||++ |.+||.
T Consensus 133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 9999999999999999999999865433222 22334568899999999999999999999999999999997 899997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
...... +. ..+....+-..|..++.++.++|.+||+.+|++|||+++|.+.|+.+
T Consensus 213 ~~~~~~---~~--------------~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 213 GMKGSE---VT--------------AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCHHH---HH--------------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHHH---HH--------------HHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 433211 11 01111112233556788899999999999999999999999988754
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=308.96 Aligned_cols=200 Identities=22% Similarity=0.297 Sum_probs=162.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+++ ++|||
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 133 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRD 133 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCc
Confidence 36789999999999999999999999999999999999864 467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+||+++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 134 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 99999999999999999999998654333333344567999999999999999999999999999999999999999743
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..... .. .+.... -.+|..++.++.++|.+||+.||++|||++|+++
T Consensus 214 ~~~~~---~~-------------~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 214 NEYLI---FQ-------------KIIKLE--YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp SHHHH---HH-------------HHHTTC--CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CHHHH---HH-------------HHHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 21110 00 000000 1134456778999999999999999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=302.57 Aligned_cols=214 Identities=26% Similarity=0.383 Sum_probs=167.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++.+.+..++|||||.++++.+++.. ....+++..+..++.|++.|++|||+++ ++|||
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrD 135 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRD 135 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCc
Confidence 36789999999999999999999999999999999998865 4577999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCc-ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNT-HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+||+|||+++........ .......|+..|+|||++.+..++.++||||||+++|||+++..|+..
T Consensus 136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 9999999999999999999999864332221 122335678999999999999999999999999999999996555432
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccCC
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRDS 236 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~~ 236 (267)
..... ++...+....+...+..++..+.+++.+||+.+|++|||++||++.|+.+.+..++
T Consensus 216 ~~~~~----------------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~~ 276 (283)
T d1mqba_ 216 ELSNH----------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276 (283)
T ss_dssp TCCHH----------------HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred cCCHH----------------HHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCccc
Confidence 21110 01111111222234556778899999999999999999999999999998876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=306.13 Aligned_cols=202 Identities=22% Similarity=0.300 Sum_probs=162.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++|||
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrD 135 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRD 135 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEee
Confidence 36789999999999999999999999999999999999865 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccc-----cCCCcccCCeeehHHHHHHHHhCCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAM-----SGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|||+|||++.++.+||+|||++..... .........|++.|+|||++. ...|+.++|||||||++|+|++|.+
T Consensus 136 iKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 136 LKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred cChhheeECCCCCEEEEechhhhccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 999999999999999999999864211 111223456899999999984 4567899999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||........... ... . .......+..++.++.++|.+||+.||++|||++|+++
T Consensus 214 Pf~~~~~~~~~~~------i~~-~--------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 214 PHHELNPMRVLLK------IAK-S--------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp TTTTSCGGGHHHH------HHH-S--------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHHHHH------HHc-C--------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9964432111100 000 0 00011224566788999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=301.02 Aligned_cols=209 Identities=22% Similarity=0.325 Sum_probs=161.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++. ++.+|+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ ++|||
T Consensus 61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 133 (273)
T d1mp8a_ 61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRD 133 (273)
T ss_dssp HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccc
Confidence 367899999999999986 5678999999999999998765 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|||+||+++.++.+||+|||+++...... ........+++.|+|||++.+..++.++||||||+++|||++ |.+||..
T Consensus 134 lKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 134 IAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp CSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 99999999999999999999997643222 222334567899999999999999999999999999999997 8899875
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
.........+. ....-..+..++.++.++|.+||..||++|||++||++.|+.+.+.+
T Consensus 213 ~~~~~~~~~i~-----------------~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 213 VKNNDVIGRIE-----------------NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCGGGHHHHHH-----------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHH-----------------cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 43221110000 00111235567888999999999999999999999999999887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=301.59 Aligned_cols=209 Identities=26% Similarity=0.415 Sum_probs=165.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++.. +..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ ++|||
T Consensus 61 ~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrD 134 (272)
T d1qpca_ 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134 (272)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCc
Confidence 3678999999999998754 5679999999999999988541 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC-Cccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK-AMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~-p~~~ 159 (267)
|||+|||++.++.+||+|||+++...... ........++..|+|||++....++.++||||||+++|||++|.. |+..
T Consensus 135 iKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 135 LRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998653221 222334567889999999998999999999999999999999654 4442
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
..... ... .+....+-..|..++.++.+++.+||+.+|++|||+++|++.|+.+.+.
T Consensus 214 ~~~~~---~~~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 214 MTNPE---VIQ--------------NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCHHH---HHH--------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH---HHH--------------HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 22110 000 0111112223456678899999999999999999999999999877653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-45 Score=303.51 Aligned_cols=201 Identities=23% Similarity=0.313 Sum_probs=154.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+++ ++|||
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 132 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRD 132 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEE
Confidence 36789999999999999999999999999999999999964 567999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLD---NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+||++. .++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||
T Consensus 133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp CCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecccceeecccCCCceEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 999999995 4678999999999753222 2233456899999999999999999999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... . .... .........+..+++++.++|.+||..||++|||++|+++
T Consensus 210 ~~~~~~~~~---~---~i~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 210 YDENDAKLF---E---QILK--------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCSSHHHHH---H---HHHT--------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHH---H---HHhc--------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 643211100 0 0000 0011111223456788999999999999999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=295.52 Aligned_cols=200 Identities=26% Similarity=0.395 Sum_probs=158.0
Q ss_pred CCCCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
+|++++||||+++++++.+ +..+|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+++ .++
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~I 135 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 135 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 4789999999999999865 4568999999999999999965 457899999999999999999999875 349
Q ss_pred eeCCCCCCcEEEc-CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLD-NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||||||+|||++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~ 210 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 210 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCC
Confidence 9999999999996 4789999999999753221 2334578999999998865 69999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||......... .. .+........++..+++++.++|.+||..||++|||++|+++
T Consensus 211 Pf~~~~~~~~~--~~-------------~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 211 PYSECQNAAQI--YR-------------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTTCSSHHHH--HH-------------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcccHHHH--HH-------------HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 99643221110 00 000000001123344667999999999999999999999985
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=295.05 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=169.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
+++++||||++++++|.+++.+++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++ ++|+||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dl 126 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 126 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCC
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccc
Confidence 6789999999999999999999999999999999999765 4567899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~~ 160 (267)
||+||+++.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 127 k~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 127 AARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp SGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceeEEEcCCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 9999999999999999999997643322 222334568899999999999999999999999999999998 79999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDY 229 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~ 229 (267)
....- .. .+....+...|..++.++.++|.+||+.+|++|||++++++.|..
T Consensus 206 ~~~~~---~~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 206 TNSET---AE--------------HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHH---HH--------------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CHHHH---HH--------------HHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 32111 10 001111122345667889999999999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=305.40 Aligned_cols=219 Identities=21% Similarity=0.254 Sum_probs=164.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~ 79 (267)
+|++++|||||+++++|.+++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||.|||+ ++ |+||
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHR 129 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHR 129 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcc
Confidence 57899999999999999999999999999999999999965 4579999999999999999999997 58 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
||||+|||++.++.+||+|||++..... .......||+.|+|||++.+..|+.++||||+||++|+|++|..||..
T Consensus 130 DiKP~NILl~~~~~vkl~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 130 DVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccCHHHeeECCCCCEEEeeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999875321 122345789999999999999999999999999999999999999965
Q ss_pred cCccCccchhhh-chhhh------------------hc---cc----ccccccCCcCCCCCcHHHHHHHHHHHHhhcccC
Q 024460 160 SKGQGEQNLVSW-SRPFL------------------KD---QK----KFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEE 213 (267)
Q Consensus 160 ~~~~~~~~~~~~-~~~~~------------------~~---~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 213 (267)
............ ..... .. .. .................++.++.+++.+||+.|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 285 (322)
T d1s9ja_ 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285 (322)
T ss_dssp CCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSS
T ss_pred CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCC
Confidence 432211000000 00000 00 00 000000000000011234578999999999999
Q ss_pred CCCCCCHHHHHH--HHHHh
Q 024460 214 ANFRPLINDIVV--ALDYL 230 (267)
Q Consensus 214 p~~Rpt~~ev~~--~l~~l 230 (267)
|.+|||++|+++ .+++.
T Consensus 286 P~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 286 PAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp TTTSCCHHHHHTSHHHHHH
T ss_pred hhHCcCHHHHhhCHhhCcC
Confidence 999999999997 45543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.4e-44 Score=302.38 Aligned_cols=202 Identities=20% Similarity=0.254 Sum_probs=165.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||++++++|.+++.+|+|||||++|+|.+++.. ....+++..+..++.||+.||+|||+++ ++|||
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRD 152 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 152 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 47889999999999999999999999999999999998864 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEc--CCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLD--NDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+|||++ .++.+||+|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|.+||.
T Consensus 153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 153 IKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cccccccccccCCCeEEEeecccceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 999999997 5689999999999864322 23455678999999999999999999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... .... ............++.++.++|.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~------~i~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 230 GEDDLETLQ------NVKR--------CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSHHHHHH------HHHH--------CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHH------HHHh--------CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 433211100 0000 0111111223455778999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-44 Score=300.23 Aligned_cols=196 Identities=26% Similarity=0.333 Sum_probs=160.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||++++++.+++.+|+|||||.+|+|..++.. .+.+++..+..++.|++.||.|||+++ ++|||
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrD 140 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 140 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccC
Confidence 47899999999999999999999999999999988766643 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc---CCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS---GKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
|||+|||++.++.+||+|||++..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|..||
T Consensus 141 iKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 141 VKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 999999999999999999999975322 233568999999999864 45889999999999999999999999
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ............+..++.++.++|.+||+.||++|||++|+++
T Consensus 215 ~~~~~~~~~----------------~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 215 FNMNAMSAL----------------YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TTSCHHHHH----------------HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHH----------------HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 643221110 0000000111113345778999999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-44 Score=302.83 Aligned_cols=202 Identities=21% Similarity=0.261 Sum_probs=164.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. ..+.+++..+..++.||+.||.|||+++ ++|||
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrD 149 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ceeee
Confidence 36789999999999999999999999999999999999965 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcC--CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDN--DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+|||++. ++.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred echhHeeeccCCCCeEEEeecchheecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 9999999963 578999999999864322 23445678999999999999999999999999999999999999996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ . ...... ..........++.++.++|.+||..||++|||++|+++
T Consensus 227 ~~~~~~~~---~---~i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 227 GENDDETL---R---NVKSCD--------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CSSHHHHH---H---HHHHTC--------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCHHHHH---H---HHHhCC--------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 43321111 0 000000 01111112345678999999999999999999999987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=297.89 Aligned_cols=198 Identities=27% Similarity=0.336 Sum_probs=165.6
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|||
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRD 130 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRD 130 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccc
Confidence 46789999999999999999999999999999999999965 567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++|+|||||++|+|++|.+||...
T Consensus 131 lKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 131 IKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 99999999999999999999998543222 2234467899999999999999999999999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
....... .... . .-.+|..++.++.++|.+||+.||++|++ ++|+++
T Consensus 209 ~~~~~~~------~i~~----------~--~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 209 DHERLFE------LILM----------E--EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SHHHHHH------HHHH----------C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CHHHHHH------HHhc----------C--CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 3211100 0000 0 01234556788999999999999999994 888886
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=293.14 Aligned_cols=206 Identities=28% Similarity=0.400 Sum_probs=162.3
Q ss_pred CCCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++++++.+ ++.+|+||||+++|+|.+++... ....+++..++.++.||+.|+.|||+.+ ++|+
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~ 127 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 127 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eecc
Confidence 3688999999999999854 56789999999999999999651 2345889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
||+|+||+++.++.++++|||+++.... ......++..|+|||++.+..++.++||||||+++|||++ |.+||.
T Consensus 128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 128 DLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp CCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999975322 1223456889999999999999999999999999999998 688876
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
....... . ..+....+-..+..++.++.++|.+||..||++|||+++|++.|+++++.
T Consensus 203 ~~~~~~~---~--------------~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 203 RIPLKDV---V--------------PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TSCGGGH---H--------------HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHH---H--------------HHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 4332111 1 11111122234556678899999999999999999999999999998764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-44 Score=299.48 Aligned_cols=209 Identities=22% Similarity=0.381 Sum_probs=168.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||+++++|.++ ..++++|++.+++|.+++.. ....+++..++.++.|++.||+|||+++ ++|||
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrD 136 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 136 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCc
Confidence 36789999999999999765 56778899999999998876 5678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~~ 159 (267)
|||+||+++.++.+||+|||+++...............|++.|+|||++.+..++.++||||||+++|||++ |.+||..
T Consensus 137 lKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp CCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999987544443333444568999999999999999999999999999999998 7888864
Q ss_pred cCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhc
Q 024460 160 SKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQ 233 (267)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~ 233 (267)
........ .+....+-..+..++.++.+++.+||..+|++|||++||++.|..+...
T Consensus 217 ~~~~~~~~-----------------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 217 IPASEISS-----------------ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp SCGGGHHH-----------------HHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCHHHHHH-----------------HHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 43211111 1111111223456778899999999999999999999999999887654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-44 Score=294.70 Aligned_cols=201 Identities=26% Similarity=0.315 Sum_probs=162.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++|||||+++++|.+++.+|+|||||++|+|.+++.. .+.+++..+..++.|++.||+|||+++ ++|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrD 138 (293)
T d1jksa_ 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFD 138 (293)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecc
Confidence 36788999999999999999999999999999999999965 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC----ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCC
Q 024460 81 LKSANILLDNDF----NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 81 i~~~nili~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||+||+++.++ .+|++|||++...... .......+++.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccceEEEecCCCcccceEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999998765 5999999999764322 223345689999999999999999999999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|...........+ .. .........+..++.++.++|.+||+.||++|||++|+++
T Consensus 216 f~~~~~~~~~~~i------~~--------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 216 FLGDTKQETLANV------SA--------VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SCCSSHHHHHHHH------HT--------TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHH------Hh--------cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9743321110000 00 0000000112345678999999999999999999999985
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=294.89 Aligned_cols=208 Identities=30% Similarity=0.411 Sum_probs=171.3
Q ss_pred CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 024460 6 HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCKAN 73 (267)
Q Consensus 6 ~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ 73 (267)
+|||||+++++|.+++..++|||||++|+|.++++.... ....+++..++.++.|++.||+|||+++
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~- 155 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK- 155 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 899999999999999999999999999999999975332 2356899999999999999999999999
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT- 152 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~- 152 (267)
++||||||+|||++.++.+||+|||++................+++.|+|||.+.+..|+.++||||||+++|+|++
T Consensus 156 --ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~ 233 (299)
T d1fgka_ 156 --CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 233 (299)
T ss_dssp --CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccC
Confidence 99999999999999999999999999986544333333445668899999999999999999999999999999998
Q ss_pred CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 153 GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
|.+||........ .. .+.....-..+..++.++.++|.+||+.+|++|||++||++.|+++.+
T Consensus 234 g~~p~~~~~~~~~---~~--------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 234 GGSPYPGVPVEEL---FK--------------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp SCCSSTTCCHHHH---HH--------------HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHH---HH--------------HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 6888864332111 00 011111112344567789999999999999999999999999998876
Q ss_pred c
Q 024460 233 Q 233 (267)
Q Consensus 233 ~ 233 (267)
.
T Consensus 297 ~ 297 (299)
T d1fgka_ 297 L 297 (299)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-44 Score=292.69 Aligned_cols=208 Identities=28% Similarity=0.365 Sum_probs=166.2
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+ +..++|||||+++++.+++.. ..+.+++..++.++.|++.||.|||+++ ++|||
T Consensus 64 ~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 136 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRD 136 (273)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---Eeeee
Confidence 3678999999999999965 467899999999999998875 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcce-eeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh-CCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHV-STRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT-GRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~-g~~p~~ 158 (267)
|||+||+++.++.+||+|||+++.......... .....++..|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999986543332222 233456789999999999999999999999999999998 899996
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
........ ..+.....+-..+..++.++.+++.+||..||++|||+++|++.|++.+
T Consensus 217 ~~~~~~~~----------------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 217 GLNGSQIL----------------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp TCCHHHHH----------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CcCHHHHH----------------HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence 44322111 0011111111234566788999999999999999999999999998763
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=293.96 Aligned_cols=211 Identities=28% Similarity=0.392 Sum_probs=170.0
Q ss_pred CCCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC------------CCCCCCCHHHHHHHHHHHHHHHHHh
Q 024460 2 LSLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------------PDQEPLSWNTRMKIAVGAARGLEYL 68 (267)
Q Consensus 2 l~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------------~~~~~~~~~~~~~~~~~l~~~l~~l 68 (267)
|+++ +||||+++++++.+++.+++||||+++|+|.++++... .....+++..+..++.|++.|+.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 5677 79999999999999999999999999999999997531 2346799999999999999999999
Q ss_pred hhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHH
Q 024460 69 HCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLL 148 (267)
Q Consensus 69 H~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~ 148 (267)
|+++ ++||||||+|||++.++.+||+|||+++... .........++..|+|||.+....++.++||||||+++|
T Consensus 144 H~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 144 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSC---EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hcCC---ccccccccceEEEcCCCceEEcccccccccc---ccccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9999 9999999999999999999999999987432 222223446789999999999999999999999999999
Q ss_pred HHHhCC-CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHH
Q 024460 149 ELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVAL 227 (267)
Q Consensus 149 ~~l~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l 227 (267)
||++|. +||....... +.. .+....+-..+..++.++.++|.+||+.+|++|||++||++.|
T Consensus 218 ell~~~~~p~~~~~~~~---~~~--------------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCAE---LYE--------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHHTTSCCTTTTCCHHH---HHH--------------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCCCCCCCHHH---HHH--------------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999975 5665332111 110 0111111223456778899999999999999999999999999
Q ss_pred HHhhhccC
Q 024460 228 DYLVSQRD 235 (267)
Q Consensus 228 ~~l~~~~~ 235 (267)
+.+.+...
T Consensus 281 ~~i~~~~~ 288 (309)
T d1fvra_ 281 NRMLEERK 288 (309)
T ss_dssp HHHHHSSS
T ss_pred HHHHhcCc
Confidence 99887554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-44 Score=292.79 Aligned_cols=209 Identities=27% Similarity=0.393 Sum_probs=162.1
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|++++|||||++++++.+ +.+++|||||++|+|..++... ....+++..++.++.|++.||+|||+++ ++|+||
T Consensus 66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~Dl 139 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 139 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccc
Confidence 678999999999999854 5689999999999999988652 2356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc-ccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM-DLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~-~~~ 160 (267)
||+|||++.++.+||+|||+++...... ........+++.|+|||++....++.++||||||+++|||++|..|+ ...
T Consensus 140 Kp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 140 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp SGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997543222 22233456899999999999999999999999999999999966554 322
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhcc
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQR 234 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~ 234 (267)
..... .. .+....+...+..++.++.+++.+||+.+|++|||+++|+++|+.+.+..
T Consensus 219 ~~~~~---~~--------------~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 219 VNREV---LD--------------QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CHHHH---HH--------------HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHHHH---HH--------------HHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 21110 00 01111122335567788999999999999999999999999998776543
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=294.07 Aligned_cols=210 Identities=26% Similarity=0.341 Sum_probs=160.8
Q ss_pred CCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCC------------CCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 024460 5 LHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEP------------DQEPLSWNTRMKIAVGAARGLEYLHCK 71 (267)
Q Consensus 5 l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~------------~~~~~~~~~~~~~~~~l~~~l~~lH~~ 71 (267)
.+|+||+.+++++.. ++.+++|||||++|+|.++++.... ....+++..++.++.|++.||+|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 478999999998765 4568999999999999999975321 234588999999999999999999999
Q ss_pred CCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHH
Q 024460 72 ANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELI 151 (267)
Q Consensus 72 ~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l 151 (267)
+ ++||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+|+++|||+
T Consensus 154 ~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 154 K---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp T---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 9 9999999999999999999999999998654433333344457899999999999999999999999999999999
Q ss_pred hC-CCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 152 TG-RKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 152 ~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
++ .+||......... .. .+.....-..+..+++++.+++.+||+.+|++|||++||++.|+.+
T Consensus 231 t~~~~p~~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 231 SLGASPYPGVKIDEEF--CR--------------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp TTSCCSSTTCCCSHHH--HH--------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHH--HH--------------HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 86 4677533321110 00 0001111123455678899999999999999999999999999988
Q ss_pred hhc
Q 024460 231 VSQ 233 (267)
Q Consensus 231 ~~~ 233 (267)
.+.
T Consensus 295 lq~ 297 (299)
T d1ywna1 295 LQA 297 (299)
T ss_dssp HHH
T ss_pred HhC
Confidence 653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-43 Score=293.01 Aligned_cols=195 Identities=27% Similarity=0.387 Sum_probs=163.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+|||||++|+|..++.. ...+++..+..++.|++.||+|||+++ ++|||
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrD 129 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRD 129 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccc
Confidence 46789999999999999999999999999999999998865 567888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 130 iKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 130 LKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 9999999999999999999999864322 23457899999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
...... .... ... ..++..++.++.+++.+||..+|.+|+ |++++++
T Consensus 205 ~~~~~~------~~i~----------~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 NTMKTY------EKIL----------NAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SHHHHH------HHHH----------HCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHH------HHHH----------cCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 321110 0000 000 122445577899999999999999996 8999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-43 Score=293.32 Aligned_cols=211 Identities=25% Similarity=0.388 Sum_probs=168.8
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC--------------------CCCCCCHHHHHHHHHH
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------------DQEPLSWNTRMKIAVG 60 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------------~~~~~~~~~~~~~~~~ 60 (267)
+|++++||||+++++++...+..+++|||+++|+|.+++..... ....+++..++.++.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 36789999999999999999999999999999999999964221 2345888999999999
Q ss_pred HHHHHHHhhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCe
Q 024460 61 AARGLEYLHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDI 140 (267)
Q Consensus 61 l~~~l~~lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv 140 (267)
++.|++|||+++ ++||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||
T Consensus 149 i~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 999999999999 99999999999999999999999999875433333333445668899999999999999999999
Q ss_pred eehHHHHHHHHhCC-CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC
Q 024460 141 YSFGVVLLELITGR-KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 141 ~slG~i~~~~l~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
||||+++|||++|. +||...........+ .+ ...-..+..++.++.+++.+||+.+|++|||
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~~e~~~~v----------------~~-~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYV----------------RD-GNILACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----------------HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccchhhHHHHHccCCCCCCCCCHHHHHHHH----------------Hc-CCCCCCCccchHHHHHHHHHHcCCChhHCcC
Confidence 99999999999985 567543321111000 00 0111234566788999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 024460 220 INDIVVALDYLV 231 (267)
Q Consensus 220 ~~ev~~~l~~l~ 231 (267)
+.||+++|+++.
T Consensus 289 ~~ev~~~L~~i~ 300 (301)
T d1lufa_ 289 FCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHhc
Confidence 999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-42 Score=295.22 Aligned_cols=198 Identities=25% Similarity=0.282 Sum_probs=162.5
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|+.++||||++++++|.+++.+|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++ ++||||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDl 133 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDL 133 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceee
Confidence 5678999999999999999999999999999999999965 467889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
||+|||++.++.+||+|||++...... ......||+.|+|||++.. ..++.++|||||||++|+|++|..||...
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999854322 2234568999999999864 57899999999999999999999999754
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCC-----HHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPL-----INDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt-----~~ev~~ 225 (267)
.......+.... . ......+..++.++.++|.+||..||++||| ++|+++
T Consensus 210 ~~~~~~~~~~~~-------------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 210 KTKDKHEIDRMT-------------L--TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CSSCHHHHHHHS-------------S--SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CHHHHHHHHHhc-------------c--cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 322211111100 0 0011223456778999999999999999999 688876
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-43 Score=293.22 Aligned_cols=212 Identities=27% Similarity=0.393 Sum_probs=172.2
Q ss_pred CCC-CCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCC--------------CCCCCCHHHHHHHHHHHHHHHHH
Q 024460 3 SLL-HHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEP--------------DQEPLSWNTRMKIAVGAARGLEY 67 (267)
Q Consensus 3 ~~l-~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--------------~~~~~~~~~~~~~~~~l~~~l~~ 67 (267)
+++ +|||||++++++.+++.+++|||||++|+|.++++.... ....+++..+..++.|++.|++|
T Consensus 81 ~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~ 160 (311)
T d1t46a_ 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (311)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 445 799999999999999999999999999999999975321 23468899999999999999999
Q ss_pred hhhcCCCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHH
Q 024460 68 LHCKANPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVL 147 (267)
Q Consensus 68 lH~~~~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~ 147 (267)
||+++ ++||||||+||+++.++.++++|||.++...............+++.|+|||++....++.++||||||+++
T Consensus 161 LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l 237 (311)
T d1t46a_ 161 LASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237 (311)
T ss_dssp HHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHH
Confidence 99999 999999999999999999999999999876554444455556789999999999999999999999999999
Q ss_pred HHHHh-CCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHH
Q 024460 148 LELIT-GRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVA 226 (267)
Q Consensus 148 ~~~l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~ 226 (267)
|||++ |.+|+......... ...+....+-..+..++.++.+||.+||+.||++|||+++|+++
T Consensus 238 ~ellt~g~p~~~~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~ 301 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPVDSKF----------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (311)
T ss_dssp HHHHTTTCCSSTTCCSSHHH----------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHH----------------HHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99998 56666543322111 11111111222344567889999999999999999999999999
Q ss_pred HHHhhhc
Q 024460 227 LDYLVSQ 233 (267)
Q Consensus 227 l~~l~~~ 233 (267)
|++..+.
T Consensus 302 L~~~i~~ 308 (311)
T d1t46a_ 302 IEKQISE 308 (311)
T ss_dssp HHHHHHH
T ss_pred HHHhhcc
Confidence 9876654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=292.01 Aligned_cols=202 Identities=15% Similarity=0.211 Sum_probs=162.9
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||++++++|.+++.+|+|||||++|+|.+++.. .+..+++..+..++.||+.||.|||+++ ++|||
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrD 127 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCccc
Confidence 36789999999999999999999999999999999999965 3457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC--CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDND--FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+|||++.+ ..++++|||++..... ........+++.|+|||...+..++.++|||||||++|+|++|.+||.
T Consensus 128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 128 IRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCGGGEEESSSSCCCEEECCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccceeecCCCceEEEEcccchhhcccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 99999999744 5799999999985432 223445678999999999999999999999999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
......... ....... .+.......++.++.++|.+||..||++|||++|+++
T Consensus 205 ~~~~~~~~~------~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 205 AETNQQIIE------NIMNAEY--------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CSSHHHHHH------HHHHTCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHH------HHHhCCC--------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 443211100 0000000 0000001234677899999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=291.45 Aligned_cols=203 Identities=20% Similarity=0.228 Sum_probs=159.9
Q ss_pred CCCCCCCccceeeEEee----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 3 SLLHHDNLVTLIGYCTS----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
+.++||||++++++|.+ +..+|+|||||++|+|.+++.. .....+++..+..++.|++.||+|||+++ ++|
T Consensus 60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiH 134 (335)
T d2ozaa1 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 134 (335)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccc
Confidence 34589999999999875 4678999999999999999975 23457999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 79 RDLKSANILLDN---DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 79 ~di~~~nili~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
|||||+|||++. .+.+||+|||+++...... ......|++.|+|||++.+..|+.++|||||||++|+|++|.+
T Consensus 135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred ccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 999999999975 4579999999998643322 2344678999999999999999999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCC--cCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDP--LLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
||............. ...... .+.......++.++.++|.+||+.||++|||++|+++
T Consensus 212 Pf~~~~~~~~~~~~~------------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 212 PFYSNHGLAISPGMK------------TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SCEETTCC--------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHH------------HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 996443221110000 000000 0111112356788999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=287.59 Aligned_cols=213 Identities=26% Similarity=0.397 Sum_probs=169.3
Q ss_pred CCCCCCCCCccceeeEEee-CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeC
Q 024460 1 MLSLLHHDNLVTLIGYCTS-GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYR 79 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~-~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~ 79 (267)
+|++++||||+++++++.. ++..++|||||++++|.+++.. .....++..++.++.|++.||.|||+.+ ++||
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHr 154 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 154 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccC
Confidence 3678999999999999865 5689999999999999999875 4567788889999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCc
Q 024460 80 DLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAM 157 (267)
Q Consensus 80 di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~ 157 (267)
||||+|||+++++.+||+|||+++........ .......|+..|+|||.+....++.++||||||+++|||++|..||
T Consensus 155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999999865433221 1222346789999999999999999999999999999999977776
Q ss_pred cccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhhccC
Q 024460 158 DLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVSQRD 235 (267)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~~~~ 235 (267)
........ +... ... ..+-..|..++.++.++|.+||..+|++|||++||++.|+.+.+.-.
T Consensus 235 ~~~~~~~~--~~~~---i~~-----------g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 235 YPDVNTFD--ITVY---LLQ-----------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp CC--------CHHH---HHT-----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCHHH--HHHH---HHc-----------CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 43221111 1110 000 00112244567789999999999999999999999999999986533
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=293.43 Aligned_cols=196 Identities=28% Similarity=0.392 Sum_probs=163.2
Q ss_pred CCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCC
Q 024460 3 SLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDLK 82 (267)
Q Consensus 3 ~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di~ 82 (267)
+.++||||+++++++.+++.+|+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++ ++|||||
T Consensus 58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDik 130 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLK 130 (320)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCC
T ss_pred HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 368999999999999999999999999999999999965 457899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCccccCc
Q 024460 83 SANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLSKG 162 (267)
Q Consensus 83 ~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~~~ 162 (267)
|+|||++.++.+||+|||++...... ........|++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 131 p~NiL~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 131 LDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceeecCCCceeccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999854322 2234446789999999999999999999999999999999999999974432
Q ss_pred cCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH-HHHH
Q 024460 163 QGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN-DIVV 225 (267)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-ev~~ 225 (267)
......+ .. ..+ .+|..++.++.++|.+||..||++|||++ ++++
T Consensus 209 ~~~~~~i------~~--------~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 209 EELFHSI------RM--------DNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHH------HH--------CCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHH------Hc--------CCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111000 00 011 12445677899999999999999999996 6764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-42 Score=292.14 Aligned_cols=195 Identities=25% Similarity=0.261 Sum_probs=163.7
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++...+.+++||||+.+|+|..++.. .+.+++..+..++.||+.||.|||+++ ++|||
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRD 166 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCc
Confidence 47889999999999999999999999999999999999965 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMDLS 160 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~~~ 160 (267)
|||+|||++.++.+||+|||+++..... .....|++.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 167 IKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 167 LKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999864322 23356899999999999999999999999999999999999999643
Q ss_pred CccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 161 KGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
...... . .... .. -..+..++.++.++|++||..||.+|+ |++++++
T Consensus 242 ~~~~~~---~---~i~~----------~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 QPIQIY---E---KIVS----------GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SHHHHH---H---HHHH----------CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHH---H---HHhc----------CC--CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 211110 0 0000 00 112345677899999999999999994 8999986
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=282.27 Aligned_cols=229 Identities=24% Similarity=0.294 Sum_probs=168.6
Q ss_pred CCCCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----
Q 024460 2 LSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----- 72 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----- 72 (267)
+++++||||+++++++..++ .+|+|||||++|+|.++++. ..+++..++.++.|++.++.|||+..
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~ 125 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 56789999999999997654 68999999999999999965 46889999999999999999999631
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccCC------CcccCCeeehH
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSGK------LTLKSDIYSFG 144 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~------~~~~~Dv~slG 144 (267)
..+++|+||||+|||++.++.+||+|||++......... .......|++.|+|||++.+.. ++.++||||||
T Consensus 126 ~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 112999999999999999999999999998764332221 1223456899999999987643 56789999999
Q ss_pred HHHHHHHhCCCCccccCccCccchh--h--hchhhhhcccccccccCCcCCCCC-cHHHHHHHHHHHHhhcccCCCCCCC
Q 024460 145 VVLLELITGRKAMDLSKGQGEQNLV--S--WSRPFLKDQKKFVHLVDPLLHGRY-PRRCLNYAVAVTAMCLNEEANFRPL 219 (267)
Q Consensus 145 ~i~~~~l~g~~p~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~Rpt 219 (267)
+++|||++|.+|+............ . ....... .........+.+.... +..+...+.+++.+||+.||++|||
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 284 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHH-HHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHH-HHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence 9999999999888544433221110 0 0000000 0011111122221111 2356778999999999999999999
Q ss_pred HHHHHHHHHHhhhccCC
Q 024460 220 INDIVVALDYLVSQRDS 236 (267)
Q Consensus 220 ~~ev~~~l~~l~~~~~~ 236 (267)
+.||++.|+++.+++..
T Consensus 285 ~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 285 ALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHhcCC
Confidence 99999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.2e-42 Score=283.03 Aligned_cols=200 Identities=25% Similarity=0.282 Sum_probs=162.1
Q ss_pred CCCCC-CCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLH-HDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++++ ||||+++++++.+++..|+|||||++|+|.+++.. .+.+++..+..++.||+.||+|||+++ ++|||
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrD 135 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRD 135 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---Ccccc
Confidence 45665 99999999999999999999999999999999964 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc------CCCcccCCeeehHHHHHHHHhCC
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS------GKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
|||+||+++.++.+||+|||++....... ......|++.|+|||.+.+ ..++.++||||+|+++|+|++|.
T Consensus 136 lkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 136 LKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 99999999999999999999998643322 2344568999999998864 34688999999999999999999
Q ss_pred CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 155 KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.||........... ..... ..........+++++.+++.+||+.+|++|||++|+++
T Consensus 213 ~Pf~~~~~~~~~~~------i~~~~--------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 213 PPFWHRKQMLMLRM------IMSGN--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CSSCCSSHHHHHHH------HHHTC--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHHHHHH------HHhCC--------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 99974432111100 01000 01111223466788999999999999999999999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.5e-42 Score=280.40 Aligned_cols=210 Identities=22% Similarity=0.306 Sum_probs=159.9
Q ss_pred CCCCCCCCCccceeeEEeeCC----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPV 76 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i 76 (267)
+|++++||||+++++++..++ .+|+|||||++++|.+++.. .+.+++..+..++.|++.||+|||+++ +
T Consensus 60 ~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---i 132 (277)
T d1o6ya_ 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---I 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 367899999999999987654 48999999999999998865 457999999999999999999999999 9
Q ss_pred eeCCCCCCcEEEcCCCceEEeccCCcccCCCCC-CcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 77 IYRDLKSANILLDNDFNPKLSDFGLAKLGPVGD-NTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 77 ~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
+||||||+||+++.++..+++|||.+....... .........|++.|+|||++.+..++.++||||||+++|+|++|.+
T Consensus 133 iHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~ 212 (277)
T d1o6ya_ 133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212 (277)
T ss_dssp ECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCC
Confidence 999999999999999999999999886543222 2223344568999999999999999999999999999999999999
Q ss_pred CccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-CHHHHHHHHHHhh
Q 024460 156 AMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-LINDIVVALDYLV 231 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-t~~ev~~~l~~l~ 231 (267)
||......... ........ .........++.++.++|.+||..||++|| |++++++.|.++.
T Consensus 213 Pf~~~~~~~~~------~~~~~~~~--------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 213 PFTGDSPVSVA------YQHVREDP--------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SCCCSSHHHHH------HHHHHCCC--------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCcCHHHHH------HHHHhcCC--------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 99743321110 00111000 000111234567899999999999999999 8999999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-42 Score=284.74 Aligned_cols=216 Identities=21% Similarity=0.188 Sum_probs=159.4
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++.+|+||||+.++++..+.. ....+++..+..++.|++.||+|||+++ ++|||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrD 125 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRD 125 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccc---eeccc
Confidence 3678899999999999999999999999998876666553 4567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+||+|||++....... .......+++.|+|||++.. ..++.++|||||||++|+|++|.+||..
T Consensus 126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 126 LKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 99999999999999999999997543222 22333568999999998865 4679999999999999999999999964
Q ss_pred cCccCccchh-hhc----hhhhhcccccccccC-CcCCCC----CcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLV-SWS----RPFLKDQKKFVHLVD-PLLHGR----YPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~-~~~----~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.........+ ... ............... ...... .....+.++.++|.+||+.||++|||++|+++
T Consensus 204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 4322111000 000 000000000000000 000000 01133578999999999999999999999984
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=284.56 Aligned_cols=212 Identities=24% Similarity=0.387 Sum_probs=170.3
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccC------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLE------PDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||+++++++..++..++||||+++|+|.+++.... .....+++..+..++.|++.|+.|||+++
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-- 153 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 153 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 4788999999999999999999999999999999999886421 12345788999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++||||||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||+|+++|||++|.
T Consensus 154 -ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 154 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999999999999999999999999997643333333334446789999999999999999999999999999999984
Q ss_pred -CCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhhh
Q 024460 155 -KAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLVS 232 (267)
Q Consensus 155 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~~ 232 (267)
+||.......... .+.+. ..-..+..++..+.++|.+||+.+|++|||+++|++.|+...+
T Consensus 233 ~~p~~~~~~~~~~~----------------~i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 233 EQPYQGLSNEQVLR----------------FVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCTTTTSCHHHHHH----------------HHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCHHHHHH----------------HHHhC-CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6775332211110 00111 1112345667889999999999999999999999999876643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=278.60 Aligned_cols=217 Identities=21% Similarity=0.275 Sum_probs=159.0
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++.+++.+|+||||+.+ ++.+++.. .....+++..+..++.|++.||+|||+++ ++|||
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrD 127 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRD 127 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccc
Confidence 47899999999999999999999999999965 55544433 24567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-CcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+||+|||.+....... .......+++.|+|||++.... ++.++|+||||+++|+|++|..||..
T Consensus 128 iKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 128 LKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 99999999999999999999987543222 2233346899999999887765 57899999999999999999999964
Q ss_pred cCccCccc-hhhh----ch---hhhhcccccccccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQN-LVSW----SR---PFLKDQKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~-~~~~----~~---~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
........ +... .. ..................... ...++.++.+++.+||..||++|||++|+++
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 43221110 0000 00 000000000000000110000 1133567899999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=275.75 Aligned_cols=213 Identities=22% Similarity=0.245 Sum_probs=157.9
Q ss_pred CCCCCCccceeeEEee-----CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 4 LLHHDNLVTLIGYCTS-----GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 4 ~l~Hpniv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
.++||||++++++|.. +...+++||+++++.+...... ....+++..+..++.|++.||+|||+++ |+|
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivH 139 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVH 139 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEe
Confidence 4589999999999853 3478999999988766554443 5677999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 79 RDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 79 ~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||||+|||++..+.+||+|||++.... .........||+.|+|||++.+..|+.++||||+||++|+|++|.+||.
T Consensus 140 rDiKp~NILi~~~~~~kl~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 140 RDLKPQNILVTSSGQIKLADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCccEEEEcCCCCeeecchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 9999999999999999999999987432 2233445678999999999999999999999999999999999999997
Q ss_pred ccCccCccchh-hhc----hhhhhcccccc----cccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 159 LSKGQGEQNLV-SWS----RPFLKDQKKFV----HLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~-~~~----~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
..........+ ... ........... ..........+....++.+.+||.+||+.||++|||++|+++
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 54322111100 000 00000000000 000000001122345677899999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=274.64 Aligned_cols=189 Identities=22% Similarity=0.304 Sum_probs=154.3
Q ss_pred CCCCC--CCCccceeeEEeeCCeeEEEEecCCC-CCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLH--HDNLVTLIGYCTSGDQRLLVYEYMPM-GSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~--Hpniv~~~~~~~~~~~~~lv~e~~~~-~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|++++ ||||+++++++.+++..++||||+.+ +++.+++.. ...+++..+..++.|++.||+|||+++ ++|
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiH 133 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLH 133 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 34454 89999999999999999999999976 577787754 467999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC-CCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCC-cccCCeeehHHHHHHHHhCCCC
Q 024460 79 RDLKSANILLDN-DFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKL-TLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 79 ~di~~~nili~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||||+||+++. ++.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..|
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 999999999985 478999999999754222 2334568999999999987665 6779999999999999999999
Q ss_pred ccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 157 MDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
|..... ..... . .++..++.++.++|.+||..||++|||++|+++
T Consensus 210 f~~~~~------------i~~~~--------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 210 FEHDEE------------IIRGQ--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCSHHH------------HHHCC--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCchH------------Hhhcc--------c----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 963210 00000 0 122345678999999999999999999999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-39 Score=267.24 Aligned_cols=216 Identities=21% Similarity=0.258 Sum_probs=157.1
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|++++||||+++++++..++..+++||++.++.+..+.. ..+.+++..+..++.|++.||+|||+.+ |+|||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrD 125 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecC
Confidence 5789999999999999999999999999997766666553 3578999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+|++|||.+....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||..
T Consensus 126 iKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 126 LKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 99999999999999999999987533221 122334578899999998764 568999999999999999999999964
Q ss_pred cCccCccchhhh--ch---hhhhccccccc------ccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQNLVSW--SR---PFLKDQKKFVH------LVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~~~~~~--~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
.........+.. .. ........... ...+..........+.++.++|.+||+.||++|||++|+++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 432111000000 00 00000000000 00111111112344678999999999999999999999984
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=271.85 Aligned_cols=224 Identities=25% Similarity=0.261 Sum_probs=158.9
Q ss_pred CCCCCCCCCccceeeEEee------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||++++++|.. ..++|+|||||+++ +.+.+.........+++..+..++.|++.||+|||+++
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-- 142 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 142 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 4678999999999999854 23579999999765 44444322224668999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCC-ceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHh
Q 024460 75 PVIYRDLKSANILLDNDF-NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~ 152 (267)
|+||||||+|||++.++ .+||+|||++....... ......|+..|+|||++.+ ..++.++||||+||++|+|++
T Consensus 143 -IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 143 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp -EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -CcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhh
Confidence 99999999999998765 89999999987543222 2334568999999998775 578999999999999999999
Q ss_pred CCCCccccCccCccchh-hh----chhhhhc------ccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 153 GRKAMDLSKGQGEQNLV-SW----SRPFLKD------QKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~-~~----~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
|.+||...........+ .. ....... ....................++++.+++.+||..||++|||++
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999654322111000 00 0000000 0000000000111111234567899999999999999999999
Q ss_pred HHHH--HHHHhh
Q 024460 222 DIVV--ALDYLV 231 (267)
Q Consensus 222 ev~~--~l~~l~ 231 (267)
|+++ .|+++.
T Consensus 299 e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 299 EACAHSFFDELR 310 (350)
T ss_dssp HHHTSGGGGGGG
T ss_pred HHhcCHhhcccc
Confidence 9997 355554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.6e-38 Score=258.66 Aligned_cols=222 Identities=16% Similarity=0.146 Sum_probs=171.4
Q ss_pred CCCCCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
++.|+| +|++.+++++..+...++||||+ +++|.+++.. ....++...+..++.|++.+|.|||+++ ++|||
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrD 126 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 345655 89999999999999999999999 6799998865 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcC-----CCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHH
Q 024460 81 LKSANILLDN-----DFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLEL 150 (267)
Q Consensus 81 i~~~nili~~-----~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~ 150 (267)
|||+||+++. .+.++++|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence 9999999964 567999999999864322111 122345689999999999999999999999999999999
Q ss_pred HhCCCCccccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHh
Q 024460 151 ITGRKAMDLSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYL 230 (267)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l 230 (267)
++|..||.................. .......+ ....+++++.+++..|+..+|++||+++.+.+.|+.+
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~-~~~~~~~~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEK-KQSTPLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHH-HHHSCHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCcCCCccchhHHHHHHHHHhc-cCCCChHH---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 9999999755433322111110000 00000000 1123467899999999999999999999999999988
Q ss_pred hhccCCCCCc
Q 024460 231 VSQRDSHPVS 240 (267)
Q Consensus 231 ~~~~~~~~~~ 240 (267)
..+.......
T Consensus 277 ~~~~~~~~~~ 286 (293)
T d1csna_ 277 LERLNTTEDE 286 (293)
T ss_dssp HHHTTCCSCS
T ss_pred HHHcCCCCCC
Confidence 7766555433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-38 Score=258.71 Aligned_cols=218 Identities=19% Similarity=0.189 Sum_probs=162.2
Q ss_pred CCCCCCCC-ccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHHDN-LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~Hpn-iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+++++|+| |+.+..++.+++..++||||+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ ++|||
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrD 128 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 45677765 555566668888999999999 5577776654 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcC---CCceEEeccCCcccCCCCCCc-----ceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHh
Q 024460 81 LKSANILLDN---DFNPKLSDFGLAKLGPVGDNT-----HVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELIT 152 (267)
Q Consensus 81 i~~~nili~~---~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~ 152 (267)
|||+||+++. +..++++|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t 208 (299)
T d1ckia_ 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208 (299)
T ss_dssp CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh
Confidence 9999999853 457999999999865332221 12234578999999999999999999999999999999999
Q ss_pred CCCCccccCccCccchh-hhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHHHHHHhh
Q 024460 153 GRKAMDLSKGQGEQNLV-SWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVVALDYLV 231 (267)
Q Consensus 153 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~~l~~l~ 231 (267)
|..||............ ........ ... + .....++.++.+++..||..+|++||+++++.+.|+.+.
T Consensus 209 g~~P~~~~~~~~~~~~~~~~~~~~~~--~~~-----~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 209 GSLPWQGLKAATKRQKYERISEKKMS--TPI-----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp SSCTTCCCC-------HHHHHHHHHH--SCH-----H----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCcccccchHHHHHHHHHhhcccCC--CCh-----h----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 99999755433322211 11110000 000 0 012245678999999999999999999999999998876
Q ss_pred hccCCC
Q 024460 232 SQRDSH 237 (267)
Q Consensus 232 ~~~~~~ 237 (267)
......
T Consensus 278 ~~~~~~ 283 (299)
T d1ckia_ 278 HRQGFS 283 (299)
T ss_dssp HHHTCC
T ss_pred HHcCCC
Confidence 544433
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-38 Score=264.21 Aligned_cols=202 Identities=28% Similarity=0.347 Sum_probs=160.9
Q ss_pred CCCCCC-CCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 2 LSLLHH-DNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 2 l~~l~H-pniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
|++++| |||+++++++++...++++|||+.+|+|.+++.. ...+++..+..++.|++.|+.|||+++ ++|+|
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrD 154 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 154 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEecc
Confidence 566766 8999999999999999999999999999999965 456788999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC--CCcccCCeeehHHHHHHHHhCCCCcc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG--KLTLKSDIYSFGVVLLELITGRKAMD 158 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~~l~g~~p~~ 158 (267)
|||+||+++.++.++|+|||++....... ........+++.|++||.+.+. .++.++|||||||++|+|++|..||.
T Consensus 155 iKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 155 IKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999987543222 2223446789999999998754 46789999999999999999999997
Q ss_pred ccCccCccchhhhchhhhhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCC-----CHHHHHH
Q 024460 159 LSKGQGEQNLVSWSRPFLKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRP-----LINDIVV 225 (267)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp-----t~~ev~~ 225 (267)
..........+... ... ..-..+..++.++.+++.+||..||.+|| |++|+++
T Consensus 234 ~~~~~~~~~~i~~~--~~~------------~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 234 VDGEKNSQAEISRR--ILK------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CTTSCCCHHHHHHH--HHH------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCHHHHHHHHHHh--ccc------------CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 55433222111100 000 00122446688899999999999999999 4788876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-38 Score=265.41 Aligned_cols=216 Identities=25% Similarity=0.346 Sum_probs=159.4
Q ss_pred CCCCCCCCCccceeeEEeeCC------eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD------QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~------~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||++++++|...+ .+|+||||| +.+|...+.. ..+++..+..++.|++.||.|||+++
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~-- 141 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG-- 141 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367899999999999997654 579999999 5678887743 57999999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++||||||+|||++.++.++++|||++...... .....+++.|+|||++.+ ..++.++||||+||++|+|++|
T Consensus 142 -IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g 215 (346)
T d1cm8a_ 142 -IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215 (346)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred -CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence 999999999999999999999999999864322 234568999999999876 4578999999999999999999
Q ss_pred CCCccccCccCccchhhhc-----hhhhh-----cccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 154 RKAMDLSKGQGEQNLVSWS-----RPFLK-----DQKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.+||............... ..... ........+....... .....+.++.+||.+||..||++|||+
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 295 (346)
T d1cm8a_ 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295 (346)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH
Confidence 9999654322111000000 00000 0000000011111111 112345678999999999999999999
Q ss_pred HHHHH--HHHHh
Q 024460 221 NDIVV--ALDYL 230 (267)
Q Consensus 221 ~ev~~--~l~~l 230 (267)
+|+++ .|+.+
T Consensus 296 ~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 296 GEALAHPYFESL 307 (346)
T ss_dssp HHHHHSGGGTTT
T ss_pred HHHhcChhhCcC
Confidence 99997 35544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-37 Score=260.42 Aligned_cols=218 Identities=22% Similarity=0.268 Sum_probs=154.1
Q ss_pred CCCCCCCCCccceeeEEee--------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 024460 1 MLSLLHHDNLVTLIGYCTS--------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA 72 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~--------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 72 (267)
+|++++||||+++++++.. ++.+|+||||+.++.+..... ....+++..+..++.|++.||.|||+++
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ 137 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK 137 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC
Confidence 3678999999999998854 456899999998766554442 4667999999999999999999999999
Q ss_pred CCCeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCc--ceeeecccccceeCCcccccC-CCcccCCeeehHHHHHH
Q 024460 73 NPPVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNT--HVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLE 149 (267)
Q Consensus 73 ~~~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~ 149 (267)
++||||||+|||++.++.++++|||++......... .......+|+.|+|||++.+. .++.++||||+|+++|+
T Consensus 138 ---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 138 ---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeee
Confidence 999999999999999999999999999754332211 122334689999999998765 68999999999999999
Q ss_pred HHhCCCCccccCccCccchhhhchhhhh-c------ccccccccCCcCCCCC--c-----HHHHHHHHHHHHhhcccCCC
Q 024460 150 LITGRKAMDLSKGQGEQNLVSWSRPFLK-D------QKKFVHLVDPLLHGRY--P-----RRCLNYAVAVTAMCLNEEAN 215 (267)
Q Consensus 150 ~l~g~~p~~~~~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~--~-----~~~~~~l~~li~~cl~~~p~ 215 (267)
|++|.+||...........+........ . ................ + .....++.+||.+||+.||+
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 9999999975432222111110000000 0 0000000000000000 0 11245678999999999999
Q ss_pred CCCCHHHHHH
Q 024460 216 FRPLINDIVV 225 (267)
Q Consensus 216 ~Rpt~~ev~~ 225 (267)
+|||++|+++
T Consensus 295 ~R~sa~elL~ 304 (318)
T d3blha1 295 QRIDSDDALN 304 (318)
T ss_dssp TSCCHHHHHH
T ss_pred HCcCHHHHHc
Confidence 9999999994
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-37 Score=259.36 Aligned_cols=211 Identities=17% Similarity=0.227 Sum_probs=155.0
Q ss_pred CCCCC-CCCccceeeEEee--CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 024460 2 LSLLH-HDNLVTLIGYCTS--GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIY 78 (267)
Q Consensus 2 l~~l~-Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h 78 (267)
|++++ ||||++++++|.. ...+++|||||.+++|.... +.+++..+..++.||+.||.|||+++ |+|
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvH 152 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMH 152 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---ccc
Confidence 55665 9999999999975 45689999999999987654 46899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCC-CceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCCCC
Q 024460 79 RDLKSANILLDND-FNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGRKA 156 (267)
Q Consensus 79 ~di~~~nili~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~~p 156 (267)
|||||+|||++.+ +.++++|||++....... ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..|
T Consensus 153 rDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p 229 (328)
T d3bqca1 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229 (328)
T ss_dssp CCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence 9999999999865 468999999997543222 23345679999999998765 579999999999999999999999
Q ss_pred ccccCccCccc--hhhh-chhh---------hhcccccccc--------cCCcCCCCCcHHHHHHHHHHHHhhcccCCCC
Q 024460 157 MDLSKGQGEQN--LVSW-SRPF---------LKDQKKFVHL--------VDPLLHGRYPRRCLNYAVAVTAMCLNEEANF 216 (267)
Q Consensus 157 ~~~~~~~~~~~--~~~~-~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 216 (267)
|.......... +... ..+. .......... ............++.++.+||.+||+.||++
T Consensus 230 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 309 (328)
T d3bqca1 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309 (328)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGG
T ss_pred CCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhH
Confidence 86443321110 0000 0000 0000000000 1111111223445678999999999999999
Q ss_pred CCCHHHHHH
Q 024460 217 RPLINDIVV 225 (267)
Q Consensus 217 Rpt~~ev~~ 225 (267)
|||++|+++
T Consensus 310 R~ta~e~L~ 318 (328)
T d3bqca1 310 RLTAREAME 318 (328)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-37 Score=253.93 Aligned_cols=216 Identities=20% Similarity=0.213 Sum_probs=160.5
Q ss_pred CCCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRD 80 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~d 80 (267)
+|+.++||||+++++++......+++++++.+++|..++.. .+.+++..+..++.|++.||+|||+++ ++|||
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrD 126 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---Eeeec
Confidence 46889999999999999999999999999999888887753 567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCC-CcccCCeeehHHHHHHHHhCCCCccc
Q 024460 81 LKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGK-LTLKSDIYSFGVVLLELITGRKAMDL 159 (267)
Q Consensus 81 i~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~~l~g~~p~~~ 159 (267)
|||+|||++.++.+|++|||.+........ ......++..|.|||++.... ++.++|||||||++|+|++|..||..
T Consensus 127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 127 LKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 999999999999999999999986433222 223345678899999887654 68999999999999999999988743
Q ss_pred cCccCcc-chhhh--ch------hh---hhcccccccccCCcCCCCCcHHHHHHHHHHHHhhcccCCCCCCCHHHHHH
Q 024460 160 SKGQGEQ-NLVSW--SR------PF---LKDQKKFVHLVDPLLHGRYPRRCLNYAVAVTAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 160 ~~~~~~~-~~~~~--~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~ev~~ 225 (267)
....... ..+.. .. .. .......................+..+.+++.+||+.||++|||++|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2221110 00000 00 00 00000000000011111123345678999999999999999999999984
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=261.76 Aligned_cols=216 Identities=22% Similarity=0.258 Sum_probs=153.6
Q ss_pred CCCCCCCCCccceeeEEeeCC-----eeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSGD-----QRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~~-----~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|++++||||+++++++.... .+|++ +++.+++|.+++.. ..+++..+..++.|++.||+|||+++
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~--- 129 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN--- 129 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 467899999999999986543 34555 55568899999964 46999999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCC-cceeeecccccceeCCccccc-CCCcccCCeeehHHHHHHHHhC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDN-THVSTRVMGTYGYCAPEYAMS-GKLTLKSDIYSFGVVLLELITG 153 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~~l~g 153 (267)
++||||||+|||++.++.+||+|||++........ ........+++.|+|||++.. ..++.++|+||+|+++|+|++|
T Consensus 130 iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g 209 (345)
T d1pmea_ 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209 (345)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS
T ss_pred CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC
Confidence 99999999999999999999999999875432211 112234568999999999854 5678999999999999999999
Q ss_pred CCCccccCccCccchhhhc--h---hhhhc-----ccccccccCCcCCCC---CcHHHHHHHHHHHHhhcccCCCCCCCH
Q 024460 154 RKAMDLSKGQGEQNLVSWS--R---PFLKD-----QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCLNEEANFRPLI 220 (267)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~--~---~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rpt~ 220 (267)
.+||............... . ..... ............... .....+.++.+++.+||+.||++|||+
T Consensus 210 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta 289 (345)
T d1pmea_ 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289 (345)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 9999644321110000000 0 00000 000000000000000 011234578999999999999999999
Q ss_pred HHHHH
Q 024460 221 NDIVV 225 (267)
Q Consensus 221 ~ev~~ 225 (267)
+|+++
T Consensus 290 ~e~L~ 294 (345)
T d1pmea_ 290 EQALA 294 (345)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-37 Score=259.85 Aligned_cols=212 Identities=23% Similarity=0.282 Sum_probs=150.0
Q ss_pred CCCCCCCCCccceeeEEee------CCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTS------GDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANP 74 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~------~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ 74 (267)
+|++++||||++++++|.. .+.+|+|||||.+ ++.+.+ ...+++..+..++.|++.||.|||+++
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g-- 139 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG-- 139 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc--
Confidence 3678899999999999954 3688999999966 455545 245899999999999999999999999
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCC
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++|+||||+|||++.++.++++|||+++.... ........+++.|+|||++.+..++.++|+||+||++|+|++|.
T Consensus 140 -iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~ 215 (355)
T d2b1pa1 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccccCCccccccccccceeeechhhhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCC
Confidence 99999999999999999999999999875322 22334456789999999999999999999999999999999999
Q ss_pred CCccccCccCccch------------hhhchh----hhhc-----ccccccccCCcCCCC---CcHHHHHHHHHHHHhhc
Q 024460 155 KAMDLSKGQGEQNL------------VSWSRP----FLKD-----QKKFVHLVDPLLHGR---YPRRCLNYAVAVTAMCL 210 (267)
Q Consensus 155 ~p~~~~~~~~~~~~------------~~~~~~----~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl 210 (267)
+||........... ...... .... ............... .....+.++.+||.+||
T Consensus 216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL 295 (355)
T d2b1pa1 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 99964431111000 000000 0000 000001111111111 12355788999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 024460 211 NEEANFRPLINDIVV 225 (267)
Q Consensus 211 ~~~p~~Rpt~~ev~~ 225 (267)
..||++|||++|+++
T Consensus 296 ~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 296 VIDPAKRISVDDALQ 310 (355)
T ss_dssp CSSTTTSCCHHHHHT
T ss_pred cCChhHCcCHHHHhc
Confidence 999999999999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-36 Score=256.17 Aligned_cols=212 Identities=22% Similarity=0.316 Sum_probs=150.8
Q ss_pred CCCCCCCCCccceeeEEeeC-----CeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 024460 1 MLSLLHHDNLVTLIGYCTSG-----DQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPP 75 (267)
Q Consensus 1 il~~l~Hpniv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~ 75 (267)
+|++++||||+++++++... ...+++++++.+|+|.+++. ...+++..+..++.|++.||+|||+++
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~g--- 141 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSAD--- 141 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46789999999999998633 34466677778999999994 357999999999999999999999999
Q ss_pred eeeCCCCCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccC-CCcccCCeeehHHHHHHHHhCC
Q 024460 76 VIYRDLKSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSG-KLTLKSDIYSFGVVLLELITGR 154 (267)
Q Consensus 76 i~h~di~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~~l~g~ 154 (267)
++||||||+|||++.++.++++|||++.... .......|++.|+|||+..+. .++.++|+||||+++|+|++|.
T Consensus 142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~ 216 (348)
T d2gfsa1 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216 (348)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcccccCCccccccccccccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCC
Confidence 9999999999999999999999999987432 123345689999999987765 4688999999999999999999
Q ss_pred CCccccCccCccchhhhc-----hhhhhc-----ccccccccCCcCCCCC---cHHHHHHHHHHHHhhcccCCCCCCCHH
Q 024460 155 KAMDLSKGQGEQNLVSWS-----RPFLKD-----QKKFVHLVDPLLHGRY---PRRCLNYAVAVTAMCLNEEANFRPLIN 221 (267)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~-----~~~~~~-----~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rpt~~ 221 (267)
+||...........+... ...... .......+.......+ ....+.++.+||.+||..||++|||++
T Consensus 217 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (348)
T d2gfsa1 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296 (348)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHH
Confidence 999644322111000000 000000 0000000000000000 113456789999999999999999999
Q ss_pred HHHH
Q 024460 222 DIVV 225 (267)
Q Consensus 222 ev~~ 225 (267)
|+++
T Consensus 297 elL~ 300 (348)
T d2gfsa1 297 QALA 300 (348)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9996
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=1.1e-30 Score=221.25 Aligned_cols=210 Identities=17% Similarity=0.208 Sum_probs=145.1
Q ss_pred CCCCccceeeEEee--CCeeEEEEecCCCCCH-HHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCC
Q 024460 6 HHDNLVTLIGYCTS--GDQRLLVYEYMPMGSL-EDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHC-KANPPVIYRDL 81 (267)
Q Consensus 6 ~Hpniv~~~~~~~~--~~~~~lv~e~~~~~sL-~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~~i~h~di 81 (267)
.|+||+++++++.. ....+++++++..+.. ...... .....+++..+..++.|++.|+.|||+ .+ |+||||
T Consensus 78 ~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDl 152 (362)
T d1q8ya_ 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDI 152 (362)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCC
T ss_pred CcCceEEEEEEeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccC
Confidence 47899999998865 3456666666544432 222222 256788999999999999999999997 87 999999
Q ss_pred CCCcEEEcCCC------ceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHHHHHHHhCCC
Q 024460 82 KSANILLDNDF------NPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVVLLELITGRK 155 (267)
Q Consensus 82 ~~~nili~~~~------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~~l~g~~ 155 (267)
||+|||++.++ .++++|||.+..... ......+++.|+|||++.+..++.++|+||+|+++++|++|..
T Consensus 153 Kp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 153 KPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp SGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 99999997554 389999999875322 2233568999999999999999999999999999999999999
Q ss_pred CccccCccCccchhhhch-----------hhhhc---------ccccccccCCc----------CCCCCcHHHHHHHHHH
Q 024460 156 AMDLSKGQGEQNLVSWSR-----------PFLKD---------QKKFVHLVDPL----------LHGRYPRRCLNYAVAV 205 (267)
Q Consensus 156 p~~~~~~~~~~~~~~~~~-----------~~~~~---------~~~~~~~~~~~----------~~~~~~~~~~~~l~~l 205 (267)
||................ ..... .......+... .........+.++.+|
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 996543322111000000 00000 00000000010 0112345678899999
Q ss_pred HHhhcccCCCCCCCHHHHHH
Q 024460 206 TAMCLNEEANFRPLINDIVV 225 (267)
Q Consensus 206 i~~cl~~~p~~Rpt~~ev~~ 225 (267)
+.+||..||.+|||++|+++
T Consensus 308 l~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHT
T ss_pred HHHHCCCChhHCcCHHHHhc
Confidence 99999999999999999986
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.53 E-value=4.1e-16 Score=119.25 Aligned_cols=121 Identities=12% Similarity=0.045 Sum_probs=81.2
Q ss_pred CCCCCCCCccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 024460 2 LSLLHHDNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKANPPVIYRDL 81 (267)
Q Consensus 2 l~~l~Hpniv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~i~h~di 81 (267)
|.++.|.+++..+++. ..+++|||+++..+.+ ++...+..++.|++.++++||+++ ++|+||
T Consensus 68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDi 129 (191)
T d1zara2 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDL 129 (191)
T ss_dssp HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHccCCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccC
Confidence 3467888888877653 2379999998755433 222345678999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEeccCCcccCCCCCCcceeeecccccceeCCcccccCCCcccCCeeehHHH
Q 024460 82 KSANILLDNDFNPKLSDFGLAKLGPVGDNTHVSTRVMGTYGYCAPEYAMSGKLTLKSDIYSFGVV 146 (267)
Q Consensus 82 ~~~nili~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i 146 (267)
||+|||++++ .++++|||++.............. ... .-.+ +....|+.++|+||+.--
T Consensus 130 KP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~r---d~~-~~~~-~f~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 130 SQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILER---DVR-NIIT-YFSRTYRTEKDINSAIDR 188 (191)
T ss_dssp STTSEEEETT-EEEECCCTTCEETTSTTHHHHHHH---HHH-HHHH-HHHHHHCCCCCHHHHHHH
T ss_pred ChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHH---HHH-HHHH-HHcCCCCCcccHHHHHHH
Confidence 9999999865 588999999875432221110000 000 0001 113567888999998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.54 E-value=0.00014 Score=56.31 Aligned_cols=85 Identities=16% Similarity=0.107 Sum_probs=57.2
Q ss_pred ccceeeEEeeCCeeEEEEecCCCCCHHHHhcccCCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----------------
Q 024460 10 LVTLIGYCTSGDQRLLVYEYMPMGSLEDHLYDLEPDQEPLSWNTRMKIAVGAARGLEYLHCKA----------------- 72 (267)
Q Consensus 10 iv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~----------------- 72 (267)
+.+++.++..++..++||++++|.++.+.... .. . ...++.++...+..||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~-----~~-~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 142 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYED-----EQ-S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTT-----CS-C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccccccc-----cc-c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence 56778888888999999999999887655422 00 0 1122333334444444211
Q ss_pred ---------------------------------------CCCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 73 ---------------------------------------NPPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 73 ---------------------------------------~~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
...++|+|+.+.||++++++.+.|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1137899999999999977666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.97 E-value=0.00035 Score=53.75 Aligned_cols=29 Identities=24% Similarity=0.173 Sum_probs=25.3
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.||+++.+..+.|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 37999999999999987667899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=94.92 E-value=0.02 Score=46.67 Aligned_cols=28 Identities=25% Similarity=0.322 Sum_probs=24.6
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.++|+|+.+.|||++.+ .++|+||..+.
T Consensus 224 ~LiHGDl~~gNIlv~~~-~~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEH-ETKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSS-CEEECCCTTCE
T ss_pred ceeccCCcCCceeEcCC-ceEEechhhcc
Confidence 48999999999999865 48999999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.15 E-value=0.017 Score=45.36 Aligned_cols=29 Identities=34% Similarity=0.280 Sum_probs=26.2
Q ss_pred CeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 75 PVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 75 ~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
+++|+|+.++|++++++...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 59999999999999988777899999875
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=89.77 E-value=0.22 Score=39.01 Aligned_cols=28 Identities=25% Similarity=0.324 Sum_probs=23.1
Q ss_pred CCeeeCCCCCCcEEEcCCCceEEeccCCcc
Q 024460 74 PPVIYRDLKSANILLDNDFNPKLSDFGLAK 103 (267)
Q Consensus 74 ~~i~h~di~~~nili~~~~~~~l~d~~~~~ 103 (267)
.+++|+|+.+.||+++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 358999999999999754 4578999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=80.15 E-value=0.37 Score=38.78 Aligned_cols=16 Identities=38% Similarity=0.501 Sum_probs=13.7
Q ss_pred CeeeCCCCCCcEEEcC
Q 024460 75 PVIYRDLKSANILLDN 90 (267)
Q Consensus 75 ~i~h~di~~~nili~~ 90 (267)
.++|+|+.+.||++..
T Consensus 219 v~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 219 TFCHNDLQEGNILLPK 234 (395)
T ss_dssp EEECSCCCGGGEEEEC
T ss_pred eEEecCCCcccEeecc
Confidence 3689999999999854
|